SubjectNum,VisitNum,VisitCode,Testname,Value
1,1,1,Occurrence #,1st primary
1,1,1,Tumor Stage,T3
1,1,1,Nodal Stage,N1
1,1,1,Metastasis,M0
1,1,1,Overall Stage,III
1,1,1,Research lab p16,p16 unknown
1,1,1,Clinical lab p16,p16 unknown
1,1,1,Research lab HPV,HPV unknown
1,1,1,Second Failure Type,no known failure
1,1,1,Status,Alive w/o disease
1,1,1,Treatment Modality,CTX-RT
1,1,1,Initial Chemotherapy Agent,carbo/doce
1,1,1,First Failure Type,no known failure
1,1,1,Radiation Dosage,70.2
1,1,1,Tumor Site,oropharynx
2,1,1,Occurrence #,1st primary
2,1,1,Research lab HPV,HPV unknown
2,1,1,Treatment Modality,CTX-RT
2,1,1,Tumor Site,oropharynx
2,1,1,Date of Death,2006-08-21 00:00:00
2,1,1,Second Failure Type,no known failure
2,1,1,Tumor Stage,T3
2,1,1,First Failure Type,no known failure
2,1,1,Radiation Dosage,45
2,1,1,Overall Stage,IVb
2,1,1,Clinical lab p16,p16 unknown
2,1,1,Status,Dead unk disease
2,1,1,Nodal Stage,N3
2,1,1,Metastasis,M0
2,1,1,Time to Death,0.3
2,1,1,Initial Chemotherapy Agent,unknown
2,1,1,Age at Death,53.9
2,1,1,Research lab p16,p16 unknown
3,1,1,Age at Death,83.0
3,1,1,Second Failure Type,no known failure
3,1,1,Metastasis,M0
3,1,1,Occurrence #,1st primary
3,1,1,Overall Stage,I
3,1,1,Research lab HPV,HPV negative
3,1,1,Status,Dead unk disease
3,1,1,Research lab p16,p16 unknown
3,1,1,Date of Death,2007-11-10 00:00:00
3,1,1,Clinical lab p16,p16 unknown
3,1,1,First Failure Type,no known failure
3,1,1,Nodal Stage,N0
3,1,1,Time to Death,7.0
3,1,1,Tumor Site,oropharynx
3,1,1,Treatment Modality,Sx
3,1,1,Tumor Stage,T1
4,1,1,Research lab p16,p16 unknown
4,1,1,Status,Alive w/ disease
4,1,1,Overall Stage,IVa
4,1,1,First Failure Type,no known failure
4,1,1,Occurrence #,1st primary
4,1,1,Tumor Stage,T2
4,1,1,Research lab HPV,HPV unknown
4,1,1,Initial Chemotherapy Agent,carbo/doce
4,1,1,Tumor Site,oropharynx
4,1,1,Clinical lab p16,p16 unknown
4,1,1,Metastasis,M0
4,1,1,Second Failure Type,no known failure
4,1,1,Treatment Modality,CTX-RT
4,1,1,Nodal Stage,N2
5,1,1,Research lab p16,p16 unknown
5,1,1,Tumor Stage,T4a
5,1,1,Occurrence #,1st primary
5,1,1,Research lab HPV,HPV unknown
5,1,1,Tumor Site,oral cavity
5,1,1,Status,Dead unk disease
5,1,1,Clinical lab p16,p16 unknown
5,1,1,First Failure Type,no known failure
5,1,1,Radiation Dosage,72
5,1,1,Nodal Stage,N2
5,1,1,Second Failure Type,no known failure
5,1,1,Time to Death,1.4
5,1,1,Date of Death,2005-04-05 00:00:00
5,1,1,Treatment Modality,Sx & RT
5,1,1,Metastasis,M0
5,1,1,Overall Stage,IVa
5,1,1,Age at Death,54.0
6,1,1,Nodal Stage,N0
6,1,1,Research lab HPV,HPV unknown
6,1,1,First Failure Type,distant
6,1,1,Tumor Stage,T3
6,1,1,Status,Alive w/ disease
6,1,1,Clinical lab p16,p16 unknown
6,1,1,Radiation Dosage,59.4
6,1,1,Treatment Modality,RT
6,1,1,Tumor Site,oropharynx
6,1,1,Overall Stage,III
6,1,1,Research lab p16,p16 unknown
6,1,1,Metastasis,M0
6,1,1,Occurrence #,1st primary
6,1,1,Time to First Failure,2.1
6,1,1,Second Failure Type,no known failure
7,1,1,Age at Death,74.7
7,1,1,Date of Death,2009-08-02 00:00:00
7,1,1,Occurrence #,recurrence
7,1,1,Nodal Stage,N2
7,1,1,Time to Death,4.1
7,1,1,Metastasis,M0
7,1,1,Overall Stage,IVa
7,1,1,Second Failure Type,no known failure
7,1,1,Treatment Modality,Sx
7,1,1,First Failure Type,no known failure
7,1,1,Research lab p16,p16 unknown
7,1,1,Tumor Stage,T4a
7,1,1,Status,Dead unk disease
7,1,1,Clinical lab p16,p16 unknown
7,1,1,Tumor Site,oropharynx
7,1,1,Research lab HPV,HPV unknown
8,1,1,Clinical lab p16,p16 unknown
8,1,1,Status,Dead unk disease
8,1,1,Date of Death,2008-03-05 00:00:00
8,1,1,Research lab p16,p16 negative
8,1,1,Research lab HPV,HPV positive
8,1,1,First Failure Type,no known failure
8,1,1,Age at Death,75.7
8,1,1,Second Failure Type,no known failure
8,1,1,Treatment Modality,RT
8,1,1,Tumor Site,oropharynx
8,1,1,Overall Stage,IVa
8,1,1,Tumor Stage,T4a
8,1,1,Occurrence #,1st primary
8,1,1,Time to Death,8.6
8,1,1,Radiation Dosage,70.2
8,1,1,Nodal Stage,N0
8,1,1,Metastasis,M0
9,1,1,Metastasis,Unknown
9,1,1,Overall Stage,Unknown
9,1,1,Clinical lab p16,p16 unknown
9,1,1,Treatment Modality,Unknown
9,1,1,Nodal Stage,Unknown
9,1,1,Research lab p16,p16 unknown
9,1,1,Research lab HPV,HPV unknown
9,1,1,First Failure Type,no known failure
9,1,1,Occurrence #,1st primary
9,1,1,Tumor Site,Unknown
9,1,1,Second Failure Type,no known failure
9,1,1,Tumor Stage,Unknown
9,1,1,Status,Unknown
10,1,1,Tumor Stage,Unknown
10,1,1,Status,Unknown
10,1,1,Treatment Modality,Unknown
10,1,1,Clinical lab p16,p16 unknown
10,1,1,Nodal Stage,Unknown
10,1,1,Research lab HPV,HPV unknown
10,1,1,Research lab p16,p16 unknown
10,1,1,Tumor Site,Unknown
10,1,1,Overall Stage,Unknown
10,1,1,Second Failure Type,no known failure
10,1,1,Metastasis,Unknown
10,1,1,First Failure Type,no known failure
10,1,1,Occurrence #,1st primary
11,1,1,Tumor Site,oropharynx
11,1,1,Radiation Dosage,70.2
11,1,1,Research lab HPV,HPV unknown
11,1,1,Initial Chemotherapy Agent,carbo/PTX
11,1,1,Clinical lab p16,p16 unknown
11,1,1,Occurrence #,1st primary
11,1,1,Second Failure Type,no known failure
11,1,1,Treatment Modality,CTX-RT
11,1,1,Research lab p16,p16 unknown
11,1,1,Time to First Failure,0.5
11,1,1,First Failure Initial Chemotherapy Agent,Cis/doce
11,1,1,Metastasis,M0
11,1,1,Age at Death,49.2
11,1,1,First Failure Treatment Modality,CTX
11,1,1,Status,Dead w/ disease
11,1,1,Overall Stage,III
11,1,1,Date of Death,2004-11-28 00:00:00
11,1,1,First Failure Site,oropharynx
11,1,1,Nodal Stage,N1
11,1,1,First Failure Type,locoregional
11,1,1,Time to Death,1.5
11,1,1,Tumor Stage,T3
12,1,1,Overall Stage,IVa
12,1,1,Tumor Site,oropharynx
12,1,1,Research lab HPV,HPV positive
12,1,1,Tumor Stage,T2
12,1,1,Occurrence #,1st primary
12,1,1,Second Failure Type,no known failure
12,1,1,Status,Alive w/o disease
12,1,1,First Failure Type,no known failure
12,1,1,Research lab p16,p16 positive
12,1,1,Nodal Stage,N2
12,1,1,Treatment Modality,CTX-RT
12,1,1,Clinical lab p16,p16 unknown
12,1,1,Radiation Dosage,70.2
12,1,1,Initial Chemotherapy Agent,carbo/doce
12,1,1,Metastasis,M0
13,1,1,Nodal Stage,N2
13,1,1,Overall Stage,IVa
13,1,1,Treatment Modality,CTX-RT
13,1,1,First Failure Type,no known failure
13,1,1,Metastasis,M0
13,1,1,Tumor Site,oropharynx
13,1,1,Second Failure Type,no known failure
13,1,1,Radiation Dosage,70.2
13,1,1,Occurrence #,1st primary
13,1,1,Research lab HPV,HPV positive
13,1,1,Status,Alive w/o disease
13,1,1,Initial Chemotherapy Agent,carbo/doce
13,1,1,Clinical lab p16,p16 unknown
13,1,1,Research lab p16,p16 positive
13,1,1,Tumor Stage,T1
14,1,1,Metastasis,Unknown
14,1,1,Research lab p16,p16 unknown
14,1,1,Clinical lab p16,p16 unknown
14,1,1,Age at Death,71.3
14,1,1,Occurrence #,1st primary
14,1,1,Overall Stage,Unknown
14,1,1,Treatment Modality,Unknown
14,1,1,Nodal Stage,Unknown
14,1,1,Date of Death,2000-10-12 00:00:00
14,1,1,Tumor Stage,Unknown
14,1,1,Tumor Site,oropharynx
14,1,1,Research lab HPV,HPV unknown
14,1,1,Status,Unknown
14,1,1,Time to Death,6.1
14,1,1,First Failure Type,no known failure
14,1,1,Second Failure Type,no known failure
15,1,1,Age at Death,48.5
15,1,1,Clinical lab p16,p16 unknown
15,1,1,Second Failure Type,no known failure
15,1,1,Treatment Modality,CTX
15,1,1,Time to Death,0.6
15,1,1,Nodal Stage,N0
15,1,1,Date of Death,1996-08-30 00:00:00
15,1,1,Occurrence #,1st primary
15,1,1,Time to First Failure,0.1
15,1,1,Overall Stage,I
15,1,1,Tumor Stage,T1
15,1,1,Tumor Site,oropharynx
15,1,1,Research lab p16,p16 unknown
15,1,1,Status,Dead w/ disease
15,1,1,Initial Chemotherapy Agent,cis/5FU
15,1,1,Research lab HPV,HPV negative
15,1,1,Metastasis,M0
15,1,1,First Failure Type,locoregional
16,1,1,First Failure Type,no known failure
16,1,1,Tumor Site,oropharynx
16,1,1,Research lab p16,p16 negative
16,1,1,Nodal Stage,Unknown
16,1,1,Overall Stage,Unknown
16,1,1,Status,Dead unk disease
16,1,1,Treatment Modality,Unknown
16,1,1,Date of Death,2000-05-08 00:00:00
16,1,1,Occurrence #,Unknown
16,1,1,Clinical lab p16,p16 unknown
16,1,1,Time to Death,2.3
16,1,1,Metastasis,Unknown
16,1,1,Tumor Stage,Unknown
16,1,1,Second Failure Type,no known failure
16,1,1,Research lab HPV,HPV negative
17,1,1,Overall Stage,Unknown
17,1,1,Occurrence #,1st primary
17,1,1,Clinical lab p16,p16 unknown
17,1,1,Research lab HPV,HPV unknown
17,1,1,Tumor Site,Unknown
17,1,1,Second Failure Type,no known failure
17,1,1,Tumor Stage,Unknown
17,1,1,Metastasis,Unknown
17,1,1,First Failure Type,no known failure
17,1,1,Treatment Modality,Unknown
17,1,1,Status,Unknown
17,1,1,Research lab p16,p16 unknown
17,1,1,Nodal Stage,Unknown
18,1,1,Age at Death,75.1
18,1,1,Tumor Stage,T4a
18,1,1,Nodal Stage,N3
18,1,1,Second Failure Type,no known failure
18,1,1,Research lab HPV,HPV negative
18,1,1,Metastasis,M0
18,1,1,Time to Death,0.1
18,1,1,Status,Dead w/ disease
18,1,1,First Failure Type,no known failure
18,1,1,Clinical lab p16,p16 unknown
18,1,1,Date of Death,2006-05-09 00:00:00
18,1,1,Occurrence #,1st primary
18,1,1,Research lab p16,p16 negative
18,1,1,Overall Stage,IVb
18,1,1,Tumor Site,oropharynx
18,1,1,Treatment Modality,Unknown
19,1,1,Overall Stage,III
19,1,1,Clinical lab p16,p16 unknown
19,1,1,Research lab HPV,HPV negative
19,1,1,Tumor Site,oropharynx
19,1,1,Metastasis,M0
19,1,1,Research lab p16,p16 negative
19,1,1,Initial Chemotherapy Agent,cis
19,1,1,Date of Death,2007-07-27 00:00:00
19,1,1,Status,Dead unk disease
19,1,1,Treatment Modality,CTX-RT
19,1,1,Time to Death,2.7
19,1,1,Age at Death,50.5
19,1,1,Tumor Stage,T3
19,1,1,Radiation Dosage,72
19,1,1,Occurrence #,1st primary
19,1,1,First Failure Type,no known failure
19,1,1,Nodal Stage,N0
19,1,1,Second Failure Type,no known failure
20,1,1,Tumor Stage,Unknown
20,1,1,Occurrence #,1st primary
20,1,1,Overall Stage,Unknown
20,1,1,Research lab p16,p16 unknown
20,1,1,Metastasis,Unknown
20,1,1,Status,Unknown
20,1,1,First Failure Type,no known failure
20,1,1,Treatment Modality,Unknown
20,1,1,Clinical lab p16,p16 unknown
20,1,1,Research lab HPV,HPV unknown
20,1,1,Second Failure Type,no known failure
20,1,1,Tumor Site,Unknown
20,1,1,Nodal Stage,Unknown
21,1,1,Metastasis,M0
21,1,1,Status,Dead w/ disease
21,1,1,Tumor Site,oropharynx
21,1,1,Initial Chemotherapy Agent,carbo
21,1,1,Occurrence #,1st primary
21,1,1,Research lab HPV,HPV negative
21,1,1,Clinical lab p16,p16 unknown
21,1,1,Time to First Failure,0.4
21,1,1,Treatment Modality,CTX-RT
21,1,1,Research lab p16,p16 negative
21,1,1,Overall Stage,III
21,1,1,Radiation Dosage,72.2
21,1,1,Nodal Stage,N1
21,1,1,Second Failure Type,no known failure
21,1,1,Second Line Chemotherapy Agent,cis/5FU
21,1,1,Tumor Stage,T3
21,1,1,First Failure Type,locoregional
21,1,1,Age at Death,56.9
21,1,1,Date of Death,1997-03-18 00:00:00
22,1,1,Status,Alive w/o disease
22,1,1,Nodal Stage,N0
22,1,1,First Failure Type,no known failure
22,1,1,Second Failure Type,no known failure
22,1,1,Radiation Dosage,70.2
22,1,1,Overall Stage,IVa
22,1,1,Research lab HPV,HPV unknown
22,1,1,Tumor Stage,T4a
22,1,1,Initial Chemotherapy Agent,carbo/doce
22,1,1,Clinical lab p16,p16 unknown
22,1,1,Treatment Modality,CTX-RT
22,1,1,Occurrence #,1st primary
22,1,1,Tumor Site,oropharynx
22,1,1,Research lab p16,p16 unknown
22,1,1,Metastasis,M0
23,1,1,Date of Death,1996-11-06 00:00:00
23,1,1,Research lab p16,p16 negative
23,1,1,Second Failure Type,no known failure
23,1,1,Overall Stage,III
23,1,1,Clinical lab p16,p16 unknown
23,1,1,Time to Death,2.2
23,1,1,Tumor Stage,T3
23,1,1,Treatment Modality,RT
23,1,1,Nodal Stage,N1
23,1,1,Status,Dead w/o disease
23,1,1,Tumor Site,oropharynx
23,1,1,Metastasis,M0
23,1,1,First Failure Type,no known failure
23,1,1,Occurrence #,1st primary
23,1,1,Research lab HPV,HPV negative
23,1,1,Age at Death,48.3
24,1,1,Second Failure Type,no known failure
24,1,1,Treatment Modality,Unknown
24,1,1,Time to Death,0.9
24,1,1,Nodal Stage,N2
24,1,1,Occurrence #,1st primary
24,1,1,Tumor Site,oropharynx
24,1,1,Date of Death,2007-02-16 00:00:00
24,1,1,Clinical lab p16,p16 unknown
24,1,1,Research lab p16,p16 positive
24,1,1,Metastasis,M0
24,1,1,Tumor Stage,T3
24,1,1,Status,Dead unk disease
24,1,1,First Failure Type,no known failure
24,1,1,Research lab HPV,HPV positive
24,1,1,Overall Stage,IVa
24,1,1,Age at Death,67.6
25,1,1,Time to First Failure,1.9
25,1,1,First Failure Type,locoregional
25,1,1,Tumor Stage,T1
25,1,1,Overall Stage,I
25,1,1,Metastasis,M0
25,1,1,Clinical lab p16,p16 unknown
25,1,1,Research lab HPV,HPV negative
25,1,1,Occurrence #,1st primary
25,1,1,Nodal Stage,N0
25,1,1,Second Failure Type,no known failure
25,1,1,Date of Death,2007-04-08 00:00:00
25,1,1,Tumor Site,oral cavity
25,1,1,Age at Death,73.2
25,1,1,Research lab p16,p16 unknown
25,1,1,Status,Dead unk disease
25,1,1,Time to Death,2.2
25,1,1,Treatment Modality,Sx
26,1,1,First Failure Site,oropharynx
26,1,1,Research lab HPV,HPV unknown
26,1,1,Radiation Dosage,70.2
26,1,1,Time to First Failure,0.6
26,1,1,Overall Stage,IVa
26,1,1,Tumor Site,oropharynx
26,1,1,Second Failure Type,no known failure
26,1,1,Nodal Stage,N2
26,1,1,Tumor Stage,T4a
26,1,1,Metastasis,M0
26,1,1,Time to Death,1.3
26,1,1,Occurrence #,1st primary
26,1,1,Treatment Modality,CTX-RT
26,1,1,First Failure Type,locoregional
26,1,1,Status,Dead w/ disease
26,1,1,Age at Death,56.5
26,1,1,First Failure Treatment Modality,Sx
26,1,1,Initial Chemotherapy Agent,carbo/cap
26,1,1,Clinical lab p16,p16 unknown
26,1,1,Research lab p16,p16 unknown
26,1,1,Date of Death,2005-11-11 00:00:00
27,1,1,Metastasis,M0
27,1,1,Nodal Stage,N1
27,1,1,Treatment Modality,Sx
27,1,1,Research lab p16,p16 unknown
27,1,1,Clinical lab p16,p16 unknown
27,1,1,Status,Alive w/ disease
27,1,1,Research lab HPV,HPV unknown
27,1,1,Occurrence #,1st primary
27,1,1,Tumor Stage,T2
27,1,1,First Failure Type,no known failure
27,1,1,Second Failure Type,no known failure
27,1,1,Overall Stage,III
27,1,1,Tumor Site,oral cavity
28,1,1,Second Failure Type,no known failure
28,1,1,Research lab HPV,HPV positive
28,1,1,Clinical lab p16,p16 unknown
28,1,1,Radiation Dosage,unknown
28,1,1,Tumor Site,oropharynx
28,1,1,Occurrence #,1st primary
28,1,1,Treatment Modality,Sx & RT
28,1,1,Nodal Stage,N3
28,1,1,Time to First Failure,1.4
28,1,1,Time to Death,1.9
28,1,1,Date of Death,2003-01-05 00:00:00
28,1,1,Tumor Stage,T1
28,1,1,First Failure Type,distant
28,1,1,Overall Stage,IVb
28,1,1,Status,Dead unk disease
28,1,1,Age at Death,53.2
28,1,1,Research lab p16,p16 positive
28,1,1,Metastasis,M0
29,1,1,Overall Stage,IVa
29,1,1,Metastasis,M0
29,1,1,Radiation Dosage,63
29,1,1,Tumor Stage,T1
29,1,1,Tumor Site,oropharynx
29,1,1,Treatment Modality,Sx & RT
29,1,1,Second Failure Type,no known failure
29,1,1,Research lab HPV,HPV unknown
29,1,1,Clinical lab p16,p16 unknown
29,1,1,Nodal Stage,N2
29,1,1,Status,Alive w/o disease
29,1,1,Research lab p16,p16 unknown
29,1,1,First Failure Type,no known failure
29,1,1,Occurrence #,1st primary
30,1,1,Tumor Stage,T3
30,1,1,Nodal Stage,N1
30,1,1,Occurrence #,recurrence
30,1,1,Overall Stage,III
30,1,1,Time to Death,0.2
30,1,1,Tumor Site,oropharynx
30,1,1,Status,Dead w/ disease
30,1,1,First Failure Type,no known failure
30,1,1,Metastasis,M0
30,1,1,Clinical lab p16,p16 unknown
30,1,1,Second Failure Type,no known failure
30,1,1,Treatment Modality,Sx
30,1,1,Research lab p16,p16 unknown
30,1,1,Date of Death,2006-11-24 00:00:00
30,1,1,Age at Death,48.7
30,1,1,Research lab HPV,HPV unknown
31,1,1,Status,Unknown
31,1,1,Treatment Modality,Unknown
31,1,1,First Failure Type,no known failure
31,1,1,Research lab HPV,HPV unknown
31,1,1,Metastasis,Unknown
31,1,1,Second Failure Type,no known failure
31,1,1,Occurrence #,1st primary
31,1,1,Nodal Stage,Unknown
31,1,1,Research lab p16,p16 unknown
31,1,1,Tumor Site,Unknown
31,1,1,Tumor Stage,Unknown
31,1,1,Clinical lab p16,p16 unknown
31,1,1,Overall Stage,Unknown
32,1,1,Metastasis,M0
32,1,1,Occurrence #,recurrence
32,1,1,First Failure Type,no known failure
32,1,1,Treatment Modality,Sx
32,1,1,Date of Death,2004-08-16 00:00:00
32,1,1,Tumor Site,oropharynx
32,1,1,Time to Death,2.2
32,1,1,Research lab p16,p16 unknown
32,1,1,Overall Stage,IVa
32,1,1,Nodal Stage,N2
32,1,1,Clinical lab p16,p16 unknown
32,1,1,Research lab HPV,HPV unknown
32,1,1,Status,Dead unk disease
32,1,1,Second Failure Type,no known failure
32,1,1,Age at Death,57.5
32,1,1,Tumor Stage,Unknown
33,1,1,Overall Stage,Unknown
33,1,1,Occurrence #,1st primary
33,1,1,Status,Unknown
33,1,1,First Failure Type,no known failure
33,1,1,Tumor Site,Unknown
33,1,1,Second Failure Type,no known failure
33,1,1,Nodal Stage,Unknown
33,1,1,Metastasis,Unknown
33,1,1,Tumor Stage,Unknown
33,1,1,Clinical lab p16,p16 unknown
33,1,1,Research lab p16,p16 unknown
33,1,1,Treatment Modality,Unknown
33,1,1,Research lab HPV,HPV unknown
34,1,1,Tumor Site,oropharynx
34,1,1,Research lab HPV,HPV unknown
34,1,1,Age at Death,72.4
34,1,1,Second Failure Type,no known failure
34,1,1,Radiation Dosage,70.2
34,1,1,Metastasis,M0
34,1,1,Research lab p16,p16 unknown
34,1,1,Occurrence #,1st primary
34,1,1,Treatment Modality,CTX-RT
34,1,1,Date of Death,1999-09-12 00:00:00
34,1,1,Time to First Failure,0.3
34,1,1,Nodal Stage,N2
34,1,1,Overall Stage,IVa
34,1,1,Time to Death,0.7
34,1,1,First Failure Type,locoregional and distant
34,1,1,Initial Chemotherapy Agent,carbo/doce
34,1,1,Clinical lab p16,p16 unknown
34,1,1,Tumor Stage,T4a
34,1,1,Status,Dead w/ disease
35,1,1,Initial Chemotherapy Agent,carbo/doce
35,1,1,Second Failure Type,no known failure
35,1,1,Time to First Failure,0.2
35,1,1,Overall Stage,IVa
35,1,1,Tumor Site,oropharynx
35,1,1,Time to Death,0.8
35,1,1,Nodal Stage,N0
35,1,1,Radiation Dosage,70.2
35,1,1,Date of Death,2001-03-29 00:00:00
35,1,1,Research lab p16,p16 unknown
35,1,1,Treatment Modality,CTX-RT
35,1,1,Clinical lab p16,p16 unknown
35,1,1,Tumor Stage,T4a
35,1,1,Research lab HPV,HPV unknown
35,1,1,Metastasis,M0
35,1,1,Status,Dead w/ disease
35,1,1,First Failure Type,locoregional and distant
35,1,1,Occurrence #,1st primary
35,1,1,Age at Death,52.9
36,1,1,Overall Stage,Unknown
36,1,1,Tumor Stage,Unknown
36,1,1,Research lab p16,p16 unknown
36,1,1,Occurrence #,1st primary
36,1,1,Metastasis,Unknown
36,1,1,Nodal Stage,Unknown
36,1,1,Tumor Site,Unknown
36,1,1,First Failure Type,no known failure
36,1,1,Clinical lab p16,p16 unknown
36,1,1,Second Failure Type,no known failure
36,1,1,Treatment Modality,Unknown
36,1,1,Research lab HPV,HPV unknown
36,1,1,Status,Unknown
37,1,1,Research lab p16,p16 unknown
37,1,1,Date of Death,2009-06-24 00:00:00
37,1,1,Treatment Modality,Sx
37,1,1,Status,Dead w/ disease
37,1,1,Tumor Stage,T3
37,1,1,Clinical lab p16,p16 unknown
37,1,1,Tumor Site,oropharynx
37,1,1,Occurrence #,recurrence
37,1,1,Second Failure Type,no known failure
37,1,1,First Failure Type,locoregional
37,1,1,Research lab HPV,HPV positive
37,1,1,Time to Death,7.3
37,1,1,Overall Stage,IVa
37,1,1,Age at Death,65.8
37,1,1,Metastasis,M0
37,1,1,Nodal Stage,N2
37,1,1,Time to First Failure,5.3
38,1,1,Age at Death,75.0
38,1,1,Research lab HPV,HPV unknown
38,1,1,Research lab p16,p16 unknown
38,1,1,Tumor Stage,T2
38,1,1,Second Failure Type,no known failure
38,1,1,Status,Dead unk disease
38,1,1,Overall Stage,IVa
38,1,1,Radiation Dosage,72
38,1,1,Time to Death,7.7
38,1,1,Occurrence #,1st primary
38,1,1,Nodal Stage,N2
38,1,1,Metastasis,M0
38,1,1,Date of Death,2009-01-11 00:00:00
38,1,1,Tumor Site,oropharynx
38,1,1,Treatment Modality,CTX-RT
38,1,1,Clinical lab p16,p16 unknown
38,1,1,Initial Chemotherapy Agent,carbo/doce
38,1,1,First Failure Type,no known failure
39,1,1,Second Failure Type,no known failure
39,1,1,Occurrence #,1st primary
39,1,1,Date of Death,1998-03-20 00:00:00
39,1,1,Research lab HPV,HPV unknown
39,1,1,Age at Death,75.6
39,1,1,Tumor Site,oropharynx
39,1,1,Tumor Stage,T4a
39,1,1,First Failure Type,locoregional
39,1,1,Time to First Failure,0.1
39,1,1,Initial Chemotherapy Agent,carbo/doce
39,1,1,Treatment Modality,CTX-RT
39,1,1,Clinical lab p16,p16 unknown
39,1,1,Research lab p16,p16 unknown
39,1,1,Overall Stage,IVb
39,1,1,Time to Death,0.5
39,1,1,Radiation Dosage,70.2
39,1,1,Status,Dead w/ disease
39,1,1,Nodal Stage,N3
39,1,1,Metastasis,M0
40,1,1,Metastasis,M0
40,1,1,Time to First Failure,0.2
40,1,1,Clinical lab p16,p16 unknown
40,1,1,Date of Death,2004-06-26 00:00:00
40,1,1,Research lab HPV,HPV unknown
40,1,1,Overall Stage,I
40,1,1,Treatment Modality,Sx
40,1,1,Time to Death,0.4
40,1,1,Nodal Stage,N0
40,1,1,Research lab p16,p16 unknown
40,1,1,First Failure Type,locoregional
40,1,1,Tumor Site,oropharynx
40,1,1,Status,Dead unk disease
40,1,1,Second Failure Type,no known failure
40,1,1,Occurrence #,recurrence
40,1,1,Tumor Stage,T1
40,1,1,Age at Death,58.9
41,1,1,Nodal Stage,Unknown
41,1,1,Metastasis,Unknown
41,1,1,Clinical lab p16,p16 unknown
41,1,1,Occurrence #,1st primary
41,1,1,Tumor Site,oropharynx
41,1,1,First Failure Type,no known failure
41,1,1,Research lab HPV,HPV unknown
41,1,1,Research lab p16,p16 unknown
41,1,1,Tumor Stage,Unknown
41,1,1,Second Failure Type,no known failure
41,1,1,Status,Unknown
41,1,1,Treatment Modality,Unknown
41,1,1,Overall Stage,Unknown
42,1,1,Clinical lab p16,p16 unknown
42,1,1,First Failure Type,locoregional
42,1,1,Initial Chemotherapy Agent,carbo/doce
42,1,1,Tumor Site,oropharynx
42,1,1,Time to Death,0.6
42,1,1,Treatment Modality,CTX-RT
42,1,1,Second Failure Type,no known failure
42,1,1,Second Line Chemotherapy Agent,doce/cap
42,1,1,Research lab p16,p16 unknown
42,1,1,Age at Death,67.3
42,1,1,Date of Death,2004-03-25 00:00:00
42,1,1,Overall Stage,IVa
42,1,1,Status,Dead w/ disease
42,1,1,Nodal Stage,N1
42,1,1,Tumor Stage,T4a
42,1,1,Time to First Failure,0.3
42,1,1,Radiation Dosage,70.2
42,1,1,Occurrence #,recurrence
42,1,1,Metastasis,M0
42,1,1,Research lab HPV,HPV unknown
43,1,1,Metastasis,M0
43,1,1,Research lab HPV,HPV unknown
43,1,1,Second Failure Type,no known failure
43,1,1,Age at Death,74.2
43,1,1,Treatment Modality,Unknown
43,1,1,Clinical lab p16,p16 unknown
43,1,1,First Failure Type,no known failure
43,1,1,Tumor Site,oral cavity
43,1,1,Overall Stage,IVa
43,1,1,Research lab p16,p16 unknown
43,1,1,Nodal Stage,N2
43,1,1,Time to Death,1.3
43,1,1,Date of Death,1998-07-17 00:00:00
43,1,1,Tumor Stage,T3
43,1,1,Occurrence #,1st primary
43,1,1,Status,Dead unk disease
44,1,1,Research lab HPV,HPV unknown
44,1,1,Age at Death,81.2
44,1,1,Radiation Dosage,64.8
44,1,1,Tumor Stage,T2
44,1,1,Research lab p16,p16 unknown
44,1,1,First Failure Type,no known failure
44,1,1,Second Failure Type,no known failure
44,1,1,Metastasis,M1
44,1,1,Time to Death,2.0
44,1,1,Initial Chemotherapy Agent,carbo/cetux
44,1,1,Date of Death,2006-09-06 00:00:00
44,1,1,Tumor Site,oropharynx
44,1,1,Clinical lab p16,p16 unknown
44,1,1,Status,Dead unk disease
44,1,1,Nodal Stage,N1
44,1,1,Overall Stage,IVc
44,1,1,Treatment Modality,CTX-RT
44,1,1,Occurrence #,1st primary
45,1,1,Date of Death,2006-07-06 00:00:00
45,1,1,Tumor Stage,Unknown
45,1,1,Occurrence #,other primary
45,1,1,Status,Dead w/ disease
45,1,1,Clinical lab p16,p16 unknown
45,1,1,Metastasis,Unknown
45,1,1,Second Failure Type,no known failure
45,1,1,Initial Chemotherapy Agent,sorafinib/17AAG
45,1,1,Nodal Stage,Unknown
45,1,1,Research lab HPV,HPV unknown
45,1,1,Time to Death,0.4
45,1,1,Treatment Modality,CTX
45,1,1,Research lab p16,p16 unknown
45,1,1,Age at Death,63.5
45,1,1,Tumor Site,oropharynx
45,1,1,Overall Stage,Unknown
45,1,1,First Failure Type,no known failure
46,1,1,Research lab p16,p16 unknown
46,1,1,First Failure Type,no known failure
46,1,1,Metastasis,M0
46,1,1,Nodal Stage,N2
46,1,1,Treatment Modality,CTX-RT
46,1,1,Research lab HPV,HPV unknown
46,1,1,Occurrence #,1st primary
46,1,1,Initial Chemotherapy Agent,carbo/PTX
46,1,1,Status,Dead unk disease
46,1,1,Second Failure Type,no known failure
46,1,1,Tumor Site,oropharynx
46,1,1,Radiation Dosage,70.2
46,1,1,Age at Death,55.6
46,1,1,Time to Death,0.8
46,1,1,Tumor Stage,T3
46,1,1,Clinical lab p16,p16 unknown
46,1,1,Overall Stage,IVa
46,1,1,Date of Death,2004-08-21 00:00:00
47,1,1,Research lab HPV,HPV unknown
47,1,1,Occurrence #,1st primary
47,1,1,Research lab p16,p16 unknown
47,1,1,Tumor Stage,Unknown
47,1,1,Status,Unknown
47,1,1,Nodal Stage,Unknown
47,1,1,Treatment Modality,Unknown
47,1,1,Clinical lab p16,p16 unknown
47,1,1,Second Failure Type,no known failure
47,1,1,First Failure Type,no known failure
47,1,1,Overall Stage,Unknown
47,1,1,Metastasis,Unknown
47,1,1,Tumor Site,Unknown
48,1,1,Second Failure Type,no known failure
48,1,1,Radiation Dosage,12.3
48,1,1,Tumor Stage,T4a
48,1,1,First Failure Type,no known failure
48,1,1,Research lab p16,p16 negative
48,1,1,Age at Death,47.6
48,1,1,Tumor Site,oropharynx
48,1,1,Status,Dead w/ disease
48,1,1,Clinical lab p16,p16 unknown
48,1,1,Overall Stage,IVa
48,1,1,Treatment Modality,RT
48,1,1,Nodal Stage,N0
48,1,1,Research lab HPV,HPV negative
48,1,1,Metastasis,M0
48,1,1,Initial Chemotherapy Agent,carbo
48,1,1,Occurrence #,1st primary
48,1,1,Time to Death,0.5
48,1,1,Date of Death,1994-03-30 00:00:00
50,1,1,Occurrence #,1st primary
50,1,1,First Failure Type,no known failure
50,1,1,Clinical lab p16,p16 unknown
50,1,1,Treatment Modality,Unknown
50,1,1,Tumor Stage,Unknown
50,1,1,Status,Unknown
50,1,1,Research lab HPV,HPV unknown
50,1,1,Research lab p16,p16 unknown
50,1,1,Second Failure Type,no known failure
50,1,1,Metastasis,Unknown
50,1,1,Nodal Stage,Unknown
50,1,1,Tumor Site,oropharynx
50,1,1,Overall Stage,Unknown
51,1,1,Age at Death,54.8
51,1,1,Time to Death,0.5
51,1,1,Date of Death,2007-10-05 00:00:00
51,1,1,Tumor Stage,T1
51,1,1,Nodal Stage,N3
51,1,1,Research lab HPV,HPV negative
51,1,1,Status,Dead w/ disease
51,1,1,Radiation Dosage,28
51,1,1,Clinical lab p16,p16 unknown
51,1,1,Treatment Modality,CTX-RT
51,1,1,Occurrence #,1st primary
51,1,1,First Failure Type,no known failure
51,1,1,Tumor Site,oropharynx
51,1,1,Metastasis,M1
51,1,1,Second Failure Type,no known failure
51,1,1,Initial Chemotherapy Agent,cis
51,1,1,Overall Stage,IVc
51,1,1,Research lab p16,p16 negative
52,1,1,Clinical lab p16,p16 unknown
52,1,1,Overall Stage,IVa
52,1,1,Status,Alive w/o disease
52,1,1,Tumor Site,oropharynx
52,1,1,Occurrence #,1st primary
52,1,1,Nodal Stage,N2
52,1,1,Treatment Modality,CTX-RT
52,1,1,Second Failure Type,no known failure
52,1,1,Metastasis,M0
52,1,1,Research lab HPV,HPV unknown
52,1,1,Radiation Dosage,70.2
52,1,1,First Failure Type,no known failure
52,1,1,Initial Chemotherapy Agent,carbo/PTX
52,1,1,Research lab p16,p16 unknown
52,1,1,Tumor Stage,T3
53,1,1,Tumor Stage,T3
53,1,1,Overall Stage,IVa
53,1,1,Second Failure Type,no known failure
53,1,1,Metastasis,M0
53,1,1,Nodal Stage,N2
53,1,1,Radiation Dosage,70.2
53,1,1,Tumor Site,oropharynx
53,1,1,Treatment Modality,CTX-RT
53,1,1,Occurrence #,1st primary
53,1,1,Clinical lab p16,p16 unknown
53,1,1,Status,Alive w/o disease
53,1,1,Research lab HPV,HPV positive
53,1,1,Initial Chemotherapy Agent,carbo/cetux
53,1,1,Research lab p16,p16 positive
53,1,1,First Failure Type,no known failure
54,1,1,Occurrence #,1st primary
54,1,1,Radiation Dosage,70.2
54,1,1,Overall Stage,IVa
54,1,1,Clinical lab p16,p16 unknown
54,1,1,Tumor Stage,T3
54,1,1,Initial Chemotherapy Agent,carbo/PTX
54,1,1,Nodal Stage,N2
54,1,1,Research lab HPV,HPV positive
54,1,1,Tumor Site,oropharynx
54,1,1,Second Failure Type,no known failure
54,1,1,First Failure Type,no known failure
54,1,1,Research lab p16,p16 positive
54,1,1,Treatment Modality,CTX-RT
54,1,1,Status,Alive w/o disease
54,1,1,Metastasis,M0
55,1,1,First Failure Treatment Modality,CTX
55,1,1,Overall Stage,IVa
55,1,1,Tumor Stage,T4a
55,1,1,First Failure Site,oral cavity
55,1,1,Occurrence #,1st primary
55,1,1,First Failure Type,locoregional
55,1,1,Time to Death,1.7
55,1,1,First Failure Initial Chemotherapy Agent,Cis/5-FU
55,1,1,First Failure Second Line Chemotherapy Agent,doce
55,1,1,Tumor Site,oral cavity
55,1,1,Second Failure Type,no known failure
55,1,1,Age at Death,58.0
55,1,1,Time to First Failure,0.0
55,1,1,Date of Death,1995-07-14 00:00:00
55,1,1,Research lab HPV,HPV negative
55,1,1,Radiation Dosage,65
55,1,1,Nodal Stage,N1
55,1,1,Clinical lab p16,p16 unknown
55,1,1,Research lab p16,p16 negative
55,1,1,Metastasis,M0
55,1,1,Status,Dead w/ disease
55,1,1,Treatment Modality,Sx & RT
56,1,1,Second Failure Type,no known failure
56,1,1,Time to Death,0.3
56,1,1,Status,Dead unk disease
56,1,1,Treatment Modality,CTX-RT
56,1,1,Date of Death,2003-12-06 00:00:00
56,1,1,Research lab HPV,HPV negative
56,1,1,First Failure Type,no known failure
56,1,1,Research lab p16,p16 negative
56,1,1,Metastasis,M0
56,1,1,Age at Death,75.5
56,1,1,Tumor Stage,T4a
56,1,1,Tumor Site,oropharynx
56,1,1,Initial Chemotherapy Agent,Carbo/PTX
56,1,1,Radiation Dosage,unknown
56,1,1,Nodal Stage,N0
56,1,1,Occurrence #,1st primary
56,1,1,Overall Stage,IVa
56,1,1,Clinical lab p16,p16 unknown
57,1,1,Date of Death,2011-06-27 00:00:00
57,1,1,Metastasis,M0
57,1,1,Clinical lab p16,p16 unknown
57,1,1,Research lab HPV,HPV unknown
57,1,1,First Failure Type,no known failure
57,1,1,Occurrence #,1st primary
57,1,1,Nodal Stage,N3
57,1,1,Research lab p16,p16 unknown
57,1,1,Tumor Stage,T4b
57,1,1,Treatment Modality,CTX-RT
57,1,1,Tumor Site,oral cavity
57,1,1,Status,Dead w/ disease
57,1,1,Initial Chemotherapy Agent,Doce/cap
57,1,1,First Failure Site,oral cavity
57,1,1,Overall Stage,IVb
57,1,1,Time to Death,8.7
57,1,1,Age at Death,55.6
57,1,1,Radiation Dosage,72
57,1,1,Second Failure Type,no known failure
58,1,1,Overall Stage,Unknown
58,1,1,Second Failure Type,no known failure
58,1,1,Metastasis,Unknown
58,1,1,Clinical lab p16,p16 unknown
58,1,1,Research lab HPV,HPV unknown
58,1,1,Date of Death,1999-02-27 00:00:00
58,1,1,Tumor Stage,Unknown
58,1,1,Time to Death,0.6
58,1,1,Nodal Stage,Unknown
58,1,1,Occurrence #,1st primary
58,1,1,Status,Dead unk disease
58,1,1,Age at Death,40.6
58,1,1,Research lab p16,p16 unknown
58,1,1,Tumor Site,oropharynx
58,1,1,Treatment Modality,Unknown
58,1,1,First Failure Type,no known failure
59,1,1,Research lab p16,p16 unknown
59,1,1,Radiation Dosage,70
59,1,1,Research lab HPV,HPV unknown
59,1,1,Treatment Modality,RT
59,1,1,First Failure Type,no known failure
59,1,1,Date of Death,2007-03-02 00:00:00
59,1,1,Tumor Site,oropharynx
59,1,1,Age at Death,54.1
59,1,1,Occurrence #,1st primary
59,1,1,Time to Death,3.5
59,1,1,Tumor Stage,T4b
59,1,1,Clinical lab p16,p16 unknown
59,1,1,Second Failure Type,no known failure
59,1,1,Nodal Stage,N2
59,1,1,Overall Stage,IVb
59,1,1,Metastasis,M0
59,1,1,Status,Dead unk disease
60,1,1,Overall Stage,Unknown
60,1,1,Tumor Site,Unknown
60,1,1,Treatment Modality,Unknown
60,1,1,Metastasis,Unknown
60,1,1,Clinical lab p16,p16 unknown
60,1,1,First Failure Type,no known failure
60,1,1,Status,Unknown
60,1,1,Research lab HPV,HPV unknown
60,1,1,Nodal Stage,Unknown
60,1,1,Tumor Stage,Unknown
60,1,1,Occurrence #,1st primary
60,1,1,Research lab p16,p16 unknown
60,1,1,Second Failure Type,no known failure
61,1,1,Metastasis,M0
61,1,1,Initial Chemotherapy Agent,cis
61,1,1,Time to First Failure,2.0
61,1,1,Tumor Site,oropharynx
61,1,1,Treatment Modality,CTX-RT
61,1,1,Clinical lab p16,p16 unknown
61,1,1,Tumor Stage,T2
61,1,1,Radiation Dosage,70.2
61,1,1,Nodal Stage,N2
61,1,1,Overall Stage,IVa
61,1,1,Occurrence #,1st primary
61,1,1,Research lab HPV,HPV unknown
61,1,1,Research lab p16,p16 positive
61,1,1,First Failure Type,distant
61,1,1,Date of Death,2010-02-12 00:00:00
61,1,1,Second Failure Type,no known failure
61,1,1,Status,Dead w/ disease
61,1,1,Time to Death,4.9
61,1,1,Age at Death,55.0
62,1,1,Research lab p16,p16 unknown
62,1,1,Treatment Modality,RT
62,1,1,Overall Stage,III
62,1,1,Clinical lab p16,p16 unknown
62,1,1,Research lab HPV,HPV unknown
62,1,1,Occurrence #,1st primary
62,1,1,Tumor Stage,T1
62,1,1,Radiation Dosage,unknown
62,1,1,First Failure Type,locoregional
62,1,1,Tumor Site,oropharynx
62,1,1,Second Failure Type,no known failure
62,1,1,Status,Alive w/ disease
62,1,1,Time to First Failure,0.3
62,1,1,Metastasis,M0
62,1,1,Nodal Stage,N1
63,1,1,Nodal Stage,N2
63,1,1,Overall Stage,IVa
63,1,1,Research lab p16,p16 positive
63,1,1,Metastasis,M0
63,1,1,Radiation Dosage,70.2
63,1,1,Second Failure Type,no known failure
63,1,1,Age at Death,53.6
63,1,1,Time to Death,2.8
63,1,1,Clinical lab p16,p16 unknown
63,1,1,Time to First Failure,1.0
63,1,1,Tumor Stage,T1
63,1,1,Status,Dead w/ disease
63,1,1,Initial Chemotherapy Agent,carbo/PTX
63,1,1,Date of Death,2006-05-07 00:00:00
63,1,1,First Failure Type,locoregional
63,1,1,Tumor Site,oropharynx
63,1,1,Research lab HPV,HPV positive
63,1,1,Occurrence #,1st primary
63,1,1,Treatment Modality,CTX-RT
64,1,1,Tumor Stage,T4a
64,1,1,Time to Death,0.1
64,1,1,Status,Dead unk disease
64,1,1,Research lab p16,p16 negative
64,1,1,Metastasis,M0
64,1,1,Date of Death,2005-07-25 00:00:00
64,1,1,Clinical lab p16,p16 unknown
64,1,1,Occurrence #,1st primary
64,1,1,Second Failure Type,no known failure
64,1,1,Age at Death,55.9
64,1,1,Treatment Modality,Unknown
64,1,1,Tumor Site,oropharynx
64,1,1,Research lab HPV,HPV negative
64,1,1,Overall Stage,IVa
64,1,1,Nodal Stage,N1
64,1,1,First Failure Type,no known failure
65,1,1,Occurrence #,1st primary
65,1,1,Treatment Modality,Unknown
65,1,1,Clinical lab p16,p16 unknown
65,1,1,First Failure Type,no known failure
65,1,1,Research lab p16,p16 unknown
65,1,1,Tumor Site,oropharynx
65,1,1,Overall Stage,Unknown
65,1,1,Tumor Stage,Unknown
65,1,1,Metastasis,Unknown
65,1,1,Research lab HPV,HPV unknown
65,1,1,Second Failure Type,no known failure
65,1,1,Status,Unknown
65,1,1,Nodal Stage,Unknown
66,1,1,Status,Alive unk disease
66,1,1,Initial Chemotherapy Agent,carbo/PTX
66,1,1,Nodal Stage,N2
66,1,1,Treatment Modality,CTX-RT
66,1,1,Metastasis,M0
66,1,1,Tumor Stage,T2
66,1,1,First Failure Type,no known failure
66,1,1,Second Failure Type,no known failure
66,1,1,Research lab HPV,HPV unknown
66,1,1,Research lab p16,p16 unknown
66,1,1,Radiation Dosage,70.2
66,1,1,Tumor Site,oropharynx
66,1,1,Overall Stage,IVa
66,1,1,Clinical lab p16,p16 unknown
66,1,1,Occurrence #,1st primary
67,1,1,Overall Stage,IVa
67,1,1,Research lab HPV,HPV unknown
67,1,1,Clinical lab p16,p16 unknown
67,1,1,Research lab p16,p16 positive
67,1,1,Radiation Dosage,70
67,1,1,Tumor Stage,T4a
67,1,1,Second Failure Type,no known failure
67,1,1,Metastasis,M0
67,1,1,Time to Death,0.6
67,1,1,Tumor Site,oropharynx
67,1,1,Date of Death,1995-11-21 00:00:00
67,1,1,Status,Dead unk disease
67,1,1,Treatment Modality,RT
67,1,1,Age at Death,71.6
67,1,1,Nodal Stage,N0
67,1,1,Occurrence #,1st primary
67,1,1,First Failure Type,no known failure
68,1,1,Treatment Modality,Unknown
68,1,1,Nodal Stage,Unknown
68,1,1,Occurrence #,1st primary
68,1,1,Overall Stage,Unknown
68,1,1,Clinical lab p16,p16 unknown
68,1,1,Status,Unknown
68,1,1,Metastasis,Unknown
68,1,1,First Failure Type,no known failure
68,1,1,Tumor Site,oropharynx
68,1,1,Research lab p16,p16 unknown
68,1,1,Tumor Stage,Unknown
68,1,1,Second Failure Type,no known failure
68,1,1,Research lab HPV,HPV unknown
69,1,1,Treatment Modality,Unknown
69,1,1,Second Failure Type,no known failure
69,1,1,Nodal Stage,N0
69,1,1,Date of Death,1997-03-15 00:00:00
69,1,1,Occurrence #,1st primary
69,1,1,Research lab HPV,HPV negative
69,1,1,Status,Dead unk disease
69,1,1,Overall Stage,IVa
69,1,1,Clinical lab p16,p16 unknown
69,1,1,Tumor Site,oropharynx
69,1,1,Age at Death,62.0
69,1,1,First Failure Type,no known failure
69,1,1,Metastasis,M0
69,1,1,Tumor Stage,T4a
69,1,1,Research lab p16,p16 negative
69,1,1,Time to Death,0.8
70,1,1,Initial Chemotherapy Agent,PTX/cap
70,1,1,Metastasis,M0
70,1,1,Research lab p16,p16 positive
70,1,1,Date of Death,2002-08-22 00:00:00
70,1,1,Tumor Site,oropharynx
70,1,1,Status,Dead unk disease
70,1,1,First Failure Type,no known failure
70,1,1,Overall Stage,IVa
70,1,1,Research lab HPV,HPV positive
70,1,1,Second Failure Type,no known failure
70,1,1,Radiation Dosage,70.2
70,1,1,Occurrence #,1st primary
70,1,1,Treatment Modality,CTX-RT
70,1,1,Tumor Stage,T2
70,1,1,Nodal Stage,N2
70,1,1,Age at Death,65.2
70,1,1,Time to Death,3.1
70,1,1,Clinical lab p16,p16 unknown
71,1,1,Tumor Stage,T2
71,1,1,Initial Chemotherapy Agent,PTX/carbo
71,1,1,Treatment Modality,CTX-RT
71,1,1,Tumor Site,oropharynx
71,1,1,First Failure Type,locoregional
71,1,1,Radiation Dosage,70.2
71,1,1,Research lab p16,p16 negative
71,1,1,Research lab HPV,HPV negative
71,1,1,Metastasis,M0
71,1,1,Clinical lab p16,p16 unknown
71,1,1,Overall Stage,IVa
71,1,1,Second Failure Type,no known failure
71,1,1,Time to First Failure,0.3
71,1,1,Nodal Stage,N2
71,1,1,Occurrence #,1st primary
71,1,1,Status,Alive w/o disease
72,1,1,Time to Death,10.9
72,1,1,First Failure Type,no known failure
72,1,1,Metastasis,M0
72,1,1,Research lab HPV,HPV unknown
72,1,1,Nodal Stage,N2
72,1,1,Status,Dead unk disease
72,1,1,Research lab p16,p16 unknown
72,1,1,Second Failure Type,no known failure
72,1,1,Tumor Stage,T3
72,1,1,Clinical lab p16,p16 unknown
72,1,1,Tumor Site,oropharynx
72,1,1,Occurrence #,1st primary
72,1,1,Treatment Modality,Unknown
72,1,1,Date of Death,2007-02-15 00:00:00
72,1,1,Overall Stage,IVa
72,1,1,Age at Death,79.7
73,1,1,Status,Dead w/o disease
73,1,1,First Failure Type,no known failure
73,1,1,Nodal Stage,N2
73,1,1,Research lab HPV,HPV unknown
73,1,1,Treatment Modality,CTX-RT
73,1,1,Occurrence #,1st primary
73,1,1,Age at Death,51.3
73,1,1,Second Failure Type,no known failure
73,1,1,Radiation Dosage,70.2
73,1,1,Date of Death,2006-07-06 00:00:00
73,1,1,Metastasis,M0
73,1,1,Research lab p16,p16 unknown
73,1,1,Tumor Stage,T4a
73,1,1,Overall Stage,IVa
73,1,1,Clinical lab p16,p16 unknown
73,1,1,Time to Death,7.9
73,1,1,Tumor Site,oropharynx
73,1,1,Initial Chemotherapy Agent,carbo/doce
74,1,1,Radiation Dosage,70.2
74,1,1,Age at Death,56.3
74,1,1,Date of Death,2003-04-13 00:00:00
74,1,1,Clinical lab p16,p16 unknown
74,1,1,Nodal Stage,N1
74,1,1,Time to Death,2.4
74,1,1,Initial Chemotherapy Agent,carbo/PTX
74,1,1,Status,Dead unk disease
74,1,1,Occurrence #,other primary
74,1,1,Tumor Site,oropharynx
74,1,1,Overall Stage,III
74,1,1,Metastasis,M0
74,1,1,First Failure Type,no known failure
74,1,1,Tumor Stage,T3
74,1,1,Second Failure Type,no known failure
74,1,1,Research lab HPV,HPV negative
74,1,1,Treatment Modality,CTX-RT
74,1,1,Research lab p16,p16 negative
75,1,1,First Failure Type,no known failure
75,1,1,Overall Stage,IVa
75,1,1,Status,Dead unk disease
75,1,1,Tumor Site,oropharynx
75,1,1,Second Failure Type,no known failure
75,1,1,Time to Death,0.8
75,1,1,Tumor Stage,T3
75,1,1,Nodal Stage,N2
75,1,1,Initial Chemotherapy Agent,unknown
75,1,1,Treatment Modality,CTX-RT
75,1,1,Age at Death,46.8
75,1,1,Radiation Dosage,unknown
75,1,1,Occurrence #,1st primary
75,1,1,Clinical lab p16,p16 unknown
75,1,1,Research lab HPV,HPV positive
75,1,1,Metastasis,M0
75,1,1,Research lab p16,p16 positive
75,1,1,Date of Death,2006-06-24 00:00:00
76,1,1,First Failure Type,locoregional
76,1,1,Nodal Stage,N2
76,1,1,Clinical lab p16,p16 unknown
76,1,1,Time to First Failure,0.4
76,1,1,Radiation Dosage,70.2
76,1,1,Research lab p16,p16 positive
76,1,1,Tumor Site,oropharynx
76,1,1,First Failure Treatment Modality,Sx
76,1,1,Research lab HPV,HPV positive
76,1,1,Occurrence #,1st primary
76,1,1,Treatment Modality,CTX-RT
76,1,1,Second Failure Type,no known failure
76,1,1,Initial Chemotherapy Agent,carbo/doce
76,1,1,Metastasis,M0
76,1,1,Tumor Stage,T4a
76,1,1,Overall Stage,IVa
76,1,1,First Failure Site,oropharynx
76,1,1,Status,Alive w/o disease
77,1,1,Clinical lab p16,p16 unknown
77,1,1,First Failure Type,no known failure
77,1,1,Research lab HPV,HPV unknown
77,1,1,Research lab p16,p16 unknown
77,1,1,Treatment Modality,Unknown
77,1,1,Tumor Site,oropharynx
77,1,1,Metastasis,M0
77,1,1,Overall Stage,IVa
77,1,1,Status,Alive w/ disease
77,1,1,Occurrence #,1st primary
77,1,1,Tumor Stage,T2
77,1,1,Second Failure Type,no known failure
77,1,1,Nodal Stage,N2
78,1,1,Status,Dead unk disease
78,1,1,Date of Death,1993-07-01 00:00:00
78,1,1,Treatment Modality,RT
78,1,1,Occurrence #,1st primary
78,1,1,Research lab HPV,HPV negative
78,1,1,Research lab p16,p16 negative
78,1,1,Metastasis,M0
78,1,1,Overall Stage,IVb
78,1,1,Radiation Dosage,38.4
78,1,1,Nodal Stage,N3
78,1,1,Second Failure Type,no known failure
78,1,1,Tumor Stage,T4a
78,1,1,Age at Death,35.3
78,1,1,Clinical lab p16,p16 unknown
78,1,1,Time to Death,0.4
78,1,1,First Failure Type,no known failure
78,1,1,Tumor Site,oropharynx
79,1,1,Treatment Modality,Unknown
79,1,1,Nodal Stage,Unknown
79,1,1,First Failure Type,no known failure
79,1,1,Tumor Site,Unknown
79,1,1,Research lab p16,p16 unknown
79,1,1,Metastasis,Unknown
79,1,1,Tumor Stage,Unknown
79,1,1,Status,Unknown
79,1,1,Second Failure Type,no known failure
79,1,1,Clinical lab p16,p16 unknown
79,1,1,Research lab HPV,HPV unknown
79,1,1,Overall Stage,Unknown
79,1,1,Occurrence #,1st primary
80,1,1,Clinical lab p16,p16 unknown
80,1,1,Nodal Stage,N2
80,1,1,First Failure Treatment Modality,Sx
80,1,1,Radiation Dosage,unknown
80,1,1,Time to Death,1.1
80,1,1,First Failure Site,oropharynx
80,1,1,Time to First Failure,0.6
80,1,1,Metastasis,M0
80,1,1,Tumor Stage,T4a
80,1,1,First Failure Type,locoregional
80,1,1,Tumor Site,oropharynx
80,1,1,Research lab HPV,HPV negative
80,1,1,Research lab p16,p16 negative
80,1,1,Treatment Modality,CTX-RT
80,1,1,Date of Death,2002-04-23 00:00:00
80,1,1,Occurrence #,1st primary
80,1,1,Age at Death,57.5
80,1,1,Initial Chemotherapy Agent,doce/cap
80,1,1,Second Failure Type,no known failure
80,1,1,Status,Dead w/ disease
80,1,1,Overall Stage,IVa
81,1,1,Overall Stage,IVa
81,1,1,Time to First Failure,1.7
81,1,1,Nodal Stage,N2
81,1,1,Second Failure Type,no known failure
81,1,1,First Failure Type,distant
81,1,1,Time to Death,2.5
81,1,1,Tumor Site,oropharynx
81,1,1,Clinical lab p16,p16 unknown
81,1,1,Research lab p16,p16 unknown
81,1,1,Age at Death,75.0
81,1,1,Treatment Modality,CTX-RT
81,1,1,Metastasis,M0
81,1,1,Status,Dead w/ disease
81,1,1,Occurrence #,1st primary
81,1,1,Initial Chemotherapy Agent,PTX/cap
81,1,1,Research lab HPV,HPV unknown
81,1,1,Tumor Stage,T3
81,1,1,Radiation Dosage,72
81,1,1,Date of Death,2006-09-07 00:00:00
82,1,1,Time to Death,0.2
82,1,1,Age at Death,62.0
82,1,1,Research lab p16,p16 unknown
82,1,1,Radiation Dosage,70.2
82,1,1,Date of Death,2000-08-14 00:00:00
82,1,1,First Failure Type,no known failure
82,1,1,Tumor Stage,T4a
82,1,1,Clinical lab p16,p16 unknown
82,1,1,Tumor Site,oropharynx
82,1,1,Second Failure Type,no known failure
82,1,1,Metastasis,M0
82,1,1,Treatment Modality,CTX-RT
82,1,1,Status,Dead unk disease
82,1,1,Nodal Stage,N3
82,1,1,Research lab HPV,HPV unknown
82,1,1,Occurrence #,1st primary
82,1,1,Initial Chemotherapy Agent,carbo/PTX
82,1,1,Overall Stage,IVb
83,1,1,Clinical lab p16,p16 unknown
83,1,1,Research lab HPV,HPV unknown
83,1,1,Date of Death,2000-03-04 00:00:00
83,1,1,Second Failure Type,no known failure
83,1,1,Tumor Site,oropharynx
83,1,1,Occurrence #,1st primary
83,1,1,Research lab p16,p16 unknown
83,1,1,Status,Dead w/ disease
83,1,1,Age at Death,63.3
83,1,1,Initial Chemotherapy Agent,PTX/cap
83,1,1,Treatment Modality,CTX-RT
83,1,1,Metastasis,M0
83,1,1,Tumor Stage,T4a
83,1,1,Radiation Dosage,7.6
83,1,1,First Failure Type,no known failure
83,1,1,Nodal Stage,N2
83,1,1,Time to Death,0.0
83,1,1,Overall Stage,IVa
84,1,1,Tumor Stage,T3
84,1,1,Tumor Site,oropharynx
84,1,1,Research lab HPV,HPV negative
84,1,1,First Failure Site,oropharynx
84,1,1,Research lab p16,p16 negative
84,1,1,Clinical lab p16,p16 unknown
84,1,1,Overall Stage,IVa
84,1,1,Nodal Stage,N2
84,1,1,First Failure Type,locoregional
84,1,1,First Failure Treatment Modality,Sx
84,1,1,Treatment Modality,CTX-RT
84,1,1,Second Failure Type,no known failure
84,1,1,Time to First Failure,0.4
84,1,1,Status,Alive w/o disease
84,1,1,Metastasis,M0
84,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
84,1,1,Radiation Dosage,70.2
84,1,1,Occurrence #,1st primary
85,1,1,Nodal Stage,N2
85,1,1,Initial Chemotherapy Agent,carbo/PTX
85,1,1,Treatment Modality,CTX-RT
85,1,1,Overall Stage,IVa
85,1,1,Occurrence #,1st primary
85,1,1,Research lab p16,p16 negative
85,1,1,Age at Death,50.3
85,1,1,First Failure Initial Chemotherapy Agent,Cis/5FU
85,1,1,Time to Death,1.5
85,1,1,Status,Dead w/ disease
85,1,1,First Failure Site,oropharynx
85,1,1,Metastasis,M0
85,1,1,Tumor Site,oropharynx
85,1,1,Radiation Dosage,72
85,1,1,Tumor Stage,T4a
85,1,1,Research lab HPV,HPV negative
85,1,1,First Failure Treatment Modality,CTX
85,1,1,First Failure Type,locoregional
85,1,1,Second Failure Type,no known failure
85,1,1,Time to First Failure,0.4
85,1,1,Clinical lab p16,p16 unknown
85,1,1,Date of Death,1996-04-18 00:00:00
86,1,1,Tumor Stage,Unknown
86,1,1,Tumor Site,Unknown
86,1,1,Overall Stage,Unknown
86,1,1,Treatment Modality,Unknown
86,1,1,Occurrence #,1st primary
86,1,1,Research lab HPV,HPV unknown
86,1,1,Clinical lab p16,p16 unknown
86,1,1,Nodal Stage,Unknown
86,1,1,Metastasis,Unknown
86,1,1,Status,Unknown
86,1,1,Second Failure Type,no known failure
86,1,1,First Failure Type,no known failure
86,1,1,Research lab p16,p16 unknown
87,1,1,Metastasis,M0
87,1,1,Research lab HPV,HPV unknown
87,1,1,Time to Death,2.0
87,1,1,Date of Death,2007-05-08 00:00:00
87,1,1,Radiation Dosage,70.2
87,1,1,First Failure Type,locoregional
87,1,1,Status,Dead w/ disease
87,1,1,Second Failure Type,no known failure
87,1,1,First Failure Site,oropharynx
87,1,1,Nodal Stage,N0
87,1,1,Time to First Failure,1.4
87,1,1,Treatment Modality,CTX-RT
87,1,1,Research lab p16,p16 unknown
87,1,1,Initial Chemotherapy Agent,cis/carbo
87,1,1,Tumor Site,oropharynx
87,1,1,Tumor Stage,T4a
87,1,1,Overall Stage,IVa
87,1,1,Age at Death,54.9
87,1,1,Occurrence #,1st primary
87,1,1,Clinical lab p16,p16 unknown
88,1,1,Nodal Stage,Unknown
88,1,1,Status,Unknown
88,1,1,Tumor Stage,Unknown
88,1,1,Occurrence #,1st primary
88,1,1,Research lab HPV,HPV unknown
88,1,1,Treatment Modality,Unknown
88,1,1,Research lab p16,p16 unknown
88,1,1,Second Failure Type,no known failure
88,1,1,Overall Stage,Unknown
88,1,1,First Failure Type,no known failure
88,1,1,Tumor Site,oropharynx
88,1,1,Clinical lab p16,p16 unknown
88,1,1,Metastasis,Unknown
89,1,1,Occurrence #,1st primary
89,1,1,Status,Alive w/o disease
89,1,1,Research lab HPV,HPV unknown
89,1,1,Second Failure Type,no known failure
89,1,1,First Failure Type,no known failure
89,1,1,Clinical lab p16,p16 unknown
89,1,1,Tumor Site,oropharynx
89,1,1,Overall Stage,IVa
89,1,1,Nodal Stage,N2
89,1,1,Treatment Modality,CTX-RT
89,1,1,Radiation Dosage,70.2
89,1,1,Initial Chemotherapy Agent,cis
89,1,1,Metastasis,M0
89,1,1,Tumor Stage,T1
89,1,1,Research lab p16,p16 unknown
90,1,1,Clinical lab p16,p16 unknown
90,1,1,Overall Stage,IVa
90,1,1,Status,Alive w/o disease
90,1,1,Tumor Stage,T4a
90,1,1,Occurrence #,1st primary
90,1,1,Research lab p16,p16 negative
90,1,1,Second Failure Type,no known failure
90,1,1,First Failure Type,no known failure
90,1,1,Nodal Stage,N0
90,1,1,Treatment Modality,Sx
90,1,1,Tumor Site,oropharynx
90,1,1,Research lab HPV,HPV negative
90,1,1,Metastasis,M0
91,1,1,Second Failure Type,no known failure
91,1,1,Tumor Stage,Unknown
91,1,1,Metastasis,Unknown
91,1,1,Age at Death,55.0
91,1,1,Tumor Site,oropharynx
91,1,1,Research lab p16,p16 unknown
91,1,1,Treatment Modality,Unknown
91,1,1,Date of Death,1994-09-18 00:00:00
91,1,1,Nodal Stage,Unknown
91,1,1,Clinical lab p16,p16 unknown
91,1,1,Time to Death,0.8
91,1,1,Overall Stage,Unknown
91,1,1,Occurrence #,1st primary
91,1,1,First Failure Type,no known failure
91,1,1,Research lab HPV,HPV unknown
91,1,1,Status,Dead unk disease
92,1,1,Tumor Site,oropharynx
92,1,1,Occurrence #,1st primary
92,1,1,Metastasis,M0
92,1,1,Radiation Dosage,70.2
92,1,1,Treatment Modality,Sx & RT
92,1,1,Nodal Stage,N3
92,1,1,Research lab p16,p16 unknown
92,1,1,First Failure Type,no known failure
92,1,1,Second Failure Type,no known failure
92,1,1,Clinical lab p16,p16 unknown
92,1,1,Overall Stage,IVb
92,1,1,Tumor Stage,T1
92,1,1,Status,Alive w/o disease
92,1,1,Research lab HPV,HPV unknown
93,1,1,Occurrence #,1st primary
93,1,1,Status,Alive w/o disease
93,1,1,Research lab HPV,HPV unknown
93,1,1,Tumor Stage,T3
93,1,1,Initial Chemotherapy Agent,carbo/doce
93,1,1,Overall Stage,IVa
93,1,1,First Failure Type,no known failure
93,1,1,Treatment Modality,CTX-RT
93,1,1,Tumor Site,oropharynx
93,1,1,Radiation Dosage,70.2
93,1,1,Second Failure Type,no known failure
93,1,1,Nodal Stage,N2
93,1,1,Clinical lab p16,p16 unknown
93,1,1,Metastasis,M0
93,1,1,Research lab p16,p16 unknown
94,1,1,Nodal Stage,Unknown
94,1,1,Tumor Stage,Unknown
94,1,1,Research lab HPV,HPV unknown
94,1,1,First Failure Type,no known failure
94,1,1,Overall Stage,Unknown
94,1,1,Clinical lab p16,p16 unknown
94,1,1,Tumor Site,oropharynx
94,1,1,Second Failure Type,no known failure
94,1,1,Status,Unknown
94,1,1,Treatment Modality,Unknown
94,1,1,Metastasis,Unknown
94,1,1,Occurrence #,1st primary
94,1,1,Research lab p16,p16 unknown
95,1,1,Treatment Modality,CTX-RT
95,1,1,Tumor Site,oropharynx
95,1,1,Second Failure Type,no known failure
95,1,1,Metastasis,M0
95,1,1,Radiation Dosage,70.2
95,1,1,Clinical lab p16,p16 unknown
95,1,1,First Failure Type,no known failure
95,1,1,Nodal Stage,N2
95,1,1,Research lab p16,p16 positive
95,1,1,Research lab HPV,HPV positive
95,1,1,Initial Chemotherapy Agent,carbo/PTX
95,1,1,Overall Stage,IVa
95,1,1,Occurrence #,1st primary
95,1,1,Tumor Stage,T3
95,1,1,Status,Alive w/o disease
96,1,1,Occurrence #,1st primary
96,1,1,Date of Death,2009-07-08 00:00:00
96,1,1,Radiation Dosage,66.6
96,1,1,Research lab HPV,HPV unknown
96,1,1,Time to Death,8.5
96,1,1,Clinical lab p16,p16 unknown
96,1,1,Nodal Stage,N2
96,1,1,First Failure Type,no known failure
96,1,1,Tumor Site,oropharynx
96,1,1,Tumor Stage,T4a
96,1,1,Age at Death,79.7
96,1,1,Status,Dead unk disease
96,1,1,Overall Stage,IVa
96,1,1,Metastasis,M0
96,1,1,Treatment Modality,Sx & RT
96,1,1,Research lab p16,p16 unknown
96,1,1,Second Failure Type,no known failure
97,1,1,Nodal Stage,N0
97,1,1,Second Failure Type,no known failure
97,1,1,Status,Alive w/o disease
97,1,1,Occurrence #,1st primary
97,1,1,Research lab p16,p16 unknown
97,1,1,Treatment Modality,Sx
97,1,1,First Failure Type,no known failure
97,1,1,Research lab HPV,HPV unknown
97,1,1,Tumor Site,oropharynx
97,1,1,Overall Stage,IVa
97,1,1,Tumor Stage,T4a
97,1,1,Clinical lab p16,p16 unknown
97,1,1,Metastasis,M0
98,1,1,Occurrence #,1st primary
98,1,1,Metastasis,M0
98,1,1,Radiation Dosage,72
98,1,1,Research lab p16,p16 positive
98,1,1,Treatment Modality,Sx & CTX-RT
98,1,1,Status,Alive w/o disease
98,1,1,Tumor Site,oropharynx
98,1,1,Clinical lab p16,p16 unknown
98,1,1,Research lab HPV,HPV positive
98,1,1,Nodal Stage,N3
98,1,1,First Failure Type,no known failure
98,1,1,Initial Chemotherapy Agent,carbo/PTX
98,1,1,Overall Stage,IVb
98,1,1,Second Failure Type,no known failure
98,1,1,Tumor Stage,T1
99,1,1,Overall Stage,IVa
99,1,1,Second Failure Type,no known failure
99,1,1,Nodal Stage,N2
99,1,1,Research lab HPV,HPV unknown
99,1,1,Tumor Stage,T4a
99,1,1,Treatment Modality,CTX-RT
99,1,1,Time to Death,1.8
99,1,1,Status,Dead unk disease
99,1,1,Radiation Dosage,70.2
99,1,1,Tumor Site,oropharynx
99,1,1,Clinical lab p16,p16 unknown
99,1,1,Age at Death,59.9
99,1,1,Initial Chemotherapy Agent,carbo/doce
99,1,1,First Failure Type,no known failure
99,1,1,Date of Death,2001-02-19 00:00:00
99,1,1,Metastasis,M0
99,1,1,Occurrence #,1st primary
99,1,1,Research lab p16,p16 unknown
100,1,1,First Failure Type,no known failure
100,1,1,Nodal Stage,N3
100,1,1,Tumor Site,oropharynx
100,1,1,Clinical lab p16,p16 unknown
100,1,1,Research lab p16,p16 unknown
100,1,1,Second Failure Type,no known failure
100,1,1,Age at Death,59.6
100,1,1,Treatment Modality,Unknown
100,1,1,Overall Stage,IVb
100,1,1,Metastasis,M0
100,1,1,Tumor Stage,T4a
100,1,1,Research lab HPV,HPV unknown
100,1,1,Status,Dead unk disease
100,1,1,Date of Death,1995-01-01 00:00:00
100,1,1,Occurrence #,1st primary
100,1,1,Time to Death,0.7
101,1,1,Status,Unknown
101,1,1,Second Failure Type,no known failure
101,1,1,Research lab HPV,HPV unknown
101,1,1,Research lab p16,p16 unknown
101,1,1,Nodal Stage,Unknown
101,1,1,Overall Stage,Unknown
101,1,1,Occurrence #,1st primary
101,1,1,First Failure Type,no known failure
101,1,1,Tumor Site,Unknown
101,1,1,Treatment Modality,Unknown
101,1,1,Tumor Stage,Unknown
101,1,1,Clinical lab p16,p16 unknown
101,1,1,Metastasis,Unknown
102,1,1,Research lab p16,p16 positive
102,1,1,Treatment Modality,RT
102,1,1,Tumor Stage,T3
102,1,1,Research lab HPV,HPV positive
102,1,1,Status,Alive w/o disease
102,1,1,Clinical lab p16,p16 unknown
102,1,1,Nodal Stage,N0
102,1,1,Metastasis,M0
102,1,1,First Failure Type,no known failure
102,1,1,Second Failure Type,no known failure
102,1,1,Tumor Site,oropharynx
102,1,1,Occurrence #,1st primary
102,1,1,Radiation Dosage,76.4
102,1,1,Overall Stage,III
103,1,1,Status,Dead w/ disease
103,1,1,Nodal Stage,N2
103,1,1,Occurrence #,1st primary
103,1,1,Time to Death,1.3
103,1,1,Metastasis,M0
103,1,1,First Failure Type,locoregional and distant
103,1,1,Time to First Failure,0.3
103,1,1,Treatment Modality,CTX-RT
103,1,1,Tumor Site,oropharynx
103,1,1,Overall Stage,IVa
103,1,1,Research lab HPV,HPV unknown
103,1,1,Tumor Stage,T1
103,1,1,Second Failure Type,no known failure
103,1,1,Research lab p16,p16 unknown
103,1,1,Radiation Dosage,72.6
103,1,1,Age at Death,55.9
103,1,1,Clinical lab p16,p16 unknown
103,1,1,Initial Chemotherapy Agent,unknown
103,1,1,Date of Death,2006-02-04 00:00:00
104,1,1,Research lab HPV,HPV positive
104,1,1,First Failure Type,distant
104,1,1,Initial Chemotherapy Agent,carbo/PTX
104,1,1,Metastasis,M0
104,1,1,Overall Stage,IVb
104,1,1,Treatment Modality,CTX-RT
104,1,1,Research lab p16,p16 positive
104,1,1,Tumor Site,oropharynx
104,1,1,Tumor Stage,T3
104,1,1,Second Failure Type,no known failure
104,1,1,Status,Dead w/ disease
104,1,1,Nodal Stage,N3
104,1,1,Clinical lab p16,p16 unknown
104,1,1,Radiation Dosage,70.2
104,1,1,Time to Death,0.5
104,1,1,Age at Death,36.9
104,1,1,Occurrence #,1st primary
104,1,1,Date of Death,2005-10-01 00:00:00
104,1,1,Time to First Failure,0.1
105,1,1,Tumor Site,oropharynx
105,1,1,Age at Death,66.2
105,1,1,Treatment Modality,CTX-RT
105,1,1,Second Failure Type,no known failure
105,1,1,First Failure Type,no known failure
105,1,1,Nodal Stage,N2
105,1,1,Overall Stage,IVa
105,1,1,Tumor Stage,T3
105,1,1,Research lab p16,p16 unknown
105,1,1,Clinical lab p16,p16 unknown
105,1,1,Occurrence #,1st primary
105,1,1,Research lab HPV,HPV unknown
105,1,1,Radiation Dosage,70.2
105,1,1,Metastasis,M0
105,1,1,Initial Chemotherapy Agent,carbo/doce
105,1,1,Date of Death,2008-06-02 00:00:00
105,1,1,Status,Dead unk disease
106,1,1,Initial Chemotherapy Agent,carbo/doce
106,1,1,Radiation Dosage,70
106,1,1,Overall Stage,IVa
106,1,1,Tumor Stage,T2
106,1,1,Status,Alive w/o disease
106,1,1,Clinical lab p16,p16 unknown
106,1,1,Second Failure Type,no known failure
106,1,1,Occurrence #,1st primary
106,1,1,Metastasis,M0
106,1,1,Tumor Site,oropharynx
106,1,1,Nodal Stage,N2
106,1,1,First Failure Type,no known failure
106,1,1,Research lab HPV,HPV unknown
106,1,1,Treatment Modality,Sx & CTX-RT
106,1,1,Research lab p16,p16 unknown
107,1,1,Metastasis,M0
107,1,1,Nodal Stage,N3
107,1,1,Clinical lab p16,p16 unknown
107,1,1,Tumor Site,oropharynx
107,1,1,Treatment Modality,CTX-RT
107,1,1,Second Failure Type,no known failure
107,1,1,Tumor Stage,T2
107,1,1,Research lab p16,p16 positive
107,1,1,Radiation Dosage,unknown
107,1,1,Initial Chemotherapy Agent,unknown
107,1,1,Status,Alive w/o disease
107,1,1,First Failure Type,no known failure
107,1,1,Research lab HPV,HPV positive
107,1,1,Overall Stage,IVb
107,1,1,Occurrence #,1st primary
108,1,1,Research lab HPV,HPV unknown
108,1,1,Tumor Site,Unknown
108,1,1,Status,Unknown
108,1,1,Clinical lab p16,p16 unknown
108,1,1,First Failure Type,no known failure
108,1,1,Occurrence #,1st primary
108,1,1,Metastasis,Unknown
108,1,1,Treatment Modality,Unknown
108,1,1,Nodal Stage,Unknown
108,1,1,Overall Stage,Unknown
108,1,1,Research lab p16,p16 unknown
108,1,1,Second Failure Type,no known failure
108,1,1,Tumor Stage,Unknown
109,1,1,Initial Chemotherapy Agent,carbo/doce
109,1,1,Nodal Stage,N0
109,1,1,Research lab HPV,HPV unknown
109,1,1,Tumor Stage,T3
109,1,1,Research lab p16,p16 unknown
109,1,1,Status,Alive w/o disease
109,1,1,Occurrence #,1st primary
109,1,1,Clinical lab p16,p16 unknown
109,1,1,First Failure Type,no known failure
109,1,1,Radiation Dosage,70.2
109,1,1,Metastasis,M0
109,1,1,Overall Stage,III
109,1,1,Treatment Modality,CTX-RT
109,1,1,Second Failure Type,no known failure
109,1,1,Tumor Site,oropharynx
110,1,1,Tumor Stage,T3
110,1,1,Metastasis,M0
110,1,1,Second Failure Type,no known failure
110,1,1,Research lab HPV,HPV negative
110,1,1,First Failure Type,no known failure
110,1,1,Overall Stage,IVa
110,1,1,Tumor Site,oropharynx
110,1,1,Age at Death,45.7
110,1,1,Time to Death,1.6
110,1,1,Date of Death,1994-08-25 00:00:00
110,1,1,Nodal Stage,N2
110,1,1,Occurrence #,1st primary
110,1,1,Research lab p16,p16 negative
110,1,1,Treatment Modality,RT
110,1,1,Clinical lab p16,p16 unknown
110,1,1,Status,Dead w/ disease
111,1,1,Metastasis,M0
111,1,1,Tumor Stage,T3
111,1,1,Second Failure Type,no known failure
111,1,1,Occurrence #,1st primary
111,1,1,Clinical lab p16,p16 unknown
111,1,1,Research lab p16,p16 unknown
111,1,1,Time to Death,4.1
111,1,1,Date of Death,2005-04-24 00:00:00
111,1,1,Status,Dead w/o disease
111,1,1,Overall Stage,III
111,1,1,Research lab HPV,HPV unknown
111,1,1,Nodal Stage,N0
111,1,1,Initial Chemotherapy Agent,carbo/doce
111,1,1,Radiation Dosage,70.2
111,1,1,Tumor Site,oropharynx
111,1,1,Age at Death,71.2
111,1,1,Treatment Modality,CTX-RT
111,1,1,First Failure Type,no known failure
112,1,1,Nodal Stage,N2
112,1,1,Treatment Modality,RT
112,1,1,Second Failure Type,no known failure
112,1,1,Radiation Dosage,10
112,1,1,Research lab HPV,HPV unknown
112,1,1,Status,Dead w/ disease
112,1,1,Time to Death,0.1
112,1,1,Tumor Stage,T4a
112,1,1,Occurrence #,1st primary
112,1,1,Research lab p16,p16 unknown
112,1,1,Overall Stage,IVa
112,1,1,Date of Death,2002-10-07 00:00:00
112,1,1,First Failure Type,no known failure
112,1,1,Age at Death,76.5
112,1,1,Tumor Site,oropharynx
112,1,1,Clinical lab p16,p16 unknown
112,1,1,Metastasis,M0
113,1,1,Occurrence #,1st primary
113,1,1,Nodal Stage,N1
113,1,1,Status,Dead w/ disease
113,1,1,Treatment Modality,CTX-RT
113,1,1,First Failure Initial Chemotherapy Agent,gemcitabine/doce/cap
113,1,1,Research lab p16,p16 unknown
113,1,1,Date of Death,2002-08-23 00:00:00
113,1,1,Metastasis,M0
113,1,1,Research lab HPV,HPV unknown
113,1,1,First Failure Type,locoregional
113,1,1,Tumor Stage,T4a
113,1,1,Time to First Failure,1.0
113,1,1,Time to Death,2.2
113,1,1,Initial Chemotherapy Agent,carbo/doce
113,1,1,Tumor Site,oropharynx
113,1,1,Radiation Dosage,70.2
113,1,1,Clinical lab p16,p16 unknown
113,1,1,Age at Death,39.4
113,1,1,First Failure Site,oropharynx
113,1,1,Overall Stage,IVa
113,1,1,Second Failure Type,no known failure
114,1,1,Time to Death,2.5
114,1,1,Initial Chemotherapy Agent,carbo/PTX
114,1,1,Research lab p16,p16 unknown
114,1,1,Clinical lab p16,p16 unknown
114,1,1,Nodal Stage,N2
114,1,1,Second Failure Type,no known failure
114,1,1,Treatment Modality,CTX-RT
114,1,1,Occurrence #,1st primary
114,1,1,Date of Death,2005-03-28 00:00:00
114,1,1,Radiation Dosage,70.2
114,1,1,Overall Stage,IVa
114,1,1,Tumor Site,oropharynx
114,1,1,Research lab HPV,HPV unknown
114,1,1,Tumor Stage,T3
114,1,1,First Failure Type,no known failure
114,1,1,Status,Dead w/ disease
114,1,1,Age at Death,55.0
114,1,1,Metastasis,M0
115,1,1,Clinical lab p16,p16 unknown
115,1,1,Time to Death,0.7
115,1,1,Nodal Stage,Unknown
115,1,1,First Failure Type,no known failure
115,1,1,Second Failure Type,no known failure
115,1,1,Treatment Modality,Unknown
115,1,1,Tumor Stage,Unknown
115,1,1,Tumor Site,oropharynx
115,1,1,Research lab HPV,HPV unknown
115,1,1,Metastasis,Unknown
115,1,1,Occurrence #,1st primary
115,1,1,Overall Stage,Unknown
115,1,1,Date of Death,1996-11-03 00:00:00
115,1,1,Status,Dead unk disease
115,1,1,Age at Death,85.8
115,1,1,Research lab p16,p16 unknown
116,1,1,Research lab p16,p16 positive
116,1,1,Radiation Dosage,70.2
116,1,1,Tumor Stage,T3
116,1,1,Metastasis,M0
116,1,1,Status,Alive w/o disease
116,1,1,Research lab HPV,HPV positive
116,1,1,Second Failure Type,no known failure
116,1,1,First Failure Type,no known failure
116,1,1,Tumor Site,oropharynx
116,1,1,Treatment Modality,CTX-RT
116,1,1,Nodal Stage,N2
116,1,1,Overall Stage,IVa
116,1,1,Occurrence #,1st primary
116,1,1,Initial Chemotherapy Agent,cis
116,1,1,Clinical lab p16,p16 unknown
117,1,1,Nodal Stage,N2
117,1,1,Date of Death,2005-04-29 00:00:00
117,1,1,Time to Death,5.3
117,1,1,Age at Death,74.2
117,1,1,Radiation Dosage,70.2
117,1,1,Occurrence #,Unknown
117,1,1,Research lab HPV,HPV unknown
117,1,1,Metastasis,M0
117,1,1,Overall Stage,IVa
117,1,1,Research lab p16,p16 unknown
117,1,1,Initial Chemotherapy Agent,PTX/cap
117,1,1,Clinical lab p16,p16 unknown
117,1,1,Tumor Site,oropharynx
117,1,1,First Failure Type,no known failure
117,1,1,Status,Dead unk disease
117,1,1,Treatment Modality,CTX-RT
117,1,1,Second Failure Type,no known failure
117,1,1,Tumor Stage,T4a
118,1,1,Clinical lab p16,p16 unknown
118,1,1,Radiation Dosage,70.2
118,1,1,Research lab p16,p16 unknown
118,1,1,Initial Chemotherapy Agent,carbo/PTX
118,1,1,Tumor Stage,T2
118,1,1,Nodal Stage,N2
118,1,1,Tumor Site,oropharynx
118,1,1,Research lab HPV,HPV unknown
118,1,1,Occurrence #,1st primary
118,1,1,Status,Alive w/o disease
118,1,1,Metastasis,M0
118,1,1,Treatment Modality,CTX-RT
118,1,1,Overall Stage,IVa
118,1,1,Second Failure Type,no known failure
118,1,1,First Failure Type,no known failure
119,1,1,Research lab HPV,HPV unknown
119,1,1,Metastasis,M0
119,1,1,First Failure Type,no known failure
119,1,1,Occurrence #,1st primary
119,1,1,Second Failure Type,no known failure
119,1,1,Tumor Site,oropharynx
119,1,1,Clinical lab p16,p16 unknown
119,1,1,Status,Alive w/o disease
119,1,1,Research lab p16,p16 unknown
119,1,1,Tumor Stage,T3
119,1,1,Radiation Dosage,72
119,1,1,Overall Stage,IVa
119,1,1,Treatment Modality,CTX-RT
119,1,1,Nodal Stage,N2
119,1,1,Initial Chemotherapy Agent,carbo/doce
120,1,1,First Failure Type,distant
120,1,1,Metastasis,M0
120,1,1,Clinical lab p16,p16 unknown
120,1,1,Research lab p16,p16 positive
120,1,1,Occurrence #,1st primary
120,1,1,Tumor Site,oropharynx
120,1,1,Initial Chemotherapy Agent,PTX/cap
120,1,1,Overall Stage,IVa
120,1,1,Tumor Stage,T4a
120,1,1,Radiation Dosage,72
120,1,1,Date of Death,2001-11-19 00:00:00
120,1,1,Research lab HPV,HPV positive
120,1,1,Status,Dead unk disease
120,1,1,Treatment Modality,CTX-RT
120,1,1,Age at Death,54.3
120,1,1,Time to First Failure,0.8
120,1,1,Nodal Stage,N2
120,1,1,Time to Death,1.0
120,1,1,Second Failure Type,no known failure
121,1,1,Time to Death,7.5
121,1,1,Radiation Dosage,76.8
121,1,1,Clinical lab p16,p16 unknown
121,1,1,Age at Death,86.5
121,1,1,Status,Dead unk disease
121,1,1,Overall Stage,IVb
121,1,1,Metastasis,M0
121,1,1,Second Failure Type,no known failure
121,1,1,First Failure Type,no known failure
121,1,1,Research lab p16,p16 unknown
121,1,1,Tumor Site,oropharynx
121,1,1,Research lab HPV,HPV unknown
121,1,1,Date of Death,2003-11-04 00:00:00
121,1,1,Treatment Modality,RT
121,1,1,Nodal Stage,N2
121,1,1,Tumor Stage,T4b
121,1,1,Occurrence #,Unknown
122,1,1,Status,Unknown
122,1,1,Tumor Stage,Unknown
122,1,1,Nodal Stage,Unknown
122,1,1,Research lab HPV,HPV unknown
122,1,1,Research lab p16,p16 unknown
122,1,1,Overall Stage,Unknown
122,1,1,Treatment Modality,Unknown
122,1,1,Tumor Site,Unknown
122,1,1,Second Failure Type,no known failure
122,1,1,Clinical lab p16,p16 unknown
122,1,1,First Failure Type,no known failure
122,1,1,Occurrence #,1st primary
122,1,1,Metastasis,Unknown
123,1,1,Research lab p16,p16 unknown
123,1,1,Nodal Stage,Unknown
123,1,1,Second Failure Type,no known failure
123,1,1,Clinical lab p16,p16 unknown
123,1,1,Treatment Modality,Unknown
123,1,1,Occurrence #,1st primary
123,1,1,Research lab HPV,HPV unknown
123,1,1,Metastasis,Unknown
123,1,1,First Failure Type,no known failure
123,1,1,Tumor Site,Unknown
123,1,1,Overall Stage,Unknown
123,1,1,Tumor Stage,Unknown
123,1,1,Status,Unknown
124,1,1,Tumor Stage,T2
124,1,1,Clinical lab p16,p16 unknown
124,1,1,Occurrence #,1st primary
124,1,1,Tumor Site,oropharynx
124,1,1,Treatment Modality,Sx
124,1,1,Date of Death,2009-06-27 00:00:00
124,1,1,Research lab p16,p16 positive
124,1,1,Metastasis,M0
124,1,1,Status,Dead unk disease
124,1,1,Nodal Stage,N1
124,1,1,Second Failure Type,no known failure
124,1,1,Overall Stage,IVa
124,1,1,Time to Death,3.0
124,1,1,Research lab HPV,HPV unknown
124,1,1,First Failure Type,no known failure
124,1,1,Age at Death,76.7
125,1,1,Treatment Modality,RT
125,1,1,Research lab p16,p16 unknown
125,1,1,Status,Dead w/ disease
125,1,1,Clinical lab p16,p16 unknown
125,1,1,First Failure Type,no known failure
125,1,1,Tumor Site,oropharynx
125,1,1,Nodal Stage,N2
125,1,1,Occurrence #,1st primary
125,1,1,Overall Stage,IVa
125,1,1,Tumor Stage,T3
125,1,1,Age at Death,40.4
125,1,1,Radiation Dosage,70.2
125,1,1,Time to Death,0.7
125,1,1,Second Failure Type,no known failure
125,1,1,Research lab HPV,HPV unknown
125,1,1,Metastasis,M0
125,1,1,Date of Death,2002-08-11 00:00:00
126,1,1,First Failure Type,locoregional
126,1,1,Second Failure Type,no known failure
126,1,1,Treatment Modality,CTX-RT
126,1,1,Time to Death,1.4
126,1,1,Metastasis,M0
126,1,1,Nodal Stage,N2
126,1,1,Time to First Failure,1.0
126,1,1,Clinical lab p16,p16 unknown
126,1,1,Tumor Stage,T4a
126,1,1,Occurrence #,1st primary
126,1,1,Date of Death,2001-05-26 00:00:00
126,1,1,Research lab p16,p16 unknown
126,1,1,Overall Stage,IVa
126,1,1,Tumor Site,oropharynx
126,1,1,Status,Dead w/ disease
126,1,1,First Failure Site,oropharynx
126,1,1,Initial Chemotherapy Agent,unknown
126,1,1,Age at Death,64.9
126,1,1,Research lab HPV,HPV unknown
127,1,1,Occurrence #,1st primary
127,1,1,Tumor Site,oropharynx
127,1,1,Research lab p16,p16 unknown
127,1,1,Status,Alive w/o disease
127,1,1,Initial Chemotherapy Agent,carbo/doce
127,1,1,Second Failure Type,no known failure
127,1,1,Tumor Stage,T4a
127,1,1,Radiation Dosage,70.2
127,1,1,Clinical lab p16,p16 unknown
127,1,1,Research lab HPV,HPV unknown
127,1,1,Treatment Modality,CTX-RT
127,1,1,Overall Stage,IVa
127,1,1,Nodal Stage,N2
127,1,1,First Failure Type,no known failure
127,1,1,Metastasis,M0
128,1,1,Tumor Stage,T4a
128,1,1,Overall Stage,IVa
128,1,1,Radiation Dosage,72
128,1,1,Time to Death,3.9
128,1,1,Second Failure Type,no known failure
128,1,1,First Failure Type,distant
128,1,1,Status,Dead w/ disease
128,1,1,Age at Death,63.9
128,1,1,Nodal Stage,N2
128,1,1,Date of Death,2006-03-01 00:00:00
128,1,1,Research lab p16,p16 positive
128,1,1,Research lab HPV,HPV positive
128,1,1,Clinical lab p16,p16 unknown
128,1,1,Time to First Failure,1.0
128,1,1,Metastasis,M0
128,1,1,Tumor Site,oropharynx
128,1,1,Initial Chemotherapy Agent,PTX/cap
128,1,1,Occurrence #,1st primary
128,1,1,Treatment Modality,CTX-RT
129,1,1,Nodal Stage,N2
129,1,1,Occurrence #,1st primary
129,1,1,First Failure Site,oropharynx
129,1,1,Treatment Modality,CTX-RT
129,1,1,Time to First Failure,0.5
129,1,1,Status,Dead w/ disease
129,1,1,Metastasis,M0
129,1,1,Second Failure Type,no known failure
129,1,1,First Failure Type,locoregional
129,1,1,Time to Death,1.2
129,1,1,Clinical lab p16,p16 unknown
129,1,1,Research lab p16,p16 positive
129,1,1,Age at Death,55.3
129,1,1,Tumor Site,oropharynx
129,1,1,First Failure Initial Chemotherapy Agent,doce/PTX/cap
129,1,1,Date of Death,2000-10-21 00:00:00
129,1,1,Overall Stage,IVa
129,1,1,Tumor Stage,T2
129,1,1,Initial Chemotherapy Agent,PTX/cap
129,1,1,Research lab HPV,HPV positive
129,1,1,Radiation Dosage,70.2
129,1,1,First Failure Treatment Modality,CTX
130,1,1,Metastasis,M0
130,1,1,Radiation Dosage,unknown
130,1,1,Second Failure Type,no known failure
130,1,1,Research lab p16,p16 positive
130,1,1,Status,Dead unk disease
130,1,1,Tumor Stage,T3
130,1,1,Time to First Failure,0.2
130,1,1,Age at Death,47.6
130,1,1,Time to Death,1.7
130,1,1,First Failure Type,locoregional
130,1,1,Tumor Site,oropharynx
130,1,1,Initial Chemotherapy Agent,unknown
130,1,1,Occurrence #,1st primary
130,1,1,Nodal Stage,N2
130,1,1,Overall Stage,IVa
130,1,1,Research lab HPV,HPV positive
130,1,1,Treatment Modality,CTX-RT
130,1,1,Clinical lab p16,p16 unknown
130,1,1,Date of Death,2004-01-08 00:00:00
131,1,1,Tumor Site,Unknown
131,1,1,Research lab p16,p16 unknown
131,1,1,First Failure Type,no known failure
131,1,1,Metastasis,Unknown
131,1,1,Tumor Stage,Unknown
131,1,1,Clinical lab p16,p16 unknown
131,1,1,Research lab HPV,HPV unknown
131,1,1,Second Failure Type,no known failure
131,1,1,Treatment Modality,Unknown
131,1,1,Status,Unknown
131,1,1,Nodal Stage,Unknown
131,1,1,Occurrence #,1st primary
131,1,1,Overall Stage,Unknown
132,1,1,Tumor Stage,T4a
132,1,1,Research lab p16,p16 positive
132,1,1,Research lab HPV,HPV unknown
132,1,1,Nodal Stage,N2
132,1,1,Radiation Dosage,68.4
132,1,1,First Failure Type,no known failure
132,1,1,Overall Stage,IVa
132,1,1,Metastasis,M0
132,1,1,Clinical lab p16,p16 unknown
132,1,1,Status,Alive w/o disease
132,1,1,Treatment Modality,CTX-RT
132,1,1,Initial Chemotherapy Agent,PTX/carbo
132,1,1,Occurrence #,1st primary
132,1,1,Second Failure Type,no known failure
132,1,1,Tumor Site,oropharynx
133,1,1,Nodal Stage,Unknown
133,1,1,First Failure Type,no known failure
133,1,1,Tumor Site,oropharynx
133,1,1,Status,Alive w/ disease
133,1,1,Overall Stage,Unknown
133,1,1,Occurrence #,1st primary
133,1,1,Clinical lab p16,p16 unknown
133,1,1,Research lab HPV,HPV unknown
133,1,1,Research lab p16,p16 unknown
133,1,1,Tumor Stage,Unknown
133,1,1,Treatment Modality,Unknown
133,1,1,Second Failure Type,no known failure
133,1,1,Metastasis,Unknown
134,1,1,Nodal Stage,N2
134,1,1,Overall Stage,IVa
134,1,1,Tumor Site,oropharynx
134,1,1,Research lab HPV,HPV positive
134,1,1,First Failure Treatment Modality,Sx
134,1,1,Occurrence #,1st primary
134,1,1,Tumor Stage,T3
134,1,1,Treatment Modality,Sx & RT
134,1,1,First Failure Site,oropharynx
134,1,1,First Failure Type,no known failure
134,1,1,Research lab p16,p16 negative
134,1,1,Second Failure Type,no known failure
134,1,1,Radiation Dosage,59.4
134,1,1,Status,Alive w/o disease
134,1,1,Metastasis,M0
134,1,1,Clinical lab p16,p16 unknown
135,1,1,Initial Chemotherapy Agent,cis
135,1,1,Research lab p16,p16 unknown
135,1,1,Research lab HPV,HPV unknown
135,1,1,Metastasis,M0
135,1,1,Tumor Stage,T2
135,1,1,Clinical lab p16,p16 unknown
135,1,1,Second Failure Type,no known failure
135,1,1,Treatment Modality,CTX-RT
135,1,1,Occurrence #,1st primary
135,1,1,Overall Stage,IVa
135,1,1,Tumor Site,oropharynx
135,1,1,Radiation Dosage,70.2
135,1,1,First Failure Type,no known failure
135,1,1,Status,Alive w/o disease
135,1,1,Nodal Stage,N2
136,1,1,Research lab p16,p16 unknown
136,1,1,Research lab HPV,HPV unknown
136,1,1,Tumor Stage,Unknown
136,1,1,Occurrence #,1st primary
136,1,1,Status,Unknown
136,1,1,Treatment Modality,Unknown
136,1,1,Nodal Stage,Unknown
136,1,1,Overall Stage,Unknown
136,1,1,First Failure Type,no known failure
136,1,1,Clinical lab p16,p16 unknown
136,1,1,Second Failure Type,no known failure
136,1,1,Tumor Site,Unknown
136,1,1,Metastasis,Unknown
137,1,1,Research lab HPV,HPV unknown
137,1,1,First Failure Type,no known failure
137,1,1,Tumor Site,oropharynx
137,1,1,Treatment Modality,CTX-RT
137,1,1,Initial Chemotherapy Agent,Cis
137,1,1,Occurrence #,1st primary
137,1,1,Research lab p16,p16 unknown
137,1,1,Status,Alive w/o disease
137,1,1,Clinical lab p16,p16 unknown
137,1,1,Tumor Stage,T2
137,1,1,Nodal Stage,N2
137,1,1,Second Failure Type,no known failure
137,1,1,Radiation Dosage,70.2
137,1,1,Metastasis,M0
137,1,1,Overall Stage,IVa
138,1,1,Occurrence #,other primary
138,1,1,Tumor Site,oropharynx
138,1,1,Second Failure Type,no known failure
138,1,1,Nodal Stage,N2
138,1,1,Status,Dead w/ disease
138,1,1,Date of Death,2007-09-13 00:00:00
138,1,1,Age at Death,84.4
138,1,1,Clinical lab p16,p16 unknown
138,1,1,Metastasis,M0
138,1,1,Research lab p16,p16 negative
138,1,1,First Failure Type,locoregional and distant
138,1,1,Time to First Failure,0.4
138,1,1,Overall Stage,IVa
138,1,1,Tumor Stage,T3
138,1,1,Time to Death,0.7
138,1,1,Treatment Modality,Sx
138,1,1,Research lab HPV,HPV negative
139,1,1,Tumor Site,oropharynx
139,1,1,Nodal Stage,N2
139,1,1,Occurrence #,Unknown
139,1,1,Overall Stage,IVa
139,1,1,Initial Chemotherapy Agent,carbo/doce
139,1,1,Status,Dead unk disease
139,1,1,Metastasis,M0
139,1,1,Time to Death,5.8
139,1,1,Tumor Stage,T4a
139,1,1,Research lab p16,p16 unknown
139,1,1,Second Failure Type,no known failure
139,1,1,Clinical lab p16,p16 unknown
139,1,1,Research lab HPV,HPV unknown
139,1,1,Radiation Dosage,70.2
139,1,1,Treatment Modality,CTX-RT
139,1,1,First Failure Type,no known failure
139,1,1,Date of Death,2004-04-28 00:00:00
139,1,1,Age at Death,45.7
140,1,1,Treatment Modality,Unknown
140,1,1,Research lab p16,p16 unknown
140,1,1,Research lab HPV,HPV unknown
140,1,1,First Failure Type,no known failure
140,1,1,Metastasis,Unknown
140,1,1,Overall Stage,Unknown
140,1,1,Second Failure Type,no known failure
140,1,1,Clinical lab p16,p16 unknown
140,1,1,Nodal Stage,Unknown
140,1,1,Tumor Site,oropharynx
140,1,1,Status,Unknown
140,1,1,Occurrence #,1st primary
140,1,1,Tumor Stage,Unknown
141,1,1,Tumor Site,oropharynx
141,1,1,Research lab HPV,HPV negative
141,1,1,Status,Alive w/o disease
141,1,1,Metastasis,M0
141,1,1,Research lab p16,p16 negative
141,1,1,Overall Stage,IVb
141,1,1,Tumor Stage,T4a
141,1,1,Clinical lab p16,p16 unknown
141,1,1,Occurrence #,1st primary
141,1,1,Treatment Modality,CTX-RT
141,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
141,1,1,Second Failure Type,no known failure
141,1,1,Radiation Dosage,70.2
141,1,1,Nodal Stage,N3
141,1,1,First Failure Type,no known failure
142,1,1,Occurrence #,1st primary
142,1,1,Tumor Stage,Unknown
142,1,1,Clinical lab p16,p16 unknown
142,1,1,Second Failure Type,no known failure
142,1,1,Tumor Site,Unknown
142,1,1,Status,Unknown
142,1,1,Metastasis,Unknown
142,1,1,Overall Stage,Unknown
142,1,1,Treatment Modality,Unknown
142,1,1,Research lab HPV,HPV unknown
142,1,1,Research lab p16,p16 unknown
142,1,1,First Failure Type,no known failure
142,1,1,Nodal Stage,Unknown
143,1,1,Age at Death,68.1
143,1,1,Treatment Modality,CTX-RT
143,1,1,Tumor Site,oropharynx
143,1,1,Second Failure Type,no known failure
143,1,1,Radiation Dosage,70.2
143,1,1,Nodal Stage,N2
143,1,1,Initial Chemotherapy Agent,carbo/tax
143,1,1,Date of Death,1999-05-02 00:00:00
143,1,1,First Failure Type,no known failure
143,1,1,Occurrence #,1st primary
143,1,1,Research lab HPV,HPV negative
143,1,1,Time to Death,4.0
143,1,1,Metastasis,M0
143,1,1,Clinical lab p16,p16 unknown
143,1,1,Overall Stage,IVa
143,1,1,Research lab p16,p16 negative
143,1,1,Status,Dead unk disease
143,1,1,Tumor Stage,T4a
144,1,1,Research lab HPV,HPV unknown
144,1,1,Date of Death,2009-05-01 00:00:00
144,1,1,Tumor Stage,Unknown
144,1,1,First Failure Type,no known failure
144,1,1,Age at Death,94.6
144,1,1,Occurrence #,1st primary
144,1,1,Second Failure Type,no known failure
144,1,1,Overall Stage,IVa
144,1,1,Tumor Site,oropharynx
144,1,1,Clinical lab p16,p16 unknown
144,1,1,Metastasis,Unknown
144,1,1,Treatment Modality,Unknown
144,1,1,Time to Death,13.9
144,1,1,Status,Dead unk disease
144,1,1,Nodal Stage,Unknown
144,1,1,Research lab p16,p16 unknown
145,1,1,Status,Alive w/o disease
145,1,1,Second Failure Type,no known failure
145,1,1,Treatment Modality,Sx
145,1,1,Occurrence #,1st primary
145,1,1,First Failure Type,no known failure
145,1,1,Nodal Stage,N2
145,1,1,Research lab HPV,HPV unknown
145,1,1,Research lab p16,p16 unknown
145,1,1,Metastasis,M0
145,1,1,Tumor Stage,T2
145,1,1,Overall Stage,IVa
145,1,1,Clinical lab p16,p16 unknown
145,1,1,Tumor Site,oropharynx
146,1,1,Clinical lab p16,p16 unknown
146,1,1,Time to Death,0.2
146,1,1,Second Failure Type,no known failure
146,1,1,First Failure Type,no known failure
146,1,1,Tumor Stage,T4a
146,1,1,Treatment Modality,CTX
146,1,1,Research lab HPV,HPV positive
146,1,1,Metastasis,M0
146,1,1,Occurrence #,1st primary
146,1,1,Status,Dead w/ disease
146,1,1,Nodal Stage,N2
146,1,1,Age at Death,53.3
146,1,1,Initial Chemotherapy Agent,carbo/doce
146,1,1,Tumor Site,oropharynx
146,1,1,Research lab p16,p16 negative
146,1,1,Date of Death,2001-09-24 00:00:00
146,1,1,Overall Stage,IVa
147,1,1,Second Failure Type,no known failure
147,1,1,Research lab p16,p16 unknown
147,1,1,Research lab HPV,HPV unknown
147,1,1,Overall Stage,III
147,1,1,Metastasis,M0
147,1,1,Tumor Site,oropharynx
147,1,1,Tumor Stage,T3
147,1,1,First Failure Type,no known failure
147,1,1,Status,Alive w/o disease
147,1,1,Occurrence #,1st primary
147,1,1,Treatment Modality,Sx & RT
147,1,1,Clinical lab p16,p16 unknown
147,1,1,Nodal Stage,N0
147,1,1,Radiation Dosage,63
148,1,1,Metastasis,M0
148,1,1,Tumor Stage,T3
148,1,1,Age at Death,85.0
148,1,1,Date of Death,2006-12-14 00:00:00
148,1,1,Nodal Stage,N3
148,1,1,Status,Dead w/o disease
148,1,1,Occurrence #,1st primary
148,1,1,First Failure Type,no known failure
148,1,1,Research lab HPV,HPV unknown
148,1,1,Second Failure Type,no known failure
148,1,1,Clinical lab p16,p16 unknown
148,1,1,Research lab p16,p16 unknown
148,1,1,Overall Stage,IVb
148,1,1,Radiation Dosage,45
148,1,1,Treatment Modality,CTX-RT
148,1,1,Tumor Site,oropharynx
148,1,1,Time to Death,0.5
148,1,1,Initial Chemotherapy Agent,unknown
149,1,1,Nodal Stage,N2
149,1,1,Radiation Dosage,70.2
149,1,1,Metastasis,M0
149,1,1,Research lab p16,p16 negative
149,1,1,First Failure Type,no known failure
149,1,1,Research lab HPV,HPV negative
149,1,1,Date of Death,1998-01-11 00:00:00
149,1,1,Time to Death,3.9
149,1,1,Second Failure Type,no known failure
149,1,1,Tumor Stage,T2
149,1,1,Clinical lab p16,p16 unknown
149,1,1,Tumor Site,oropharynx
149,1,1,Age at Death,65.7
149,1,1,Status,Dead unk disease
149,1,1,Overall Stage,IVa
149,1,1,Treatment Modality,RT
149,1,1,Occurrence #,1st primary
150,1,1,Occurrence #,1st primary
150,1,1,Tumor Site,oropharynx
150,1,1,Research lab p16,p16 positive
150,1,1,Overall Stage,IVa
150,1,1,Clinical lab p16,p16 unknown
150,1,1,Research lab HPV,HPV unknown
150,1,1,Radiation Dosage,70
150,1,1,Date of Death,2004-06-21 00:00:00
150,1,1,Treatment Modality,CTX-RT
150,1,1,Initial Chemotherapy Agent,carbo/PTX
150,1,1,Age at Death,68.4
150,1,1,Nodal Stage,N1
150,1,1,Status,Dead w/ disease
150,1,1,First Failure Type,locoregional
150,1,1,Second Failure Type,no known failure
150,1,1,Metastasis,M0
150,1,1,Time to First Failure,1.9
150,1,1,Time to Death,2.7
150,1,1,Tumor Stage,T4a
151,1,1,Age at Death,85.9
151,1,1,Date of Death,1997-02-27 00:00:00
151,1,1,Clinical lab p16,p16 unknown
151,1,1,Tumor Site,oral cavity
151,1,1,Metastasis,Unknown
151,1,1,Status,Dead unk disease
151,1,1,Nodal Stage,Unknown
151,1,1,Second Failure Type,no known failure
151,1,1,First Failure Type,no known failure
151,1,1,Tumor Stage,Unknown
151,1,1,Time to Death,3.4
151,1,1,Overall Stage,Unknown
151,1,1,Research lab p16,p16 unknown
151,1,1,Research lab HPV,HPV unknown
151,1,1,Occurrence #,Unknown
151,1,1,Treatment Modality,Unknown
152,1,1,Status,Dead w/ disease
152,1,1,Radiation Dosage,70.2
152,1,1,Second Failure Type,no known failure
152,1,1,Clinical lab p16,p16 unknown
152,1,1,Occurrence #,1st primary
152,1,1,Treatment Modality,CTX-RT
152,1,1,Tumor Site,oropharynx
152,1,1,Time to Death,0.8
152,1,1,Age at Death,50.6
152,1,1,Overall Stage,IVa
152,1,1,Date of Death,1996-04-01 00:00:00
152,1,1,Metastasis,M0
152,1,1,Research lab HPV,HPV positive
152,1,1,Research lab p16,p16 positive
152,1,1,Initial Chemotherapy Agent,carbo/PTX
152,1,1,First Failure Type,locoregional
152,1,1,Tumor Stage,T3
152,1,1,Nodal Stage,N2
152,1,1,Time to First Failure,0.1
153,1,1,Age at Death,60.9
153,1,1,Time to Death,3.9
153,1,1,Research lab p16,p16 positive
153,1,1,Occurrence #,1st primary
153,1,1,First Failure Type,distant
153,1,1,Time to First Failure,0.9
153,1,1,Treatment Modality,CTX-RT
153,1,1,Research lab HPV,HPV unknown
153,1,1,Tumor Site,oropharynx
153,1,1,Metastasis,M0
153,1,1,Nodal Stage,N2
153,1,1,Clinical lab p16,p16 unknown
153,1,1,Initial Chemotherapy Agent,carbo/PTX
153,1,1,Status,Dead w/ disease
153,1,1,Tumor Stage,T4a
153,1,1,Second Failure Type,no known failure
153,1,1,Radiation Dosage,70.2
153,1,1,Date of Death,2007-07-29 00:00:00
153,1,1,Overall Stage,IVa
154,1,1,Research lab p16,p16 negative
154,1,1,Time to First Failure,0.2
154,1,1,Clinical lab p16,p16 unknown
154,1,1,Metastasis,M0
154,1,1,Age at Death,51.8
154,1,1,Research lab HPV,HPV negative
154,1,1,First Failure Type,locoregional
154,1,1,Date of Death,2004-03-30 00:00:00
154,1,1,Tumor Stage,T4a
154,1,1,Time to Death,0.6
154,1,1,Overall Stage,IVa
154,1,1,Second Failure Type,no known failure
154,1,1,Occurrence #,1st primary
154,1,1,Treatment Modality,Sx
154,1,1,Nodal Stage,N0
154,1,1,Tumor Site,oropharynx
154,1,1,Status,Dead w/ disease
155,1,1,Metastasis,Unknown
155,1,1,Occurrence #,1st primary
155,1,1,Treatment Modality,Unknown
155,1,1,Research lab HPV,HPV unknown
155,1,1,Overall Stage,Unknown
155,1,1,Research lab p16,p16 unknown
155,1,1,Clinical lab p16,p16 unknown
155,1,1,Second Failure Type,no known failure
155,1,1,Nodal Stage,Unknown
155,1,1,Status,Unknown
155,1,1,First Failure Type,no known failure
155,1,1,Tumor Site,Unknown
155,1,1,Tumor Stage,Unknown
156,1,1,Treatment Modality,CTX-RT
156,1,1,Research lab p16,p16 unknown
156,1,1,Occurrence #,1st primary
156,1,1,Tumor Site,oropharynx
156,1,1,Research lab HPV,HPV unknown
156,1,1,First Failure Type,no known failure
156,1,1,Date of Death,2003-09-10 00:00:00
156,1,1,Status,Dead w/o disease
156,1,1,Time to Death,5.7
156,1,1,Overall Stage,IVa
156,1,1,Second Failure Type,no known failure
156,1,1,Nodal Stage,N2
156,1,1,Clinical lab p16,p16 unknown
156,1,1,Initial Chemotherapy Agent,carbo/doce
156,1,1,Metastasis,M0
156,1,1,Age at Death,59.2
156,1,1,Radiation Dosage,70.2
156,1,1,Tumor Stage,T4a
157,1,1,Metastasis,M0
157,1,1,Tumor Site,oropharynx
157,1,1,Second Failure Type,no known failure
157,1,1,Overall Stage,IVa
157,1,1,Radiation Dosage,70.2
157,1,1,Research lab HPV,HPV unknown
157,1,1,First Failure Type,no known failure
157,1,1,Tumor Stage,T4a
157,1,1,Time to Death,1.0
157,1,1,Date of Death,2000-04-28 00:00:00
157,1,1,Status,Dead w/o disease
157,1,1,Age at Death,51.1
157,1,1,Research lab p16,p16 unknown
157,1,1,Nodal Stage,N2
157,1,1,Occurrence #,Unknown
157,1,1,Treatment Modality,CTX-RT
157,1,1,Initial Chemotherapy Agent,carbo/doce
157,1,1,Clinical lab p16,p16 unknown
158,1,1,Clinical lab p16,p16 unknown
158,1,1,Treatment Modality,CTX-RT
158,1,1,Date of Death,2005-05-14 00:00:00
158,1,1,Time to Death,3.3
158,1,1,Research lab p16,p16 unknown
158,1,1,Age at Death,62.5
158,1,1,Overall Stage,III
158,1,1,Nodal Stage,N0
158,1,1,First Failure Site,oropharynx
158,1,1,Research lab HPV,HPV unknown
158,1,1,Second Failure Type,no known failure
158,1,1,Time to First Failure,1.2
158,1,1,Tumor Site,oropharynx
158,1,1,Occurrence #,1st primary
158,1,1,First Failure Treatment Modality,Sx
158,1,1,Metastasis,M0
158,1,1,Status,Dead unk disease
158,1,1,Tumor Stage,T3
158,1,1,Initial Chemotherapy Agent,carbo/PTX
158,1,1,First Failure Type,locoregional
158,1,1,Radiation Dosage,72
159,1,1,Status,Dead w/o disease
159,1,1,Metastasis,M0
159,1,1,Nodal Stage,N0
159,1,1,Date of Death,1994-03-15 00:00:00
159,1,1,Overall Stage,III
159,1,1,Tumor Site,oropharynx
159,1,1,Occurrence #,1st primary
159,1,1,Time to Death,2.1
159,1,1,Second Failure Type,no known failure
159,1,1,Radiation Dosage,59.4
159,1,1,Tumor Stage,T3
159,1,1,Research lab HPV,HPV negative
159,1,1,Treatment Modality,RT
159,1,1,Age at Death,60.4
159,1,1,Research lab p16,p16 negative
159,1,1,Clinical lab p16,p16 unknown
159,1,1,First Failure Type,no known failure
160,1,1,Treatment Modality,RT
160,1,1,Overall Stage,IVb
160,1,1,First Failure Site,oral cavity
160,1,1,Tumor Stage,T1
160,1,1,Time to Death,6.0
160,1,1,Occurrence #,1st primary
160,1,1,Second Failure Type,no known failure
160,1,1,Date of Death,1999-07-18 00:00:00
160,1,1,First Failure Type,no known failure
160,1,1,Tumor Site,oropharynx
160,1,1,Status,Dead unk disease
160,1,1,Research lab p16,p16 unknown
160,1,1,Clinical lab p16,p16 unknown
160,1,1,First Failure Treatment Modality,Sx
160,1,1,Age at Death,46.5
160,1,1,Research lab HPV,HPV unknown
160,1,1,Nodal Stage,N3
160,1,1,Metastasis,M0
160,1,1,Radiation Dosage,68
161,1,1,Occurrence #,1st primary
161,1,1,Tumor Site,oropharynx
161,1,1,Overall Stage,IVb
161,1,1,Treatment Modality,Unknown
161,1,1,Research lab p16,p16 positive
161,1,1,Clinical lab p16,p16 unknown
161,1,1,Age at Death,43.2
161,1,1,Metastasis,M0
161,1,1,Tumor Stage,T3
161,1,1,Second Failure Type,no known failure
161,1,1,Nodal Stage,N3
161,1,1,Date of Death,2005-04-13 00:00:00
161,1,1,Research lab HPV,HPV positive
161,1,1,Status,Dead w/ disease
161,1,1,Time to Death,1.9
161,1,1,First Failure Type,no known failure
162,1,1,Second Failure Type,no known failure
162,1,1,Tumor Stage,T4a
162,1,1,Research lab p16,p16 positive
162,1,1,Treatment Modality,CTX-RT
162,1,1,Status,Alive w/o disease
162,1,1,Clinical lab p16,p16 unknown
162,1,1,Research lab HPV,HPV positive
162,1,1,First Failure Type,no known failure
162,1,1,Tumor Site,oropharynx
162,1,1,Metastasis,M0
162,1,1,Initial Chemotherapy Agent,carbo/PTX
162,1,1,Radiation Dosage,70.2
162,1,1,Overall Stage,IVa
162,1,1,Occurrence #,1st primary
162,1,1,Nodal Stage,N1
163,1,1,Research lab HPV,HPV unknown
163,1,1,Nodal Stage,Unknown
163,1,1,Tumor Stage,Unknown
163,1,1,Second Failure Type,no known failure
163,1,1,Overall Stage,Unknown
163,1,1,Clinical lab p16,p16 unknown
163,1,1,Status,Unknown
163,1,1,Research lab p16,p16 unknown
163,1,1,Treatment Modality,Unknown
163,1,1,Tumor Site,oropharynx
163,1,1,First Failure Type,no known failure
163,1,1,Occurrence #,1st primary
163,1,1,Metastasis,Unknown
164,1,1,First Failure Type,no known failure
164,1,1,Clinical lab p16,p16 unknown
164,1,1,Metastasis,M0
164,1,1,Nodal Stage,N2
164,1,1,Second Failure Type,no known failure
164,1,1,Radiation Dosage,unknown
164,1,1,Tumor Stage,T3
164,1,1,Research lab HPV,HPV unknown
164,1,1,Status,Dead unk disease
164,1,1,Treatment Modality,RT
164,1,1,Overall Stage,IVa
164,1,1,Age at Death,51.1
164,1,1,Occurrence #,1st primary
164,1,1,Time to Death,0.4
164,1,1,Date of Death,2004-03-03 00:00:00
164,1,1,Tumor Site,oropharynx
164,1,1,Research lab p16,p16 unknown
165,1,1,Tumor Stage,T2
165,1,1,Metastasis,M0
165,1,1,Research lab HPV,HPV unknown
165,1,1,Research lab p16,p16 positive
165,1,1,Overall Stage,IVa
165,1,1,Second Failure Type,no known failure
165,1,1,Status,Alive w/ disease
165,1,1,Tumor Site,oropharynx
165,1,1,First Failure Type,no known failure
165,1,1,Treatment Modality,Unknown
165,1,1,Occurrence #,1st primary
165,1,1,Nodal Stage,N2
165,1,1,Clinical lab p16,p16 unknown
166,1,1,Date of Death,1998-09-12 00:00:00
166,1,1,Status,Dead w/ disease
166,1,1,Treatment Modality,CTX-RT
166,1,1,Radiation Dosage,70.2
166,1,1,Second Failure Type,no known failure
166,1,1,Research lab p16,p16 unknown
166,1,1,Tumor Site,oropharynx
166,1,1,Research lab HPV,HPV unknown
166,1,1,Tumor Stage,T4a
166,1,1,First Failure Type,no known failure
166,1,1,Initial Chemotherapy Agent,carbo/doce
166,1,1,Occurrence #,1st primary
166,1,1,Age at Death,74.4
166,1,1,Metastasis,M0
166,1,1,Clinical lab p16,p16 unknown
166,1,1,Nodal Stage,N2
166,1,1,Overall Stage,IVa
167,1,1,First Failure Type,no known failure
167,1,1,Research lab p16,p16 negative
167,1,1,Research lab HPV,HPV negative
167,1,1,Overall Stage,IVa
167,1,1,Second Failure Type,no known failure
167,1,1,Radiation Dosage,unknown
167,1,1,Time to Death,0.6
167,1,1,Treatment Modality,CTX-RT
167,1,1,Date of Death,2001-12-12 00:00:00
167,1,1,Status,Dead unk disease
167,1,1,Nodal Stage,N2
167,1,1,Age at Death,71.9
167,1,1,Tumor Site,oropharynx
167,1,1,Occurrence #,1st primary
167,1,1,Tumor Stage,T4a
167,1,1,Clinical lab p16,p16 unknown
167,1,1,Metastasis,M0
167,1,1,Initial Chemotherapy Agent,unknown
168,1,1,Time to Death,1.4
168,1,1,Tumor Site,oropharynx
168,1,1,Second Failure Type,no known failure
168,1,1,Treatment Modality,Unknown
168,1,1,Status,Dead unk disease
168,1,1,Occurrence #,1st primary
168,1,1,Age at Death,52.1
168,1,1,Metastasis,M0
168,1,1,Nodal Stage,N3
168,1,1,Date of Death,2000-10-31 00:00:00
168,1,1,Tumor Stage,T3
168,1,1,First Failure Type,no known failure
168,1,1,Research lab HPV,HPV negative
168,1,1,Research lab p16,p16 negative
168,1,1,Clinical lab p16,p16 unknown
168,1,1,Overall Stage,IVb
169,1,1,Second Failure Type,no known failure
169,1,1,Research lab p16,p16 unknown
169,1,1,Status,Unknown
169,1,1,Research lab HPV,HPV unknown
169,1,1,Occurrence #,1st primary
169,1,1,Metastasis,Unknown
169,1,1,Tumor Stage,Unknown
169,1,1,Nodal Stage,Unknown
169,1,1,Treatment Modality,Unknown
169,1,1,First Failure Type,no known failure
169,1,1,Overall Stage,Unknown
169,1,1,Clinical lab p16,p16 unknown
169,1,1,Tumor Site,Unknown
170,1,1,Age at Death,64.3
170,1,1,Overall Stage,IVa
170,1,1,Nodal Stage,N2
170,1,1,Initial Chemotherapy Agent,carbo/ PTX
170,1,1,Metastasis,M0
170,1,1,First Failure Type,locoregional
170,1,1,Time to Death,1.7
170,1,1,Occurrence #,1st primary
170,1,1,Radiation Dosage,70.2
170,1,1,Status,Dead w/ disease
170,1,1,Tumor Stage,T2
170,1,1,Time to First Failure,1.3
170,1,1,Treatment Modality,CTX-RT
170,1,1,Date of Death,2004-07-29 00:00:00
170,1,1,Tumor Site,oropharynx
170,1,1,Research lab HPV,HPV unknown
170,1,1,Clinical lab p16,p16 unknown
170,1,1,Research lab p16,p16 unknown
170,1,1,Second Failure Type,no known failure
171,1,1,Date of Death,2006-08-13 00:00:00
171,1,1,Occurrence #,1st primary
171,1,1,Research lab p16,p16 negative
171,1,1,Tumor Site,oropharynx
171,1,1,Time to First Failure,1.0
171,1,1,Age at Death,65.6
171,1,1,Time to Death,1.6
171,1,1,Clinical lab p16,p16 unknown
171,1,1,Second Failure Type,no known failure
171,1,1,Status,Dead w/ disease
171,1,1,Nodal Stage,N2
171,1,1,Overall Stage,IVa
171,1,1,Radiation Dosage,70.2
171,1,1,First Failure Type,locoregional and distant
171,1,1,Metastasis,M0
171,1,1,Treatment Modality,CTX-RT
171,1,1,Initial Chemotherapy Agent,"carbo, PTX"
171,1,1,Tumor Stage,T3
171,1,1,Research lab HPV,HPV negative
172,1,1,Second Failure Type,no known failure
172,1,1,Clinical lab p16,p16 unknown
172,1,1,Age at Death,57.2
172,1,1,Time to First Failure,0.5
172,1,1,Tumor Stage,T4a
172,1,1,Tumor Site,oropharynx
172,1,1,Research lab p16,p16 negative
172,1,1,Initial Chemotherapy Agent,carbo/doce
172,1,1,Research lab HPV,HPV negative
172,1,1,First Failure Type,locoregional
172,1,1,Occurrence #,1st primary
172,1,1,Time to Death,1.1
172,1,1,Overall Stage,IVb
172,1,1,Metastasis,M0
172,1,1,Nodal Stage,N3
172,1,1,Status,Dead w/ disease
172,1,1,Treatment Modality,CTX-RT
172,1,1,Radiation Dosage,70.2
172,1,1,Date of Death,2004-01-02 00:00:00
173,1,1,Metastasis,M0
173,1,1,Research lab HPV,HPV unknown
173,1,1,Occurrence #,recurrence
173,1,1,Tumor Stage,T1
173,1,1,Overall Stage,IVa
173,1,1,Research lab p16,p16 unknown
173,1,1,Clinical lab p16,p16 unknown
173,1,1,Treatment Modality,Sx
173,1,1,First Failure Type,locoregional
173,1,1,Tumor Site,oropharynx
173,1,1,Time to First Failure,-0.0
173,1,1,Nodal Stage,N2
173,1,1,Second Failure Type,no known failure
173,1,1,Status,Alive unk disease
174,1,1,Nodal Stage,N3
174,1,1,Metastasis,M0
174,1,1,Tumor Site,oropharynx
174,1,1,Clinical lab p16,p16 unknown
174,1,1,Overall Stage,IVb
174,1,1,Status,Alive w/ disease
174,1,1,Tumor Stage,T4b
174,1,1,Treatment Modality,Unknown
174,1,1,Second Failure Type,no known failure
174,1,1,Occurrence #,1st primary
174,1,1,First Failure Type,no known failure
174,1,1,Research lab HPV,HPV unknown
174,1,1,Research lab p16,p16 unknown
175,1,1,Age at Death,67.7
175,1,1,Nodal Stage,N3
175,1,1,Metastasis,M0
175,1,1,Second Failure Type,no known failure
175,1,1,Radiation Dosage,135
175,1,1,Tumor Stage,T3
175,1,1,Occurrence #,1st primary
175,1,1,Status,Dead unk disease
175,1,1,Research lab p16,p16 unknown
175,1,1,Date of Death,2008-10-17 00:00:00
175,1,1,Clinical lab p16,p16 unknown
175,1,1,Research lab HPV,HPV unknown
175,1,1,Treatment Modality,Sx & CTX-RT
175,1,1,Overall Stage,IVb
175,1,1,Tumor Site,oropharynx
175,1,1,Initial Chemotherapy Agent,cis
175,1,1,Time to Death,0.4
175,1,1,First Failure Type,no known failure
176,1,1,Occurrence #,1st primary
176,1,1,Metastasis,M0
176,1,1,Status,Dead w/ disease
176,1,1,Research lab p16,p16 unknown
176,1,1,Date of Death,2005-10-07 00:00:00
176,1,1,Initial Chemotherapy Agent,carbo/doce
176,1,1,Clinical lab p16,p16 unknown
176,1,1,Age at Death,57.7
176,1,1,First Failure Type,locoregional
176,1,1,Research lab HPV,HPV unknown
176,1,1,Second Failure Type,no known failure
176,1,1,Tumor Stage,T2
176,1,1,Radiation Dosage,70.2
176,1,1,Tumor Site,oropharynx
176,1,1,Nodal Stage,N2
176,1,1,Time to First Failure,0.6
176,1,1,Overall Stage,IVa
176,1,1,Treatment Modality,CTX-RT
176,1,1,Time to Death,1.7
177,1,1,Treatment Modality,Unknown
177,1,1,Tumor Stage,T3
177,1,1,Occurrence #,1st primary
177,1,1,Status,Dead w/ disease
177,1,1,First Failure Type,no known failure
177,1,1,Research lab HPV,HPV negative
177,1,1,Research lab p16,p16 negative
177,1,1,Time to Death,0.2
177,1,1,Metastasis,M0
177,1,1,Nodal Stage,N2
177,1,1,Second Failure Type,no known failure
177,1,1,Clinical lab p16,p16 unknown
177,1,1,Date of Death,2004-12-30 00:00:00
177,1,1,Tumor Site,oropharynx
177,1,1,Age at Death,47.9
177,1,1,Overall Stage,IVa
178,1,1,First Failure Type,distant
178,1,1,Date of Death,2003-08-29 00:00:00
178,1,1,Research lab HPV,HPV negative
178,1,1,Occurrence #,1st primary
178,1,1,Initial Chemotherapy Agent,carbo/PTX
178,1,1,Radiation Dosage,70.2
178,1,1,Status,Dead w/ disease
178,1,1,Overall Stage,IVa
178,1,1,Tumor Site,oropharynx
178,1,1,Nodal Stage,N2
178,1,1,Research lab p16,p16 negative
178,1,1,Clinical lab p16,p16 unknown
178,1,1,Age at Death,66.3
178,1,1,Time to Death,0.7
178,1,1,Tumor Stage,T4a
178,1,1,Metastasis,M0
178,1,1,Time to First Failure,0.4
178,1,1,Second Failure Type,no known failure
178,1,1,Treatment Modality,CTX-RT
179,1,1,First Failure Type,no known failure
179,1,1,Overall Stage,Unknown
179,1,1,Age at Death,66.1
179,1,1,Tumor Site,Unknown
179,1,1,Second Failure Type,no known failure
179,1,1,Nodal Stage,Unknown
179,1,1,Status,Dead unk disease
179,1,1,Research lab p16,p16 unknown
179,1,1,Tumor Stage,Unknown
179,1,1,Metastasis,Unknown
179,1,1,Treatment Modality,Unknown
179,1,1,Occurrence #,1st primary
179,1,1,Research lab HPV,HPV unknown
179,1,1,Clinical lab p16,p16 unknown
179,1,1,Date of Death,2001-08-08 00:00:00
179,1,1,Time to Death,1.5
180,1,1,Time to Death,1.0
180,1,1,Nodal Stage,N2
180,1,1,Treatment Modality,CTX-RT
180,1,1,Metastasis,M0
180,1,1,Status,Dead w/ disease
180,1,1,Research lab p16,p16 unknown
180,1,1,Occurrence #,1st primary
180,1,1,Tumor Stage,T3
180,1,1,First Failure Treatment Modality,Sx
180,1,1,Tumor Site,oropharynx
180,1,1,Age at Death,71.9
180,1,1,Time to First Failure,0.1
180,1,1,Radiation Dosage,70.2
180,1,1,First Failure Site,oropharynx
180,1,1,Overall Stage,IVa
180,1,1,Clinical lab p16,p16 unknown
180,1,1,Research lab HPV,HPV unknown
180,1,1,Initial Chemotherapy Agent,cis
180,1,1,First Failure Type,locoregional
180,1,1,Second Failure Type,no known failure
180,1,1,Date of Death,2007-09-15 00:00:00
181,1,1,Initial Chemotherapy Agent,carbo
181,1,1,Date of Death,1998-04-30 00:00:00
181,1,1,Tumor Stage,T4a
181,1,1,Second Failure Type,no known failure
181,1,1,Nodal Stage,N2
181,1,1,Clinical lab p16,p16 unknown
181,1,1,Age at Death,47.1
181,1,1,Research lab p16,p16 unknown
181,1,1,Tumor Site,oral cavity
181,1,1,Overall Stage,IVa
181,1,1,Time to Death,1.7
181,1,1,Metastasis,M0
181,1,1,Occurrence #,1st primary
181,1,1,Treatment Modality,Sx & CTX-RT
181,1,1,Time to First Failure,0.3
181,1,1,Research lab HPV,HPV unknown
181,1,1,First Failure Type,locoregional
181,1,1,Radiation Dosage,70.2
181,1,1,Status,Dead w/ disease
182,1,1,First Failure Type,locoregional
182,1,1,Metastasis,M0
182,1,1,Research lab HPV,HPV negative
182,1,1,Time to First Failure,0.1
182,1,1,Age at Death,67.9
182,1,1,Tumor Site,oropharynx
182,1,1,Occurrence #,1st primary
182,1,1,Date of Death,2002-07-30 00:00:00
182,1,1,Second Failure Type,no known failure
182,1,1,Treatment Modality,CTX-RT
182,1,1,Initial Chemotherapy Agent,carbo/doce
182,1,1,Clinical lab p16,p16 unknown
182,1,1,Radiation Dosage,72
182,1,1,Nodal Stage,N2
182,1,1,Time to Death,0.6
182,1,1,Tumor Stage,T4a
182,1,1,Research lab p16,p16 negative
182,1,1,Overall Stage,IVa
182,1,1,Status,Dead w/ disease
183,1,1,Clinical lab p16,p16 unknown
183,1,1,Treatment Modality,Unknown
183,1,1,Research lab HPV,HPV unknown
183,1,1,Tumor Site,Unknown
183,1,1,Second Failure Type,no known failure
183,1,1,Research lab p16,p16 unknown
183,1,1,Occurrence #,1st primary
183,1,1,First Failure Type,no known failure
183,1,1,Metastasis,Unknown
183,1,1,Nodal Stage,Unknown
183,1,1,Overall Stage,Unknown
183,1,1,Status,Unknown
183,1,1,Tumor Stage,Unknown
184,1,1,Overall Stage,Unknown
184,1,1,Second Failure Type,no known failure
184,1,1,Tumor Stage,Unknown
184,1,1,Research lab HPV,HPV unknown
184,1,1,Treatment Modality,Unknown
184,1,1,Occurrence #,1st primary
184,1,1,Metastasis,Unknown
184,1,1,First Failure Type,no known failure
184,1,1,Tumor Site,Unknown
184,1,1,Nodal Stage,Unknown
184,1,1,Clinical lab p16,p16 unknown
184,1,1,Research lab p16,p16 unknown
184,1,1,Status,Unknown
185,1,1,Age at Death,50.3
185,1,1,First Failure Initial Chemotherapy Agent,cap
185,1,1,Tumor Site,oropharynx
185,1,1,Occurrence #,1st primary
185,1,1,Date of Death,2006-07-15 00:00:00
185,1,1,Research lab p16,p16 negative
185,1,1,Metastasis,M0
185,1,1,Nodal Stage,N2
185,1,1,Clinical lab p16,p16 unknown
185,1,1,Research lab HPV,HPV negative
185,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
185,1,1,First Failure Treatment Modality,CTX
185,1,1,Tumor Stage,T4b
185,1,1,First Failure Site,oropharynx
185,1,1,Treatment Modality,CTX-RT
185,1,1,Time to First Failure,0.3
185,1,1,Time to Death,1.1
185,1,1,Radiation Dosage,70.2
185,1,1,Status,Dead w/ disease
185,1,1,Second Failure Type,no known failure
185,1,1,Overall Stage,IVb
185,1,1,First Failure Type,locoregional
186,1,1,Tumor Site,oropharynx
186,1,1,Radiation Dosage,70.2
186,1,1,Age at Death,51.5
186,1,1,First Failure Type,no known failure
186,1,1,Nodal Stage,N2
186,1,1,Treatment Modality,CTX-RT
186,1,1,Overall Stage,IVa
186,1,1,Initial Chemotherapy Agent,carbo/doce
186,1,1,Second Failure Type,no known failure
186,1,1,Occurrence #,1st primary
186,1,1,Date of Death,2000-06-15 00:00:00
186,1,1,Tumor Stage,T4a
186,1,1,Status,Dead unk disease
186,1,1,Research lab HPV,HPV negative
186,1,1,Clinical lab p16,p16 unknown
186,1,1,Time to Death,1.6
186,1,1,Research lab p16,p16 negative
186,1,1,Metastasis,M0
187,1,1,Research lab HPV,HPV unknown
187,1,1,First Failure Type,no known failure
187,1,1,Clinical lab p16,p16 unknown
187,1,1,Overall Stage,Unknown
187,1,1,Treatment Modality,Unknown
187,1,1,Status,Unknown
187,1,1,Tumor Stage,Unknown
187,1,1,Metastasis,Unknown
187,1,1,Tumor Site,oropharynx
187,1,1,Research lab p16,p16 unknown
187,1,1,Nodal Stage,Unknown
187,1,1,Second Failure Type,no known failure
187,1,1,Occurrence #,1st primary
188,1,1,Initial Chemotherapy Agent,PTX/cap
188,1,1,Occurrence #,1st primary
188,1,1,Clinical lab p16,p16 unknown
188,1,1,Status,Dead unk disease
188,1,1,Radiation Dosage,70.2
188,1,1,First Failure Type,no known failure
188,1,1,Research lab p16,p16 unknown
188,1,1,Time to Death,10.5
188,1,1,Age at Death,59.4
188,1,1,Date of Death,2010-10-21 00:00:00
188,1,1,Tumor Site,oropharynx
188,1,1,Overall Stage,IVa
188,1,1,Nodal Stage,N2
188,1,1,Second Failure Type,no known failure
188,1,1,Research lab HPV,HPV unknown
188,1,1,Metastasis,M0
188,1,1,Tumor Stage,T2
188,1,1,Treatment Modality,CTX-RT
189,1,1,Second Failure Type,no known failure
189,1,1,Research lab HPV,HPV unknown
189,1,1,Overall Stage,Unknown
189,1,1,Metastasis,Unknown
189,1,1,Tumor Site,Unknown
189,1,1,Status,Unknown
189,1,1,Clinical lab p16,p16 unknown
189,1,1,Research lab p16,p16 unknown
189,1,1,Nodal Stage,Unknown
189,1,1,First Failure Type,no known failure
189,1,1,Occurrence #,1st primary
189,1,1,Tumor Stage,Unknown
189,1,1,Treatment Modality,Unknown
190,1,1,Clinical lab p16,p16 unknown
190,1,1,Treatment Modality,CTX-RT
190,1,1,Time to Death,0.5
190,1,1,First Failure Type,no known failure
190,1,1,Tumor Stage,T3
190,1,1,Age at Death,56.5
190,1,1,Status,Dead w/o disease
190,1,1,Initial Chemotherapy Agent,carbo/doce
190,1,1,Nodal Stage,N1
190,1,1,Research lab p16,p16 unknown
190,1,1,Overall Stage,III
190,1,1,Second Failure Type,no known failure
190,1,1,Occurrence #,1st primary
190,1,1,Radiation Dosage,70.2
190,1,1,Tumor Site,oropharynx
190,1,1,Date of Death,2005-07-28 00:00:00
190,1,1,Metastasis,M0
190,1,1,Research lab HPV,HPV unknown
191,1,1,Metastasis,M0
191,1,1,Tumor Stage,T2
191,1,1,Research lab HPV,HPV unknown
191,1,1,Treatment Modality,CTX-RT
191,1,1,Initial Chemotherapy Agent,unk
191,1,1,Status,Alive w/o disease
191,1,1,Nodal Stage,N2
191,1,1,Research lab p16,p16 unknown
191,1,1,Overall Stage,IVa
191,1,1,Second Failure Type,no known failure
191,1,1,Occurrence #,1st primary
191,1,1,First Failure Type,no known failure
191,1,1,Clinical lab p16,p16 unknown
191,1,1,Tumor Site,oropharynx
191,1,1,Radiation Dosage,unknown
192,1,1,Tumor Stage,T2
192,1,1,Initial Chemotherapy Agent,unknown
192,1,1,Treatment Modality,CTX-RT
192,1,1,Overall Stage,IVa
192,1,1,Nodal Stage,N2
192,1,1,Research lab p16,p16 negative
192,1,1,Tumor Site,oropharynx
192,1,1,Occurrence #,1st primary
192,1,1,Second Failure Type,no known failure
192,1,1,Metastasis,M0
192,1,1,First Failure Type,no known failure
192,1,1,Radiation Dosage,70.2
192,1,1,Status,Dead unk disease
192,1,1,Clinical lab p16,p16 unknown
192,1,1,Date of Death,1996-11-15 00:00:00
192,1,1,Research lab HPV,HPV negative
192,1,1,Age at Death,47.3
192,1,1,Time to Death,2.6
193,1,1,Research lab HPV,HPV unknown
193,1,1,First Failure Type,locoregional
193,1,1,Occurrence #,1st primary
193,1,1,Metastasis,M0
193,1,1,Time to Death,2.0
193,1,1,Research lab p16,p16 unknown
193,1,1,Tumor Site,oral cavity
193,1,1,Overall Stage,II
193,1,1,Second Failure Type,no known failure
193,1,1,Status,Dead unk disease
193,1,1,First Failure Treatment Modality,Sx
193,1,1,Date of Death,2005-04-27 00:00:00
193,1,1,Treatment Modality,RT
193,1,1,Age at Death,68.1
193,1,1,Clinical lab p16,p16 unknown
193,1,1,First Failure Site,oral cavity
193,1,1,Nodal Stage,N0
193,1,1,Tumor Stage,T2
194,1,1,Occurrence #,1st primary
194,1,1,Tumor Stage,T4a
194,1,1,First Failure Type,no known failure
194,1,1,Status,Dead w/ disease
194,1,1,Metastasis,M1
194,1,1,Tumor Site,oropharynx
194,1,1,Overall Stage,IVc
194,1,1,Clinical lab p16,p16 unknown
194,1,1,Date of Death,2006-04-06 00:00:00
194,1,1,Research lab HPV,HPV negative
194,1,1,Age at Death,55.7
194,1,1,Treatment Modality,Unknown
194,1,1,Nodal Stage,N2
194,1,1,Time to Death,0.2
194,1,1,Second Failure Type,no known failure
194,1,1,Research lab p16,p16 negative
195,1,1,Overall Stage,IVa
195,1,1,Clinical lab p16,p16 unknown
195,1,1,Tumor Site,oropharynx
195,1,1,Research lab HPV,HPV unknown
195,1,1,Treatment Modality,Unknown
195,1,1,Occurrence #,1st primary
195,1,1,Time to Death,0.0
195,1,1,First Failure Type,no known failure
195,1,1,Metastasis,M0
195,1,1,Age at Death,74.4
195,1,1,Second Failure Type,no known failure
195,1,1,Nodal Stage,N0
195,1,1,Date of Death,2001-04-06 00:00:00
195,1,1,Tumor Stage,T4a
195,1,1,Status,Dead w/ disease
195,1,1,Research lab p16,p16 unknown
196,1,1,Time to Death,0.1
196,1,1,Nodal Stage,N2
196,1,1,Research lab p16,p16 negative
196,1,1,First Failure Type,no known failure
196,1,1,Status,Dead w/ disease
196,1,1,Second Failure Type,no known failure
196,1,1,Radiation Dosage,54
196,1,1,Treatment Modality,RT
196,1,1,Occurrence #,1st primary
196,1,1,Age at Death,63.2
196,1,1,Overall Stage,IVa
196,1,1,Tumor Site,oropharynx
196,1,1,Metastasis,M0
196,1,1,Clinical lab p16,p16 unknown
196,1,1,Research lab HPV,HPV negative
196,1,1,Date of Death,1995-04-16 00:00:00
196,1,1,Tumor Stage,T4a
197,1,1,Metastasis,M0
197,1,1,Research lab HPV,HPV positive
197,1,1,Tumor Stage,T3
197,1,1,Treatment Modality,Sx & CTX-RT
197,1,1,Second Failure Type,no known failure
197,1,1,Initial Chemotherapy Agent,cis
197,1,1,Overall Stage,IVa
197,1,1,Clinical lab p16,p16 unknown
197,1,1,Occurrence #,1st primary
197,1,1,Tumor Site,oropharynx
197,1,1,Research lab p16,p16 positive
197,1,1,Nodal Stage,N2
197,1,1,Status,Alive w/o disease
197,1,1,First Failure Type,no known failure
197,1,1,Radiation Dosage,70.2
198,1,1,Tumor Stage,Unknown
198,1,1,Second Failure Type,no known failure
198,1,1,Status,Unknown
198,1,1,Nodal Stage,Unknown
198,1,1,Research lab HPV,HPV unknown
198,1,1,Research lab p16,p16 unknown
198,1,1,Overall Stage,Unknown
198,1,1,Tumor Site,Unknown
198,1,1,First Failure Type,no known failure
198,1,1,Metastasis,Unknown
198,1,1,Treatment Modality,Unknown
198,1,1,Occurrence #,1st primary
198,1,1,Clinical lab p16,p16 unknown
199,1,1,Tumor Stage,T4a
199,1,1,Treatment Modality,CTX-RT
199,1,1,Clinical lab p16,p16 unknown
199,1,1,Overall Stage,IVa
199,1,1,Radiation Dosage,70.8
199,1,1,Second Failure Type,no known failure
199,1,1,Tumor Site,oropharynx
199,1,1,Status,Alive w/o disease
199,1,1,First Failure Type,no known failure
199,1,1,Metastasis,M0
199,1,1,Occurrence #,1st primary
199,1,1,Research lab p16,p16 unknown
199,1,1,Initial Chemotherapy Agent,unknown
199,1,1,Nodal Stage,N1
199,1,1,Research lab HPV,HPV unknown
200,1,1,Clinical lab p16,p16 unknown
200,1,1,Research lab p16,p16 negative
200,1,1,Metastasis,M0
200,1,1,Treatment Modality,CTX-RT
200,1,1,Radiation Dosage,72
200,1,1,Nodal Stage,N2
200,1,1,Initial Chemotherapy Agent,cis
200,1,1,First Failure Type,no known failure
200,1,1,Research lab HPV,HPV negative
200,1,1,Overall Stage,IVa
200,1,1,Second Failure Type,no known failure
200,1,1,Tumor Site,oropharynx
200,1,1,Occurrence #,1st primary
200,1,1,Status,Alive w/o disease
200,1,1,Tumor Stage,T3
201,1,1,Tumor Stage,T4a
201,1,1,First Failure Type,locoregional
201,1,1,Second Failure Type,no known failure
201,1,1,Occurrence #,1st primary
201,1,1,Time to First Failure,0.3
201,1,1,Treatment Modality,CTX-RT
201,1,1,Clinical lab p16,p16 unknown
201,1,1,Overall Stage,IVa
201,1,1,Status,Dead w/ disease
201,1,1,Research lab HPV,HPV unknown
201,1,1,Tumor Site,oropharynx
201,1,1,Initial Chemotherapy Agent,carbo/doce
201,1,1,Research lab p16,p16 unknown
201,1,1,Time to Death,1.2
201,1,1,Metastasis,M0
201,1,1,Nodal Stage,N2
201,1,1,Radiation Dosage,70.2
201,1,1,Date of Death,1999-04-15 00:00:00
201,1,1,Age at Death,58.0
202,1,1,Metastasis,M0
202,1,1,Tumor Site,oropharynx
202,1,1,Nodal Stage,N2
202,1,1,Initial Chemotherapy Agent,carbo
202,1,1,Research lab HPV,HPV negative
202,1,1,Second Failure Type,no known failure
202,1,1,Clinical lab p16,p16 unknown
202,1,1,Radiation Dosage,30
202,1,1,Overall Stage,IVa
202,1,1,Occurrence #,1st primary
202,1,1,Date of Death,1994-08-16 00:00:00
202,1,1,Tumor Stage,T4a
202,1,1,Treatment Modality,CTX-RT
202,1,1,Research lab p16,p16 negative
202,1,1,First Failure Type,no known failure
202,1,1,Status,Dead w/o disease
202,1,1,Time to Death,0.3
202,1,1,Age at Death,63.6
203,1,1,Nodal Stage,N2
203,1,1,Clinical lab p16,p16 unknown
203,1,1,Research lab p16,p16 unknown
203,1,1,Treatment Modality,CTX-RT
203,1,1,Occurrence #,1st primary
203,1,1,Radiation Dosage,70.2
203,1,1,Second Failure Type,no known failure
203,1,1,Initial Chemotherapy Agent,carbo/doce
203,1,1,Metastasis,M0
203,1,1,Tumor Site,oropharynx
203,1,1,Status,Alive w/o disease
203,1,1,First Failure Type,no known failure
203,1,1,Research lab HPV,HPV unknown
203,1,1,Overall Stage,IVa
203,1,1,Tumor Stage,T2
204,1,1,Age at Death,74.8
204,1,1,Tumor Site,oropharynx
204,1,1,Overall Stage,IVc
204,1,1,Occurrence #,Unknown
204,1,1,Status,Dead unk disease
204,1,1,Date of Death,2007-08-19 00:00:00
204,1,1,Time to Death,1.5
204,1,1,Treatment Modality,Unknown
204,1,1,Second Failure Type,no known failure
204,1,1,Tumor Stage,Unknown
204,1,1,Research lab HPV,HPV unknown
204,1,1,First Failure Type,no known failure
204,1,1,Nodal Stage,Unknown
204,1,1,Clinical lab p16,p16 unknown
204,1,1,Metastasis,M1
204,1,1,Research lab p16,p16 unknown
205,1,1,First Failure Type,no known failure
205,1,1,Research lab HPV,HPV negative
205,1,1,Tumor Site,oropharynx
205,1,1,Metastasis,M0
205,1,1,Radiation Dosage,unknown
205,1,1,Treatment Modality,CTX-RT
205,1,1,Overall Stage,IVa
205,1,1,Research lab p16,p16 negative
205,1,1,Clinical lab p16,p16 unknown
205,1,1,Tumor Stage,Unknown
205,1,1,Time to Death,2.9
205,1,1,Date of Death,2000-01-26 00:00:00
205,1,1,Second Failure Type,no known failure
205,1,1,Age at Death,49.8
205,1,1,Nodal Stage,Unknown
205,1,1,Occurrence #,1st primary
205,1,1,Initial Chemotherapy Agent,carbo/doce
205,1,1,Status,Dead unk disease
206,1,1,Tumor Stage,T1
206,1,1,Nodal Stage,N1
206,1,1,Radiation Dosage,66.6
206,1,1,Second Failure Type,no known failure
206,1,1,Metastasis,M0
206,1,1,Treatment Modality,Sx & RT
206,1,1,Tumor Site,oropharynx
206,1,1,Research lab p16,p16 positive
206,1,1,Clinical lab p16,p16 unknown
206,1,1,Occurrence #,1st primary
206,1,1,Research lab HPV,HPV positive
206,1,1,Status,Alive w/o disease
206,1,1,Overall Stage,III
206,1,1,First Failure Type,no known failure
207,1,1,First Failure Site,oral cavity
207,1,1,Clinical lab p16,p16 unknown
207,1,1,Radiation Dosage,70.2
207,1,1,Tumor Site,oropharynx
207,1,1,Research lab HPV,HPV unknown
207,1,1,First Failure Type,locoregional
207,1,1,Status,Dead w/ disease
207,1,1,Overall Stage,IVb
207,1,1,Tumor Stage,T4a
207,1,1,Date of Death,2001-03-31 00:00:00
207,1,1,First Failure Initial Chemotherapy Agent,Cis
207,1,1,Metastasis,M0
207,1,1,Nodal Stage,N3
207,1,1,Treatment Modality,RT
207,1,1,Age at Death,40.9
207,1,1,Research lab p16,p16 unknown
207,1,1,Time to Death,2.5
207,1,1,Second Failure Type,no known failure
207,1,1,Time to First Failure,1.3
207,1,1,First Failure Second Line Chemotherapy Agent,unk
207,1,1,First Failure Treatment Modality,CTX
207,1,1,Occurrence #,1st primary
208,1,1,Treatment Modality,CTX-RT
208,1,1,Age at Death,65.3
208,1,1,Tumor Site,oropharynx
208,1,1,Clinical lab p16,p16 unknown
208,1,1,Second Failure Type,no known failure
208,1,1,Research lab p16,p16 positive
208,1,1,Nodal Stage,N1
208,1,1,Metastasis,M0
208,1,1,Overall Stage,IVa
208,1,1,Radiation Dosage,70.2
208,1,1,Initial Chemotherapy Agent,cis
208,1,1,Status,Dead w/o disease
208,1,1,Date of Death,2009-12-17 00:00:00
208,1,1,Research lab HPV,HPV positive
208,1,1,Time to Death,3.6
208,1,1,Occurrence #,1st primary
208,1,1,Tumor Stage,T4a
208,1,1,First Failure Type,no known failure
209,1,1,Research lab p16,p16 unknown
209,1,1,Research lab HPV,HPV unknown
209,1,1,Tumor Site,oropharynx
209,1,1,Date of Death,2004-07-08 00:00:00
209,1,1,Clinical lab p16,p16 unknown
209,1,1,Metastasis,Unknown
209,1,1,Overall Stage,Unknown
209,1,1,Tumor Stage,Unknown
209,1,1,Radiation Dosage,74.4
209,1,1,Occurrence #,recurrence
209,1,1,First Failure Type,no known failure
209,1,1,Treatment Modality,RT
209,1,1,Time to Death,0.6
209,1,1,Age at Death,64.0
209,1,1,Status,Dead unk disease
209,1,1,Second Failure Type,no known failure
209,1,1,Nodal Stage,Unknown
210,1,1,Research lab p16,p16 unknown
210,1,1,Initial Chemotherapy Agent,carbo/doce
210,1,1,Date of Death,2005-06-01 00:00:00
210,1,1,Clinical lab p16,p16 unknown
210,1,1,Research lab HPV,HPV unknown
210,1,1,First Failure Type,locoregional
210,1,1,Status,Dead w/ disease
210,1,1,Time to Death,1.0
210,1,1,Age at Death,57.5
210,1,1,Tumor Stage,T4a
210,1,1,Overall Stage,IVa
210,1,1,Tumor Site,oropharynx
210,1,1,Occurrence #,1st primary
210,1,1,Treatment Modality,CTX-RT
210,1,1,Metastasis,M0
210,1,1,Radiation Dosage,70.2
210,1,1,Time to First Failure,0.1
210,1,1,Nodal Stage,N2
210,1,1,Second Failure Type,no known failure
211,1,1,Tumor Site,oropharynx
211,1,1,Nodal Stage,N2
211,1,1,Time to Death,0.4
211,1,1,Occurrence #,1st primary
211,1,1,Clinical lab p16,p16 unknown
211,1,1,Date of Death,1998-04-20 00:00:00
211,1,1,Status,Dead w/o disease
211,1,1,First Failure Type,no known failure
211,1,1,Age at Death,78.7
211,1,1,Metastasis,M0
211,1,1,Overall Stage,IVa
211,1,1,Tumor Stage,T4a
211,1,1,Radiation Dosage,23.4
211,1,1,Research lab p16,p16 negative
211,1,1,Treatment Modality,RT
211,1,1,Second Failure Type,no known failure
211,1,1,Research lab HPV,HPV negative
212,1,1,Time to Death,0.2
212,1,1,Metastasis,M0
212,1,1,Overall Stage,IVa
212,1,1,Tumor Stage,T4a
212,1,1,Date of Death,2006-03-03 00:00:00
212,1,1,Age at Death,55.1
212,1,1,Status,Dead w/ disease
212,1,1,Nodal Stage,N0
212,1,1,First Failure Type,no known failure
212,1,1,Second Failure Type,no known failure
212,1,1,Treatment Modality,Sx
212,1,1,Occurrence #,1st primary
212,1,1,Research lab p16,p16 unknown
212,1,1,Clinical lab p16,p16 unknown
212,1,1,Tumor Site,oral cavity
212,1,1,Research lab HPV,HPV unknown
213,1,1,Research lab p16,p16 unknown
213,1,1,Tumor Stage,T3
213,1,1,Treatment Modality,Sx
213,1,1,Radiation Dosage,unknown
213,1,1,Second Failure Type,no known failure
213,1,1,Overall Stage,III
213,1,1,Occurrence #,1st primary
213,1,1,Research lab HPV,HPV unknown
213,1,1,Metastasis,M0
213,1,1,First Failure Type,no known failure
213,1,1,Tumor Site,oropharynx
213,1,1,Nodal Stage,N0
213,1,1,Initial Chemotherapy Agent,unknown
213,1,1,Status,Alive w/o disease
213,1,1,Clinical lab p16,p16 unknown
214,1,1,First Failure Type,distant
214,1,1,Second Failure Type,no known failure
214,1,1,Initial Chemotherapy Agent,carbo/doce
214,1,1,Treatment Modality,CTX-RT
214,1,1,Metastasis,M0
214,1,1,Nodal Stage,N2
214,1,1,Radiation Dosage,70.2
214,1,1,Time to First Failure,0.2
214,1,1,Occurrence #,1st primary
214,1,1,Research lab p16,p16 unknown
214,1,1,Research lab HPV,HPV unknown
214,1,1,Tumor Site,oropharynx
214,1,1,Clinical lab p16,p16 unknown
214,1,1,Status,Dead w/ disease
214,1,1,Date of Death,1999-10-26 00:00:00
214,1,1,Age at Death,51.3
214,1,1,Time to Death,0.8
214,1,1,Tumor Stage,T4a
214,1,1,Overall Stage,IVa
215,1,1,Research lab HPV,HPV unknown
215,1,1,Second Failure Type,no known failure
215,1,1,Research lab p16,p16 unknown
215,1,1,Date of Death,2002-11-22 00:00:00
215,1,1,Time to Death,3.3
215,1,1,Metastasis,Unknown
215,1,1,Occurrence #,1st primary
215,1,1,Overall Stage,Unknown
215,1,1,Nodal Stage,Unknown
215,1,1,Treatment Modality,Unknown
215,1,1,Tumor Site,oropharynx
215,1,1,Tumor Stage,Unknown
215,1,1,Age at Death,71.4
215,1,1,Clinical lab p16,p16 unknown
215,1,1,First Failure Type,no known failure
215,1,1,Status,Dead unk disease
216,1,1,Second Failure Type,no known failure
216,1,1,Tumor Site,oropharynx
216,1,1,Tumor Stage,T3
216,1,1,Occurrence #,1st primary
216,1,1,Research lab HPV,HPV unknown
216,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
216,1,1,First Failure Type,no known failure
216,1,1,Status,Alive w/o disease
216,1,1,Nodal Stage,N2
216,1,1,Radiation Dosage,70.2
216,1,1,Treatment Modality,CTX-RT
216,1,1,Clinical lab p16,p16 unknown
216,1,1,Research lab p16,p16 unknown
216,1,1,Metastasis,M0
216,1,1,Overall Stage,IVa
217,1,1,First Failure Type,locoregional
217,1,1,Research lab p16,p16 unknown
217,1,1,Research lab HPV,HPV unknown
217,1,1,First Failure Radiation Dosage,60
217,1,1,Treatment Modality,CTX-RT
217,1,1,Time to First Failure,0.3
217,1,1,Clinical lab p16,p16 unknown
217,1,1,Metastasis,M0
217,1,1,Occurrence #,1st primary
217,1,1,Initial Chemotherapy Agent,carbo/doce
217,1,1,Nodal Stage,N2
217,1,1,Time to Death,3.2
217,1,1,Date of Death,2008-05-08 00:00:00
217,1,1,Overall Stage,IVa
217,1,1,Status,Dead unk disease
217,1,1,Tumor Site,oropharynx
217,1,1,First Failure Treatment Modality,CTX-RT
217,1,1,Radiation Dosage,70.2
217,1,1,First Failure Site,oropharynx
217,1,1,Age at Death,60.8
217,1,1,First Failure Initial Chemotherapy Agent,Carbo/doce
217,1,1,Tumor Stage,T3
217,1,1,Second Failure Type,no known failure
218,1,1,Treatment Modality,Unknown
218,1,1,Tumor Stage,Unknown
218,1,1,Status,Alive w/ disease
218,1,1,First Failure Type,no known failure
218,1,1,Clinical lab p16,p16 unknown
218,1,1,Nodal Stage,Unknown
218,1,1,Research lab p16,p16 unknown
218,1,1,Overall Stage,IVa
218,1,1,Tumor Site,oropharynx
218,1,1,Research lab HPV,HPV unknown
218,1,1,Metastasis,M0
218,1,1,Second Failure Type,no known failure
218,1,1,Occurrence #,1st primary
219,1,1,Second Failure Type,no known failure
219,1,1,Tumor Site,oropharynx
219,1,1,Overall Stage,IVa
219,1,1,Radiation Dosage,72
219,1,1,Date of Death,2002-09-30 00:00:00
219,1,1,Clinical lab p16,p16 unknown
219,1,1,Age at Death,62.5
219,1,1,Status,Dead w/ disease
219,1,1,Time to First Failure,0.4
219,1,1,Research lab p16,p16 negative
219,1,1,Occurrence #,1st primary
219,1,1,Metastasis,M0
219,1,1,Initial Chemotherapy Agent,unknown
219,1,1,Nodal Stage,N2
219,1,1,First Failure Type,distant
219,1,1,Research lab HPV,HPV negative
219,1,1,Tumor Stage,T3
219,1,1,Time to Death,1.5
219,1,1,Treatment Modality,CTX-RT
220,1,1,Research lab HPV,HPV negative
220,1,1,Date of Death,2001-04-19 00:00:00
220,1,1,Tumor Site,oropharynx
220,1,1,Age at Death,43.1
220,1,1,Treatment Modality,RT
220,1,1,Time to Death,0.5
220,1,1,Nodal Stage,N2
220,1,1,Time to First Failure,0.1
220,1,1,Metastasis,M0
220,1,1,Research lab p16,p16 negative
220,1,1,Status,Dead w/ disease
220,1,1,Second Failure Type,no known failure
220,1,1,Tumor Stage,T4a
220,1,1,Overall Stage,IVa
220,1,1,First Failure Type,distant
220,1,1,Radiation Dosage,72
220,1,1,Clinical lab p16,p16 unknown
220,1,1,Occurrence #,1st primary
221,1,1,Research lab HPV,HPV negative
221,1,1,Time to Death,0.6
221,1,1,Treatment Modality,Unknown
221,1,1,Metastasis,M0
221,1,1,Overall Stage,IVa
221,1,1,Occurrence #,1st primary
221,1,1,Research lab p16,p16 negative
221,1,1,Clinical lab p16,p16 unknown
221,1,1,Age at Death,44.6
221,1,1,First Failure Type,distant
221,1,1,Tumor Site,oropharynx
221,1,1,Tumor Stage,T3
221,1,1,Nodal Stage,N2
221,1,1,Second Failure Type,no known failure
221,1,1,Date of Death,2002-03-16 00:00:00
221,1,1,Status,Dead w/ disease
222,1,1,Age at Death,73.5
222,1,1,Occurrence #,other primary
222,1,1,Clinical lab p16,p16 unknown
222,1,1,Date of Death,2007-10-05 00:00:00
222,1,1,Metastasis,M0
222,1,1,First Failure Type,no known failure
222,1,1,Tumor Stage,T1
222,1,1,Overall Stage,I
222,1,1,Research lab HPV,HPV unknown
222,1,1,Nodal Stage,N0
222,1,1,Treatment Modality,RT
222,1,1,Time to Death,7.3
222,1,1,Second Failure Type,no known failure
222,1,1,Status,Dead w/o disease
222,1,1,Tumor Site,oropharynx
222,1,1,Radiation Dosage,66.6
222,1,1,Research lab p16,p16 unknown
223,1,1,Tumor Site,oropharynx
223,1,1,Research lab HPV,HPV positive
223,1,1,Nodal Stage,N2
223,1,1,Overall Stage,IVa
223,1,1,First Failure Type,no known failure
223,1,1,Initial Chemotherapy Agent,carbo/PTX
223,1,1,Tumor Stage,T2
223,1,1,Second Failure Type,no known failure
223,1,1,Status,Alive w/o disease
223,1,1,Research lab p16,p16 unknown
223,1,1,Radiation Dosage,70.2
223,1,1,Metastasis,M0
223,1,1,Treatment Modality,CTX-RT
223,1,1,Clinical lab p16,p16 unknown
223,1,1,Occurrence #,1st primary
224,1,1,Date of Death,2000-01-24 00:00:00
224,1,1,Occurrence #,1st primary
224,1,1,Research lab HPV,HPV unknown
224,1,1,Time to Death,1.8
224,1,1,Status,Dead unk disease
224,1,1,Radiation Dosage,68.4
224,1,1,Tumor Stage,T4a
224,1,1,Tumor Site,oropharynx
224,1,1,Initial Chemotherapy Agent,unknown
224,1,1,Clinical lab p16,p16 unknown
224,1,1,Treatment Modality,CTX-RT
224,1,1,Metastasis,M0
224,1,1,Research lab p16,p16 unknown
224,1,1,Time to First Failure,0.6
224,1,1,Age at Death,42.5
224,1,1,First Failure Site,oropharynx
224,1,1,Second Failure Type,no known failure
224,1,1,Overall Stage,IVa
224,1,1,Nodal Stage,N2
224,1,1,First Failure Type,locoregional
224,1,1,First Failure Treatment Modality,Sx
225,1,1,Time to Death,9.3
225,1,1,Status,Dead unk disease
225,1,1,Second Failure Type,no known failure
225,1,1,Treatment Modality,Unknown
225,1,1,Age at Death,77.2
225,1,1,Occurrence #,Unknown
225,1,1,Tumor Site,oropharynx
225,1,1,First Failure Type,no known failure
225,1,1,Nodal Stage,Unknown
225,1,1,Overall Stage,Unknown
225,1,1,Research lab HPV,HPV positive
225,1,1,Research lab p16,p16 positive
225,1,1,Metastasis,Unknown
225,1,1,Clinical lab p16,p16 unknown
225,1,1,Date of Death,2008-02-12 00:00:00
225,1,1,Tumor Stage,Unknown
226,1,1,Time to Death,0.0
226,1,1,Overall Stage,I
226,1,1,Clinical lab p16,p16 unknown
226,1,1,Nodal Stage,N0
226,1,1,Tumor Site,oropharynx
226,1,1,Date of Death,1999-02-20 00:00:00
226,1,1,Research lab p16,p16 unknown
226,1,1,First Failure Type,no known failure
226,1,1,Status,Dead unk disease
226,1,1,Metastasis,M0
226,1,1,Age at Death,48.9
226,1,1,Research lab HPV,HPV unknown
226,1,1,Tumor Stage,T1
226,1,1,Second Failure Type,no known failure
226,1,1,Treatment Modality,Unknown
226,1,1,Occurrence #,1st primary
227,1,1,Occurrence #,1st primary
227,1,1,Radiation Dosage,70.2
227,1,1,Date of Death,1996-09-01 00:00:00
227,1,1,Time to First Failure,0.1
227,1,1,Research lab p16,p16 negative
227,1,1,Metastasis,M0
227,1,1,Clinical lab p16,p16 unknown
227,1,1,Age at Death,44.0
227,1,1,Overall Stage,IVa
227,1,1,Second Failure Type,no known failure
227,1,1,Treatment Modality,CTX-RT
227,1,1,First Failure Type,locoregional
227,1,1,Nodal Stage,N2
227,1,1,Initial Chemotherapy Agent,carbo/doce
227,1,1,Research lab HPV,HPV negative
227,1,1,Time to Death,0.5
227,1,1,Tumor Site,oropharynx
227,1,1,Tumor Stage,T4a
227,1,1,Status,Dead w/ disease
228,1,1,Research lab p16,p16 negative
228,1,1,Clinical lab p16,p16 unknown
228,1,1,Radiation Dosage,70.2
228,1,1,Research lab HPV,HPV unknown
228,1,1,Date of Death,2007-04-10 00:00:00
228,1,1,Metastasis,M0
228,1,1,Tumor Site,oropharynx
228,1,1,Tumor Stage,T2
228,1,1,Age at Death,82.8
228,1,1,Overall Stage,III
228,1,1,First Failure Type,locoregional and distant
228,1,1,Status,Dead w/ disease
228,1,1,Time to Death,2.7
228,1,1,Second Failure Type,no known failure
228,1,1,Nodal Stage,N1
228,1,1,First Failure Initial Chemotherapy Agent,cis/doce
228,1,1,Occurrence #,1st primary
228,1,1,Treatment Modality,RT
228,1,1,Time to First Failure,0.7
228,1,1,First Failure Treatment Modality,CTX
229,1,1,Status,Dead unk disease
229,1,1,Nodal Stage,N1
229,1,1,Metastasis,M0
229,1,1,Clinical lab p16,p16 unknown
229,1,1,Tumor Stage,T3
229,1,1,Age at Death,67.8
229,1,1,Overall Stage,III
229,1,1,Second Failure Type,no known failure
229,1,1,Treatment Modality,RT
229,1,1,Date of Death,2003-02-11 00:00:00
229,1,1,Research lab p16,p16 unknown
229,1,1,Tumor Site,oropharynx
229,1,1,Occurrence #,1st primary
229,1,1,Research lab HPV,HPV unknown
229,1,1,Radiation Dosage,76.8
229,1,1,First Failure Type,no known failure
229,1,1,Time to Death,0.9
230,1,1,Research lab p16,p16 unknown
230,1,1,Tumor Site,oropharynx
230,1,1,Metastasis,M0
230,1,1,Research lab HPV,HPV unknown
230,1,1,Tumor Stage,T2
230,1,1,Clinical lab p16,p16 unknown
230,1,1,Radiation Dosage,70.2
230,1,1,Second Failure Type,no known failure
230,1,1,Time to Death,2.0
230,1,1,Overall Stage,IVa
230,1,1,Time to First Failure,1.4
230,1,1,Treatment Modality,Sx & RT
230,1,1,Status,Dead w/ disease
230,1,1,Occurrence #,1st primary
230,1,1,Age at Death,56.7
230,1,1,Date of Death,2005-04-05 00:00:00
230,1,1,Nodal Stage,N2
230,1,1,First Failure Type,distant
231,1,1,Research lab HPV,HPV negative
231,1,1,Second Failure Type,no known failure
231,1,1,Age at Death,53.9
231,1,1,Treatment Modality,CTX-RT
231,1,1,Overall Stage,III
231,1,1,Date of Death,2004-02-28 00:00:00
231,1,1,Occurrence #,1st primary
231,1,1,Initial Chemotherapy Agent,unknown
231,1,1,Radiation Dosage,70.2
231,1,1,Status,Dead unk disease
231,1,1,First Failure Type,no known failure
231,1,1,Time to Death,0.8
231,1,1,Nodal Stage,N0
231,1,1,Tumor Site,oropharynx
231,1,1,Research lab p16,p16 negative
231,1,1,Metastasis,M0
231,1,1,Clinical lab p16,p16 unknown
231,1,1,Tumor Stage,T3
232,1,1,Tumor Stage,T3
232,1,1,Occurrence #,1st primary
232,1,1,Second Line Chemotherapy Agent,carb
232,1,1,Overall Stage,IVb
232,1,1,Radiation Dosage,70.2
232,1,1,Time to First Failure,0.2
232,1,1,Clinical lab p16,p16 unknown
232,1,1,Status,Dead w/ disease
232,1,1,Metastasis,M0
232,1,1,Nodal Stage,N3
232,1,1,Research lab p16,p16 negative
232,1,1,Age at Death,58.8
232,1,1,Time to Death,1.4
232,1,1,Research lab HPV,HPV negative
232,1,1,Initial Chemotherapy Agent,cis/doce
232,1,1,First Failure Type,locoregional
232,1,1,Tumor Site,oropharynx
232,1,1,Second Failure Type,no known failure
232,1,1,Treatment Modality,CTX-RT
232,1,1,Date of Death,2008-09-20 00:00:00
233,1,1,Second Failure Type,no known failure
233,1,1,Status,Unknown
233,1,1,Research lab HPV,HPV unknown
233,1,1,Metastasis,Unknown
233,1,1,First Failure Type,no known failure
233,1,1,Research lab p16,p16 unknown
233,1,1,Occurrence #,1st primary
233,1,1,Tumor Site,oropharynx
233,1,1,Clinical lab p16,p16 unknown
233,1,1,Tumor Stage,Unknown
233,1,1,Nodal Stage,Unknown
233,1,1,Treatment Modality,Unknown
233,1,1,Overall Stage,Unknown
234,1,1,Research lab p16,p16 unknown
234,1,1,Occurrence #,1st primary
234,1,1,Date of Death,2004-07-29 00:00:00
234,1,1,Radiation Dosage,70.2
234,1,1,Time to First Failure,0.7
234,1,1,Metastasis,M0
234,1,1,Treatment Modality,CTX-RT
234,1,1,Tumor Site,oropharynx
234,1,1,Time to Death,4.1
234,1,1,Overall Stage,III
234,1,1,Clinical lab p16,p16 unknown
234,1,1,Age at Death,56.7
234,1,1,Tumor Stage,T3
234,1,1,Research lab HPV,HPV unknown
234,1,1,Initial Chemotherapy Agent,carbo/doce
234,1,1,First Failure Type,locoregional
234,1,1,Second Failure Type,no known failure
234,1,1,Status,Dead w/ disease
234,1,1,Nodal Stage,N1
235,1,1,Nodal Stage,N3
235,1,1,First Failure Type,no known failure
235,1,1,Research lab p16,p16 unknown
235,1,1,Initial Chemotherapy Agent,carbo/doce
235,1,1,Radiation Dosage,70.2
235,1,1,Status,Alive unk disease
235,1,1,Overall Stage,IVb
235,1,1,Tumor Site,oropharynx
235,1,1,Second Failure Type,no known failure
235,1,1,Research lab HPV,HPV unknown
235,1,1,Tumor Stage,T2
235,1,1,Clinical lab p16,p16 unknown
235,1,1,Occurrence #,1st primary
235,1,1,Metastasis,M0
235,1,1,Treatment Modality,Sx & CTX-RT
236,1,1,Radiation Dosage,72
236,1,1,Date of Death,2002-04-01 00:00:00
236,1,1,Tumor Site,oropharynx
236,1,1,Research lab HPV,HPV unknown
236,1,1,Time to Death,0.7
236,1,1,Status,Dead w/o disease
236,1,1,Occurrence #,1st primary
236,1,1,Tumor Stage,T3
236,1,1,Initial Chemotherapy Agent,carbo/doce
236,1,1,Treatment Modality,CTX-RT
236,1,1,Metastasis,M0
236,1,1,Overall Stage,IVa
236,1,1,Research lab p16,p16 unknown
236,1,1,First Failure Type,no known failure
236,1,1,Age at Death,54.9
236,1,1,Clinical lab p16,p16 unknown
236,1,1,Nodal Stage,N2
236,1,1,Second Failure Type,no known failure
237,1,1,Time to Death,0.7
237,1,1,Second Failure Type,no known failure
237,1,1,Research lab p16,p16 positive
237,1,1,Status,Dead unk disease
237,1,1,Research lab HPV,HPV positive
237,1,1,Nodal Stage,N0
237,1,1,Age at Death,84.8
237,1,1,Tumor Site,oropharynx
237,1,1,Metastasis,M0
237,1,1,Date of Death,2004-06-01 00:00:00
237,1,1,Clinical lab p16,p16 unknown
237,1,1,Occurrence #,recurrence
237,1,1,Treatment Modality,Unknown
237,1,1,Overall Stage,III
237,1,1,Tumor Stage,T3
237,1,1,First Failure Type,no known failure
238,1,1,First Failure Site,oropharynx
238,1,1,Research lab HPV,HPV negative
238,1,1,Status,Dead w/ disease
238,1,1,Second Failure Type,no known failure
238,1,1,Age at Death,58.4
238,1,1,Tumor Site,oropharynx
238,1,1,Treatment Modality,Sx & RT
238,1,1,Tumor Stage,T4a
238,1,1,Overall Stage,IVa
238,1,1,Date of Death,2007-09-12 00:00:00
238,1,1,Clinical lab p16,p16 unknown
238,1,1,Occurrence #,1st primary
238,1,1,Metastasis,M0
238,1,1,Research lab p16,p16 negative
238,1,1,Radiation Dosage,76.8
238,1,1,Nodal Stage,N0
238,1,1,First Failure Type,locoregional
238,1,1,Time to First Failure,0.8
238,1,1,Time to Death,2.3
239,1,1,Time to Death,0.7
239,1,1,Nodal Stage,N3
239,1,1,Second Failure Type,no known failure
239,1,1,Overall Stage,IVb
239,1,1,Occurrence #,1st primary
239,1,1,Tumor Site,oropharynx
239,1,1,Research lab p16,p16 negative
239,1,1,Status,Dead unk disease
239,1,1,Radiation Dosage,70.2
239,1,1,Tumor Stage,T4a
239,1,1,Age at Death,54.5
239,1,1,Treatment Modality,CTX-RT
239,1,1,Initial Chemotherapy Agent,carbo
239,1,1,Metastasis,M0
239,1,1,Research lab HPV,HPV negative
239,1,1,Time to First Failure,0.1
239,1,1,Clinical lab p16,p16 unknown
239,1,1,Date of Death,1994-07-01 00:00:00
239,1,1,First Failure Type,locoregional
240,1,1,Radiation Dosage,76.8
240,1,1,Occurrence #,1st primary
240,1,1,Initial Chemotherapy Agent,unknown
240,1,1,Tumor Stage,T2
240,1,1,Clinical lab p16,p16 unknown
240,1,1,Overall Stage,IVa
240,1,1,Date of Death,2010-10-30 00:00:00
240,1,1,Second Failure Type,no known failure
240,1,1,Research lab HPV,HPV positive
240,1,1,Metastasis,M0
240,1,1,Time to Death,13.1
240,1,1,Research lab p16,p16 positive
240,1,1,Status,Dead w/o disease
240,1,1,Nodal Stage,N2
240,1,1,Age at Death,59.9
240,1,1,First Failure Type,no known failure
240,1,1,Treatment Modality,CTX-RT
240,1,1,Tumor Site,oropharynx
241,1,1,Initial Chemotherapy Agent,carbo/doce/5-FU
241,1,1,Clinical lab p16,p16 unknown
241,1,1,Metastasis,M0
241,1,1,Radiation Dosage,70.2
241,1,1,Second Failure Type,no known failure
241,1,1,Nodal Stage,N2
241,1,1,Tumor Site,oropharynx
241,1,1,Treatment Modality,CTX-RT
241,1,1,Occurrence #,1st primary
241,1,1,Research lab HPV,HPV unknown
241,1,1,Research lab p16,p16 unknown
241,1,1,Status,Alive w/o disease
241,1,1,Tumor Stage,T3
241,1,1,Overall Stage,IVa
241,1,1,First Failure Type,no known failure
242,1,1,Initial Chemotherapy Agent,carbo/doce
242,1,1,Research lab p16,p16 unknown
242,1,1,Metastasis,M0
242,1,1,Tumor Site,oropharynx
242,1,1,Status,Alive w/o disease
242,1,1,Nodal Stage,N2
242,1,1,Clinical lab p16,p16 unknown
242,1,1,Tumor Stage,T1
242,1,1,Overall Stage,IVa
242,1,1,Radiation Dosage,70.2
242,1,1,Treatment Modality,CTX-RT
242,1,1,Occurrence #,1st primary
242,1,1,Research lab HPV,HPV unknown
242,1,1,Second Failure Type,no known failure
242,1,1,First Failure Type,no known failure
243,1,1,Research lab p16,p16 unknown
243,1,1,Time to Death,8.4
243,1,1,Overall Stage,IVa
243,1,1,Tumor Site,oral cavity
243,1,1,Clinical lab p16,p16 unknown
243,1,1,Age at Death,50.7
243,1,1,Metastasis,M0
243,1,1,First Failure Type,no known failure
243,1,1,Tumor Stage,T4a
243,1,1,Research lab HPV,HPV unknown
243,1,1,Treatment Modality,Sx
243,1,1,Status,Dead unk disease
243,1,1,Occurrence #,1st primary
243,1,1,Date of Death,2007-07-01 00:00:00
243,1,1,Second Failure Type,no known failure
243,1,1,Nodal Stage,N1
244,1,1,Clinical lab p16,p16 unknown
244,1,1,First Failure Type,no known failure
244,1,1,Radiation Dosage,70.2
244,1,1,Tumor Stage,T2
244,1,1,Second Failure Type,no known failure
244,1,1,Occurrence #,1st primary
244,1,1,Treatment Modality,CTX-RT
244,1,1,Research lab HPV,HPV positive
244,1,1,Metastasis,M0
244,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
244,1,1,Nodal Stage,N2
244,1,1,Research lab p16,p16 positive
244,1,1,Overall Stage,IVa
244,1,1,Status,Alive w/o disease
244,1,1,Tumor Site,oropharynx
245,1,1,First Failure Type,no known failure
245,1,1,Research lab HPV,HPV unknown
245,1,1,Tumor Stage,Unknown
245,1,1,Occurrence #,1st primary
245,1,1,Clinical lab p16,p16 unknown
245,1,1,Overall Stage,Unknown
245,1,1,Status,Unknown
245,1,1,Nodal Stage,Unknown
245,1,1,Treatment Modality,Unknown
245,1,1,Second Failure Type,no known failure
245,1,1,Metastasis,Unknown
245,1,1,Tumor Site,Unknown
245,1,1,Research lab p16,p16 unknown
246,1,1,Metastasis,M0
246,1,1,Treatment Modality,CTX-RT
246,1,1,Tumor Stage,T4a
246,1,1,Initial Chemotherapy Agent,carbo/doce
246,1,1,Research lab p16,p16 unknown
246,1,1,Overall Stage,IVa
246,1,1,Tumor Site,oropharynx
246,1,1,Clinical lab p16,p16 unknown
246,1,1,Status,Alive w/o disease
246,1,1,Nodal Stage,N2
246,1,1,Radiation Dosage,70.2
246,1,1,Occurrence #,1st primary
246,1,1,Second Failure Type,no known failure
246,1,1,Research lab HPV,HPV unknown
246,1,1,First Failure Type,no known failure
247,1,1,Second Failure Type,no known failure
247,1,1,Tumor Site,oropharynx
247,1,1,Radiation Dosage,70.2
247,1,1,Age at Death,49.2
247,1,1,Status,Dead w/ disease
247,1,1,Occurrence #,1st primary
247,1,1,Date of Death,2006-11-01 00:00:00
247,1,1,Time to First Failure,0.2
247,1,1,Initial Chemotherapy Agent,PTX
247,1,1,Treatment Modality,CTX-RT
247,1,1,Research lab HPV,HPV negative
247,1,1,Metastasis,M0
247,1,1,Nodal Stage,N2
247,1,1,Overall Stage,IVa
247,1,1,Clinical lab p16,p16 unknown
247,1,1,Time to Death,0.7
247,1,1,Tumor Stage,T4a
247,1,1,First Failure Type,locoregional
247,1,1,Research lab p16,p16 negative
248,1,1,Treatment Modality,Sx & RT
248,1,1,Radiation Dosage,unknown
248,1,1,Tumor Stage,T1
248,1,1,Metastasis,M0
248,1,1,Status,Dead unk disease
248,1,1,Nodal Stage,N2
248,1,1,Date of Death,2008-07-13 00:00:00
248,1,1,Second Failure Type,no known failure
248,1,1,Tumor Site,oropharynx
248,1,1,Research lab HPV,HPV positive
248,1,1,Occurrence #,1st primary
248,1,1,First Failure Type,no known failure
248,1,1,Research lab p16,p16 positive
248,1,1,Age at Death,56.6
248,1,1,Overall Stage,IVa
248,1,1,Time to Death,8.9
248,1,1,Clinical lab p16,p16 unknown
249,1,1,Age at Death,76.1
249,1,1,Date of Death,2009-02-14 00:00:00
249,1,1,First Failure Type,no known failure
249,1,1,Status,Dead unk disease
249,1,1,Treatment Modality,CTX-RT
249,1,1,Tumor Site,oropharynx
249,1,1,Overall Stage,IVb
249,1,1,Nodal Stage,N3
249,1,1,Research lab HPV,HPV unknown
249,1,1,Metastasis,M0
249,1,1,Occurrence #,1st primary
249,1,1,Initial Chemotherapy Agent,carbo/doce
249,1,1,Tumor Stage,T4b
249,1,1,Radiation Dosage,70.2
249,1,1,Second Failure Type,no known failure
249,1,1,Research lab p16,p16 unknown
249,1,1,Time to Death,7.7
249,1,1,Clinical lab p16,p16 unknown
250,1,1,Clinical lab p16,p16 unknown
250,1,1,Radiation Dosage,70.2
250,1,1,Research lab HPV,HPV positive
250,1,1,Second Failure Type,no known failure
250,1,1,First Failure Type,no known failure
250,1,1,Tumor Site,oropharynx
250,1,1,Occurrence #,1st primary
250,1,1,Research lab p16,p16 positive
250,1,1,Initial Chemotherapy Agent,PTX/cap
250,1,1,Tumor Stage,T2
250,1,1,Status,Dead unk disease
250,1,1,Treatment Modality,CTX-RT
250,1,1,Metastasis,M0
250,1,1,Overall Stage,IVa
250,1,1,Time to Death,8.1
250,1,1,Nodal Stage,N2
250,1,1,Age at Death,67.5
250,1,1,Date of Death,2008-03-16 00:00:00
251,1,1,Tumor Stage,T4a
251,1,1,Time to First Failure,1.7
251,1,1,Occurrence #,1st primary
251,1,1,First Failure Treatment Modality,CTX
251,1,1,Second Failure Type,no known failure
251,1,1,Age at Death,56.0
251,1,1,Tumor Site,oropharynx
251,1,1,Research lab p16,p16 negative
251,1,1,Clinical lab p16,p16 unknown
251,1,1,Radiation Dosage,61.2
251,1,1,Time to Death,2.3
251,1,1,Research lab HPV,HPV negative
251,1,1,Nodal Stage,N1
251,1,1,Metastasis,M0
251,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
251,1,1,Overall Stage,IVa
251,1,1,First Failure Type,distant
251,1,1,Treatment Modality,Sx & RT
251,1,1,Date of Death,1996-02-13 00:00:00
251,1,1,Status,Dead w/ disease
252,1,1,Time to First Failure,1.8
252,1,1,Overall Stage,IVa
252,1,1,Radiation Dosage,70.2
252,1,1,Research lab HPV,HPV negative
252,1,1,Clinical lab p16,p16 unknown
252,1,1,Occurrence #,1st primary
252,1,1,First Failure Type,locoregional and distant
252,1,1,Status,Dead w/ disease
252,1,1,Age at Death,47.8
252,1,1,Date of Death,1995-09-20 00:00:00
252,1,1,Second Failure Type,no known failure
252,1,1,Tumor Site,oropharynx
252,1,1,Research lab p16,p16 negative
252,1,1,Metastasis,M0
252,1,1,Nodal Stage,N2
252,1,1,Tumor Stage,T4a
252,1,1,Time to Death,2.1
252,1,1,Initial Chemotherapy Agent,carbo/PTX
252,1,1,Treatment Modality,CTX-RT
253,1,1,Status,Dead w/ disease
253,1,1,Clinical lab p16,p16 unknown
253,1,1,Radiation Dosage,unknown
253,1,1,Tumor Site,oropharynx
253,1,1,Research lab p16,p16 unknown
253,1,1,Initial Chemotherapy Agent,unknown
253,1,1,Age at Death,70.1
253,1,1,First Failure Treatment Modality,Sx
253,1,1,Treatment Modality,CTX-RT
253,1,1,Nodal Stage,N2
253,1,1,Metastasis,M0
253,1,1,Date of Death,2011-03-03 00:00:00
253,1,1,Research lab HPV,HPV unknown
253,1,1,First Failure Site,oropharynx
253,1,1,Tumor Stage,T3
253,1,1,First Failure Type,locoregional
253,1,1,Time to Death,7.7
253,1,1,Overall Stage,IVa
253,1,1,Second Failure Type,no known failure
253,1,1,Time to First Failure,0.8
253,1,1,Occurrence #,1st primary
254,1,1,First Failure Site,oropharynx
254,1,1,Time to Death,3.8
254,1,1,Nodal Stage,N0
254,1,1,Treatment Modality,RT
254,1,1,Time to First Failure,2.1
254,1,1,Age at Death,61.2
254,1,1,Status,Dead w/ disease
254,1,1,Second Failure Type,no known failure
254,1,1,Research lab p16,p16 unknown
254,1,1,Metastasis,M0
254,1,1,Overall Stage,II
254,1,1,Tumor Stage,T2
254,1,1,Tumor Site,oropharynx
254,1,1,Radiation Dosage,68.4
254,1,1,Research lab HPV,HPV unknown
254,1,1,First Failure Type,locoregional
254,1,1,Occurrence #,1st primary
254,1,1,Date of Death,2004-12-30 00:00:00
254,1,1,Clinical lab p16,p16 unknown
255,1,1,Clinical lab p16,p16 unknown
255,1,1,Time to Death,1.0
255,1,1,Treatment Modality,Sx
255,1,1,Tumor Site,oropharynx
255,1,1,Tumor Stage,T1
255,1,1,Metastasis,M0
255,1,1,Occurrence #,other primary
255,1,1,First Failure Type,no known failure
255,1,1,Research lab HPV,HPV unknown
255,1,1,Status,Dead unk disease
255,1,1,Date of Death,2006-12-14 00:00:00
255,1,1,Age at Death,73.8
255,1,1,Nodal Stage,N0
255,1,1,Second Failure Type,no known failure
255,1,1,Research lab p16,p16 unknown
255,1,1,Overall Stage,I
256,1,1,Research lab HPV,HPV unknown
256,1,1,Overall Stage,Unknown
256,1,1,Status,Unknown
256,1,1,Tumor Site,oropharynx
256,1,1,Metastasis,Unknown
256,1,1,Research lab p16,p16 unknown
256,1,1,Tumor Stage,Unknown
256,1,1,Nodal Stage,Unknown
256,1,1,Clinical lab p16,p16 unknown
256,1,1,First Failure Type,no known failure
256,1,1,Treatment Modality,Unknown
256,1,1,Occurrence #,1st primary
256,1,1,Second Failure Type,no known failure
257,1,1,Status,Dead unk disease
257,1,1,Nodal Stage,N0
257,1,1,Age at Death,66.5
257,1,1,Research lab p16,p16 negative
257,1,1,Radiation Dosage,72
257,1,1,Overall Stage,II
257,1,1,First Failure Type,no known failure
257,1,1,Metastasis,M0
257,1,1,Research lab HPV,HPV negative
257,1,1,Date of Death,2011-08-25 00:00:00
257,1,1,Tumor Site,oropharynx
257,1,1,Tumor Stage,T2
257,1,1,Clinical lab p16,p16 unknown
257,1,1,Treatment Modality,RT
257,1,1,Time to Death,4.4
257,1,1,Occurrence #,1st primary
257,1,1,Second Failure Type,no known failure
258,1,1,First Failure Type,locoregional
258,1,1,Clinical lab p16,p16 unknown
258,1,1,Research lab p16,p16 positive
258,1,1,Occurrence #,1st primary
258,1,1,Radiation Dosage,66.6
258,1,1,Tumor Stage,T1
258,1,1,Second Failure Type,no known failure
258,1,1,Metastasis,M0
258,1,1,Overall Stage,IVa
258,1,1,Research lab HPV,HPV positive
258,1,1,Status,Alive w/o disease
258,1,1,Treatment Modality,Sx & RT
258,1,1,Time to First Failure,0.7
258,1,1,Tumor Site,oropharynx
258,1,1,First Failure Site,oropharynx
258,1,1,First Failure Treatment Modality,Sx
258,1,1,Nodal Stage,N2
259,1,1,Overall Stage,III
259,1,1,Date of Death,2004-08-01 00:00:00
259,1,1,Metastasis,M0
259,1,1,Second Failure Type,no known failure
259,1,1,Research lab HPV,HPV negative
259,1,1,Occurrence #,1st primary
259,1,1,Age at Death,65.4
259,1,1,First Failure Type,no known failure
259,1,1,Tumor Site,oropharynx
259,1,1,Clinical lab p16,p16 unknown
259,1,1,Treatment Modality,RT
259,1,1,Nodal Stage,N0
259,1,1,Tumor Stage,T3
259,1,1,Status,Dead unk disease
259,1,1,Radiation Dosage,72
259,1,1,Time to Death,4.1
259,1,1,Research lab p16,p16 negative
260,1,1,Tumor Site,oropharynx
260,1,1,Treatment Modality,CTX-RT
260,1,1,First Failure Site,oropharynx
260,1,1,Second Failure Type,no known failure
260,1,1,Time to Death,4.9
260,1,1,Tumor Stage,T3
260,1,1,Occurrence #,1st primary
260,1,1,Clinical lab p16,p16 unknown
260,1,1,First Failure Treatment Modality,Sx
260,1,1,First Failure Type,locoregional
260,1,1,Overall Stage,III
260,1,1,Initial Chemotherapy Agent,carbo/doce
260,1,1,Date of Death,2004-04-30 00:00:00
260,1,1,Status,Dead w/ disease
260,1,1,Nodal Stage,N1
260,1,1,Radiation Dosage,70.2
260,1,1,Age at Death,58.4
260,1,1,Research lab HPV,HPV unknown
260,1,1,Metastasis,M0
260,1,1,Time to First Failure,0.5
260,1,1,Research lab p16,p16 positive
261,1,1,Occurrence #,1st primary
261,1,1,Research lab HPV,HPV unknown
261,1,1,Tumor Stage,T1
261,1,1,Treatment Modality,Sx & CTX-RT
261,1,1,Radiation Dosage,70.2
261,1,1,Nodal Stage,N3
261,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
261,1,1,First Failure Type,no known failure
261,1,1,Age at Death,57.7
261,1,1,Time to Death,0.8
261,1,1,Research lab p16,p16 unknown
261,1,1,Date of Death,2006-11-27 00:00:00
261,1,1,Second Failure Type,no known failure
261,1,1,Tumor Site,oropharynx
261,1,1,Clinical lab p16,p16 unknown
261,1,1,Metastasis,M0
261,1,1,Status,Dead w/o disease
261,1,1,Overall Stage,IVb
262,1,1,Tumor Stage,T3
262,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
262,1,1,First Failure Radiation Dosage,unk
262,1,1,Age at Death,61.6
262,1,1,Research lab p16,p16 negative
262,1,1,Treatment Modality,CTX-RT
262,1,1,Metastasis,M0
262,1,1,Tumor Site,oropharynx
262,1,1,Overall Stage,IVa
262,1,1,Time to First Failure,0.2
262,1,1,Status,Dead w/ disease
262,1,1,Clinical lab p16,p16 unknown
262,1,1,First Failure Site,oropharynx
262,1,1,Date of Death,2003-09-21 00:00:00
262,1,1,Time to Death,1.6
262,1,1,Occurrence #,1st primary
262,1,1,Second Failure Type,no known failure
262,1,1,First Failure Type,locoregional and distant
262,1,1,Initial Chemotherapy Agent,carbo/doce
262,1,1,Nodal Stage,N2
262,1,1,Radiation Dosage,unknown
262,1,1,Research lab HPV,HPV negative
262,1,1,First Failure Treatment Modality,CTX-RT
263,1,1,Date of Death,2006-06-07 00:00:00
263,1,1,Initial Chemotherapy Agent,cis
263,1,1,Tumor Site,oropharynx
263,1,1,Research lab HPV,HPV unknown
263,1,1,Metastasis,M1
263,1,1,Clinical lab p16,p16 unknown
263,1,1,Overall Stage,IVc
263,1,1,Status,Dead w/ disease
263,1,1,Time to First Failure,0.0
263,1,1,Tumor Stage,T4a
263,1,1,Radiation Dosage,50
263,1,1,Treatment Modality,CTX-RT
263,1,1,Time to Death,0.3
263,1,1,Research lab p16,p16 unknown
263,1,1,Second Failure Type,no known failure
263,1,1,Nodal Stage,N2
263,1,1,First Failure Type,locoregional and distant
263,1,1,Age at Death,54.0
263,1,1,Occurrence #,1st primary
264,1,1,Second Failure Type,no known failure
264,1,1,Overall Stage,IVb
264,1,1,Tumor Stage,T4b
264,1,1,Status,Dead w/ disease
264,1,1,Nodal Stage,N2
264,1,1,Age at Death,50.4
264,1,1,Clinical lab p16,p16 unknown
264,1,1,Initial Chemotherapy Agent,unknown
264,1,1,Tumor Site,oropharynx
264,1,1,Metastasis,M0
264,1,1,Time to Death,1.2
264,1,1,First Failure Type,locoregional and distant
264,1,1,Date of Death,2007-12-14 00:00:00
264,1,1,Occurrence #,1st primary
264,1,1,Research lab p16,p16 unknown
264,1,1,Radiation Dosage,45
264,1,1,Research lab HPV,HPV unknown
264,1,1,Treatment Modality,CTX-RT
264,1,1,Time to First Failure,0.1
265,1,1,Treatment Modality,Unknown
265,1,1,Research lab p16,p16 positive
265,1,1,Tumor Stage,T2
265,1,1,Second Failure Type,no known failure
265,1,1,Tumor Site,oropharynx
265,1,1,Occurrence #,1st primary
265,1,1,First Failure Type,no known failure
265,1,1,Overall Stage,III
265,1,1,Clinical lab p16,p16 unknown
265,1,1,Metastasis,M0
265,1,1,Status,Alive unk disease
265,1,1,Nodal Stage,N2
265,1,1,Research lab HPV,HPV positive
266,1,1,First Failure Type,locoregional
266,1,1,Nodal Stage,N2
266,1,1,Tumor Site,oropharynx
266,1,1,Initial Chemotherapy Agent,carbo/doce
266,1,1,Research lab HPV,HPV negative
266,1,1,Metastasis,M0
266,1,1,Overall Stage,IVa
266,1,1,First Failure Radiation Dosage,67.3
266,1,1,Tumor Stage,T4a
266,1,1,Status,Dead w/ disease
266,1,1,Radiation Dosage,70.2
266,1,1,Time to First Failure,10.4
266,1,1,Age at Death,46.9
266,1,1,First Failure Site,oropharynx
266,1,1,Research lab p16,p16 negative
266,1,1,Time to Death,11.3
266,1,1,Second Failure Type,no known failure
266,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
266,1,1,Date of Death,2008-02-25 00:00:00
266,1,1,Treatment Modality,CTX-RT
266,1,1,Occurrence #,1st primary
266,1,1,First Failure Treatment Modality,CTX-RT
266,1,1,Clinical lab p16,p16 unknown
267,1,1,Research lab HPV,HPV unknown
267,1,1,Tumor Stage,T1
267,1,1,Treatment Modality,Sx & CTX-RT
267,1,1,Time to Death,3.9
267,1,1,Date of Death,2010-06-14 00:00:00
267,1,1,Overall Stage,IVa
267,1,1,Status,Dead unk disease
267,1,1,Clinical lab p16,p16 unknown
267,1,1,Second Failure Type,no known failure
267,1,1,Age at Death,59.8
267,1,1,Occurrence #,1st primary
267,1,1,Research lab p16,p16 unknown
267,1,1,Tumor Site,oropharynx
267,1,1,Metastasis,M0
267,1,1,Initial Chemotherapy Agent,cis/carbo
267,1,1,First Failure Type,no known failure
267,1,1,Nodal Stage,N2
267,1,1,Radiation Dosage,70.2
268,1,1,Metastasis,M0
268,1,1,Research lab p16,p16 unknown
268,1,1,Age at Death,50.0
268,1,1,Tumor Site,oropharynx
268,1,1,Research lab HPV,HPV unknown
268,1,1,Overall Stage,IVa
268,1,1,Status,Dead w/ disease
268,1,1,Clinical lab p16,p16 unknown
268,1,1,Second Failure Type,no known failure
268,1,1,Date of Death,2007-07-02 00:00:00
268,1,1,Occurrence #,1st primary
268,1,1,First Failure Type,no known failure
268,1,1,Nodal Stage,N2
268,1,1,Radiation Dosage,70.2
268,1,1,Time to Death,2.1
268,1,1,Tumor Stage,T2
268,1,1,Treatment Modality,CTX-RT
268,1,1,Initial Chemotherapy Agent,carbo/doce
269,1,1,Time to First Failure,0.6
269,1,1,Research lab HPV,HPV negative
269,1,1,Treatment Modality,CTX-RT
269,1,1,Second Failure Type,no known failure
269,1,1,Metastasis,M0
269,1,1,First Failure Site,oropharynx
269,1,1,Age at Death,61.2
269,1,1,Date of Death,1998-09-16 00:00:00
269,1,1,Research lab p16,p16 negative
269,1,1,First Failure Type,locoregional
269,1,1,Radiation Dosage,64.5
269,1,1,Tumor Site,oropharynx
269,1,1,Clinical lab p16,p16 unknown
269,1,1,Initial Chemotherapy Agent,carbo/PTX
269,1,1,Occurrence #,1st primary
269,1,1,Time to Death,1.4
269,1,1,Nodal Stage,N2
269,1,1,Status,Dead w/ disease
269,1,1,Overall Stage,IVa
269,1,1,Tumor Stage,T4a
270,1,1,Nodal Stage,Unknown
270,1,1,Tumor Site,Unknown
270,1,1,Clinical lab p16,p16 unknown
270,1,1,Research lab p16,p16 unknown
270,1,1,First Failure Type,no known failure
270,1,1,Treatment Modality,Unknown
270,1,1,Research lab HPV,HPV unknown
270,1,1,Tumor Stage,Unknown
270,1,1,Second Failure Type,no known failure
270,1,1,Status,Unknown
270,1,1,Occurrence #,1st primary
270,1,1,Metastasis,Unknown
270,1,1,Overall Stage,Unknown
271,1,1,Initial Chemotherapy Agent,cis
271,1,1,Tumor Site,oropharynx
271,1,1,Metastasis,M0
271,1,1,Tumor Stage,T2
271,1,1,Radiation Dosage,72
271,1,1,Research lab HPV,HPV positive
271,1,1,Occurrence #,1st primary
271,1,1,Research lab p16,p16 positive
271,1,1,First Failure Type,no known failure
271,1,1,Status,Alive w/o disease
271,1,1,Clinical lab p16,p16 unknown
271,1,1,Treatment Modality,CTX-RT
271,1,1,Overall Stage,IVa
271,1,1,Nodal Stage,N2
271,1,1,Second Failure Type,no known failure
272,1,1,Overall Stage,Unknown
272,1,1,Research lab p16,p16 unknown
272,1,1,Second Failure Type,no known failure
272,1,1,Nodal Stage,Unknown
272,1,1,Date of Death,2002-12-12 00:00:00
272,1,1,Time to Death,3.0
272,1,1,Metastasis,Unknown
272,1,1,Clinical lab p16,p16 unknown
272,1,1,First Failure Type,no known failure
272,1,1,Age at Death,56.3
272,1,1,Tumor Site,oropharynx
272,1,1,Occurrence #,1st primary
272,1,1,Status,Dead unk disease
272,1,1,Tumor Stage,Unknown
272,1,1,Treatment Modality,Unknown
272,1,1,Research lab HPV,HPV unknown
273,1,1,Research lab HPV,HPV unknown
273,1,1,Nodal Stage,N0
273,1,1,Date of Death,2004-12-27 00:00:00
273,1,1,Research lab p16,p16 unknown
273,1,1,Metastasis,M0
273,1,1,Tumor Stage,T4a
273,1,1,Age at Death,59.4
273,1,1,Clinical lab p16,p16 unknown
273,1,1,Treatment Modality,Sx
273,1,1,Occurrence #,1st primary
273,1,1,First Failure Type,no known failure
273,1,1,Time to Death,1.0
273,1,1,Status,Dead unk disease
273,1,1,Second Failure Type,no known failure
273,1,1,Overall Stage,IVa
273,1,1,Tumor Site,oropharynx
274,1,1,Clinical lab p16,p16 unknown
274,1,1,Second Failure Type,no known failure
274,1,1,Tumor Stage,T4a
274,1,1,Status,Alive w/o disease
274,1,1,Research lab p16,p16 positive
274,1,1,Tumor Site,oropharynx
274,1,1,Nodal Stage,N1
274,1,1,Metastasis,M0
274,1,1,First Failure Type,no known failure
274,1,1,Radiation Dosage,53
274,1,1,Occurrence #,1st primary
274,1,1,Treatment Modality,Sx & RT
274,1,1,Research lab HPV,HPV positive
274,1,1,Overall Stage,IVa
275,1,1,Status,Dead w/ disease
275,1,1,Nodal Stage,N2
275,1,1,Clinical lab p16,p16 unknown
275,1,1,Tumor Site,oropharynx
275,1,1,Treatment Modality,CTX-RT
275,1,1,Tumor Stage,T3
275,1,1,Age at Death,44.2
275,1,1,Occurrence #,1st primary
275,1,1,Second Failure Type,no known failure
275,1,1,Radiation Dosage,12.6
275,1,1,Time to Death,0.6
275,1,1,Research lab p16,p16 negative
275,1,1,Initial Chemotherapy Agent,PTX/carbo
275,1,1,Metastasis,M0
275,1,1,Overall Stage,IVa
275,1,1,Research lab HPV,HPV negative
275,1,1,First Failure Type,no known failure
275,1,1,Date of Death,2001-08-04 00:00:00
276,1,1,Metastasis,M0
276,1,1,Status,Dead w/ disease
276,1,1,Nodal Stage,N2
276,1,1,Treatment Modality,RT
276,1,1,Occurrence #,1st primary
276,1,1,Research lab HPV,HPV negative
276,1,1,Radiation Dosage,91
276,1,1,Date of Death,1994-07-04 00:00:00
276,1,1,Time to Death,0.2
276,1,1,Overall Stage,IVa
276,1,1,Tumor Stage,T4a
276,1,1,Second Failure Type,no known failure
276,1,1,Tumor Site,oropharynx
276,1,1,Research lab p16,p16 negative
276,1,1,Clinical lab p16,p16 unknown
276,1,1,First Failure Type,no known failure
276,1,1,Age at Death,63.4
277,1,1,Time to Death,10.2
277,1,1,Tumor Stage,T4a
277,1,1,Research lab HPV,HPV unknown
277,1,1,Radiation Dosage,unknown
277,1,1,Time to First Failure,0.1
277,1,1,Treatment Modality,CTX-RT
277,1,1,Clinical lab p16,p16 unknown
277,1,1,Status,Dead w/o disease
277,1,1,Overall Stage,IVa
277,1,1,Occurrence #,1st primary
277,1,1,Metastasis,M0
277,1,1,First Failure Treatment Modality,Sx
277,1,1,Initial Chemotherapy Agent,unknown
277,1,1,Nodal Stage,N2
277,1,1,Age at Death,68.6
277,1,1,First Failure Type,locoregional
277,1,1,Date of Death,2011-09-07 00:00:00
277,1,1,Second Failure Type,no known failure
277,1,1,Research lab p16,p16 unknown
277,1,1,First Failure Site,oropharynx
277,1,1,Tumor Site,oropharynx
278,1,1,Tumor Site,oropharynx
278,1,1,Second Failure Type,no known failure
278,1,1,Age at Death,84.3
278,1,1,Research lab HPV,HPV unknown
278,1,1,Initial Chemotherapy Agent,carbo/doce
278,1,1,Clinical lab p16,p16 unknown
278,1,1,Tumor Stage,T2
278,1,1,Status,Dead unk disease
278,1,1,Radiation Dosage,70.2
278,1,1,Overall Stage,IVa
278,1,1,Occurrence #,Unknown
278,1,1,First Failure Type,no known failure
278,1,1,Treatment Modality,CTX-RT
278,1,1,Time to Death,9.3
278,1,1,Date of Death,2008-10-17 00:00:00
278,1,1,Research lab p16,p16 unknown
278,1,1,Metastasis,M0
278,1,1,Nodal Stage,N2
279,1,1,Research lab p16,p16 negative
279,1,1,Status,Dead unk disease
279,1,1,Date of Death,1998-05-22 00:00:00
279,1,1,Metastasis,M0
279,1,1,Tumor Site,oropharynx
279,1,1,Research lab HPV,HPV unknown
279,1,1,Time to Death,2.7
279,1,1,Nodal Stage,N0
279,1,1,First Failure Type,no known failure
279,1,1,Age at Death,53.5
279,1,1,Overall Stage,II
279,1,1,Occurrence #,1st primary
279,1,1,Tumor Stage,T2
279,1,1,Radiation Dosage,58
279,1,1,Clinical lab p16,p16 unknown
279,1,1,Second Failure Type,no known failure
279,1,1,Treatment Modality,RT
280,1,1,Date of Death,2008-08-22 00:00:00
280,1,1,Second Failure Type,no known failure
280,1,1,Research lab HPV,HPV unknown
280,1,1,Nodal Stage,Unknown
280,1,1,Metastasis,Unknown
280,1,1,Treatment Modality,Unknown
280,1,1,Tumor Stage,Unknown
280,1,1,Occurrence #,1st primary
280,1,1,Time to Death,12.0
280,1,1,Age at Death,61.0
280,1,1,Overall Stage,Unknown
280,1,1,Tumor Site,oropharynx
280,1,1,Status,Dead unk disease
280,1,1,Research lab p16,p16 unknown
280,1,1,First Failure Type,no known failure
280,1,1,Clinical lab p16,p16 unknown
281,1,1,Second Failure Type,no known failure
281,1,1,Metastasis,M0
281,1,1,Tumor Stage,T2
281,1,1,Tumor Site,oropharynx
281,1,1,Overall Stage,III
281,1,1,Status,Alive w/o disease
281,1,1,Occurrence #,1st primary
281,1,1,Research lab HPV,HPV negative
281,1,1,Research lab p16,p16 negative
281,1,1,Clinical lab p16,p16 unknown
281,1,1,First Failure Type,no known failure
281,1,1,Treatment Modality,Sx
281,1,1,Nodal Stage,N1
282,1,1,Radiation Dosage,70.2
282,1,1,Clinical lab p16,p16 unknown
282,1,1,First Failure Type,no known failure
282,1,1,Metastasis,M0
282,1,1,Research lab p16,p16 unknown
282,1,1,Overall Stage,IVa
282,1,1,Occurrence #,1st primary
282,1,1,Tumor Stage,T4b
282,1,1,Treatment Modality,CTX-RT
282,1,1,Second Failure Type,no known failure
282,1,1,Nodal Stage,N2
282,1,1,Status,Dead w/o disease
282,1,1,Research lab HPV,HPV unknown
282,1,1,Initial Chemotherapy Agent,cap/doce
282,1,1,Date of Death,2010-03-20 00:00:00
282,1,1,Tumor Site,oropharynx
282,1,1,Age at Death,60.9
282,1,1,Time to Death,9.6
283,1,1,Treatment Modality,CTX-RT
283,1,1,Overall Stage,III
283,1,1,Occurrence #,Unknown
283,1,1,Age at Death,72.4
283,1,1,Time to Death,3.1
283,1,1,Tumor Stage,T3
283,1,1,Research lab p16,p16 unknown
283,1,1,Radiation Dosage,70.2
283,1,1,Nodal Stage,N1
283,1,1,Second Failure Type,no known failure
283,1,1,Research lab HPV,HPV unknown
283,1,1,Status,Dead w/o disease
283,1,1,Initial Chemotherapy Agent,carbo/doce
283,1,1,Date of Death,2001-10-26 00:00:00
283,1,1,Tumor Site,oropharynx
283,1,1,Clinical lab p16,p16 unknown
283,1,1,Metastasis,M0
283,1,1,First Failure Type,no known failure
284,1,1,Clinical lab p16,p16 unknown
284,1,1,First Failure Type,locoregional
284,1,1,Second Failure Type,no known failure
284,1,1,Nodal Stage,N2
284,1,1,Time to Death,2.1
284,1,1,Tumor Site,oropharynx
284,1,1,Initial Chemotherapy Agent,carbo/doce
284,1,1,Treatment Modality,CTX-RT
284,1,1,Status,Dead w/ disease
284,1,1,Overall Stage,IVa
284,1,1,Tumor Stage,T4a
284,1,1,Time to First Failure,0.4
284,1,1,Occurrence #,Unknown
284,1,1,Radiation Dosage,70.2
284,1,1,Date of Death,1999-03-04 00:00:00
284,1,1,Age at Death,50.5
284,1,1,Metastasis,M0
284,1,1,Research lab p16,p16 unknown
284,1,1,Research lab HPV,HPV unknown
285,1,1,Overall Stage,Unknown
285,1,1,Occurrence #,1st primary
285,1,1,Treatment Modality,Unknown
285,1,1,Second Failure Type,no known failure
285,1,1,Age at Death,77.9
285,1,1,Tumor Site,oropharynx
285,1,1,Date of Death,2005-04-26 00:00:00
285,1,1,Metastasis,Unknown
285,1,1,Time to Death,9.9
285,1,1,Nodal Stage,Unknown
285,1,1,Clinical lab p16,p16 unknown
285,1,1,Research lab HPV,HPV unknown
285,1,1,Status,Dead unk disease
285,1,1,Research lab p16,p16 unknown
285,1,1,Tumor Stage,Unknown
285,1,1,First Failure Type,no known failure
286,1,1,Age at Death,58.8
286,1,1,Research lab p16,p16 unknown
286,1,1,Initial Chemotherapy Agent,carbo/doce
286,1,1,First Failure Type,locoregional
286,1,1,Occurrence #,other primary
286,1,1,Nodal Stage,N2
286,1,1,Date of Death,2007-10-23 00:00:00
286,1,1,Radiation Dosage,70.2
286,1,1,Status,Dead w/ disease
286,1,1,Time to Death,2.4
286,1,1,Research lab HPV,HPV unknown
286,1,1,Clinical lab p16,p16 unknown
286,1,1,Time to First Failure,2.0
286,1,1,Tumor Stage,T2
286,1,1,Metastasis,M0
286,1,1,Tumor Site,oropharynx
286,1,1,Treatment Modality,CTX-RT
286,1,1,Second Failure Type,no known failure
286,1,1,Overall Stage,IVa
287,1,1,Time to Death,12.6
287,1,1,Tumor Stage,T3
287,1,1,Nodal Stage,N0
287,1,1,Tumor Site,oropharynx
287,1,1,Second Failure Type,no known failure
287,1,1,Initial Chemotherapy Agent,unk
287,1,1,Metastasis,M0
287,1,1,Occurrence #,1st primary
287,1,1,Status,Dead w/o disease
287,1,1,Age at Death,72.5
287,1,1,Date of Death,2011-04-18 00:00:00
287,1,1,Research lab HPV,HPV unknown
287,1,1,Clinical lab p16,p16 unknown
287,1,1,Treatment Modality,CTX-RT
287,1,1,Radiation Dosage,unk
287,1,1,First Failure Type,no known failure
287,1,1,Overall Stage,III
287,1,1,Research lab p16,p16 unknown
288,1,1,Metastasis,M0
288,1,1,Tumor Site,oropharynx
288,1,1,Status,Alive w/o disease
288,1,1,Research lab HPV,HPV negative
288,1,1,Radiation Dosage,70.2
288,1,1,Overall Stage,III
288,1,1,Clinical lab p16,p16 unknown
288,1,1,Research lab p16,p16 negative
288,1,1,Initial Chemotherapy Agent,cis
288,1,1,First Failure Type,no known failure
288,1,1,Occurrence #,1st primary
288,1,1,Nodal Stage,N0
288,1,1,Second Failure Type,no known failure
288,1,1,Treatment Modality,CTX-RT
288,1,1,Tumor Stage,T3
289,1,1,Metastasis,Unknown
289,1,1,Occurrence #,1st primary
289,1,1,First Failure Type,no known failure
289,1,1,Nodal Stage,Unknown
289,1,1,Research lab p16,p16 unknown
289,1,1,Treatment Modality,Unknown
289,1,1,Tumor Site,Unknown
289,1,1,Status,Unknown
289,1,1,Overall Stage,Unknown
289,1,1,Clinical lab p16,p16 unknown
289,1,1,Tumor Stage,Unknown
289,1,1,Second Failure Type,no known failure
289,1,1,Research lab HPV,HPV unknown
290,1,1,Clinical lab p16,p16 unknown
290,1,1,Age at Death,67.9
290,1,1,Status,Dead unk disease
290,1,1,First Failure Type,no known failure
290,1,1,Overall Stage,Unknown
290,1,1,Treatment Modality,Unknown
290,1,1,Occurrence #,1st primary
290,1,1,Tumor Stage,Unknown
290,1,1,Date of Death,2001-09-18 00:00:00
290,1,1,Research lab p16,p16 unknown
290,1,1,Time to Death,7.6
290,1,1,Second Failure Type,no known failure
290,1,1,Metastasis,Unknown
290,1,1,Nodal Stage,Unknown
290,1,1,Tumor Site,oropharynx
290,1,1,Research lab HPV,HPV unknown
291,1,1,Research lab HPV,HPV unknown
291,1,1,Clinical lab p16,p16 unknown
291,1,1,Metastasis,Unknown
291,1,1,Nodal Stage,Unknown
291,1,1,Treatment Modality,Unknown
291,1,1,Second Failure Type,no known failure
291,1,1,Tumor Site,oropharynx
291,1,1,Tumor Stage,Unknown
291,1,1,Research lab p16,p16 unknown
291,1,1,Overall Stage,Unknown
291,1,1,First Failure Type,no known failure
291,1,1,Occurrence #,1st primary
291,1,1,Status,Unknown
292,1,1,Radiation Dosage,70.2
292,1,1,Status,Alive w/o disease
292,1,1,Overall Stage,IVa
292,1,1,Treatment Modality,CTX-RT
292,1,1,Tumor Stage,T2
292,1,1,Occurrence #,1st primary
292,1,1,Initial Chemotherapy Agent,carbo/PTX
292,1,1,Nodal Stage,N2
292,1,1,Research lab p16,p16 positive
292,1,1,Metastasis,M0
292,1,1,Second Failure Type,no known failure
292,1,1,Research lab HPV,HPV positive
292,1,1,Tumor Site,oropharynx
292,1,1,Clinical lab p16,p16 unknown
292,1,1,First Failure Type,no known failure
293,1,1,Tumor Site,oropharynx
293,1,1,Metastasis,M0
293,1,1,Age at Death,52.5
293,1,1,Initial Chemotherapy Agent,5FU/cis
293,1,1,Research lab p16,p16 negative
293,1,1,Occurrence #,other primary
293,1,1,Tumor Stage,T4a
293,1,1,Status,Dead unk disease
293,1,1,Date of Death,1994-10-15 00:00:00
293,1,1,Research lab HPV,HPV negative
293,1,1,Treatment Modality,CTX
293,1,1,Second Failure Type,no known failure
293,1,1,First Failure Type,no known failure
293,1,1,Clinical lab p16,p16 unknown
293,1,1,Nodal Stage,N0
293,1,1,Overall Stage,IVa
293,1,1,Time to Death,1.4
294,1,1,First Failure Type,no known failure
294,1,1,Initial Chemotherapy Agent,unk
294,1,1,Occurrence #,1st primary
294,1,1,Treatment Modality,CTX-RT
294,1,1,Research lab p16,p16 unknown
294,1,1,Date of Death,2009-01-18 00:00:00
294,1,1,Status,Dead w/o disease
294,1,1,Overall Stage,II
294,1,1,Metastasis,M0
294,1,1,Tumor Stage,T2
294,1,1,Research lab HPV,HPV unknown
294,1,1,Time to Death,9.7
294,1,1,Tumor Site,oropharynx
294,1,1,Age at Death,78.5
294,1,1,Nodal Stage,N0
294,1,1,Radiation Dosage,unk
294,1,1,Second Failure Type,no known failure
294,1,1,Clinical lab p16,p16 unknown
295,1,1,Date of Death,2003-10-21 00:00:00
295,1,1,Status,Dead w/o disease
295,1,1,First Failure Type,no known failure
295,1,1,Occurrence #,1st primary
295,1,1,Research lab p16,p16 positive
295,1,1,Age at Death,46.5
295,1,1,Time to Death,1.9
295,1,1,Treatment Modality,RT
295,1,1,Second Failure Type,no known failure
295,1,1,Nodal Stage,N0
295,1,1,Tumor Site,oropharynx
295,1,1,Tumor Stage,T3
295,1,1,Research lab HPV,HPV positive
295,1,1,Overall Stage,III
295,1,1,Clinical lab p16,p16 unknown
295,1,1,Radiation Dosage,70.2
295,1,1,Metastasis,M0
296,1,1,Second Failure Type,no known failure
296,1,1,Date of Death,2001-09-05 00:00:00
296,1,1,Research lab p16,p16 negative
296,1,1,Nodal Stage,Unknown
296,1,1,Status,Dead unk disease
296,1,1,Occurrence #,Unknown
296,1,1,Overall Stage,Unknown
296,1,1,Research lab HPV,HPV negative
296,1,1,Tumor Stage,Unknown
296,1,1,Tumor Site,oropharynx
296,1,1,First Failure Type,no known failure
296,1,1,Metastasis,Unknown
296,1,1,Treatment Modality,Unknown
296,1,1,Time to Death,4.5
296,1,1,Age at Death,74.1
296,1,1,Clinical lab p16,p16 unknown
297,1,1,Treatment Modality,Sx & CTX-RT
297,1,1,Radiation Dosage,unknown
297,1,1,Initial Chemotherapy Agent,unknown
297,1,1,Research lab p16,p16 unknown
297,1,1,Overall Stage,IVb
297,1,1,Second Failure Type,no known failure
297,1,1,Occurrence #,recurrence
297,1,1,Tumor Stage,T2
297,1,1,First Failure Type,no known failure
297,1,1,Clinical lab p16,p16 unknown
297,1,1,Research lab HPV,HPV unknown
297,1,1,Nodal Stage,N3
297,1,1,Status,Alive unk disease
297,1,1,Tumor Site,oropharynx
297,1,1,Metastasis,M0
298,1,1,Treatment Modality,CTX-RT
298,1,1,Age at Death,75.7
298,1,1,Occurrence #,1st primary
298,1,1,Metastasis,M0
298,1,1,Overall Stage,III
298,1,1,Research lab HPV,HPV unknown
298,1,1,Initial Chemotherapy Agent,carbo/PTX
298,1,1,Radiation Dosage,70.2
298,1,1,Time to Death,13.7
298,1,1,First Failure Type,no known failure
298,1,1,Tumor Site,oropharynx
298,1,1,Second Failure Type,no known failure
298,1,1,Clinical lab p16,p16 unknown
298,1,1,Status,Dead unk disease
298,1,1,Date of Death,2010-03-12 00:00:00
298,1,1,Nodal Stage,N0
298,1,1,Tumor Stage,T3
298,1,1,Research lab p16,p16 unknown
299,1,1,Metastasis,M0
299,1,1,Nodal Stage,N0
299,1,1,Tumor Site,oropharynx
299,1,1,Research lab HPV,HPV unknown
299,1,1,Treatment Modality,Sx
299,1,1,Second Failure Type,no known failure
299,1,1,Tumor Stage,T4a
299,1,1,Clinical lab p16,p16 unknown
299,1,1,Date of Death,2003-06-28 00:00:00
299,1,1,Status,Dead w/ disease
299,1,1,Time to First Failure,1.5
299,1,1,Research lab p16,p16 unknown
299,1,1,First Failure Type,locoregional
299,1,1,Overall Stage,IVa
299,1,1,Age at Death,62.7
299,1,1,Time to Death,3.6
299,1,1,Occurrence #,recurrence
300,1,1,Research lab HPV,HPV positive
300,1,1,Metastasis,Unknown
300,1,1,Date of Death,2000-12-11 00:00:00
300,1,1,Age at Death,64.2
300,1,1,Tumor Site,oropharynx
300,1,1,Nodal Stage,Unknown
300,1,1,Tumor Stage,Unknown
300,1,1,Second Failure Type,no known failure
300,1,1,Occurrence #,Unknown
300,1,1,Time to Death,2.0
300,1,1,Treatment Modality,Unknown
300,1,1,Overall Stage,Unknown
300,1,1,First Failure Type,no known failure
300,1,1,Research lab p16,p16 negative
300,1,1,Clinical lab p16,p16 unknown
300,1,1,Status,Dead unk disease
301,1,1,Tumor Site,oral cavity
301,1,1,Nodal Stage,N2
301,1,1,Second Failure Type,no known failure
301,1,1,Time to Death,0.0
301,1,1,First Failure Type,no known failure
301,1,1,Date of Death,2005-05-25 00:00:00
301,1,1,Clinical lab p16,p16 unknown
301,1,1,Overall Stage,IVa
301,1,1,Research lab HPV,HPV unknown
301,1,1,Metastasis,M0
301,1,1,Age at Death,93.3
301,1,1,Tumor Stage,T2
301,1,1,Research lab p16,p16 unknown
301,1,1,Status,Dead unk disease
301,1,1,Occurrence #,1st primary
301,1,1,Treatment Modality,Unknown
302,1,1,Status,Dead unk disease
302,1,1,Occurrence #,1st primary
302,1,1,Age at Death,65.7
302,1,1,Date of Death,1997-12-29 00:00:00
302,1,1,Metastasis,M0
302,1,1,Tumor Site,oral cavity
302,1,1,Clinical lab p16,p16 unknown
302,1,1,Second Failure Type,no known failure
302,1,1,Time to Death,4.5
302,1,1,First Failure Type,no known failure
302,1,1,Research lab HPV,HPV unknown
302,1,1,Nodal Stage,N1
302,1,1,Treatment Modality,Unknown
302,1,1,Research lab p16,p16 unknown
302,1,1,Tumor Stage,T2
302,1,1,Overall Stage,III
303,1,1,Nodal Stage,N2
303,1,1,Tumor Site,oropharynx
303,1,1,Status,Dead unk disease
303,1,1,Occurrence #,1st primary
303,1,1,Research lab p16,p16 positive
303,1,1,Initial Chemotherapy Agent,carbo/doce
303,1,1,Date of Death,2009-09-27 00:00:00
303,1,1,Metastasis,M0
303,1,1,Tumor Stage,T4a
303,1,1,Research lab HPV,HPV positive
303,1,1,Second Failure Type,no known failure
303,1,1,Clinical lab p16,p16 unknown
303,1,1,First Failure Type,locoregional
303,1,1,Time to Death,8.1
303,1,1,Radiation Dosage,70.2
303,1,1,Overall Stage,IVa
303,1,1,Age at Death,73.7
303,1,1,Time to First Failure,0.7
303,1,1,Treatment Modality,CTX-RT
304,1,1,Tumor Site,oropharynx
304,1,1,Tumor Stage,T2
304,1,1,Research lab HPV,HPV negative
304,1,1,Research lab p16,p16 negative
304,1,1,Date of Death,2006-03-03 00:00:00
304,1,1,Nodal Stage,N0
304,1,1,Second Failure Type,no known failure
304,1,1,First Failure Type,no known failure
304,1,1,Overall Stage,II
304,1,1,Metastasis,M0
304,1,1,Status,Dead unk disease
304,1,1,Radiation Dosage,unknown
304,1,1,Occurrence #,other primary
304,1,1,Treatment Modality,RT
304,1,1,Age at Death,79.1
304,1,1,Time to Death,0.4
304,1,1,Clinical lab p16,p16 unknown
305,1,1,First Failure Type,no known failure
305,1,1,Tumor Site,oropharynx
305,1,1,Age at Death,81.9
305,1,1,Treatment Modality,CTX-RT
305,1,1,Radiation Dosage,70.2
305,1,1,Overall Stage,IVa
305,1,1,Occurrence #,1st primary
305,1,1,Clinical lab p16,p16 unknown
305,1,1,Time to Death,2.3
305,1,1,Second Failure Type,no known failure
305,1,1,Tumor Stage,T4a
305,1,1,Research lab HPV,HPV unknown
305,1,1,Metastasis,M0
305,1,1,Status,Dead w/o disease
305,1,1,Nodal Stage,N0
305,1,1,Date of Death,2001-03-26 00:00:00
305,1,1,Research lab p16,p16 unknown
305,1,1,Initial Chemotherapy Agent,carbo/doce
306,1,1,Tumor Stage,T4a
306,1,1,Nodal Stage,N2
306,1,1,Clinical lab p16,p16 unknown
306,1,1,Research lab p16,p16 negative
306,1,1,Date of Death,2006-02-15 00:00:00
306,1,1,Time to Death,2.6
306,1,1,Second Failure Type,no known failure
306,1,1,Occurrence #,1st primary
306,1,1,Tumor Site,oropharynx
306,1,1,Metastasis,M0
306,1,1,Treatment Modality,Unknown
306,1,1,Overall Stage,IVa
306,1,1,First Failure Type,no known failure
306,1,1,Status,Dead unk disease
306,1,1,Age at Death,43.1
306,1,1,Research lab HPV,HPV negative
307,1,1,Time to Death,1.0
307,1,1,Clinical lab p16,p16 unknown
307,1,1,Nodal Stage,Unknown
307,1,1,Tumor Stage,Unknown
307,1,1,Status,Dead unk disease
307,1,1,Overall Stage,Unknown
307,1,1,Tumor Site,oropharynx
307,1,1,Research lab HPV,HPV negative
307,1,1,Second Failure Type,no known failure
307,1,1,Age at Death,39.9
307,1,1,Treatment Modality,Unknown
307,1,1,Research lab p16,p16 negative
307,1,1,Occurrence #,1st primary
307,1,1,Date of Death,2000-09-22 00:00:00
307,1,1,Metastasis,Unknown
307,1,1,First Failure Type,no known failure
308,1,1,Tumor Site,Unknown
308,1,1,Nodal Stage,Unknown
308,1,1,Tumor Stage,Unknown
308,1,1,First Failure Type,no known failure
308,1,1,Research lab p16,p16 unknown
308,1,1,Status,Unknown
308,1,1,Overall Stage,Unknown
308,1,1,Clinical lab p16,p16 unknown
308,1,1,Treatment Modality,Unknown
308,1,1,Occurrence #,1st primary
308,1,1,Metastasis,Unknown
308,1,1,Research lab HPV,HPV unknown
308,1,1,Second Failure Type,no known failure
309,1,1,Metastasis,M0
309,1,1,Date of Death,2004-02-22 00:00:00
309,1,1,Occurrence #,1st primary
309,1,1,Research lab p16,p16 negative
309,1,1,Clinical lab p16,p16 unknown
309,1,1,Treatment Modality,RT
309,1,1,Radiation Dosage,72
309,1,1,Time to First Failure,0.2
309,1,1,Overall Stage,IVa
309,1,1,Nodal Stage,N2
309,1,1,Age at Death,81.6
309,1,1,Status,Dead w/ disease
309,1,1,Tumor Site,oropharynx
309,1,1,Time to Death,1.3
309,1,1,Research lab HPV,HPV negative
309,1,1,Tumor Stage,T2
309,1,1,Second Failure Type,no known failure
309,1,1,First Failure Type,locoregional
310,1,1,Second Failure Type,no known failure
310,1,1,Overall Stage,Unknown
310,1,1,Nodal Stage,Unknown
310,1,1,Status,Unknown
310,1,1,Tumor Stage,Unknown
310,1,1,Research lab p16,p16 unknown
310,1,1,First Failure Type,no known failure
310,1,1,Occurrence #,1st primary
310,1,1,Metastasis,Unknown
310,1,1,Research lab HPV,HPV unknown
310,1,1,Tumor Site,oropharynx
310,1,1,Clinical lab p16,p16 unknown
310,1,1,Treatment Modality,Unknown
311,1,1,Time to Death,0.2
311,1,1,Metastasis,M1
311,1,1,Initial Chemotherapy Agent,carbo/PTX
311,1,1,Status,Dead w/ disease
311,1,1,Occurrence #,1st primary
311,1,1,Nodal Stage,N0
311,1,1,Second Failure Type,no known failure
311,1,1,Overall Stage,IVc
311,1,1,Clinical lab p16,p16 unknown
311,1,1,Treatment Modality,CTX-RT
311,1,1,Age at Death,65.4
311,1,1,Research lab HPV,HPV negative
311,1,1,First Failure Type,no known failure
311,1,1,Tumor Stage,T4a
311,1,1,Research lab p16,p16 negative
311,1,1,Radiation Dosage,33
311,1,1,Tumor Site,oropharynx
311,1,1,Date of Death,1998-08-13 00:00:00
312,1,1,Treatment Modality,Unknown
312,1,1,Second Failure Type,no known failure
312,1,1,Status,Dead w/o disease
312,1,1,Occurrence #,Unknown
312,1,1,Tumor Stage,T2
312,1,1,Metastasis,M0
312,1,1,Nodal Stage,N3
312,1,1,Overall Stage,IVb
312,1,1,Date of Death,1995-07-20 00:00:00
312,1,1,Clinical lab p16,p16 unknown
312,1,1,Research lab p16,p16 positive
312,1,1,Tumor Site,oropharynx
312,1,1,Time to Death,2.0
312,1,1,Age at Death,74.1
312,1,1,First Failure Type,no known failure
312,1,1,Research lab HPV,HPV positive
313,1,1,Research lab HPV,HPV positive
313,1,1,Radiation Dosage,70
313,1,1,Initial Chemotherapy Agent,carbo/ PTX
313,1,1,Clinical lab p16,p16 unknown
313,1,1,Treatment Modality,CTX-RT
313,1,1,Occurrence #,1st primary
313,1,1,Second Failure Type,no known failure
313,1,1,First Failure Type,no known failure
313,1,1,Research lab p16,p16 positive
313,1,1,Tumor Stage,T3
313,1,1,Tumor Site,oropharynx
313,1,1,Nodal Stage,N1
313,1,1,Metastasis,M0
313,1,1,Overall Stage,III
313,1,1,Status,Alive w/o disease
314,1,1,Metastasis,M0
314,1,1,Tumor Site,oropharynx
314,1,1,Research lab HPV,HPV unknown
314,1,1,Second Failure Type,no known failure
314,1,1,Radiation Dosage,70.2
314,1,1,Initial Chemotherapy Agent,cap/doce
314,1,1,Research lab p16,p16 unknown
314,1,1,Status,Alive w/o disease
314,1,1,First Failure Type,no known failure
314,1,1,Overall Stage,IVa
314,1,1,Occurrence #,1st primary
314,1,1,Clinical lab p16,p16 unknown
314,1,1,Treatment Modality,CTX-RT
314,1,1,Nodal Stage,N2
314,1,1,Tumor Stage,T3
315,1,1,Nodal Stage,N2
315,1,1,Tumor Stage,T4a
315,1,1,Tumor Site,oropharynx
315,1,1,Time to Death,0.3
315,1,1,Research lab HPV,HPV negative
315,1,1,Second Failure Type,no known failure
315,1,1,First Failure Type,no known failure
315,1,1,Research lab p16,p16 negative
315,1,1,Age at Death,61.7
315,1,1,Status,Dead unk disease
315,1,1,Treatment Modality,Sx
315,1,1,Metastasis,M0
315,1,1,Date of Death,2006-01-29 00:00:00
315,1,1,Occurrence #,1st primary
315,1,1,Clinical lab p16,p16 unknown
315,1,1,Overall Stage,IVa
316,1,1,First Failure Type,no known failure
316,1,1,Date of Death,2005-11-30 00:00:00
316,1,1,Research lab p16,p16 unknown
316,1,1,Nodal Stage,Unknown
316,1,1,Age at Death,84.6
316,1,1,Status,Dead unk disease
316,1,1,Treatment Modality,Unknown
316,1,1,Metastasis,Unknown
316,1,1,Clinical lab p16,p16 unknown
316,1,1,Overall Stage,Unknown
316,1,1,Occurrence #,1st primary
316,1,1,Tumor Site,oropharynx
316,1,1,Tumor Stage,Unknown
316,1,1,Second Failure Type,no known failure
316,1,1,Time to Death,11.7
316,1,1,Research lab HPV,HPV unknown
317,1,1,Metastasis,M0
317,1,1,Treatment Modality,CTX-RT
317,1,1,Status,Alive w/o disease
317,1,1,Research lab p16,p16 positive
317,1,1,Second Failure Type,no known failure
317,1,1,Clinical lab p16,p16 unknown
317,1,1,Occurrence #,1st primary
317,1,1,Tumor Stage,T4a
317,1,1,Overall Stage,IVb
317,1,1,Research lab HPV,HPV positive
317,1,1,Radiation Dosage,70.2
317,1,1,First Failure Type,no known failure
317,1,1,Nodal Stage,N3
317,1,1,Initial Chemotherapy Agent,carbo/doce
317,1,1,Tumor Site,oropharynx
318,1,1,Date of Death,2003-10-23 00:00:00
318,1,1,Tumor Stage,T3
318,1,1,Overall Stage,IVb
318,1,1,First Failure Type,no known failure
318,1,1,Metastasis,M0
318,1,1,Radiation Dosage,unknown
318,1,1,Nodal Stage,N3
318,1,1,Second Failure Type,no known failure
318,1,1,Clinical lab p16,p16 unknown
318,1,1,Tumor Site,oropharynx
318,1,1,Initial Chemotherapy Agent,unknown
318,1,1,Status,Dead unk disease
318,1,1,Research lab p16,p16 unknown
318,1,1,Treatment Modality,Sx & CTX-RT
318,1,1,Occurrence #,1st primary
318,1,1,Age at Death,75.9
318,1,1,Time to Death,4.0
318,1,1,Research lab HPV,HPV unknown
319,1,1,First Failure Type,no known failure
319,1,1,Time to Death,0.3
319,1,1,Research lab HPV,HPV negative
319,1,1,Age at Death,76.0
319,1,1,Overall Stage,IVa
319,1,1,Status,Dead unk disease
319,1,1,Treatment Modality,Unknown
319,1,1,Metastasis,M0
319,1,1,Date of Death,2001-07-02 00:00:00
319,1,1,Nodal Stage,N0
319,1,1,Occurrence #,1st primary
319,1,1,Research lab p16,p16 negative
319,1,1,Clinical lab p16,p16 unknown
319,1,1,Tumor Site,oropharynx
319,1,1,Tumor Stage,T4a
319,1,1,Second Failure Type,no known failure
320,1,1,Occurrence #,1st primary
320,1,1,Nodal Stage,N2
320,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
320,1,1,Second Failure Type,no known failure
320,1,1,Radiation Dosage,70.2
320,1,1,Tumor Site,oropharynx
320,1,1,Metastasis,M0
320,1,1,Clinical lab p16,p16 unknown
320,1,1,Time to First Failure,0.8
320,1,1,Status,Dead w/ disease
320,1,1,Time to Death,3.3
320,1,1,Date of Death,2009-05-10 00:00:00
320,1,1,Research lab p16,p16 positive
320,1,1,Overall Stage,IVa
320,1,1,Tumor Stage,T3
320,1,1,Age at Death,78.0
320,1,1,Research lab HPV,HPV positive
320,1,1,Treatment Modality,CTX-RT
320,1,1,First Failure Type,distant
321,1,1,Clinical lab p16,p16 unknown
321,1,1,Tumor Stage,T2
321,1,1,Date of Death,2002-07-15 00:00:00
321,1,1,Nodal Stage,N2
321,1,1,Status,Dead unk disease
321,1,1,Radiation Dosage,64
321,1,1,First Failure Type,no known failure
321,1,1,Second Failure Type,no known failure
321,1,1,Treatment Modality,Sx & RT
321,1,1,Research lab HPV,HPV positive
321,1,1,Occurrence #,1st primary
321,1,1,Overall Stage,IVa
321,1,1,Time to Death,1.3
321,1,1,Metastasis,M0
321,1,1,Tumor Site,oropharynx
321,1,1,Research lab p16,p16 positive
321,1,1,Age at Death,48.7
322,1,1,Research lab p16,p16 positive
322,1,1,Age at Death,59.0
322,1,1,Status,Dead unk disease
322,1,1,Research lab HPV,HPV positive
322,1,1,Time to Death,14.9
322,1,1,Clinical lab p16,p16 unknown
322,1,1,Initial Chemotherapy Agent,carbo/doce
322,1,1,Occurrence #,1st primary
322,1,1,Treatment Modality,CTX-RT
322,1,1,Metastasis,M0
322,1,1,Overall Stage,IVa
322,1,1,Tumor Stage,T4a
322,1,1,Date of Death,2012-12-04 00:00:00
322,1,1,Tumor Site,oropharynx
322,1,1,First Failure Type,no known failure
322,1,1,Radiation Dosage,70.2
322,1,1,Nodal Stage,N2
322,1,1,Second Failure Type,no known failure
323,1,1,Status,Dead unk disease
323,1,1,Research lab HPV,HPV unknown
323,1,1,Overall Stage,Unknown
323,1,1,Tumor Site,oropharynx
323,1,1,First Failure Type,no known failure
323,1,1,Date of Death,2010-02-06 00:00:00
323,1,1,Tumor Stage,Unknown
323,1,1,Research lab p16,p16 unknown
323,1,1,Metastasis,Unknown
323,1,1,Nodal Stage,Unknown
323,1,1,Age at Death,63.6
323,1,1,Occurrence #,1st primary
323,1,1,Treatment Modality,Unknown
323,1,1,Time to Death,10.6
323,1,1,Second Failure Type,no known failure
323,1,1,Clinical lab p16,p16 unknown
324,1,1,Occurrence #,1st primary
324,1,1,First Failure Type,no known failure
324,1,1,Tumor Site,Unknown
324,1,1,Tumor Stage,Unknown
324,1,1,Research lab HPV,HPV unknown
324,1,1,Research lab p16,p16 unknown
324,1,1,Overall Stage,Unknown
324,1,1,Treatment Modality,Unknown
324,1,1,Second Failure Type,no known failure
324,1,1,Status,Unknown
324,1,1,Metastasis,Unknown
324,1,1,Nodal Stage,Unknown
324,1,1,Clinical lab p16,p16 unknown
325,1,1,Second Failure Type,no known failure
325,1,1,Tumor Site,oropharynx
325,1,1,Radiation Dosage,70.2
325,1,1,Treatment Modality,CTX-RT
325,1,1,Clinical lab p16,p16 unknown
325,1,1,Nodal Stage,N2
325,1,1,Research lab p16,p16 positive
325,1,1,Research lab HPV,HPV positive
325,1,1,Metastasis,M0
325,1,1,First Failure Type,no known failure
325,1,1,Overall Stage,IVa
325,1,1,Status,Alive w/o disease
325,1,1,Occurrence #,1st primary
325,1,1,Initial Chemotherapy Agent,unknown
325,1,1,Tumor Stage,T1
326,1,1,Research lab p16,p16 negative
326,1,1,Research lab HPV,HPV negative
326,1,1,First Failure Type,locoregional
326,1,1,Initial Chemotherapy Agent,various
326,1,1,Overall Stage,IVa
326,1,1,Treatment Modality,Sx & CTX
326,1,1,Status,Dead w/ disease
326,1,1,Second Failure Type,no known failure
326,1,1,Metastasis,M0
326,1,1,Age at Death,45.4
326,1,1,Time to First Failure,0.2
326,1,1,Nodal Stage,N2
326,1,1,Tumor Stage,T4a
326,1,1,Occurrence #,recurrence
326,1,1,Date of Death,2005-11-24 00:00:00
326,1,1,Clinical lab p16,p16 unknown
326,1,1,Time to Death,1.1
326,1,1,Tumor Site,oropharynx
327,1,1,Overall Stage,Unknown
327,1,1,Clinical lab p16,p16 unknown
327,1,1,Research lab p16,p16 unknown
327,1,1,Tumor Stage,Unknown
327,1,1,Metastasis,Unknown
327,1,1,Treatment Modality,Unknown
327,1,1,Nodal Stage,Unknown
327,1,1,Occurrence #,1st primary
327,1,1,Second Failure Type,no known failure
327,1,1,Status,Unknown
327,1,1,Research lab HPV,HPV unknown
327,1,1,Tumor Site,Unknown
327,1,1,First Failure Type,no known failure
328,1,1,Metastasis,Unknown
328,1,1,Tumor Site,Unknown
328,1,1,First Failure Type,no known failure
328,1,1,Nodal Stage,Unknown
328,1,1,Overall Stage,Unknown
328,1,1,Research lab HPV,HPV unknown
328,1,1,Occurrence #,1st primary
328,1,1,Clinical lab p16,p16 unknown
328,1,1,Status,Unknown
328,1,1,Tumor Stage,Unknown
328,1,1,Research lab p16,p16 unknown
328,1,1,Treatment Modality,Unknown
328,1,1,Second Failure Type,no known failure
329,1,1,Research lab p16,p16 unknown
329,1,1,Clinical lab p16,p16 unknown
329,1,1,Metastasis,M0
329,1,1,Second Failure Type,no known failure
329,1,1,Initial Chemotherapy Agent,carbo/doce
329,1,1,Time to Death,2.2
329,1,1,Age at Death,47.3
329,1,1,Time to First Failure,0.8
329,1,1,Treatment Modality,CTX-RT
329,1,1,Nodal Stage,N2
329,1,1,Status,Dead w/ disease
329,1,1,Research lab HPV,HPV unknown
329,1,1,Radiation Dosage,70.2
329,1,1,Occurrence #,1st primary
329,1,1,Date of Death,1999-01-08 00:00:00
329,1,1,Overall Stage,IVa
329,1,1,Tumor Site,oropharynx
329,1,1,Tumor Stage,T4a
329,1,1,First Failure Type,locoregional
330,1,1,Status,Alive unk disease
330,1,1,Tumor Stage,T2
330,1,1,Treatment Modality,RT
330,1,1,First Failure Type,locoregional
330,1,1,Tumor Site,oropharynx
330,1,1,Second Failure Type,no known failure
330,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
330,1,1,Time to First Failure,0.8
330,1,1,Overall Stage,II
330,1,1,Research lab HPV,HPV unknown
330,1,1,Metastasis,M0
330,1,1,Radiation Dosage,unknown
330,1,1,First Failure Second Line Chemotherapy Agent,doce/cap
330,1,1,Nodal Stage,N0
330,1,1,First Failure Treatment Modality,CTX
330,1,1,First Failure Site,oropharynx
330,1,1,Research lab p16,p16 unknown
330,1,1,Clinical lab p16,p16 unknown
330,1,1,Occurrence #,1st primary
331,1,1,First Failure Type,locoregional
331,1,1,Initial Chemotherapy Agent,carbo/doce
331,1,1,Research lab p16,p16 unknown
331,1,1,Metastasis,M0
331,1,1,Tumor Stage,T3
331,1,1,Second Failure Type,no known failure
331,1,1,Date of Death,2000-11-06 00:00:00
331,1,1,Radiation Dosage,70.2
331,1,1,Time to Death,1.2
331,1,1,Occurrence #,1st primary
331,1,1,Age at Death,67.6
331,1,1,Clinical lab p16,p16 unknown
331,1,1,Time to First Failure,0.5
331,1,1,Overall Stage,III
331,1,1,Treatment Modality,CTX-RT
331,1,1,Status,Dead w/ disease
331,1,1,Research lab HPV,HPV unknown
331,1,1,Nodal Stage,N0
331,1,1,Tumor Site,oropharynx
332,1,1,Time to Death,0.8
332,1,1,Age at Death,60.7
332,1,1,Occurrence #,recurrence
332,1,1,Status,Dead unk disease
332,1,1,First Failure Type,no known failure
332,1,1,Second Failure Type,no known failure
332,1,1,Metastasis,Unknown
332,1,1,Tumor Stage,Unknown
332,1,1,Nodal Stage,Unknown
332,1,1,Research lab HPV,HPV unknown
332,1,1,Research lab p16,p16 unknown
332,1,1,Overall Stage,Unknown
332,1,1,Clinical lab p16,p16 unknown
332,1,1,Treatment Modality,Unknown
332,1,1,Date of Death,2006-08-13 00:00:00
332,1,1,Tumor Site,oropharynx
333,1,1,Status,Alive unk disease
333,1,1,First Failure Type,no known failure
333,1,1,Research lab HPV,HPV unknown
333,1,1,Research lab p16,p16 unknown
333,1,1,Clinical lab p16,p16 unknown
333,1,1,Treatment Modality,Sx
333,1,1,Tumor Stage,T2
333,1,1,Nodal Stage,N0
333,1,1,Tumor Site,oropharynx
333,1,1,Second Failure Type,no known failure
333,1,1,Occurrence #,recurrence
333,1,1,Overall Stage,II
333,1,1,Metastasis,M0
334,1,1,Status,Dead unk disease
334,1,1,Date of Death,2009-01-21 00:00:00
334,1,1,Treatment Modality,Unknown
334,1,1,Overall Stage,IVa
334,1,1,First Failure Type,no known failure
334,1,1,Tumor Site,larynx
334,1,1,Second Failure Type,no known failure
334,1,1,Nodal Stage,N2
334,1,1,Clinical lab p16,p16 unknown
334,1,1,Age at Death,65.9
334,1,1,Tumor Stage,T4a
334,1,1,Research lab HPV,HPV unknown
334,1,1,Occurrence #,1st primary
334,1,1,Initial Chemotherapy Agent,cis/5-FU
334,1,1,Metastasis,M0
334,1,1,Radiation Dosage,70.2
334,1,1,Research lab p16,p16 unknown
334,1,1,Time to Death,11.1
335,1,1,Treatment Modality,Unknown
335,1,1,Nodal Stage,Unknown
335,1,1,Research lab p16,p16 unknown
335,1,1,Tumor Stage,Unknown
335,1,1,First Failure Type,no known failure
335,1,1,Overall Stage,Unknown
335,1,1,Metastasis,Unknown
335,1,1,Second Failure Type,no known failure
335,1,1,Status,Unknown
335,1,1,Clinical lab p16,p16 unknown
335,1,1,Research lab HPV,HPV unknown
335,1,1,Occurrence #,1st primary
335,1,1,Tumor Site,Unknown
336,1,1,Clinical lab p16,p16 unknown
336,1,1,Research lab HPV,HPV unknown
336,1,1,Occurrence #,1st primary
336,1,1,Nodal Stage,Unknown
336,1,1,Research lab p16,p16 unknown
336,1,1,First Failure Type,no known failure
336,1,1,Tumor Site,oropharynx
336,1,1,Treatment Modality,Unknown
336,1,1,Second Failure Type,no known failure
336,1,1,Overall Stage,Unknown
336,1,1,Tumor Stage,Unknown
336,1,1,Status,Unknown
336,1,1,Metastasis,Unknown
337,1,1,Status,Dead w/ disease
337,1,1,Time to Death,2.4
337,1,1,Treatment Modality,CTX-RT
337,1,1,Radiation Dosage,70.2
337,1,1,Tumor Site,oropharynx
337,1,1,Tumor Stage,T3
337,1,1,Overall Stage,III
337,1,1,Second Failure Type,no known failure
337,1,1,Nodal Stage,N0
337,1,1,Initial Chemotherapy Agent,cis
337,1,1,First Failure Type,locoregional
337,1,1,Research lab p16,p16 unknown
337,1,1,Age at Death,77.9
337,1,1,Clinical lab p16,p16 unknown
337,1,1,Time to First Failure,0.7
337,1,1,Date of Death,1999-06-16 00:00:00
337,1,1,Research lab HPV,HPV unknown
337,1,1,Occurrence #,1st primary
337,1,1,Metastasis,M0
338,1,1,Tumor Site,oropharynx
338,1,1,Treatment Modality,Unknown
338,1,1,Date of Death,1995-03-26 00:00:00
338,1,1,Tumor Stage,T4a
338,1,1,Overall Stage,IVa
338,1,1,Nodal Stage,N2
338,1,1,Age at Death,48.3
338,1,1,Clinical lab p16,p16 unknown
338,1,1,Occurrence #,1st primary
338,1,1,Research lab HPV,HPV negative
338,1,1,Second Failure Type,no known failure
338,1,1,First Failure Type,no known failure
338,1,1,Time to Death,0.7
338,1,1,Metastasis,M0
338,1,1,Research lab p16,p16 negative
338,1,1,Status,Dead w/ disease
339,1,1,Date of Death,2000-12-07 00:00:00
339,1,1,Treatment Modality,CTX-RT
339,1,1,Tumor Stage,T4a
339,1,1,Second Failure Type,no known failure
339,1,1,Age at Death,62.9
339,1,1,Radiation Dosage,70.2
339,1,1,Tumor Site,oropharynx
339,1,1,Research lab p16,p16 negative
339,1,1,Occurrence #,1st primary
339,1,1,First Failure Type,no known failure
339,1,1,Time to Death,2.3
339,1,1,Clinical lab p16,p16 unknown
339,1,1,Initial Chemotherapy Agent,carbo/ PTX
339,1,1,Metastasis,M0
339,1,1,Research lab HPV,HPV unknown
339,1,1,Status,Dead unk disease
339,1,1,Nodal Stage,N0
339,1,1,Overall Stage,IVa
340,1,1,Overall Stage,IVa
340,1,1,Occurrence #,1st primary
340,1,1,Clinical lab p16,p16 unknown
340,1,1,Treatment Modality,CTX-RT
340,1,1,Research lab HPV,HPV unknown
340,1,1,Initial Chemotherapy Agent,cis
340,1,1,First Failure Type,no known failure
340,1,1,Status,Alive w/o disease
340,1,1,Tumor Stage,T4a
340,1,1,Research lab p16,p16 unknown
340,1,1,Radiation Dosage,70.2
340,1,1,Nodal Stage,N0
340,1,1,Tumor Site,oropharynx
340,1,1,Metastasis,M0
340,1,1,Second Failure Type,no known failure
341,1,1,Nodal Stage,N1
341,1,1,Date of Death,1997-05-11 00:00:00
341,1,1,Metastasis,M0
341,1,1,Research lab HPV,HPV negative
341,1,1,Occurrence #,1st primary
341,1,1,Overall Stage,III
341,1,1,Clinical lab p16,p16 unknown
341,1,1,Research lab p16,p16 negative
341,1,1,Time to First Failure,3.0
341,1,1,First Failure Type,locoregional
341,1,1,Tumor Site,oropharynx
341,1,1,Age at Death,55.8
341,1,1,Second Failure Type,no known failure
341,1,1,Status,Dead unk disease
341,1,1,Tumor Stage,T1
341,1,1,Time to Death,3.8
341,1,1,Treatment Modality,Sx
342,1,1,Tumor Stage,T2
342,1,1,Treatment Modality,CTX-RT
342,1,1,Research lab HPV,HPV positive
342,1,1,Initial Chemotherapy Agent,unknown
342,1,1,Metastasis,M0
342,1,1,Nodal Stage,N2
342,1,1,Occurrence #,1st primary
342,1,1,Radiation Dosage,70.2
342,1,1,Status,Alive w/o disease
342,1,1,Research lab p16,p16 positive
342,1,1,Second Failure Type,no known failure
342,1,1,Tumor Site,oropharynx
342,1,1,Clinical lab p16,p16 unknown
342,1,1,First Failure Type,no known failure
342,1,1,Overall Stage,IVa
343,1,1,Time to Death,1.7
343,1,1,Date of Death,2000-03-19 00:00:00
343,1,1,Occurrence #,1st primary
343,1,1,Research lab p16,p16 negative
343,1,1,Research lab HPV,HPV negative
343,1,1,Status,Dead unk disease
343,1,1,Clinical lab p16,p16 unknown
343,1,1,Nodal Stage,N0
343,1,1,Tumor Stage,T1
343,1,1,Overall Stage,I
343,1,1,Second Failure Type,no known failure
343,1,1,Metastasis,M0
343,1,1,Tumor Site,oropharynx
343,1,1,Radiation Dosage,70.2
343,1,1,Treatment Modality,RT
343,1,1,First Failure Type,no known failure
343,1,1,Age at Death,68.5
344,1,1,Occurrence #,1st primary
344,1,1,Second Failure Type,no known failure
344,1,1,Research lab p16,p16 unknown
344,1,1,Radiation Dosage,70.2
344,1,1,Nodal Stage,N1
344,1,1,Clinical lab p16,p16 unknown
344,1,1,Metastasis,M0
344,1,1,First Failure Type,no known failure
344,1,1,Overall Stage,III
344,1,1,Treatment Modality,CTX-RT
344,1,1,Initial Chemotherapy Agent,cis
344,1,1,Status,Alive w/o disease
344,1,1,Tumor Site,oropharynx
344,1,1,Research lab HPV,HPV unknown
344,1,1,Tumor Stage,T2
345,1,1,Radiation Dosage,70.2
345,1,1,Overall Stage,IVa
345,1,1,First Failure Type,no known failure
345,1,1,Metastasis,M0
345,1,1,Date of Death,2006-05-23 00:00:00
345,1,1,Clinical lab p16,p16 unknown
345,1,1,Tumor Site,oropharynx
345,1,1,Age at Death,57.7
345,1,1,Occurrence #,1st primary
345,1,1,Tumor Stage,T3
345,1,1,Second Failure Type,no known failure
345,1,1,Treatment Modality,CTX-RT
345,1,1,Initial Chemotherapy Agent,carbo/doce
345,1,1,Nodal Stage,N2
345,1,1,Time to Death,2.2
345,1,1,Research lab p16,p16 unknown
345,1,1,Status,Dead w/o disease
345,1,1,Research lab HPV,HPV unknown
346,1,1,Time to First Failure,0.0
346,1,1,Nodal Stage,N2
346,1,1,First Failure Type,locoregional
346,1,1,Clinical lab p16,p16 unknown
346,1,1,Treatment Modality,CTX-RT
346,1,1,First Failure Treatment Modality,Sx
346,1,1,First Failure Site,oropharynx
346,1,1,Tumor Stage,T2
346,1,1,Radiation Dosage,unkn
346,1,1,Time to Death,0.9
346,1,1,Date of Death,2004-11-16 00:00:00
346,1,1,Status,Dead unk disease
346,1,1,Tumor Site,oropharynx
346,1,1,Overall Stage,IVa
346,1,1,Second Failure Type,no known failure
346,1,1,Research lab p16,p16 positive
346,1,1,Research lab HPV,HPV positive
346,1,1,Age at Death,51.5
346,1,1,Initial Chemotherapy Agent,PTX/cap
346,1,1,Occurrence #,1st primary
346,1,1,Metastasis,M0
347,1,1,Date of Death,2001-10-04 00:00:00
347,1,1,Overall Stage,III
347,1,1,Tumor Stage,T3
347,1,1,Radiation Dosage,70.2
347,1,1,Time to Death,0.6
347,1,1,Metastasis,M0
347,1,1,Occurrence #,1st primary
347,1,1,Tumor Site,oropharynx
347,1,1,Clinical lab p16,p16 unknown
347,1,1,Second Failure Type,no known failure
347,1,1,Treatment Modality,RT
347,1,1,Research lab HPV,HPV negative
347,1,1,Status,Dead unk disease
347,1,1,First Failure Type,no known failure
347,1,1,Research lab p16,p16 negative
347,1,1,Age at Death,66.3
347,1,1,Nodal Stage,N0
348,1,1,Second Failure Type,no known failure
348,1,1,Tumor Site,Unknown
348,1,1,Metastasis,Unknown
348,1,1,Status,Unknown
348,1,1,Occurrence #,1st primary
348,1,1,Overall Stage,Unknown
348,1,1,Clinical lab p16,p16 unknown
348,1,1,Treatment Modality,Unknown
348,1,1,Nodal Stage,Unknown
348,1,1,Research lab HPV,HPV unknown
348,1,1,Research lab p16,p16 unknown
348,1,1,First Failure Type,no known failure
348,1,1,Tumor Stage,Unknown
349,1,1,Overall Stage,IVa
349,1,1,Research lab HPV,HPV positive
349,1,1,Nodal Stage,N2
349,1,1,Time to First Failure,0.1
349,1,1,Status,Dead unk disease
349,1,1,Second Failure Type,no known failure
349,1,1,Age at Death,68.4
349,1,1,Tumor Site,oropharynx
349,1,1,Research lab p16,p16 positive
349,1,1,Occurrence #,1st primary
349,1,1,Tumor Stage,T2
349,1,1,Time to Death,4.0
349,1,1,First Failure Type,locoregional
349,1,1,Radiation Dosage,59.4
349,1,1,Clinical lab p16,p16 unknown
349,1,1,Metastasis,M0
349,1,1,Treatment Modality,RT
349,1,1,Date of Death,2002-03-20 00:00:00
350,1,1,Time to Death,2.8
350,1,1,Age at Death,58.0
350,1,1,Tumor Stage,T1
350,1,1,Research lab p16,p16 positive
350,1,1,Occurrence #,1st primary
350,1,1,Tumor Site,oropharynx
350,1,1,Clinical lab p16,p16 unknown
350,1,1,Treatment Modality,Sx & RT
350,1,1,Nodal Stage,N2
350,1,1,Second Failure Type,no known failure
350,1,1,Research lab HPV,HPV positive
350,1,1,Radiation Dosage,70.2
350,1,1,First Failure Type,no known failure
350,1,1,Overall Stage,IVa
350,1,1,Status,Dead unk disease
350,1,1,Date of Death,2003-07-21 00:00:00
350,1,1,Metastasis,M0
351,1,1,Overall Stage,Unknown
351,1,1,Treatment Modality,Sx
351,1,1,Tumor Site,oropharynx
351,1,1,Nodal Stage,Unknown
351,1,1,Metastasis,Unknown
351,1,1,Occurrence #,1st primary
351,1,1,First Failure Type,no known failure
351,1,1,Time to Death,7.7
351,1,1,Clinical lab p16,p16 unknown
351,1,1,Age at Death,57.4
351,1,1,Status,Dead unk disease
351,1,1,Research lab HPV,HPV positive
351,1,1,Research lab p16,p16 positive
351,1,1,Date of Death,2007-07-28 00:00:00
351,1,1,Second Failure Type,no known failure
351,1,1,Tumor Stage,Unknown
352,1,1,Treatment Modality,Sx & CTX-RT
352,1,1,Metastasis,M0
352,1,1,Tumor Stage,T3
352,1,1,Time to Death,1.0
352,1,1,First Failure Treatment Modality,Sx
352,1,1,Clinical lab p16,p16 unknown
352,1,1,First Failure Type,locoregional
352,1,1,Date of Death,2006-10-13 00:00:00
352,1,1,Radiation Dosage,70.2
352,1,1,Initial Chemotherapy Agent,carbo/doce
352,1,1,Second Failure Type,no known failure
352,1,1,Overall Stage,IVb
352,1,1,Research lab p16,p16 negative
352,1,1,Research lab HPV,HPV negative
352,1,1,Status,Dead w/ disease
352,1,1,Tumor Site,oropharynx
352,1,1,Time to First Failure,0.3
352,1,1,Age at Death,52.8
352,1,1,Nodal Stage,N3
352,1,1,Occurrence #,1st primary
353,1,1,Clinical lab p16,p16 unknown
353,1,1,Second Failure Type,no known failure
353,1,1,Research lab p16,p16 unknown
353,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
353,1,1,Tumor Stage,T2
353,1,1,Time to Death,2.7
353,1,1,Age at Death,69.5
353,1,1,Research lab HPV,HPV unknown
353,1,1,Occurrence #,other primary
353,1,1,Status,Dead w/ disease
353,1,1,Nodal Stage,N2
353,1,1,First Failure Type,distant
353,1,1,Time to First Failure,2.3
353,1,1,Tumor Site,oropharynx
353,1,1,Metastasis,M0
353,1,1,Overall Stage,IVa
353,1,1,Date of Death,2008-08-01 00:00:00
353,1,1,Radiation Dosage,70.2
353,1,1,Treatment Modality,CTX-RT
354,1,1,Occurrence #,1st primary
354,1,1,Research lab HPV,HPV negative
354,1,1,Radiation Dosage,70.2
354,1,1,Time to Death,8.8
354,1,1,Date of Death,2010-10-03 00:00:00
354,1,1,First Failure Type,no known failure
354,1,1,Metastasis,M0
354,1,1,Status,Dead w/o disease
354,1,1,Nodal Stage,N0
354,1,1,Second Failure Type,no known failure
354,1,1,Tumor Site,oropharynx
354,1,1,Treatment Modality,CTX-RT
354,1,1,Overall Stage,IVa
354,1,1,Research lab p16,p16 negative
354,1,1,Clinical lab p16,p16 unknown
354,1,1,Age at Death,69.9
354,1,1,Tumor Stage,T4a
354,1,1,Initial Chemotherapy Agent,doce/cap
355,1,1,Date of Death,2004-03-08 00:00:00
355,1,1,Metastasis,Unknown
355,1,1,Time to Death,1.3
355,1,1,Research lab p16,p16 unknown
355,1,1,Research lab HPV,HPV unknown
355,1,1,Age at Death,58.0
355,1,1,First Failure Type,no known failure
355,1,1,Overall Stage,Unknown
355,1,1,Clinical lab p16,p16 unknown
355,1,1,Tumor Stage,Unknown
355,1,1,Nodal Stage,Unknown
355,1,1,Tumor Site,oropharynx
355,1,1,Treatment Modality,Unknown
355,1,1,Occurrence #,1st primary
355,1,1,Second Failure Type,no known failure
355,1,1,Status,Dead unk disease
356,1,1,Research lab HPV,HPV unknown
356,1,1,Treatment Modality,CTX-RT
356,1,1,Research lab p16,p16 unknown
356,1,1,Tumor Stage,T3
356,1,1,Radiation Dosage,70.2
356,1,1,Status,Alive w/o disease
356,1,1,Clinical lab p16,p16 unknown
356,1,1,Nodal Stage,N1
356,1,1,Tumor Site,oropharynx
356,1,1,Second Failure Type,no known failure
356,1,1,Occurrence #,1st primary
356,1,1,Overall Stage,III
356,1,1,First Failure Type,no known failure
356,1,1,Metastasis,M0
356,1,1,Initial Chemotherapy Agent,carbo/doce
357,1,1,Time to Death,3.7
357,1,1,Tumor Stage,T4a
357,1,1,Initial Chemotherapy Agent,PTX/cap
357,1,1,Clinical lab p16,p16 unknown
357,1,1,Tumor Site,oropharynx
357,1,1,Status,Dead unk disease
357,1,1,Radiation Dosage,70.2
357,1,1,Overall Stage,IVa
357,1,1,Research lab HPV,HPV unknown
357,1,1,Occurrence #,1st primary
357,1,1,Research lab p16,p16 unknown
357,1,1,Date of Death,2004-04-10 00:00:00
357,1,1,Age at Death,76.7
357,1,1,Second Failure Type,no known failure
357,1,1,Treatment Modality,CTX-RT
357,1,1,Nodal Stage,N0
357,1,1,Metastasis,M0
357,1,1,First Failure Type,no known failure
358,1,1,First Failure Type,no known failure
358,1,1,Tumor Site,oropharynx
358,1,1,Initial Chemotherapy Agent,cis
358,1,1,Second Failure Type,no known failure
358,1,1,Research lab HPV,HPV unknown
358,1,1,Nodal Stage,N2
358,1,1,Status,Alive w/o disease
358,1,1,Overall Stage,IVa
358,1,1,Metastasis,M0
358,1,1,Research lab p16,p16 unknown
358,1,1,Treatment Modality,CTX-RT
358,1,1,Occurrence #,1st primary
358,1,1,Tumor Stage,T3
358,1,1,Radiation Dosage,70
358,1,1,Clinical lab p16,p16 unknown
359,1,1,Clinical lab p16,p16 unknown
359,1,1,Nodal Stage,N3
359,1,1,Status,Alive w/o disease
359,1,1,Research lab p16,p16 positive
359,1,1,Research lab HPV,HPV positive
359,1,1,Tumor Stage,T2
359,1,1,Metastasis,M0
359,1,1,Overall Stage,IVb
359,1,1,First Failure Type,no known failure
359,1,1,Tumor Site,oropharynx
359,1,1,Occurrence #,1st primary
359,1,1,Second Failure Type,no known failure
359,1,1,Initial Chemotherapy Agent,carbo/doce
359,1,1,Radiation Dosage,63
359,1,1,Treatment Modality,Sx & CTX-RT
360,1,1,First Failure Type,no known failure
360,1,1,Clinical lab p16,p16 unknown
360,1,1,Overall Stage,II
360,1,1,Second Failure Type,no known failure
360,1,1,Status,Dead unk disease
360,1,1,Tumor Site,oropharynx
360,1,1,Occurrence #,1st primary
360,1,1,Nodal Stage,N0
360,1,1,Date of Death,2009-04-25 00:00:00
360,1,1,Age at Death,64.6
360,1,1,Radiation Dosage,68
360,1,1,Metastasis,M0
360,1,1,Treatment Modality,RT
360,1,1,Research lab HPV,HPV unknown
360,1,1,Research lab p16,p16 unknown
360,1,1,Tumor Stage,T2
360,1,1,Time to Death,6.5
361,1,1,Treatment Modality,CTX-RT
361,1,1,Research lab p16,p16 positive
361,1,1,Clinical lab p16,p16 unknown
361,1,1,Tumor Stage,T1
361,1,1,First Failure Type,no known failure
361,1,1,Tumor Site,oropharynx
361,1,1,Initial Chemotherapy Agent,cis
361,1,1,Second Failure Type,no known failure
361,1,1,Status,Alive w/o disease
361,1,1,Nodal Stage,N2
361,1,1,Overall Stage,IVa
361,1,1,Metastasis,M0
361,1,1,Radiation Dosage,70.2
361,1,1,Research lab HPV,HPV positive
361,1,1,Occurrence #,1st primary
362,1,1,Research lab HPV,HPV unknown
362,1,1,Metastasis,M0
362,1,1,Occurrence #,1st primary
362,1,1,Tumor Stage,T1
362,1,1,First Failure Treatment Modality,Sx & CTX-RT
362,1,1,Second Failure Type,no known failure
362,1,1,First Failure Type,locoregional
362,1,1,Nodal Stage,N0
362,1,1,Research lab p16,p16 unknown
362,1,1,First Failure Radiation Dosage,60
362,1,1,Overall Stage,I
362,1,1,Status,Dead w/o disease
362,1,1,Time to First Failure,0.1
362,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
362,1,1,Treatment Modality,RT
362,1,1,Date of Death,2006-10-09 00:00:00
362,1,1,Radiation Dosage,78.2
362,1,1,First Failure Site,oropharynx
362,1,1,Tumor Site,oropharynx
362,1,1,Time to Death,2.7
362,1,1,Age at Death,51.2
362,1,1,Clinical lab p16,p16 unknown
363,1,1,Research lab HPV,HPV unknown
363,1,1,Research lab p16,p16 unknown
363,1,1,Date of Death,2006-05-27 00:00:00
363,1,1,Treatment Modality,Unknown
363,1,1,Occurrence #,1st primary
363,1,1,First Failure Type,no known failure
363,1,1,Clinical lab p16,p16 unknown
363,1,1,Second Failure Type,no known failure
363,1,1,Nodal Stage,N2
363,1,1,Overall Stage,IVa
363,1,1,Status,Dead w/ disease
363,1,1,Tumor Stage,T4a
363,1,1,Metastasis,M0
363,1,1,Tumor Site,oropharynx
363,1,1,Time to Death,0.3
363,1,1,Age at Death,74.9
364,1,1,Radiation Dosage,unknown
364,1,1,Time to Death,3.3
364,1,1,First Failure Type,locoregional
364,1,1,Treatment Modality,Sx & RT
364,1,1,Time to First Failure,0.1
364,1,1,Nodal Stage,N0
364,1,1,Research lab HPV,HPV negative
364,1,1,Clinical lab p16,p16 unknown
364,1,1,Age at Death,69.0
364,1,1,Date of Death,1995-11-08 00:00:00
364,1,1,Research lab p16,p16 negative
364,1,1,Metastasis,M0
364,1,1,Tumor Stage,T4a
364,1,1,Second Failure Type,no known failure
364,1,1,Status,Dead unk disease
364,1,1,Overall Stage,IVa
364,1,1,Occurrence #,1st primary
364,1,1,Tumor Site,oropharynx
365,1,1,Clinical lab p16,p16 unknown
365,1,1,Research lab HPV,HPV unknown
365,1,1,Research lab p16,p16 unknown
365,1,1,Second Failure Type,no known failure
365,1,1,Date of Death,2005-07-19 00:00:00
365,1,1,Treatment Modality,CTX-RT
365,1,1,Status,Dead w/ disease
365,1,1,Occurrence #,1st primary
365,1,1,Age at Death,44.6
365,1,1,Tumor Site,oropharynx
365,1,1,Overall Stage,IVa
365,1,1,Nodal Stage,N2
365,1,1,Initial Chemotherapy Agent,carbo/doce
365,1,1,First Failure Type,no known failure
365,1,1,Metastasis,M0
365,1,1,Tumor Stage,T3
365,1,1,Radiation Dosage,61.2
366,1,1,Occurrence #,1st primary
366,1,1,Research lab HPV,HPV positive
366,1,1,Research lab p16,p16 positive
366,1,1,Clinical lab p16,p16 unknown
366,1,1,Metastasis,M0
366,1,1,Nodal Stage,N2
366,1,1,Radiation Dosage,70.2
366,1,1,Treatment Modality,RT
366,1,1,Second Failure Type,no known failure
366,1,1,Overall Stage,IVa
366,1,1,Status,Alive w/o disease
366,1,1,Tumor Site,oropharynx
366,1,1,Tumor Stage,T1
366,1,1,First Failure Type,no known failure
367,1,1,Tumor Site,oropharynx
367,1,1,Nodal Stage,N2
367,1,1,Second Failure Type,no known failure
367,1,1,Overall Stage,IVa
367,1,1,Metastasis,M0
367,1,1,Research lab HPV,HPV negative
367,1,1,Occurrence #,1st primary
367,1,1,Age at Death,62.7
367,1,1,Status,Dead w/ disease
367,1,1,Time to Death,8.0
367,1,1,Tumor Stage,T3
367,1,1,Treatment Modality,Unknown
367,1,1,Date of Death,2010-05-01 00:00:00
367,1,1,Clinical lab p16,p16 unknown
367,1,1,Research lab p16,p16 negative
367,1,1,First Failure Type,no known failure
368,1,1,Radiation Dosage,70.2
368,1,1,First Failure Type,no known failure
368,1,1,Metastasis,M0
368,1,1,Clinical lab p16,p16 unknown
368,1,1,Overall Stage,IVa
368,1,1,Second Failure Type,no known failure
368,1,1,Occurrence #,1st primary
368,1,1,Research lab p16,p16 positive
368,1,1,Research lab HPV,HPV positive
368,1,1,Treatment Modality,CTX-RT
368,1,1,Status,Alive w/o disease
368,1,1,Tumor Stage,T3
368,1,1,Nodal Stage,N2
368,1,1,Tumor Site,oropharynx
368,1,1,Initial Chemotherapy Agent,carbo/doce
369,1,1,Metastasis,M0
369,1,1,Date of Death,2008-07-15 00:00:00
369,1,1,Overall Stage,IVa
369,1,1,Age at Death,51.3
369,1,1,Clinical lab p16,p16 unknown
369,1,1,Initial Chemotherapy Agent,carbo/doce
369,1,1,Occurrence #,1st primary
369,1,1,Radiation Dosage,70.2
369,1,1,Time to First Failure,1.1
369,1,1,Tumor Stage,T4a
369,1,1,Research lab HPV,HPV negative
369,1,1,Time to Death,1.8
369,1,1,Second Failure Type,no known failure
369,1,1,Treatment Modality,CTX-RT
369,1,1,Tumor Site,oropharynx
369,1,1,First Failure Type,locoregional and distant
369,1,1,Status,Dead w/ disease
369,1,1,Nodal Stage,N2
369,1,1,Research lab p16,p16 negative
370,1,1,Metastasis,M0
370,1,1,Research lab p16,p16 positive
370,1,1,Radiation Dosage,70.2
370,1,1,Occurrence #,1st primary
370,1,1,Tumor Stage,T4a
370,1,1,Initial Chemotherapy Agent,carbo/doce
370,1,1,Tumor Site,oropharynx
370,1,1,Second Failure Type,no known failure
370,1,1,Clinical lab p16,p16 unknown
370,1,1,Treatment Modality,CTX-RT
370,1,1,Research lab HPV,HPV positive
370,1,1,First Failure Type,no known failure
370,1,1,Overall Stage,IVa
370,1,1,Status,Alive w/o disease
370,1,1,Nodal Stage,N2
371,1,1,Time to First Failure,0.3
371,1,1,Age at Death,64.8
371,1,1,Initial Chemotherapy Agent,unknown
371,1,1,Date of Death,1999-07-10 00:00:00
371,1,1,Research lab p16,p16 negative
371,1,1,Research lab HPV,HPV negative
371,1,1,Clinical lab p16,p16 unknown
371,1,1,Occurrence #,recurrence
371,1,1,First Failure Type,locoregional
371,1,1,Time to Death,0.6
371,1,1,Second Failure Type,no known failure
371,1,1,Tumor Site,oropharynx
371,1,1,Overall Stage,III
371,1,1,Metastasis,M0
371,1,1,Tumor Stage,T2
371,1,1,Status,Dead unk disease
371,1,1,Nodal Stage,N1
371,1,1,Treatment Modality,Sx & CTX-RT
372,1,1,Status,Alive w/ disease
372,1,1,Research lab p16,p16 positive
372,1,1,Treatment Modality,Unknown
372,1,1,Tumor Site,oropharynx
372,1,1,Second Failure Type,no known failure
372,1,1,Overall Stage,III
372,1,1,Nodal Stage,Unknown
372,1,1,Clinical lab p16,p16 unknown
372,1,1,First Failure Type,no known failure
372,1,1,Tumor Stage,T3
372,1,1,Research lab HPV,HPV unknown
372,1,1,Metastasis,M0
372,1,1,Occurrence #,1st primary
373,1,1,Overall Stage,IVa
373,1,1,Time to First Failure,1.7
373,1,1,Treatment Modality,Sx
373,1,1,Tumor Site,oropharynx
373,1,1,Research lab HPV,HPV positive
373,1,1,Clinical lab p16,p16 unknown
373,1,1,Status,Dead w/ disease
373,1,1,Second Failure Type,no known failure
373,1,1,Date of Death,2005-06-04 00:00:00
373,1,1,Occurrence #,1st primary
373,1,1,Metastasis,M0
373,1,1,Age at Death,60.0
373,1,1,Time to Death,4.4
373,1,1,Research lab p16,p16 positive
373,1,1,First Failure Type,distant
373,1,1,Nodal Stage,N2
373,1,1,Tumor Stage,T2
374,1,1,Nodal Stage,N2
374,1,1,Occurrence #,1st primary
374,1,1,Treatment Modality,CTX-RT
374,1,1,Overall Stage,IVa
374,1,1,Second Failure Type,no known failure
374,1,1,Research lab HPV,HPV unknown
374,1,1,Age at Death,60.8
374,1,1,Tumor Stage,T4a
374,1,1,Radiation Dosage,72
374,1,1,Initial Chemotherapy Agent,doce/cap
374,1,1,Status,Dead unk disease
374,1,1,Metastasis,M0
374,1,1,First Failure Type,no known failure
374,1,1,Tumor Site,oropharynx
374,1,1,Time to Death,2.7
374,1,1,Research lab p16,p16 unknown
374,1,1,Clinical lab p16,p16 unknown
374,1,1,Date of Death,2005-10-11 00:00:00
375,1,1,Initial Chemotherapy Agent,cis
375,1,1,Overall Stage,IVa
375,1,1,Status,Alive w/o disease
375,1,1,First Failure Type,no known failure
375,1,1,Research lab p16,p16 unknown
375,1,1,Radiation Dosage,70.2
375,1,1,Tumor Stage,T3
375,1,1,Nodal Stage,N2
375,1,1,Research lab HPV,HPV unknown
375,1,1,Clinical lab p16,p16 unknown
375,1,1,Second Failure Type,no known failure
375,1,1,Metastasis,M0
375,1,1,Tumor Site,oropharynx
375,1,1,Occurrence #,1st primary
375,1,1,Treatment Modality,CTX-RT
376,1,1,Initial Chemotherapy Agent,cis/doce
376,1,1,Occurrence #,1st primary
376,1,1,First Failure Type,distant
376,1,1,Time to First Failure,0.2
376,1,1,Clinical lab p16,p16 unknown
376,1,1,Tumor Stage,T1
376,1,1,Time to Death,1.5
376,1,1,Nodal Stage,N2
376,1,1,Second Failure Type,no known failure
376,1,1,Research lab p16,p16 positive
376,1,1,Tumor Site,oropharynx
376,1,1,Research lab HPV,HPV positive
376,1,1,Date of Death,2008-07-31 00:00:00
376,1,1,Age at Death,60.5
376,1,1,Overall Stage,IVc
376,1,1,Treatment Modality,CTX-RT
376,1,1,Radiation Dosage,70
376,1,1,Metastasis,M1
376,1,1,Status,Dead w/ disease
377,1,1,Nodal Stage,N3
377,1,1,Research lab p16,p16 unknown
377,1,1,Date of Death,2001-06-24 00:00:00
377,1,1,Treatment Modality,CTX-RT
377,1,1,Research lab HPV,HPV unknown
377,1,1,Time to Death,4.5
377,1,1,Tumor Stage,T4a
377,1,1,Metastasis,M0
377,1,1,Age at Death,58.3
377,1,1,Status,Dead w/o disease
377,1,1,Second Failure Type,no known failure
377,1,1,First Failure Type,no known failure
377,1,1,Tumor Site,oropharynx
377,1,1,Initial Chemotherapy Agent,carbo/doce
377,1,1,Overall Stage,IVb
377,1,1,Clinical lab p16,p16 unknown
377,1,1,Occurrence #,1st primary
377,1,1,Radiation Dosage,70.2
378,1,1,Clinical lab p16,p16 unknown
378,1,1,First Failure Type,no known failure
378,1,1,Nodal Stage,N2
378,1,1,Time to Death,3.7
378,1,1,Status,Dead w/ disease
378,1,1,Metastasis,M0
378,1,1,Second Failure Type,no known failure
378,1,1,Radiation Dosage,70.2
378,1,1,Overall Stage,IVa
378,1,1,Treatment Modality,CTX-RT
378,1,1,Occurrence #,1st primary
378,1,1,Tumor Stage,T3
378,1,1,Tumor Site,oropharynx
378,1,1,Date of Death,2010-10-27 00:00:00
378,1,1,Research lab p16,p16 positive
378,1,1,Research lab HPV,HPV positive
378,1,1,Initial Chemotherapy Agent,carbo/PTX
378,1,1,Age at Death,55.6
379,1,1,Time to Death,0.1
379,1,1,Status,Dead w/ disease
379,1,1,Research lab HPV,HPV unknown
379,1,1,Second Failure Type,no known failure
379,1,1,First Failure Type,no known failure
379,1,1,Research lab p16,p16 unknown
379,1,1,Age at Death,63.4
379,1,1,Tumor Site,oropharynx
379,1,1,Date of Death,2005-10-08 00:00:00
379,1,1,Clinical lab p16,p16 unknown
379,1,1,Radiation Dosage,18
379,1,1,Metastasis,M0
379,1,1,Overall Stage,IVa
379,1,1,Occurrence #,1st primary
379,1,1,Nodal Stage,N2
379,1,1,Tumor Stage,T4a
379,1,1,Treatment Modality,RT
380,1,1,Occurrence #,1st primary
380,1,1,Tumor Stage,T3
380,1,1,Research lab p16,p16 unknown
380,1,1,Research lab HPV,HPV unknown
380,1,1,Second Failure Type,no known failure
380,1,1,Nodal Stage,N0
380,1,1,Treatment Modality,CTX-RT
380,1,1,Tumor Site,oropharynx
380,1,1,Overall Stage,III
380,1,1,Status,Alive w/o disease
380,1,1,Metastasis,M0
380,1,1,First Failure Type,no known failure
380,1,1,Clinical lab p16,p16 unknown
381,1,1,Nodal Stage,N2
381,1,1,Radiation Dosage,70.2
381,1,1,Second Failure Type,no known failure
381,1,1,Treatment Modality,CTX-RT
381,1,1,Clinical lab p16,p16 unknown
381,1,1,Initial Chemotherapy Agent,carbo/doce
381,1,1,Research lab HPV,HPV positive
381,1,1,Status,Alive w/o disease
381,1,1,First Failure Type,no known failure
381,1,1,Tumor Stage,T3
381,1,1,Overall Stage,IVa
381,1,1,Research lab p16,p16 positive
381,1,1,Occurrence #,1st primary
381,1,1,Metastasis,M0
381,1,1,Tumor Site,oropharynx
382,1,1,Overall Stage,IVa
382,1,1,Initial Chemotherapy Agent,carbo/PTX
382,1,1,Nodal Stage,N2
382,1,1,Tumor Stage,T1
382,1,1,Clinical lab p16,p16 unknown
382,1,1,Occurrence #,1st primary
382,1,1,Metastasis,M0
382,1,1,Treatment Modality,CTX-RT
382,1,1,Radiation Dosage,70.2
382,1,1,Second Failure Type,no known failure
382,1,1,First Failure Type,no known failure
382,1,1,Tumor Site,oropharynx
382,1,1,Research lab p16,p16 negative
382,1,1,Research lab HPV,HPV negative
382,1,1,Status,Alive w/o disease
383,1,1,Research lab p16,p16 unknown
383,1,1,Occurrence #,1st primary
383,1,1,Radiation Dosage,63
383,1,1,Clinical lab p16,p16 unknown
383,1,1,Tumor Site,oropharynx
383,1,1,Tumor Stage,T1
383,1,1,Metastasis,M0
383,1,1,Second Failure Type,no known failure
383,1,1,Research lab HPV,HPV unknown
383,1,1,Nodal Stage,N2
383,1,1,Status,Alive w/o disease
383,1,1,Overall Stage,IVa
383,1,1,First Failure Type,no known failure
383,1,1,Treatment Modality,Sx & RT
384,1,1,Nodal Stage,N2
384,1,1,Clinical lab p16,p16 unknown
384,1,1,Time to Death,0.2
384,1,1,Initial Chemotherapy Agent,carbo/doce
384,1,1,First Failure Type,no known failure
384,1,1,Radiation Dosage,25.2
384,1,1,Metastasis,M0
384,1,1,Overall Stage,IVb
384,1,1,Research lab p16,p16 negative
384,1,1,Status,Dead w/ disease
384,1,1,Occurrence #,1st primary
384,1,1,Research lab HPV,HPV negative
384,1,1,Treatment Modality,CTX-RT
384,1,1,Age at Death,40.0
384,1,1,Second Failure Type,no known failure
384,1,1,Tumor Site,oropharynx
384,1,1,Tumor Stage,T4b
384,1,1,Date of Death,1999-06-19 00:00:00
385,1,1,First Failure Type,no known failure
385,1,1,Radiation Dosage,70.2
385,1,1,Metastasis,M0
385,1,1,Time to Death,6.9
385,1,1,Nodal Stage,N2
385,1,1,Occurrence #,1st primary
385,1,1,Research lab HPV,HPV unknown
385,1,1,Treatment Modality,CTX-RT
385,1,1,Age at Death,74.7
385,1,1,Date of Death,2003-08-04 00:00:00
385,1,1,Overall Stage,IVa
385,1,1,Research lab p16,p16 unknown
385,1,1,Second Failure Type,no known failure
385,1,1,Status,Dead w/o disease
385,1,1,Tumor Site,oropharynx
385,1,1,Initial Chemotherapy Agent,carbo/doce
385,1,1,Clinical lab p16,p16 unknown
385,1,1,Tumor Stage,T4a
386,1,1,Research lab HPV,HPV unknown
386,1,1,Date of Death,2007-01-27 00:00:00
386,1,1,Age at Death,54.0
386,1,1,Occurrence #,1st primary
386,1,1,Tumor Stage,T3
386,1,1,Tumor Site,oropharynx
386,1,1,Time to Death,0.3
386,1,1,Treatment Modality,CTX-RT
386,1,1,Overall Stage,IVa
386,1,1,Research lab p16,p16 unknown
386,1,1,Second Failure Type,no known failure
386,1,1,Status,Dead w/ disease
386,1,1,Nodal Stage,N2
386,1,1,Radiation Dosage,45
386,1,1,Clinical lab p16,p16 unknown
386,1,1,First Failure Type,no known failure
386,1,1,Metastasis,M0
386,1,1,Initial Chemotherapy Agent,carbo/PTX
387,1,1,First Failure Type,no known failure
387,1,1,Radiation Dosage,unknown
387,1,1,Tumor Stage,T4a
387,1,1,Second Failure Type,no known failure
387,1,1,Clinical lab p16,p16 unknown
387,1,1,Tumor Site,oropharynx
387,1,1,Nodal Stage,N2
387,1,1,Research lab HPV,HPV unknown
387,1,1,Occurrence #,1st primary
387,1,1,Metastasis,M0
387,1,1,Research lab p16,p16 unknown
387,1,1,Initial Chemotherapy Agent,unk
387,1,1,Treatment Modality,CTX-RT
387,1,1,Status,Alive unk disease
387,1,1,Overall Stage,IVa
388,1,1,Treatment Modality,CTX-RT
388,1,1,Nodal Stage,N2
388,1,1,Research lab p16,p16 positive
388,1,1,Radiation Dosage,70
388,1,1,Metastasis,M0
388,1,1,Status,Alive w/o disease
388,1,1,Tumor Site,oropharynx
388,1,1,First Failure Type,no known failure
388,1,1,Tumor Stage,T3
388,1,1,Occurrence #,1st primary
388,1,1,Clinical lab p16,p16 unknown
388,1,1,Research lab HPV,HPV positive
388,1,1,Second Failure Type,no known failure
388,1,1,Overall Stage,IVa
388,1,1,Initial Chemotherapy Agent,Cis
389,1,1,Date of Death,1993-11-15 00:00:00
389,1,1,Nodal Stage,N2
389,1,1,Time to First Failure,0.0
389,1,1,Research lab HPV,HPV negative
389,1,1,Occurrence #,1st primary
389,1,1,Treatment Modality,CTX-RT
389,1,1,Research lab p16,p16 negative
389,1,1,Overall Stage,IVa
389,1,1,Clinical lab p16,p16 unknown
389,1,1,Metastasis,M0
389,1,1,Status,Dead w/ disease
389,1,1,Radiation Dosage,70.2
389,1,1,Initial Chemotherapy Agent,carbo/PTX
389,1,1,Age at Death,47.9
389,1,1,Second Failure Type,no known failure
389,1,1,First Failure Type,locoregional
389,1,1,Time to Death,0.3
389,1,1,Tumor Stage,T4a
389,1,1,Tumor Site,oropharynx
390,1,1,Treatment Modality,Sx
390,1,1,Research lab p16,p16 negative
390,1,1,Second Failure Type,no known failure
390,1,1,Clinical lab p16,p16 unknown
390,1,1,Overall Stage,IVa
390,1,1,Time to Death,0.9
390,1,1,First Failure Type,distant
390,1,1,Metastasis,M0
390,1,1,Tumor Stage,T3
390,1,1,Status,Dead w/ disease
390,1,1,Nodal Stage,N2
390,1,1,Age at Death,54.9
390,1,1,Date of Death,2000-06-07 00:00:00
390,1,1,Time to First Failure,0.8
390,1,1,Tumor Site,oropharynx
390,1,1,Research lab HPV,HPV negative
390,1,1,Occurrence #,1st primary
391,1,1,Treatment Modality,CTX-RT
391,1,1,Occurrence #,1st primary
391,1,1,Status,Dead w/ disease
391,1,1,Radiation Dosage,70.2
391,1,1,Tumor Site,oropharynx
391,1,1,First Failure Type,distant
391,1,1,Initial Chemotherapy Agent,cis
391,1,1,Time to First Failure,0.9
391,1,1,Second Failure Type,no known failure
391,1,1,Research lab HPV,HPV negative
391,1,1,Tumor Stage,T3
391,1,1,Metastasis,M0
391,1,1,Age at Death,51.4
391,1,1,Research lab p16,p16 negative
391,1,1,Clinical lab p16,p16 unknown
391,1,1,Overall Stage,IVa
391,1,1,Nodal Stage,N2
391,1,1,Date of Death,2006-10-05 00:00:00
391,1,1,Time to Death,1.5
392,1,1,Status,Dead unk disease
392,1,1,Time to Death,1.2
392,1,1,Tumor Stage,T4a
392,1,1,Clinical lab p16,p16 unknown
392,1,1,First Failure Type,no known failure
392,1,1,Tumor Site,oropharynx
392,1,1,Metastasis,M0
392,1,1,Research lab HPV,HPV negative
392,1,1,Date of Death,1997-06-01 00:00:00
392,1,1,Research lab p16,p16 negative
392,1,1,Age at Death,71.0
392,1,1,Overall Stage,IVa
392,1,1,Treatment Modality,Sx & RT
392,1,1,Occurrence #,1st primary
392,1,1,Second Failure Type,no known failure
392,1,1,Radiation Dosage,45
392,1,1,Nodal Stage,N0
393,1,1,Research lab HPV,HPV unknown
393,1,1,Tumor Stage,T4a
393,1,1,Second Failure Type,no known failure
393,1,1,Tumor Site,oropharynx
393,1,1,Initial Chemotherapy Agent,carbo/doce
393,1,1,First Failure Type,no known failure
393,1,1,Status,Alive w/o disease
393,1,1,Radiation Dosage,70.2
393,1,1,Metastasis,M0
393,1,1,Overall Stage,IVa
393,1,1,Clinical lab p16,p16 unknown
393,1,1,Treatment Modality,Sx & CTX-RT
393,1,1,Occurrence #,1st primary
393,1,1,Nodal Stage,N2
393,1,1,Research lab p16,p16 unknown
394,1,1,First Failure Treatment Modality,Sx & CTX
394,1,1,Date of Death,2007-09-15 00:00:00
394,1,1,Overall Stage,IVa
394,1,1,Time to First Failure,0.8
394,1,1,Status,Dead w/ disease
394,1,1,First Failure Type,locoregional
394,1,1,Research lab p16,p16 unknown
394,1,1,Tumor Stage,T2
394,1,1,Clinical lab p16,p16 unknown
394,1,1,Tumor Site,oropharynx
394,1,1,Time to Death,4.7
394,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
394,1,1,Metastasis,M0
394,1,1,Nodal Stage,N2
394,1,1,Initial Chemotherapy Agent,carbo/doce
394,1,1,Occurrence #,1st primary
394,1,1,Radiation Dosage,70.2
394,1,1,Age at Death,58.6
394,1,1,Research lab HPV,HPV unknown
394,1,1,First Failure Second Line Chemotherapy Agent,vinblastine
394,1,1,Treatment Modality,CTX-RT
394,1,1,First Failure Site,oral cavity
394,1,1,Second Failure Type,no known failure
395,1,1,Radiation Dosage,64.4
395,1,1,Metastasis,M0
395,1,1,Overall Stage,III
395,1,1,Tumor Site,oropharynx
395,1,1,Treatment Modality,RT
395,1,1,Research lab p16,p16 negative
395,1,1,Nodal Stage,N1
395,1,1,Status,Dead unk disease
395,1,1,Second Failure Type,no known failure
395,1,1,First Failure Type,no known failure
395,1,1,Time to Death,0.3
395,1,1,Clinical lab p16,p16 unknown
395,1,1,Occurrence #,1st primary
395,1,1,Research lab HPV,HPV negative
395,1,1,Date of Death,2006-02-17 00:00:00
395,1,1,Age at Death,72.0
395,1,1,Tumor Stage,T2
396,1,1,First Failure Type,no known failure
396,1,1,Time to Death,0.8
396,1,1,Tumor Stage,T4a
396,1,1,Research lab HPV,HPV unknown
396,1,1,Research lab p16,p16 unknown
396,1,1,Radiation Dosage,70.2
396,1,1,Second Failure Type,no known failure
396,1,1,Initial Chemotherapy Agent,carbo/doce
396,1,1,Date of Death,1998-06-26 00:00:00
396,1,1,Status,Dead unk disease
396,1,1,Occurrence #,1st primary
396,1,1,Age at Death,65.2
396,1,1,Metastasis,M0
396,1,1,Overall Stage,IVa
396,1,1,Treatment Modality,CTX-RT
396,1,1,Nodal Stage,N2
396,1,1,Tumor Site,oropharynx
396,1,1,Clinical lab p16,p16 unknown
397,1,1,Clinical lab p16,p16 unknown
397,1,1,Status,Dead w/ disease
397,1,1,Tumor Stage,T4a
397,1,1,Age at Death,48.0
397,1,1,Metastasis,M0
397,1,1,Research lab p16,p16 negative
397,1,1,Date of Death,1993-07-15 00:00:00
397,1,1,Second Failure Type,no known failure
397,1,1,Time to First Failure,0.1
397,1,1,Treatment Modality,RT
397,1,1,Overall Stage,IVa
397,1,1,Tumor Site,oropharynx
397,1,1,Time to Death,0.5
397,1,1,Nodal Stage,N2
397,1,1,First Failure Type,locoregional and distant
397,1,1,Occurrence #,1st primary
397,1,1,Radiation Dosage,55
397,1,1,Research lab HPV,HPV negative
398,1,1,Clinical lab p16,p16 unknown
398,1,1,Nodal Stage,Unknown
398,1,1,Metastasis,Unknown
398,1,1,Status,Unknown
398,1,1,First Failure Type,no known failure
398,1,1,Treatment Modality,Unknown
398,1,1,Tumor Site,Unknown
398,1,1,Overall Stage,Unknown
398,1,1,Research lab HPV,HPV unknown
398,1,1,Research lab p16,p16 unknown
398,1,1,Occurrence #,1st primary
398,1,1,Second Failure Type,no known failure
398,1,1,Tumor Stage,Unknown
399,1,1,First Failure Initial Chemotherapy Agent,cis/doce/cap
399,1,1,Time to Death,2.0
399,1,1,Date of Death,2000-09-22 00:00:00
399,1,1,Tumor Stage,T4a
399,1,1,Occurrence #,recurrence
399,1,1,Status,Dead w/ disease
399,1,1,First Failure Type,locoregional
399,1,1,Research lab HPV,HPV unknown
399,1,1,Metastasis,M0
399,1,1,First Failure Treatment Modality,Sx & CTX
399,1,1,Clinical lab p16,p16 unknown
399,1,1,Age at Death,51.8
399,1,1,Time to First Failure,0.4
399,1,1,Treatment Modality,CTX-RT
399,1,1,Overall Stage,IVa
399,1,1,Initial Chemotherapy Agent,carbo/doce
399,1,1,Radiation Dosage,68.4
399,1,1,Research lab p16,p16 unknown
399,1,1,Tumor Site,oral cavity
399,1,1,Second Failure Type,no known failure
399,1,1,First Failure Site,oral cavity
399,1,1,Nodal Stage,N2
400,1,1,Radiation Dosage,60.5
400,1,1,Research lab p16,p16 positive
400,1,1,Research lab HPV,HPV positive
400,1,1,Tumor Stage,T2
400,1,1,Clinical lab p16,p16 unknown
400,1,1,Occurrence #,1st primary
400,1,1,Overall Stage,IVb
400,1,1,Treatment Modality,RT
400,1,1,Tumor Site,oropharynx
400,1,1,Status,Alive w/ disease
400,1,1,Nodal Stage,N3
400,1,1,Second Failure Type,no known failure
400,1,1,First Failure Type,no known failure
400,1,1,Metastasis,M0
401,1,1,Research lab HPV,HPV negative
401,1,1,Second Failure Type,no known failure
401,1,1,Date of Death,2006-01-29 00:00:00
401,1,1,Radiation Dosage,76.8
401,1,1,First Failure Site,oropharynx
401,1,1,Occurrence #,1st primary
401,1,1,Age at Death,47.9
401,1,1,First Failure Initial Chemotherapy Agent,cap
401,1,1,First Failure Treatment Modality,Sx & RT
401,1,1,First Failure Type,locoregional
401,1,1,Overall Stage,III
401,1,1,Time to First Failure,1.5
401,1,1,Tumor Stage,T3
401,1,1,Metastasis,M0
401,1,1,Status,Dead w/ disease
401,1,1,Treatment Modality,RT
401,1,1,Research lab p16,p16 negative
401,1,1,Clinical lab p16,p16 unknown
401,1,1,Time to Death,2.1
401,1,1,Nodal Stage,N0
401,1,1,Tumor Site,oropharynx
402,1,1,Status,Dead unk disease
402,1,1,Radiation Dosage,66.6
402,1,1,Research lab p16,p16 unknown
402,1,1,Clinical lab p16,p16 unknown
402,1,1,Metastasis,M0
402,1,1,Occurrence #,1st primary
402,1,1,Research lab HPV,HPV unknown
402,1,1,Time to Death,0.7
402,1,1,Overall Stage,IVb
402,1,1,Second Failure Type,no known failure
402,1,1,Initial Chemotherapy Agent,carbo/doce
402,1,1,Age at Death,66.4
402,1,1,First Failure Type,no known failure
402,1,1,Date of Death,2003-03-21 00:00:00
402,1,1,Nodal Stage,N3
402,1,1,Tumor Stage,T4a
402,1,1,Tumor Site,oropharynx
402,1,1,Treatment Modality,CTX-RT
403,1,1,Second Failure Type,no known failure
403,1,1,Status,Unknown
403,1,1,Occurrence #,1st primary
403,1,1,Nodal Stage,Unknown
403,1,1,First Failure Type,no known failure
403,1,1,Overall Stage,Unknown
403,1,1,Tumor Site,Unknown
403,1,1,Clinical lab p16,p16 unknown
403,1,1,Research lab p16,p16 unknown
403,1,1,Research lab HPV,HPV unknown
403,1,1,Metastasis,Unknown
403,1,1,Tumor Stage,Unknown
403,1,1,Treatment Modality,Unknown
404,1,1,Nodal Stage,N2
404,1,1,Clinical lab p16,p16 unknown
404,1,1,Status,Dead unk disease
404,1,1,Occurrence #,1st primary
404,1,1,Treatment Modality,CTX-RT
404,1,1,Overall Stage,IVa
404,1,1,Initial Chemotherapy Agent,carbo/doce
404,1,1,Age at Death,65.6
404,1,1,Metastasis,M0
404,1,1,Tumor Site,oropharynx
404,1,1,Research lab p16,p16 unknown
404,1,1,Tumor Stage,T3
404,1,1,Date of Death,2003-10-21 00:00:00
404,1,1,First Failure Type,locoregional
404,1,1,Radiation Dosage,72
404,1,1,Time to First Failure,0.3
404,1,1,Time to Death,0.7
404,1,1,Second Failure Type,no known failure
404,1,1,Research lab HPV,HPV unknown
405,1,1,Second Failure Type,no known failure
405,1,1,Metastasis,M0
405,1,1,Date of Death,2003-01-02 00:00:00
405,1,1,Age at Death,54.4
405,1,1,Treatment Modality,CTX-RT
405,1,1,Research lab HPV,HPV unknown
405,1,1,Status,Dead unk disease
405,1,1,Tumor Stage,T4a
405,1,1,Tumor Site,oropharynx
405,1,1,Nodal Stage,N0
405,1,1,First Failure Type,no known failure
405,1,1,Overall Stage,IVa
405,1,1,Initial Chemotherapy Agent,carbo/5FU
405,1,1,Time to Death,0.4
405,1,1,Clinical lab p16,p16 unknown
405,1,1,Radiation Dosage,70.2
405,1,1,Occurrence #,1st primary
405,1,1,Research lab p16,p16 unknown
406,1,1,Treatment Modality,CTX-RT
406,1,1,Tumor Site,oropharynx
406,1,1,Clinical lab p16,p16 unknown
406,1,1,Research lab HPV,HPV unknown
406,1,1,Overall Stage,IVa
406,1,1,Initial Chemotherapy Agent,PTX/cap
406,1,1,Status,Alive w/o disease
406,1,1,Tumor Stage,T3
406,1,1,Occurrence #,1st primary
406,1,1,Metastasis,M0
406,1,1,First Failure Type,no known failure
406,1,1,Radiation Dosage,70.2
406,1,1,Nodal Stage,N2
406,1,1,Second Failure Type,no known failure
406,1,1,Research lab p16,p16 unknown
407,1,1,Tumor Stage,Unknown
407,1,1,Nodal Stage,Unknown
407,1,1,Research lab p16,p16 unknown
407,1,1,Research lab HPV,HPV unknown
407,1,1,Tumor Site,larynx
407,1,1,Clinical lab p16,p16 unknown
407,1,1,Second Failure Type,no known failure
407,1,1,Overall Stage,Unknown
407,1,1,First Failure Type,no known failure
407,1,1,Time to Death,0.5
407,1,1,Metastasis,Unknown
407,1,1,Age at Death,68.3
407,1,1,Date of Death,2000-10-22 00:00:00
407,1,1,Treatment Modality,Unknown
407,1,1,Occurrence #,1st primary
407,1,1,Status,Dead w/ disease
408,1,1,Nodal Stage,N1
408,1,1,Radiation Dosage,70.2
408,1,1,Occurrence #,1st primary
408,1,1,Initial Chemotherapy Agent,unknown
408,1,1,Tumor Stage,T2
408,1,1,Tumor Site,oropharynx
408,1,1,First Failure Type,no known failure
408,1,1,Research lab HPV,HPV positive
408,1,1,Second Failure Type,no known failure
408,1,1,Research lab p16,p16 positive
408,1,1,Status,Alive w/o disease
408,1,1,Metastasis,M0
408,1,1,Treatment Modality,CTX-RT
408,1,1,Clinical lab p16,p16 unknown
408,1,1,Overall Stage,III
409,1,1,Second Failure Type,no known failure
409,1,1,Research lab HPV,HPV positive
409,1,1,Research lab p16,p16 positive
409,1,1,Status,Alive w/o disease
409,1,1,Overall Stage,II
409,1,1,Treatment Modality,RT
409,1,1,First Failure Type,no known failure
409,1,1,Occurrence #,1st primary
409,1,1,Metastasis,M0
409,1,1,Nodal Stage,N0
409,1,1,Tumor Site,oropharynx
409,1,1,Tumor Stage,T2
409,1,1,Radiation Dosage,76.8
409,1,1,Clinical lab p16,p16 unknown
410,1,1,Research lab HPV,HPV unknown
410,1,1,First Failure Type,no known failure
410,1,1,Tumor Stage,Unknown
410,1,1,Treatment Modality,Unknown
410,1,1,Tumor Site,oropharynx
410,1,1,Second Failure Type,no known failure
410,1,1,Nodal Stage,Unknown
410,1,1,Status,Unknown
410,1,1,Clinical lab p16,p16 unknown
410,1,1,Occurrence #,1st primary
410,1,1,Metastasis,Unknown
410,1,1,Research lab p16,p16 unknown
410,1,1,Overall Stage,Unknown
411,1,1,Nodal Stage,N0
411,1,1,Radiation Dosage,70.2
411,1,1,Status,Dead w/o disease
411,1,1,Treatment Modality,RT
411,1,1,Overall Stage,IVa
411,1,1,Second Failure Type,no known failure
411,1,1,First Failure Type,no known failure
411,1,1,Time to Death,2.5
411,1,1,Research lab p16,p16 unknown
411,1,1,Metastasis,M0
411,1,1,Clinical lab p16,p16 unknown
411,1,1,Occurrence #,other primary
411,1,1,Research lab HPV,HPV unknown
411,1,1,Age at Death,68.3
411,1,1,Date of Death,2002-11-21 00:00:00
411,1,1,Tumor Stage,T4a
411,1,1,Tumor Site,oropharynx
412,1,1,Tumor Site,Unknown
412,1,1,Metastasis,Unknown
412,1,1,Research lab p16,p16 unknown
412,1,1,Overall Stage,Unknown
412,1,1,Nodal Stage,Unknown
412,1,1,Clinical lab p16,p16 unknown
412,1,1,Occurrence #,1st primary
412,1,1,Second Failure Type,no known failure
412,1,1,Research lab HPV,HPV unknown
412,1,1,Status,Unknown
412,1,1,First Failure Type,no known failure
412,1,1,Tumor Stage,Unknown
412,1,1,Treatment Modality,Unknown
413,1,1,Tumor Stage,T2
413,1,1,Status,Alive w/o disease
413,1,1,First Failure Type,no known failure
413,1,1,Overall Stage,IVa
413,1,1,Clinical lab p16,p16 unknown
413,1,1,Treatment Modality,RT
413,1,1,Metastasis,M0
413,1,1,Tumor Site,oropharynx
413,1,1,Occurrence #,1st primary
413,1,1,Nodal Stage,N0
413,1,1,Radiation Dosage,74.4
413,1,1,Second Failure Type,no known failure
413,1,1,Research lab HPV,HPV unknown
413,1,1,Research lab p16,p16 unknown
414,1,1,Treatment Modality,Unknown
414,1,1,Tumor Site,oropharynx
414,1,1,Age at Death,56.3
414,1,1,First Failure Type,no known failure
414,1,1,Date of Death,2000-12-27 00:00:00
414,1,1,Overall Stage,Unknown
414,1,1,Second Failure Type,no known failure
414,1,1,Occurrence #,1st primary
414,1,1,Tumor Stage,T4a
414,1,1,Clinical lab p16,p16 unknown
414,1,1,Metastasis,Unknown
414,1,1,Time to Death,0.2
414,1,1,Research lab HPV,HPV unknown
414,1,1,Nodal Stage,Unknown
414,1,1,Research lab p16,p16 unknown
414,1,1,Status,Dead w/ disease
415,1,1,Overall Stage,IVa
415,1,1,Time to First Failure,4.9
415,1,1,Status,Dead unk disease
415,1,1,Treatment Modality,CTX-RT
415,1,1,Tumor Site,oral cavity
415,1,1,Metastasis,M0
415,1,1,First Failure Site,oropharynx
415,1,1,Initial Chemotherapy Agent,carbo/doce
415,1,1,First Failure Type,locoregional and distant
415,1,1,Second Failure Type,no known failure
415,1,1,Radiation Dosage,70.2
415,1,1,Age at Death,56.6
415,1,1,Research lab HPV,HPV unknown
415,1,1,Clinical lab p16,p16 unknown
415,1,1,Research lab p16,p16 unknown
415,1,1,Tumor Stage,T4a
415,1,1,Time to Death,2.9
415,1,1,Nodal Stage,N0
415,1,1,Date of Death,2003-04-10 00:00:00
415,1,1,Occurrence #,recurrence
416,1,1,Status,Dead unk disease
416,1,1,Tumor Stage,T3
416,1,1,Nodal Stage,N0
416,1,1,Research lab p16,p16 negative
416,1,1,Metastasis,M0
416,1,1,Treatment Modality,Sx
416,1,1,First Failure Type,no known failure
416,1,1,Time to Death,0.3
416,1,1,Research lab HPV,HPV negative
416,1,1,Clinical lab p16,p16 unknown
416,1,1,Second Failure Type,no known failure
416,1,1,Date of Death,1996-03-01 00:00:00
416,1,1,Occurrence #,1st primary
416,1,1,Tumor Site,oropharynx
416,1,1,Overall Stage,III
416,1,1,Age at Death,93.8
417,1,1,Treatment Modality,CTX-RT
417,1,1,Date of Death,2003-08-18 00:00:00
417,1,1,First Failure Type,locoregional
417,1,1,Time to Death,2.0
417,1,1,Tumor Stage,T4a
417,1,1,Clinical lab p16,p16 unknown
417,1,1,Metastasis,M0
417,1,1,Nodal Stage,N3
417,1,1,Research lab HPV,HPV unknown
417,1,1,Age at Death,68.7
417,1,1,Radiation Dosage,unknown
417,1,1,Occurrence #,1st primary
417,1,1,Overall Stage,IVb
417,1,1,Tumor Site,oropharynx
417,1,1,Initial Chemotherapy Agent,cap/doce/gemcitabine
417,1,1,Second Failure Type,no known failure
417,1,1,Status,Dead unk disease
417,1,1,Time to First Failure,0.8
417,1,1,Research lab p16,p16 unknown
418,1,1,Nodal Stage,N0
418,1,1,Second Failure Type,no known failure
418,1,1,Occurrence #,1st primary
418,1,1,Time to First Failure,1.5
418,1,1,Status,Dead unk disease
418,1,1,Research lab HPV,HPV unknown
418,1,1,Tumor Stage,T1
418,1,1,Time to Death,3.9
418,1,1,Age at Death,67.8
418,1,1,Clinical lab p16,p16 unknown
418,1,1,Treatment Modality,Sx
418,1,1,Tumor Site,oropharynx
418,1,1,First Failure Type,locoregional
418,1,1,Date of Death,2005-09-09 00:00:00
418,1,1,Metastasis,M0
418,1,1,Research lab p16,p16 positive
418,1,1,Overall Stage,I
419,1,1,Radiation Dosage,72.6
419,1,1,Research lab p16,p16 unknown
419,1,1,Time to First Failure,4.8
419,1,1,Metastasis,M0
419,1,1,Status,Alive w/ disease
419,1,1,Tumor Stage,T2
419,1,1,Overall Stage,III
419,1,1,Research lab HPV,HPV unknown
419,1,1,First Failure Type,distant
419,1,1,Occurrence #,1st primary
419,1,1,Tumor Site,oropharynx
419,1,1,Nodal Stage,N1
419,1,1,Treatment Modality,RT
419,1,1,Second Failure Type,no known failure
419,1,1,Clinical lab p16,p16 unknown
420,1,1,Research lab HPV,HPV unknown
420,1,1,Tumor Stage,Unknown
420,1,1,Clinical lab p16,p16 unknown
420,1,1,Metastasis,Unknown
420,1,1,Tumor Site,Unknown
420,1,1,Occurrence #,1st primary
420,1,1,First Failure Type,no known failure
420,1,1,Research lab p16,p16 unknown
420,1,1,Status,Unknown
420,1,1,Overall Stage,Unknown
420,1,1,Treatment Modality,Unknown
420,1,1,Second Failure Type,no known failure
420,1,1,Nodal Stage,Unknown
421,1,1,Second Failure Type,no known failure
421,1,1,Research lab p16,p16 negative
421,1,1,Metastasis,M0
421,1,1,Radiation Dosage,70
421,1,1,Status,Dead unk disease
421,1,1,Date of Death,2008-11-07 00:00:00
421,1,1,First Failure Type,distant
421,1,1,Treatment Modality,CTX-RT
421,1,1,Overall Stage,IVa
421,1,1,Nodal Stage,N1
421,1,1,Initial Chemotherapy Agent,cis
421,1,1,Occurrence #,1st primary
421,1,1,Age at Death,73.0
421,1,1,Research lab HPV,HPV negative
421,1,1,Tumor Stage,T4a
421,1,1,Clinical lab p16,p16 unknown
421,1,1,Time to First Failure,1.9
421,1,1,Tumor Site,oropharynx
421,1,1,Time to Death,4.3
422,1,1,Metastasis,Unknown
422,1,1,Occurrence #,1st primary
422,1,1,Clinical lab p16,p16 unknown
422,1,1,Overall Stage,Unknown
422,1,1,Treatment Modality,Unknown
422,1,1,Nodal Stage,Unknown
422,1,1,Status,Unknown
422,1,1,Research lab p16,p16 unknown
422,1,1,Tumor Site,oropharynx
422,1,1,Second Failure Type,no known failure
422,1,1,First Failure Type,no known failure
422,1,1,Tumor Stage,Unknown
422,1,1,Research lab HPV,HPV unknown
423,1,1,Tumor Site,oropharynx
423,1,1,Clinical lab p16,p16 unknown
423,1,1,Research lab p16,p16 unknown
423,1,1,Status,Alive w/o disease
423,1,1,Tumor Stage,T3
423,1,1,Overall Stage,IVa
423,1,1,Treatment Modality,CTX-RT
423,1,1,Radiation Dosage,70.2
423,1,1,Initial Chemotherapy Agent,cap/doce
423,1,1,Metastasis,M0
423,1,1,Occurrence #,1st primary
423,1,1,Second Failure Type,no known failure
423,1,1,Research lab HPV,HPV unknown
423,1,1,First Failure Type,no known failure
423,1,1,Nodal Stage,N2
424,1,1,Overall Stage,Unknown
424,1,1,Tumor Site,Unknown
424,1,1,Research lab p16,p16 unknown
424,1,1,Status,Unknown
424,1,1,First Failure Type,no known failure
424,1,1,Tumor Stage,Unknown
424,1,1,Research lab HPV,HPV unknown
424,1,1,Clinical lab p16,p16 unknown
424,1,1,Nodal Stage,Unknown
424,1,1,Second Failure Type,no known failure
424,1,1,Occurrence #,1st primary
424,1,1,Treatment Modality,Unknown
424,1,1,Metastasis,Unknown
425,1,1,Overall Stage,III
425,1,1,First Failure Type,no known failure
425,1,1,Clinical lab p16,p16 unknown
425,1,1,Time to Death,5.4
425,1,1,Date of Death,2007-09-05 00:00:00
425,1,1,Treatment Modality,RT
425,1,1,Status,Dead w/o disease
425,1,1,Occurrence #,1st primary
425,1,1,Second Failure Type,no known failure
425,1,1,Nodal Stage,N1
425,1,1,Age at Death,70.0
425,1,1,Research lab HPV,HPV positive
425,1,1,Tumor Stage,T2
425,1,1,Tumor Site,oropharynx
425,1,1,Metastasis,M0
425,1,1,Radiation Dosage,66
425,1,1,Research lab p16,p16 positive
426,1,1,First Failure Type,no known failure
426,1,1,Research lab HPV,HPV unknown
426,1,1,Second Failure Type,no known failure
426,1,1,Occurrence #,1st primary
426,1,1,Clinical lab p16,p16 unknown
426,1,1,Date of Death,2003-09-22 00:00:00
426,1,1,Metastasis,Unknown
426,1,1,Age at Death,72.3
426,1,1,Nodal Stage,Unknown
426,1,1,Overall Stage,Unknown
426,1,1,Time to Death,0.1
426,1,1,Treatment Modality,Unknown
426,1,1,Tumor Site,oropharynx
426,1,1,Research lab p16,p16 unknown
426,1,1,Tumor Stage,Unknown
426,1,1,Status,Dead unk disease
427,1,1,Second Failure Type,no known failure
427,1,1,Treatment Modality,Unknown
427,1,1,Tumor Stage,Unknown
427,1,1,Nodal Stage,Unknown
427,1,1,Research lab p16,p16 unknown
427,1,1,First Failure Type,no known failure
427,1,1,Research lab HPV,HPV unknown
427,1,1,Clinical lab p16,p16 unknown
427,1,1,Overall Stage,Unknown
427,1,1,Tumor Site,Unknown
427,1,1,Metastasis,Unknown
427,1,1,Status,Unknown
427,1,1,Occurrence #,1st primary
428,1,1,Treatment Modality,Sx & CTX-RT
428,1,1,Tumor Site,oropharynx
428,1,1,Nodal Stage,N2
428,1,1,Status,Alive w/o disease
428,1,1,Research lab p16,p16 positive
428,1,1,Tumor Stage,T1
428,1,1,Overall Stage,IVa
428,1,1,Occurrence #,1st primary
428,1,1,Research lab HPV,HPV positive
428,1,1,Clinical lab p16,p16 unknown
428,1,1,Metastasis,M0
428,1,1,First Failure Type,no known failure
428,1,1,Radiation Dosage,66.6
428,1,1,Second Failure Type,no known failure
428,1,1,Initial Chemotherapy Agent,carbo/PTX
429,1,1,Occurrence #,1st primary
429,1,1,Tumor Stage,Unknown
429,1,1,Nodal Stage,Unknown
429,1,1,Status,Alive unk disease
429,1,1,Research lab p16,p16 unknown
429,1,1,Clinical lab p16,p16 unknown
429,1,1,Overall Stage,III
429,1,1,Research lab HPV,HPV unknown
429,1,1,First Failure Type,no known failure
429,1,1,Metastasis,M0
429,1,1,Second Failure Type,no known failure
429,1,1,Tumor Site,oropharynx
429,1,1,Treatment Modality,Unknown
430,1,1,Research lab HPV,HPV unknown
430,1,1,Tumor Site,oropharynx
430,1,1,Age at Death,86.1
430,1,1,Time to Death,0.4
430,1,1,Occurrence #,1st primary
430,1,1,Nodal Stage,N0
430,1,1,Treatment Modality,RT
430,1,1,Status,Dead unk disease
430,1,1,Research lab p16,p16 unknown
430,1,1,Overall Stage,IVa
430,1,1,Radiation Dosage,14.4
430,1,1,First Failure Type,no known failure
430,1,1,Metastasis,M0
430,1,1,Clinical lab p16,p16 unknown
430,1,1,Second Failure Type,no known failure
430,1,1,Date of Death,2005-11-01 00:00:00
430,1,1,Tumor Stage,T4a
431,1,1,Occurrence #,1st primary
431,1,1,Clinical lab p16,p16 unknown
431,1,1,Tumor Site,oropharynx
431,1,1,First Failure Type,no known failure
431,1,1,Nodal Stage,N2
431,1,1,Treatment Modality,CTX-RT
431,1,1,Status,Alive w/o disease
431,1,1,Research lab p16,p16 unknown
431,1,1,Overall Stage,IVa
431,1,1,Radiation Dosage,72
431,1,1,Research lab HPV,HPV unknown
431,1,1,Tumor Stage,T3
431,1,1,Metastasis,M0
431,1,1,Second Failure Type,no known failure
431,1,1,Initial Chemotherapy Agent,PTX/cap
432,1,1,Tumor Stage,T3
432,1,1,Time to Death,0.7
432,1,1,Metastasis,M0
432,1,1,Nodal Stage,N0
432,1,1,Date of Death,2004-04-02 00:00:00
432,1,1,Research lab p16,p16 negative
432,1,1,Clinical lab p16,p16 unknown
432,1,1,Research lab HPV,HPV negative
432,1,1,Age at Death,56.3
432,1,1,Second Failure Type,no known failure
432,1,1,Tumor Site,oropharynx
432,1,1,Overall Stage,III
432,1,1,Status,Dead unk disease
432,1,1,Occurrence #,1st primary
432,1,1,Treatment Modality,Sx
432,1,1,First Failure Type,no known failure
433,1,1,Research lab HPV,HPV unknown
433,1,1,Second Failure Type,no known failure
433,1,1,Metastasis,M0
433,1,1,Time to Death,2.0
433,1,1,First Failure Type,distant
433,1,1,Research lab p16,p16 unknown
433,1,1,Nodal Stage,N2
433,1,1,Date of Death,2003-08-10 00:00:00
433,1,1,Status,Dead w/ disease
433,1,1,Time to First Failure,1.3
433,1,1,Treatment Modality,CTX-RT
433,1,1,Radiation Dosage,72
433,1,1,Overall Stage,IVa
433,1,1,Clinical lab p16,p16 unknown
433,1,1,Tumor Site,oropharynx
433,1,1,Initial Chemotherapy Agent,PTX/cap
433,1,1,Tumor Stage,T3
433,1,1,Age at Death,57.7
433,1,1,Occurrence #,1st primary
434,1,1,First Failure Type,locoregional
434,1,1,Research lab p16,p16 negative
434,1,1,Time to First Failure,0.6
434,1,1,Nodal Stage,N0
434,1,1,Treatment Modality,RT
434,1,1,Overall Stage,II
434,1,1,Metastasis,M0
434,1,1,Age at Death,42.4
434,1,1,Tumor Site,oropharynx
434,1,1,Radiation Dosage,66
434,1,1,Time to Death,1.2
434,1,1,Occurrence #,1st primary
434,1,1,Second Failure Type,no known failure
434,1,1,Clinical lab p16,p16 unknown
434,1,1,Tumor Stage,T2
434,1,1,Status,Dead w/ disease
434,1,1,Research lab HPV,HPV positive
434,1,1,Date of Death,1995-05-31 00:00:00
435,1,1,Nodal Stage,N3
435,1,1,Overall Stage,IVb
435,1,1,Time to First Failure,0.6
435,1,1,Research lab p16,p16 unknown
435,1,1,Age at Death,53.1
435,1,1,Initial Chemotherapy Agent,carbo/doce
435,1,1,Status,Dead w/ disease
435,1,1,Occurrence #,1st primary
435,1,1,Tumor Site,oropharynx
435,1,1,Research lab HPV,HPV unknown
435,1,1,Date of Death,2005-01-28 00:00:00
435,1,1,Radiation Dosage,70.2
435,1,1,Tumor Stage,T4a
435,1,1,Second Failure Type,no known failure
435,1,1,Time to Death,1.4
435,1,1,Metastasis,M0
435,1,1,Clinical lab p16,p16 unknown
435,1,1,First Failure Type,locoregional and distant
435,1,1,Treatment Modality,CTX-RT
436,1,1,First Failure Treatment Modality,Sx & CTX-RT
436,1,1,Time to First Failure,5.1
436,1,1,Clinical lab p16,p16 unknown
436,1,1,Radiation Dosage,76.8
436,1,1,Nodal Stage,N0
436,1,1,First Failure Type,locoregional
436,1,1,Research lab HPV,HPV unknown
436,1,1,First Failure Site,oropharynx
436,1,1,Metastasis,M0
436,1,1,Treatment Modality,RT
436,1,1,First Failure Initial Chemotherapy Agent,cis
436,1,1,First Failure Radiation Dosage,60
436,1,1,Second Failure Type,no known failure
436,1,1,Overall Stage,II
436,1,1,Tumor Site,oropharynx
436,1,1,Occurrence #,1st primary
436,1,1,Research lab p16,p16 unknown
436,1,1,Status,Alive w/o disease
436,1,1,Tumor Stage,T2
437,1,1,Occurrence #,1st primary
437,1,1,Time to Death,0.4
437,1,1,Date of Death,2000-11-16 00:00:00
437,1,1,Research lab HPV,HPV unknown
437,1,1,Radiation Dosage,70
437,1,1,Tumor Stage,T4a
437,1,1,Tumor Site,oropharynx
437,1,1,Second Failure Type,no known failure
437,1,1,Treatment Modality,RT
437,1,1,Research lab p16,p16 unknown
437,1,1,Overall Stage,IVa
437,1,1,Nodal Stage,N0
437,1,1,Age at Death,85.0
437,1,1,Metastasis,M0
437,1,1,Clinical lab p16,p16 unknown
437,1,1,Status,Dead w/ disease
437,1,1,First Failure Type,no known failure
438,1,1,Treatment Modality,Sx & CTX-RT
438,1,1,Tumor Site,oropharynx
438,1,1,First Failure Type,locoregional and distant
438,1,1,Metastasis,M0
438,1,1,Time to First Failure,-0.2
438,1,1,Occurrence #,1st primary
438,1,1,Second Failure Type,no known failure
438,1,1,Date of Death,2008-04-13 00:00:00
438,1,1,Overall Stage,IVa
438,1,1,Tumor Stage,T3
438,1,1,Clinical lab p16,p16 unknown
438,1,1,Research lab p16,p16 positive
438,1,1,Age at Death,55.0
438,1,1,Nodal Stage,N2
438,1,1,Initial Chemotherapy Agent,doce
438,1,1,Research lab HPV,HPV positive
438,1,1,Time to Death,1.5
438,1,1,Radiation Dosage,unknown
438,1,1,Status,Dead w/ disease
439,1,1,Occurrence #,1st primary
439,1,1,Tumor Site,oropharynx
439,1,1,Second Failure Type,no known failure
439,1,1,Overall Stage,IVa
439,1,1,Status,Alive unk disease
439,1,1,Treatment Modality,Sx
439,1,1,First Failure Type,no known failure
439,1,1,Research lab HPV,HPV unknown
439,1,1,Research lab p16,p16 positive
439,1,1,Tumor Stage,T2
439,1,1,Metastasis,M0
439,1,1,Nodal Stage,N2
439,1,1,Clinical lab p16,p16 unknown
440,1,1,Status,Dead unk disease
440,1,1,Second Failure Type,no known failure
440,1,1,Date of Death,2011-05-02 00:00:00
440,1,1,Metastasis,M0
440,1,1,Nodal Stage,Unknown
440,1,1,Treatment Modality,RT
440,1,1,Occurrence #,1st primary
440,1,1,Overall Stage,III
440,1,1,Research lab p16,p16 unknown
440,1,1,First Failure Type,no known failure
440,1,1,Radiation Dosage,unknown
440,1,1,Tumor Stage,Unknown
440,1,1,Research lab HPV,HPV unknown
440,1,1,Tumor Site,oropharynx
440,1,1,Time to Death,12.7
440,1,1,Age at Death,69.2
440,1,1,Clinical lab p16,p16 unknown
441,1,1,Research lab HPV,HPV unknown
441,1,1,First Failure Type,no known failure
441,1,1,Status,Unknown
441,1,1,Treatment Modality,Unknown
441,1,1,Nodal Stage,Unknown
441,1,1,Research lab p16,p16 unknown
441,1,1,Tumor Stage,Unknown
441,1,1,Occurrence #,1st primary
441,1,1,Overall Stage,Unknown
441,1,1,Tumor Site,Unknown
441,1,1,Clinical lab p16,p16 unknown
441,1,1,Second Failure Type,no known failure
441,1,1,Metastasis,Unknown
442,1,1,Initial Chemotherapy Agent,carbo/PTX
442,1,1,Clinical lab p16,p16 unknown
442,1,1,Age at Death,62.3
442,1,1,Research lab HPV,HPV negative
442,1,1,Tumor Site,oropharynx
442,1,1,Overall Stage,IVb
442,1,1,First Failure Type,no known failure
442,1,1,Treatment Modality,CTX-RT
442,1,1,Tumor Stage,T3
442,1,1,Nodal Stage,N3
442,1,1,Time to Death,7.3
442,1,1,Occurrence #,1st primary
442,1,1,Metastasis,M0
442,1,1,Research lab p16,p16 negative
442,1,1,Second Failure Type,no known failure
442,1,1,Date of Death,2003-03-11 00:00:00
442,1,1,Radiation Dosage,70.2
442,1,1,Status,Dead unk disease
443,1,1,Treatment Modality,Unknown
443,1,1,Status,Unknown
443,1,1,Tumor Site,Unknown
443,1,1,Clinical lab p16,p16 unknown
443,1,1,Occurrence #,1st primary
443,1,1,Tumor Stage,Unknown
443,1,1,Overall Stage,Unknown
443,1,1,Second Failure Type,no known failure
443,1,1,First Failure Type,no known failure
443,1,1,Research lab p16,p16 unknown
443,1,1,Nodal Stage,Unknown
443,1,1,Metastasis,Unknown
443,1,1,Research lab HPV,HPV unknown
444,1,1,Status,Unknown
444,1,1,Research lab p16,p16 unknown
444,1,1,Second Failure Type,no known failure
444,1,1,Nodal Stage,Unknown
444,1,1,First Failure Type,no known failure
444,1,1,Research lab HPV,HPV unknown
444,1,1,Overall Stage,Unknown
444,1,1,Clinical lab p16,p16 unknown
444,1,1,Occurrence #,1st primary
444,1,1,Tumor Site,oropharynx
444,1,1,Tumor Stage,Unknown
444,1,1,Treatment Modality,Unknown
444,1,1,Metastasis,Unknown
445,1,1,Overall Stage,IVa
445,1,1,Research lab p16,p16 unknown
445,1,1,Tumor Site,oropharynx
445,1,1,Occurrence #,1st primary
445,1,1,Initial Chemotherapy Agent,carbo/doce/amifostine
445,1,1,First Failure Type,locoregional
445,1,1,Clinical lab p16,p16 unknown
445,1,1,Status,Alive w/ disease
445,1,1,Treatment Modality,CTX-RT
445,1,1,First Failure Treatment Modality,Sx
445,1,1,Research lab HPV,HPV unknown
445,1,1,Metastasis,M0
445,1,1,First Failure Site,oropharynx
445,1,1,Second Failure Type,no known failure
445,1,1,Tumor Stage,T4a
445,1,1,Radiation Dosage,702
445,1,1,Time to First Failure,7.8
445,1,1,Nodal Stage,N0
446,1,1,Nodal Stage,N2
446,1,1,Time to Death,2.9
446,1,1,Tumor Site,oropharynx
446,1,1,Time to First Failure,0.2
446,1,1,Age at Death,57.6
446,1,1,Radiation Dosage,70
446,1,1,Metastasis,M0
446,1,1,Initial Chemotherapy Agent,carbo/PTX
446,1,1,Clinical lab p16,p16 unknown
446,1,1,Date of Death,2006-06-02 00:00:00
446,1,1,Research lab p16,p16 unknown
446,1,1,Occurrence #,1st primary
446,1,1,Tumor Stage,T4b
446,1,1,Status,Dead w/ disease
446,1,1,Second Failure Type,no known failure
446,1,1,Research lab HPV,HPV unknown
446,1,1,First Failure Type,distant
446,1,1,Treatment Modality,CTX-RT
446,1,1,Overall Stage,IVb
447,1,1,Date of Death,2005-08-01 00:00:00
447,1,1,Radiation Dosage,70.2
447,1,1,Overall Stage,IVa
447,1,1,Initial Chemotherapy Agent,carbo/doce
447,1,1,Occurrence #,1st primary
447,1,1,First Failure Type,no known failure
447,1,1,Tumor Site,oropharynx
447,1,1,Age at Death,59.4
447,1,1,Status,Dead unk disease
447,1,1,Nodal Stage,N0
447,1,1,Research lab p16,p16 unknown
447,1,1,Metastasis,M0
447,1,1,Tumor Stage,T4a
447,1,1,Second Failure Type,no known failure
447,1,1,Clinical lab p16,p16 unknown
447,1,1,Research lab HPV,HPV unknown
447,1,1,Time to Death,6.0
447,1,1,Treatment Modality,CTX-RT
448,1,1,Status,Dead unk disease
448,1,1,Tumor Site,oropharynx
448,1,1,Second Failure Type,no known failure
448,1,1,Tumor Stage,Unknown
448,1,1,Research lab p16,p16 unknown
448,1,1,Treatment Modality,RT
448,1,1,Clinical lab p16,p16 unknown
448,1,1,Age at Death,53.7
448,1,1,Date of Death,2011-02-10 00:00:00
448,1,1,Nodal Stage,Unknown
448,1,1,Overall Stage,Unknown
448,1,1,Occurrence #,1st primary
448,1,1,Time to Death,7.6
448,1,1,Radiation Dosage,unknown
448,1,1,First Failure Type,no known failure
448,1,1,Research lab HPV,HPV unknown
448,1,1,Metastasis,Unknown
449,1,1,First Failure Type,no known failure
449,1,1,Date of Death,2001-02-15 00:00:00
449,1,1,Treatment Modality,Sx & RT
449,1,1,Research lab p16,p16 negative
449,1,1,Age at Death,72.3
449,1,1,Nodal Stage,N0
449,1,1,Research lab HPV,HPV negative
449,1,1,Second Failure Type,no known failure
449,1,1,Time to Death,6.0
449,1,1,Tumor Stage,T4a
449,1,1,Occurrence #,1st primary
449,1,1,Overall Stage,IVa
449,1,1,Metastasis,M0
449,1,1,Radiation Dosage,43.2
449,1,1,Status,Dead unk disease
449,1,1,Tumor Site,oropharynx
449,1,1,Clinical lab p16,p16 unknown
450,1,1,Research lab p16,p16 unknown
450,1,1,Status,Unknown
450,1,1,Metastasis,Unknown
450,1,1,Nodal Stage,Unknown
450,1,1,First Failure Type,no known failure
450,1,1,Treatment Modality,Unknown
450,1,1,Tumor Site,Unknown
450,1,1,Overall Stage,Unknown
450,1,1,Occurrence #,1st primary
450,1,1,Research lab HPV,HPV unknown
450,1,1,Tumor Stage,Unknown
450,1,1,Clinical lab p16,p16 unknown
450,1,1,Second Failure Type,no known failure
451,1,1,Tumor Stage,T4a
451,1,1,Status,Dead w/o disease
451,1,1,Research lab HPV,HPV negative
451,1,1,Overall Stage,IVa
451,1,1,Metastasis,M0
451,1,1,Occurrence #,1st primary
451,1,1,Second Failure Type,no known failure
451,1,1,Age at Death,57.3
451,1,1,Time to Death,4.8
451,1,1,Clinical lab p16,p16 unknown
451,1,1,Nodal Stage,N0
451,1,1,Tumor Site,oropharynx
451,1,1,Research lab p16,p16 negative
451,1,1,Initial Chemotherapy Agent,carbo/doce
451,1,1,Date of Death,2002-07-25 00:00:00
451,1,1,Treatment Modality,CTX-RT
451,1,1,First Failure Type,no known failure
451,1,1,Radiation Dosage,70.2
452,1,1,First Failure Type,distant
452,1,1,Initial Chemotherapy Agent,carbo/doce
452,1,1,Second Failure Type,no known failure
452,1,1,Clinical lab p16,p16 unknown
452,1,1,Radiation Dosage,unknown
452,1,1,Research lab p16,p16 unknown
452,1,1,Date of Death,2004-09-17 00:00:00
452,1,1,Time to First Failure,0.1
452,1,1,Occurrence #,1st primary
452,1,1,Status,Dead w/ disease
452,1,1,Research lab HPV,HPV unknown
452,1,1,Treatment Modality,CTX-RT
452,1,1,Tumor Site,oropharynx
452,1,1,Nodal Stage,N2
452,1,1,Age at Death,45.1
452,1,1,Time to Death,0.7
452,1,1,Tumor Stage,T3
452,1,1,Overall Stage,IVa
452,1,1,Metastasis,M0
453,1,1,Research lab p16,p16 unknown
453,1,1,Clinical lab p16,p16 unknown
453,1,1,Tumor Site,Unknown
453,1,1,Status,Unknown
453,1,1,Treatment Modality,Unknown
453,1,1,Second Failure Type,no known failure
453,1,1,Overall Stage,Unknown
453,1,1,Tumor Stage,Unknown
453,1,1,First Failure Type,no known failure
453,1,1,Research lab HPV,HPV unknown
453,1,1,Nodal Stage,Unknown
453,1,1,Occurrence #,1st primary
453,1,1,Metastasis,Unknown
454,1,1,Second Failure Type,no known failure
454,1,1,Overall Stage,Unknown
454,1,1,Clinical lab p16,p16 unknown
454,1,1,Tumor Site,oropharynx
454,1,1,Metastasis,Unknown
454,1,1,Research lab HPV,HPV unknown
454,1,1,Nodal Stage,Unknown
454,1,1,Research lab p16,p16 unknown
454,1,1,First Failure Type,no known failure
454,1,1,Occurrence #,1st primary
454,1,1,Tumor Stage,Unknown
454,1,1,Status,Unknown
454,1,1,Treatment Modality,Unknown
455,1,1,Treatment Modality,RT
455,1,1,Research lab HPV,HPV unknown
455,1,1,Metastasis,M0
455,1,1,Occurrence #,1st primary
455,1,1,Tumor Stage,T2
455,1,1,First Failure Type,no known failure
455,1,1,Second Failure Type,no known failure
455,1,1,Overall Stage,III
455,1,1,Tumor Site,oropharynx
455,1,1,Radiation Dosage,70.2
455,1,1,Nodal Stage,N1
455,1,1,Research lab p16,p16 unknown
455,1,1,Clinical lab p16,p16 unknown
455,1,1,Status,Alive w/o disease
456,1,1,Radiation Dosage,70.2
456,1,1,Research lab HPV,HPV positive
456,1,1,Status,Alive w/o disease
456,1,1,Treatment Modality,Sx & CTX-RT
456,1,1,Nodal Stage,N2
456,1,1,First Failure Type,no known failure
456,1,1,Tumor Stage,T3
456,1,1,Metastasis,M0
456,1,1,Occurrence #,1st primary
456,1,1,Tumor Site,oropharynx
456,1,1,Overall Stage,IVa
456,1,1,Clinical lab p16,p16 unknown
456,1,1,Initial Chemotherapy Agent,cis
456,1,1,Second Failure Type,no known failure
456,1,1,Research lab p16,p16 positive
457,1,1,Metastasis,M0
457,1,1,Overall Stage,IVb
457,1,1,Treatment Modality,CTX-RT
457,1,1,Status,Alive w/o disease
457,1,1,Nodal Stage,N3
457,1,1,Initial Chemotherapy Agent,carbo/doce
457,1,1,Second Failure Type,no known failure
457,1,1,Tumor Stage,T2
457,1,1,First Failure Type,no known failure
457,1,1,Research lab p16,p16 unknown
457,1,1,Research lab HPV,HPV unknown
457,1,1,Radiation Dosage,70
457,1,1,Tumor Site,oropharynx
457,1,1,Occurrence #,1st primary
457,1,1,Clinical lab p16,p16 unknown
458,1,1,Nodal Stage,N1
458,1,1,Tumor Stage,T3
458,1,1,Tumor Site,oropharynx
458,1,1,Overall Stage,IVc
458,1,1,Second Failure Type,no known failure
458,1,1,Research lab p16,p16 unknown
458,1,1,Age at Death,67.3
458,1,1,Metastasis,M1
458,1,1,Initial Chemotherapy Agent,cis/alimta
458,1,1,Occurrence #,recurrence
458,1,1,Clinical lab p16,p16 unknown
458,1,1,Date of Death,2006-12-20 00:00:00
458,1,1,Status,Dead w/ disease
458,1,1,First Failure Type,no known failure
458,1,1,Radiation Dosage,50.4
458,1,1,Research lab HPV,HPV unknown
458,1,1,Time to Death,2.8
458,1,1,Treatment Modality,CTX-RT
459,1,1,Status,Alive w/o disease
459,1,1,Occurrence #,recurrence
459,1,1,Nodal Stage,N0
459,1,1,Tumor Site,oropharynx
459,1,1,Clinical lab p16,p16 unknown
459,1,1,Second Failure Type,no known failure
459,1,1,First Failure Type,no known failure
459,1,1,Metastasis,M0
459,1,1,Overall Stage,I
459,1,1,Tumor Stage,T1
459,1,1,Research lab HPV,HPV positive
459,1,1,Research lab p16,p16 unknown
459,1,1,Treatment Modality,Sx
460,1,1,Time to Death,1.8
460,1,1,Treatment Modality,RT
460,1,1,Clinical lab p16,p16 unknown
460,1,1,Radiation Dosage,unknown
460,1,1,Research lab p16,p16 unknown
460,1,1,Status,Dead unk disease
460,1,1,Age at Death,77.7
460,1,1,First Failure Type,locoregional
460,1,1,Date of Death,2002-10-04 00:00:00
460,1,1,Research lab HPV,HPV unknown
460,1,1,Time to First Failure,0.8
460,1,1,Nodal Stage,N0
460,1,1,Tumor Site,oropharynx
460,1,1,Occurrence #,1st primary
460,1,1,Metastasis,M0
460,1,1,Overall Stage,II
460,1,1,Second Failure Type,no known failure
460,1,1,Tumor Stage,T2
461,1,1,Metastasis,M0
461,1,1,Status,Dead unk disease
461,1,1,Occurrence #,1st primary
461,1,1,Treatment Modality,Sx
461,1,1,Nodal Stage,N0
461,1,1,Tumor Stage,T3
461,1,1,First Failure Type,no known failure
461,1,1,Age at Death,82.4
461,1,1,Time to Death,4.9
461,1,1,Research lab HPV,HPV unknown
461,1,1,Overall Stage,III
461,1,1,Second Failure Type,no known failure
461,1,1,Tumor Site,oropharynx
461,1,1,Research lab p16,p16 unknown
461,1,1,Clinical lab p16,p16 unknown
461,1,1,Date of Death,2009-07-26 00:00:00
462,1,1,Treatment Modality,CTX-RT
462,1,1,Metastasis,M0
462,1,1,Second Failure Type,no known failure
462,1,1,Radiation Dosage,72
462,1,1,Tumor Stage,T3
462,1,1,Occurrence #,1st primary
462,1,1,Research lab HPV,HPV unknown
462,1,1,Date of Death,2010-05-28 00:00:00
462,1,1,Initial Chemotherapy Agent,carbo/doce
462,1,1,Status,Dead w/o disease
462,1,1,Clinical lab p16,p16 unknown
462,1,1,Time to Death,8.2
462,1,1,Research lab p16,p16 unknown
462,1,1,Nodal Stage,N2
462,1,1,Overall Stage,IVa
462,1,1,Tumor Site,oropharynx
462,1,1,Age at Death,64.7
462,1,1,First Failure Type,no known failure
463,1,1,Research lab p16,p16 unknown
463,1,1,Treatment Modality,Unknown
463,1,1,Occurrence #,1st primary
463,1,1,Nodal Stage,Unknown
463,1,1,Tumor Site,Unknown
463,1,1,Research lab HPV,HPV unknown
463,1,1,Status,Unknown
463,1,1,Clinical lab p16,p16 unknown
463,1,1,First Failure Type,no known failure
463,1,1,Metastasis,Unknown
463,1,1,Tumor Stage,Unknown
463,1,1,Overall Stage,Unknown
463,1,1,Second Failure Type,no known failure
464,1,1,Overall Stage,IVa
464,1,1,Initial Chemotherapy Agent,carbo/ PTX
464,1,1,Date of Death,2002-10-15 00:00:00
464,1,1,First Failure Type,no known failure
464,1,1,Age at Death,70.9
464,1,1,Time to Death,0.2
464,1,1,Clinical lab p16,p16 unknown
464,1,1,Radiation Dosage,63
464,1,1,Status,Dead w/ disease
464,1,1,Metastasis,M0
464,1,1,Tumor Site,oropharynx
464,1,1,Tumor Stage,T4a
464,1,1,Second Failure Type,no known failure
464,1,1,Research lab HPV,HPV negative
464,1,1,Treatment Modality,CTX-RT
464,1,1,Research lab p16,p16 negative
464,1,1,Nodal Stage,N2
464,1,1,Occurrence #,1st primary
465,1,1,Metastasis,M0
465,1,1,Occurrence #,1st primary
465,1,1,Status,Alive w/o disease
465,1,1,Research lab HPV,HPV unknown
465,1,1,Radiation Dosage,70
465,1,1,Nodal Stage,N2
465,1,1,First Failure Type,no known failure
465,1,1,Second Failure Type,no known failure
465,1,1,Initial Chemotherapy Agent,cis
465,1,1,Treatment Modality,CTX-RT
465,1,1,Overall Stage,IVa
465,1,1,Tumor Stage,T2
465,1,1,Research lab p16,p16 unknown
465,1,1,Tumor Site,oropharynx
465,1,1,Clinical lab p16,p16 unknown
466,1,1,Overall Stage,IVa
466,1,1,Status,Alive w/o disease
466,1,1,First Failure Type,no known failure
466,1,1,Research lab HPV,HPV unknown
466,1,1,Occurrence #,1st primary
466,1,1,Second Failure Type,no known failure
466,1,1,Initial Chemotherapy Agent,cis/cetux
466,1,1,Tumor Site,oropharynx
466,1,1,Radiation Dosage,64
466,1,1,Clinical lab p16,p16 unknown
466,1,1,Research lab p16,p16 unknown
466,1,1,Metastasis,M0
466,1,1,Treatment Modality,CTX-RT
466,1,1,Tumor Stage,T1
466,1,1,Nodal Stage,N2
467,1,1,Metastasis,M0
467,1,1,Research lab HPV,HPV negative
467,1,1,Occurrence #,1st primary
467,1,1,Overall Stage,IVa
467,1,1,Second Failure Type,no known failure
467,1,1,Date of Death,2003-03-27 00:00:00
467,1,1,Tumor Site,oropharynx
467,1,1,Tumor Stage,T4a
467,1,1,Clinical lab p16,p16 unknown
467,1,1,Nodal Stage,N2
467,1,1,Status,Dead w/ disease
467,1,1,Initial Chemotherapy Agent,carbo/PTX
467,1,1,First Failure Type,locoregional
467,1,1,Age at Death,42.5
467,1,1,Research lab p16,p16 negative
467,1,1,Treatment Modality,CTX-RT
467,1,1,Time to First Failure,0.1
467,1,1,Time to Death,0.5
467,1,1,Radiation Dosage,70.2
468,1,1,Nodal Stage,N0
468,1,1,Clinical lab p16,p16 unknown
468,1,1,Metastasis,M0
468,1,1,Time to Death,0.2
468,1,1,First Failure Type,no known failure
468,1,1,Overall Stage,III
468,1,1,Radiation Dosage,32.4
468,1,1,Initial Chemotherapy Agent,carbo/doce
468,1,1,Research lab p16,p16 unknown
468,1,1,Research lab HPV,HPV unknown
468,1,1,Status,Dead w/ disease
468,1,1,Age at Death,71.6
468,1,1,Tumor Stage,T3
468,1,1,Second Failure Type,no known failure
468,1,1,Occurrence #,1st primary
468,1,1,Date of Death,2004-07-27 00:00:00
468,1,1,Tumor Site,oropharynx
468,1,1,Treatment Modality,CTX-RT
469,1,1,Tumor Site,oropharynx
469,1,1,Nodal Stage,Unknown
469,1,1,Status,Alive w/o disease
469,1,1,Research lab p16,p16 unknown
469,1,1,Metastasis,Unknown
469,1,1,Radiation Dosage,unknown
469,1,1,Treatment Modality,Sx & CTX-RT
469,1,1,Research lab HPV,HPV unknown
469,1,1,Tumor Stage,Unknown
469,1,1,First Failure Type,no known failure
469,1,1,Clinical lab p16,p16 unknown
469,1,1,Occurrence #,1st primary
469,1,1,Second Failure Type,no known failure
469,1,1,Overall Stage,Unknown
469,1,1,Initial Chemotherapy Agent,unknown
470,1,1,Time to Death,0.9
470,1,1,Date of Death,1994-05-23 00:00:00
470,1,1,Overall Stage,IVa
470,1,1,Radiation Dosage,70.2
470,1,1,Clinical lab p16,p16 unknown
470,1,1,Second Failure Type,no known failure
470,1,1,Tumor Site,oropharynx
470,1,1,Metastasis,M0
470,1,1,Research lab p16,p16 negative
470,1,1,First Failure Type,no known failure
470,1,1,Age at Death,54.3
470,1,1,Research lab HPV,HPV negative
470,1,1,Status,Dead unk disease
470,1,1,Nodal Stage,N2
470,1,1,Tumor Stage,T3
470,1,1,Occurrence #,1st primary
470,1,1,Treatment Modality,RT
471,1,1,Tumor Stage,Unknown
471,1,1,Second Failure Type,no known failure
471,1,1,Clinical lab p16,p16 unknown
471,1,1,Overall Stage,Unknown
471,1,1,Tumor Site,Unknown
471,1,1,Nodal Stage,Unknown
471,1,1,Research lab HPV,HPV unknown
471,1,1,Research lab p16,p16 unknown
471,1,1,First Failure Type,no known failure
471,1,1,Treatment Modality,Unknown
471,1,1,Status,Unknown
471,1,1,Metastasis,Unknown
471,1,1,Occurrence #,1st primary
472,1,1,Clinical lab p16,p16 unknown
472,1,1,Treatment Modality,CTX-RT
472,1,1,Research lab HPV,HPV unknown
472,1,1,Time to Death,0.3
472,1,1,Nodal Stage,N2
472,1,1,Tumor Site,oropharynx
472,1,1,Second Failure Type,no known failure
472,1,1,Occurrence #,1st primary
472,1,1,Tumor Stage,T3
472,1,1,Metastasis,M0
472,1,1,Research lab p16,p16 unknown
472,1,1,Age at Death,61.4
472,1,1,Overall Stage,IVa
472,1,1,Radiation Dosage,70.2
472,1,1,Initial Chemotherapy Agent,carbo/doce
472,1,1,Date of Death,2005-01-24 00:00:00
472,1,1,First Failure Type,no known failure
472,1,1,Status,Dead unk disease
473,1,1,Time to First Failure,0.6
473,1,1,Occurrence #,1st primary
473,1,1,Time to Death,1.2
473,1,1,Tumor Stage,T2
473,1,1,Research lab p16,p16 positive
473,1,1,Age at Death,51.1
473,1,1,Second Failure Type,no known failure
473,1,1,Overall Stage,IVb
473,1,1,Research lab HPV,HPV positive
473,1,1,Tumor Site,oropharynx
473,1,1,Clinical lab p16,p16 unknown
473,1,1,Radiation Dosage,70.2
473,1,1,Nodal Stage,N3
473,1,1,Status,Dead w/ disease
473,1,1,First Failure Type,locoregional
473,1,1,Treatment Modality,Sx & RT
473,1,1,Metastasis,M0
473,1,1,Date of Death,2002-07-25 00:00:00
474,1,1,Overall Stage,IVa
474,1,1,Tumor Stage,T4a
474,1,1,Occurrence #,1st primary
474,1,1,Clinical lab p16,p16 unknown
474,1,1,Status,Alive w/o disease
474,1,1,Nodal Stage,N0
474,1,1,Tumor Site,oral cavity
474,1,1,First Failure Type,no known failure
474,1,1,Research lab HPV,HPV unknown
474,1,1,Research lab p16,p16 unknown
474,1,1,Metastasis,M0
474,1,1,Second Failure Type,no known failure
474,1,1,Treatment Modality,Sx
475,1,1,Research lab HPV,HPV unknown
475,1,1,Occurrence #,1st primary
475,1,1,Tumor Stage,Unknown
475,1,1,Overall Stage,Unknown
475,1,1,First Failure Type,no known failure
475,1,1,Clinical lab p16,p16 unknown
475,1,1,Status,Unknown
475,1,1,Nodal Stage,Unknown
475,1,1,Metastasis,Unknown
475,1,1,Treatment Modality,Unknown
475,1,1,Tumor Site,Unknown
475,1,1,Second Failure Type,no known failure
475,1,1,Research lab p16,p16 unknown
476,1,1,Tumor Stage,T2
476,1,1,Metastasis,M0
476,1,1,Treatment Modality,Sx & RT
476,1,1,First Failure Type,no known failure
476,1,1,Overall Stage,II
476,1,1,Nodal Stage,N0
476,1,1,Second Failure Type,no known failure
476,1,1,Research lab p16,p16 unknown
476,1,1,Tumor Site,oral cavity
476,1,1,Occurrence #,1st primary
476,1,1,Radiation Dosage,66.6
476,1,1,Status,Alive w/o disease
476,1,1,Clinical lab p16,p16 unknown
476,1,1,Research lab HPV,HPV unknown
477,1,1,Time to Death,0.0
477,1,1,First Failure Type,no known failure
477,1,1,Research lab HPV,HPV unknown
477,1,1,Clinical lab p16,p16 unknown
477,1,1,Treatment Modality,Sx
477,1,1,Metastasis,M0
477,1,1,Nodal Stage,N0
477,1,1,Date of Death,2001-02-27 00:00:00
477,1,1,Age at Death,76.8
477,1,1,Occurrence #,1st primary
477,1,1,Research lab p16,p16 unknown
477,1,1,Tumor Site,oral cavity
477,1,1,Tumor Stage,T1
477,1,1,Second Failure Type,no known failure
477,1,1,Overall Stage,I
477,1,1,Status,Dead unk disease
478,1,1,Research lab p16,p16 unknown
478,1,1,Occurrence #,1st primary
478,1,1,Research lab HPV,HPV unknown
478,1,1,First Failure Type,no known failure
478,1,1,Tumor Site,oral cavity
478,1,1,Second Failure Type,no known failure
478,1,1,Clinical lab p16,p16 unknown
478,1,1,Date of Death,2002-03-06 00:00:00
478,1,1,Treatment Modality,Sx
478,1,1,Nodal Stage,N0
478,1,1,Overall Stage,IVa
478,1,1,Metastasis,M0
478,1,1,Age at Death,67.1
478,1,1,Time to Death,0.7
478,1,1,Status,Dead unk disease
478,1,1,Tumor Stage,T4a
479,1,1,Research lab p16,p16 unknown
479,1,1,Time to First Failure,0.2
479,1,1,Treatment Modality,Sx
479,1,1,Age at Death,81.8
479,1,1,Tumor Site,oral cavity
479,1,1,Second Failure Type,no known failure
479,1,1,Metastasis,M0
479,1,1,Occurrence #,1st primary
479,1,1,Research lab HPV,HPV unknown
479,1,1,Nodal Stage,N0
479,1,1,Time to Death,0.9
479,1,1,Clinical lab p16,p16 unknown
479,1,1,Date of Death,2009-04-24 00:00:00
479,1,1,Tumor Stage,T4a
479,1,1,Status,Dead unk disease
479,1,1,Overall Stage,IVa
479,1,1,First Failure Type,locoregional
480,1,1,Date of Death,1999-06-17 00:00:00
480,1,1,Second Failure Type,no known failure
480,1,1,Occurrence #,1st primary
480,1,1,Status,Dead unk disease
480,1,1,Treatment Modality,Unknown
480,1,1,Age at Death,81.6
480,1,1,Clinical lab p16,p16 unknown
480,1,1,Tumor Site,Unknown
480,1,1,Metastasis,Unknown
480,1,1,Research lab HPV,HPV unknown
480,1,1,First Failure Type,no known failure
480,1,1,Time to Death,1.8
480,1,1,Nodal Stage,Unknown
480,1,1,Tumor Stage,Unknown
480,1,1,Research lab p16,p16 unknown
480,1,1,Overall Stage,Unknown
481,1,1,Overall Stage,IVa
481,1,1,Treatment Modality,Sx
481,1,1,Second Failure Type,no known failure
481,1,1,Tumor Stage,T3
481,1,1,First Failure Type,no known failure
481,1,1,Status,Dead w/ disease
481,1,1,Nodal Stage,N2
481,1,1,Research lab HPV,HPV unknown
481,1,1,Date of Death,2002-12-30 00:00:00
481,1,1,Research lab p16,p16 unknown
481,1,1,Clinical lab p16,p16 unknown
481,1,1,Metastasis,M0
481,1,1,Tumor Site,oropharynx
481,1,1,Initial Chemotherapy Agent,unknown
481,1,1,Occurrence #,recurrence
481,1,1,Age at Death,70.0
482,1,1,First Failure Type,no known failure
482,1,1,Status,Dead unk disease
482,1,1,Occurrence #,1st primary
482,1,1,Nodal Stage,N2
482,1,1,Research lab HPV,HPV unknown
482,1,1,Date of Death,2002-10-01 00:00:00
482,1,1,Clinical lab p16,p16 unknown
482,1,1,Overall Stage,IVa
482,1,1,Metastasis,M0
482,1,1,Research lab p16,p16 unknown
482,1,1,Tumor Stage,T4a
482,1,1,Age at Death,66.9
482,1,1,Time to Death,1.6
482,1,1,Tumor Site,oral cavity
482,1,1,Treatment Modality,Sx
482,1,1,Second Failure Type,no known failure
484,1,1,Research lab HPV,HPV unknown
484,1,1,Tumor Stage,Unknown
484,1,1,Nodal Stage,Unknown
484,1,1,Clinical lab p16,p16 unknown
484,1,1,Metastasis,Unknown
484,1,1,Status,Unknown
484,1,1,Tumor Site,Unknown
484,1,1,Second Failure Type,no known failure
484,1,1,Research lab p16,p16 unknown
484,1,1,Overall Stage,Unknown
484,1,1,Occurrence #,1st primary
484,1,1,Treatment Modality,Unknown
484,1,1,First Failure Type,no known failure
485,1,1,Treatment Modality,Sx
485,1,1,Occurrence #,1st primary
485,1,1,Clinical lab p16,p16 unknown
485,1,1,Metastasis,M0
485,1,1,Age at Death,66.5
485,1,1,Research lab p16,p16 unknown
485,1,1,Nodal Stage,N0
485,1,1,Tumor Stage,T2
485,1,1,Tumor Site,oral cavity
485,1,1,Overall Stage,II
485,1,1,Date of Death,2010-08-20 00:00:00
485,1,1,Second Failure Type,no known failure
485,1,1,Time to Death,16.1
485,1,1,First Failure Type,no known failure
485,1,1,Research lab HPV,HPV unknown
485,1,1,Status,Dead w/ disease
487,1,1,Overall Stage,IVa
487,1,1,Age at Death,50.9
487,1,1,Second Failure Type,no known failure
487,1,1,Time to First Failure,0.5
487,1,1,Treatment Modality,Sx & CTX-RT
487,1,1,Research lab HPV,HPV unknown
487,1,1,Initial Chemotherapy Agent,cis
487,1,1,Metastasis,M0
487,1,1,Occurrence #,1st primary
487,1,1,Research lab p16,p16 unknown
487,1,1,Tumor Stage,T1
487,1,1,Time to Death,1.7
487,1,1,First Failure Type,distant
487,1,1,Tumor Site,oropharynx
487,1,1,Nodal Stage,N2
487,1,1,Date of Death,2009-09-19 00:00:00
487,1,1,Radiation Dosage,66.6
487,1,1,Status,Dead w/o disease
487,1,1,Clinical lab p16,p16 unknown
488,1,1,Age at Death,81.6
488,1,1,Overall Stage,IVa
488,1,1,Research lab HPV,HPV unknown
488,1,1,Research lab p16,p16 unknown
488,1,1,Date of Death,2007-04-07 00:00:00
488,1,1,Tumor Stage,T4a
488,1,1,Status,Dead unk disease
488,1,1,Metastasis,M0
488,1,1,Second Failure Type,no known failure
488,1,1,First Failure Type,no known failure
488,1,1,Treatment Modality,Sx
488,1,1,Clinical lab p16,p16 unknown
488,1,1,Tumor Site,hypopharynx
488,1,1,Nodal Stage,N2
488,1,1,Time to Death,0.2
488,1,1,Occurrence #,1st primary
490,1,1,Time to Death,2.4
490,1,1,Date of Death,1999-04-30 00:00:00
490,1,1,Occurrence #,1st primary
490,1,1,Research lab p16,p16 negative
490,1,1,Tumor Stage,T4a
490,1,1,Clinical lab p16,p16 unknown
490,1,1,First Failure Type,locoregional
490,1,1,Radiation Dosage,54
490,1,1,Initial Chemotherapy Agent,5FU/cis
490,1,1,Tumor Site,oropharynx
490,1,1,Metastasis,M0
490,1,1,Research lab HPV,HPV negative
490,1,1,Second Failure Type,no known failure
490,1,1,Status,Dead w/ disease
490,1,1,Nodal Stage,N3
490,1,1,Age at Death,48.9
490,1,1,Time to First Failure,0.8
490,1,1,Treatment Modality,CTX-RT
490,1,1,Overall Stage,IVb
491,1,1,Time to First Failure,-1.2
491,1,1,Nodal Stage,N2
491,1,1,Treatment Modality,CTX-RT
491,1,1,Second Failure Type,no known failure
491,1,1,Time to Death,2.9
491,1,1,First Failure Type,locoregional
491,1,1,Tumor Stage,T3
491,1,1,Tumor Site,oropharynx
491,1,1,Clinical lab p16,p16 unknown
491,1,1,Date of Death,2005-09-21 00:00:00
491,1,1,Metastasis,M0
491,1,1,Research lab HPV,HPV negative
491,1,1,Occurrence #,1st primary
491,1,1,Age at Death,62.5
491,1,1,Status,Dead w/ disease
491,1,1,First Failure Treatment Modality,Sx
491,1,1,Research lab p16,p16 negative
491,1,1,First Failure Site,larynx
491,1,1,Overall Stage,IVa
491,1,1,Initial Chemotherapy Agent,carbo/PTX
491,1,1,Radiation Dosage,70.2
492,1,1,Time to Death,0.3
492,1,1,Metastasis,M0
492,1,1,Age at Death,57.3
492,1,1,Treatment Modality,CTX-RT
492,1,1,Date of Death,2004-09-22 00:00:00
492,1,1,Research lab p16,p16 negative
492,1,1,Overall Stage,III
492,1,1,Initial Chemotherapy Agent,cis
492,1,1,Status,Dead w/o disease
492,1,1,Tumor Stage,T3
492,1,1,Nodal Stage,N0
492,1,1,Second Failure Type,no known failure
492,1,1,Occurrence #,1st primary
492,1,1,Research lab HPV,HPV negative
492,1,1,Radiation Dosage,70
492,1,1,Clinical lab p16,p16 unknown
492,1,1,First Failure Type,no known failure
492,1,1,Tumor Site,larynx
493,1,1,Overall Stage,IVa
493,1,1,Time to Death,3.6
493,1,1,Clinical lab p16,p16 unknown
493,1,1,Status,Dead w/ disease
493,1,1,Second Failure Type,no known failure
493,1,1,Research lab p16,p16 unknown
493,1,1,Treatment Modality,CTX-RT
493,1,1,Date of Death,2005-10-29 00:00:00
493,1,1,First Failure Site,hypopharynx
493,1,1,First Failure Treatment Modality,Sx
493,1,1,Tumor Stage,T3
493,1,1,First Failure Type,locoregional
493,1,1,Tumor Site,hypopharynx
493,1,1,Radiation Dosage,70.2
493,1,1,Occurrence #,1st primary
493,1,1,Metastasis,M0
493,1,1,Nodal Stage,N2
493,1,1,Age at Death,57.3
493,1,1,Time to First Failure,2.4
493,1,1,Research lab HPV,HPV positive
493,1,1,Initial Chemotherapy Agent,Carbo/PTX
494,1,1,First Failure Treatment Modality,Sx & CTX-RT
494,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
494,1,1,Time to First Failure,0.6
494,1,1,Clinical lab p16,p16 unknown
494,1,1,First Failure Type,locoregional
494,1,1,Initial Chemotherapy Agent,carbo/PTX
494,1,1,Date of Death,2007-05-17 00:00:00
494,1,1,Age at Death,73.0
494,1,1,Second Failure Type,no known failure
494,1,1,Nodal Stage,N2
494,1,1,First Failure Radiation Dosage,60
494,1,1,Tumor Stage,T2
494,1,1,Radiation Dosage,70.2
494,1,1,Treatment Modality,CTX-RT
494,1,1,Tumor Site,oral cavity
494,1,1,Metastasis,M0
494,1,1,Occurrence #,1st primary
494,1,1,Overall Stage,IVa
494,1,1,Research lab HPV,HPV positive
494,1,1,First Failure Site,oral cavity
494,1,1,Time to Death,2.4
494,1,1,Research lab p16,p16 unknown
494,1,1,Status,Dead w/ disease
495,1,1,Research lab HPV,HPV unknown
495,1,1,Tumor Stage,T2
495,1,1,Occurrence #,1st primary
495,1,1,Age at Death,56.9
495,1,1,Date of Death,2008-08-27 00:00:00
495,1,1,Nodal Stage,N3
495,1,1,Status,Dead w/ disease
495,1,1,Tumor Site,larynx
495,1,1,First Failure Treatment Modality,CTX
495,1,1,Second Failure Type,no known failure
495,1,1,First Failure Site,oropharynx
495,1,1,Time to Death,4.7
495,1,1,First Failure Type,locoregional and distant
495,1,1,Research lab p16,p16 unknown
495,1,1,Metastasis,M0
495,1,1,Treatment Modality,CTX-RT
495,1,1,Initial Chemotherapy Agent,doce/Carbo
495,1,1,Clinical lab p16,p16 unknown
495,1,1,Time to First Failure,3.5
495,1,1,First Failure Initial Chemotherapy Agent,cis/doce
495,1,1,Radiation Dosage,70.2
495,1,1,Overall Stage,IVb
496,1,1,Overall Stage,Unknown
496,1,1,Time to Death,0.4
496,1,1,Research lab p16,p16 unknown
496,1,1,Nodal Stage,Unknown
496,1,1,Research lab HPV,HPV unknown
496,1,1,Treatment Modality,Unknown
496,1,1,Date of Death,2002-01-11 00:00:00
496,1,1,Metastasis,Unknown
496,1,1,Clinical lab p16,p16 unknown
496,1,1,First Failure Type,no known failure
496,1,1,Second Failure Type,no known failure
496,1,1,Age at Death,68.7
496,1,1,Status,Dead unk disease
496,1,1,Occurrence #,recurrence
496,1,1,Tumor Site,larynx
496,1,1,Tumor Stage,Unknown
497,1,1,Occurrence #,1st primary
497,1,1,Status,Alive unk disease
497,1,1,Overall Stage,I
497,1,1,Metastasis,M0
497,1,1,Second Failure Type,no known failure
497,1,1,Clinical lab p16,p16 unknown
497,1,1,Nodal Stage,N0
497,1,1,Tumor Site,oral cavity
497,1,1,Treatment Modality,Sx
497,1,1,Research lab HPV,HPV unknown
497,1,1,Tumor Stage,T1
497,1,1,Research lab p16,p16 unknown
497,1,1,First Failure Type,no known failure
498,1,1,Treatment Modality,Sx
498,1,1,Status,Alive w/o disease
498,1,1,Nodal Stage,N0
498,1,1,Occurrence #,1st primary
498,1,1,Tumor Stage,T1
498,1,1,Clinical lab p16,p16 unknown
498,1,1,Tumor Site,oral cavity
498,1,1,Second Failure Type,no known failure
498,1,1,Research lab HPV,HPV unknown
498,1,1,First Failure Type,no known failure
498,1,1,Research lab p16,p16 unknown
498,1,1,Overall Stage,I
498,1,1,Metastasis,M0
499,1,1,Treatment Modality,Sx
499,1,1,Clinical lab p16,p16 unknown
499,1,1,Metastasis,M0
499,1,1,Occurrence #,1st primary
499,1,1,Status,Alive unk disease
499,1,1,Tumor Stage,Unknown
499,1,1,Tumor Site,oral cavity
499,1,1,Second Failure Type,no known failure
499,1,1,Research lab HPV,HPV unknown
499,1,1,Nodal Stage,N2
499,1,1,Overall Stage,IVa
499,1,1,First Failure Type,no known failure
499,1,1,Research lab p16,p16 unknown
500,1,1,Status,Alive unk disease
500,1,1,Research lab p16,p16 unknown
500,1,1,Metastasis,M0
500,1,1,Treatment Modality,Sx
500,1,1,Nodal Stage,N0
500,1,1,Tumor Stage,T4a
500,1,1,Research lab HPV,HPV unknown
500,1,1,Clinical lab p16,p16 unknown
500,1,1,Tumor Site,oral cavity
500,1,1,Overall Stage,IVa
500,1,1,Occurrence #,1st primary
500,1,1,Second Failure Type,no known failure
500,1,1,First Failure Type,no known failure
501,1,1,Tumor Site,oral cavity
501,1,1,Second Failure Type,no known failure
501,1,1,Tumor Stage,T2
501,1,1,Research lab p16,p16 unknown
501,1,1,Metastasis,M0
501,1,1,Nodal Stage,N0
501,1,1,First Failure Type,no known failure
501,1,1,Research lab HPV,HPV unknown
501,1,1,Clinical lab p16,p16 unknown
501,1,1,Treatment Modality,Sx
501,1,1,Status,Alive unk disease
501,1,1,Occurrence #,1st primary
501,1,1,Overall Stage,II
502,1,1,Research lab HPV,HPV unknown
502,1,1,Date of Death,2002-09-18 00:00:00
502,1,1,First Failure Type,no known failure
502,1,1,Tumor Stage,T3
502,1,1,Age at Death,80.0
502,1,1,Tumor Site,oral cavity
502,1,1,Nodal Stage,N2
502,1,1,Treatment Modality,Sx
502,1,1,Clinical lab p16,p16 unknown
502,1,1,Metastasis,M0
502,1,1,Status,Dead unk disease
502,1,1,Second Failure Type,no known failure
502,1,1,Research lab p16,p16 unknown
502,1,1,Time to Death,0.5
502,1,1,Occurrence #,1st primary
502,1,1,Overall Stage,IVa
503,1,1,Metastasis,M0
503,1,1,Overall Stage,IVa
503,1,1,Occurrence #,1st primary
503,1,1,Research lab p16,p16 unknown
503,1,1,Treatment Modality,Sx
503,1,1,Status,Alive w/o disease
503,1,1,First Failure Type,no known failure
503,1,1,Nodal Stage,N2
503,1,1,Research lab HPV,HPV unknown
503,1,1,Clinical lab p16,p16 unknown
503,1,1,Second Failure Type,no known failure
503,1,1,Tumor Site,oral cavity
503,1,1,Tumor Stage,T4a
505,1,1,First Failure Radiation Dosage,63
505,1,1,Research lab HPV,HPV unknown
505,1,1,Time to First Failure,1.9
505,1,1,Treatment Modality,Sx
505,1,1,Status,Dead w/ disease
505,1,1,Date of Death,2010-06-28 00:00:00
505,1,1,Tumor Stage,T1
505,1,1,Age at Death,35.1
505,1,1,Overall Stage,I
505,1,1,First Failure Type,locoregional
505,1,1,Tumor Site,oral cavity
505,1,1,Second Failure Type,no known failure
505,1,1,Clinical lab p16,p16 unknown
505,1,1,Time to Death,9.0
505,1,1,First Failure Treatment Modality,Sx & CTX-RT
505,1,1,Occurrence #,1st primary
505,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
505,1,1,First Failure Site,oral cavity
505,1,1,Research lab p16,p16 unknown
505,1,1,Nodal Stage,N0
505,1,1,Metastasis,M0
506,1,1,Overall Stage,I
506,1,1,Tumor Site,oral cavity
506,1,1,Occurrence #,1st primary
506,1,1,First Failure Type,no known failure
506,1,1,Tumor Stage,T1
506,1,1,Research lab p16,p16 unknown
506,1,1,Metastasis,M0
506,1,1,Research lab HPV,HPV unknown
506,1,1,Second Failure Type,no known failure
506,1,1,Nodal Stage,N0
506,1,1,Status,Alive w/o disease
506,1,1,Clinical lab p16,p16 unknown
506,1,1,Treatment Modality,Sx
507,1,1,Nodal Stage,N0
507,1,1,Date of Death,2010-12-24 00:00:00
507,1,1,Occurrence #,1st primary
507,1,1,Research lab HPV,HPV unknown
507,1,1,First Failure Treatment Modality,Sx
507,1,1,Tumor Stage,T1
507,1,1,Time to First Failure,1.2
507,1,1,Metastasis,M0
507,1,1,First Failure Site,oral cavity
507,1,1,Second Failure Type,no known failure
507,1,1,First Failure Type,locoregional
507,1,1,Overall Stage,I
507,1,1,Time to Death,4.0
507,1,1,Tumor Site,oral cavity
507,1,1,Age at Death,76.0
507,1,1,Clinical lab p16,p16 unknown
507,1,1,Research lab p16,p16 unknown
507,1,1,Status,Dead unk disease
507,1,1,Treatment Modality,Sx
509,1,1,Research lab p16,p16 unknown
509,1,1,Treatment Modality,Sx
509,1,1,Age at Death,47.8
509,1,1,Clinical lab p16,p16 unknown
509,1,1,Tumor Stage,T2
509,1,1,Overall Stage,II
509,1,1,Tumor Site,oral cavity
509,1,1,Status,Dead w/ disease
509,1,1,Second Failure Type,no known failure
509,1,1,Time to Death,5.0
509,1,1,Metastasis,M0
509,1,1,First Failure Type,no known failure
509,1,1,Nodal Stage,N0
509,1,1,Date of Death,2009-03-08 00:00:00
509,1,1,Research lab HPV,HPV unknown
509,1,1,Occurrence #,1st primary
510,1,1,Clinical lab p16,p16 unknown
510,1,1,Overall Stage,IVa
510,1,1,Time to First Failure,0.2
510,1,1,Tumor Stage,T4a
510,1,1,First Failure Site,oral cavity
510,1,1,Occurrence #,1st primary
510,1,1,Metastasis,M0
510,1,1,Second Failure Type,no known failure
510,1,1,First Failure Radiation Dosage,70.2
510,1,1,Tumor Site,oral cavity
510,1,1,Nodal Stage,N1
510,1,1,Research lab p16,p16 unknown
510,1,1,First Failure Initial Chemotherapy Agent,carbo/cap
510,1,1,Time to Death,0.6
510,1,1,First Failure Treatment Modality,CTX-RT
510,1,1,Date of Death,2004-12-20 00:00:00
510,1,1,Treatment Modality,Sx
510,1,1,Age at Death,74.8
510,1,1,Status,Dead w/ disease
510,1,1,Research lab HPV,HPV unknown
510,1,1,First Failure Type,locoregional
511,1,1,Treatment Modality,Sx
511,1,1,First Failure Type,no known failure
511,1,1,Overall Stage,I
511,1,1,Research lab HPV,HPV unknown
511,1,1,Clinical lab p16,p16 unknown
511,1,1,Tumor Site,oral cavity
511,1,1,Status,Alive unk disease
511,1,1,Research lab p16,p16 unknown
511,1,1,Metastasis,M0
511,1,1,Nodal Stage,N0
511,1,1,Second Failure Type,no known failure
511,1,1,Occurrence #,1st primary
511,1,1,Tumor Stage,T1
512,1,1,Research lab p16,p16 unknown
512,1,1,Tumor Stage,T1
512,1,1,Treatment Modality,Sx
512,1,1,Status,Dead unk disease
512,1,1,Age at Death,84.3
512,1,1,Time to Death,4.3
512,1,1,Date of Death,2006-07-18 00:00:00
512,1,1,Nodal Stage,N0
512,1,1,Occurrence #,1st primary
512,1,1,Second Failure Type,no known failure
512,1,1,Clinical lab p16,p16 unknown
512,1,1,Overall Stage,I
512,1,1,Tumor Site,oral cavity
512,1,1,Research lab HPV,HPV unknown
512,1,1,Metastasis,M0
512,1,1,First Failure Type,no known failure
513,1,1,Research lab HPV,HPV unknown
513,1,1,Metastasis,M0
513,1,1,Occurrence #,1st primary
513,1,1,Status,Alive unk disease
513,1,1,Clinical lab p16,p16 unknown
513,1,1,Nodal Stage,N0
513,1,1,First Failure Type,no known failure
513,1,1,Tumor Site,oral cavity
513,1,1,Overall Stage,I
513,1,1,Second Failure Type,no known failure
513,1,1,Tumor Stage,T1
513,1,1,Research lab p16,p16 unknown
513,1,1,Treatment Modality,Sx
514,1,1,Age at Death,75.5
514,1,1,Tumor Site,oral cavity
514,1,1,First Failure Type,locoregional
514,1,1,Nodal Stage,N0
514,1,1,Tumor Stage,T4a
514,1,1,Second Failure Type,no known failure
514,1,1,Time to First Failure,0.3
514,1,1,Time to Death,0.4
514,1,1,Status,Dead w/ disease
514,1,1,Research lab p16,p16 unknown
514,1,1,Research lab HPV,HPV unknown
514,1,1,Metastasis,M0
514,1,1,Treatment Modality,Sx
514,1,1,Clinical lab p16,p16 unknown
514,1,1,Occurrence #,other primary
514,1,1,Date of Death,2000-08-04 00:00:00
514,1,1,Overall Stage,IVa
515,1,1,Tumor Stage,T2
515,1,1,Clinical lab p16,p16 unknown
515,1,1,Second Failure Type,no known failure
515,1,1,Nodal Stage,N0
515,1,1,Research lab p16,p16 unknown
515,1,1,Occurrence #,1st primary
515,1,1,Status,Alive unk disease
515,1,1,Metastasis,M0
515,1,1,First Failure Type,no known failure
515,1,1,Treatment Modality,Sx
515,1,1,Research lab HPV,HPV unknown
515,1,1,Tumor Site,oral cavity
515,1,1,Overall Stage,II
516,1,1,Tumor Stage,T4a
516,1,1,Status,Alive w/ disease
516,1,1,Occurrence #,1st primary
516,1,1,Research lab p16,p16 unknown
516,1,1,Nodal Stage,N2
516,1,1,Second Failure Type,no known failure
516,1,1,Overall Stage,IVa
516,1,1,Time to First Failure,0.8
516,1,1,First Failure Type,locoregional and distant
516,1,1,Clinical lab p16,p16 unknown
516,1,1,Research lab HPV,HPV unknown
516,1,1,Metastasis,M0
516,1,1,Tumor Site,oral cavity
516,1,1,Treatment Modality,Sx
517,1,1,First Failure Radiation Dosage,60
517,1,1,Treatment Modality,Sx & RT
517,1,1,Metastasis,M0
517,1,1,Research lab HPV,HPV unknown
517,1,1,Status,Alive w/o disease
517,1,1,Occurrence #,1st primary
517,1,1,Clinical lab p16,p16 unknown
517,1,1,Tumor Site,oral cavity
517,1,1,Radiation Dosage,63
517,1,1,First Failure Treatment Modality,Sx & CTX-RT
517,1,1,Research lab p16,p16 unknown
517,1,1,Tumor Stage,T4a
517,1,1,Nodal Stage,N0
517,1,1,First Failure Initial Chemotherapy Agent,unknown
517,1,1,First Failure Site,oral cavity
517,1,1,Time to First Failure,6.6
517,1,1,First Failure Type,locoregional
517,1,1,Second Failure Type,no known failure
517,1,1,Overall Stage,IVa
518,1,1,Status,Alive w/o disease
518,1,1,Clinical lab p16,p16 unknown
518,1,1,Treatment Modality,Sx
518,1,1,Research lab HPV,HPV unknown
518,1,1,Nodal Stage,N0
518,1,1,Tumor Stage,T4a
518,1,1,Second Failure Type,no known failure
518,1,1,First Failure Type,no known failure
518,1,1,Research lab p16,p16 unknown
518,1,1,Metastasis,M0
518,1,1,Overall Stage,IVa
518,1,1,Tumor Site,oral cavity
518,1,1,Occurrence #,1st primary
519,1,1,Overall Stage,II
519,1,1,Treatment Modality,RT
519,1,1,Metastasis,M0
519,1,1,Second Failure Type,no known failure
519,1,1,Nodal Stage,N0
519,1,1,Clinical lab p16,p16 unknown
519,1,1,Time to Death,0.7
519,1,1,Status,Dead unk disease
519,1,1,Date of Death,2001-10-22 00:00:00
519,1,1,Age at Death,75.0
519,1,1,Tumor Stage,T2
519,1,1,First Failure Type,no known failure
519,1,1,Occurrence #,1st primary
519,1,1,Radiation Dosage,32
519,1,1,Tumor Site,oral cavity
519,1,1,Research lab p16,p16 unknown
519,1,1,Research lab HPV,HPV unknown
520,1,1,Tumor Stage,T4a
520,1,1,Tumor Site,oral cavity
520,1,1,Research lab HPV,HPV unknown
520,1,1,First Failure Type,no known failure
520,1,1,Clinical lab p16,p16 unknown
520,1,1,Research lab p16,p16 unknown
520,1,1,Treatment Modality,Sx
520,1,1,Metastasis,M0
520,1,1,Overall Stage,IVa
520,1,1,Status,Dead unk disease
520,1,1,Nodal Stage,N0
520,1,1,Occurrence #,1st primary
520,1,1,Age at Death,65.4
520,1,1,Second Failure Type,no known failure
520,1,1,Time to Death,1.3
520,1,1,Date of Death,2003-11-26 00:00:00
521,1,1,Tumor Stage,T2
521,1,1,Treatment Modality,Sx
521,1,1,Overall Stage,II
521,1,1,Status,Alive w/o disease
521,1,1,Research lab p16,p16 unknown
521,1,1,Metastasis,M0
521,1,1,Second Failure Type,no known failure
521,1,1,Occurrence #,1st primary
521,1,1,Clinical lab p16,p16 unknown
521,1,1,Nodal Stage,N0
521,1,1,First Failure Type,no known failure
521,1,1,Tumor Site,oral cavity
521,1,1,Research lab HPV,HPV unknown
522,1,1,Treatment Modality,Sx
522,1,1,Tumor Site,oral cavity
522,1,1,Clinical lab p16,p16 unknown
522,1,1,Overall Stage,I
522,1,1,First Failure Type,no known failure
522,1,1,Date of Death,2003-01-03 00:00:00
522,1,1,Time to Death,1.1
522,1,1,Metastasis,M0
522,1,1,Age at Death,66.3
522,1,1,Tumor Stage,T1
522,1,1,Nodal Stage,N0
522,1,1,Research lab HPV,HPV unknown
522,1,1,Second Failure Type,no known failure
522,1,1,Research lab p16,p16 unknown
522,1,1,Status,Dead unk disease
522,1,1,Occurrence #,1st primary
524,1,1,Occurrence #,1st primary
524,1,1,Age at Death,71.5
524,1,1,Status,Dead w/o disease
524,1,1,First Failure Type,no known failure
524,1,1,Second Failure Type,no known failure
524,1,1,Date of Death,2014-06-24 00:00:00
524,1,1,Tumor Site,oral cavity
524,1,1,Research lab HPV,HPV unknown
524,1,1,Time to Death,11.2
524,1,1,Metastasis,M0
524,1,1,Clinical lab p16,p16 unknown
524,1,1,Research lab p16,p16 unknown
524,1,1,First Failure Treatment Modality,Sx
524,1,1,Treatment Modality,Sx
524,1,1,Overall Stage,I
524,1,1,Nodal Stage,N0
524,1,1,Tumor Stage,T1
524,1,1,First Failure Site,oral cavity
525,1,1,Tumor Stage,T2
525,1,1,Clinical lab p16,p16 unknown
525,1,1,Second Failure Type,no known failure
525,1,1,Overall Stage,II
525,1,1,Occurrence #,1st primary
525,1,1,First Failure Type,no known failure
525,1,1,Research lab HPV,HPV unknown
525,1,1,Tumor Site,oral cavity
525,1,1,Nodal Stage,N0
525,1,1,Status,Alive unk disease
525,1,1,Metastasis,M0
525,1,1,Research lab p16,p16 unknown
525,1,1,Treatment Modality,Sx
526,1,1,Second Failure Type,no known failure
526,1,1,Occurrence #,recurrence
526,1,1,Tumor Stage,T4a
526,1,1,Overall Stage,IVa
526,1,1,Time to First Failure,0.0
526,1,1,Research lab p16,p16 unknown
526,1,1,Metastasis,M0
526,1,1,Treatment Modality,CTX
526,1,1,Nodal Stage,N2
526,1,1,Clinical lab p16,p16 unknown
526,1,1,Status,Dead w/ disease
526,1,1,First Failure Type,locoregional
526,1,1,Initial Chemotherapy Agent,carbo/PTX
526,1,1,Age at Death,81.2
526,1,1,Tumor Site,oral cavity
526,1,1,Date of Death,2008-02-06 00:00:00
526,1,1,Research lab HPV,HPV unknown
526,1,1,Time to Death,0.3
527,1,1,Tumor Site,oral cavity
527,1,1,Time to Death,1.7
527,1,1,First Failure Type,locoregional
527,1,1,Metastasis,M0
527,1,1,Nodal Stage,N0
527,1,1,Research lab HPV,HPV unknown
527,1,1,Treatment Modality,Sx
527,1,1,Clinical lab p16,p16 unknown
527,1,1,Research lab p16,p16 unknown
527,1,1,Tumor Stage,T4a
527,1,1,Time to First Failure,0.9
527,1,1,Status,Dead unk disease
527,1,1,Age at Death,81.8
527,1,1,Date of Death,2008-08-16 00:00:00
527,1,1,Overall Stage,IVa
527,1,1,Second Failure Type,no known failure
527,1,1,Occurrence #,1st primary
528,1,1,Tumor Stage,T1
528,1,1,Treatment Modality,Sx
528,1,1,Occurrence #,1st primary
528,1,1,Research lab HPV,HPV unknown
528,1,1,Metastasis,M0
528,1,1,Nodal Stage,N0
528,1,1,First Failure Type,no known failure
528,1,1,Clinical lab p16,p16 unknown
528,1,1,Tumor Site,oral cavity
528,1,1,Second Failure Type,no known failure
528,1,1,Research lab p16,p16 unknown
528,1,1,Status,Alive unk disease
528,1,1,Overall Stage,I
529,1,1,Time to Death,0.6
529,1,1,Second Failure Type,no known failure
529,1,1,Age at Death,74.3
529,1,1,Research lab HPV,HPV unknown
529,1,1,Tumor Site,oral cavity
529,1,1,Status,Dead unk disease
529,1,1,Date of Death,2003-09-26 00:00:00
529,1,1,First Failure Type,no known failure
529,1,1,Research lab p16,p16 unknown
529,1,1,Metastasis,M0
529,1,1,Nodal Stage,N2
529,1,1,Overall Stage,IVa
529,1,1,Tumor Stage,T4a
529,1,1,Clinical lab p16,p16 unknown
529,1,1,Occurrence #,1st primary
529,1,1,Treatment Modality,Sx
530,1,1,Tumor Site,oral cavity
530,1,1,Occurrence #,1st primary
530,1,1,Status,Alive w/o disease
530,1,1,Research lab HPV,HPV unknown
530,1,1,First Failure Type,no known failure
530,1,1,Treatment Modality,Sx
530,1,1,Metastasis,M0
530,1,1,Nodal Stage,N0
530,1,1,Second Failure Type,no known failure
530,1,1,Clinical lab p16,p16 unknown
530,1,1,Overall Stage,I
530,1,1,Tumor Stage,T1
530,1,1,Research lab p16,p16 unknown
531,1,1,Metastasis,M0
531,1,1,Status,Dead unk disease
531,1,1,Occurrence #,1st primary
531,1,1,Research lab HPV,HPV unknown
531,1,1,First Failure Type,no known failure
531,1,1,Time to Death,2.7
531,1,1,Treatment Modality,Sx
531,1,1,Research lab p16,p16 unknown
531,1,1,Date of Death,2004-08-19 00:00:00
531,1,1,Overall Stage,IVa
531,1,1,Second Failure Type,no known failure
531,1,1,Nodal Stage,N2
531,1,1,Age at Death,76.2
531,1,1,Clinical lab p16,p16 unknown
531,1,1,Tumor Stage,T1
531,1,1,Tumor Site,oral cavity
532,1,1,Tumor Site,oral cavity
532,1,1,Metastasis,M0
532,1,1,First Failure Treatment Modality,CTX-RT
532,1,1,Initial Chemotherapy Agent,carbo/PTX/amifostine
532,1,1,Time to First Failure,0.5
532,1,1,Date of Death,2003-08-09 00:00:00
532,1,1,First Failure Site,oral cavity
532,1,1,Age at Death,66.3
532,1,1,Radiation Dosage,70.2
532,1,1,Tumor Stage,T4a
532,1,1,Clinical lab p16,p16 unknown
532,1,1,Occurrence #,1st primary
532,1,1,Overall Stage,IVa
532,1,1,Nodal Stage,N3
532,1,1,Status,Dead w/ disease
532,1,1,Treatment Modality,CTX-RT
532,1,1,Research lab p16,p16 unknown
532,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
532,1,1,First Failure Radiation Dosage,unknown
532,1,1,Second Failure Type,no known failure
532,1,1,Research lab HPV,HPV unknown
532,1,1,First Failure Type,distant
532,1,1,Time to Death,0.9
533,1,1,Second Failure Type,no known failure
533,1,1,Tumor Stage,T4a
533,1,1,Overall Stage,IVa
533,1,1,Occurrence #,1st primary
533,1,1,Treatment Modality,Sx
533,1,1,Tumor Site,oral cavity
533,1,1,Nodal Stage,N0
533,1,1,Research lab p16,p16 unknown
533,1,1,First Failure Type,no known failure
533,1,1,Research lab HPV,HPV unknown
533,1,1,Clinical lab p16,p16 unknown
533,1,1,Metastasis,M0
533,1,1,Status,Alive unk disease
534,1,1,Tumor Stage,T2
534,1,1,Research lab HPV,HPV unknown
534,1,1,Clinical lab p16,p16 unknown
534,1,1,Age at Death,53.1
534,1,1,Occurrence #,1st primary
534,1,1,Research lab p16,p16 unknown
534,1,1,Treatment Modality,Sx
534,1,1,Metastasis,M0
534,1,1,First Failure Site,oral cavity
534,1,1,Status,Dead w/ disease
534,1,1,Nodal Stage,N1
534,1,1,Second Failure Type,no known failure
534,1,1,Overall Stage,III
534,1,1,Date of Death,2014-03-28 00:00:00
534,1,1,Tumor Site,oral cavity
534,1,1,Time to Death,6.1
534,1,1,First Failure Treatment Modality,Sx
534,1,1,First Failure Type,no known failure
535,1,1,Tumor Stage,T1
535,1,1,First Failure Type,no known failure
535,1,1,Status,Alive unk disease
535,1,1,Nodal Stage,N0
535,1,1,Research lab HPV,HPV unknown
535,1,1,Clinical lab p16,p16 unknown
535,1,1,Treatment Modality,Sx
535,1,1,Metastasis,M0
535,1,1,Second Failure Type,no known failure
535,1,1,Research lab p16,p16 unknown
535,1,1,Overall Stage,I
535,1,1,Occurrence #,1st primary
535,1,1,Tumor Site,oral cavity
536,1,1,Date of Death,2010-06-29 00:00:00
536,1,1,Overall Stage,II
536,1,1,Tumor Site,oral cavity
536,1,1,Research lab HPV,HPV unknown
536,1,1,Occurrence #,1st primary
536,1,1,Status,Dead w/ disease
536,1,1,Clinical lab p16,p16 unknown
536,1,1,Time to First Failure,0.5
536,1,1,Research lab p16,p16 unknown
536,1,1,Age at Death,87.7
536,1,1,Second Failure Type,no known failure
536,1,1,Tumor Stage,T2
536,1,1,Metastasis,M0
536,1,1,Treatment Modality,Sx
536,1,1,Nodal Stage,N0
536,1,1,First Failure Type,locoregional
536,1,1,Time to Death,0.7
537,1,1,Tumor Stage,T1
537,1,1,Research lab HPV,HPV unknown
537,1,1,Treatment Modality,Sx
537,1,1,Research lab p16,p16 unknown
537,1,1,Second Failure Type,no known failure
537,1,1,Metastasis,M0
537,1,1,Occurrence #,1st primary
537,1,1,Overall Stage,I
537,1,1,Clinical lab p16,p16 unknown
537,1,1,First Failure Type,no known failure
537,1,1,Status,Alive w/o disease
537,1,1,Nodal Stage,N0
537,1,1,Tumor Site,oral cavity
538,1,1,Tumor Site,oral cavity
538,1,1,First Failure Site,oropharynx
538,1,1,Treatment Modality,Sx & CTX
538,1,1,Status,Dead unk disease
538,1,1,Clinical lab p16,p16 unknown
538,1,1,Research lab p16,p16 unknown
538,1,1,Second Failure Type,no known failure
538,1,1,First Failure Initial Chemotherapy Agent,cis/doce
538,1,1,Metastasis,M0
538,1,1,First Failure Type,no known failure
538,1,1,Overall Stage,IVa
538,1,1,Occurrence #,recurrence
538,1,1,Age at Death,55.5
538,1,1,Date of Death,2002-05-06 00:00:00
538,1,1,Research lab HPV,HPV unknown
538,1,1,Tumor Stage,T3
538,1,1,Initial Chemotherapy Agent,Cis/doce
538,1,1,First Failure Second Line Chemotherapy Agent,gemcitabine/doce/cap
538,1,1,Nodal Stage,N2
538,1,1,First Failure Treatment Modality,CTX
538,1,1,Time to Death,0.8
539,1,1,Metastasis,M0
539,1,1,Overall Stage,I
539,1,1,Occurrence #,1st primary
539,1,1,Treatment Modality,Sx
539,1,1,Research lab HPV,HPV unknown
539,1,1,First Failure Type,no known failure
539,1,1,Clinical lab p16,p16 unknown
539,1,1,Tumor Site,oral cavity
539,1,1,Status,Alive w/o disease
539,1,1,Nodal Stage,N0
539,1,1,Second Failure Type,no known failure
539,1,1,Tumor Stage,T1
539,1,1,Research lab p16,p16 unknown
540,1,1,Age at Death,77.0
540,1,1,Status,Dead unk disease
540,1,1,Date of Death,2003-09-29 00:00:00
540,1,1,Treatment Modality,Sx
540,1,1,Overall Stage,II
540,1,1,Metastasis,M0
540,1,1,Second Failure Type,no known failure
540,1,1,First Failure Type,no known failure
540,1,1,Time to Death,2.2
540,1,1,Tumor Site,oral cavity
540,1,1,Clinical lab p16,p16 unknown
540,1,1,Tumor Stage,T2
540,1,1,Occurrence #,1st primary
540,1,1,Research lab HPV,HPV unknown
540,1,1,Nodal Stage,N0
540,1,1,Research lab p16,p16 unknown
541,1,1,Status,Dead w/ disease
541,1,1,Clinical lab p16,p16 unknown
541,1,1,Research lab HPV,HPV unknown
541,1,1,Tumor Stage,Unknown
541,1,1,First Failure Type,no known failure
541,1,1,Nodal Stage,Unknown
541,1,1,Metastasis,Unknown
541,1,1,Time to Death,0.1
541,1,1,Date of Death,2003-02-27 00:00:00
541,1,1,Second Failure Type,no known failure
541,1,1,Tumor Site,oral cavity
541,1,1,Treatment Modality,Unknown
541,1,1,Age at Death,95.4
541,1,1,Occurrence #,1st primary
541,1,1,Overall Stage,Unknown
541,1,1,Research lab p16,p16 unknown
542,1,1,Status,Alive w/o disease
542,1,1,Research lab HPV,HPV unknown
542,1,1,Nodal Stage,N0
542,1,1,Metastasis,M0
542,1,1,Second Failure Type,no known failure
542,1,1,Tumor Stage,T2
542,1,1,Occurrence #,1st primary
542,1,1,Overall Stage,II
542,1,1,Tumor Site,oral cavity
542,1,1,Clinical lab p16,p16 unknown
542,1,1,First Failure Type,no known failure
542,1,1,Treatment Modality,Sx
542,1,1,Research lab p16,p16 unknown
543,1,1,Treatment Modality,Sx
543,1,1,Second Failure Type,no known failure
543,1,1,Occurrence #,1st primary
543,1,1,Metastasis,M0
543,1,1,Status,Alive unk disease
543,1,1,First Failure Type,no known failure
543,1,1,Clinical lab p16,p16 unknown
543,1,1,Overall Stage,I
543,1,1,Tumor Stage,T1
543,1,1,Nodal Stage,N0
543,1,1,Tumor Site,oral cavity
543,1,1,Research lab HPV,HPV unknown
543,1,1,Research lab p16,p16 unknown
544,1,1,Status,Alive unk disease
544,1,1,Research lab p16,p16 unknown
544,1,1,Tumor Site,oral cavity
544,1,1,Research lab HPV,HPV unknown
544,1,1,Treatment Modality,Sx
544,1,1,Overall Stage,I
544,1,1,Occurrence #,1st primary
544,1,1,Metastasis,M0
544,1,1,Tumor Stage,T1
544,1,1,First Failure Type,no known failure
544,1,1,Clinical lab p16,p16 unknown
544,1,1,Nodal Stage,N0
544,1,1,Second Failure Type,no known failure
545,1,1,Research lab HPV,HPV unknown
545,1,1,Nodal Stage,N0
545,1,1,Tumor Site,oral cavity
545,1,1,Metastasis,M0
545,1,1,Research lab p16,p16 unknown
545,1,1,Clinical lab p16,p16 unknown
545,1,1,First Failure Type,locoregional
545,1,1,Status,Unknown
545,1,1,Treatment Modality,Sx
545,1,1,First Failure Site,oral cavity
545,1,1,Overall Stage,I
545,1,1,Tumor Stage,T1
545,1,1,First Failure Treatment Modality,Sx
545,1,1,Second Failure Type,no known failure
545,1,1,Time to First Failure,2.9
545,1,1,Occurrence #,1st primary
546,1,1,Date of Death,2004-09-11 00:00:00
546,1,1,Age at Death,55.9
546,1,1,Research lab HPV,HPV unknown
546,1,1,Occurrence #,1st primary
546,1,1,Second Failure Type,no known failure
546,1,1,Tumor Site,oral cavity
546,1,1,Tumor Stage,T4b
546,1,1,Research lab p16,p16 unknown
546,1,1,First Failure Type,no known failure
546,1,1,Status,Dead unk disease
546,1,1,Overall Stage,IVb
546,1,1,Nodal Stage,N2
546,1,1,Treatment Modality,Sx
546,1,1,Time to Death,0.2
546,1,1,Metastasis,M0
546,1,1,Clinical lab p16,p16 unknown
547,1,1,First Failure Type,no known failure
547,1,1,Nodal Stage,N0
547,1,1,Research lab p16,p16 unknown
547,1,1,First Failure Site,oral cavity
547,1,1,First Failure Treatment Modality,Sx
547,1,1,Tumor Site,oral cavity
547,1,1,Overall Stage,II
547,1,1,Date of Death,2008-11-29 00:00:00
547,1,1,Time to Death,6.3
547,1,1,Treatment Modality,RT
547,1,1,Clinical lab p16,p16 unknown
547,1,1,Status,Dead unk disease
547,1,1,Radiation Dosage,unknown
547,1,1,Second Failure Type,no known failure
547,1,1,Research lab HPV,HPV unknown
547,1,1,Metastasis,M0
547,1,1,Occurrence #,recurrence
547,1,1,Tumor Stage,T2
547,1,1,Age at Death,89.6
549,1,1,Age at Death,84.0
549,1,1,Metastasis,M0
549,1,1,Nodal Stage,N0
549,1,1,Overall Stage,I
549,1,1,First Failure Type,no known failure
549,1,1,Occurrence #,1st primary
549,1,1,Clinical lab p16,p16 unknown
549,1,1,Tumor Stage,T1
549,1,1,Research lab p16,p16 unknown
549,1,1,Time to Death,1.7
549,1,1,Treatment Modality,Sx
549,1,1,Status,Dead unk disease
549,1,1,Research lab HPV,HPV unknown
549,1,1,Date of Death,2003-12-07 00:00:00
549,1,1,Second Failure Type,no known failure
549,1,1,First Failure Treatment Modality,Sx & RT
549,1,1,Tumor Site,oral cavity
549,1,1,First Failure Site,oral cavity
549,1,1,First Failure Radiation Dosage,unk
550,1,1,Clinical lab p16,p16 unknown
550,1,1,Metastasis,M0
550,1,1,Treatment Modality,Sx
550,1,1,Overall Stage,I
550,1,1,Research lab HPV,HPV unknown
550,1,1,Status,Alive unk disease
550,1,1,Tumor Stage,T1
550,1,1,Research lab p16,p16 unknown
550,1,1,Nodal Stage,N0
550,1,1,Tumor Site,oral cavity
550,1,1,Second Failure Type,no known failure
550,1,1,Occurrence #,1st primary
550,1,1,First Failure Type,no known failure
551,1,1,Research lab HPV,HPV unknown
551,1,1,Treatment Modality,Sx
551,1,1,Status,Alive unk disease
551,1,1,Tumor Site,oral cavity
551,1,1,Nodal Stage,N1
551,1,1,Metastasis,M0
551,1,1,First Failure Type,no known failure
551,1,1,Occurrence #,1st primary
551,1,1,Tumor Stage,T1
551,1,1,Research lab p16,p16 unknown
551,1,1,Second Failure Type,no known failure
551,1,1,Clinical lab p16,p16 unknown
551,1,1,Overall Stage,III
552,1,1,Age at Death,91.5
552,1,1,Nodal Stage,N0
552,1,1,Research lab p16,p16 unknown
552,1,1,First Failure Type,locoregional
552,1,1,Occurrence #,1st primary
552,1,1,Date of Death,2010-09-16 00:00:00
552,1,1,Second Failure Type,no known failure
552,1,1,Overall Stage,II
552,1,1,Time to Death,7.5
552,1,1,Tumor Stage,T2
552,1,1,Time to First Failure,6.9
552,1,1,Treatment Modality,Sx
552,1,1,Research lab HPV,HPV unknown
552,1,1,Clinical lab p16,p16 unknown
552,1,1,Metastasis,M0
552,1,1,Tumor Site,oral cavity
552,1,1,Status,Dead unk disease
553,1,1,Overall Stage,I
553,1,1,Treatment Modality,Sx
553,1,1,First Failure Type,locoregional
553,1,1,Occurrence #,1st primary
553,1,1,Tumor Stage,T1
553,1,1,Tumor Site,oral cavity
553,1,1,Research lab HPV,HPV unknown
553,1,1,Time to Death,4.3
553,1,1,Research lab p16,p16 unknown
553,1,1,Clinical lab p16,p16 unknown
553,1,1,Age at Death,80.4
553,1,1,Time to First Failure,1.3
553,1,1,Second Failure Type,no known failure
553,1,1,Status,Dead unk disease
553,1,1,Nodal Stage,N0
553,1,1,Date of Death,2011-02-26 00:00:00
553,1,1,Metastasis,M0
554,1,1,Tumor Site,oral cavity
554,1,1,Occurrence #,1st primary
554,1,1,Metastasis,M0
554,1,1,Clinical lab p16,p16 unknown
554,1,1,Research lab p16,p16 unknown
554,1,1,Treatment Modality,Sx
554,1,1,Research lab HPV,HPV unknown
554,1,1,Second Failure Type,no known failure
554,1,1,Status,Alive unk disease
554,1,1,Tumor Stage,T4a
554,1,1,Nodal Stage,N0
554,1,1,First Failure Type,no known failure
554,1,1,Overall Stage,IVa
555,1,1,Research lab p16,p16 unknown
555,1,1,Overall Stage,I
555,1,1,Status,Alive unk disease
555,1,1,Occurrence #,1st primary
555,1,1,Metastasis,M0
555,1,1,Time to First Failure,7.1
555,1,1,Clinical lab p16,p16 unknown
555,1,1,Second Failure Type,no known failure
555,1,1,Research lab HPV,HPV unknown
555,1,1,Tumor Site,oral cavity
555,1,1,Nodal Stage,N0
555,1,1,Tumor Stage,T1
555,1,1,First Failure Treatment Modality,Sx
555,1,1,First Failure Type,locoregional
555,1,1,Treatment Modality,Sx
555,1,1,First Failure Site,oral cavity
556,1,1,Overall Stage,IVb
556,1,1,Time to Death,0.7
556,1,1,Date of Death,2004-08-24 00:00:00
556,1,1,Research lab HPV,HPV unknown
556,1,1,Nodal Stage,N3
556,1,1,First Failure Type,no known failure
556,1,1,Age at Death,62.9
556,1,1,Treatment Modality,Unknown
556,1,1,Clinical lab p16,p16 unknown
556,1,1,Status,Dead unk disease
556,1,1,Tumor Site,oral cavity
556,1,1,Metastasis,M0
556,1,1,Second Failure Type,no known failure
556,1,1,Occurrence #,1st primary
556,1,1,Tumor Stage,T4a
556,1,1,Research lab p16,p16 unknown
557,1,1,Metastasis,M0
557,1,1,Research lab HPV,HPV unknown
557,1,1,First Failure Type,no known failure
557,1,1,Treatment Modality,Sx
557,1,1,Occurrence #,1st primary
557,1,1,Overall Stage,I
557,1,1,Research lab p16,p16 unknown
557,1,1,Tumor Site,oral cavity
557,1,1,Tumor Stage,T1
557,1,1,Status,Alive unk disease
557,1,1,Second Failure Type,no known failure
557,1,1,Nodal Stage,N0
557,1,1,Clinical lab p16,p16 unknown
558,1,1,Status,Alive unk disease
558,1,1,Second Failure Type,no known failure
558,1,1,Tumor Site,oral cavity
558,1,1,Research lab HPV,HPV unknown
558,1,1,Tumor Stage,T1
558,1,1,Metastasis,M0
558,1,1,Research lab p16,p16 unknown
558,1,1,First Failure Type,no known failure
558,1,1,Treatment Modality,Sx
558,1,1,Overall Stage,I
558,1,1,Clinical lab p16,p16 unknown
558,1,1,Nodal Stage,N0
558,1,1,Occurrence #,1st primary
559,1,1,Clinical lab p16,p16 unknown
559,1,1,Research lab HPV,HPV unknown
559,1,1,Second Failure Type,no known failure
559,1,1,Tumor Stage,T1
559,1,1,Occurrence #,1st primary
559,1,1,Tumor Site,oral cavity
559,1,1,Status,Alive w/o disease
559,1,1,Overall Stage,I
559,1,1,First Failure Type,no known failure
559,1,1,Treatment Modality,Sx
559,1,1,Nodal Stage,N0
559,1,1,Metastasis,M0
559,1,1,Research lab p16,p16 unknown
560,1,1,Metastasis,M0
560,1,1,Tumor Site,oral cavity
560,1,1,Status,Alive w/o disease
560,1,1,Research lab p16,p16 unknown
560,1,1,Occurrence #,1st primary
560,1,1,Treatment Modality,Sx
560,1,1,Clinical lab p16,p16 unknown
560,1,1,Tumor Stage,T1
560,1,1,Second Failure Type,no known failure
560,1,1,Nodal Stage,N0
560,1,1,First Failure Type,no known failure
560,1,1,Research lab HPV,HPV unknown
560,1,1,Overall Stage,I
561,1,1,Age at Death,77.1
561,1,1,Metastasis,M0
561,1,1,First Failure Type,no known failure
561,1,1,Nodal Stage,N0
561,1,1,Occurrence #,1st primary
561,1,1,Status,Dead unk disease
561,1,1,Research lab p16,p16 unknown
561,1,1,Overall Stage,I
561,1,1,Tumor Stage,T1
561,1,1,Clinical lab p16,p16 unknown
561,1,1,Research lab HPV,HPV unknown
561,1,1,Second Failure Type,no known failure
561,1,1,Treatment Modality,Sx
561,1,1,Time to Death,1.6
561,1,1,Tumor Site,oral cavity
561,1,1,Date of Death,2003-06-16 00:00:00
562,1,1,Time to Death,0.4
562,1,1,First Failure Type,no known failure
562,1,1,Clinical lab p16,p16 unknown
562,1,1,Overall Stage,IVa
562,1,1,Date of Death,2006-04-04 00:00:00
562,1,1,Treatment Modality,Sx
562,1,1,Metastasis,M0
562,1,1,Age at Death,81.2
562,1,1,Second Failure Type,no known failure
562,1,1,Tumor Site,oral cavity
562,1,1,Research lab HPV,HPV unknown
562,1,1,Tumor Stage,T4a
562,1,1,Status,Dead unk disease
562,1,1,Nodal Stage,N2
562,1,1,Occurrence #,1st primary
562,1,1,Research lab p16,p16 unknown
563,1,1,Clinical lab p16,p16 unknown
563,1,1,Research lab p16,p16 unknown
563,1,1,Second Failure Type,no known failure
563,1,1,Nodal Stage,N2
563,1,1,Tumor Site,oral cavity
563,1,1,Status,Dead w/ disease
563,1,1,Date of Death,2010-12-02 00:00:00
563,1,1,Age at Death,62.4
563,1,1,Time to First Failure,3.6
563,1,1,Tumor Stage,T1
563,1,1,Occurrence #,1st primary
563,1,1,First Failure Type,locoregional
563,1,1,Radiation Dosage,unknown
563,1,1,First Failure Site,oral cavity
563,1,1,Treatment Modality,Sx & RT
563,1,1,First Failure Treatment Modality,Sx
563,1,1,Time to Death,4.0
563,1,1,Metastasis,M0
563,1,1,Research lab HPV,HPV unknown
563,1,1,Overall Stage,IVa
564,1,1,Status,Alive unk disease
564,1,1,Research lab HPV,HPV unknown
564,1,1,Treatment Modality,Sx
564,1,1,Occurrence #,1st primary
564,1,1,Second Failure Type,no known failure
564,1,1,Nodal Stage,N1
564,1,1,Tumor Stage,T1
564,1,1,Metastasis,M0
564,1,1,Research lab p16,p16 unknown
564,1,1,First Failure Type,no known failure
564,1,1,Tumor Site,oral cavity
564,1,1,Clinical lab p16,p16 unknown
564,1,1,Overall Stage,III
565,1,1,Overall Stage,IVa
565,1,1,Research lab HPV,HPV unknown
565,1,1,Metastasis,M0
565,1,1,Clinical lab p16,p16 unknown
565,1,1,Status,Dead unk disease
565,1,1,Tumor Site,oral cavity
565,1,1,Research lab p16,p16 unknown
565,1,1,Second Failure Type,no known failure
565,1,1,Nodal Stage,N2
565,1,1,Occurrence #,1st primary
565,1,1,Date of Death,2009-09-12 00:00:00
565,1,1,Tumor Stage,T4a
565,1,1,First Failure Type,no known failure
565,1,1,Treatment Modality,Sx
565,1,1,Time to Death,0.6
565,1,1,Age at Death,70.6
566,1,1,Metastasis,M0
566,1,1,First Failure Treatment Modality,CTX-RT
566,1,1,Research lab p16,p16 unknown
566,1,1,Time to Death,1.6
566,1,1,Second Failure Type,no known failure
566,1,1,Tumor Stage,T4b
566,1,1,Overall Stage,IVb
566,1,1,Time to First Failure,0.6
566,1,1,First Failure Radiation Dosage,59.4
566,1,1,Tumor Site,oral cavity
566,1,1,Nodal Stage,N1
566,1,1,Clinical lab p16,p16 unknown
566,1,1,First Failure Type,locoregional
566,1,1,Date of Death,2005-02-06 00:00:00
566,1,1,Occurrence #,1st primary
566,1,1,Age at Death,63.9
566,1,1,First Failure Initial Chemotherapy Agent,doce
566,1,1,Treatment Modality,Sx
566,1,1,Research lab HPV,HPV unknown
566,1,1,Status,Dead w/ disease
566,1,1,First Failure Site,oral cavity
567,1,1,First Failure Type,no known failure
567,1,1,Clinical lab p16,p16 unknown
567,1,1,Nodal Stage,N0
567,1,1,Second Failure Type,no known failure
567,1,1,Overall Stage,I
567,1,1,Occurrence #,1st primary
567,1,1,Radiation Dosage,unknown
567,1,1,Research lab HPV,HPV unknown
567,1,1,Tumor Stage,T1
567,1,1,Treatment Modality,Sx & RT
567,1,1,Status,Alive w/o disease
567,1,1,Metastasis,M0
567,1,1,Research lab p16,p16 unknown
567,1,1,Tumor Site,oral cavity
568,1,1,Status,Alive w/o disease
568,1,1,Radiation Dosage,unknown
568,1,1,Research lab HPV,HPV unknown
568,1,1,Metastasis,M0
568,1,1,Treatment Modality,Sx & CTX-RT
568,1,1,Initial Chemotherapy Agent,unknown
568,1,1,Tumor Stage,T1
568,1,1,Nodal Stage,N2
568,1,1,Second Failure Type,no known failure
568,1,1,Clinical lab p16,p16 unknown
568,1,1,Tumor Site,oral cavity
568,1,1,Overall Stage,IVa
568,1,1,First Failure Type,no known failure
568,1,1,Occurrence #,1st primary
568,1,1,Research lab p16,p16 unknown
569,1,1,Tumor Site,oral cavity
569,1,1,Clinical lab p16,p16 unknown
569,1,1,First Failure Type,no known failure
569,1,1,Nodal Stage,N0
569,1,1,Status,Alive unk disease
569,1,1,Research lab HPV,HPV unknown
569,1,1,Metastasis,M0
569,1,1,Occurrence #,recurrence
569,1,1,Treatment Modality,Sx
569,1,1,Second Failure Type,no known failure
569,1,1,Research lab p16,p16 unknown
569,1,1,Overall Stage,I
569,1,1,Tumor Stage,T1
570,1,1,Tumor Site,oral cavity
570,1,1,First Failure Treatment Modality,Sx
570,1,1,Research lab p16,p16 unknown
570,1,1,Time to Death,1.5
570,1,1,Research lab HPV,HPV unknown
570,1,1,Occurrence #,1st primary
570,1,1,Clinical lab p16,p16 unknown
570,1,1,First Failure Type,locoregional
570,1,1,Treatment Modality,Sx
570,1,1,First Failure Site,oral cavity
570,1,1,Metastasis,M0
570,1,1,Age at Death,92.5
570,1,1,Overall Stage,I
570,1,1,Time to First Failure,0.9
570,1,1,Tumor Stage,T1
570,1,1,Second Failure Type,no known failure
570,1,1,Status,Dead unk disease
570,1,1,Nodal Stage,N0
570,1,1,Date of Death,2006-09-02 00:00:00
571,1,1,Clinical lab p16,p16 unknown
571,1,1,Tumor Stage,T1
571,1,1,Nodal Stage,N0
571,1,1,Occurrence #,recurrence
571,1,1,Research lab HPV,HPV unknown
571,1,1,First Failure Type,no known failure
571,1,1,Status,Alive unk disease
571,1,1,Treatment Modality,Sx
571,1,1,Metastasis,M0
571,1,1,Research lab p16,p16 unknown
571,1,1,Second Failure Type,no known failure
571,1,1,Overall Stage,I
571,1,1,Tumor Site,oral cavity
572,1,1,Status,Alive w/o disease
572,1,1,First Failure Treatment Modality,CTX-RT
572,1,1,First Failure Site,oral cavity
572,1,1,First Failure Initial Chemotherapy Agent,carbo
572,1,1,Metastasis,M0
572,1,1,Overall Stage,IVa
572,1,1,Nodal Stage,N0
572,1,1,First Failure Radiation Dosage,60
572,1,1,Treatment Modality,Sx & RT
572,1,1,Research lab p16,p16 unknown
572,1,1,Second Failure Type,no known failure
572,1,1,Tumor Site,oral cavity
572,1,1,Occurrence #,1st primary
572,1,1,Radiation Dosage,60
572,1,1,Clinical lab p16,p16 unknown
572,1,1,Tumor Stage,T4a
572,1,1,Time to First Failure,0.4
572,1,1,Research lab HPV,HPV unknown
572,1,1,First Failure Type,locoregional
573,1,1,Status,Alive w/o disease
573,1,1,Second Failure Type,no known failure
573,1,1,Research lab HPV,HPV unknown
573,1,1,Research lab p16,p16 unknown
573,1,1,Metastasis,M0
573,1,1,Tumor Stage,T1
573,1,1,Occurrence #,1st primary
573,1,1,Treatment Modality,Sx & RT
573,1,1,Tumor Site,oral cavity
573,1,1,Clinical lab p16,p16 unknown
573,1,1,First Failure Type,no known failure
573,1,1,Nodal Stage,N2
573,1,1,Overall Stage,IVa
573,1,1,Radiation Dosage,unknown
574,1,1,Status,Alive w/o disease
574,1,1,Occurrence #,1st primary
574,1,1,First Failure Type,no known failure
574,1,1,Clinical lab p16,p16 unknown
574,1,1,Research lab HPV,HPV unknown
574,1,1,Treatment Modality,Sx
574,1,1,Nodal Stage,N0
574,1,1,Research lab p16,p16 unknown
574,1,1,Metastasis,M0
574,1,1,Tumor Site,oral cavity
574,1,1,Tumor Stage,T2
574,1,1,Overall Stage,II
574,1,1,Second Failure Type,no known failure
575,1,1,Research lab HPV,HPV unknown
575,1,1,First Failure Type,no known failure
575,1,1,Research lab p16,p16 unknown
575,1,1,Overall Stage,I
575,1,1,Clinical lab p16,p16 unknown
575,1,1,Occurrence #,1st primary
575,1,1,Second Failure Type,no known failure
575,1,1,Metastasis,M0
575,1,1,Nodal Stage,N0
575,1,1,Tumor Stage,T1
575,1,1,Tumor Site,oral cavity
575,1,1,Date of Death,2006-08-27 00:00:00
575,1,1,Status,Dead unk disease
575,1,1,Age at Death,38.2
575,1,1,Treatment Modality,Sx
575,1,1,Time to Death,2.5
576,1,1,Nodal Stage,N0
576,1,1,Age at Death,68.6
576,1,1,Overall Stage,IVa
576,1,1,Tumor Site,oral cavity
576,1,1,Second Failure Type,no known failure
576,1,1,Radiation Dosage,59.4
576,1,1,Tumor Stage,T4a
576,1,1,Research lab p16,p16 unknown
576,1,1,Metastasis,M0
576,1,1,Date of Death,2006-04-22 00:00:00
576,1,1,Research lab HPV,HPV unknown
576,1,1,Time to Death,5.9
576,1,1,First Failure Type,distant
576,1,1,Occurrence #,1st primary
576,1,1,Clinical lab p16,p16 unknown
576,1,1,Time to First Failure,5.5
576,1,1,Treatment Modality,Sx & RT
576,1,1,Status,Dead unk disease
577,1,1,Tumor Stage,T1
577,1,1,Tumor Site,oral cavity
577,1,1,Nodal Stage,N1
577,1,1,Overall Stage,III
577,1,1,Research lab HPV,HPV unknown
577,1,1,Treatment Modality,Sx & RT
577,1,1,Status,Alive w/o disease
577,1,1,First Failure Type,no known failure
577,1,1,Second Failure Type,no known failure
577,1,1,Radiation Dosage,59.4
577,1,1,Metastasis,M0
577,1,1,Clinical lab p16,p16 unknown
577,1,1,Occurrence #,1st primary
577,1,1,Research lab p16,p16 unknown
578,1,1,Clinical lab p16,p16 unknown
578,1,1,Treatment Modality,Sx
578,1,1,Overall Stage,III
578,1,1,First Failure Type,no known failure
578,1,1,Nodal Stage,N1
578,1,1,Date of Death,2009-01-30 00:00:00
578,1,1,Status,Dead unk disease
578,1,1,Tumor Stage,T1
578,1,1,Tumor Site,oral cavity
578,1,1,Metastasis,M0
578,1,1,Research lab HPV,HPV unknown
578,1,1,Occurrence #,1st primary
578,1,1,Research lab p16,p16 unknown
578,1,1,Second Failure Type,no known failure
578,1,1,Time to Death,1.7
578,1,1,Age at Death,67.6
580,1,1,Date of Death,2006-12-14 00:00:00
580,1,1,Treatment Modality,Sx
580,1,1,Clinical lab p16,p16 unknown
580,1,1,Research lab HPV,HPV unknown
580,1,1,Metastasis,M0
580,1,1,Status,Dead unk disease
580,1,1,Age at Death,66.7
580,1,1,Nodal Stage,N0
580,1,1,Overall Stage,I
580,1,1,Occurrence #,1st primary
580,1,1,Time to Death,1.9
580,1,1,Tumor Site,oral cavity
580,1,1,Tumor Stage,T1
580,1,1,Second Failure Type,no known failure
580,1,1,Research lab p16,p16 unknown
580,1,1,First Failure Type,no known failure
581,1,1,Tumor Stage,T2
581,1,1,Metastasis,Unknown
581,1,1,Second Failure Type,no known failure
581,1,1,Treatment Modality,Sx
581,1,1,Tumor Site,oral cavity
581,1,1,Research lab p16,p16 unknown
581,1,1,First Failure Type,no known failure
581,1,1,Occurrence #,1st primary
581,1,1,Overall Stage,IVa
581,1,1,Research lab HPV,HPV unknown
581,1,1,Clinical lab p16,p16 unknown
581,1,1,Nodal Stage,N2
581,1,1,Status,Alive w/o disease
582,1,1,Date of Death,2009-01-18 00:00:00
582,1,1,Status,Dead unk disease
582,1,1,First Failure Radiation Dosage,70.2
582,1,1,First Failure Second Line Chemotherapy Agent,carbo
582,1,1,Tumor Site,oral cavity
582,1,1,Metastasis,M0
582,1,1,Tumor Stage,T3
582,1,1,Age at Death,54.5
582,1,1,Nodal Stage,N2
582,1,1,Research lab HPV,HPV unknown
582,1,1,Clinical lab p16,p16 unknown
582,1,1,First Failure Type,locoregional
582,1,1,Treatment Modality,Sx
582,1,1,Research lab p16,p16 unknown
582,1,1,Second Failure Type,no known failure
582,1,1,Time to Death,1.0
582,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
582,1,1,Overall Stage,IVa
582,1,1,Occurrence #,1st primary
583,1,1,Research lab p16,p16 unknown
583,1,1,Tumor Stage,T4a
583,1,1,Occurrence #,1st primary
583,1,1,Tumor Site,oral cavity
583,1,1,Metastasis,M0
583,1,1,Radiation Dosage,unknown
583,1,1,Research lab HPV,HPV unknown
583,1,1,Nodal Stage,N1
583,1,1,Treatment Modality,Sx & RT
583,1,1,First Failure Type,no known failure
583,1,1,Second Failure Type,no known failure
583,1,1,Overall Stage,IVa
583,1,1,Status,Alive w/o disease
583,1,1,Clinical lab p16,p16 unknown
585,1,1,Tumor Stage,T1
585,1,1,Nodal Stage,N0
585,1,1,Treatment Modality,Sx
585,1,1,First Failure Treatment Modality,Sx
585,1,1,Clinical lab p16,p16 unknown
585,1,1,Age at Death,67.9
585,1,1,Research lab HPV,HPV unknown
585,1,1,Occurrence #,1st primary
585,1,1,Overall Stage,I
585,1,1,First Failure Type,no known failure
585,1,1,Research lab p16,p16 unknown
585,1,1,Time to Death,3.4
585,1,1,First Failure Site,oral cavity
585,1,1,Second Failure Type,no known failure
585,1,1,Metastasis,M0
585,1,1,Status,Dead w/o disease
585,1,1,Date of Death,2004-07-01 00:00:00
585,1,1,Tumor Site,oral cavity
586,1,1,Research lab p16,p16 unknown
586,1,1,First Failure Type,no known failure
586,1,1,Occurrence #,1st primary
586,1,1,Research lab HPV,HPV unknown
586,1,1,Tumor Stage,T1
586,1,1,Overall Stage,III
586,1,1,Status,Alive unk disease
586,1,1,Metastasis,M0
586,1,1,Radiation Dosage,unknown
586,1,1,Treatment Modality,Sx & RT
586,1,1,Second Failure Type,no known failure
586,1,1,Tumor Site,oral cavity
586,1,1,Nodal Stage,N1
586,1,1,Clinical lab p16,p16 unknown
587,1,1,Second Failure Type,no known failure
587,1,1,Clinical lab p16,p16 unknown
587,1,1,Occurrence #,1st primary
587,1,1,Research lab HPV,HPV unknown
587,1,1,First Failure Type,no known failure
587,1,1,Treatment Modality,Sx
587,1,1,Metastasis,M0
587,1,1,Research lab p16,p16 unknown
587,1,1,Tumor Site,oral cavity
587,1,1,Status,Alive unk disease
587,1,1,Tumor Stage,T1
587,1,1,Overall Stage,I
587,1,1,Nodal Stage,N0
588,1,1,Clinical lab p16,p16 unknown
588,1,1,Time to First Failure,1.5
588,1,1,Second Failure Type,no known failure
588,1,1,Research lab HPV,HPV unknown
588,1,1,Occurrence #,1st primary
588,1,1,First Failure Type,locoregional and distant
588,1,1,Tumor Stage,T3
588,1,1,Time to Death,2.1
588,1,1,Overall Stage,IVa
588,1,1,Research lab p16,p16 unknown
588,1,1,Treatment Modality,Sx & CTX-RT
588,1,1,Age at Death,62.3
588,1,1,Nodal Stage,N2
588,1,1,Initial Chemotherapy Agent,unknown
588,1,1,Status,Dead w/ disease
588,1,1,Radiation Dosage,unknown
588,1,1,Tumor Site,oral cavity
588,1,1,Date of Death,2011-06-25 00:00:00
588,1,1,Metastasis,M0
589,1,1,Treatment Modality,Sx
589,1,1,Time to Death,1.4
589,1,1,Status,Alive unk disease
589,1,1,Time to First Failure,1.1
589,1,1,Occurrence #,1st primary
589,1,1,Overall Stage,IVa
589,1,1,Research lab p16,p16 unknown
589,1,1,Nodal Stage,N2
589,1,1,Age at Death,62.8
589,1,1,Tumor Site,oral cavity
589,1,1,Metastasis,M0
589,1,1,Date of Death,2003-10-15 00:00:00
589,1,1,Second Failure Type,no known failure
589,1,1,Tumor Stage,T4a
589,1,1,First Failure Type,locoregional
589,1,1,Research lab HPV,HPV unknown
589,1,1,Clinical lab p16,p16 unknown
590,1,1,Tumor Stage,T1
590,1,1,Occurrence #,1st primary
590,1,1,Status,Alive w/o disease
590,1,1,Metastasis,Unknown
590,1,1,Nodal Stage,N0
590,1,1,Treatment Modality,Sx
590,1,1,Clinical lab p16,p16 unknown
590,1,1,Second Failure Type,no known failure
590,1,1,Research lab HPV,HPV unknown
590,1,1,Research lab p16,p16 unknown
590,1,1,First Failure Type,no known failure
590,1,1,Tumor Site,oral cavity
590,1,1,Overall Stage,I
591,1,1,First Failure Type,no known failure
591,1,1,Second Failure Type,no known failure
591,1,1,Treatment Modality,Sx
591,1,1,Metastasis,M0
591,1,1,Status,Alive unk disease
591,1,1,Tumor Stage,T1
591,1,1,Tumor Site,oral cavity
591,1,1,Research lab HPV,HPV unknown
591,1,1,Overall Stage,I
591,1,1,Research lab p16,p16 unknown
591,1,1,Nodal Stage,N0
591,1,1,Occurrence #,1st primary
591,1,1,Clinical lab p16,p16 unknown
592,1,1,First Failure Type,locoregional
592,1,1,Metastasis,M0
592,1,1,First Failure Treatment Modality,Sx & RT
592,1,1,Tumor Stage,T3
592,1,1,Radiation Dosage,70.2
592,1,1,Second Failure Type,no known failure
592,1,1,Overall Stage,III
592,1,1,Time to Death,8.6
592,1,1,First Failure Site,oral cavity
592,1,1,Clinical lab p16,p16 unknown
592,1,1,Nodal Stage,N0
592,1,1,Tumor Site,oral cavity
592,1,1,Research lab p16,p16 unknown
592,1,1,Date of Death,2011-09-02 00:00:00
592,1,1,Treatment Modality,Sx & RT
592,1,1,Time to First Failure,4.5
592,1,1,Status,Dead unk disease
592,1,1,First Failure Radiation Dosage,69.6
592,1,1,Research lab HPV,HPV unknown
592,1,1,Age at Death,85.3
592,1,1,Occurrence #,1st primary
593,1,1,Occurrence #,recurrence
593,1,1,Research lab HPV,HPV unknown
593,1,1,Nodal Stage,N0
593,1,1,First Failure Type,locoregional
593,1,1,Treatment Modality,Sx
593,1,1,Overall Stage,II
593,1,1,Second Failure Type,no known failure
593,1,1,Status,Alive unk disease
593,1,1,Tumor Site,oral cavity
593,1,1,Tumor Stage,T2
593,1,1,Time to First Failure,1.2
593,1,1,Research lab p16,p16 unknown
593,1,1,Clinical lab p16,p16 unknown
593,1,1,Metastasis,M0
593,1,1,First Failure Treatment Modality,Sx
593,1,1,First Failure Site,oral cavity
594,1,1,Time to First Failure,0.5
594,1,1,Status,Dead w/ disease
594,1,1,Date of Death,2006-07-01 00:00:00
594,1,1,Metastasis,M0
594,1,1,Nodal Stage,N2
594,1,1,First Failure Type,locoregional
594,1,1,Age at Death,70.5
594,1,1,Research lab p16,p16 unknown
594,1,1,Tumor Stage,T4a
594,1,1,Clinical lab p16,p16 unknown
594,1,1,Second Failure Type,no known failure
594,1,1,Overall Stage,IVa
594,1,1,Time to Death,0.6
594,1,1,Tumor Site,oral cavity
594,1,1,Research lab HPV,HPV unknown
594,1,1,Treatment Modality,Sx
594,1,1,Occurrence #,1st primary
595,1,1,Occurrence #,1st primary
595,1,1,Age at Death,74.1
595,1,1,Research lab p16,p16 unknown
595,1,1,Nodal Stage,N0
595,1,1,Status,Dead w/o disease
595,1,1,Treatment Modality,Sx
595,1,1,Date of Death,2011-07-14 00:00:00
595,1,1,Metastasis,M0
595,1,1,First Failure Type,no known failure
595,1,1,Research lab HPV,HPV unknown
595,1,1,Tumor Stage,T4a
595,1,1,Overall Stage,IVa
595,1,1,Time to Death,0.7
595,1,1,Second Failure Type,no known failure
595,1,1,Tumor Site,oral cavity
595,1,1,Clinical lab p16,p16 unknown
596,1,1,Time to Death,0.6
596,1,1,Nodal Stage,N3
596,1,1,Initial Chemotherapy Agent,cis
596,1,1,Status,Dead w/ disease
596,1,1,Clinical lab p16,p16 unknown
596,1,1,Research lab HPV,HPV unknown
596,1,1,Occurrence #,1st primary
596,1,1,Tumor Stage,T4a
596,1,1,Treatment Modality,Sx & CTX
596,1,1,Second Failure Type,no known failure
596,1,1,Time to First Failure,-0.0
596,1,1,Metastasis,M0
596,1,1,Research lab p16,p16 unknown
596,1,1,Overall Stage,IVb
596,1,1,Date of Death,2011-02-12 00:00:00
596,1,1,Age at Death,48.8
596,1,1,First Failure Type,distant
596,1,1,Tumor Site,oral cavity
597,1,1,Overall Stage,II
597,1,1,Tumor Stage,T2
597,1,1,Metastasis,M0
597,1,1,Treatment Modality,Sx & CTX-RT
597,1,1,Research lab p16,p16 unknown
597,1,1,Tumor Site,oral cavity
597,1,1,Research lab HPV,HPV unknown
597,1,1,Occurrence #,recurrence
597,1,1,First Failure Type,no known failure
597,1,1,Nodal Stage,N0
597,1,1,Initial Chemotherapy Agent,cis
597,1,1,Radiation Dosage,63
597,1,1,Status,Alive w/o disease
597,1,1,Clinical lab p16,p16 unknown
597,1,1,Second Failure Type,no known failure
598,1,1,Tumor Site,oral cavity
598,1,1,Research lab p16,p16 unknown
598,1,1,First Failure Type,distant
598,1,1,Overall Stage,IVa
598,1,1,Treatment Modality,Sx & RT
598,1,1,Tumor Stage,T2
598,1,1,Research lab HPV,HPV unknown
598,1,1,Radiation Dosage,unknown
598,1,1,Nodal Stage,N2
598,1,1,Second Failure Type,no known failure
598,1,1,Clinical lab p16,p16 unknown
598,1,1,Status,Alive w/ disease
598,1,1,Time to First Failure,2.7
598,1,1,Occurrence #,1st primary
598,1,1,Metastasis,M0
599,1,1,Metastasis,M0
599,1,1,Research lab p16,p16 unknown
599,1,1,Clinical lab p16,p16 unknown
599,1,1,First Failure Type,no known failure
599,1,1,Research lab HPV,HPV unknown
599,1,1,Occurrence #,1st primary
599,1,1,Overall Stage,I
599,1,1,Treatment Modality,Sx
599,1,1,Tumor Stage,T1
599,1,1,Second Failure Type,no known failure
599,1,1,Status,Alive unk disease
599,1,1,Tumor Site,oral cavity
599,1,1,Nodal Stage,N0
600,1,1,Age at Death,71.9
600,1,1,Radiation Dosage,unknown
600,1,1,Tumor Stage,T2
600,1,1,Nodal Stage,N2
600,1,1,Occurrence #,1st primary
600,1,1,Treatment Modality,Sx & RT
600,1,1,Second Failure Type,no known failure
600,1,1,Research lab HPV,HPV unknown
600,1,1,Overall Stage,IVa
600,1,1,First Failure Type,no known failure
600,1,1,Metastasis,M0
600,1,1,Time to Death,5.3
600,1,1,Research lab p16,p16 unknown
600,1,1,Clinical lab p16,p16 unknown
600,1,1,Tumor Site,oral cavity
600,1,1,Status,Dead unk disease
600,1,1,Date of Death,2007-02-13 00:00:00
601,1,1,First Failure Type,no known failure
601,1,1,Clinical lab p16,p16 unknown
601,1,1,Status,Alive unk disease
601,1,1,Tumor Stage,T1
601,1,1,Nodal Stage,N0
601,1,1,Research lab HPV,HPV unknown
601,1,1,Research lab p16,p16 unknown
601,1,1,Occurrence #,1st primary
601,1,1,Tumor Site,oral cavity
601,1,1,Overall Stage,I
601,1,1,Metastasis,M0
601,1,1,Second Failure Type,no known failure
601,1,1,Treatment Modality,Sx
602,1,1,Status,Alive w/o disease
602,1,1,First Failure Radiation Dosage,60
602,1,1,Tumor Stage,T4a
602,1,1,Overall Stage,IVa
602,1,1,Nodal Stage,N0
602,1,1,Tumor Site,oral cavity
602,1,1,Second Failure Type,no known failure
602,1,1,Occurrence #,1st primary
602,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
602,1,1,First Failure Type,locoregional
602,1,1,Treatment Modality,Sx & RT
602,1,1,Research lab HPV,HPV unknown
602,1,1,First Failure Site,oral cavity
602,1,1,Metastasis,M0
602,1,1,Radiation Dosage,59.4
602,1,1,Time to First Failure,5.4
602,1,1,Clinical lab p16,p16 unknown
602,1,1,Research lab p16,p16 unknown
602,1,1,First Failure Treatment Modality,Sx & CTX-RT
603,1,1,Nodal Stage,N0
603,1,1,First Failure Type,no known failure
603,1,1,Tumor Site,oral cavity
603,1,1,Tumor Stage,T2
603,1,1,Occurrence #,other primary
603,1,1,Status,Dead w/o disease
603,1,1,Research lab p16,p16 unknown
603,1,1,Overall Stage,II
603,1,1,Research lab HPV,HPV unknown
603,1,1,Clinical lab p16,p16 unknown
603,1,1,Second Failure Type,no known failure
603,1,1,Treatment Modality,Sx
603,1,1,Metastasis,M0
604,1,1,Status,Dead unk disease
604,1,1,Research lab HPV,HPV unknown
604,1,1,Treatment Modality,Sx
604,1,1,Metastasis,M0
604,1,1,Research lab p16,p16 unknown
604,1,1,Age at Death,77.5
604,1,1,Clinical lab p16,p16 unknown
604,1,1,Nodal Stage,N0
604,1,1,Second Failure Type,no known failure
604,1,1,Occurrence #,1st primary
604,1,1,Time to Death,1.0
604,1,1,Tumor Stage,T4a
604,1,1,Tumor Site,oral cavity
604,1,1,Overall Stage,IVa
604,1,1,First Failure Type,no known failure
604,1,1,Date of Death,2006-07-01 00:00:00
605,1,1,Research lab HPV,HPV unknown
605,1,1,Research lab p16,p16 unknown
605,1,1,Tumor Site,oral cavity
605,1,1,Date of Death,2006-08-22 00:00:00
605,1,1,Second Failure Type,no known failure
605,1,1,Time to First Failure,3.0
605,1,1,Metastasis,M0
605,1,1,Nodal Stage,N1
605,1,1,Time to Death,5.6
605,1,1,Status,Dead w/o disease
605,1,1,Occurrence #,1st primary
605,1,1,First Failure Radiation Dosage,60
605,1,1,Initial Chemotherapy Agent,carbo/PTX
605,1,1,Tumor Stage,T2
605,1,1,Age at Death,50.0
605,1,1,First Failure Site,oral cavity
605,1,1,Overall Stage,III
605,1,1,First Failure Type,locoregional
605,1,1,Clinical lab p16,p16 unknown
605,1,1,First Failure Treatment Modality,Sx & RT
605,1,1,Treatment Modality,CTX-RT
605,1,1,Radiation Dosage,70.2
606,1,1,Tumor Stage,T1
606,1,1,First Failure Treatment Modality,Sx
606,1,1,Research lab HPV,HPV unknown
606,1,1,Overall Stage,I
606,1,1,Occurrence #,1st primary
606,1,1,Tumor Site,oral cavity
606,1,1,Treatment Modality,Sx
606,1,1,Research lab p16,p16 unknown
606,1,1,Status,Alive w/o disease
606,1,1,Clinical lab p16,p16 unknown
606,1,1,Nodal Stage,N0
606,1,1,First Failure Type,no known failure
606,1,1,Metastasis,M0
606,1,1,Second Failure Type,no known failure
606,1,1,First Failure Site,oral cavity
607,1,1,Clinical lab p16,p16 unknown
607,1,1,Metastasis,M0
607,1,1,Research lab HPV,HPV unknown
607,1,1,Overall Stage,I
607,1,1,Treatment Modality,Sx
607,1,1,Occurrence #,1st primary
607,1,1,Status,Alive unk disease
607,1,1,Second Failure Type,no known failure
607,1,1,First Failure Type,no known failure
607,1,1,Tumor Stage,T1
607,1,1,Tumor Site,oral cavity
607,1,1,Research lab p16,p16 unknown
607,1,1,Nodal Stage,N0
608,1,1,Second Failure Type,no known failure
608,1,1,Research lab HPV,HPV unknown
608,1,1,Research lab p16,p16 unknown
608,1,1,Tumor Stage,T1
608,1,1,Occurrence #,1st primary
608,1,1,First Failure Type,no known failure
608,1,1,Tumor Site,oral cavity
608,1,1,Status,Dead w/o disease
608,1,1,Clinical lab p16,p16 unknown
608,1,1,Overall Stage,I
608,1,1,Treatment Modality,Sx
608,1,1,Nodal Stage,N0
608,1,1,Metastasis,M0
609,1,1,Status,Alive unk disease
609,1,1,Tumor Stage,T2
609,1,1,Metastasis,M0
609,1,1,Overall Stage,II
609,1,1,Occurrence #,1st primary
609,1,1,First Failure Type,no known failure
609,1,1,Nodal Stage,N0
609,1,1,Second Failure Type,no known failure
609,1,1,Tumor Site,oral cavity
609,1,1,Clinical lab p16,p16 unknown
609,1,1,Treatment Modality,Sx
609,1,1,Research lab p16,p16 unknown
609,1,1,Research lab HPV,HPV unknown
610,1,1,Clinical lab p16,p16 unknown
610,1,1,Research lab p16,p16 unknown
610,1,1,Tumor Site,oral cavity
610,1,1,First Failure Site,oral cavity
610,1,1,Second Failure Type,no known failure
610,1,1,Metastasis,M0
610,1,1,First Failure Treatment Modality,Sx
610,1,1,First Failure Type,no known failure
610,1,1,Nodal Stage,N0
610,1,1,Occurrence #,1st primary
610,1,1,Research lab HPV,HPV unknown
610,1,1,Overall Stage,I
610,1,1,Treatment Modality,Sx
610,1,1,Tumor Stage,T1
610,1,1,Status,Alive w/o disease
611,1,1,Nodal Stage,N2
611,1,1,Second Failure Type,no known failure
611,1,1,Research lab p16,p16 unknown
611,1,1,Clinical lab p16,p16 unknown
611,1,1,Tumor Site,oral cavity
611,1,1,Treatment Modality,Sx & RT
611,1,1,First Failure Type,no known failure
611,1,1,Status,Dead w/o disease
611,1,1,Radiation Dosage,62.6
611,1,1,Occurrence #,1st primary
611,1,1,First Failure Site,oral cavity
611,1,1,Research lab HPV,HPV unknown
611,1,1,Metastasis,M0
611,1,1,First Failure Treatment Modality,Sx
611,1,1,Tumor Stage,T1
611,1,1,Overall Stage,IVa
612,1,1,Tumor Site,oral cavity
612,1,1,Overall Stage,IVa
612,1,1,Status,Alive unk disease
612,1,1,Tumor Stage,T2
612,1,1,Clinical lab p16,p16 unknown
612,1,1,Research lab HPV,HPV unknown
612,1,1,Treatment Modality,Sx
612,1,1,Metastasis,M0
612,1,1,Nodal Stage,N2
612,1,1,Occurrence #,1st primary
612,1,1,Second Failure Type,no known failure
612,1,1,First Failure Type,no known failure
612,1,1,Research lab p16,p16 unknown
613,1,1,Metastasis,M0
613,1,1,Date of Death,2003-03-28 00:00:00
613,1,1,Second Failure Type,no known failure
613,1,1,Research lab HPV,HPV unknown
613,1,1,Clinical lab p16,p16 unknown
613,1,1,Tumor Stage,T2
613,1,1,Overall Stage,III
613,1,1,Occurrence #,1st primary
613,1,1,Age at Death,87.0
613,1,1,Time to Death,2.8
613,1,1,Research lab p16,p16 unknown
613,1,1,Status,Dead unk disease
613,1,1,Nodal Stage,N1
613,1,1,Treatment Modality,Sx
613,1,1,First Failure Type,no known failure
613,1,1,Tumor Site,oral cavity
614,1,1,Tumor Site,oral cavity
614,1,1,Occurrence #,1st primary
614,1,1,Age at Death,86.1
614,1,1,Nodal Stage,N0
614,1,1,Research lab HPV,HPV unknown
614,1,1,Time to Death,5.4
614,1,1,Research lab p16,p16 unknown
614,1,1,Metastasis,M0
614,1,1,Treatment Modality,Sx
614,1,1,Overall Stage,II
614,1,1,Second Failure Type,no known failure
614,1,1,Date of Death,2010-06-15 00:00:00
614,1,1,Status,Dead unk disease
614,1,1,Clinical lab p16,p16 unknown
614,1,1,First Failure Type,no known failure
614,1,1,Tumor Stage,T2
615,1,1,First Failure Type,no known failure
615,1,1,Clinical lab p16,p16 unknown
615,1,1,Tumor Site,oral cavity
615,1,1,Status,Alive w/o disease
615,1,1,Treatment Modality,Sx
615,1,1,Overall Stage,I
615,1,1,Occurrence #,1st primary
615,1,1,Second Failure Type,no known failure
615,1,1,Research lab p16,p16 unknown
615,1,1,Nodal Stage,N0
615,1,1,Tumor Stage,T1
615,1,1,Metastasis,M0
615,1,1,Research lab HPV,HPV unknown
616,1,1,Status,Dead w/ disease
616,1,1,Time to First Failure,0.9
616,1,1,Occurrence #,recurrence
616,1,1,Treatment Modality,Sx
616,1,1,Tumor Stage,T2
616,1,1,Research lab HPV,HPV unknown
616,1,1,Overall Stage,II
616,1,1,Tumor Site,oral cavity
616,1,1,Nodal Stage,N0
616,1,1,Metastasis,M0
616,1,1,First Failure Treatment Modality,Sx
616,1,1,Clinical lab p16,p16 unknown
616,1,1,First Failure Type,locoregional
616,1,1,Research lab p16,p16 unknown
616,1,1,Second Failure Type,no known failure
616,1,1,First Failure Site,oral cavity
616,1,1,Date of Death,2010-10-29 00:00:00
616,1,1,Time to Death,3.7
616,1,1,Age at Death,85.0
617,1,1,Tumor Stage,T4a
617,1,1,Status,Dead w/o disease
617,1,1,Treatment Modality,Sx & RT
617,1,1,Nodal Stage,N2
617,1,1,Overall Stage,IVa
617,1,1,Tumor Site,oral cavity
617,1,1,First Failure Type,no known failure
617,1,1,Time to Death,3.5
617,1,1,Second Failure Type,no known failure
617,1,1,Occurrence #,1st primary
617,1,1,Age at Death,69.7
617,1,1,Clinical lab p16,p16 unknown
617,1,1,Date of Death,2007-04-19 00:00:00
617,1,1,Research lab p16,p16 unknown
617,1,1,Research lab HPV,HPV unknown
617,1,1,Radiation Dosage,63
617,1,1,Metastasis,M0
618,1,1,Metastasis,M0
618,1,1,Occurrence #,1st primary
618,1,1,Treatment Modality,Sx
618,1,1,Status,Dead unk disease
618,1,1,Research lab HPV,HPV unknown
618,1,1,Nodal Stage,N0
618,1,1,Clinical lab p16,p16 unknown
618,1,1,Date of Death,2008-08-15 00:00:00
618,1,1,Age at Death,56.3
618,1,1,Overall Stage,I
618,1,1,Tumor Site,oral cavity
618,1,1,Research lab p16,p16 unknown
618,1,1,Time to Death,1.8
618,1,1,Second Failure Type,no known failure
618,1,1,First Failure Type,no known failure
618,1,1,Tumor Stage,T1
619,1,1,Overall Stage,II
619,1,1,Time to Death,3.9
619,1,1,Clinical lab p16,p16 unknown
619,1,1,Research lab p16,p16 unknown
619,1,1,First Failure Type,no known failure
619,1,1,Second Failure Type,no known failure
619,1,1,Research lab HPV,HPV unknown
619,1,1,Treatment Modality,Sx
619,1,1,Tumor Stage,T2
619,1,1,Tumor Site,oral cavity
619,1,1,Status,Dead unk disease
619,1,1,Nodal Stage,N0
619,1,1,Metastasis,M0
619,1,1,Occurrence #,1st primary
619,1,1,Date of Death,2007-05-16 00:00:00
619,1,1,Age at Death,69.1
621,1,1,First Failure Site,oral cavity
621,1,1,Age at Death,89.1
621,1,1,Status,Dead unk disease
621,1,1,Metastasis,M0
621,1,1,First Failure Treatment Modality,Sx & RT
621,1,1,Clinical lab p16,p16 unknown
621,1,1,Nodal Stage,N0
621,1,1,First Failure Type,no known failure
621,1,1,Research lab p16,p16 unknown
621,1,1,Tumor Site,oral cavity
621,1,1,Treatment Modality,Sx
621,1,1,Time to Death,6.5
621,1,1,Research lab HPV,HPV unknown
621,1,1,Overall Stage,I
621,1,1,Date of Death,2008-08-23 00:00:00
621,1,1,Occurrence #,1st primary
621,1,1,First Failure Radiation Dosage,unk
621,1,1,Tumor Stage,T1
621,1,1,Second Failure Type,no known failure
622,1,1,Tumor Site,oral cavity
622,1,1,Nodal Stage,N0
622,1,1,Tumor Stage,T2
622,1,1,Status,Alive w/o disease
622,1,1,Clinical lab p16,p16 unknown
622,1,1,First Failure Type,no known failure
622,1,1,Second Failure Type,no known failure
622,1,1,Research lab p16,p16 unknown
622,1,1,Treatment Modality,Sx
622,1,1,Overall Stage,II
622,1,1,Research lab HPV,HPV unknown
622,1,1,Occurrence #,1st primary
622,1,1,Metastasis,M0
623,1,1,Second Failure Type,no known failure
623,1,1,Tumor Site,oral cavity
623,1,1,First Failure Type,no known failure
623,1,1,Treatment Modality,Sx
623,1,1,Metastasis,M0
623,1,1,Nodal Stage,N0
623,1,1,Research lab p16,p16 unknown
623,1,1,Research lab HPV,HPV unknown
623,1,1,Clinical lab p16,p16 unknown
623,1,1,Status,Alive unk disease
623,1,1,Overall Stage,IVa
623,1,1,Occurrence #,1st primary
623,1,1,Tumor Stage,T4a
624,1,1,Tumor Site,oral cavity
624,1,1,First Failure Type,no known failure
624,1,1,Treatment Modality,Sx
624,1,1,Second Failure Type,no known failure
624,1,1,Occurrence #,1st primary
624,1,1,Clinical lab p16,p16 unknown
624,1,1,Overall Stage,II
624,1,1,Status,Alive unk disease
624,1,1,Research lab HPV,HPV unknown
624,1,1,Nodal Stage,N0
624,1,1,Tumor Stage,T2
624,1,1,Metastasis,M0
624,1,1,Research lab p16,p16 unknown
625,1,1,Clinical lab p16,p16 unknown
625,1,1,Tumor Site,oral cavity
625,1,1,Research lab p16,p16 unknown
625,1,1,Treatment Modality,Sx
625,1,1,Time to Death,4.5
625,1,1,Research lab HPV,HPV unknown
625,1,1,Date of Death,2008-12-01 00:00:00
625,1,1,Overall Stage,IVa
625,1,1,Second Failure Type,no known failure
625,1,1,First Failure Type,no known failure
625,1,1,Age at Death,62.8
625,1,1,Metastasis,M0
625,1,1,Occurrence #,1st primary
625,1,1,Nodal Stage,N2
625,1,1,Status,Dead unk disease
625,1,1,Tumor Stage,T4a
626,1,1,Tumor Stage,T1
626,1,1,Clinical lab p16,p16 unknown
626,1,1,Research lab HPV,HPV unknown
626,1,1,Treatment Modality,Sx
626,1,1,Occurrence #,1st primary
626,1,1,Metastasis,M0
626,1,1,Status,Alive unk disease
626,1,1,Second Failure Type,no known failure
626,1,1,First Failure Type,no known failure
626,1,1,Tumor Site,oral cavity
626,1,1,Overall Stage,I
626,1,1,Nodal Stage,N0
626,1,1,Research lab p16,p16 unknown
627,1,1,Nodal Stage,N0
627,1,1,Tumor Stage,T2
627,1,1,Overall Stage,II
627,1,1,Second Failure Type,no known failure
627,1,1,Research lab p16,p16 unknown
627,1,1,Metastasis,M0
627,1,1,Treatment Modality,Sx
627,1,1,Clinical lab p16,p16 unknown
627,1,1,Research lab HPV,HPV unknown
627,1,1,Tumor Site,oral cavity
627,1,1,Occurrence #,1st primary
627,1,1,First Failure Type,no known failure
627,1,1,Status,Alive unk disease
628,1,1,Research lab HPV,HPV unknown
628,1,1,Tumor Site,oral cavity
628,1,1,Research lab p16,p16 unknown
628,1,1,Clinical lab p16,p16 unknown
628,1,1,Treatment Modality,Sx
628,1,1,Occurrence #,1st primary
628,1,1,Age at Death,51.5
628,1,1,Metastasis,M0
628,1,1,Second Failure Type,no known failure
628,1,1,Time to Death,3.5
628,1,1,Tumor Stage,T2
628,1,1,Overall Stage,II
628,1,1,First Failure Type,no known failure
628,1,1,Status,Dead unk disease
628,1,1,Date of Death,2004-01-05 00:00:00
628,1,1,Nodal Stage,N0
629,1,1,Nodal Stage,N0
629,1,1,Treatment Modality,Sx
629,1,1,Clinical lab p16,p16 unknown
629,1,1,First Failure Type,no known failure
629,1,1,Tumor Site,oral cavity
629,1,1,Metastasis,M0
629,1,1,Second Failure Type,no known failure
629,1,1,Tumor Stage,T1
629,1,1,Research lab p16,p16 unknown
629,1,1,Status,Alive unk disease
629,1,1,Overall Stage,I
629,1,1,Occurrence #,1st primary
629,1,1,Research lab HPV,HPV unknown
630,1,1,Overall Stage,I
630,1,1,Metastasis,M0
630,1,1,Nodal Stage,N0
630,1,1,Second Failure Type,no known failure
630,1,1,Tumor Stage,T1
630,1,1,Research lab p16,p16 unknown
630,1,1,Status,Alive w/o disease
630,1,1,Research lab HPV,HPV unknown
630,1,1,First Failure Treatment Modality,Sx
630,1,1,Treatment Modality,Sx
630,1,1,First Failure Site,oral cavity
630,1,1,Clinical lab p16,p16 unknown
630,1,1,First Failure Type,no known failure
630,1,1,Tumor Site,oral cavity
630,1,1,Occurrence #,1st primary
631,1,1,Tumor Site,oral cavity
631,1,1,Tumor Stage,T2
631,1,1,First Failure Type,no known failure
631,1,1,Research lab HPV,HPV unknown
631,1,1,Treatment Modality,Sx
631,1,1,Date of Death,2007-02-14 00:00:00
631,1,1,Metastasis,M0
631,1,1,Overall Stage,II
631,1,1,Clinical lab p16,p16 unknown
631,1,1,Time to Death,4.8
631,1,1,Second Failure Type,no known failure
631,1,1,Research lab p16,p16 unknown
631,1,1,Nodal Stage,N0
631,1,1,Occurrence #,1st primary
631,1,1,Status,Dead unk disease
631,1,1,Age at Death,80.3
632,1,1,Metastasis,M0
632,1,1,Nodal Stage,N0
632,1,1,Treatment Modality,Sx
632,1,1,Status,Dead unk disease
632,1,1,Tumor Site,oral cavity
632,1,1,Tumor Stage,T4a
632,1,1,Research lab HPV,HPV unknown
632,1,1,Age at Death,93.8
632,1,1,Second Failure Type,no known failure
632,1,1,First Failure Type,no known failure
632,1,1,Clinical lab p16,p16 unknown
632,1,1,Research lab p16,p16 unknown
632,1,1,Occurrence #,1st primary
632,1,1,Time to Death,1.1
632,1,1,Date of Death,2005-09-27 00:00:00
632,1,1,Overall Stage,IVa
633,1,1,First Failure Type,no known failure
633,1,1,Occurrence #,1st primary
633,1,1,Research lab HPV,HPV unknown
633,1,1,Status,Alive w/o disease
633,1,1,Tumor Site,oral cavity
633,1,1,Treatment Modality,Sx & RT
633,1,1,Nodal Stage,N0
633,1,1,Overall Stage,IVa
633,1,1,Research lab p16,p16 unknown
633,1,1,Radiation Dosage,63
633,1,1,Clinical lab p16,p16 unknown
633,1,1,Tumor Stage,T4a
633,1,1,Metastasis,M0
633,1,1,Second Failure Type,no known failure
634,1,1,Tumor Site,oral cavity
634,1,1,First Failure Type,no known failure
634,1,1,Treatment Modality,Sx
634,1,1,Date of Death,2009-01-18 00:00:00
634,1,1,Time to Death,0.1
634,1,1,Research lab p16,p16 unknown
634,1,1,Metastasis,M0
634,1,1,Clinical lab p16,p16 unknown
634,1,1,Overall Stage,IVa
634,1,1,Second Failure Type,no known failure
634,1,1,Age at Death,70.5
634,1,1,Nodal Stage,N2
634,1,1,Research lab HPV,HPV unknown
634,1,1,Status,Dead unk disease
634,1,1,Tumor Stage,T3
634,1,1,Occurrence #,1st primary
635,1,1,Tumor Site,oral cavity
635,1,1,Metastasis,M0
635,1,1,Tumor Stage,T1
635,1,1,Research lab p16,p16 unknown
635,1,1,Nodal Stage,N0
635,1,1,Clinical lab p16,p16 unknown
635,1,1,Occurrence #,1st primary
635,1,1,Second Failure Type,no known failure
635,1,1,First Failure Type,no known failure
635,1,1,Overall Stage,I
635,1,1,Research lab HPV,HPV unknown
635,1,1,Treatment Modality,Sx
635,1,1,Status,Alive w/o disease
636,1,1,Clinical lab p16,p16 unknown
636,1,1,Age at Death,65.8
636,1,1,Date of Death,2000-11-15 00:00:00
636,1,1,Metastasis,M0
636,1,1,Tumor Stage,T2
636,1,1,Radiation Dosage,unknown
636,1,1,Research lab p16,p16 unknown
636,1,1,First Failure Type,no known failure
636,1,1,Nodal Stage,N2
636,1,1,Treatment Modality,Sx & RT
636,1,1,Time to Death,0.7
636,1,1,Overall Stage,IVa
636,1,1,Research lab HPV,HPV unknown
636,1,1,Status,Dead w/o disease
636,1,1,Occurrence #,1st primary
636,1,1,Tumor Site,oral cavity
636,1,1,Second Failure Type,no known failure
637,1,1,Research lab HPV,HPV unknown
637,1,1,Second Failure Type,no known failure
637,1,1,Clinical lab p16,p16 unknown
637,1,1,Research lab p16,p16 unknown
637,1,1,Overall Stage,I
637,1,1,Status,Alive unk disease
637,1,1,Treatment Modality,Sx
637,1,1,Metastasis,M0
637,1,1,Occurrence #,1st primary
637,1,1,First Failure Type,no known failure
637,1,1,Tumor Site,oral cavity
637,1,1,Tumor Stage,T1
637,1,1,Nodal Stage,N0
638,1,1,First Failure Type,no known failure
638,1,1,Research lab p16,p16 unknown
638,1,1,Overall Stage,IVa
638,1,1,Clinical lab p16,p16 unknown
638,1,1,Status,Alive unk disease
638,1,1,Second Failure Type,no known failure
638,1,1,Metastasis,M0
638,1,1,Tumor Stage,T4a
638,1,1,Occurrence #,1st primary
638,1,1,Nodal Stage,N1
638,1,1,Tumor Site,oral cavity
638,1,1,Research lab HPV,HPV unknown
638,1,1,Treatment Modality,Sx
639,1,1,Tumor Stage,T1
639,1,1,Tumor Site,oral cavity
639,1,1,Nodal Stage,N0
639,1,1,First Failure Type,no known failure
639,1,1,Occurrence #,1st primary
639,1,1,Overall Stage,I
639,1,1,Research lab HPV,HPV unknown
639,1,1,Treatment Modality,Sx
639,1,1,Metastasis,M0
639,1,1,Status,Alive unk disease
639,1,1,Clinical lab p16,p16 unknown
639,1,1,Research lab p16,p16 unknown
639,1,1,Second Failure Type,no known failure
640,1,1,Time to Death,1.0
640,1,1,Research lab p16,p16 unknown
640,1,1,Status,Dead w/ disease
640,1,1,Occurrence #,recurrence
640,1,1,Date of Death,2008-12-21 00:00:00
640,1,1,Nodal Stage,N2
640,1,1,Clinical lab p16,p16 unknown
640,1,1,Research lab HPV,HPV unknown
640,1,1,Radiation Dosage,70.2
640,1,1,Treatment Modality,CTX-RT
640,1,1,Metastasis,M0
640,1,1,Age at Death,77.5
640,1,1,First Failure Type,locoregional
640,1,1,Overall Stage,IVa
640,1,1,Tumor Stage,T3
640,1,1,Tumor Site,oral cavity
640,1,1,Second Failure Type,no known failure
640,1,1,Second Line Chemotherapy Agent,cap
640,1,1,Initial Chemotherapy Agent,carbo/PTX
640,1,1,Time to First Failure,0.4
642,1,1,Overall Stage,III
642,1,1,Nodal Stage,N0
642,1,1,First Failure Type,no known failure
642,1,1,First Failure Site,oral cavity
642,1,1,Occurrence #,1st primary
642,1,1,First Failure Treatment Modality,Sx
642,1,1,Tumor Stage,T3
642,1,1,Clinical lab p16,p16 unknown
642,1,1,Treatment Modality,Sx
642,1,1,Metastasis,M0
642,1,1,Research lab p16,p16 unknown
642,1,1,Status,Alive w/ disease
642,1,1,Tumor Site,oral cavity
642,1,1,Research lab HPV,HPV unknown
642,1,1,Second Failure Type,no known failure
643,1,1,Second Failure Type,no known failure
643,1,1,Occurrence #,1st primary
643,1,1,Treatment Modality,Sx & RT
643,1,1,Research lab p16,p16 unknown
643,1,1,First Failure Type,no known failure
643,1,1,Tumor Stage,T1
643,1,1,Tumor Site,oral cavity
643,1,1,Clinical lab p16,p16 unknown
643,1,1,Overall Stage,III
643,1,1,Nodal Stage,N1
643,1,1,Radiation Dosage,unknown
643,1,1,Status,Alive w/o disease
643,1,1,Metastasis,M0
643,1,1,Research lab HPV,HPV unknown
644,1,1,Overall Stage,IVa
644,1,1,Time to First Failure,0.7
644,1,1,Occurrence #,1st primary
644,1,1,First Failure Treatment Modality,CTX
644,1,1,Date of Death,2004-09-15 00:00:00
644,1,1,Radiation Dosage,63
644,1,1,First Failure Second Line Chemotherapy Agent,cap
644,1,1,Treatment Modality,Sx & RT
644,1,1,Tumor Site,oral cavity
644,1,1,First Failure Type,locoregional
644,1,1,Time to Death,1.9
644,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
644,1,1,Metastasis,M0
644,1,1,Clinical lab p16,p16 unknown
644,1,1,Research lab p16,p16 unknown
644,1,1,Second Failure Type,no known failure
644,1,1,Age at Death,42.9
644,1,1,Nodal Stage,N2
644,1,1,Status,Dead w/ disease
644,1,1,Research lab HPV,HPV unknown
644,1,1,First Failure Site,oral cavity
644,1,1,Tumor Stage,T1
645,1,1,Metastasis,M0
645,1,1,Tumor Site,oral cavity
645,1,1,Status,Dead unk disease
645,1,1,Second Failure Type,no known failure
645,1,1,Time to Death,2.9
645,1,1,Clinical lab p16,p16 unknown
645,1,1,Research lab p16,p16 unknown
645,1,1,Date of Death,2005-02-12 00:00:00
645,1,1,Research lab HPV,HPV unknown
645,1,1,Age at Death,73.6
645,1,1,Overall Stage,I
645,1,1,Treatment Modality,Sx
645,1,1,First Failure Type,no known failure
645,1,1,Tumor Stage,T1
645,1,1,Nodal Stage,N0
645,1,1,Occurrence #,1st primary
646,1,1,Tumor Site,oral cavity
646,1,1,Clinical lab p16,p16 unknown
646,1,1,Occurrence #,1st primary
646,1,1,Tumor Stage,T2
646,1,1,Metastasis,M1
646,1,1,Second Failure Type,no known failure
646,1,1,Status,Alive unk disease
646,1,1,Research lab HPV,HPV unknown
646,1,1,Overall Stage,III
646,1,1,Nodal Stage,N1
646,1,1,Treatment Modality,Sx
646,1,1,First Failure Type,no known failure
646,1,1,Research lab p16,p16 unknown
647,1,1,Overall Stage,II
647,1,1,Tumor Site,oral cavity
647,1,1,Second Failure Type,no known failure
647,1,1,First Failure Type,locoregional
647,1,1,Clinical lab p16,p16 unknown
647,1,1,Time to First Failure,4.0
647,1,1,Treatment Modality,Sx
647,1,1,Research lab p16,p16 unknown
647,1,1,Nodal Stage,N0
647,1,1,Tumor Stage,T2
647,1,1,First Failure Radiation Dosage,59.4
647,1,1,Status,Alive w/o disease
647,1,1,Research lab HPV,HPV unknown
647,1,1,First Failure Treatment Modality,Sx & RT
647,1,1,Metastasis,M0
647,1,1,First Failure Site,oral cavity
647,1,1,Occurrence #,1st primary
648,1,1,Status,Dead w/o disease
648,1,1,Clinical lab p16,p16 unknown
648,1,1,Occurrence #,1st primary
648,1,1,Time to Death,1.2
648,1,1,Research lab HPV,HPV unknown
648,1,1,First Failure Type,no known failure
648,1,1,Research lab p16,p16 unknown
648,1,1,Overall Stage,I
648,1,1,Tumor Stage,T1
648,1,1,Treatment Modality,Sx
648,1,1,Second Failure Type,no known failure
648,1,1,Date of Death,2008-05-06 00:00:00
648,1,1,Age at Death,81.9
648,1,1,Tumor Site,oral cavity
648,1,1,Metastasis,M0
648,1,1,Nodal Stage,N0
649,1,1,Tumor Site,oral cavity
649,1,1,First Failure Type,no known failure
649,1,1,Occurrence #,1st primary
649,1,1,Research lab p16,p16 unknown
649,1,1,Research lab HPV,HPV unknown
649,1,1,Second Failure Type,no known failure
649,1,1,Clinical lab p16,p16 unknown
649,1,1,Nodal Stage,Unknown
649,1,1,Tumor Stage,Unknown
649,1,1,Overall Stage,Unknown
649,1,1,Metastasis,Unknown
649,1,1,Treatment Modality,Unknown
649,1,1,Status,Dead w/ disease
650,1,1,Tumor Site,oral cavity
650,1,1,Research lab HPV,HPV unknown
650,1,1,Time to Death,7.3
650,1,1,Treatment Modality,Sx
650,1,1,Date of Death,2010-12-11 00:00:00
650,1,1,Nodal Stage,N1
650,1,1,Overall Stage,III
650,1,1,Occurrence #,1st primary
650,1,1,Status,Dead unk disease
650,1,1,Age at Death,91.6
650,1,1,First Failure Type,no known failure
650,1,1,Clinical lab p16,p16 unknown
650,1,1,Second Failure Type,no known failure
650,1,1,Research lab p16,p16 unknown
650,1,1,Metastasis,M0
650,1,1,Tumor Stage,T1
651,1,1,Overall Stage,IVa
651,1,1,Status,Dead unk disease
651,1,1,Tumor Stage,T4a
651,1,1,Nodal Stage,N2
651,1,1,Metastasis,M0
651,1,1,Research lab HPV,HPV unknown
651,1,1,Research lab p16,p16 unknown
651,1,1,First Failure Type,no known failure
651,1,1,Time to Death,1.4
651,1,1,Second Failure Type,no known failure
651,1,1,Radiation Dosage,63
651,1,1,Clinical lab p16,p16 unknown
651,1,1,Occurrence #,1st primary
651,1,1,Tumor Site,oral cavity
651,1,1,Date of Death,2001-12-13 00:00:00
651,1,1,Age at Death,58.3
651,1,1,Treatment Modality,Sx & RT
652,1,1,Research lab HPV,HPV unknown
652,1,1,Clinical lab p16,p16 unknown
652,1,1,Tumor Stage,T2
652,1,1,First Failure Type,no known failure
652,1,1,Research lab p16,p16 unknown
652,1,1,Nodal Stage,Unknown
652,1,1,Treatment Modality,Sx
652,1,1,Age at Death,74.5
652,1,1,Date of Death,2005-09-08 00:00:00
652,1,1,Status,Dead w/ disease
652,1,1,Second Failure Type,no known failure
652,1,1,Occurrence #,recurrence
652,1,1,Tumor Site,oral cavity
652,1,1,Overall Stage,IVc
652,1,1,Metastasis,M1
652,1,1,Time to Death,0.6
653,1,1,Occurrence #,1st primary
653,1,1,Nodal Stage,N0
653,1,1,Treatment Modality,Sx
653,1,1,Overall Stage,IVa
653,1,1,Tumor Stage,T4a
653,1,1,Research lab p16,p16 unknown
653,1,1,First Failure Type,no known failure
653,1,1,Metastasis,M0
653,1,1,Second Failure Type,no known failure
653,1,1,Time to Death,3.3
653,1,1,Date of Death,2006-12-31 00:00:00
653,1,1,Status,Dead unk disease
653,1,1,Clinical lab p16,p16 unknown
653,1,1,Research lab HPV,HPV unknown
653,1,1,Age at Death,57.6
653,1,1,Tumor Site,oral cavity
654,1,1,Tumor Site,oral cavity
654,1,1,Tumor Stage,T4a
654,1,1,Overall Stage,IVa
654,1,1,Age at Death,59.8
654,1,1,Status,Dead unk disease
654,1,1,Nodal Stage,N2
654,1,1,Occurrence #,1st primary
654,1,1,Metastasis,M0
654,1,1,Date of Death,2000-09-01 00:00:00
654,1,1,Research lab HPV,HPV unknown
654,1,1,Time to Death,0.3
654,1,1,Treatment Modality,Sx
654,1,1,Research lab p16,p16 unknown
654,1,1,Second Failure Type,no known failure
654,1,1,Clinical lab p16,p16 unknown
654,1,1,First Failure Type,no known failure
655,1,1,Tumor Site,oral cavity
655,1,1,Radiation Dosage,59.4
655,1,1,Research lab HPV,HPV unknown
655,1,1,Second Failure Type,no known failure
655,1,1,Clinical lab p16,p16 unknown
655,1,1,Time to First Failure,1.0
655,1,1,Overall Stage,II
655,1,1,Status,Alive w/o disease
655,1,1,Research lab p16,p16 unknown
655,1,1,Tumor Stage,T2
655,1,1,First Failure Type,distant
655,1,1,Treatment Modality,Sx & RT
655,1,1,Occurrence #,1st primary
655,1,1,Nodal Stage,N0
655,1,1,Metastasis,M0
656,1,1,Treatment Modality,Sx & RT
656,1,1,Time to First Failure,0.5
656,1,1,Tumor Site,oral cavity
656,1,1,Nodal Stage,N2
656,1,1,First Failure Treatment Modality,Sx
656,1,1,Clinical lab p16,p16 unknown
656,1,1,Research lab p16,p16 unknown
656,1,1,Date of Death,2010-01-19 00:00:00
656,1,1,First Failure Type,locoregional
656,1,1,Radiation Dosage,unknown
656,1,1,Occurrence #,1st primary
656,1,1,Second Failure Type,no known failure
656,1,1,Time to Death,0.7
656,1,1,Research lab HPV,HPV unknown
656,1,1,Tumor Stage,T2
656,1,1,Metastasis,M0
656,1,1,Status,Dead unk disease
656,1,1,First Failure Site,oral cavity
656,1,1,Overall Stage,IVa
656,1,1,Age at Death,76.6
657,1,1,Occurrence #,recurrence
657,1,1,Metastasis,M0
657,1,1,Time to Death,0.6
657,1,1,Research lab p16,p16 unknown
657,1,1,Second Failure Type,no known failure
657,1,1,Tumor Stage,T1
657,1,1,Age at Death,49.1
657,1,1,Research lab HPV,HPV unknown
657,1,1,Status,Dead unk disease
657,1,1,Overall Stage,IVa
657,1,1,Treatment Modality,Sx & CTX-RT
657,1,1,First Failure Type,no known failure
657,1,1,Radiation Dosage,unknown
657,1,1,Initial Chemotherapy Agent,unknown
657,1,1,Nodal Stage,N2
657,1,1,Clinical lab p16,p16 unknown
657,1,1,Tumor Site,oral cavity
657,1,1,Date of Death,2005-09-28 00:00:00
658,1,1,Tumor Stage,T1
658,1,1,Research lab HPV,HPV unknown
658,1,1,Status,Alive unk disease
658,1,1,Metastasis,M0
658,1,1,Tumor Site,oral cavity
658,1,1,Clinical lab p16,p16 unknown
658,1,1,Occurrence #,1st primary
658,1,1,First Failure Type,no known failure
658,1,1,Treatment Modality,Sx
658,1,1,Overall Stage,I
658,1,1,Research lab p16,p16 unknown
658,1,1,Nodal Stage,N0
658,1,1,Second Failure Type,no known failure
659,1,1,Nodal Stage,N0
659,1,1,Research lab HPV,HPV unknown
659,1,1,Clinical lab p16,p16 unknown
659,1,1,Status,Dead w/o disease
659,1,1,Occurrence #,1st primary
659,1,1,Tumor Site,oral cavity
659,1,1,Treatment Modality,Sx
659,1,1,Age at Death,83.5
659,1,1,First Failure Type,locoregional
659,1,1,Research lab p16,p16 unknown
659,1,1,Date of Death,2011-08-12 00:00:00
659,1,1,Time to Death,5.7
659,1,1,Overall Stage,II
659,1,1,First Failure Site,oral cavity
659,1,1,Time to First Failure,0.5
659,1,1,Second Failure Type,no known failure
659,1,1,First Failure Treatment Modality,Sx
659,1,1,Tumor Stage,T2
659,1,1,Metastasis,M0
660,1,1,First Failure Type,no known failure
660,1,1,Nodal Stage,Unknown
660,1,1,Radiation Dosage,68
660,1,1,Research lab HPV,HPV unknown
660,1,1,Clinical lab p16,p16 unknown
660,1,1,Second Failure Type,no known failure
660,1,1,Overall Stage,IVa
660,1,1,Time to Death,0.5
660,1,1,Occurrence #,1st primary
660,1,1,Age at Death,88.8
660,1,1,Tumor Stage,T4a
660,1,1,Metastasis,Unknown
660,1,1,Date of Death,2010-03-02 00:00:00
660,1,1,Initial Chemotherapy Agent,cetux
660,1,1,Status,Dead unk disease
660,1,1,Research lab p16,p16 unknown
660,1,1,Treatment Modality,Sx & CTX-RT
660,1,1,Tumor Site,oral cavity
661,1,1,Research lab p16,p16 unknown
661,1,1,Status,Dead unk disease
661,1,1,Overall Stage,IVa
661,1,1,Clinical lab p16,p16 unknown
661,1,1,Age at Death,54.4
661,1,1,Tumor Site,oral cavity
661,1,1,First Failure Type,no known failure
661,1,1,Second Failure Type,no known failure
661,1,1,Date of Death,2006-01-30 00:00:00
661,1,1,Time to Death,0.9
661,1,1,Metastasis,M0
661,1,1,Occurrence #,1st primary
661,1,1,Nodal Stage,N1
661,1,1,Research lab HPV,HPV unknown
661,1,1,Treatment Modality,Unknown
661,1,1,Tumor Stage,T4a
662,1,1,Treatment Modality,Sx
662,1,1,Second Failure Type,no known failure
662,1,1,Tumor Site,oral cavity
662,1,1,Nodal Stage,N0
662,1,1,Age at Death,61.4
662,1,1,Occurrence #,1st primary
662,1,1,Clinical lab p16,p16 unknown
662,1,1,Status,Dead unk disease
662,1,1,First Failure Treatment Modality,Sx
662,1,1,Time to Death,2.0
662,1,1,Research lab HPV,HPV unknown
662,1,1,First Failure Type,locoregional
662,1,1,Tumor Stage,T1
662,1,1,First Failure Site,oral cavity
662,1,1,Time to First Failure,1.4
662,1,1,Overall Stage,I
662,1,1,Research lab p16,p16 unknown
662,1,1,Metastasis,M0
662,1,1,Date of Death,2010-11-24 00:00:00
664,1,1,Second Failure Type,no known failure
664,1,1,Radiation Dosage,66.6
664,1,1,Research lab HPV,HPV unknown
664,1,1,First Failure Site,oral cavity
664,1,1,Occurrence #,1st primary
664,1,1,Treatment Modality,RT
664,1,1,Time to Death,0.9
664,1,1,Overall Stage,I
664,1,1,First Failure Type,locoregional
664,1,1,Tumor Site,oral cavity
664,1,1,Metastasis,M0
664,1,1,Tumor Stage,T1
664,1,1,Age at Death,56.8
664,1,1,Clinical lab p16,p16 unknown
664,1,1,Research lab p16,p16 unknown
664,1,1,First Failure Treatment Modality,Sx
664,1,1,Status,Dead w/ disease
664,1,1,Nodal Stage,N0
664,1,1,Time to First Failure,1.2
664,1,1,Date of Death,2008-02-09 00:00:00
665,1,1,Second Failure Type,no known failure
665,1,1,Time to First Failure,3.0
665,1,1,Research lab p16,p16 unknown
665,1,1,Metastasis,M0
665,1,1,Nodal Stage,N1
665,1,1,First Failure Site,oral cavity
665,1,1,Tumor Site,oral cavity
665,1,1,First Failure Treatment Modality,Sx
665,1,1,Clinical lab p16,p16 unknown
665,1,1,Status,Alive unk disease
665,1,1,Research lab HPV,HPV unknown
665,1,1,Tumor Stage,T4a
665,1,1,Overall Stage,IVa
665,1,1,Treatment Modality,Sx
665,1,1,First Failure Type,locoregional
665,1,1,Occurrence #,1st primary
666,1,1,Metastasis,Unknown
666,1,1,Status,Dead w/ disease
666,1,1,Age at Death,67.1
666,1,1,Research lab HPV,HPV unknown
666,1,1,Overall Stage,Unknown
666,1,1,Research lab p16,p16 unknown
666,1,1,Tumor Stage,Unknown
666,1,1,Tumor Site,oral cavity
666,1,1,Date of Death,2011-07-02 00:00:00
666,1,1,Occurrence #,1st primary
666,1,1,Clinical lab p16,p16 unknown
666,1,1,Time to Death,0.5
666,1,1,Nodal Stage,Unknown
666,1,1,First Failure Type,no known failure
666,1,1,Treatment Modality,Unknown
666,1,1,Second Failure Type,no known failure
667,1,1,Research lab HPV,HPV unknown
667,1,1,Overall Stage,IVa
667,1,1,Tumor Site,oral cavity
667,1,1,Clinical lab p16,p16 unknown
667,1,1,Radiation Dosage,59.4
667,1,1,Second Failure Type,no known failure
667,1,1,First Failure Type,no known failure
667,1,1,Tumor Stage,T4a
667,1,1,Treatment Modality,Sx & RT
667,1,1,Occurrence #,1st primary
667,1,1,Research lab p16,p16 unknown
667,1,1,Status,Alive w/o disease
667,1,1,Nodal Stage,N0
667,1,1,Metastasis,M0
668,1,1,First Failure Type,no known failure
668,1,1,Tumor Stage,T2
668,1,1,Status,Alive w/o disease
668,1,1,Occurrence #,1st primary
668,1,1,Overall Stage,II
668,1,1,Clinical lab p16,p16 unknown
668,1,1,Research lab HPV,HPV unknown
668,1,1,Research lab p16,p16 unknown
668,1,1,Metastasis,M0
668,1,1,Treatment Modality,Sx
668,1,1,Tumor Site,oral cavity
668,1,1,Nodal Stage,N0
668,1,1,Second Failure Type,no known failure
669,1,1,Status,Alive unk disease
669,1,1,Nodal Stage,N0
669,1,1,Metastasis,M0
669,1,1,Occurrence #,1st primary
669,1,1,Tumor Stage,T1
669,1,1,Overall Stage,I
669,1,1,First Failure Type,no known failure
669,1,1,Clinical lab p16,p16 unknown
669,1,1,Second Failure Type,no known failure
669,1,1,Research lab HPV,HPV unknown
669,1,1,Research lab p16,p16 unknown
669,1,1,Tumor Site,oral cavity
669,1,1,Treatment Modality,Sx
670,1,1,Second Failure Type,no known failure
670,1,1,Overall Stage,IVa
670,1,1,Metastasis,M0
670,1,1,Tumor Site,oral cavity
670,1,1,Occurrence #,recurrence
670,1,1,Radiation Dosage,63
670,1,1,Treatment Modality,Sx & CTX-RT
670,1,1,Research lab p16,p16 unknown
670,1,1,First Failure Type,no known failure
670,1,1,Clinical lab p16,p16 unknown
670,1,1,Research lab HPV,HPV unknown
670,1,1,Tumor Stage,T4a
670,1,1,Status,Alive unk disease
670,1,1,Initial Chemotherapy Agent,carbo/PTX
670,1,1,Nodal Stage,N2
671,1,1,Metastasis,M1
671,1,1,Clinical lab p16,p16 unknown
671,1,1,First Failure Type,no known failure
671,1,1,Treatment Modality,Sx
671,1,1,Research lab p16,p16 unknown
671,1,1,Tumor Site,oral cavity
671,1,1,Research lab HPV,HPV unknown
671,1,1,Tumor Stage,T1
671,1,1,Overall Stage,IVc
671,1,1,Nodal Stage,N0
671,1,1,Occurrence #,1st primary
671,1,1,Second Failure Type,no known failure
671,1,1,Status,Alive w/o disease
672,1,1,Research lab p16,p16 unknown
672,1,1,Treatment Modality,Sx
672,1,1,First Failure Type,no known failure
672,1,1,Research lab HPV,HPV unknown
672,1,1,Clinical lab p16,p16 unknown
672,1,1,Nodal Stage,N0
672,1,1,Status,Alive unk disease
672,1,1,Overall Stage,I
672,1,1,Metastasis,M0
672,1,1,Second Failure Type,no known failure
672,1,1,Tumor Site,oral cavity
672,1,1,Tumor Stage,T1
672,1,1,Occurrence #,1st primary
673,1,1,Second Failure Type,no known failure
673,1,1,Metastasis,M0
673,1,1,Overall Stage,IVa
673,1,1,Status,Dead w/ disease
673,1,1,Age at Death,66.7
673,1,1,Date of Death,2010-01-23 00:00:00
673,1,1,Clinical lab p16,p16 unknown
673,1,1,Research lab p16,p16 unknown
673,1,1,Nodal Stage,N1
673,1,1,Time to Death,2.5
673,1,1,First Failure Type,no known failure
673,1,1,Treatment Modality,Unknown
673,1,1,Occurrence #,1st primary
673,1,1,Tumor Stage,T4a
673,1,1,Research lab HPV,HPV unknown
673,1,1,Tumor Site,oral cavity
674,1,1,Treatment Modality,Sx & RT
674,1,1,Tumor Stage,T4a
674,1,1,Research lab p16,p16 unknown
674,1,1,Nodal Stage,N1
674,1,1,Date of Death,2004-01-02 00:00:00
674,1,1,Status,Dead unk disease
674,1,1,Age at Death,57.7
674,1,1,Time to Death,0.9
674,1,1,Occurrence #,1st primary
674,1,1,Second Failure Type,no known failure
674,1,1,Metastasis,M0
674,1,1,Clinical lab p16,p16 unknown
674,1,1,Tumor Site,oral cavity
674,1,1,Overall Stage,IVa
674,1,1,First Failure Type,no known failure
674,1,1,Research lab HPV,HPV unknown
674,1,1,Radiation Dosage,60
675,1,1,Nodal Stage,N1
675,1,1,First Failure Type,no known failure
675,1,1,Research lab HPV,HPV unknown
675,1,1,Time to Death,0.2
675,1,1,Metastasis,M0
675,1,1,Date of Death,2009-05-02 00:00:00
675,1,1,Treatment Modality,Sx
675,1,1,Tumor Stage,T4a
675,1,1,Research lab p16,p16 unknown
675,1,1,Second Failure Type,no known failure
675,1,1,Occurrence #,1st primary
675,1,1,Age at Death,57.0
675,1,1,Tumor Site,oral cavity
675,1,1,Overall Stage,IVa
675,1,1,Status,Dead unk disease
675,1,1,Clinical lab p16,p16 unknown
676,1,1,Occurrence #,1st primary
676,1,1,Tumor Site,oral cavity
676,1,1,Tumor Stage,T1
676,1,1,Overall Stage,I
676,1,1,Nodal Stage,N0
676,1,1,Metastasis,M0
676,1,1,Clinical lab p16,p16 unknown
676,1,1,Second Failure Type,no known failure
676,1,1,Status,Alive unk disease
676,1,1,Research lab p16,p16 unknown
676,1,1,Treatment Modality,Sx
676,1,1,Research lab HPV,HPV unknown
676,1,1,First Failure Type,no known failure
677,1,1,Second Failure Type,no known failure
677,1,1,Status,Alive w/o disease
677,1,1,Overall Stage,II
677,1,1,Metastasis,M0
677,1,1,Time to First Failure,1.0
677,1,1,Research lab p16,p16 unknown
677,1,1,Treatment Modality,Sx
677,1,1,Nodal Stage,N0
677,1,1,First Failure Type,locoregional
677,1,1,Clinical lab p16,p16 unknown
677,1,1,First Failure Treatment Modality,Sx
677,1,1,First Failure Site,oral cavity
677,1,1,Occurrence #,1st primary
677,1,1,Research lab HPV,HPV unknown
677,1,1,Tumor Stage,T2
677,1,1,Tumor Site,oral cavity
678,1,1,Clinical lab p16,p16 unknown
678,1,1,Tumor Stage,T1
678,1,1,Radiation Dosage,unknown
678,1,1,Nodal Stage,N1
678,1,1,Overall Stage,III
678,1,1,Tumor Site,oral cavity
678,1,1,Status,Alive unk disease
678,1,1,Research lab HPV,HPV unknown
678,1,1,Treatment Modality,Sx & RT
678,1,1,Occurrence #,1st primary
678,1,1,Second Failure Type,no known failure
678,1,1,Metastasis,M0
678,1,1,Research lab p16,p16 unknown
678,1,1,First Failure Type,no known failure
679,1,1,Treatment Modality,Sx
679,1,1,Research lab HPV,HPV unknown
679,1,1,Tumor Stage,T1
679,1,1,Clinical lab p16,p16 unknown
679,1,1,Occurrence #,1st primary
679,1,1,Overall Stage,I
679,1,1,Nodal Stage,N0
679,1,1,Metastasis,M0
679,1,1,First Failure Type,no known failure
679,1,1,Second Failure Type,no known failure
679,1,1,Status,Alive unk disease
679,1,1,Tumor Site,oral cavity
679,1,1,Research lab p16,p16 unknown
680,1,1,Tumor Site,oral cavity
680,1,1,Second Failure Type,no known failure
680,1,1,Metastasis,M0
680,1,1,Overall Stage,IVa
680,1,1,Radiation Dosage,63
680,1,1,Tumor Stage,T1
680,1,1,Initial Chemotherapy Agent,carbo/PTX
680,1,1,Research lab p16,p16 unknown
680,1,1,Occurrence #,1st primary
680,1,1,Status,Alive unk disease
680,1,1,Treatment Modality,Sx & CTX-RT
680,1,1,Clinical lab p16,p16 unknown
680,1,1,Research lab HPV,HPV unknown
680,1,1,Nodal Stage,N2
680,1,1,First Failure Type,no known failure
681,1,1,Tumor Site,oral cavity
681,1,1,Status,Alive w/o disease
681,1,1,Second Failure Type,no known failure
681,1,1,Research lab p16,p16 unknown
681,1,1,Metastasis,M0
681,1,1,Occurrence #,1st primary
681,1,1,Nodal Stage,N2
681,1,1,Overall Stage,IVa
681,1,1,Clinical lab p16,p16 unknown
681,1,1,First Failure Type,no known failure
681,1,1,Tumor Stage,T1
681,1,1,Research lab HPV,HPV unknown
681,1,1,Treatment Modality,Sx
682,1,1,Research lab HPV,HPV unknown
682,1,1,Nodal Stage,N0
682,1,1,Overall Stage,IVa
682,1,1,Tumor Stage,T4a
682,1,1,Metastasis,M0
682,1,1,Research lab p16,p16 unknown
682,1,1,Second Failure Type,no known failure
682,1,1,Occurrence #,1st primary
682,1,1,Treatment Modality,Sx
682,1,1,First Failure Type,no known failure
682,1,1,Tumor Site,oral cavity
682,1,1,Status,Alive unk disease
682,1,1,Clinical lab p16,p16 unknown
683,1,1,Occurrence #,1st primary
683,1,1,Overall Stage,I
683,1,1,Tumor Site,oral cavity
683,1,1,Research lab HPV,HPV unknown
683,1,1,Tumor Stage,T1
683,1,1,Status,Alive unk disease
683,1,1,Second Failure Type,no known failure
683,1,1,First Failure Type,no known failure
683,1,1,Nodal Stage,N0
683,1,1,Metastasis,M0
683,1,1,Treatment Modality,Sx
683,1,1,Research lab p16,p16 unknown
683,1,1,Clinical lab p16,p16 unknown
684,1,1,Initial Chemotherapy Agent,cis/5 FU
684,1,1,Second Line Chemotherapy Agent,doce
684,1,1,Status,Dead unk disease
684,1,1,Overall Stage,IVa
684,1,1,Date of Death,2004-01-26 00:00:00
684,1,1,Nodal Stage,N2
684,1,1,Second Failure Type,no known failure
684,1,1,Time to Death,1.8
684,1,1,Clinical lab p16,p16 unknown
684,1,1,Treatment Modality,Sx & CTX
684,1,1,Age at Death,59.0
684,1,1,Research lab p16,p16 unknown
684,1,1,Metastasis,M0
684,1,1,Occurrence #,1st primary
684,1,1,Tumor Stage,T2
684,1,1,First Failure Type,no known failure
684,1,1,Tumor Site,oral cavity
684,1,1,Research lab HPV,HPV unknown
685,1,1,Nodal Stage,N0
685,1,1,Research lab HPV,HPV unknown
685,1,1,First Failure Type,no known failure
685,1,1,Tumor Site,oral cavity
685,1,1,Treatment Modality,Sx
685,1,1,Metastasis,M0
685,1,1,Second Failure Type,no known failure
685,1,1,Time to Death,4.5
685,1,1,Tumor Stage,T4a
685,1,1,Age at Death,81.5
685,1,1,Clinical lab p16,p16 unknown
685,1,1,Date of Death,2011-03-05 00:00:00
685,1,1,Occurrence #,1st primary
685,1,1,Research lab p16,p16 unknown
685,1,1,Overall Stage,IVa
685,1,1,Status,Dead unk disease
686,1,1,Treatment Modality,Sx
686,1,1,Tumor Site,oral cavity
686,1,1,Second Failure Type,no known failure
686,1,1,Status,Dead unk disease
686,1,1,Research lab HPV,HPV unknown
686,1,1,Occurrence #,1st primary
686,1,1,Research lab p16,p16 unknown
686,1,1,Tumor Stage,T1
686,1,1,Overall Stage,I
686,1,1,Age at Death,70.7
686,1,1,Time to Death,6.3
686,1,1,Date of Death,2008-05-21 00:00:00
686,1,1,Nodal Stage,N0
686,1,1,Metastasis,M0
686,1,1,Clinical lab p16,p16 unknown
686,1,1,First Failure Type,no known failure
688,1,1,Second Failure Type,no known failure
688,1,1,Research lab p16,p16 unknown
688,1,1,Time to First Failure,5.0
688,1,1,Occurrence #,1st primary
688,1,1,Research lab HPV,HPV unknown
688,1,1,First Failure Treatment Modality,Sx & RT
688,1,1,Status,Alive w/o disease
688,1,1,Tumor Stage,T1
688,1,1,Metastasis,M0
688,1,1,First Failure Site,oral cavity
688,1,1,Nodal Stage,N0
688,1,1,First Failure Type,locoregional
688,1,1,First Failure Radiation Dosage,59.4
688,1,1,Clinical lab p16,p16 unknown
688,1,1,Treatment Modality,Sx
688,1,1,Overall Stage,I
688,1,1,Tumor Site,oral cavity
689,1,1,Treatment Modality,Sx & RT
689,1,1,Clinical lab p16,p16 unknown
689,1,1,Date of Death,2000-10-30 00:00:00
689,1,1,Tumor Stage,T4a
689,1,1,Status,Dead w/ disease
689,1,1,Research lab HPV,HPV unknown
689,1,1,Time to Death,0.8
689,1,1,Tumor Site,oral cavity
689,1,1,Research lab p16,p16 unknown
689,1,1,Age at Death,59.0
689,1,1,Second Failure Type,no known failure
689,1,1,Time to First Failure,0.1
689,1,1,Radiation Dosage,unknown
689,1,1,Overall Stage,IVa
689,1,1,First Failure Type,locoregional
689,1,1,Occurrence #,1st primary
689,1,1,First Failure Site,oral cavity
689,1,1,Metastasis,M0
689,1,1,Nodal Stage,N1
690,1,1,Status,Dead w/ disease
690,1,1,Treatment Modality,Sx & RT
690,1,1,Overall Stage,IVa
690,1,1,Time to First Failure,0.7
690,1,1,Time to Death,1.4
690,1,1,Age at Death,81.4
690,1,1,Research lab HPV,HPV unknown
690,1,1,Radiation Dosage,60
690,1,1,Nodal Stage,N2
690,1,1,Metastasis,M0
690,1,1,First Failure Type,locoregional
690,1,1,Clinical lab p16,p16 unknown
690,1,1,Occurrence #,1st primary
690,1,1,Date of Death,2011-08-12 00:00:00
690,1,1,Tumor Site,oral cavity
690,1,1,Research lab p16,p16 unknown
690,1,1,Tumor Stage,T4a
690,1,1,Second Failure Type,no known failure
691,1,1,Date of Death,2004-06-13 00:00:00
691,1,1,Research lab HPV,HPV unknown
691,1,1,Overall Stage,IVa
691,1,1,Age at Death,56.8
691,1,1,Tumor Stage,T2
691,1,1,Time to Death,1.8
691,1,1,Metastasis,M0
691,1,1,Occurrence #,1st primary
691,1,1,Research lab p16,p16 unknown
691,1,1,Nodal Stage,N2
691,1,1,Tumor Site,oral cavity
691,1,1,Second Failure Type,no known failure
691,1,1,Treatment Modality,Sx & RT
691,1,1,Radiation Dosage,unknown
691,1,1,Clinical lab p16,p16 unknown
691,1,1,First Failure Type,distant
691,1,1,Time to First Failure,1.5
691,1,1,Status,Dead w/ disease
692,1,1,Clinical lab p16,p16 unknown
692,1,1,Research lab p16,p16 unknown
692,1,1,Second Failure Type,no known failure
692,1,1,Treatment Modality,Sx
692,1,1,First Failure Type,no known failure
692,1,1,Status,Alive w/o disease
692,1,1,Overall Stage,I
692,1,1,Tumor Stage,T1
692,1,1,Nodal Stage,N0
692,1,1,Tumor Site,oral cavity
692,1,1,Research lab HPV,HPV unknown
692,1,1,Metastasis,M0
692,1,1,Occurrence #,1st primary
693,1,1,First Failure Type,no known failure
693,1,1,Metastasis,M0
693,1,1,Radiation Dosage,63
693,1,1,Tumor Site,oral cavity
693,1,1,Research lab p16,p16 unknown
693,1,1,Second Failure Type,no known failure
693,1,1,Research lab HPV,HPV unknown
693,1,1,Treatment Modality,Sx & RT
693,1,1,Nodal Stage,N2
693,1,1,Overall Stage,IVa
693,1,1,Status,Alive w/o disease
693,1,1,Tumor Stage,T2
693,1,1,Clinical lab p16,p16 unknown
693,1,1,Occurrence #,1st primary
694,1,1,Overall Stage,IVa
694,1,1,Initial Chemotherapy Agent,cis
694,1,1,Clinical lab p16,p16 unknown
694,1,1,Status,Dead w/ disease
694,1,1,Occurrence #,1st primary
694,1,1,Date of Death,2005-03-29 00:00:00
694,1,1,Age at Death,59.9
694,1,1,Research lab p16,p16 unknown
694,1,1,Metastasis,M0
694,1,1,Radiation Dosage,63
694,1,1,Research lab HPV,HPV unknown
694,1,1,Nodal Stage,N2
694,1,1,Time to Death,1.4
694,1,1,First Failure Type,distant
694,1,1,Time to First Failure,0.2
694,1,1,Tumor Stage,T4a
694,1,1,Tumor Site,oral cavity
694,1,1,Treatment Modality,Sx & CTX-RT
694,1,1,Second Failure Type,no known failure
695,1,1,Research lab HPV,HPV unknown
695,1,1,Clinical lab p16,p16 unknown
695,1,1,Overall Stage,II
695,1,1,Time to Death,0.3
695,1,1,Treatment Modality,RT
695,1,1,First Failure Type,no known failure
695,1,1,Research lab p16,p16 unknown
695,1,1,Nodal Stage,N0
695,1,1,Occurrence #,1st primary
695,1,1,Age at Death,76.7
695,1,1,Date of Death,2001-10-20 00:00:00
695,1,1,Status,Dead unk disease
695,1,1,Tumor Site,oral cavity
695,1,1,Second Failure Type,no known failure
695,1,1,Tumor Stage,T2
695,1,1,Radiation Dosage,50
695,1,1,Metastasis,M0
696,1,1,Treatment Modality,Sx
696,1,1,Occurrence #,1st primary
696,1,1,Research lab HPV,HPV unknown
696,1,1,Status,Alive unk disease
696,1,1,Clinical lab p16,p16 unknown
696,1,1,First Failure Site,oral cavity
696,1,1,First Failure Treatment Modality,Sx
696,1,1,Overall Stage,I
696,1,1,Research lab p16,p16 unknown
696,1,1,Tumor Stage,T1
696,1,1,Nodal Stage,N0
696,1,1,Time to First Failure,2.9
696,1,1,First Failure Type,locoregional
696,1,1,Tumor Site,oral cavity
696,1,1,Metastasis,M0
696,1,1,Second Failure Type,no known failure
698,1,1,Second Failure Type,no known failure
698,1,1,First Failure Type,no known failure
698,1,1,Overall Stage,I
698,1,1,Tumor Stage,T1
698,1,1,Status,Alive unk disease
698,1,1,Treatment Modality,Sx
698,1,1,Tumor Site,oral cavity
698,1,1,Occurrence #,1st primary
698,1,1,Metastasis,M0
698,1,1,Nodal Stage,N0
698,1,1,Clinical lab p16,p16 unknown
698,1,1,Research lab p16,p16 unknown
698,1,1,Research lab HPV,HPV unknown
699,1,1,Nodal Stage,N0
699,1,1,Research lab HPV,HPV unknown
699,1,1,Second Failure Type,no known failure
699,1,1,Occurrence #,1st primary
699,1,1,Clinical lab p16,p16 unknown
699,1,1,Metastasis,M0
699,1,1,Research lab p16,p16 unknown
699,1,1,Tumor Stage,T1
699,1,1,Tumor Site,oral cavity
699,1,1,First Failure Type,no known failure
699,1,1,Treatment Modality,Sx
699,1,1,Overall Stage,I
699,1,1,Status,Alive w/o disease
700,1,1,Tumor Stage,T1
700,1,1,Tumor Site,oral cavity
700,1,1,Research lab HPV,HPV unknown
700,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
700,1,1,Time to Death,1.9
700,1,1,Occurrence #,1st primary
700,1,1,First Failure Radiation Dosage,30.6
700,1,1,Metastasis,M0
700,1,1,Date of Death,2007-01-14 00:00:00
700,1,1,Treatment Modality,Sx
700,1,1,Clinical lab p16,p16 unknown
700,1,1,Second Failure Type,no known failure
700,1,1,First Failure Type,locoregional
700,1,1,Age at Death,40.9
700,1,1,Research lab p16,p16 unknown
700,1,1,Overall Stage,IVa
700,1,1,First Failure Treatment Modality,Sx & CTX-RT
700,1,1,Nodal Stage,N2
700,1,1,Status,Dead w/ disease
700,1,1,Time to First Failure,-0.1
701,1,1,Second Failure Type,no known failure
701,1,1,Research lab p16,p16 unknown
701,1,1,Metastasis,M0
701,1,1,Occurrence #,1st primary
701,1,1,Clinical lab p16,p16 unknown
701,1,1,Research lab HPV,HPV unknown
701,1,1,Nodal Stage,N1
701,1,1,Tumor Site,oral cavity
701,1,1,Overall Stage,III
701,1,1,Treatment Modality,Sx
701,1,1,Tumor Stage,T2
701,1,1,First Failure Type,no known failure
701,1,1,Status,Alive unk disease
702,1,1,Second Failure Type,no known failure
702,1,1,Tumor Stage,T1
702,1,1,Research lab p16,p16 unknown
702,1,1,Overall Stage,I
702,1,1,Research lab HPV,HPV unknown
702,1,1,Metastasis,M0
702,1,1,Clinical lab p16,p16 unknown
702,1,1,Tumor Site,oral cavity
702,1,1,Status,Alive unk disease
702,1,1,First Failure Type,no known failure
702,1,1,Treatment Modality,Sx
702,1,1,Occurrence #,1st primary
702,1,1,Nodal Stage,N0
703,1,1,Status,Dead unk disease
703,1,1,Second Failure Type,no known failure
703,1,1,Metastasis,M0
703,1,1,Overall Stage,IVa
703,1,1,Age at Death,53.2
703,1,1,Research lab p16,p16 unknown
703,1,1,Treatment Modality,Sx
703,1,1,First Failure Type,no known failure
703,1,1,Nodal Stage,N2
703,1,1,Tumor Site,oral cavity
703,1,1,Time to Death,0.3
703,1,1,Tumor Stage,T4a
703,1,1,Clinical lab p16,p16 unknown
703,1,1,Date of Death,2001-11-30 00:00:00
703,1,1,Occurrence #,1st primary
703,1,1,Research lab HPV,HPV unknown
704,1,1,Clinical lab p16,p16 unknown
704,1,1,Research lab p16,p16 unknown
704,1,1,Second Failure Type,no known failure
704,1,1,First Failure Type,no known failure
704,1,1,Research lab HPV,HPV unknown
704,1,1,Metastasis,M0
704,1,1,Treatment Modality,Sx
704,1,1,Nodal Stage,N0
704,1,1,Occurrence #,1st primary
704,1,1,Tumor Site,oral cavity
704,1,1,Status,Alive unk disease
704,1,1,Tumor Stage,T1
704,1,1,Overall Stage,I
705,1,1,First Failure Type,no known failure
705,1,1,Tumor Stage,T3
705,1,1,Research lab p16,p16 unknown
705,1,1,Nodal Stage,N0
705,1,1,Metastasis,M0
705,1,1,Clinical lab p16,p16 unknown
705,1,1,Research lab HPV,HPV unknown
705,1,1,Occurrence #,1st primary
705,1,1,Tumor Site,oral cavity
705,1,1,Treatment Modality,Sx
705,1,1,Status,Alive unk disease
705,1,1,Second Failure Type,no known failure
705,1,1,Overall Stage,III
706,1,1,Tumor Site,oral cavity
706,1,1,Overall Stage,IVa
706,1,1,Status,Alive w/o disease
706,1,1,First Failure Type,no known failure
706,1,1,Second Failure Type,no known failure
706,1,1,Nodal Stage,N2
706,1,1,Metastasis,M0
706,1,1,Research lab HPV,HPV unknown
706,1,1,Research lab p16,p16 unknown
706,1,1,Tumor Stage,T4a
706,1,1,Clinical lab p16,p16 unknown
706,1,1,Treatment Modality,Sx
706,1,1,Occurrence #,1st primary
707,1,1,Research lab HPV,HPV unknown
707,1,1,Status,Alive unk disease
707,1,1,Overall Stage,IVa
707,1,1,First Failure Type,no known failure
707,1,1,Clinical lab p16,p16 unknown
707,1,1,Metastasis,M0
707,1,1,Research lab p16,p16 unknown
707,1,1,Nodal Stage,N1
707,1,1,Occurrence #,1st primary
707,1,1,Second Failure Type,no known failure
707,1,1,Tumor Stage,T4a
707,1,1,Tumor Site,oral cavity
707,1,1,Treatment Modality,Sx
708,1,1,Research lab HPV,HPV unknown
708,1,1,First Failure Type,no known failure
708,1,1,Treatment Modality,Sx
708,1,1,Overall Stage,I
708,1,1,Tumor Site,oral cavity
708,1,1,Occurrence #,1st primary
708,1,1,Tumor Stage,T1
708,1,1,Clinical lab p16,p16 unknown
708,1,1,Status,Alive w/o disease
708,1,1,Second Failure Type,no known failure
708,1,1,Nodal Stage,N0
708,1,1,Metastasis,M0
708,1,1,Research lab p16,p16 unknown
709,1,1,Tumor Site,oral cavity
709,1,1,Status,Alive unk disease
709,1,1,Occurrence #,1st primary
709,1,1,Second Failure Type,no known failure
709,1,1,First Failure Type,no known failure
709,1,1,Overall Stage,I
709,1,1,Clinical lab p16,p16 unknown
709,1,1,Treatment Modality,Sx
709,1,1,Tumor Stage,T1
709,1,1,Nodal Stage,N0
709,1,1,Research lab p16,p16 unknown
709,1,1,Metastasis,M0
709,1,1,Research lab HPV,HPV unknown
710,1,1,First Failure Type,no known failure
710,1,1,Age at Death,80.7
710,1,1,Research lab p16,p16 unknown
710,1,1,Second Failure Type,no known failure
710,1,1,Status,Dead unk disease
710,1,1,Nodal Stage,N0
710,1,1,Overall Stage,I
710,1,1,Metastasis,M0
710,1,1,Treatment Modality,Sx
710,1,1,Research lab HPV,HPV unknown
710,1,1,Clinical lab p16,p16 unknown
710,1,1,Date of Death,2004-01-04 00:00:00
710,1,1,Tumor Site,oral cavity
710,1,1,Time to Death,1.7
710,1,1,Tumor Stage,T1
710,1,1,Occurrence #,1st primary
711,1,1,Treatment Modality,Sx
711,1,1,Metastasis,M0
711,1,1,Clinical lab p16,p16 unknown
711,1,1,Research lab HPV,HPV unknown
711,1,1,Age at Death,61.9
711,1,1,Overall Stage,IVa
711,1,1,First Failure Type,no known failure
711,1,1,Nodal Stage,N0
711,1,1,Research lab p16,p16 unknown
711,1,1,Time to Death,3.6
711,1,1,Tumor Stage,T4a
711,1,1,Date of Death,2004-02-19 00:00:00
711,1,1,Occurrence #,1st primary
711,1,1,Tumor Site,oral cavity
711,1,1,Status,Dead unk disease
711,1,1,Second Failure Type,no known failure
712,1,1,Tumor Site,oral cavity
712,1,1,Clinical lab p16,p16 unknown
712,1,1,Nodal Stage,N0
712,1,1,Age at Death,84.3
712,1,1,Treatment Modality,Sx & RT
712,1,1,First Failure Type,locoregional
712,1,1,Date of Death,2011-01-21 00:00:00
712,1,1,Time to Death,7.0
712,1,1,Overall Stage,IVa
712,1,1,Research lab HPV,HPV unknown
712,1,1,Status,Dead unk disease
712,1,1,Radiation Dosage,60
712,1,1,First Failure Site,oral cavity
712,1,1,Metastasis,M0
712,1,1,Occurrence #,recurrence
712,1,1,Tumor Stage,T4a
712,1,1,First Failure Treatment Modality,Sx
712,1,1,Second Failure Type,no known failure
712,1,1,Time to First Failure,2.8
712,1,1,Research lab p16,p16 unknown
713,1,1,Tumor Stage,T1
713,1,1,Overall Stage,I
713,1,1,Occurrence #,1st primary
713,1,1,Research lab p16,p16 unknown
713,1,1,Nodal Stage,N0
713,1,1,First Failure Type,no known failure
713,1,1,Second Failure Type,no known failure
713,1,1,Metastasis,M0
713,1,1,Clinical lab p16,p16 unknown
713,1,1,Treatment Modality,Sx
713,1,1,Tumor Site,oral cavity
713,1,1,Research lab HPV,HPV unknown
713,1,1,Status,Alive unk disease
714,1,1,Nodal Stage,Unknown
714,1,1,Status,Dead unk disease
714,1,1,Occurrence #,recurrence
714,1,1,Metastasis,M1
714,1,1,Tumor Site,oral cavity
714,1,1,Second Failure Type,no known failure
714,1,1,Treatment Modality,Unknown
714,1,1,Research lab HPV,HPV unknown
714,1,1,Tumor Stage,Unknown
714,1,1,Age at Death,55.9
714,1,1,Date of Death,2005-01-21 00:00:00
714,1,1,Time to Death,1.0
714,1,1,Overall Stage,IVc
714,1,1,First Failure Type,distant
714,1,1,Clinical lab p16,p16 unknown
714,1,1,Research lab p16,p16 unknown
715,1,1,Occurrence #,1st primary
715,1,1,Treatment Modality,Sx
715,1,1,Metastasis,M0
715,1,1,First Failure Type,no known failure
715,1,1,Research lab p16,p16 unknown
715,1,1,Clinical lab p16,p16 unknown
715,1,1,Nodal Stage,N0
715,1,1,Research lab HPV,HPV unknown
715,1,1,Status,Alive unk disease
715,1,1,Second Failure Type,no known failure
715,1,1,Tumor Stage,T1
715,1,1,Tumor Site,oral cavity
715,1,1,Overall Stage,I
716,1,1,Tumor Stage,T1
716,1,1,Treatment Modality,Sx
716,1,1,First Failure Type,no known failure
716,1,1,Clinical lab p16,p16 unknown
716,1,1,Metastasis,M0
716,1,1,Overall Stage,I
716,1,1,Status,Alive unk disease
716,1,1,Second Failure Type,no known failure
716,1,1,Tumor Site,oral cavity
716,1,1,Occurrence #,1st primary
716,1,1,Research lab HPV,HPV unknown
716,1,1,Research lab p16,p16 unknown
716,1,1,Nodal Stage,N0
717,1,1,Second Failure Type,no known failure
717,1,1,Time to Death,4.1
717,1,1,Nodal Stage,N2
717,1,1,Overall Stage,IVa
717,1,1,Research lab HPV,HPV unknown
717,1,1,Treatment Modality,Sx
717,1,1,Metastasis,M0
717,1,1,Tumor Stage,T4a
717,1,1,Status,Dead unk disease
717,1,1,Clinical lab p16,p16 unknown
717,1,1,Occurrence #,1st primary
717,1,1,Age at Death,57.7
717,1,1,Research lab p16,p16 unknown
717,1,1,Tumor Site,oral cavity
717,1,1,First Failure Type,no known failure
717,1,1,Date of Death,2005-09-08 00:00:00
718,1,1,Tumor Stage,T2
718,1,1,Occurrence #,1st primary
718,1,1,Status,Dead unk disease
718,1,1,Nodal Stage,N0
718,1,1,Clinical lab p16,p16 unknown
718,1,1,Metastasis,M0
718,1,1,Treatment Modality,Sx
718,1,1,Age at Death,83.8
718,1,1,Research lab p16,p16 unknown
718,1,1,First Failure Type,no known failure
718,1,1,Research lab HPV,HPV unknown
718,1,1,Date of Death,2005-01-17 00:00:00
718,1,1,Second Failure Type,no known failure
718,1,1,Tumor Site,oral cavity
718,1,1,Time to Death,3.6
718,1,1,Overall Stage,II
719,1,1,Overall Stage,II
719,1,1,Nodal Stage,N0
719,1,1,Date of Death,2005-12-30 00:00:00
719,1,1,Status,Dead unk disease
719,1,1,Second Failure Type,no known failure
719,1,1,Research lab p16,p16 unknown
719,1,1,Occurrence #,1st primary
719,1,1,Metastasis,M0
719,1,1,Tumor Stage,T2
719,1,1,Research lab HPV,HPV unknown
719,1,1,Age at Death,86.5
719,1,1,Time to Death,0.7
719,1,1,Treatment Modality,Unknown
719,1,1,First Failure Type,no known failure
719,1,1,Tumor Site,oral cavity
719,1,1,Clinical lab p16,p16 unknown
720,1,1,Research lab p16,p16 unknown
720,1,1,Occurrence #,1st primary
720,1,1,Overall Stage,III
720,1,1,First Failure Type,no known failure
720,1,1,Nodal Stage,N1
720,1,1,Metastasis,M0
720,1,1,Clinical lab p16,p16 unknown
720,1,1,Tumor Site,oral cavity
720,1,1,Status,Alive w/o disease
720,1,1,Second Failure Type,no known failure
720,1,1,Research lab HPV,HPV unknown
720,1,1,Tumor Stage,T2
720,1,1,Treatment Modality,Sx
721,1,1,Overall Stage,I
721,1,1,Second Failure Type,no known failure
721,1,1,Status,Alive w/ disease
721,1,1,Tumor Site,oral cavity
721,1,1,Tumor Stage,T1
721,1,1,Treatment Modality,Sx
721,1,1,First Failure Type,locoregional
721,1,1,First Failure Treatment Modality,Sx
721,1,1,Clinical lab p16,p16 unknown
721,1,1,Metastasis,M0
721,1,1,Time to First Failure,0.2
721,1,1,First Failure Site,oral cavity
721,1,1,Research lab p16,p16 unknown
721,1,1,Nodal Stage,N0
721,1,1,Occurrence #,1st primary
721,1,1,Research lab HPV,HPV unknown
722,1,1,Tumor Site,oral cavity
722,1,1,Nodal Stage,N0
722,1,1,Metastasis,M0
722,1,1,Age at Death,57.7
722,1,1,Tumor Stage,T1
722,1,1,First Failure Site,oral cavity
722,1,1,First Failure Treatment Modality,Sx
722,1,1,Time to Death,4.9
722,1,1,Treatment Modality,Sx
722,1,1,First Failure Type,locoregional
722,1,1,Clinical lab p16,p16 unknown
722,1,1,Time to First Failure,2.5
722,1,1,Research lab HPV,HPV unknown
722,1,1,Second Failure Type,no known failure
722,1,1,Occurrence #,1st primary
722,1,1,Research lab p16,p16 unknown
722,1,1,Overall Stage,I
722,1,1,Status,Dead unk disease
722,1,1,Date of Death,2008-07-04 00:00:00
723,1,1,Status,Alive unk disease
723,1,1,Clinical lab p16,p16 unknown
723,1,1,Overall Stage,I
723,1,1,Occurrence #,1st primary
723,1,1,Research lab HPV,HPV unknown
723,1,1,Second Failure Type,no known failure
723,1,1,Research lab p16,p16 unknown
723,1,1,First Failure Type,no known failure
723,1,1,Nodal Stage,N0
723,1,1,Tumor Stage,T1
723,1,1,Tumor Site,oral cavity
723,1,1,Metastasis,M0
723,1,1,Treatment Modality,Sx
724,1,1,Time to Death,0.8
724,1,1,Tumor Stage,Unknown
724,1,1,Metastasis,M0
724,1,1,Age at Death,52.9
724,1,1,Occurrence #,1st primary
724,1,1,Nodal Stage,N2
724,1,1,Tumor Site,oral cavity
724,1,1,Status,Dead unk disease
724,1,1,Treatment Modality,Unknown
724,1,1,Second Failure Type,no known failure
724,1,1,First Failure Type,no known failure
724,1,1,Research lab HPV,HPV unknown
724,1,1,Research lab p16,p16 unknown
724,1,1,Date of Death,2007-04-01 00:00:00
724,1,1,Clinical lab p16,p16 unknown
724,1,1,Overall Stage,IVa
725,1,1,Tumor Stage,T1
725,1,1,Occurrence #,1st primary
725,1,1,Overall Stage,I
725,1,1,Research lab p16,p16 unknown
725,1,1,Status,Alive unk disease
725,1,1,Second Failure Type,no known failure
725,1,1,First Failure Type,locoregional
725,1,1,Research lab HPV,HPV unknown
725,1,1,Time to First Failure,3.2
725,1,1,Clinical lab p16,p16 unknown
725,1,1,First Failure Site,oral cavity
725,1,1,Treatment Modality,Sx
725,1,1,First Failure Treatment Modality,Sx
725,1,1,Metastasis,M0
725,1,1,Nodal Stage,N0
725,1,1,Tumor Site,oral cavity
726,1,1,Tumor Stage,T4a
726,1,1,Research lab HPV,HPV unknown
726,1,1,Time to Death,7.7
726,1,1,Nodal Stage,N0
726,1,1,Radiation Dosage,59.4
726,1,1,Metastasis,M0
726,1,1,Clinical lab p16,p16 unknown
726,1,1,Treatment Modality,Sx & RT
726,1,1,First Failure Type,no known failure
726,1,1,Overall Stage,IVa
726,1,1,Age at Death,66.6
726,1,1,Date of Death,2009-09-11 00:00:00
726,1,1,Occurrence #,1st primary
726,1,1,Tumor Site,oral cavity
726,1,1,Status,Dead unk disease
726,1,1,Research lab p16,p16 unknown
726,1,1,Second Failure Type,no known failure
727,1,1,Time to First Failure,0.4
727,1,1,Tumor Stage,T4a
727,1,1,Time to Death,0.8
727,1,1,Second Failure Type,no known failure
727,1,1,Occurrence #,recurrence
727,1,1,Tumor Site,oral cavity
727,1,1,Status,Dead unk disease
727,1,1,Date of Death,2001-07-28 00:00:00
727,1,1,Overall Stage,IVa
727,1,1,Age at Death,62.9
727,1,1,First Failure Type,distant
727,1,1,Clinical lab p16,p16 unknown
727,1,1,Radiation Dosage,unknown
727,1,1,Research lab p16,p16 unknown
727,1,1,Treatment Modality,Sx
727,1,1,Metastasis,M0
727,1,1,Research lab HPV,HPV unknown
727,1,1,Nodal Stage,N2
728,1,1,Occurrence #,1st primary
728,1,1,First Failure Type,locoregional
728,1,1,Clinical lab p16,p16 unknown
728,1,1,Time to First Failure,5.5
728,1,1,First Failure Site,oral cavity
728,1,1,Treatment Modality,Sx
728,1,1,Metastasis,M0
728,1,1,Tumor Site,oral cavity
728,1,1,Tumor Stage,T1
728,1,1,Status,Dead w/ disease
728,1,1,Second Failure Type,no known failure
728,1,1,Overall Stage,I
728,1,1,Research lab HPV,HPV unknown
728,1,1,Nodal Stage,N0
728,1,1,First Failure Treatment Modality,Sx
728,1,1,Research lab p16,p16 unknown
729,1,1,Nodal Stage,N1
729,1,1,Treatment Modality,Sx
729,1,1,Time to First Failure,1.0
729,1,1,Clinical lab p16,p16 unknown
729,1,1,Metastasis,M0
729,1,1,Tumor Stage,T4a
729,1,1,Overall Stage,IVa
729,1,1,Age at Death,82.6
729,1,1,Research lab HPV,HPV unknown
729,1,1,Time to Death,1.6
729,1,1,Second Failure Type,no known failure
729,1,1,Tumor Site,oral cavity
729,1,1,Occurrence #,1st primary
729,1,1,Status,Dead unk disease
729,1,1,First Failure Type,locoregional
729,1,1,Research lab p16,p16 unknown
729,1,1,Date of Death,2002-06-11 00:00:00
730,1,1,Overall Stage,IVa
730,1,1,Occurrence #,recurrence
730,1,1,Nodal Stage,N1
730,1,1,Age at Death,81.4
730,1,1,Time to Death,0.4
730,1,1,Tumor Stage,T4a
730,1,1,Status,Dead w/ disease
730,1,1,Research lab p16,p16 unknown
730,1,1,First Failure Type,locoregional and distant
730,1,1,Research lab HPV,HPV unknown
730,1,1,Date of Death,2011-02-27 00:00:00
730,1,1,Clinical lab p16,p16 unknown
730,1,1,Time to First Failure,0.2
730,1,1,Second Failure Type,no known failure
730,1,1,Metastasis,M0
730,1,1,Tumor Site,oral cavity
730,1,1,Treatment Modality,Sx
731,1,1,Clinical lab p16,p16 unknown
731,1,1,Time to Death,4.5
731,1,1,Metastasis,M0
731,1,1,Treatment Modality,Sx
731,1,1,First Failure Type,no known failure
731,1,1,Research lab p16,p16 unknown
731,1,1,Overall Stage,IVa
731,1,1,Research lab HPV,HPV unknown
731,1,1,Nodal Stage,N0
731,1,1,Tumor Stage,T4a
731,1,1,Date of Death,2006-09-04 00:00:00
731,1,1,Second Failure Type,no known failure
731,1,1,Tumor Site,oral cavity
731,1,1,Occurrence #,1st primary
731,1,1,Status,Dead unk disease
731,1,1,Age at Death,59.5
732,1,1,Time to Death,7.0
732,1,1,Tumor Site,oral cavity
732,1,1,First Failure Site,oral cavity
732,1,1,Treatment Modality,Sx & RT
732,1,1,Age at Death,77.5
732,1,1,Overall Stage,IVa
732,1,1,Status,Dead w/o disease
732,1,1,Research lab HPV,HPV unknown
732,1,1,Occurrence #,1st primary
732,1,1,Date of Death,2010-05-23 00:00:00
732,1,1,Second Failure Type,no known failure
732,1,1,First Failure Type,locoregional
732,1,1,Nodal Stage,N0
732,1,1,Time to First Failure,1.0
732,1,1,Clinical lab p16,p16 unknown
732,1,1,Research lab p16,p16 unknown
732,1,1,Radiation Dosage,unknown
732,1,1,First Failure Treatment Modality,Sx
732,1,1,Metastasis,M0
732,1,1,Tumor Stage,T4a
733,1,1,Occurrence #,recurrence
733,1,1,Research lab HPV,HPV unknown
733,1,1,Metastasis,M0
733,1,1,Second Failure Type,no known failure
733,1,1,Overall Stage,IVb
733,1,1,Treatment Modality,Sx
733,1,1,Tumor Site,oral cavity
733,1,1,Research lab p16,p16 unknown
733,1,1,First Failure Type,distant
733,1,1,Tumor Stage,T2
733,1,1,Time to Death,1.8
733,1,1,Date of Death,2005-04-21 00:00:00
733,1,1,Nodal Stage,N3
733,1,1,Status,Dead unk disease
733,1,1,Time to First Failure,0.7
733,1,1,Age at Death,51.5
733,1,1,Clinical lab p16,p16 unknown
734,1,1,Tumor Stage,T2
734,1,1,Treatment Modality,Sx
734,1,1,Clinical lab p16,p16 unknown
734,1,1,Second Failure Type,no known failure
734,1,1,Tumor Site,oral cavity
734,1,1,Metastasis,M0
734,1,1,Research lab HPV,HPV unknown
734,1,1,First Failure Type,no known failure
734,1,1,Research lab p16,p16 unknown
734,1,1,Status,Alive unk disease
734,1,1,Occurrence #,1st primary
734,1,1,Overall Stage,II
734,1,1,Nodal Stage,N0
735,1,1,Status,Dead w/o disease
735,1,1,First Failure Type,no known failure
735,1,1,Clinical lab p16,p16 unknown
735,1,1,Second Failure Type,no known failure
735,1,1,Metastasis,M0
735,1,1,Research lab p16,p16 unknown
735,1,1,First Failure Site,oral cavity
735,1,1,Occurrence #,other primary
735,1,1,Tumor Stage,T1
735,1,1,Tumor Site,oral cavity
735,1,1,Research lab HPV,HPV unknown
735,1,1,First Failure Treatment Modality,Sx
735,1,1,Nodal Stage,N0
735,1,1,Treatment Modality,Sx
735,1,1,Overall Stage,I
737,1,1,Second Failure Type,no known failure
737,1,1,Overall Stage,IVa
737,1,1,Metastasis,M0
737,1,1,Nodal Stage,N2
737,1,1,Radiation Dosage,unknown
737,1,1,Age at Death,59.0
737,1,1,Research lab HPV,HPV unknown
737,1,1,Research lab p16,p16 unknown
737,1,1,Occurrence #,1st primary
737,1,1,Date of Death,2011-12-23 00:00:00
737,1,1,Clinical lab p16,p16 unknown
737,1,1,Time to First Failure,0.8
737,1,1,Time to Death,3.2
737,1,1,Initial Chemotherapy Agent,carbo/doce/panitumab
737,1,1,Tumor Site,oral cavity
737,1,1,Tumor Stage,T4a
737,1,1,Treatment Modality,Sx & CTX-RT
737,1,1,First Failure Type,distant
737,1,1,Status,Dead w/ disease
738,1,1,Status,Alive w/o disease
738,1,1,First Failure Type,no known failure
738,1,1,Occurrence #,1st primary
738,1,1,Clinical lab p16,p16 unknown
738,1,1,Research lab p16,p16 unknown
738,1,1,Tumor Site,oral cavity
738,1,1,Second Failure Type,no known failure
738,1,1,Treatment Modality,Sx
738,1,1,Tumor Stage,T1
738,1,1,Overall Stage,I
738,1,1,Nodal Stage,N0
738,1,1,Research lab HPV,HPV unknown
738,1,1,Metastasis,M0
739,1,1,Nodal Stage,Unknown
739,1,1,Date of Death,2006-01-17 00:00:00
739,1,1,Second Failure Type,no known failure
739,1,1,Overall Stage,Unknown
739,1,1,Metastasis,Unknown
739,1,1,Research lab HPV,HPV unknown
739,1,1,First Failure Type,no known failure
739,1,1,Tumor Stage,Unknown
739,1,1,Time to Death,5.2
739,1,1,Status,Dead unk disease
739,1,1,Occurrence #,1st primary
739,1,1,Research lab p16,p16 unknown
739,1,1,Treatment Modality,Unknown
739,1,1,Tumor Site,oral cavity
739,1,1,Age at Death,69.3
739,1,1,Clinical lab p16,p16 unknown
740,1,1,Research lab HPV,HPV unknown
740,1,1,Clinical lab p16,p16 unknown
740,1,1,Research lab p16,p16 unknown
740,1,1,Overall Stage,I
740,1,1,Second Failure Type,no known failure
740,1,1,First Failure Type,no known failure
740,1,1,Nodal Stage,N0
740,1,1,Status,Dead unk disease
740,1,1,Occurrence #,1st primary
740,1,1,Age at Death,57.5
740,1,1,Tumor Site,oral cavity
740,1,1,Metastasis,M0
740,1,1,Date of Death,2006-10-07 00:00:00
740,1,1,Tumor Stage,T1
740,1,1,Treatment Modality,Sx
740,1,1,Time to Death,6.8
741,1,1,Tumor Stage,T1
741,1,1,First Failure Site,oral cavity
741,1,1,First Failure Type,locoregional
741,1,1,First Failure Treatment Modality,Sx
741,1,1,Occurrence #,1st primary
741,1,1,Date of Death,2010-05-18 00:00:00
741,1,1,Second Failure Type,no known failure
741,1,1,Radiation Dosage,unknown
741,1,1,Clinical lab p16,p16 unknown
741,1,1,Metastasis,M0
741,1,1,Time to Death,0.6
741,1,1,Research lab p16,p16 unknown
741,1,1,Nodal Stage,N0
741,1,1,Status,Dead w/ disease
741,1,1,Treatment Modality,Sx & RT
741,1,1,Research lab HPV,HPV unknown
741,1,1,Overall Stage,I
741,1,1,Tumor Site,oral cavity
741,1,1,Time to First Failure,0.1
741,1,1,Age at Death,52.0
742,1,1,Tumor Site,oral cavity
742,1,1,Research lab p16,p16 unknown
742,1,1,Treatment Modality,Sx
742,1,1,First Failure Type,no known failure
742,1,1,Overall Stage,III
742,1,1,Metastasis,M0
742,1,1,Second Failure Type,no known failure
742,1,1,Occurrence #,recurrence
742,1,1,First Failure Treatment Modality,Sx
742,1,1,Tumor Stage,T2
742,1,1,Status,Alive unk disease
742,1,1,Clinical lab p16,p16 unknown
742,1,1,First Failure Site,oral cavity
742,1,1,Research lab HPV,HPV unknown
742,1,1,Nodal Stage,N1
743,1,1,Age at Death,80.4
743,1,1,Second Failure Type,no known failure
743,1,1,Occurrence #,1st primary
743,1,1,Nodal Stage,N0
743,1,1,Tumor Site,oral cavity
743,1,1,Tumor Stage,T1
743,1,1,Date of Death,2010-03-26 00:00:00
743,1,1,Overall Stage,I
743,1,1,First Failure Type,no known failure
743,1,1,Research lab HPV,HPV unknown
743,1,1,Metastasis,M0
743,1,1,Treatment Modality,Sx
743,1,1,Research lab p16,p16 unknown
743,1,1,Clinical lab p16,p16 unknown
743,1,1,Status,Dead unk disease
743,1,1,Time to Death,8.7
744,1,1,Date of Death,2005-04-26 00:00:00
744,1,1,Treatment Modality,Sx
744,1,1,Status,Dead w/o disease
744,1,1,Metastasis,M0
744,1,1,Tumor Site,oral cavity
744,1,1,Overall Stage,II
744,1,1,Nodal Stage,N0
744,1,1,Clinical lab p16,p16 unknown
744,1,1,Age at Death,68.9
744,1,1,Second Failure Type,no known failure
744,1,1,Research lab p16,p16 unknown
744,1,1,Time to Death,0.1
744,1,1,Research lab HPV,HPV unknown
744,1,1,Tumor Stage,T2
744,1,1,Occurrence #,1st primary
744,1,1,First Failure Type,no known failure
745,1,1,Time to Death,0.5
745,1,1,Occurrence #,1st primary
745,1,1,Metastasis,M0
745,1,1,Status,Dead w/ disease
745,1,1,Clinical lab p16,p16 unknown
745,1,1,Research lab p16,p16 unknown
745,1,1,Research lab HPV,HPV unknown
745,1,1,Age at Death,77.9
745,1,1,Date of Death,2000-11-07 00:00:00
745,1,1,Tumor Stage,T3
745,1,1,Overall Stage,III
745,1,1,Nodal Stage,N0
745,1,1,First Failure Type,locoregional
745,1,1,Time to First Failure,0.2
745,1,1,Second Failure Type,no known failure
745,1,1,Tumor Site,oral cavity
745,1,1,Initial Chemotherapy Agent,PTX
745,1,1,Treatment Modality,CTX-RT
745,1,1,Radiation Dosage,unknown
746,1,1,Treatment Modality,Sx
746,1,1,Research lab HPV,HPV unknown
746,1,1,Overall Stage,IVa
746,1,1,Nodal Stage,N2
746,1,1,Occurrence #,1st primary
746,1,1,Research lab p16,p16 unknown
746,1,1,Metastasis,M0
746,1,1,First Failure Type,no known failure
746,1,1,Tumor Site,oral cavity
746,1,1,Tumor Stage,T4a
746,1,1,Clinical lab p16,p16 unknown
746,1,1,Second Failure Type,no known failure
746,1,1,Status,Alive unk disease
747,1,1,Age at Death,83.3
747,1,1,Time to Death,3.1
747,1,1,Tumor Site,oral cavity
747,1,1,Tumor Stage,T1
747,1,1,Occurrence #,1st primary
747,1,1,Second Failure Type,no known failure
747,1,1,Nodal Stage,N0
747,1,1,Research lab HPV,HPV unknown
747,1,1,Clinical lab p16,p16 unknown
747,1,1,Treatment Modality,Sx
747,1,1,First Failure Type,locoregional
747,1,1,First Failure Treatment Modality,Sx
747,1,1,Time to First Failure,3.0
747,1,1,Metastasis,M0
747,1,1,Overall Stage,I
747,1,1,Date of Death,2011-04-02 00:00:00
747,1,1,Status,Dead unk disease
747,1,1,First Failure Site,oral cavity
747,1,1,Research lab p16,p16 unknown
748,1,1,Research lab p16,p16 unknown
748,1,1,Treatment Modality,Sx & RT
748,1,1,Radiation Dosage,63
748,1,1,Second Failure Type,no known failure
748,1,1,Tumor Stage,T2
748,1,1,Tumor Site,oral cavity
748,1,1,Occurrence #,1st primary
748,1,1,Clinical lab p16,p16 unknown
748,1,1,Date of Death,2005-12-31 00:00:00
748,1,1,Time to Death,2.5
748,1,1,First Failure Type,no known failure
748,1,1,Metastasis,M0
748,1,1,Age at Death,67.2
748,1,1,Nodal Stage,N2
748,1,1,Research lab HPV,HPV unknown
748,1,1,Status,Dead w/o disease
748,1,1,Overall Stage,IVa
749,1,1,Occurrence #,1st primary
749,1,1,Status,Alive unk disease
749,1,1,Research lab p16,p16 unknown
749,1,1,Research lab HPV,HPV unknown
749,1,1,Treatment Modality,Sx
749,1,1,Overall Stage,I
749,1,1,Tumor Site,oral cavity
749,1,1,First Failure Type,no known failure
749,1,1,Second Failure Type,no known failure
749,1,1,Tumor Stage,T1
749,1,1,Clinical lab p16,p16 unknown
749,1,1,Metastasis,M0
749,1,1,Nodal Stage,N0
750,1,1,Overall Stage,IVa
750,1,1,Metastasis,M0
750,1,1,Treatment Modality,Sx
750,1,1,Status,Alive unk disease
750,1,1,Research lab p16,p16 unknown
750,1,1,Nodal Stage,N2
750,1,1,First Failure Type,no known failure
750,1,1,Tumor Site,oral cavity
750,1,1,Tumor Stage,T4a
750,1,1,Occurrence #,1st primary
750,1,1,Research lab HPV,HPV unknown
750,1,1,Second Failure Type,no known failure
750,1,1,Clinical lab p16,p16 unknown
751,1,1,Metastasis,M0
751,1,1,Research lab HPV,HPV unknown
751,1,1,Age at Death,70.6
751,1,1,Overall Stage,II
751,1,1,Occurrence #,1st primary
751,1,1,Tumor Stage,T2
751,1,1,Date of Death,2010-05-22 00:00:00
751,1,1,Research lab p16,p16 unknown
751,1,1,Nodal Stage,N0
751,1,1,Treatment Modality,Sx
751,1,1,First Failure Type,no known failure
751,1,1,Time to Death,1.0
751,1,1,Status,Dead unk disease
751,1,1,Clinical lab p16,p16 unknown
751,1,1,Tumor Site,oral cavity
751,1,1,Second Failure Type,no known failure
752,1,1,Research lab HPV,HPV unknown
752,1,1,First Failure Type,no known failure
752,1,1,Metastasis,M0
752,1,1,Treatment Modality,Sx
752,1,1,Research lab p16,p16 unknown
752,1,1,Occurrence #,1st primary
752,1,1,Overall Stage,III
752,1,1,Second Failure Type,no known failure
752,1,1,Tumor Site,oral cavity
752,1,1,Tumor Stage,T1
752,1,1,Clinical lab p16,p16 unknown
752,1,1,Status,Alive w/o disease
752,1,1,Nodal Stage,N1
753,1,1,Tumor Stage,T1
753,1,1,Time to First Failure,0.7
753,1,1,Occurrence #,1st primary
753,1,1,Age at Death,72.7
753,1,1,Metastasis,M0
753,1,1,Date of Death,2004-04-08 00:00:00
753,1,1,Clinical lab p16,p16 unknown
753,1,1,First Failure Site,oral cavity
753,1,1,First Failure Type,locoregional
753,1,1,Tumor Site,oral cavity
753,1,1,Nodal Stage,N0
753,1,1,Research lab HPV,HPV unknown
753,1,1,Overall Stage,IVa
753,1,1,Time to Death,1.3
753,1,1,Second Failure Type,no known failure
753,1,1,First Failure Treatment Modality,Sx
753,1,1,Treatment Modality,Sx
753,1,1,Research lab p16,p16 unknown
753,1,1,Status,Dead unk disease
754,1,1,Tumor Stage,T1
754,1,1,Second Failure Type,no known failure
754,1,1,Treatment Modality,Sx
754,1,1,Tumor Site,oral cavity
754,1,1,Research lab p16,p16 unknown
754,1,1,Nodal Stage,N0
754,1,1,Research lab HPV,HPV unknown
754,1,1,Overall Stage,I
754,1,1,First Failure Type,no known failure
754,1,1,Clinical lab p16,p16 unknown
754,1,1,Metastasis,M0
754,1,1,Status,Alive unk disease
754,1,1,Occurrence #,1st primary
755,1,1,Status,Dead unk disease
755,1,1,Nodal Stage,N0
755,1,1,Second Failure Type,no known failure
755,1,1,Clinical lab p16,p16 unknown
755,1,1,Time to Death,4.9
755,1,1,First Failure Type,no known failure
755,1,1,Research lab p16,p16 unknown
755,1,1,Age at Death,62.8
755,1,1,Overall Stage,IVa
755,1,1,Occurrence #,1st primary
755,1,1,Metastasis,M0
755,1,1,Research lab HPV,HPV unknown
755,1,1,Tumor Site,oral cavity
755,1,1,Radiation Dosage,63
755,1,1,Treatment Modality,Sx & RT
755,1,1,Tumor Stage,T4a
755,1,1,Date of Death,2007-10-30 00:00:00
756,1,1,Status,Dead w/o disease
756,1,1,Research lab HPV,HPV unknown
756,1,1,Clinical lab p16,p16 unknown
756,1,1,Metastasis,M0
756,1,1,Date of Death,2011-07-08 00:00:00
756,1,1,Tumor Stage,T4a
756,1,1,First Failure Type,no known failure
756,1,1,Tumor Site,oral cavity
756,1,1,Time to Death,1.5
756,1,1,Research lab p16,p16 unknown
756,1,1,Age at Death,80.9
756,1,1,Occurrence #,1st primary
756,1,1,Treatment Modality,Sx
756,1,1,Second Failure Type,no known failure
756,1,1,Nodal Stage,N0
756,1,1,Overall Stage,IVa
757,1,1,Tumor Stage,T4a
757,1,1,Status,Dead unk disease
757,1,1,First Failure Type,locoregional
757,1,1,Time to Death,0.3
757,1,1,Treatment Modality,Sx & RT
757,1,1,Age at Death,71.8
757,1,1,Tumor Site,oral cavity
757,1,1,Research lab p16,p16 unknown
757,1,1,Date of Death,2000-05-15 00:00:00
757,1,1,Research lab HPV,HPV unknown
757,1,1,Nodal Stage,N2
757,1,1,Metastasis,M0
757,1,1,Clinical lab p16,p16 unknown
757,1,1,Time to First Failure,0.1
757,1,1,Occurrence #,1st primary
757,1,1,Radiation Dosage,2
757,1,1,Second Failure Type,no known failure
757,1,1,Overall Stage,IVa
758,1,1,Occurrence #,1st primary
758,1,1,Tumor Site,oral cavity
758,1,1,Overall Stage,IVa
758,1,1,Nodal Stage,N0
758,1,1,First Failure Type,no known failure
758,1,1,Metastasis,M0
758,1,1,Time to Death,2.2
758,1,1,Second Failure Type,no known failure
758,1,1,Status,Dead unk disease
758,1,1,Treatment Modality,Sx
758,1,1,Clinical lab p16,p16 unknown
758,1,1,Research lab HPV,HPV unknown
758,1,1,Research lab p16,p16 unknown
758,1,1,Tumor Stage,T4a
758,1,1,Age at Death,91.7
758,1,1,Date of Death,2011-02-23 00:00:00
759,1,1,Research lab HPV,HPV unknown
759,1,1,Overall Stage,IVa
759,1,1,Tumor Site,oral cavity
759,1,1,Date of Death,2002-12-25 00:00:00
759,1,1,Tumor Stage,T2
759,1,1,Metastasis,M0
759,1,1,Nodal Stage,N2
759,1,1,Occurrence #,1st primary
759,1,1,Research lab p16,p16 unknown
759,1,1,Clinical lab p16,p16 unknown
759,1,1,Age at Death,63.0
759,1,1,Treatment Modality,Sx
759,1,1,Second Failure Type,no known failure
759,1,1,Status,Dead unk disease
759,1,1,First Failure Type,no known failure
759,1,1,Time to Death,0.9
760,1,1,Status,Alive w/o disease
760,1,1,Research lab p16,p16 unknown
760,1,1,Treatment Modality,Sx & CTX-RT
760,1,1,Tumor Site,oral cavity
760,1,1,Occurrence #,1st primary
760,1,1,Metastasis,M0
760,1,1,Overall Stage,IVa
760,1,1,Nodal Stage,N2
760,1,1,Research lab HPV,HPV unknown
760,1,1,Second Failure Type,no known failure
760,1,1,Tumor Stage,T2
760,1,1,Radiation Dosage,50.4
760,1,1,Initial Chemotherapy Agent,cetux
760,1,1,Clinical lab p16,p16 unknown
760,1,1,First Failure Type,no known failure
761,1,1,Treatment Modality,Sx
761,1,1,Research lab p16,p16 unknown
761,1,1,Second Failure Type,no known failure
761,1,1,Occurrence #,1st primary
761,1,1,Status,Alive w/o disease
761,1,1,First Failure Type,no known failure
761,1,1,Clinical lab p16,p16 unknown
761,1,1,Research lab HPV,HPV unknown
761,1,1,Overall Stage,I
761,1,1,Tumor Stage,T1
761,1,1,Tumor Site,oral cavity
761,1,1,Nodal Stage,N0
761,1,1,Metastasis,M0
762,1,1,Research lab HPV,HPV unknown
762,1,1,Nodal Stage,N2
762,1,1,Clinical lab p16,p16 unknown
762,1,1,Age at Death,65.5
762,1,1,First Failure Type,no known failure
762,1,1,Metastasis,M0
762,1,1,Status,Dead unk disease
762,1,1,Date of Death,2009-09-20 00:00:00
762,1,1,Occurrence #,1st primary
762,1,1,Treatment Modality,Sx
762,1,1,Time to Death,0.2
762,1,1,Overall Stage,IVa
762,1,1,Tumor Stage,T4a
762,1,1,Research lab p16,p16 unknown
762,1,1,Tumor Site,oral cavity
762,1,1,Second Failure Type,no known failure
763,1,1,Clinical lab p16,p16 unknown
763,1,1,Nodal Stage,N1
763,1,1,Status,Alive unk disease
763,1,1,Tumor Stage,T2
763,1,1,Tumor Site,oral cavity
763,1,1,Occurrence #,1st primary
763,1,1,Research lab HPV,HPV unknown
763,1,1,Metastasis,M0
763,1,1,Research lab p16,p16 unknown
763,1,1,Overall Stage,III
763,1,1,First Failure Type,no known failure
763,1,1,Second Failure Type,no known failure
763,1,1,Treatment Modality,Sx
765,1,1,Second Failure Type,no known failure
765,1,1,Time to First Failure,5.2
765,1,1,Research lab p16,p16 unknown
765,1,1,Research lab HPV,HPV unknown
765,1,1,First Failure Site,oral cavity
765,1,1,Metastasis,M0
765,1,1,First Failure Treatment Modality,Sx
765,1,1,Clinical lab p16,p16 unknown
765,1,1,Tumor Stage,T1
765,1,1,Occurrence #,1st primary
765,1,1,Treatment Modality,Sx
765,1,1,Nodal Stage,N0
765,1,1,Status,Alive w/o disease
765,1,1,Tumor Site,oral cavity
765,1,1,Overall Stage,I
765,1,1,First Failure Type,locoregional
766,1,1,Time to First Failure,0.3
766,1,1,Date of Death,2001-08-23 00:00:00
766,1,1,Research lab p16,p16 unknown
766,1,1,Research lab HPV,HPV unknown
766,1,1,Age at Death,48.8
766,1,1,Radiation Dosage,64.8
766,1,1,Second Failure Type,no known failure
766,1,1,Treatment Modality,Sx & RT
766,1,1,First Failure Type,locoregional
766,1,1,Tumor Site,oral cavity
766,1,1,Nodal Stage,N2
766,1,1,Metastasis,M0
766,1,1,Overall Stage,IVa
766,1,1,Clinical lab p16,p16 unknown
766,1,1,Time to Death,1.3
766,1,1,Status,Dead w/ disease
766,1,1,Occurrence #,1st primary
766,1,1,Tumor Stage,T4a
768,1,1,Clinical lab p16,p16 unknown
768,1,1,First Failure Site,oral cavity
768,1,1,Research lab p16,p16 unknown
768,1,1,Overall Stage,I
768,1,1,First Failure Type,locoregional
768,1,1,Treatment Modality,Sx
768,1,1,Metastasis,M0
768,1,1,Tumor Stage,T1
768,1,1,Nodal Stage,N0
768,1,1,Tumor Site,oral cavity
768,1,1,Occurrence #,1st primary
768,1,1,First Failure Treatment Modality,Sx
768,1,1,Time to First Failure,1.9
768,1,1,Second Failure Type,no known failure
768,1,1,Research lab HPV,HPV unknown
768,1,1,Status,Dead w/ disease
769,1,1,Status,Alive unk disease
769,1,1,Second Failure Type,no known failure
769,1,1,Overall Stage,I
769,1,1,Tumor Stage,T1
769,1,1,Research lab p16,p16 unknown
769,1,1,Metastasis,M0
769,1,1,Tumor Site,oral cavity
769,1,1,Occurrence #,1st primary
769,1,1,Nodal Stage,N0
769,1,1,Research lab HPV,HPV unknown
769,1,1,First Failure Type,no known failure
769,1,1,Clinical lab p16,p16 unknown
769,1,1,Treatment Modality,Sx
770,1,1,Nodal Stage,N0
770,1,1,Overall Stage,II
770,1,1,Tumor Stage,T2
770,1,1,Research lab p16,p16 unknown
770,1,1,Second Failure Type,no known failure
770,1,1,Research lab HPV,HPV unknown
770,1,1,Metastasis,M0
770,1,1,Occurrence #,1st primary
770,1,1,Tumor Site,oral cavity
770,1,1,Status,Alive unk disease
770,1,1,Clinical lab p16,p16 unknown
770,1,1,First Failure Type,no known failure
770,1,1,Treatment Modality,Sx
771,1,1,Metastasis,M0
771,1,1,Research lab p16,p16 unknown
771,1,1,Status,Alive unk disease
771,1,1,Occurrence #,1st primary
771,1,1,First Failure Type,no known failure
771,1,1,Tumor Site,oral cavity
771,1,1,Treatment Modality,Sx
771,1,1,Nodal Stage,N0
771,1,1,Research lab HPV,HPV unknown
771,1,1,Clinical lab p16,p16 unknown
771,1,1,Tumor Stage,T1
771,1,1,Second Failure Type,no known failure
771,1,1,Overall Stage,I
772,1,1,Tumor Stage,T4a
772,1,1,Nodal Stage,N1
772,1,1,Tumor Site,oral cavity
772,1,1,Second Failure Type,no known failure
772,1,1,Radiation Dosage,63
772,1,1,Status,Alive unk disease
772,1,1,Overall Stage,IVa
772,1,1,Occurrence #,1st primary
772,1,1,Research lab HPV,HPV unknown
772,1,1,First Failure Type,no known failure
772,1,1,Treatment Modality,Sx & RT
772,1,1,Clinical lab p16,p16 unknown
772,1,1,Research lab p16,p16 unknown
772,1,1,Metastasis,M0
773,1,1,Nodal Stage,N0
773,1,1,Tumor Stage,T1
773,1,1,Research lab HPV,HPV unknown
773,1,1,Clinical lab p16,p16 unknown
773,1,1,Second Failure Type,no known failure
773,1,1,Occurrence #,1st primary
773,1,1,Metastasis,M0
773,1,1,Tumor Site,oral cavity
773,1,1,Research lab p16,p16 unknown
773,1,1,Treatment Modality,Sx
773,1,1,First Failure Type,no known failure
773,1,1,Status,Alive w/o disease
773,1,1,Overall Stage,I
774,1,1,Second Failure Type,no known failure
774,1,1,First Failure Type,locoregional
774,1,1,Research lab p16,p16 unknown
774,1,1,Nodal Stage,N0
774,1,1,First Failure Site,oral cavity
774,1,1,Status,Alive unk disease
774,1,1,Treatment Modality,Sx
774,1,1,Time to First Failure,0.6
774,1,1,Occurrence #,1st primary
774,1,1,Tumor Stage,T1
774,1,1,Metastasis,M0
774,1,1,Clinical lab p16,p16 unknown
774,1,1,First Failure Treatment Modality,Sx
774,1,1,Overall Stage,I
774,1,1,Research lab HPV,HPV unknown
774,1,1,Tumor Site,oral cavity
775,1,1,Overall Stage,I
775,1,1,Clinical lab p16,p16 unknown
775,1,1,Metastasis,M0
775,1,1,First Failure Type,no known failure
775,1,1,Occurrence #,1st primary
775,1,1,Nodal Stage,N0
775,1,1,Research lab p16,p16 unknown
775,1,1,Tumor Stage,T1
775,1,1,Status,Alive unk disease
775,1,1,Research lab HPV,HPV unknown
775,1,1,Second Failure Type,no known failure
775,1,1,Treatment Modality,Sx
775,1,1,Tumor Site,oral cavity
776,1,1,Date of Death,2009-01-16 00:00:00
776,1,1,Time to Death,4.9
776,1,1,Research lab HPV,HPV unknown
776,1,1,Overall Stage,IVa
776,1,1,Clinical lab p16,p16 unknown
776,1,1,Treatment Modality,Sx
776,1,1,First Failure Type,no known failure
776,1,1,Research lab p16,p16 unknown
776,1,1,Status,Dead unk disease
776,1,1,Nodal Stage,N2
776,1,1,Tumor Stage,T4a
776,1,1,Age at Death,60.9
776,1,1,Second Failure Type,no known failure
776,1,1,Occurrence #,1st primary
776,1,1,Metastasis,M0
776,1,1,Tumor Site,oral cavity
777,1,1,Treatment Modality,Sx
777,1,1,Metastasis,M0
777,1,1,First Failure Type,no known failure
777,1,1,Tumor Site,oral cavity
777,1,1,Research lab HPV,HPV unknown
777,1,1,Occurrence #,1st primary
777,1,1,Status,Alive unk disease
777,1,1,Tumor Stage,T1
777,1,1,Research lab p16,p16 unknown
777,1,1,Clinical lab p16,p16 unknown
777,1,1,Second Failure Type,no known failure
777,1,1,Nodal Stage,N0
777,1,1,Overall Stage,I
778,1,1,Clinical lab p16,p16 unknown
778,1,1,Research lab HPV,HPV unknown
778,1,1,Tumor Stage,T2
778,1,1,Metastasis,M0
778,1,1,Second Failure Type,no known failure
778,1,1,Nodal Stage,N0
778,1,1,Tumor Site,oral cavity
778,1,1,Occurrence #,1st primary
778,1,1,Overall Stage,II
778,1,1,First Failure Type,no known failure
778,1,1,Research lab p16,p16 unknown
778,1,1,Status,Alive w/o disease
778,1,1,Treatment Modality,Sx & RT
779,1,1,Treatment Modality,Sx
779,1,1,Overall Stage,I
779,1,1,Tumor Site,oral cavity
779,1,1,Second Failure Type,no known failure
779,1,1,Tumor Stage,T1
779,1,1,Nodal Stage,N0
779,1,1,Status,Alive unk disease
779,1,1,Research lab p16,p16 unknown
779,1,1,Clinical lab p16,p16 unknown
779,1,1,Metastasis,M0
779,1,1,First Failure Type,no known failure
779,1,1,Occurrence #,1st primary
779,1,1,Research lab HPV,HPV unknown
780,1,1,Tumor Stage,T2
780,1,1,Status,Alive unk disease
780,1,1,Overall Stage,IVa
780,1,1,First Failure Type,no known failure
780,1,1,Research lab p16,p16 unknown
780,1,1,Clinical lab p16,p16 unknown
780,1,1,Treatment Modality,Sx
780,1,1,Second Failure Type,no known failure
780,1,1,Metastasis,M0
780,1,1,Nodal Stage,N2
780,1,1,Research lab HPV,HPV unknown
780,1,1,Occurrence #,1st primary
780,1,1,Tumor Site,oral cavity
781,1,1,Second Failure Type,no known failure
781,1,1,Occurrence #,1st primary
781,1,1,First Failure Type,no known failure
781,1,1,Overall Stage,III
781,1,1,Clinical lab p16,p16 unknown
781,1,1,Nodal Stage,N1
781,1,1,Research lab HPV,HPV unknown
781,1,1,Tumor Site,oral cavity
781,1,1,Tumor Stage,T2
781,1,1,Treatment Modality,Sx
781,1,1,Research lab p16,p16 unknown
781,1,1,Metastasis,M0
781,1,1,Status,Alive unk disease
782,1,1,Date of Death,2004-10-19 00:00:00
782,1,1,Status,Dead unk disease
782,1,1,Metastasis,M0
782,1,1,First Failure Type,no known failure
782,1,1,Research lab p16,p16 unknown
782,1,1,Occurrence #,1st primary
782,1,1,Research lab HPV,HPV unknown
782,1,1,Nodal Stage,N2
782,1,1,Age at Death,64.2
782,1,1,Treatment Modality,Sx & RT
782,1,1,Second Failure Type,no known failure
782,1,1,Overall Stage,IVa
782,1,1,Time to Death,0.8
782,1,1,Radiation Dosage,63
782,1,1,Tumor Stage,T1
782,1,1,Clinical lab p16,p16 unknown
782,1,1,Tumor Site,oral cavity
783,1,1,Overall Stage,II
783,1,1,First Failure Type,locoregional
783,1,1,Metastasis,M0
783,1,1,Tumor Stage,T2
783,1,1,Occurrence #,1st primary
783,1,1,Research lab HPV,HPV unknown
783,1,1,Initial Chemotherapy Agent,unknown
783,1,1,Age at Death,72.0
783,1,1,Clinical lab p16,p16 unknown
783,1,1,Time to Death,1.4
783,1,1,Radiation Dosage,unknown
783,1,1,Tumor Site,oral cavity
783,1,1,Status,Dead w/ disease
783,1,1,Date of Death,2007-03-23 00:00:00
783,1,1,Treatment Modality,Sx & CTX-RT
783,1,1,Research lab p16,p16 unknown
783,1,1,Second Failure Type,no known failure
783,1,1,Nodal Stage,N0
784,1,1,Tumor Site,oral cavity
784,1,1,Research lab p16,p16 unknown
784,1,1,Research lab HPV,HPV unknown
784,1,1,Date of Death,2011-11-13 00:00:00
784,1,1,Overall Stage,I
784,1,1,Status,Dead unk disease
784,1,1,Second Failure Type,no known failure
784,1,1,Nodal Stage,N0
784,1,1,Time to Death,3.3
784,1,1,Treatment Modality,Sx
784,1,1,Age at Death,61.2
784,1,1,Tumor Stage,T1
784,1,1,Occurrence #,recurrence
784,1,1,Metastasis,M0
784,1,1,First Failure Type,no known failure
784,1,1,Clinical lab p16,p16 unknown
785,1,1,Status,Dead w/o disease
785,1,1,Time to Death,7.3
785,1,1,Clinical lab p16,p16 unknown
785,1,1,Tumor Site,oral cavity
785,1,1,Tumor Stage,T2
785,1,1,Overall Stage,II
785,1,1,Second Failure Type,no known failure
785,1,1,Research lab p16,p16 unknown
785,1,1,Metastasis,M0
785,1,1,Treatment Modality,Sx
785,1,1,Nodal Stage,N0
785,1,1,Date of Death,2007-10-05 00:00:00
785,1,1,First Failure Type,no known failure
785,1,1,Age at Death,73.5
785,1,1,Occurrence #,1st primary
785,1,1,Research lab HPV,HPV unknown
786,1,1,Tumor Site,oral cavity
786,1,1,Status,Alive w/o disease
786,1,1,Radiation Dosage,63
786,1,1,Clinical lab p16,p16 unknown
786,1,1,Research lab p16,p16 unknown
786,1,1,First Failure Type,no known failure
786,1,1,Metastasis,M0
786,1,1,Treatment Modality,Sx & RT
786,1,1,Occurrence #,1st primary
786,1,1,Research lab HPV,HPV unknown
786,1,1,Tumor Stage,T4a
786,1,1,Second Failure Type,no known failure
786,1,1,Overall Stage,IVa
786,1,1,Nodal Stage,N0
787,1,1,Research lab p16,p16 unknown
787,1,1,First Failure Type,no known failure
787,1,1,Age at Death,64.6
787,1,1,Metastasis,M0
787,1,1,Treatment Modality,CTX-RT
787,1,1,Time to Death,2.4
787,1,1,Initial Chemotherapy Agent,carbo/PTX
787,1,1,Nodal Stage,N0
787,1,1,Overall Stage,II
787,1,1,Date of Death,2002-08-27 00:00:00
787,1,1,Radiation Dosage,70.2
787,1,1,Tumor Stage,T2
787,1,1,Research lab HPV,HPV unknown
787,1,1,Status,Dead unk disease
787,1,1,Clinical lab p16,p16 unknown
787,1,1,Occurrence #,other primary
787,1,1,Second Failure Type,no known failure
787,1,1,Tumor Site,oral cavity
788,1,1,Age at Death,40.2
788,1,1,Time to Death,1.2
788,1,1,Research lab HPV,HPV unknown
788,1,1,Occurrence #,1st primary
788,1,1,Second Failure Type,no known failure
788,1,1,Metastasis,Unknown
788,1,1,Research lab p16,p16 unknown
788,1,1,Clinical lab p16,p16 unknown
788,1,1,Treatment Modality,Unknown
788,1,1,Status,Dead unk disease
788,1,1,Tumor Site,oral cavity
788,1,1,Overall Stage,Unknown
788,1,1,Date of Death,2006-05-28 00:00:00
788,1,1,Tumor Stage,Unknown
788,1,1,Nodal Stage,Unknown
788,1,1,First Failure Type,no known failure
789,1,1,Status,Dead unk disease
789,1,1,Metastasis,M0
789,1,1,Nodal Stage,N0
789,1,1,First Failure Type,locoregional
789,1,1,Research lab HPV,HPV unknown
789,1,1,First Failure Site,oral cavity
789,1,1,Second Failure Type,no known failure
789,1,1,Age at Death,89.9
789,1,1,Treatment Modality,Sx
789,1,1,Date of Death,2009-11-14 00:00:00
789,1,1,Tumor Stage,T1
789,1,1,Time to Death,5.2
789,1,1,Clinical lab p16,p16 unknown
789,1,1,Time to First Failure,3.9
789,1,1,Research lab p16,p16 unknown
789,1,1,Overall Stage,I
789,1,1,Tumor Site,oral cavity
789,1,1,Occurrence #,recurrence
789,1,1,First Failure Treatment Modality,Sx
790,1,1,Nodal Stage,N0
790,1,1,Clinical lab p16,p16 unknown
790,1,1,Occurrence #,1st primary
790,1,1,First Failure Type,no known failure
790,1,1,Radiation Dosage,63
790,1,1,Research lab p16,p16 unknown
790,1,1,Tumor Stage,T1
790,1,1,Treatment Modality,Sx & RT
790,1,1,Tumor Site,oral cavity
790,1,1,Overall Stage,I
790,1,1,Status,Alive unk disease
790,1,1,Second Failure Type,no known failure
790,1,1,Metastasis,M0
790,1,1,Research lab HPV,HPV unknown
791,1,1,Clinical lab p16,p16 unknown
791,1,1,First Failure Site,oral cavity
791,1,1,Research lab HPV,HPV unknown
791,1,1,Date of Death,2011-02-25 00:00:00
791,1,1,Tumor Site,oral cavity
791,1,1,Nodal Stage,N0
791,1,1,Time to Death,3.2
791,1,1,First Failure Treatment Modality,Sx & CTX-RT
791,1,1,First Failure Initial Chemotherapy Agent,carbo
791,1,1,Research lab p16,p16 unknown
791,1,1,Treatment Modality,Sx
791,1,1,Tumor Stage,T1
791,1,1,Second Failure Type,no known failure
791,1,1,Age at Death,58.4
791,1,1,Status,Dead w/ disease
791,1,1,Metastasis,M0
791,1,1,Overall Stage,I
791,1,1,First Failure Type,locoregional
791,1,1,First Failure Radiation Dosage,70.2
791,1,1,Time to First Failure,1.4
791,1,1,Occurrence #,1st primary
792,1,1,Second Failure Type,no known failure
792,1,1,Overall Stage,I
792,1,1,Treatment Modality,Sx
792,1,1,Metastasis,M0
792,1,1,First Failure Type,no known failure
792,1,1,Status,Alive unk disease
792,1,1,Nodal Stage,N0
792,1,1,Tumor Stage,T1
792,1,1,Occurrence #,recurrence
792,1,1,Clinical lab p16,p16 unknown
792,1,1,Research lab HPV,HPV unknown
792,1,1,Tumor Site,oral cavity
792,1,1,Research lab p16,p16 unknown
793,1,1,Second Failure Type,no known failure
793,1,1,Treatment Modality,Sx & RT
793,1,1,Nodal Stage,N2
793,1,1,Occurrence #,1st primary
793,1,1,First Failure Type,no known failure
793,1,1,Status,Alive w/o disease
793,1,1,Research lab HPV,HPV unknown
793,1,1,Tumor Site,oral cavity
793,1,1,Metastasis,M0
793,1,1,Overall Stage,IVa
793,1,1,Clinical lab p16,p16 unknown
793,1,1,Tumor Stage,T3
793,1,1,Research lab p16,p16 unknown
793,1,1,Radiation Dosage,63
794,1,1,Status,Alive unk disease
794,1,1,Clinical lab p16,p16 unknown
794,1,1,First Failure Type,no known failure
794,1,1,Tumor Site,oral cavity
794,1,1,Nodal Stage,N0
794,1,1,Metastasis,M0
794,1,1,Tumor Stage,T2
794,1,1,Treatment Modality,Sx
794,1,1,Research lab p16,p16 unknown
794,1,1,Occurrence #,1st primary
794,1,1,Research lab HPV,HPV unknown
794,1,1,Second Failure Type,no known failure
794,1,1,Overall Stage,II
795,1,1,Nodal Stage,N0
795,1,1,Overall Stage,II
795,1,1,First Failure Type,no known failure
795,1,1,Occurrence #,1st primary
795,1,1,Metastasis,M0
795,1,1,Research lab HPV,HPV unknown
795,1,1,Tumor Stage,T2
795,1,1,Treatment Modality,Sx
795,1,1,Tumor Site,oral cavity
795,1,1,Clinical lab p16,p16 unknown
795,1,1,Research lab p16,p16 unknown
795,1,1,Status,Alive unk disease
795,1,1,Second Failure Type,no known failure
796,1,1,Metastasis,M0
796,1,1,Second Failure Type,no known failure
796,1,1,Nodal Stage,N0
796,1,1,Treatment Modality,Sx & RT
796,1,1,Research lab p16,p16 unknown
796,1,1,Time to Death,4.2
796,1,1,Tumor Stage,T3
796,1,1,Time to First Failure,0.9
796,1,1,Overall Stage,III
796,1,1,Research lab HPV,HPV unknown
796,1,1,First Failure Treatment Modality,CTX
796,1,1,First Failure Type,locoregional
796,1,1,Date of Death,2006-08-24 00:00:00
796,1,1,Age at Death,54.1
796,1,1,First Failure Site,oral cavity
796,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
796,1,1,Status,Dead w/ disease
796,1,1,Radiation Dosage,45
796,1,1,Occurrence #,recurrence
796,1,1,Clinical lab p16,p16 unknown
796,1,1,Tumor Site,oral cavity
797,1,1,Research lab p16,p16 unknown
797,1,1,Time to Death,0.9
797,1,1,Clinical lab p16,p16 unknown
797,1,1,Tumor Stage,T2
797,1,1,Research lab HPV,HPV unknown
797,1,1,Age at Death,57.8
797,1,1,Overall Stage,II
797,1,1,Status,Dead unk disease
797,1,1,Nodal Stage,N0
797,1,1,Treatment Modality,Sx
797,1,1,Metastasis,M0
797,1,1,Occurrence #,1st primary
797,1,1,Time to First Failure,0.8
797,1,1,Date of Death,2007-11-01 00:00:00
797,1,1,Tumor Site,oral cavity
797,1,1,Second Failure Type,no known failure
797,1,1,First Failure Site,oropharynx
797,1,1,First Failure Type,locoregional
797,1,1,First Failure Treatment Modality,Sx
798,1,1,Second Failure Type,no known failure
798,1,1,Status,Alive w/ disease
798,1,1,Treatment Modality,Sx & CTX-RT
798,1,1,Tumor Stage,T2
798,1,1,Initial Chemotherapy Agent,carbo/PTX
798,1,1,Radiation Dosage,63
798,1,1,Metastasis,M0
798,1,1,Clinical lab p16,p16 unknown
798,1,1,Research lab p16,p16 unknown
798,1,1,First Failure Type,no known failure
798,1,1,Nodal Stage,N2
798,1,1,Tumor Site,oral cavity
798,1,1,Overall Stage,IVa
798,1,1,Occurrence #,1st primary
798,1,1,Research lab HPV,HPV unknown
799,1,1,Clinical lab p16,p16 unknown
799,1,1,Metastasis,M0
799,1,1,Tumor Site,oral cavity
799,1,1,Tumor Stage,T1
799,1,1,Overall Stage,I
799,1,1,Status,Alive unk disease
799,1,1,First Failure Type,no known failure
799,1,1,Nodal Stage,N0
799,1,1,Occurrence #,1st primary
799,1,1,Research lab p16,p16 unknown
799,1,1,Second Failure Type,no known failure
799,1,1,Research lab HPV,HPV unknown
799,1,1,Treatment Modality,Sx
800,1,1,Tumor Stage,T2
800,1,1,Nodal Stage,N2
800,1,1,Radiation Dosage,unknown
800,1,1,First Failure Type,distant
800,1,1,Research lab p16,p16 unknown
800,1,1,Treatment Modality,Sx & RT
800,1,1,Clinical lab p16,p16 unknown
800,1,1,Second Failure Type,no known failure
800,1,1,Tumor Site,oral cavity
800,1,1,Status,Dead w/ disease
800,1,1,Date of Death,2007-07-30 00:00:00
800,1,1,Time to Death,0.6
800,1,1,Metastasis,M0
800,1,1,Research lab HPV,HPV unknown
800,1,1,Time to First Failure,0.4
800,1,1,Age at Death,82.2
800,1,1,Overall Stage,IVa
800,1,1,Occurrence #,1st primary
801,1,1,Research lab HPV,HPV unknown
801,1,1,Clinical lab p16,p16 unknown
801,1,1,Occurrence #,1st primary
801,1,1,Nodal Stage,N0
801,1,1,Status,Alive w/o disease
801,1,1,Metastasis,M0
801,1,1,Second Failure Type,no known failure
801,1,1,Treatment Modality,Sx
801,1,1,Overall Stage,IVa
801,1,1,First Failure Type,no known failure
801,1,1,Research lab p16,p16 unknown
801,1,1,Tumor Stage,T4a
801,1,1,Tumor Site,oral cavity
802,1,1,Occurrence #,1st primary
802,1,1,Time to First Failure,2.1
802,1,1,Overall Stage,IVa
802,1,1,Research lab p16,p16 unknown
802,1,1,Research lab HPV,HPV unknown
802,1,1,Time to Death,3.6
802,1,1,Age at Death,73.8
802,1,1,First Failure Site,oral cavity
802,1,1,Treatment Modality,Sx & RT
802,1,1,First Failure Treatment Modality,Sx & RT
802,1,1,Status,Dead unk disease
802,1,1,First Failure Type,locoregional
802,1,1,Radiation Dosage,unknown
802,1,1,Second Failure Type,no known failure
802,1,1,Clinical lab p16,p16 unknown
802,1,1,Tumor Site,oral cavity
802,1,1,Tumor Stage,T4a
802,1,1,Date of Death,2004-09-03 00:00:00
802,1,1,Metastasis,M0
802,1,1,Nodal Stage,Unknown
803,1,1,Occurrence #,1st primary
803,1,1,Status,Alive unk disease
803,1,1,First Failure Type,no known failure
803,1,1,Research lab p16,p16 unknown
803,1,1,Overall Stage,III
803,1,1,Metastasis,M0
803,1,1,Tumor Stage,T1
803,1,1,Research lab HPV,HPV unknown
803,1,1,Treatment Modality,Sx & RT
803,1,1,Second Failure Type,no known failure
803,1,1,Tumor Site,oral cavity
803,1,1,Clinical lab p16,p16 unknown
803,1,1,Nodal Stage,N1
803,1,1,Radiation Dosage,unknown
804,1,1,Date of Death,2007-01-04 00:00:00
804,1,1,Age at Death,62.7
804,1,1,Initial Chemotherapy Agent,CPT/5-FU/leucovorin
804,1,1,Research lab p16,p16 unknown
804,1,1,Research lab HPV,HPV unknown
804,1,1,Overall Stage,Unknown
804,1,1,Tumor Stage,Unknown
804,1,1,Treatment Modality,Sx & CTX
804,1,1,Time to First Failure,0.6
804,1,1,Nodal Stage,Unknown
804,1,1,Metastasis,Unknown
804,1,1,Tumor Site,oral cavity
804,1,1,Second Failure Type,no known failure
804,1,1,Time to Death,1.9
804,1,1,First Failure Type,locoregional
804,1,1,Status,Dead w/ disease
804,1,1,Clinical lab p16,p16 unknown
804,1,1,Second Line Chemotherapy Agent,carbo/doce
804,1,1,Occurrence #,recurrence
805,1,1,Metastasis,M0
805,1,1,Overall Stage,IVa
805,1,1,Tumor Stage,T4a
805,1,1,Nodal Stage,N0
805,1,1,Treatment Modality,Sx & CTX-RT
805,1,1,Initial Chemotherapy Agent,carbo/PTX
805,1,1,Radiation Dosage,63
805,1,1,Clinical lab p16,p16 unknown
805,1,1,Time to Death,1.9
805,1,1,Tumor Site,oral cavity
805,1,1,Status,Dead w/o disease
805,1,1,Occurrence #,1st primary
805,1,1,Research lab p16,p16 unknown
805,1,1,Research lab HPV,HPV unknown
805,1,1,Date of Death,2006-11-17 00:00:00
805,1,1,Second Failure Type,no known failure
805,1,1,First Failure Type,no known failure
805,1,1,Age at Death,66.8
806,1,1,Metastasis,M0
806,1,1,Initial Chemotherapy Agent,unknown
806,1,1,Status,Alive unk disease
806,1,1,Tumor Stage,T3
806,1,1,Clinical lab p16,p16 unknown
806,1,1,Research lab HPV,HPV unknown
806,1,1,First Failure Type,no known failure
806,1,1,Occurrence #,1st primary
806,1,1,Second Failure Type,no known failure
806,1,1,Tumor Site,oral cavity
806,1,1,Radiation Dosage,unknown
806,1,1,Research lab p16,p16 unknown
806,1,1,Overall Stage,III
806,1,1,Nodal Stage,N1
806,1,1,Treatment Modality,CTX-RT
807,1,1,Metastasis,M0
807,1,1,Clinical lab p16,p16 unknown
807,1,1,Time to Death,0.5
807,1,1,First Failure Type,no known failure
807,1,1,Occurrence #,recurrence
807,1,1,Tumor Site,oral cavity
807,1,1,Second Failure Type,no known failure
807,1,1,Treatment Modality,Sx
807,1,1,Overall Stage,IVa
807,1,1,Age at Death,82.7
807,1,1,Research lab p16,p16 unknown
807,1,1,Date of Death,2010-02-24 00:00:00
807,1,1,Status,Dead unk disease
807,1,1,Nodal Stage,N0
807,1,1,Research lab HPV,HPV unknown
807,1,1,Tumor Stage,T4a
808,1,1,Clinical lab p16,p16 unknown
808,1,1,Second Failure Type,no known failure
808,1,1,Overall Stage,I
808,1,1,Time to Death,4.9
808,1,1,Age at Death,73.3
808,1,1,Research lab p16,p16 unknown
808,1,1,Tumor Site,oral cavity
808,1,1,Nodal Stage,N0
808,1,1,Research lab HPV,HPV unknown
808,1,1,Occurrence #,1st primary
808,1,1,Treatment Modality,Sx
808,1,1,Date of Death,2008-09-15 00:00:00
808,1,1,Status,Dead unk disease
808,1,1,Metastasis,M0
808,1,1,Tumor Stage,T1
808,1,1,First Failure Type,no known failure
809,1,1,First Failure Type,no known failure
809,1,1,Tumor Site,oral cavity
809,1,1,Second Failure Type,no known failure
809,1,1,Clinical lab p16,p16 unknown
809,1,1,Treatment Modality,Sx & RT
809,1,1,Tumor Stage,T1
809,1,1,Metastasis,M0
809,1,1,Nodal Stage,N0
809,1,1,Research lab p16,p16 unknown
809,1,1,Occurrence #,1st primary
809,1,1,Research lab HPV,HPV unknown
809,1,1,Overall Stage,I
809,1,1,Radiation Dosage,60
809,1,1,Status,Alive w/o disease
810,1,1,Status,Alive unk disease
810,1,1,Tumor Site,oral cavity
810,1,1,Metastasis,M0
810,1,1,Tumor Stage,T1
810,1,1,Treatment Modality,Sx
810,1,1,Research lab HPV,HPV unknown
810,1,1,Nodal Stage,N0
810,1,1,Research lab p16,p16 unknown
810,1,1,Second Failure Type,no known failure
810,1,1,Overall Stage,I
810,1,1,First Failure Type,no known failure
810,1,1,Occurrence #,1st primary
810,1,1,Clinical lab p16,p16 unknown
811,1,1,Status,Alive w/o disease
811,1,1,Research lab p16,p16 unknown
811,1,1,Occurrence #,other primary
811,1,1,Tumor Stage,T1
811,1,1,First Failure Treatment Modality,Sx
811,1,1,First Failure Type,locoregional
811,1,1,Tumor Site,oral cavity
811,1,1,First Failure Site,oral cavity
811,1,1,Nodal Stage,N0
811,1,1,Research lab HPV,HPV unknown
811,1,1,Treatment Modality,Sx
811,1,1,Metastasis,M0
811,1,1,Overall Stage,I
811,1,1,Time to First Failure,1.8
811,1,1,Clinical lab p16,p16 unknown
811,1,1,Second Failure Type,no known failure
812,1,1,Clinical lab p16,p16 unknown
812,1,1,Tumor Stage,T1
812,1,1,Second Failure Type,no known failure
812,1,1,Nodal Stage,N0
812,1,1,Treatment Modality,Sx
812,1,1,Research lab HPV,HPV unknown
812,1,1,First Failure Type,no known failure
812,1,1,Tumor Site,oral cavity
812,1,1,Occurrence #,1st primary
812,1,1,Status,Alive w/o disease
812,1,1,Overall Stage,I
812,1,1,Research lab p16,p16 unknown
812,1,1,Metastasis,M0
813,1,1,Overall Stage,IVa
813,1,1,Research lab HPV,HPV unknown
813,1,1,Second Failure Type,no known failure
813,1,1,Age at Death,70.8
813,1,1,Clinical lab p16,p16 unknown
813,1,1,Tumor Site,oral cavity
813,1,1,Research lab p16,p16 unknown
813,1,1,First Failure Type,locoregional and distant
813,1,1,Treatment Modality,Sx & RT
813,1,1,First Failure Site,oral cavity
813,1,1,Metastasis,M0
813,1,1,Status,Dead w/ disease
813,1,1,Occurrence #,1st primary
813,1,1,Time to First Failure,0.3
813,1,1,Radiation Dosage,61.2
813,1,1,Time to Death,0.7
813,1,1,First Failure Treatment Modality,CTX
813,1,1,Nodal Stage,N2
813,1,1,Tumor Stage,T4a
813,1,1,Date of Death,2002-03-04 00:00:00
813,1,1,First Failure Initial Chemotherapy Agent,doce/cap/gemcitibine
814,1,1,Occurrence #,1st primary
814,1,1,Clinical lab p16,p16 unknown
814,1,1,Second Failure Type,no known failure
814,1,1,Nodal Stage,N1
814,1,1,Research lab p16,p16 unknown
814,1,1,Treatment Modality,Sx
814,1,1,Overall Stage,III
814,1,1,Research lab HPV,HPV unknown
814,1,1,Tumor Stage,T1
814,1,1,First Failure Type,no known failure
814,1,1,Tumor Site,oral cavity
814,1,1,Status,Alive unk disease
814,1,1,Metastasis,M0
815,1,1,Overall Stage,IVa
815,1,1,Occurrence #,1st primary
815,1,1,Status,Dead w/o disease
815,1,1,Tumor Stage,T3
815,1,1,Date of Death,2010-12-31 00:00:00
815,1,1,Metastasis,M0
815,1,1,Treatment Modality,Sx
815,1,1,Nodal Stage,N2
815,1,1,Age at Death,52.3
815,1,1,Second Failure Type,no known failure
815,1,1,First Failure Type,no known failure
815,1,1,Tumor Site,oral cavity
815,1,1,Time to Death,0.2
815,1,1,Clinical lab p16,p16 unknown
815,1,1,Research lab HPV,HPV unknown
815,1,1,Research lab p16,p16 unknown
816,1,1,Research lab p16,p16 unknown
816,1,1,Overall Stage,IVa
816,1,1,First Failure Type,no known failure
816,1,1,Research lab HPV,HPV unknown
816,1,1,Metastasis,M0
816,1,1,Clinical lab p16,p16 unknown
816,1,1,Status,Alive unk disease
816,1,1,Tumor Stage,T4a
816,1,1,Second Failure Type,no known failure
816,1,1,Tumor Site,oral cavity
816,1,1,Nodal Stage,N1
816,1,1,Occurrence #,1st primary
816,1,1,Treatment Modality,Sx
817,1,1,Status,Alive unk disease
817,1,1,Overall Stage,III
817,1,1,Research lab HPV,HPV unknown
817,1,1,Occurrence #,1st primary
817,1,1,Tumor Site,oral cavity
817,1,1,Treatment Modality,Sx
817,1,1,Metastasis,M0
817,1,1,Second Failure Type,no known failure
817,1,1,First Failure Type,no known failure
817,1,1,Clinical lab p16,p16 unknown
817,1,1,Research lab p16,p16 unknown
817,1,1,Nodal Stage,N1
817,1,1,Tumor Stage,T2
818,1,1,Occurrence #,1st primary
818,1,1,Nodal Stage,N2
818,1,1,Tumor Stage,T4a
818,1,1,Tumor Site,oral cavity
818,1,1,Metastasis,M0
818,1,1,Research lab HPV,HPV unknown
818,1,1,Second Failure Type,no known failure
818,1,1,Overall Stage,IVa
818,1,1,First Failure Type,no known failure
818,1,1,Clinical lab p16,p16 unknown
818,1,1,Research lab p16,p16 unknown
818,1,1,Treatment Modality,Sx
818,1,1,Status,Alive w/ disease
819,1,1,First Failure Type,no known failure
819,1,1,Age at Death,74.5
819,1,1,Research lab p16,p16 unknown
819,1,1,Clinical lab p16,p16 unknown
819,1,1,Second Failure Type,no known failure
819,1,1,Metastasis,M0
819,1,1,Time to Death,1.5
819,1,1,Occurrence #,1st primary
819,1,1,Tumor Site,oral cavity
819,1,1,Overall Stage,I
819,1,1,Nodal Stage,N0
819,1,1,Tumor Stage,T1
819,1,1,Treatment Modality,Sx
819,1,1,Research lab HPV,HPV unknown
819,1,1,Status,Dead unk disease
819,1,1,Date of Death,2008-09-23 00:00:00
820,1,1,Research lab p16,p16 unknown
820,1,1,Research lab HPV,HPV unknown
820,1,1,Nodal Stage,N0
820,1,1,Second Failure Type,no known failure
820,1,1,Tumor Stage,T1
820,1,1,Treatment Modality,Sx
820,1,1,Status,Alive unk disease
820,1,1,Metastasis,M0
820,1,1,Occurrence #,1st primary
820,1,1,Overall Stage,I
820,1,1,First Failure Type,no known failure
820,1,1,Tumor Site,oral cavity
820,1,1,Clinical lab p16,p16 unknown
821,1,1,Research lab HPV,HPV unknown
821,1,1,First Failure Type,no known failure
821,1,1,Date of Death,2007-07-28 00:00:00
821,1,1,Second Failure Type,no known failure
821,1,1,Tumor Stage,T3
821,1,1,Nodal Stage,N1
821,1,1,Metastasis,M0
821,1,1,Occurrence #,1st primary
821,1,1,Overall Stage,III
821,1,1,Tumor Site,oral cavity
821,1,1,Initial Chemotherapy Agent,carbo/PTX
821,1,1,Time to Death,1.4
821,1,1,Radiation Dosage,70.2
821,1,1,Research lab p16,p16 unknown
821,1,1,Age at Death,70.9
821,1,1,Clinical lab p16,p16 unknown
821,1,1,Status,Dead w/o disease
821,1,1,Treatment Modality,CTX-RT
822,1,1,Research lab HPV,HPV unknown
822,1,1,Status,Alive unk disease
822,1,1,Occurrence #,1st primary
822,1,1,Tumor Site,oral cavity
822,1,1,Overall Stage,I
822,1,1,First Failure Type,no known failure
822,1,1,Metastasis,M0
822,1,1,Nodal Stage,N0
822,1,1,Second Failure Type,no known failure
822,1,1,Research lab p16,p16 unknown
822,1,1,Clinical lab p16,p16 unknown
822,1,1,Tumor Stage,T1
822,1,1,Treatment Modality,Sx
823,1,1,Tumor Stage,T4a
823,1,1,Nodal Stage,N0
823,1,1,Overall Stage,IVa
823,1,1,Research lab HPV,HPV unknown
823,1,1,Treatment Modality,Sx
823,1,1,Second Failure Type,no known failure
823,1,1,First Failure Type,no known failure
823,1,1,Research lab p16,p16 unknown
823,1,1,Clinical lab p16,p16 unknown
823,1,1,Occurrence #,recurrence
823,1,1,Tumor Site,oral cavity
823,1,1,Status,Alive unk disease
823,1,1,Metastasis,M0
824,1,1,Tumor Site,oral cavity
824,1,1,Research lab HPV,HPV unknown
824,1,1,First Failure Type,no known failure
824,1,1,Research lab p16,p16 unknown
824,1,1,Clinical lab p16,p16 unknown
824,1,1,Status,Alive w/o disease
824,1,1,Tumor Stage,T1
824,1,1,Nodal Stage,N0
824,1,1,Second Failure Type,no known failure
824,1,1,Occurrence #,1st primary
824,1,1,Metastasis,M0
824,1,1,Overall Stage,I
824,1,1,Treatment Modality,Sx
825,1,1,Occurrence #,1st primary
825,1,1,Tumor Site,oral cavity
825,1,1,First Failure Treatment Modality,Sx
825,1,1,Status,Alive w/o disease
825,1,1,Research lab HPV,HPV unknown
825,1,1,Tumor Stage,T1
825,1,1,Clinical lab p16,p16 unknown
825,1,1,Metastasis,M0
825,1,1,Treatment Modality,Sx
825,1,1,First Failure Type,locoregional
825,1,1,Second Failure Type,no known failure
825,1,1,First Failure Site,oral cavity
825,1,1,Nodal Stage,N0
825,1,1,Overall Stage,I
825,1,1,Research lab p16,p16 unknown
825,1,1,Time to First Failure,1.9
826,1,1,Second Failure Type,no known failure
826,1,1,Overall Stage,II
826,1,1,Occurrence #,1st primary
826,1,1,Metastasis,M0
826,1,1,Tumor Site,oral cavity
826,1,1,Research lab p16,p16 unknown
826,1,1,Status,Alive w/o disease
826,1,1,Research lab HPV,HPV unknown
826,1,1,Nodal Stage,N0
826,1,1,Tumor Stage,T2
826,1,1,First Failure Type,no known failure
826,1,1,Treatment Modality,Sx
826,1,1,Clinical lab p16,p16 unknown
827,1,1,Metastasis,M0
827,1,1,Treatment Modality,Sx
827,1,1,First Failure Type,no known failure
827,1,1,Tumor Stage,T1
827,1,1,Research lab HPV,HPV unknown
827,1,1,Second Failure Type,no known failure
827,1,1,Occurrence #,1st primary
827,1,1,Nodal Stage,N0
827,1,1,Overall Stage,I
827,1,1,Status,Alive w/o disease
827,1,1,Clinical lab p16,p16 unknown
827,1,1,Research lab p16,p16 unknown
827,1,1,Tumor Site,oral cavity
828,1,1,Second Failure Type,no known failure
828,1,1,Clinical lab p16,p16 unknown
828,1,1,Treatment Modality,Sx
828,1,1,Tumor Stage,T4a
828,1,1,Nodal Stage,N0
828,1,1,Research lab HPV,HPV unknown
828,1,1,First Failure Type,no known failure
828,1,1,Occurrence #,1st primary
828,1,1,Status,Alive unk disease
828,1,1,Metastasis,M0
828,1,1,Tumor Site,oral cavity
828,1,1,Research lab p16,p16 unknown
828,1,1,Overall Stage,IVa
829,1,1,Clinical lab p16,p16 unknown
829,1,1,Metastasis,M0
829,1,1,Status,Alive w/o disease
829,1,1,First Failure Type,no known failure
829,1,1,Treatment Modality,RT
829,1,1,Research lab HPV,HPV unknown
829,1,1,Tumor Site,oral cavity
829,1,1,Second Failure Type,no known failure
829,1,1,Research lab p16,p16 unknown
829,1,1,Overall Stage,II
829,1,1,Occurrence #,1st primary
829,1,1,Tumor Stage,T2
829,1,1,Nodal Stage,N0
829,1,1,Radiation Dosage,69
830,1,1,Tumor Site,oral cavity
830,1,1,Nodal Stage,N2
830,1,1,Second Failure Type,no known failure
830,1,1,First Failure Type,distant
830,1,1,Overall Stage,IVa
830,1,1,Tumor Stage,T2
830,1,1,Occurrence #,1st primary
830,1,1,Date of Death,2009-09-27 00:00:00
830,1,1,Metastasis,M0
830,1,1,First Failure Site,oral cavity
830,1,1,First Failure Initial Chemotherapy Agent,cap
830,1,1,First Failure Treatment Modality,CTX-RT
830,1,1,Clinical lab p16,p16 unknown
830,1,1,Research lab p16,p16 unknown
830,1,1,Treatment Modality,Sx & RT
830,1,1,Radiation Dosage,66
830,1,1,Status,Dead w/ disease
830,1,1,Time to Death,2.0
830,1,1,First Failure Radiation Dosage,unknown
830,1,1,Time to First Failure,0.6
830,1,1,Age at Death,70.1
830,1,1,Research lab HPV,HPV unknown
831,1,1,Status,Dead w/ disease
831,1,1,Research lab p16,p16 unknown
831,1,1,Overall Stage,IVa
831,1,1,Clinical lab p16,p16 unknown
831,1,1,Second Failure Type,no known failure
831,1,1,Treatment Modality,Sx & CTX-RT
831,1,1,Initial Chemotherapy Agent,cis
831,1,1,Occurrence #,1st primary
831,1,1,Nodal Stage,N2
831,1,1,Time to Death,1.3
831,1,1,Research lab HPV,HPV unknown
831,1,1,Age at Death,55.8
831,1,1,First Failure Type,locoregional and distant
831,1,1,Tumor Site,oral cavity
831,1,1,Radiation Dosage,70.2
831,1,1,Tumor Stage,T3
831,1,1,Date of Death,2010-06-02 00:00:00
831,1,1,Time to First Failure,0.3
831,1,1,Metastasis,M0
832,1,1,Metastasis,M0
832,1,1,Tumor Site,oral cavity
832,1,1,Overall Stage,IVa
832,1,1,Nodal Stage,N0
832,1,1,Clinical lab p16,p16 unknown
832,1,1,Status,Alive unk disease
832,1,1,Treatment Modality,Sx
832,1,1,First Failure Type,no known failure
832,1,1,Tumor Stage,T4a
832,1,1,Research lab p16,p16 unknown
832,1,1,Research lab HPV,HPV unknown
832,1,1,Occurrence #,1st primary
832,1,1,Second Failure Type,no known failure
833,1,1,Tumor Stage,T1
833,1,1,Research lab HPV,HPV unknown
833,1,1,Metastasis,M0
833,1,1,Status,Alive unk disease
833,1,1,Tumor Site,oral cavity
833,1,1,Occurrence #,1st primary
833,1,1,First Failure Type,no known failure
833,1,1,Clinical lab p16,p16 unknown
833,1,1,Research lab p16,p16 unknown
833,1,1,Overall Stage,I
833,1,1,Treatment Modality,Sx
833,1,1,Nodal Stage,N0
833,1,1,Second Failure Type,no known failure
834,1,1,Treatment Modality,Sx
834,1,1,First Failure Treatment Modality,Sx & RT
834,1,1,Status,Alive unk disease
834,1,1,Metastasis,M0
834,1,1,Clinical lab p16,p16 unknown
834,1,1,Time to First Failure,0.7
834,1,1,First Failure Site,oral cavity
834,1,1,Research lab p16,p16 unknown
834,1,1,Research lab HPV,HPV unknown
834,1,1,First Failure Type,locoregional
834,1,1,Nodal Stage,N0
834,1,1,Tumor Stage,T1
834,1,1,Overall Stage,I
834,1,1,Second Failure Type,no known failure
834,1,1,Occurrence #,recurrence
834,1,1,First Failure Radiation Dosage,unknown
834,1,1,Tumor Site,oral cavity
836,1,1,Tumor Site,oral cavity
836,1,1,Clinical lab p16,p16 unknown
836,1,1,Radiation Dosage,63
836,1,1,Nodal Stage,N2
836,1,1,Tumor Stage,T4a
836,1,1,Research lab HPV,HPV unknown
836,1,1,Second Failure Type,no known failure
836,1,1,Date of Death,2011-08-27 00:00:00
836,1,1,Status,Dead w/o disease
836,1,1,Occurrence #,1st primary
836,1,1,First Failure Site,oral cavity
836,1,1,Time to First Failure,5.3
836,1,1,Age at Death,54.2
836,1,1,Metastasis,M0
836,1,1,Overall Stage,IVa
836,1,1,Research lab p16,p16 unknown
836,1,1,First Failure Treatment Modality,Sx
836,1,1,Treatment Modality,Sx & RT
836,1,1,First Failure Type,locoregional
836,1,1,Time to Death,9.2
837,1,1,Tumor Stage,T1
837,1,1,First Failure Type,no known failure
837,1,1,Tumor Site,oral cavity
837,1,1,Occurrence #,1st primary
837,1,1,Overall Stage,I
837,1,1,Clinical lab p16,p16 unknown
837,1,1,Status,Alive unk disease
837,1,1,Nodal Stage,N0
837,1,1,Research lab p16,p16 unknown
837,1,1,Second Failure Type,no known failure
837,1,1,Treatment Modality,Sx
837,1,1,Metastasis,M0
837,1,1,Research lab HPV,HPV unknown
838,1,1,Second Failure Type,no known failure
838,1,1,Time to First Failure,0.8
838,1,1,Time to Death,1.6
838,1,1,Initial Chemotherapy Agent,"vandetanib, cis"
838,1,1,First Failure Site,oral cavity
838,1,1,Occurrence #,1st primary
838,1,1,Research lab p16,p16 unknown
838,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
838,1,1,Nodal Stage,N1
838,1,1,First Failure Radiation Dosage,30
838,1,1,Status,Dead w/ disease
838,1,1,Metastasis,M0
838,1,1,First Failure Treatment Modality,CTX-RT
838,1,1,Age at Death,47.5
838,1,1,Treatment Modality,Sx & CTX-RT
838,1,1,Overall Stage,III
838,1,1,Clinical lab p16,p16 unknown
838,1,1,Tumor Site,oral cavity
838,1,1,Research lab HPV,HPV unknown
838,1,1,Date of Death,2011-05-20 00:00:00
838,1,1,First Failure Type,distant
838,1,1,Radiation Dosage,63
838,1,1,Tumor Stage,T2
839,1,1,Metastasis,M0
839,1,1,Nodal Stage,N0
839,1,1,Tumor Site,oral cavity
839,1,1,Research lab p16,p16 unknown
839,1,1,Status,Alive w/o disease
839,1,1,Tumor Stage,T1
839,1,1,Second Failure Type,no known failure
839,1,1,First Failure Type,no known failure
839,1,1,Overall Stage,I
839,1,1,Occurrence #,1st primary
839,1,1,Research lab HPV,HPV unknown
839,1,1,Clinical lab p16,p16 unknown
839,1,1,Treatment Modality,Sx
840,1,1,First Failure Type,no known failure
840,1,1,Time to Death,0.6
840,1,1,Age at Death,82.7
840,1,1,Overall Stage,II
840,1,1,Treatment Modality,Sx
840,1,1,Metastasis,M0
840,1,1,Status,Dead w/ disease
840,1,1,Tumor Stage,T2
840,1,1,Second Failure Type,no known failure
840,1,1,Date of Death,2008-04-25 00:00:00
840,1,1,Occurrence #,recurrence
840,1,1,Research lab HPV,HPV unknown
840,1,1,Clinical lab p16,p16 unknown
840,1,1,Research lab p16,p16 unknown
840,1,1,Tumor Site,oral cavity
840,1,1,Nodal Stage,N0
841,1,1,Age at Death,61.0
841,1,1,Time to Death,1.1
841,1,1,Radiation Dosage,unknown
841,1,1,First Failure Treatment Modality,Sx & RT
841,1,1,Clinical lab p16,p16 unknown
841,1,1,First Failure Site,oral cavity
841,1,1,Treatment Modality,Sx & CTX-RT
841,1,1,Research lab HPV,HPV unknown
841,1,1,Overall Stage,III
841,1,1,Tumor Stage,T2
841,1,1,Time to First Failure,-0.1
841,1,1,Status,Dead w/ disease
841,1,1,Nodal Stage,N1
841,1,1,Tumor Site,oral cavity
841,1,1,Occurrence #,1st primary
841,1,1,Metastasis,M0
841,1,1,Research lab p16,p16 unknown
841,1,1,Second Failure Type,no known failure
841,1,1,Initial Chemotherapy Agent,unknown
841,1,1,Date of Death,2008-05-17 00:00:00
841,1,1,First Failure Type,locoregional
842,1,1,Research lab HPV,HPV unknown
842,1,1,Age at Death,75.9
842,1,1,First Failure Type,no known failure
842,1,1,Date of Death,2002-12-26 00:00:00
842,1,1,Radiation Dosage,64
842,1,1,Metastasis,M0
842,1,1,Treatment Modality,Sx & RT
842,1,1,Second Failure Type,no known failure
842,1,1,Clinical lab p16,p16 unknown
842,1,1,Research lab p16,p16 unknown
842,1,1,Tumor Site,oral cavity
842,1,1,Nodal Stage,N2
842,1,1,Time to Death,0.9
842,1,1,Occurrence #,1st primary
842,1,1,Status,Dead unk disease
842,1,1,Overall Stage,IVa
842,1,1,Tumor Stage,T1
843,1,1,Tumor Stage,T1
843,1,1,Occurrence #,1st primary
843,1,1,First Failure Type,no known failure
843,1,1,Overall Stage,I
843,1,1,Treatment Modality,Sx
843,1,1,Tumor Site,oral cavity
843,1,1,Metastasis,M0
843,1,1,Research lab p16,p16 unknown
843,1,1,Clinical lab p16,p16 unknown
843,1,1,Research lab HPV,HPV unknown
843,1,1,Status,Alive w/o disease
843,1,1,Second Failure Type,no known failure
843,1,1,Nodal Stage,N0
844,1,1,Tumor Stage,T1
844,1,1,Date of Death,2009-09-27 00:00:00
844,1,1,Research lab HPV,HPV unknown
844,1,1,Second Failure Type,no known failure
844,1,1,Time to Death,8.7
844,1,1,Status,Dead unk disease
844,1,1,Treatment Modality,Sx
844,1,1,Clinical lab p16,p16 unknown
844,1,1,Research lab p16,p16 unknown
844,1,1,Age at Death,98.9
844,1,1,First Failure Type,no known failure
844,1,1,Metastasis,M0
844,1,1,Nodal Stage,N0
844,1,1,Overall Stage,I
844,1,1,Tumor Site,oral cavity
844,1,1,Occurrence #,1st primary
845,1,1,Second Failure Type,no known failure
845,1,1,Research lab HPV,HPV unknown
845,1,1,Nodal Stage,N0
845,1,1,Metastasis,M0
845,1,1,Clinical lab p16,p16 unknown
845,1,1,Research lab p16,p16 unknown
845,1,1,Treatment Modality,Sx
845,1,1,Status,Alive unk disease
845,1,1,Tumor Stage,T4a
845,1,1,Occurrence #,1st primary
845,1,1,Tumor Site,oral cavity
845,1,1,First Failure Type,no known failure
845,1,1,Overall Stage,IVa
846,1,1,Nodal Stage,N0
846,1,1,First Failure Type,no known failure
846,1,1,Research lab p16,p16 unknown
846,1,1,Research lab HPV,HPV unknown
846,1,1,Status,Alive unk disease
846,1,1,Second Failure Type,no known failure
846,1,1,Occurrence #,other primary
846,1,1,Tumor Stage,T1
846,1,1,Tumor Site,oral cavity
846,1,1,Clinical lab p16,p16 unknown
846,1,1,Treatment Modality,Sx
846,1,1,Metastasis,M0
846,1,1,Overall Stage,I
847,1,1,Tumor Site,oral cavity
847,1,1,Overall Stage,IVa
847,1,1,First Failure Type,no known failure
847,1,1,Status,Alive unk disease
847,1,1,Tumor Stage,T4a
847,1,1,Second Failure Type,no known failure
847,1,1,Occurrence #,1st primary
847,1,1,Metastasis,M0
847,1,1,Treatment Modality,Sx
847,1,1,Research lab p16,p16 unknown
847,1,1,Research lab HPV,HPV unknown
847,1,1,Nodal Stage,N0
847,1,1,Clinical lab p16,p16 unknown
848,1,1,Tumor Site,oral cavity
848,1,1,Overall Stage,I
848,1,1,Nodal Stage,N0
848,1,1,Metastasis,M0
848,1,1,Treatment Modality,Sx
848,1,1,Research lab HPV,HPV unknown
848,1,1,Research lab p16,p16 unknown
848,1,1,First Failure Type,no known failure
848,1,1,Clinical lab p16,p16 unknown
848,1,1,Occurrence #,1st primary
848,1,1,Second Failure Type,no known failure
848,1,1,Tumor Stage,T1
848,1,1,Status,Alive unk disease
849,1,1,Tumor Site,oral cavity
849,1,1,Occurrence #,1st primary
849,1,1,Research lab HPV,HPV unknown
849,1,1,Status,Dead w/o disease
849,1,1,Treatment Modality,Sx
849,1,1,Date of Death,2007-11-01 00:00:00
849,1,1,Tumor Stage,T1
849,1,1,First Failure Type,no known failure
849,1,1,Overall Stage,I
849,1,1,Time to Death,5.3
849,1,1,Nodal Stage,N0
849,1,1,Clinical lab p16,p16 unknown
849,1,1,Age at Death,61.7
849,1,1,Second Failure Type,no known failure
849,1,1,Research lab p16,p16 unknown
849,1,1,Metastasis,M0
850,1,1,Second Failure Type,no known failure
850,1,1,Nodal Stage,N2
850,1,1,Tumor Stage,T2
850,1,1,Clinical lab p16,p16 unknown
850,1,1,Occurrence #,1st primary
850,1,1,Time to Death,2.2
850,1,1,First Failure Type,no known failure
850,1,1,Research lab HPV,HPV unknown
850,1,1,Overall Stage,IVa
850,1,1,Research lab p16,p16 unknown
850,1,1,Treatment Modality,Sx & CTX-RT
850,1,1,Initial Chemotherapy Agent,unknown
850,1,1,Metastasis,M0
850,1,1,Age at Death,33.1
850,1,1,Status,Dead unk disease
850,1,1,Tumor Site,oral cavity
850,1,1,Date of Death,2006-06-07 00:00:00
850,1,1,Radiation Dosage,unknown
851,1,1,Occurrence #,1st primary
851,1,1,Clinical lab p16,p16 unknown
851,1,1,Treatment Modality,Sx
851,1,1,Overall Stage,I
851,1,1,Research lab HPV,HPV unknown
851,1,1,Metastasis,M0
851,1,1,Status,Alive w/o disease
851,1,1,Research lab p16,p16 unknown
851,1,1,Tumor Site,oral cavity
851,1,1,Nodal Stage,N0
851,1,1,Tumor Stage,T1
851,1,1,First Failure Type,no known failure
851,1,1,Second Failure Type,no known failure
852,1,1,Occurrence #,1st primary
852,1,1,First Failure Type,no known failure
852,1,1,Research lab HPV,HPV unknown
852,1,1,Tumor Site,oral cavity
852,1,1,Metastasis,M0
852,1,1,Tumor Stage,T1
852,1,1,Overall Stage,I
852,1,1,Status,Alive w/o disease
852,1,1,Clinical lab p16,p16 unknown
852,1,1,Nodal Stage,N0
852,1,1,Second Failure Type,no known failure
852,1,1,Research lab p16,p16 unknown
852,1,1,Treatment Modality,Sx
853,1,1,Tumor Stage,T4a
853,1,1,Tumor Site,oral cavity
853,1,1,Treatment Modality,Sx
853,1,1,Metastasis,M0
853,1,1,Nodal Stage,N3
853,1,1,Status,Alive unk disease
853,1,1,Second Failure Type,no known failure
853,1,1,Occurrence #,1st primary
853,1,1,Research lab HPV,HPV unknown
853,1,1,Research lab p16,p16 unknown
853,1,1,First Failure Type,no known failure
853,1,1,Overall Stage,IVb
853,1,1,Clinical lab p16,p16 unknown
854,1,1,Second Failure Type,no known failure
854,1,1,Clinical lab p16,p16 unknown
854,1,1,Tumor Site,oral cavity
854,1,1,Treatment Modality,Sx
854,1,1,Metastasis,M0
854,1,1,Tumor Stage,T2
854,1,1,Occurrence #,1st primary
854,1,1,Overall Stage,II
854,1,1,Research lab p16,p16 unknown
854,1,1,Research lab HPV,HPV unknown
854,1,1,First Failure Type,no known failure
854,1,1,Status,Alive unk disease
854,1,1,Nodal Stage,N0
855,1,1,Status,Alive w/o disease
855,1,1,Tumor Site,oral cavity
855,1,1,Tumor Stage,T4a
855,1,1,Occurrence #,1st primary
855,1,1,First Failure Type,no known failure
855,1,1,Overall Stage,IVa
855,1,1,Metastasis,M0
855,1,1,Research lab HPV,HPV unknown
855,1,1,Treatment Modality,Sx
855,1,1,Nodal Stage,N1
855,1,1,Research lab p16,p16 unknown
855,1,1,Clinical lab p16,p16 unknown
855,1,1,Second Failure Type,no known failure
856,1,1,Treatment Modality,Sx
856,1,1,Nodal Stage,N0
856,1,1,Status,Alive unk disease
856,1,1,Occurrence #,1st primary
856,1,1,Clinical lab p16,p16 unknown
856,1,1,Tumor Stage,T4a
856,1,1,Tumor Site,oral cavity
856,1,1,Metastasis,M0
856,1,1,Overall Stage,IVa
856,1,1,First Failure Type,no known failure
856,1,1,Second Failure Type,no known failure
856,1,1,Research lab p16,p16 unknown
856,1,1,Research lab HPV,HPV unknown
857,1,1,Occurrence #,1st primary
857,1,1,Clinical lab p16,p16 unknown
857,1,1,First Failure Second Line Chemotherapy Agent,cis
857,1,1,Tumor Stage,T1
857,1,1,Time to Death,0.8
857,1,1,Time to First Failure,0.4
857,1,1,Metastasis,M0
857,1,1,Radiation Dosage,unknown
857,1,1,Nodal Stage,N0
857,1,1,First Failure Site,oral cavity
857,1,1,Overall Stage,I
857,1,1,Tumor Site,oral cavity
857,1,1,Second Failure Type,no known failure
857,1,1,Date of Death,2011-01-19 00:00:00
857,1,1,Research lab p16,p16 unknown
857,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
857,1,1,Research lab HPV,HPV unknown
857,1,1,Age at Death,61.5
857,1,1,First Failure Type,locoregional
857,1,1,Status,Dead w/ disease
857,1,1,First Failure Treatment Modality,Sx & CTX
857,1,1,Treatment Modality,Sx & RT
858,1,1,Research lab HPV,HPV unknown
858,1,1,Time to Death,0.4
858,1,1,Status,Dead w/ disease
858,1,1,Clinical lab p16,p16 unknown
858,1,1,Metastasis,M1
858,1,1,Age at Death,39.0
858,1,1,Treatment Modality,Sx & CTX
858,1,1,Research lab p16,p16 unknown
858,1,1,Second Failure Type,no known failure
858,1,1,Overall Stage,IVc
858,1,1,Date of Death,2004-09-08 00:00:00
858,1,1,Occurrence #,1st primary
858,1,1,First Failure Type,no known failure
858,1,1,Nodal Stage,N2
858,1,1,Initial Chemotherapy Agent,cis/PTX
858,1,1,Tumor Site,oral cavity
858,1,1,Tumor Stage,T3
859,1,1,Research lab p16,p16 unknown
859,1,1,Nodal Stage,N0
859,1,1,Date of Death,2006-04-27 00:00:00
859,1,1,Tumor Site,oral cavity
859,1,1,Research lab HPV,HPV unknown
859,1,1,Metastasis,M0
859,1,1,Overall Stage,I
859,1,1,Occurrence #,1st primary
859,1,1,Time to Death,4.5
859,1,1,Tumor Stage,T1
859,1,1,Second Failure Type,no known failure
859,1,1,Treatment Modality,Sx
859,1,1,First Failure Type,no known failure
859,1,1,Status,Dead unk disease
859,1,1,Age at Death,86.4
859,1,1,Clinical lab p16,p16 unknown
860,1,1,Status,Alive w/o disease
860,1,1,Clinical lab p16,p16 unknown
860,1,1,Overall Stage,I
860,1,1,Radiation Dosage,55.2
860,1,1,Second Failure Type,no known failure
860,1,1,First Failure Type,no known failure
860,1,1,Tumor Stage,T1
860,1,1,Metastasis,M0
860,1,1,Research lab p16,p16 unknown
860,1,1,Occurrence #,recurrence
860,1,1,Nodal Stage,N0
860,1,1,Treatment Modality,Sx & RT
860,1,1,Research lab HPV,HPV unknown
860,1,1,Tumor Site,oral cavity
861,1,1,Tumor Stage,T2
861,1,1,Tumor Site,oral cavity
861,1,1,Status,Alive w/o disease
861,1,1,Occurrence #,1st primary
861,1,1,Metastasis,M0
861,1,1,Second Failure Type,no known failure
861,1,1,Clinical lab p16,p16 unknown
861,1,1,Nodal Stage,N0
861,1,1,Research lab HPV,HPV unknown
861,1,1,Overall Stage,II
861,1,1,Treatment Modality,Sx
861,1,1,Research lab p16,p16 unknown
861,1,1,First Failure Type,no known failure
862,1,1,Metastasis,M0
862,1,1,Tumor Site,oral cavity
862,1,1,Occurrence #,1st primary
862,1,1,Age at Death,72.5
862,1,1,First Failure Type,no known failure
862,1,1,Treatment Modality,Sx & RT
862,1,1,Research lab p16,p16 unknown
862,1,1,Date of Death,2005-11-13 00:00:00
862,1,1,Overall Stage,IVa
862,1,1,Research lab HPV,HPV unknown
862,1,1,Tumor Stage,T1
862,1,1,Nodal Stage,N2
862,1,1,Status,Dead w/o disease
862,1,1,Radiation Dosage,63
862,1,1,Time to Death,2.5
862,1,1,Second Failure Type,no known failure
862,1,1,Clinical lab p16,p16 unknown
863,1,1,Status,Dead unk disease
863,1,1,Second Failure Type,no known failure
863,1,1,Research lab p16,p16 unknown
863,1,1,Research lab HPV,HPV unknown
863,1,1,First Failure Type,no known failure
863,1,1,Overall Stage,Unknown
863,1,1,Occurrence #,1st primary
863,1,1,Date of Death,2009-02-01 00:00:00
863,1,1,Age at Death,50.8
863,1,1,Tumor Site,oral cavity
863,1,1,Tumor Stage,Unknown
863,1,1,Time to Death,0.1
863,1,1,Metastasis,Unknown
863,1,1,Nodal Stage,Unknown
863,1,1,Clinical lab p16,p16 unknown
863,1,1,Treatment Modality,Unknown
864,1,1,Age at Death,37.6
864,1,1,Metastasis,M0
864,1,1,Tumor Stage,T2
864,1,1,Tumor Site,oral cavity
864,1,1,Nodal Stage,N2
864,1,1,Overall Stage,IVa
864,1,1,Initial Chemotherapy Agent,cis
864,1,1,Research lab HPV,HPV unknown
864,1,1,Time to First Failure,0.3
864,1,1,Time to Death,0.9
864,1,1,Date of Death,2009-09-01 00:00:00
864,1,1,Radiation Dosage,16.2
864,1,1,Second Failure Type,no known failure
864,1,1,Status,Dead w/ disease
864,1,1,Research lab p16,p16 unknown
864,1,1,Occurrence #,1st primary
864,1,1,First Failure Type,locoregional
864,1,1,Clinical lab p16,p16 unknown
864,1,1,Treatment Modality,CTX-RT
865,1,1,Nodal Stage,N0
865,1,1,Treatment Modality,Sx
865,1,1,Clinical lab p16,p16 unknown
865,1,1,Research lab p16,p16 unknown
865,1,1,Tumor Stage,T1
865,1,1,Research lab HPV,HPV unknown
865,1,1,First Failure Type,no known failure
865,1,1,Overall Stage,I
865,1,1,Occurrence #,1st primary
865,1,1,Tumor Site,oral cavity
865,1,1,Time to Death,0.8
865,1,1,Age at Death,80.8
865,1,1,Status,Dead unk disease
865,1,1,Second Failure Type,no known failure
865,1,1,Date of Death,2004-01-17 00:00:00
865,1,1,Metastasis,M0
866,1,1,Time to Death,3.1
866,1,1,Nodal Stage,N1
866,1,1,Second Failure Type,no known failure
866,1,1,Clinical lab p16,p16 unknown
866,1,1,Tumor Site,oral cavity
866,1,1,Occurrence #,1st primary
866,1,1,Status,Dead unk disease
866,1,1,Age at Death,79.3
866,1,1,Date of Death,2007-11-24 00:00:00
866,1,1,Tumor Stage,T4a
866,1,1,First Failure Type,no known failure
866,1,1,Overall Stage,IVa
866,1,1,Research lab p16,p16 unknown
866,1,1,Metastasis,M0
866,1,1,Research lab HPV,HPV unknown
866,1,1,Treatment Modality,Sx
867,1,1,Treatment Modality,Sx & RT
867,1,1,Research lab p16,p16 unknown
867,1,1,Research lab HPV,HPV unknown
867,1,1,Overall Stage,IVa
867,1,1,Nodal Stage,N0
867,1,1,First Failure Type,no known failure
867,1,1,Metastasis,M0
867,1,1,Clinical lab p16,p16 unknown
867,1,1,Tumor Site,oral cavity
867,1,1,Occurrence #,1st primary
867,1,1,Tumor Stage,T4a
867,1,1,Status,Alive w/o disease
867,1,1,Second Failure Type,no known failure
867,1,1,Radiation Dosage,60.1
868,1,1,Overall Stage,IVa
868,1,1,Time to Death,0.7
868,1,1,Occurrence #,1st primary
868,1,1,Clinical lab p16,p16 unknown
868,1,1,Status,Dead w/ disease
868,1,1,Date of Death,2004-08-26 00:00:00
868,1,1,Metastasis,M0
868,1,1,Age at Death,73.1
868,1,1,First Failure Type,locoregional
868,1,1,Tumor Site,oral cavity
868,1,1,Second Failure Type,no known failure
868,1,1,Research lab p16,p16 unknown
868,1,1,Treatment Modality,Sx & RT
868,1,1,Nodal Stage,N2
868,1,1,Tumor Stage,T1
868,1,1,Time to First Failure,0.2
868,1,1,Radiation Dosage,unknown
868,1,1,Research lab HPV,HPV unknown
869,1,1,Research lab p16,p16 unknown
869,1,1,Overall Stage,II
869,1,1,Nodal Stage,N0
869,1,1,First Failure Type,no known failure
869,1,1,Treatment Modality,Sx
869,1,1,Occurrence #,1st primary
869,1,1,Tumor Stage,T2
869,1,1,Metastasis,M0
869,1,1,Tumor Site,oral cavity
869,1,1,Research lab HPV,HPV unknown
869,1,1,Second Failure Type,no known failure
869,1,1,Status,Alive unk disease
869,1,1,Clinical lab p16,p16 unknown
870,1,1,Treatment Modality,Sx
870,1,1,Research lab p16,p16 unknown
870,1,1,Metastasis,M0
870,1,1,Overall Stage,II
870,1,1,Tumor Site,oral cavity
870,1,1,Nodal Stage,N0
870,1,1,Second Failure Type,no known failure
870,1,1,Tumor Stage,T2
870,1,1,Research lab HPV,HPV unknown
870,1,1,First Failure Type,no known failure
870,1,1,Status,Alive unk disease
870,1,1,Clinical lab p16,p16 unknown
870,1,1,Occurrence #,1st primary
871,1,1,Second Failure Type,no known failure
871,1,1,Nodal Stage,N0
871,1,1,Research lab p16,p16 unknown
871,1,1,Tumor Stage,T4a
871,1,1,Tumor Site,oral cavity
871,1,1,First Failure Type,no known failure
871,1,1,Research lab HPV,HPV unknown
871,1,1,Occurrence #,1st primary
871,1,1,Metastasis,M0
871,1,1,Treatment Modality,Sx
871,1,1,Overall Stage,IVa
871,1,1,Clinical lab p16,p16 unknown
871,1,1,Status,Alive w/o disease
872,1,1,Metastasis,M0
872,1,1,Status,Dead w/o disease
872,1,1,Tumor Site,oral cavity
872,1,1,First Failure Type,locoregional
872,1,1,Research lab HPV,HPV unknown
872,1,1,Clinical lab p16,p16 unknown
872,1,1,Tumor Stage,T4a
872,1,1,Time to First Failure,0.3
872,1,1,Nodal Stage,N0
872,1,1,Overall Stage,IVa
872,1,1,Occurrence #,1st primary
872,1,1,Treatment Modality,Sx
872,1,1,Second Failure Type,no known failure
872,1,1,Research lab p16,p16 unknown
873,1,1,Second Failure Type,no known failure
873,1,1,Nodal Stage,N0
873,1,1,Overall Stage,II
873,1,1,Date of Death,2004-07-09 00:00:00
873,1,1,Clinical lab p16,p16 unknown
873,1,1,Treatment Modality,Sx
873,1,1,Tumor Stage,T2
873,1,1,Tumor Site,oral cavity
873,1,1,Research lab p16,p16 unknown
873,1,1,Metastasis,M0
873,1,1,Research lab HPV,HPV unknown
873,1,1,First Failure Type,no known failure
873,1,1,Occurrence #,other primary
873,1,1,Status,Dead unk disease
873,1,1,Age at Death,47.9
873,1,1,Time to Death,0.3
874,1,1,First Failure Site,oral cavity
874,1,1,First Failure Type,no known failure
874,1,1,Tumor Stage,T4a
874,1,1,Overall Stage,IVa
874,1,1,Research lab p16,p16 unknown
874,1,1,Tumor Site,oral cavity
874,1,1,Second Failure Type,no known failure
874,1,1,Occurrence #,1st primary
874,1,1,Treatment Modality,Sx
874,1,1,Research lab HPV,HPV unknown
874,1,1,Metastasis,M0
874,1,1,First Failure Treatment Modality,Sx
874,1,1,Clinical lab p16,p16 unknown
874,1,1,Status,Alive w/o disease
874,1,1,Nodal Stage,N0
875,1,1,Nodal Stage,N2
875,1,1,Research lab p16,p16 unknown
875,1,1,Research lab HPV,HPV unknown
875,1,1,Time to Death,0.1
875,1,1,Metastasis,M0
875,1,1,Date of Death,2006-08-17 00:00:00
875,1,1,Overall Stage,IVa
875,1,1,Second Failure Type,no known failure
875,1,1,Age at Death,94.1
875,1,1,Treatment Modality,Sx
875,1,1,Tumor Stage,T4a
875,1,1,Occurrence #,1st primary
875,1,1,Status,Dead unk disease
875,1,1,First Failure Type,no known failure
875,1,1,Tumor Site,oral cavity
875,1,1,Clinical lab p16,p16 unknown
876,1,1,Treatment Modality,Sx
876,1,1,Nodal Stage,N0
876,1,1,Second Failure Type,no known failure
876,1,1,Occurrence #,1st primary
876,1,1,First Failure Radiation Dosage,70
876,1,1,Research lab HPV,HPV unknown
876,1,1,Tumor Site,oral cavity
876,1,1,Metastasis,M0
876,1,1,Tumor Stage,T1
876,1,1,First Failure Type,no known failure
876,1,1,First Failure Initial Chemotherapy Agent,Cis
876,1,1,First Failure Site,oropharynx
876,1,1,First Failure Treatment Modality,CTX-RT
876,1,1,Clinical lab p16,p16 unknown
876,1,1,Overall Stage,I
876,1,1,Status,Alive unk disease
876,1,1,Research lab p16,p16 unknown
877,1,1,Research lab HPV,HPV unknown
877,1,1,Metastasis,M0
877,1,1,Tumor Site,oral cavity
877,1,1,Tumor Stage,T1
877,1,1,First Failure Type,no known failure
877,1,1,Overall Stage,I
877,1,1,Research lab p16,p16 unknown
877,1,1,Status,Alive w/o disease
877,1,1,Second Failure Type,no known failure
877,1,1,Nodal Stage,N0
877,1,1,Treatment Modality,Sx
877,1,1,Occurrence #,1st primary
877,1,1,Clinical lab p16,p16 unknown
878,1,1,Status,Alive unk disease
878,1,1,Nodal Stage,N0
878,1,1,Tumor Stage,T2
878,1,1,Tumor Site,oral cavity
878,1,1,Research lab p16,p16 unknown
878,1,1,Treatment Modality,Sx
878,1,1,Research lab HPV,HPV unknown
878,1,1,Metastasis,M0
878,1,1,First Failure Type,no known failure
878,1,1,Second Failure Type,no known failure
878,1,1,Occurrence #,1st primary
878,1,1,Clinical lab p16,p16 unknown
878,1,1,Overall Stage,II
879,1,1,Tumor Site,oral cavity
879,1,1,Research lab p16,p16 unknown
879,1,1,Tumor Stage,T4a
879,1,1,Occurrence #,recurrence
879,1,1,First Failure Type,no known failure
879,1,1,Research lab HPV,HPV unknown
879,1,1,Overall Stage,IVa
879,1,1,Second Failure Type,no known failure
879,1,1,Status,Alive unk disease
879,1,1,Metastasis,M0
879,1,1,Treatment Modality,Unknown
879,1,1,Clinical lab p16,p16 unknown
879,1,1,Nodal Stage,N0
880,1,1,Second Failure Type,no known failure
880,1,1,Treatment Modality,Sx
880,1,1,Research lab HPV,HPV unknown
880,1,1,First Failure Type,no known failure
880,1,1,Tumor Stage,T1
880,1,1,Metastasis,M0
880,1,1,Overall Stage,I
880,1,1,Clinical lab p16,p16 unknown
880,1,1,Nodal Stage,N0
880,1,1,Research lab p16,p16 unknown
880,1,1,Occurrence #,1st primary
880,1,1,Tumor Site,oral cavity
880,1,1,Status,Alive unk disease
881,1,1,Occurrence #,1st primary
881,1,1,Metastasis,M0
881,1,1,Clinical lab p16,p16 unknown
881,1,1,Time to Death,4.3
881,1,1,Overall Stage,II
881,1,1,First Failure Type,no known failure
881,1,1,Age at Death,99.9
881,1,1,Date of Death,2004-09-16 00:00:00
881,1,1,Nodal Stage,N0
881,1,1,Tumor Site,oral cavity
881,1,1,Status,Dead unk disease
881,1,1,Tumor Stage,T2
881,1,1,Radiation Dosage,unknown
881,1,1,Research lab p16,p16 unknown
881,1,1,Treatment Modality,Sx & RT
881,1,1,Second Failure Type,no known failure
881,1,1,Research lab HPV,HPV unknown
882,1,1,Date of Death,2008-09-27 00:00:00
882,1,1,Time to Death,0.8
882,1,1,Initial Chemotherapy Agent,unknown
882,1,1,Treatment Modality,Sx & CTX-RT
882,1,1,Occurrence #,1st primary
882,1,1,Tumor Site,oral cavity
882,1,1,Clinical lab p16,p16 unknown
882,1,1,Overall Stage,IVa
882,1,1,Research lab p16,p16 unknown
882,1,1,Age at Death,68.0
882,1,1,Status,Dead unk disease
882,1,1,Metastasis,M0
882,1,1,Research lab HPV,HPV unknown
882,1,1,Radiation Dosage,unknown
882,1,1,First Failure Type,no known failure
882,1,1,Tumor Stage,T1
882,1,1,Nodal Stage,N2
882,1,1,Second Failure Type,no known failure
883,1,1,Age at Death,73.5
883,1,1,Overall Stage,IVa
883,1,1,Date of Death,2002-10-15 00:00:00
883,1,1,Clinical lab p16,p16 unknown
883,1,1,Time to Death,0.2
883,1,1,Tumor Stage,T4a
883,1,1,Nodal Stage,N1
883,1,1,Tumor Site,oral cavity
883,1,1,Research lab p16,p16 unknown
883,1,1,Treatment Modality,Sx
883,1,1,Occurrence #,recurrence
883,1,1,Research lab HPV,HPV unknown
883,1,1,Status,Dead unk disease
883,1,1,First Failure Type,no known failure
883,1,1,Metastasis,M0
883,1,1,Second Failure Type,no known failure
884,1,1,Research lab HPV,HPV unknown
884,1,1,Second Failure Type,no known failure
884,1,1,Clinical lab p16,p16 unknown
884,1,1,Radiation Dosage,unknown
884,1,1,Occurrence #,recurrence
884,1,1,Tumor Stage,T1
884,1,1,Treatment Modality,Sx & CTX-RT
884,1,1,Initial Chemotherapy Agent,unknown
884,1,1,Metastasis,M0
884,1,1,Status,Alive w/o disease
884,1,1,Research lab p16,p16 unknown
884,1,1,First Failure Type,no known failure
884,1,1,Tumor Site,oral cavity
884,1,1,Nodal Stage,N2
884,1,1,Overall Stage,III
885,1,1,Second Failure Type,no known failure
885,1,1,Status,Alive w/o disease
885,1,1,Nodal Stage,N0
885,1,1,First Failure Type,no known failure
885,1,1,Occurrence #,1st primary
885,1,1,First Failure Site,oral cavity
885,1,1,Overall Stage,II
885,1,1,Treatment Modality,Sx
885,1,1,Tumor Stage,T2
885,1,1,Clinical lab p16,p16 unknown
885,1,1,First Failure Treatment Modality,Sx
885,1,1,Metastasis,M0
885,1,1,Research lab p16,p16 unknown
885,1,1,Research lab HPV,HPV unknown
885,1,1,Tumor Site,oral cavity
886,1,1,Time to Death,2.0
886,1,1,First Failure Type,no known failure
886,1,1,Metastasis,M0
886,1,1,Status,Dead unk disease
886,1,1,Nodal Stage,N0
886,1,1,Tumor Site,oral cavity
886,1,1,Occurrence #,1st primary
886,1,1,Research lab HPV,HPV unknown
886,1,1,Treatment Modality,Sx
886,1,1,Date of Death,2011-11-03 00:00:00
886,1,1,Clinical lab p16,p16 unknown
886,1,1,Age at Death,74.2
886,1,1,Tumor Stage,T4a
886,1,1,Research lab p16,p16 unknown
886,1,1,Overall Stage,IVa
886,1,1,Second Failure Type,no known failure
887,1,1,Status,Alive unk disease
887,1,1,Clinical lab p16,p16 unknown
887,1,1,Nodal Stage,N2
887,1,1,Research lab p16,p16 unknown
887,1,1,Metastasis,M0
887,1,1,Tumor Stage,T4a
887,1,1,Tumor Site,oral cavity
887,1,1,Research lab HPV,HPV unknown
887,1,1,Second Failure Type,no known failure
887,1,1,First Failure Type,no known failure
887,1,1,Treatment Modality,Sx
887,1,1,Occurrence #,1st primary
887,1,1,Overall Stage,IVa
888,1,1,Clinical lab p16,p16 unknown
888,1,1,Metastasis,M0
888,1,1,First Failure Treatment Modality,Sx
888,1,1,Second Failure Type,no known failure
888,1,1,Treatment Modality,Sx
888,1,1,First Failure Type,locoregional
888,1,1,First Failure Site,oral cavity
888,1,1,Tumor Stage,T4a
888,1,1,Research lab p16,p16 unknown
888,1,1,Status,Dead unk disease
888,1,1,Time to First Failure,1.1
888,1,1,Age at Death,65.0
888,1,1,Date of Death,2008-06-22 00:00:00
888,1,1,Time to Death,1.8
888,1,1,Overall Stage,IVa
888,1,1,Research lab HPV,HPV unknown
888,1,1,Nodal Stage,N2
888,1,1,Occurrence #,1st primary
888,1,1,Tumor Site,oral cavity
889,1,1,Overall Stage,III
889,1,1,Treatment Modality,Sx
889,1,1,Second Failure Type,no known failure
889,1,1,Tumor Stage,T3
889,1,1,Research lab p16,p16 unknown
889,1,1,Occurrence #,other primary
889,1,1,Research lab HPV,HPV unknown
889,1,1,Tumor Site,oral cavity
889,1,1,Date of Death,2011-08-07 00:00:00
889,1,1,Age at Death,61.4
889,1,1,First Failure Type,no known failure
889,1,1,Metastasis,M0
889,1,1,Clinical lab p16,p16 unknown
889,1,1,Nodal Stage,N0
889,1,1,Time to Death,3.6
889,1,1,Status,Dead w/o disease
890,1,1,Tumor Site,oral cavity
890,1,1,Time to Death,1.0
890,1,1,Research lab HPV,HPV unknown
890,1,1,Occurrence #,1st primary
890,1,1,Research lab p16,p16 unknown
890,1,1,Treatment Modality,Sx
890,1,1,Clinical lab p16,p16 unknown
890,1,1,First Failure Type,no known failure
890,1,1,Second Failure Type,no known failure
890,1,1,Overall Stage,II
890,1,1,Tumor Stage,T2
890,1,1,Date of Death,2004-08-27 00:00:00
890,1,1,Metastasis,M0
890,1,1,Nodal Stage,N0
890,1,1,Status,Dead unk disease
890,1,1,Age at Death,82.1
891,1,1,First Failure Type,locoregional
891,1,1,Nodal Stage,N0
891,1,1,Second Failure Type,no known failure
891,1,1,Radiation Dosage,40.8
891,1,1,Metastasis,M0
891,1,1,Initial Chemotherapy Agent,Carbo/PTX
891,1,1,Research lab p16,p16 unknown
891,1,1,Treatment Modality,Sx & CTX-RT
891,1,1,Age at Death,71.8
891,1,1,Tumor Site,oral cavity
891,1,1,Overall Stage,IVa
891,1,1,Clinical lab p16,p16 unknown
891,1,1,Time to First Failure,-0.1
891,1,1,Time to Death,0.3
891,1,1,Status,Dead w/ disease
891,1,1,Occurrence #,1st primary
891,1,1,Research lab HPV,HPV unknown
891,1,1,Date of Death,2010-08-06 00:00:00
891,1,1,Tumor Stage,T4a
892,1,1,Tumor Site,oral cavity
892,1,1,Treatment Modality,Sx & RT
892,1,1,Occurrence #,1st primary
892,1,1,Research lab p16,p16 unknown
892,1,1,Research lab HPV,HPV unknown
892,1,1,Metastasis,M0
892,1,1,First Failure Type,no known failure
892,1,1,Radiation Dosage,60
892,1,1,Second Failure Type,no known failure
892,1,1,Status,Alive unk disease
892,1,1,Nodal Stage,N0
892,1,1,Clinical lab p16,p16 unknown
892,1,1,Tumor Stage,T2
892,1,1,Overall Stage,II
893,1,1,Time to Death,8.5
893,1,1,Clinical lab p16,p16 unknown
893,1,1,Metastasis,Unknown
893,1,1,Research lab HPV,HPV unknown
893,1,1,Age at Death,72.4
893,1,1,Occurrence #,other primary
893,1,1,Treatment Modality,Unknown
893,1,1,Nodal Stage,Unknown
893,1,1,Status,Dead unk disease
893,1,1,Overall Stage,IVa
893,1,1,Date of Death,2010-07-13 00:00:00
893,1,1,First Failure Type,no known failure
893,1,1,Second Failure Type,no known failure
893,1,1,Tumor Stage,T2
893,1,1,Tumor Site,oral cavity
893,1,1,Research lab p16,p16 unknown
894,1,1,Metastasis,M0
894,1,1,Tumor Stage,T1
894,1,1,Status,Alive w/o disease
894,1,1,Occurrence #,1st primary
894,1,1,Tumor Site,oral cavity
894,1,1,Second Failure Type,no known failure
894,1,1,Nodal Stage,N0
894,1,1,First Failure Treatment Modality,Sx
894,1,1,First Failure Type,locoregional
894,1,1,Overall Stage,I
894,1,1,First Failure Site,oral cavity
894,1,1,Treatment Modality,Sx
894,1,1,Research lab p16,p16 unknown
894,1,1,Clinical lab p16,p16 unknown
894,1,1,Research lab HPV,HPV unknown
895,1,1,Nodal Stage,N1
895,1,1,Tumor Site,oral cavity
895,1,1,Second Failure Type,no known failure
895,1,1,Overall Stage,III
895,1,1,Research lab p16,p16 unknown
895,1,1,Research lab HPV,HPV unknown
895,1,1,Radiation Dosage,63
895,1,1,Initial Chemotherapy Agent,cis
895,1,1,Status,Alive w/o disease
895,1,1,Second Line Chemotherapy Agent,carbo
895,1,1,Metastasis,M0
895,1,1,Clinical lab p16,p16 unknown
895,1,1,Occurrence #,1st primary
895,1,1,Treatment Modality,Sx & CTX-RT
895,1,1,Tumor Stage,T1
895,1,1,First Failure Type,no known failure
896,1,1,Date of Death,2007-04-14 00:00:00
896,1,1,Clinical lab p16,p16 unknown
896,1,1,Status,Dead unk disease
896,1,1,Tumor Site,oral cavity
896,1,1,Treatment Modality,Sx
896,1,1,Nodal Stage,N0
896,1,1,Metastasis,M0
896,1,1,Second Failure Type,no known failure
896,1,1,Time to Death,5.5
896,1,1,Research lab HPV,HPV unknown
896,1,1,Occurrence #,1st primary
896,1,1,Tumor Stage,T1
896,1,1,Overall Stage,I
896,1,1,Age at Death,80.3
896,1,1,Research lab p16,p16 unknown
896,1,1,First Failure Type,no known failure
897,1,1,Occurrence #,1st primary
897,1,1,Treatment Modality,Sx & RT
897,1,1,Clinical lab p16,p16 unknown
897,1,1,Tumor Site,oral cavity
897,1,1,Radiation Dosage,66
897,1,1,Second Failure Type,no known failure
897,1,1,Research lab p16,p16 unknown
897,1,1,Metastasis,M0
897,1,1,Research lab HPV,HPV unknown
897,1,1,Nodal Stage,N0
897,1,1,Tumor Stage,T4a
897,1,1,Status,Alive w/o disease
897,1,1,Overall Stage,IVa
897,1,1,First Failure Type,no known failure
898,1,1,Treatment Modality,Sx & CTX-RT
898,1,1,Tumor Site,oral cavity
898,1,1,Tumor Stage,T1
898,1,1,Occurrence #,other primary
898,1,1,Status,Alive w/o disease
898,1,1,First Failure Type,no known failure
898,1,1,Radiation Dosage,60
898,1,1,Research lab HPV,HPV unknown
898,1,1,Nodal Stage,N2
898,1,1,Metastasis,M0
898,1,1,Clinical lab p16,p16 unknown
898,1,1,Research lab p16,p16 unknown
898,1,1,Overall Stage,IVa
898,1,1,Initial Chemotherapy Agent,carbo/PTX
898,1,1,Second Failure Type,no known failure
899,1,1,Research lab HPV,HPV unknown
899,1,1,Status,Alive w/o disease
899,1,1,First Failure Type,no known failure
899,1,1,Metastasis,M0
899,1,1,Overall Stage,IVa
899,1,1,Tumor Stage,T4a
899,1,1,Second Failure Type,no known failure
899,1,1,Nodal Stage,N0
899,1,1,Clinical lab p16,p16 unknown
899,1,1,Occurrence #,1st primary
899,1,1,Research lab p16,p16 unknown
899,1,1,Tumor Site,oral cavity
899,1,1,Treatment Modality,Sx
900,1,1,Overall Stage,II
900,1,1,Tumor Site,oral cavity
900,1,1,Treatment Modality,Sx
900,1,1,Tumor Stage,T2
900,1,1,Second Failure Type,no known failure
900,1,1,Nodal Stage,N0
900,1,1,Clinical lab p16,p16 unknown
900,1,1,Status,Alive w/o disease
900,1,1,First Failure Type,no known failure
900,1,1,Metastasis,M0
900,1,1,Research lab HPV,HPV unknown
900,1,1,Research lab p16,p16 unknown
900,1,1,Occurrence #,1st primary
901,1,1,Overall Stage,IVa
901,1,1,Status,Alive unk disease
901,1,1,Metastasis,M0
901,1,1,Clinical lab p16,p16 unknown
901,1,1,Occurrence #,1st primary
901,1,1,Treatment Modality,Sx
901,1,1,Research lab p16,p16 unknown
901,1,1,Research lab HPV,HPV unknown
901,1,1,First Failure Type,no known failure
901,1,1,Tumor Site,oral cavity
901,1,1,Second Failure Type,no known failure
901,1,1,Tumor Stage,T4a
901,1,1,Nodal Stage,N0
902,1,1,Research lab p16,p16 unknown
902,1,1,Clinical lab p16,p16 unknown
902,1,1,Occurrence #,recurrence
902,1,1,Second Failure Type,no known failure
902,1,1,Nodal Stage,N2
902,1,1,Metastasis,M0
902,1,1,Treatment Modality,Sx
902,1,1,Research lab HPV,HPV unknown
902,1,1,Tumor Site,oropharynx
902,1,1,Time to Death,1.6
902,1,1,Overall Stage,IVa
902,1,1,Tumor Stage,T4a
902,1,1,First Failure Type,no known failure
902,1,1,Date of Death,2006-03-29 00:00:00
902,1,1,Age at Death,73.5
902,1,1,Status,Dead unk disease
903,1,1,Date of Death,2010-03-22 00:00:00
903,1,1,Research lab HPV,HPV unknown
903,1,1,Second Failure Type,no known failure
903,1,1,Occurrence #,1st primary
903,1,1,Overall Stage,I
903,1,1,Research lab p16,p16 unknown
903,1,1,Clinical lab p16,p16 unknown
903,1,1,Tumor Stage,T1
903,1,1,First Failure Type,no known failure
903,1,1,Status,Dead unk disease
903,1,1,Age at Death,96.3
903,1,1,Metastasis,M0
903,1,1,Tumor Site,oral cavity
903,1,1,Treatment Modality,Sx
903,1,1,Nodal Stage,N0
903,1,1,Time to Death,6.0
904,1,1,Nodal Stage,N1
904,1,1,Metastasis,M0
904,1,1,Clinical lab p16,p16 unknown
904,1,1,Overall Stage,III
904,1,1,First Failure Type,no known failure
904,1,1,Research lab p16,p16 unknown
904,1,1,Second Failure Type,no known failure
904,1,1,Research lab HPV,HPV unknown
904,1,1,Tumor Site,oral cavity
904,1,1,Tumor Stage,T2
904,1,1,Treatment Modality,Sx
904,1,1,Status,Alive w/o disease
904,1,1,Occurrence #,recurrence
905,1,1,Nodal Stage,Unknown
905,1,1,Age at Death,73.7
905,1,1,Occurrence #,1st primary
905,1,1,Treatment Modality,Sx
905,1,1,Research lab p16,p16 unknown
905,1,1,Time to Death,3.3
905,1,1,Clinical lab p16,p16 unknown
905,1,1,Second Failure Type,no known failure
905,1,1,Metastasis,M0
905,1,1,Overall Stage,IVb
905,1,1,Status,Dead unk disease
905,1,1,Date of Death,2003-11-18 00:00:00
905,1,1,Tumor Site,oral cavity
905,1,1,First Failure Type,no known failure
905,1,1,Research lab HPV,HPV unknown
905,1,1,Tumor Stage,T4b
906,1,1,Overall Stage,IVa
906,1,1,Occurrence #,1st primary
906,1,1,Time to Death,2.1
906,1,1,Metastasis,M0
906,1,1,Time to First Failure,1.9
906,1,1,Clinical lab p16,p16 unknown
906,1,1,Research lab HPV,HPV unknown
906,1,1,Nodal Stage,N2
906,1,1,Treatment Modality,Sx
906,1,1,Status,Dead w/ disease
906,1,1,Tumor Site,oral cavity
906,1,1,First Failure Type,locoregional
906,1,1,Tumor Stage,T4a
906,1,1,Date of Death,2004-11-24 00:00:00
906,1,1,Second Failure Type,no known failure
906,1,1,Research lab p16,p16 unknown
906,1,1,Age at Death,75.2
907,1,1,Tumor Site,oral cavity
907,1,1,Treatment Modality,Sx
907,1,1,Overall Stage,IVa
907,1,1,Research lab HPV,HPV unknown
907,1,1,Research lab p16,p16 unknown
907,1,1,First Failure Type,no known failure
907,1,1,Status,Alive unk disease
907,1,1,Tumor Stage,T1
907,1,1,Clinical lab p16,p16 unknown
907,1,1,Occurrence #,1st primary
907,1,1,Second Failure Type,no known failure
907,1,1,Nodal Stage,N2
907,1,1,Metastasis,M0
908,1,1,Tumor Stage,T2
908,1,1,Research lab HPV,HPV unknown
908,1,1,Tumor Site,oral cavity
908,1,1,First Failure Type,no known failure
908,1,1,Research lab p16,p16 unknown
908,1,1,Occurrence #,recurrence
908,1,1,Overall Stage,II
908,1,1,Second Failure Type,no known failure
908,1,1,Nodal Stage,N0
908,1,1,Status,Alive w/o disease
908,1,1,Metastasis,M0
908,1,1,Clinical lab p16,p16 unknown
908,1,1,Treatment Modality,Sx
909,1,1,Metastasis,M0
909,1,1,Tumor Stage,T1
909,1,1,Second Failure Type,no known failure
909,1,1,Date of Death,2007-05-25 00:00:00
909,1,1,Research lab HPV,HPV unknown
909,1,1,Overall Stage,I
909,1,1,Research lab p16,p16 unknown
909,1,1,Treatment Modality,Sx
909,1,1,First Failure Type,no known failure
909,1,1,Time to Death,2.3
909,1,1,Occurrence #,1st primary
909,1,1,Nodal Stage,N0
909,1,1,Age at Death,76.1
909,1,1,Status,Dead unk disease
909,1,1,Tumor Site,oral cavity
909,1,1,Clinical lab p16,p16 unknown
910,1,1,Second Failure Type,no known failure
910,1,1,Clinical lab p16,p16 unknown
910,1,1,Treatment Modality,Sx
910,1,1,Research lab p16,p16 unknown
910,1,1,Overall Stage,I
910,1,1,Research lab HPV,HPV unknown
910,1,1,Metastasis,M0
910,1,1,Tumor Site,oral cavity
910,1,1,Date of Death,2000-11-21 00:00:00
910,1,1,First Failure Type,no known failure
910,1,1,Age at Death,68.6
910,1,1,Nodal Stage,N0
910,1,1,Tumor Stage,T1
910,1,1,Status,Dead w/o disease
910,1,1,Time to Death,0.3
910,1,1,Occurrence #,1st primary
911,1,1,Status,Dead unk disease
911,1,1,Time to Death,1.4
911,1,1,Occurrence #,1st primary
911,1,1,Tumor Site,oral cavity
911,1,1,First Failure Type,no known failure
911,1,1,Treatment Modality,Sx & RT
911,1,1,Radiation Dosage,63
911,1,1,Overall Stage,IVa
911,1,1,Tumor Stage,T4a
911,1,1,Age at Death,56.1
911,1,1,Metastasis,M0
911,1,1,Clinical lab p16,p16 unknown
911,1,1,Date of Death,2005-02-14 00:00:00
911,1,1,Second Failure Type,no known failure
911,1,1,Research lab HPV,HPV unknown
911,1,1,Nodal Stage,N1
911,1,1,Research lab p16,p16 unknown
912,1,1,Tumor Stage,T2
912,1,1,Status,Dead w/o disease
912,1,1,Occurrence #,1st primary
912,1,1,Time to Death,1.5
912,1,1,Metastasis,M0
912,1,1,Age at Death,55.8
912,1,1,Tumor Site,oral cavity
912,1,1,Nodal Stage,N0
912,1,1,Treatment Modality,Sx
912,1,1,Date of Death,2002-01-02 00:00:00
912,1,1,First Failure Type,no known failure
912,1,1,Research lab HPV,HPV unknown
912,1,1,Clinical lab p16,p16 unknown
912,1,1,Overall Stage,II
912,1,1,Research lab p16,p16 unknown
912,1,1,Second Failure Type,no known failure
913,1,1,Second Failure Type,no known failure
913,1,1,Occurrence #,1st primary
913,1,1,Age at Death,57.8
913,1,1,Overall Stage,IVa
913,1,1,Metastasis,M0
913,1,1,Nodal Stage,N0
913,1,1,First Failure Type,no known failure
913,1,1,Research lab HPV,HPV unknown
913,1,1,Research lab p16,p16 unknown
913,1,1,Tumor Stage,T4a
913,1,1,Treatment Modality,Sx
913,1,1,Date of Death,2009-09-07 00:00:00
913,1,1,Time to Death,8.4
913,1,1,Status,Dead unk disease
913,1,1,Clinical lab p16,p16 unknown
913,1,1,Tumor Site,oral cavity
914,1,1,Research lab HPV,HPV unknown
914,1,1,Clinical lab p16,p16 unknown
914,1,1,Tumor Stage,T4a
914,1,1,Age at Death,71.0
914,1,1,Nodal Stage,N1
914,1,1,Second Failure Type,no known failure
914,1,1,Metastasis,M0
914,1,1,Status,Dead unk disease
914,1,1,First Failure Type,no known failure
914,1,1,Treatment Modality,Sx
914,1,1,Overall Stage,IVa
914,1,1,Time to Death,1.5
914,1,1,Research lab p16,p16 unknown
914,1,1,Date of Death,2005-12-26 00:00:00
914,1,1,Tumor Site,oral cavity
914,1,1,Occurrence #,1st primary
915,1,1,Clinical lab p16,p16 unknown
915,1,1,Tumor Site,oral cavity
915,1,1,Research lab HPV,HPV unknown
915,1,1,Metastasis,M0
915,1,1,Tumor Stage,T4a
915,1,1,Status,Alive w/o disease
915,1,1,Second Failure Type,no known failure
915,1,1,Initial Chemotherapy Agent,cis
915,1,1,Nodal Stage,N2
915,1,1,Occurrence #,1st primary
915,1,1,Overall Stage,IVa
915,1,1,Research lab p16,p16 unknown
915,1,1,Radiation Dosage,59.4
915,1,1,Treatment Modality,Sx & CTX-RT
915,1,1,First Failure Type,no known failure
916,1,1,Time to First Failure,4.3
916,1,1,Occurrence #,1st primary
916,1,1,Overall Stage,I
916,1,1,First Failure Treatment Modality,Sx
916,1,1,Nodal Stage,N0
916,1,1,Research lab p16,p16 unknown
916,1,1,Second Failure Type,no known failure
916,1,1,Metastasis,M0
916,1,1,Tumor Stage,T1
916,1,1,First Failure Type,locoregional
916,1,1,Tumor Site,oral cavity
916,1,1,Treatment Modality,Sx
916,1,1,First Failure Site,oral cavity
916,1,1,Research lab HPV,HPV unknown
916,1,1,Status,Alive w/o disease
916,1,1,Clinical lab p16,p16 unknown
916,1,1,First Failure Radiation Dosage,unknown
917,1,1,Research lab p16,p16 unknown
917,1,1,Second Failure Type,no known failure
917,1,1,First Failure Type,locoregional
917,1,1,Tumor Site,oral cavity
917,1,1,Treatment Modality,Sx
917,1,1,Status,Alive w/o disease
917,1,1,Occurrence #,1st primary
917,1,1,Time to First Failure,0.2
917,1,1,Research lab HPV,HPV unknown
917,1,1,Metastasis,M0
917,1,1,Clinical lab p16,p16 unknown
917,1,1,Overall Stage,I
917,1,1,Nodal Stage,N0
917,1,1,Tumor Stage,T1
919,1,1,Metastasis,M0
919,1,1,First Failure Type,no known failure
919,1,1,Tumor Stage,T2
919,1,1,Nodal Stage,N0
919,1,1,Occurrence #,1st primary
919,1,1,Tumor Site,oral cavity
919,1,1,Treatment Modality,Sx
919,1,1,Status,Alive unk disease
919,1,1,Overall Stage,II
919,1,1,Research lab p16,p16 unknown
919,1,1,Second Failure Type,no known failure
919,1,1,Research lab HPV,HPV unknown
919,1,1,Clinical lab p16,p16 unknown
920,1,1,Research lab HPV,HPV unknown
920,1,1,Status,Dead w/ disease
920,1,1,Nodal Stage,N2
920,1,1,Metastasis,M0
920,1,1,First Failure Site,oral cavity
920,1,1,First Failure Treatment Modality,Sx & RT
920,1,1,Age at Death,83.0
920,1,1,Clinical lab p16,p16 unknown
920,1,1,Tumor Stage,T2
920,1,1,Date of Death,2010-08-07 00:00:00
920,1,1,Radiation Dosage,unknown
920,1,1,Time to First Failure,0.1
920,1,1,Tumor Site,oral cavity
920,1,1,Time to Death,1.0
920,1,1,Occurrence #,1st primary
920,1,1,First Failure Type,distant
920,1,1,Second Failure Type,no known failure
920,1,1,Overall Stage,IVa
920,1,1,Research lab p16,p16 unknown
920,1,1,First Failure Radiation Dosage,unk
920,1,1,Treatment Modality,Sx & RT
921,1,1,Clinical lab p16,p16 unknown
921,1,1,Research lab HPV,HPV unknown
921,1,1,Research lab p16,p16 unknown
921,1,1,Radiation Dosage,unknown
921,1,1,Metastasis,M0
921,1,1,First Failure Type,no known failure
921,1,1,Tumor Site,oral cavity
921,1,1,Tumor Stage,T2
921,1,1,Status,Alive w/o disease
921,1,1,Treatment Modality,Sx & RT
921,1,1,Second Failure Type,no known failure
921,1,1,Nodal Stage,N1
921,1,1,Occurrence #,1st primary
921,1,1,Overall Stage,III
922,1,1,Overall Stage,IVa
922,1,1,First Failure Treatment Modality,Sx
922,1,1,Research lab HPV,HPV unknown
922,1,1,Second Failure Type,no known failure
922,1,1,First Failure Site,oral cavity
922,1,1,Metastasis,M0
922,1,1,First Failure Type,no known failure
922,1,1,Treatment Modality,Sx & RT
922,1,1,Time to Death,1.1
922,1,1,Occurrence #,1st primary
922,1,1,Radiation Dosage,unknown
922,1,1,Research lab p16,p16 unknown
922,1,1,Tumor Site,oral cavity
922,1,1,Clinical lab p16,p16 unknown
922,1,1,Tumor Stage,T4a
922,1,1,Status,Dead unk disease
922,1,1,Age at Death,81.9
922,1,1,Nodal Stage,N2
922,1,1,Date of Death,2003-07-08 00:00:00
923,1,1,Metastasis,M0
923,1,1,First Failure Type,no known failure
923,1,1,Status,Alive w/o disease
923,1,1,Treatment Modality,Sx
923,1,1,Nodal Stage,N0
923,1,1,Second Failure Type,no known failure
923,1,1,Tumor Stage,T1
923,1,1,Research lab HPV,HPV unknown
923,1,1,Overall Stage,I
923,1,1,Tumor Site,oral cavity
923,1,1,Research lab p16,p16 unknown
923,1,1,Clinical lab p16,p16 unknown
923,1,1,Occurrence #,1st primary
924,1,1,Clinical lab p16,p16 unknown
924,1,1,Status,Alive w/o disease
924,1,1,Tumor Stage,T1
924,1,1,Second Failure Type,no known failure
924,1,1,Nodal Stage,N2
924,1,1,Metastasis,M0
924,1,1,Treatment Modality,Sx & CTX-RT
924,1,1,First Failure Type,no known failure
924,1,1,Radiation Dosage,70.2
924,1,1,Occurrence #,1st primary
924,1,1,Tumor Site,oral cavity
924,1,1,Overall Stage,III
924,1,1,Research lab p16,p16 unknown
924,1,1,Research lab HPV,HPV unknown
924,1,1,Initial Chemotherapy Agent,cis
925,1,1,Second Failure Type,no known failure
925,1,1,First Failure Initial Chemotherapy Agent,cis/doce
925,1,1,First Failure Type,locoregional
925,1,1,First Failure Site,oral cavity
925,1,1,Research lab HPV,HPV unknown
925,1,1,Overall Stage,IVa
925,1,1,Metastasis,M0
925,1,1,Clinical lab p16,p16 unknown
925,1,1,First Failure Treatment Modality,Sx & CTX-RT
925,1,1,Tumor Stage,T4a
925,1,1,Nodal Stage,N0
925,1,1,Research lab p16,p16 unknown
925,1,1,Occurrence #,other primary
925,1,1,Status,Alive w/o disease
925,1,1,First Failure Radiation Dosage,60
925,1,1,Time to First Failure,0.2
925,1,1,Treatment Modality,Sx
925,1,1,Tumor Site,oral cavity
926,1,1,Research lab p16,p16 unknown
926,1,1,Clinical lab p16,p16 unknown
926,1,1,Research lab HPV,HPV unknown
926,1,1,Occurrence #,1st primary
926,1,1,Metastasis,M0
926,1,1,Nodal Stage,N0
926,1,1,Treatment Modality,Sx
926,1,1,First Failure Type,no known failure
926,1,1,Status,Dead w/ disease
926,1,1,Tumor Stage,T1
926,1,1,Overall Stage,I
926,1,1,Second Failure Type,no known failure
926,1,1,Tumor Site,oral cavity
927,1,1,Status,Alive w/o disease
927,1,1,Nodal Stage,N0
927,1,1,Tumor Stage,T1
927,1,1,Research lab p16,p16 unknown
927,1,1,Clinical lab p16,p16 unknown
927,1,1,Treatment Modality,Sx
927,1,1,Second Failure Type,no known failure
927,1,1,Metastasis,M0
927,1,1,Overall Stage,I
927,1,1,Occurrence #,1st primary
927,1,1,Tumor Site,oral cavity
927,1,1,Research lab HPV,HPV unknown
927,1,1,First Failure Type,no known failure
928,1,1,Overall Stage,III
928,1,1,Tumor Site,oral cavity
928,1,1,Research lab p16,p16 unknown
928,1,1,Research lab HPV,HPV unknown
928,1,1,Second Failure Type,no known failure
928,1,1,Status,Alive w/o disease
928,1,1,First Failure Type,no known failure
928,1,1,Treatment Modality,Sx
928,1,1,Clinical lab p16,p16 unknown
928,1,1,Nodal Stage,N1
928,1,1,Metastasis,M0
928,1,1,Occurrence #,1st primary
928,1,1,Tumor Stage,T1
929,1,1,Occurrence #,1st primary
929,1,1,Nodal Stage,N0
929,1,1,Clinical lab p16,p16 unknown
929,1,1,Research lab p16,p16 unknown
929,1,1,Treatment Modality,Sx
929,1,1,Overall Stage,II
929,1,1,Tumor Stage,T2
929,1,1,Tumor Site,oral cavity
929,1,1,Second Failure Type,no known failure
929,1,1,Research lab HPV,HPV unknown
929,1,1,Metastasis,M0
929,1,1,Status,Alive w/o disease
929,1,1,First Failure Type,no known failure
930,1,1,Status,Dead unk disease
930,1,1,Age at Death,80.7
930,1,1,Clinical lab p16,p16 unknown
930,1,1,Research lab p16,p16 unknown
930,1,1,Tumor Stage,T4a
930,1,1,First Failure Type,no known failure
930,1,1,Time to Death,0.4
930,1,1,Research lab HPV,HPV unknown
930,1,1,Overall Stage,IVa
930,1,1,Date of Death,2008-01-13 00:00:00
930,1,1,Metastasis,M0
930,1,1,Nodal Stage,N2
930,1,1,Second Failure Type,no known failure
930,1,1,Tumor Site,oral cavity
930,1,1,Occurrence #,1st primary
930,1,1,Treatment Modality,Sx
931,1,1,Metastasis,M0
931,1,1,Overall Stage,I
931,1,1,First Failure Treatment Modality,Sx & RT
931,1,1,Date of Death,2004-08-18 00:00:00
931,1,1,Second Failure Type,no known failure
931,1,1,Time to First Failure,3.1
931,1,1,First Failure Radiation Dosage,unknown
931,1,1,Clinical lab p16,p16 unknown
931,1,1,First Failure Type,locoregional
931,1,1,Occurrence #,1st primary
931,1,1,Status,Dead w/ disease
931,1,1,Tumor Site,oral cavity
931,1,1,Time to Death,4.0
931,1,1,First Failure Site,oral cavity
931,1,1,Treatment Modality,Sx
931,1,1,Nodal Stage,N0
931,1,1,Tumor Stage,T1
931,1,1,Research lab p16,p16 unknown
931,1,1,Research lab HPV,HPV unknown
931,1,1,Age at Death,64.5
932,1,1,Nodal Stage,N0
932,1,1,Clinical lab p16,p16 unknown
932,1,1,Occurrence #,1st primary
932,1,1,First Failure Type,no known failure
932,1,1,Status,Alive unk disease
932,1,1,Treatment Modality,Sx
932,1,1,Tumor Site,oral cavity
932,1,1,Metastasis,M0
932,1,1,Research lab p16,p16 unknown
932,1,1,Tumor Stage,T1
932,1,1,Second Failure Type,no known failure
932,1,1,Research lab HPV,HPV unknown
932,1,1,Overall Stage,I
933,1,1,Time to Death,2.1
933,1,1,First Failure Initial Chemotherapy Agent,cis/doce/5-FU
933,1,1,Research lab HPV,HPV unknown
933,1,1,Overall Stage,IVa
933,1,1,Nodal Stage,N2
933,1,1,First Failure Type,locoregional
933,1,1,Treatment Modality,Sx & CTX-RT
933,1,1,Status,Dead w/ disease
933,1,1,Research lab p16,p16 unknown
933,1,1,First Failure Site,oral cavity
933,1,1,Date of Death,2008-02-11 00:00:00
933,1,1,Age at Death,37.9
933,1,1,Second Failure Type,no known failure
933,1,1,First Failure Treatment Modality,Sx & CTX
933,1,1,Metastasis,M0
933,1,1,Radiation Dosage,60
933,1,1,Tumor Site,oral cavity
933,1,1,Second Line Chemotherapy Agent,carbo
933,1,1,Clinical lab p16,p16 unknown
933,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
933,1,1,Time to First Failure,0.3
933,1,1,Tumor Stage,T4a
933,1,1,Occurrence #,1st primary
934,1,1,Date of Death,2007-10-14 00:00:00
934,1,1,Second Failure Type,no known failure
934,1,1,Time to Death,2.0
934,1,1,Research lab HPV,HPV unknown
934,1,1,Tumor Site,oral cavity
934,1,1,Treatment Modality,Sx & CTX-RT
934,1,1,Clinical lab p16,p16 unknown
934,1,1,Research lab p16,p16 unknown
934,1,1,Status,Dead unk disease
934,1,1,Nodal Stage,N1
934,1,1,Occurrence #,1st primary
934,1,1,Initial Chemotherapy Agent,unknown
934,1,1,Age at Death,69.2
934,1,1,Overall Stage,III
934,1,1,First Failure Type,locoregional
934,1,1,Radiation Dosage,unknown
934,1,1,Metastasis,M0
934,1,1,Time to First Failure,1.5
934,1,1,Tumor Stage,T2
935,1,1,Tumor Stage,T1
935,1,1,Research lab HPV,HPV unknown
935,1,1,Occurrence #,1st primary
935,1,1,Time to Death,3.9
935,1,1,Age at Death,82.8
935,1,1,Clinical lab p16,p16 unknown
935,1,1,Second Failure Type,no known failure
935,1,1,First Failure Type,no known failure
935,1,1,Research lab p16,p16 unknown
935,1,1,Nodal Stage,N0
935,1,1,Treatment Modality,Sx
935,1,1,Status,Dead unk disease
935,1,1,Metastasis,M0
935,1,1,Tumor Site,oral cavity
935,1,1,Date of Death,2008-07-08 00:00:00
935,1,1,Overall Stage,I
936,1,1,First Failure Treatment Modality,CTX-RT
936,1,1,Radiation Dosage,70.2
936,1,1,Research lab p16,p16 unknown
936,1,1,Tumor Stage,T2
936,1,1,Metastasis,M0
936,1,1,Status,Alive w/o disease
936,1,1,Initial Chemotherapy Agent,cetux
936,1,1,Research lab HPV,HPV unknown
936,1,1,Treatment Modality,Sx & CTX-RT
936,1,1,Tumor Site,oral cavity
936,1,1,Time to First Failure,-0.3
936,1,1,First Failure Site,oral cavity
936,1,1,Occurrence #,1st primary
936,1,1,Nodal Stage,N1
936,1,1,Overall Stage,III
936,1,1,Second Failure Type,no known failure
936,1,1,First Failure Type,locoregional
936,1,1,Clinical lab p16,p16 unknown
937,1,1,Occurrence #,1st primary
937,1,1,Research lab p16,p16 unknown
937,1,1,Date of Death,2009-06-28 00:00:00
937,1,1,First Failure Site,oral cavity
937,1,1,First Failure Radiation Dosage,63
937,1,1,First Failure Treatment Modality,Sx & RT
937,1,1,Tumor Stage,T2
937,1,1,Time to First Failure,3.2
937,1,1,Research lab HPV,HPV unknown
937,1,1,Nodal Stage,N0
937,1,1,Time to Death,4.5
937,1,1,Metastasis,M0
937,1,1,Clinical lab p16,p16 unknown
937,1,1,Treatment Modality,Sx
937,1,1,First Failure Type,locoregional
937,1,1,Second Failure Type,no known failure
937,1,1,Status,Dead w/ disease
937,1,1,Age at Death,71.8
937,1,1,Tumor Site,oral cavity
937,1,1,Overall Stage,II
938,1,1,Tumor Stage,T1
938,1,1,Nodal Stage,N0
938,1,1,Research lab p16,p16 unknown
938,1,1,Second Failure Type,no known failure
938,1,1,Overall Stage,I
938,1,1,Research lab HPV,HPV unknown
938,1,1,Occurrence #,1st primary
938,1,1,Metastasis,M0
938,1,1,First Failure Type,no known failure
938,1,1,Tumor Site,oral cavity
938,1,1,Treatment Modality,Sx
938,1,1,Clinical lab p16,p16 unknown
938,1,1,Status,Alive unk disease
939,1,1,Time to First Failure,1.5
939,1,1,Tumor Site,oral cavity
939,1,1,Research lab HPV,HPV unknown
939,1,1,Tumor Stage,T1
939,1,1,Metastasis,M0
939,1,1,Date of Death,2009-09-13 00:00:00
939,1,1,Age at Death,74.2
939,1,1,Overall Stage,III
939,1,1,Second Failure Type,no known failure
939,1,1,Status,Dead w/ disease
939,1,1,Radiation Dosage,63
939,1,1,Clinical lab p16,p16 unknown
939,1,1,Time to Death,2.0
939,1,1,Treatment Modality,Sx & RT
939,1,1,Research lab p16,p16 unknown
939,1,1,Nodal Stage,N1
939,1,1,Occurrence #,1st primary
939,1,1,First Failure Type,locoregional
940,1,1,Second Failure Type,no known failure
940,1,1,Research lab p16,p16 unknown
940,1,1,Clinical lab p16,p16 unknown
940,1,1,Research lab HPV,HPV unknown
940,1,1,Overall Stage,II
940,1,1,Treatment Modality,Sx
940,1,1,Tumor Site,oral cavity
940,1,1,Occurrence #,1st primary
940,1,1,Status,Dead w/o disease
940,1,1,Nodal Stage,N0
940,1,1,Tumor Stage,T2
940,1,1,Metastasis,M0
940,1,1,First Failure Type,no known failure
941,1,1,Tumor Stage,T1
941,1,1,Tumor Site,oral cavity
941,1,1,Occurrence #,1st primary
941,1,1,First Failure Type,no known failure
941,1,1,Clinical lab p16,p16 unknown
941,1,1,Overall Stage,IVa
941,1,1,Status,Alive unk disease
941,1,1,Metastasis,M0
941,1,1,Treatment Modality,Sx
941,1,1,Second Failure Type,no known failure
941,1,1,Research lab HPV,HPV unknown
941,1,1,Research lab p16,p16 unknown
941,1,1,Nodal Stage,N2
942,1,1,First Failure Type,no known failure
942,1,1,Occurrence #,1st primary
942,1,1,Overall Stage,II
942,1,1,Clinical lab p16,p16 unknown
942,1,1,Nodal Stage,N0
942,1,1,Research lab HPV,HPV unknown
942,1,1,Second Failure Type,no known failure
942,1,1,Status,Alive unk disease
942,1,1,Tumor Stage,T2
942,1,1,Metastasis,M0
942,1,1,Tumor Site,oral cavity
942,1,1,Treatment Modality,Sx
942,1,1,Research lab p16,p16 unknown
943,1,1,Research lab HPV,HPV unknown
943,1,1,Clinical lab p16,p16 unknown
943,1,1,Metastasis,M0
943,1,1,Overall Stage,II
943,1,1,Date of Death,2010-03-24 00:00:00
943,1,1,Occurrence #,1st primary
943,1,1,Status,Dead unk disease
943,1,1,Tumor Site,oral cavity
943,1,1,Age at Death,81.2
943,1,1,Treatment Modality,Sx
943,1,1,Tumor Stage,T2
943,1,1,Nodal Stage,N0
943,1,1,Second Failure Type,no known failure
943,1,1,Research lab p16,p16 unknown
943,1,1,First Failure Type,no known failure
943,1,1,Time to Death,2.1
944,1,1,Tumor Site,oral cavity
944,1,1,Tumor Stage,T3
944,1,1,Research lab p16,p16 unknown
944,1,1,Nodal Stage,N1
944,1,1,Second Failure Type,no known failure
944,1,1,Research lab HPV,HPV unknown
944,1,1,Age at Death,77.1
944,1,1,Time to First Failure,0.2
944,1,1,Date of Death,2003-09-12 00:00:00
944,1,1,Metastasis,M0
944,1,1,Status,Dead unk disease
944,1,1,Radiation Dosage,60
944,1,1,First Failure Type,locoregional
944,1,1,Clinical lab p16,p16 unknown
944,1,1,Occurrence #,1st primary
944,1,1,Treatment Modality,Sx
944,1,1,Overall Stage,III
944,1,1,Time to Death,1.1
945,1,1,Treatment Modality,Sx & RT
945,1,1,First Failure Treatment Modality,CTX
945,1,1,Research lab HPV,HPV unknown
945,1,1,Clinical lab p16,p16 unknown
945,1,1,Metastasis,M0
945,1,1,First Failure Type,distant
945,1,1,Time to First Failure,0.2
945,1,1,Overall Stage,IVa
945,1,1,Occurrence #,1st primary
945,1,1,Radiation Dosage,unknown
945,1,1,Time to Death,0.9
945,1,1,Research lab p16,p16 unknown
945,1,1,Date of Death,2006-02-20 00:00:00
945,1,1,Tumor Site,oral cavity
945,1,1,Tumor Stage,T2
945,1,1,Age at Death,70.3
945,1,1,Nodal Stage,N2
945,1,1,First Failure Site,oral cavity
945,1,1,Second Failure Type,no known failure
945,1,1,First Failure Initial Chemotherapy Agent,cis/doce
945,1,1,Status,Dead w/ disease
946,1,1,Overall Stage,IVa
946,1,1,Status,Dead unk disease
946,1,1,Age at Death,50.9
946,1,1,Treatment Modality,Sx
946,1,1,First Failure Type,no known failure
946,1,1,Research lab p16,p16 unknown
946,1,1,Occurrence #,recurrence
946,1,1,Date of Death,2008-03-11 00:00:00
946,1,1,Time to Death,1.4
946,1,1,Tumor Stage,T4a
946,1,1,Tumor Site,oral cavity
946,1,1,Nodal Stage,N0
946,1,1,Second Failure Type,no known failure
946,1,1,Metastasis,M0
946,1,1,Research lab HPV,HPV unknown
946,1,1,Clinical lab p16,p16 unknown
947,1,1,Tumor Site,oral cavity
947,1,1,First Failure Type,no known failure
947,1,1,Metastasis,M0
947,1,1,Radiation Dosage,unknown
947,1,1,Age at Death,69.2
947,1,1,Treatment Modality,Sx & CTX-RT
947,1,1,Clinical lab p16,p16 unknown
947,1,1,Date of Death,2004-02-08 00:00:00
947,1,1,Research lab HPV,HPV unknown
947,1,1,Nodal Stage,N2
947,1,1,Initial Chemotherapy Agent,unknown
947,1,1,Second Failure Type,no known failure
947,1,1,Tumor Stage,T1
947,1,1,Occurrence #,recurrence
947,1,1,Research lab p16,p16 unknown
947,1,1,Overall Stage,IVa
947,1,1,Status,Dead unk disease
947,1,1,Time to Death,1.5
948,1,1,Research lab p16,p16 unknown
948,1,1,Occurrence #,1st primary
948,1,1,Clinical lab p16,p16 unknown
948,1,1,Tumor Stage,T1
948,1,1,Treatment Modality,Sx
948,1,1,Second Failure Type,no known failure
948,1,1,Tumor Site,oral cavity
948,1,1,Status,Alive unk disease
948,1,1,Nodal Stage,N0
948,1,1,First Failure Type,no known failure
948,1,1,Overall Stage,I
948,1,1,Metastasis,M0
948,1,1,Research lab HPV,HPV unknown
949,1,1,Time to Death,1.5
949,1,1,Age at Death,55.6
949,1,1,Metastasis,M0
949,1,1,Research lab HPV,HPV unknown
949,1,1,Tumor Stage,T1
949,1,1,Date of Death,2002-04-14 00:00:00
949,1,1,Second Failure Type,no known failure
949,1,1,Treatment Modality,Sx
949,1,1,First Failure Type,locoregional
949,1,1,Overall Stage,I
949,1,1,Nodal Stage,N0
949,1,1,First Failure Initial Chemotherapy Agent,unknown
949,1,1,Clinical lab p16,p16 unknown
949,1,1,Tumor Site,oral cavity
949,1,1,Research lab p16,p16 unknown
949,1,1,First Failure Treatment Modality,Sx & CTX-RT
949,1,1,Occurrence #,1st primary
949,1,1,Status,Dead w/ disease
949,1,1,Time to First Failure,0.7
949,1,1,First Failure Site,oral cavity
949,1,1,First Failure Radiation Dosage,63
950,1,1,Second Failure Type,no known failure
950,1,1,Tumor Site,oral cavity
950,1,1,Research lab HPV,HPV unknown
950,1,1,Status,Alive unk disease
950,1,1,Overall Stage,IVa
950,1,1,Clinical lab p16,p16 unknown
950,1,1,Research lab p16,p16 unknown
950,1,1,Occurrence #,recurrence
950,1,1,Treatment Modality,Sx
950,1,1,Nodal Stage,N2
950,1,1,First Failure Type,no known failure
950,1,1,Tumor Stage,T1
950,1,1,Metastasis,M0
951,1,1,Second Failure Type,no known failure
951,1,1,Nodal Stage,N1
951,1,1,Overall Stage,III
951,1,1,Occurrence #,1st primary
951,1,1,First Failure Type,no known failure
951,1,1,Tumor Site,oral cavity
951,1,1,Metastasis,M0
951,1,1,Clinical lab p16,p16 unknown
951,1,1,Tumor Stage,T2
951,1,1,Treatment Modality,Sx
951,1,1,Status,Alive unk disease
951,1,1,Research lab HPV,HPV unknown
951,1,1,Research lab p16,p16 unknown
952,1,1,Overall Stage,III
952,1,1,First Failure Type,locoregional
952,1,1,Metastasis,M0
952,1,1,Tumor Site,oral cavity
952,1,1,Occurrence #,1st primary
952,1,1,Time to Death,1.7
952,1,1,Nodal Stage,N0
952,1,1,Tumor Stage,T3
952,1,1,Date of Death,2003-04-28 00:00:00
952,1,1,Second Failure Type,no known failure
952,1,1,Status,Dead unk disease
952,1,1,Clinical lab p16,p16 unknown
952,1,1,Research lab HPV,HPV unknown
952,1,1,Age at Death,39.5
952,1,1,Research lab p16,p16 unknown
952,1,1,Radiation Dosage,68
952,1,1,Time to First Failure,1.2
952,1,1,Treatment Modality,RT
953,1,1,Metastasis,M0
953,1,1,Status,Alive unk disease
953,1,1,First Failure Type,no known failure
953,1,1,Overall Stage,III
953,1,1,Second Failure Type,no known failure
953,1,1,Research lab p16,p16 unknown
953,1,1,Tumor Stage,T2
953,1,1,Nodal Stage,N1
953,1,1,Treatment Modality,Sx
953,1,1,Occurrence #,1st primary
953,1,1,Clinical lab p16,p16 unknown
953,1,1,Research lab HPV,HPV unknown
953,1,1,Tumor Site,oral cavity
954,1,1,First Failure Type,no known failure
954,1,1,Nodal Stage,N1
954,1,1,Tumor Stage,T1
954,1,1,Occurrence #,1st primary
954,1,1,Status,Alive unk disease
954,1,1,Metastasis,M0
954,1,1,Treatment Modality,Sx
954,1,1,Research lab p16,p16 unknown
954,1,1,Overall Stage,III
954,1,1,Tumor Site,oral cavity
954,1,1,Research lab HPV,HPV unknown
954,1,1,Clinical lab p16,p16 unknown
954,1,1,Second Failure Type,no known failure
955,1,1,Clinical lab p16,p16 unknown
955,1,1,Treatment Modality,Sx
955,1,1,Time to Death,0.8
955,1,1,Occurrence #,1st primary
955,1,1,Age at Death,84.7
955,1,1,Metastasis,M0
955,1,1,Nodal Stage,N0
955,1,1,First Failure Type,no known failure
955,1,1,Tumor Site,oral cavity
955,1,1,Overall Stage,IVa
955,1,1,Research lab p16,p16 unknown
955,1,1,Second Failure Type,no known failure
955,1,1,Status,Dead unk disease
955,1,1,Research lab HPV,HPV unknown
955,1,1,Date of Death,2009-02-24 00:00:00
955,1,1,Tumor Stage,T4a
956,1,1,Research lab p16,p16 unknown
956,1,1,Occurrence #,1st primary
956,1,1,Nodal Stage,N0
956,1,1,Tumor Stage,T1
956,1,1,Second Failure Type,no known failure
956,1,1,Status,Alive unk disease
956,1,1,Tumor Site,oral cavity
956,1,1,Research lab HPV,HPV unknown
956,1,1,Clinical lab p16,p16 unknown
956,1,1,Treatment Modality,Sx
956,1,1,Overall Stage,I
956,1,1,Metastasis,M0
956,1,1,First Failure Type,no known failure
957,1,1,Occurrence #,1st primary
957,1,1,Metastasis,M0
957,1,1,Nodal Stage,N2
957,1,1,First Failure Type,no known failure
957,1,1,Second Failure Type,no known failure
957,1,1,Treatment Modality,Sx
957,1,1,Tumor Stage,T3
957,1,1,Status,Alive unk disease
957,1,1,Tumor Site,oral cavity
957,1,1,Research lab HPV,HPV unknown
957,1,1,Clinical lab p16,p16 unknown
957,1,1,Overall Stage,IVa
957,1,1,Research lab p16,p16 unknown
958,1,1,Second Failure Type,no known failure
958,1,1,Clinical lab p16,p16 unknown
958,1,1,Tumor Stage,T4a
958,1,1,First Failure Type,no known failure
958,1,1,Research lab p16,p16 unknown
958,1,1,Treatment Modality,Sx
958,1,1,Research lab HPV,HPV unknown
958,1,1,Overall Stage,IVa
958,1,1,Occurrence #,1st primary
958,1,1,Tumor Site,oral cavity
958,1,1,Status,Alive unk disease
958,1,1,Nodal Stage,N0
958,1,1,Metastasis,M0
959,1,1,Second Failure Type,no known failure
959,1,1,Time to First Failure,3.4
959,1,1,Date of Death,2011-07-20 00:00:00
959,1,1,First Failure Type,locoregional
959,1,1,Overall Stage,II
959,1,1,Research lab HPV,HPV unknown
959,1,1,Status,Dead w/o disease
959,1,1,Age at Death,71.1
959,1,1,Metastasis,M0
959,1,1,Clinical lab p16,p16 unknown
959,1,1,Tumor Stage,T2
959,1,1,Nodal Stage,N0
959,1,1,Occurrence #,1st primary
959,1,1,Time to Death,0.5
959,1,1,Treatment Modality,Sx
959,1,1,Research lab p16,p16 unknown
959,1,1,Tumor Site,oral cavity
960,1,1,Clinical lab p16,p16 unknown
960,1,1,Metastasis,M0
960,1,1,Second Failure Type,no known failure
960,1,1,Status,Alive w/o disease
960,1,1,Occurrence #,1st primary
960,1,1,Treatment Modality,Sx
960,1,1,Overall Stage,I
960,1,1,Tumor Site,oral cavity
960,1,1,Research lab HPV,HPV unknown
960,1,1,Nodal Stage,N0
960,1,1,Research lab p16,p16 unknown
960,1,1,First Failure Type,no known failure
960,1,1,Tumor Stage,T1
961,1,1,Time to Death,2.8
961,1,1,Research lab p16,p16 unknown
961,1,1,Age at Death,54.7
961,1,1,Research lab HPV,HPV unknown
961,1,1,Clinical lab p16,p16 unknown
961,1,1,First Failure Type,no known failure
961,1,1,Tumor Site,oral cavity
961,1,1,Date of Death,2004-01-06 00:00:00
961,1,1,Overall Stage,III
961,1,1,Occurrence #,1st primary
961,1,1,Tumor Stage,T3
961,1,1,Second Failure Type,no known failure
961,1,1,Treatment Modality,Sx
961,1,1,Metastasis,M0
961,1,1,Status,Dead unk disease
961,1,1,Nodal Stage,N0
962,1,1,First Failure Type,no known failure
962,1,1,Overall Stage,IVa
962,1,1,Clinical lab p16,p16 unknown
962,1,1,Research lab HPV,HPV unknown
962,1,1,Treatment Modality,Sx
962,1,1,Tumor Stage,T1
962,1,1,Tumor Site,oral cavity
962,1,1,Status,Alive unk disease
962,1,1,Nodal Stage,N2
962,1,1,Occurrence #,1st primary
962,1,1,Metastasis,M0
962,1,1,Second Failure Type,no known failure
962,1,1,Research lab p16,p16 unknown
963,1,1,Age at Death,72.6
963,1,1,Status,Dead unk disease
963,1,1,Tumor Stage,T4a
963,1,1,First Failure Type,no known failure
963,1,1,Second Failure Type,no known failure
963,1,1,Research lab HPV,HPV unknown
963,1,1,Clinical lab p16,p16 unknown
963,1,1,Nodal Stage,N0
963,1,1,Overall Stage,IVa
963,1,1,Time to Death,5.5
963,1,1,Metastasis,M0
963,1,1,Research lab p16,p16 unknown
963,1,1,Treatment Modality,Sx & RT
963,1,1,Date of Death,2009-11-09 00:00:00
963,1,1,Occurrence #,1st primary
963,1,1,Radiation Dosage,unknown
963,1,1,Tumor Site,oral cavity
964,1,1,Research lab p16,p16 unknown
964,1,1,Overall Stage,IVa
964,1,1,Clinical lab p16,p16 unknown
964,1,1,First Failure Type,no known failure
964,1,1,Tumor Stage,T4a
964,1,1,Status,Alive unk disease
964,1,1,Second Failure Type,no known failure
964,1,1,Research lab HPV,HPV unknown
964,1,1,Nodal Stage,Unknown
964,1,1,Metastasis,Unknown
964,1,1,Tumor Site,oral cavity
964,1,1,Treatment Modality,Sx
964,1,1,Occurrence #,1st primary
965,1,1,Nodal Stage,N0
965,1,1,Date of Death,2003-11-25 00:00:00
965,1,1,Second Failure Type,no known failure
965,1,1,Tumor Stage,T4a
965,1,1,Treatment Modality,Sx
965,1,1,Research lab p16,p16 unknown
965,1,1,Time to First Failure,0.7
965,1,1,First Failure Site,oral cavity
965,1,1,Overall Stage,IVa
965,1,1,Clinical lab p16,p16 unknown
965,1,1,Status,Dead w/ disease
965,1,1,Age at Death,47.2
965,1,1,Tumor Site,oral cavity
965,1,1,Time to Death,2.4
965,1,1,First Failure Radiation Dosage,unknown
965,1,1,First Failure Treatment Modality,CTX-RT
965,1,1,First Failure Initial Chemotherapy Agent,unknown
965,1,1,Metastasis,M0
965,1,1,First Failure Type,locoregional
965,1,1,Occurrence #,1st primary
965,1,1,Research lab HPV,HPV unknown
966,1,1,Age at Death,40.9
966,1,1,Treatment Modality,Sx
966,1,1,Research lab p16,p16 unknown
966,1,1,Status,Dead unk disease
966,1,1,Tumor Stage,T2
966,1,1,Clinical lab p16,p16 unknown
966,1,1,Nodal Stage,N2
966,1,1,Overall Stage,IVa
966,1,1,Research lab HPV,HPV unknown
966,1,1,Tumor Site,oral cavity
966,1,1,First Failure Type,no known failure
966,1,1,Second Failure Type,no known failure
966,1,1,Time to Death,0.5
966,1,1,Date of Death,2000-10-01 00:00:00
966,1,1,Metastasis,M0
966,1,1,Occurrence #,1st primary
967,1,1,Tumor Site,oral cavity
967,1,1,Overall Stage,II
967,1,1,Status,Alive w/o disease
967,1,1,Clinical lab p16,p16 unknown
967,1,1,Research lab HPV,HPV unknown
967,1,1,Metastasis,M0
967,1,1,Nodal Stage,N0
967,1,1,Tumor Stage,T2
967,1,1,Treatment Modality,Sx
967,1,1,Research lab p16,p16 unknown
967,1,1,Second Failure Type,no known failure
967,1,1,Occurrence #,1st primary
967,1,1,First Failure Type,no known failure
968,1,1,Date of Death,2010-10-11 00:00:00
968,1,1,Second Failure Type,no known failure
968,1,1,Clinical lab p16,p16 unknown
968,1,1,First Failure Radiation Dosage,68.4
968,1,1,Tumor Site,oral cavity
968,1,1,Metastasis,M0
968,1,1,Tumor Stage,T2
968,1,1,Time to Death,8.0
968,1,1,Research lab HPV,HPV unknown
968,1,1,Status,Dead w/ disease
968,1,1,First Failure Treatment Modality,Sx & RT
968,1,1,Nodal Stage,N0
968,1,1,First Failure Site,oral cavity
968,1,1,Overall Stage,II
968,1,1,Occurrence #,1st primary
968,1,1,Research lab p16,p16 unknown
968,1,1,First Failure Type,no known failure
968,1,1,Treatment Modality,Sx
968,1,1,Age at Death,42.8
970,1,1,Tumor Site,oral cavity
970,1,1,Tumor Stage,T1
970,1,1,Time to Death,1.5
970,1,1,Research lab p16,p16 unknown
970,1,1,Overall Stage,I
970,1,1,Date of Death,2001-09-23 00:00:00
970,1,1,Clinical lab p16,p16 unknown
970,1,1,First Failure Type,no known failure
970,1,1,Treatment Modality,RT
970,1,1,Occurrence #,other primary
970,1,1,Status,Dead w/ disease
970,1,1,Second Failure Type,no known failure
970,1,1,Age at Death,66.4
970,1,1,Nodal Stage,N0
970,1,1,Metastasis,M0
970,1,1,Radiation Dosage,70.2
970,1,1,Research lab HPV,HPV unknown
971,1,1,Second Failure Type,no known failure
971,1,1,Treatment Modality,Sx
971,1,1,Research lab HPV,HPV unknown
971,1,1,Status,Alive unk disease
971,1,1,Occurrence #,1st primary
971,1,1,Overall Stage,I
971,1,1,Research lab p16,p16 unknown
971,1,1,Nodal Stage,N0
971,1,1,First Failure Type,no known failure
971,1,1,Metastasis,M0
971,1,1,Clinical lab p16,p16 unknown
971,1,1,Tumor Site,oral cavity
971,1,1,Tumor Stage,T1
972,1,1,Research lab p16,p16 unknown
972,1,1,Second Failure Type,no known failure
972,1,1,Treatment Modality,Sx
972,1,1,Tumor Stage,T2
972,1,1,First Failure Type,no known failure
972,1,1,Research lab HPV,HPV unknown
972,1,1,Occurrence #,1st primary
972,1,1,Tumor Site,oral cavity
972,1,1,Metastasis,M0
972,1,1,Clinical lab p16,p16 unknown
972,1,1,Status,Alive unk disease
972,1,1,Nodal Stage,N2
972,1,1,Overall Stage,IVa
973,1,1,Overall Stage,Unknown
973,1,1,Date of Death,2008-11-24 00:00:00
973,1,1,Clinical lab p16,p16 unknown
973,1,1,Tumor Site,oral cavity
973,1,1,Tumor Stage,T2
973,1,1,Metastasis,Unknown
973,1,1,First Failure Type,no known failure
973,1,1,Age at Death,63.5
973,1,1,Research lab p16,p16 unknown
973,1,1,Research lab HPV,HPV unknown
973,1,1,Nodal Stage,Unknown
973,1,1,Occurrence #,1st primary
973,1,1,Time to Death,6.3
973,1,1,Status,Alive unk disease
973,1,1,Treatment Modality,Sx
973,1,1,Second Failure Type,no known failure
974,1,1,Research lab p16,p16 unknown
974,1,1,Tumor Site,oral cavity
974,1,1,Treatment Modality,Sx
974,1,1,Metastasis,M0
974,1,1,Age at Death,77.1
974,1,1,Nodal Stage,N0
974,1,1,Overall Stage,I
974,1,1,Second Failure Type,no known failure
974,1,1,Occurrence #,1st primary
974,1,1,Status,Dead w/o disease
974,1,1,Clinical lab p16,p16 unknown
974,1,1,Time to Death,2.2
974,1,1,Research lab HPV,HPV unknown
974,1,1,First Failure Type,no known failure
974,1,1,Tumor Stage,T1
974,1,1,Date of Death,2009-04-19 00:00:00
975,1,1,Treatment Modality,Sx
975,1,1,Overall Stage,IVa
975,1,1,Research lab p16,p16 unknown
975,1,1,Status,Dead unk disease
975,1,1,Second Failure Type,no known failure
975,1,1,Metastasis,M0
975,1,1,Occurrence #,1st primary
975,1,1,Time to Death,1.3
975,1,1,Nodal Stage,N2
975,1,1,Age at Death,78.7
975,1,1,Date of Death,2009-12-18 00:00:00
975,1,1,First Failure Type,no known failure
975,1,1,Research lab HPV,HPV unknown
975,1,1,Tumor Site,oral cavity
975,1,1,Clinical lab p16,p16 unknown
975,1,1,Tumor Stage,T2
976,1,1,Occurrence #,1st primary
976,1,1,Nodal Stage,N0
976,1,1,First Failure Type,no known failure
976,1,1,Overall Stage,I
976,1,1,Research lab p16,p16 unknown
976,1,1,Research lab HPV,HPV unknown
976,1,1,Tumor Site,oral cavity
976,1,1,Clinical lab p16,p16 unknown
976,1,1,Tumor Stage,T1
976,1,1,Treatment Modality,Sx
976,1,1,Status,Alive unk disease
976,1,1,Metastasis,M0
976,1,1,Second Failure Type,no known failure
977,1,1,Overall Stage,II
977,1,1,Metastasis,M0
977,1,1,Date of Death,2010-07-24 00:00:00
977,1,1,Nodal Stage,N0
977,1,1,Tumor Site,oral cavity
977,1,1,Clinical lab p16,p16 unknown
977,1,1,Time to Death,4.4
977,1,1,First Failure Type,no known failure
977,1,1,Age at Death,91.2
977,1,1,Second Failure Type,no known failure
977,1,1,Treatment Modality,Sx
977,1,1,Tumor Stage,T2
977,1,1,Occurrence #,1st primary
977,1,1,Research lab p16,p16 unknown
977,1,1,Status,Dead unk disease
977,1,1,Research lab HPV,HPV unknown
978,1,1,Time to Death,2.2
978,1,1,Date of Death,2010-11-24 00:00:00
978,1,1,Clinical lab p16,p16 unknown
978,1,1,Tumor Stage,T2
978,1,1,Research lab HPV,HPV unknown
978,1,1,Tumor Site,oral cavity
978,1,1,Treatment Modality,Sx
978,1,1,Status,Dead unk disease
978,1,1,Nodal Stage,N0
978,1,1,First Failure Type,no known failure
978,1,1,Overall Stage,II
978,1,1,Research lab p16,p16 unknown
978,1,1,Occurrence #,1st primary
978,1,1,Age at Death,77.8
978,1,1,Metastasis,M0
978,1,1,Second Failure Type,no known failure
979,1,1,Status,Alive unk disease
979,1,1,Research lab HPV,HPV unknown
979,1,1,Tumor Site,oral cavity
979,1,1,Nodal Stage,N1
979,1,1,Second Failure Type,no known failure
979,1,1,Occurrence #,1st primary
979,1,1,Metastasis,M0
979,1,1,Tumor Stage,T2
979,1,1,Research lab p16,p16 unknown
979,1,1,Treatment Modality,Sx
979,1,1,First Failure Type,no known failure
979,1,1,Overall Stage,III
979,1,1,Clinical lab p16,p16 unknown
980,1,1,Research lab p16,p16 unknown
980,1,1,Status,Dead unk disease
980,1,1,Research lab HPV,HPV unknown
980,1,1,Time to Death,2.3
980,1,1,Tumor Stage,T3
980,1,1,First Failure Site,oropharynx
980,1,1,First Failure Type,locoregional
980,1,1,Metastasis,M0
980,1,1,Nodal Stage,N0
980,1,1,Time to First Failure,0.0
980,1,1,Age at Death,48.5
980,1,1,Occurrence #,1st primary
980,1,1,Tumor Site,oral cavity
980,1,1,Overall Stage,III
980,1,1,Second Failure Type,no known failure
980,1,1,Treatment Modality,Sx
980,1,1,Clinical lab p16,p16 unknown
980,1,1,Date of Death,2011-10-15 00:00:00
981,1,1,Clinical lab p16,p16 unknown
981,1,1,Treatment Modality,Sx
981,1,1,Tumor Stage,T2
981,1,1,Metastasis,M0
981,1,1,First Failure Type,no known failure
981,1,1,Nodal Stage,N1
981,1,1,Research lab HPV,HPV unknown
981,1,1,Occurrence #,1st primary
981,1,1,Research lab p16,p16 unknown
981,1,1,Tumor Site,oral cavity
981,1,1,Second Failure Type,no known failure
981,1,1,Status,Alive w/o disease
981,1,1,Overall Stage,III
982,1,1,Second Failure Type,no known failure
982,1,1,Nodal Stage,N0
982,1,1,Occurrence #,1st primary
982,1,1,Overall Stage,I
982,1,1,Research lab p16,p16 unknown
982,1,1,Treatment Modality,Sx
982,1,1,Status,Alive w/o disease
982,1,1,First Failure Type,no known failure
982,1,1,Research lab HPV,HPV unknown
982,1,1,Clinical lab p16,p16 unknown
982,1,1,Metastasis,M0
982,1,1,Tumor Site,oral cavity
982,1,1,Tumor Stage,T1
983,1,1,Tumor Stage,T3
983,1,1,First Failure Treatment Modality,CTX
983,1,1,Occurrence #,1st primary
983,1,1,First Failure Initial Chemotherapy Agent,cis/doce/5-FU
983,1,1,Time to Death,1.4
983,1,1,Research lab p16,p16 unknown
983,1,1,Research lab HPV,HPV unknown
983,1,1,Status,Dead w/ disease
983,1,1,Radiation Dosage,63
983,1,1,First Failure Site,oral cavity
983,1,1,Second Failure Type,no known failure
983,1,1,First Failure Type,locoregional and distant
983,1,1,Tumor Site,oral cavity
983,1,1,Clinical lab p16,p16 unknown
983,1,1,Time to First Failure,0.8
983,1,1,Metastasis,M0
983,1,1,Treatment Modality,Sx & RT
983,1,1,Age at Death,30.7
983,1,1,Date of Death,2007-10-04 00:00:00
983,1,1,Overall Stage,III
983,1,1,Nodal Stage,N1
984,1,1,First Failure Type,no known failure
984,1,1,Occurrence #,recurrence
984,1,1,Second Failure Type,no known failure
984,1,1,Clinical lab p16,p16 unknown
984,1,1,Overall Stage,I
984,1,1,Research lab p16,p16 unknown
984,1,1,Treatment Modality,Sx
984,1,1,Metastasis,M0
984,1,1,Tumor Site,oral cavity
984,1,1,Nodal Stage,N0
984,1,1,Research lab HPV,HPV unknown
984,1,1,Status,Alive unk disease
984,1,1,Tumor Stage,T1
985,1,1,Second Failure Type,no known failure
985,1,1,Research lab p16,p16 unknown
985,1,1,Metastasis,M0
985,1,1,Nodal Stage,N0
985,1,1,Treatment Modality,Sx
985,1,1,Occurrence #,1st primary
985,1,1,Overall Stage,I
985,1,1,Tumor Site,oral cavity
985,1,1,Status,Alive unk disease
985,1,1,First Failure Type,no known failure
985,1,1,Clinical lab p16,p16 unknown
985,1,1,Research lab HPV,HPV unknown
985,1,1,Tumor Stage,T1
986,1,1,Overall Stage,I
986,1,1,Clinical lab p16,p16 unknown
986,1,1,First Failure Type,no known failure
986,1,1,Treatment Modality,Sx
986,1,1,Metastasis,M0
986,1,1,Date of Death,2005-10-07 00:00:00
986,1,1,Nodal Stage,N0
986,1,1,Tumor Site,oral cavity
986,1,1,Status,Dead unk disease
986,1,1,Tumor Stage,T1
986,1,1,Research lab HPV,HPV unknown
986,1,1,Occurrence #,1st primary
986,1,1,Second Failure Type,no known failure
986,1,1,Research lab p16,p16 unknown
986,1,1,Age at Death,50.3
986,1,1,Time to Death,1.3
987,1,1,Tumor Stage,T4a
987,1,1,Treatment Modality,Sx
987,1,1,Metastasis,M0
987,1,1,Research lab HPV,HPV unknown
987,1,1,Overall Stage,IVa
987,1,1,First Failure Type,no known failure
987,1,1,Nodal Stage,N0
987,1,1,Status,Alive unk disease
987,1,1,Tumor Site,oral cavity
987,1,1,Research lab p16,p16 unknown
987,1,1,Clinical lab p16,p16 unknown
987,1,1,Occurrence #,1st primary
987,1,1,Second Failure Type,no known failure
988,1,1,Clinical lab p16,p16 unknown
988,1,1,Treatment Modality,Sx
988,1,1,Tumor Stage,T4a
988,1,1,Tumor Site,oral cavity
988,1,1,Date of Death,2004-07-15 00:00:00
988,1,1,First Failure Type,no known failure
988,1,1,Time to Death,0.4
988,1,1,Research lab HPV,HPV unknown
988,1,1,Research lab p16,p16 unknown
988,1,1,Status,Dead unk disease
988,1,1,Nodal Stage,N2
988,1,1,Second Failure Type,no known failure
988,1,1,Age at Death,72.7
988,1,1,Overall Stage,IVa
988,1,1,Metastasis,M0
988,1,1,Occurrence #,1st primary
989,1,1,Occurrence #,1st primary
989,1,1,Treatment Modality,Sx & RT
989,1,1,Research lab HPV,HPV unknown
989,1,1,Radiation Dosage,unknown
989,1,1,Nodal Stage,N0
989,1,1,Metastasis,M0
989,1,1,First Failure Site,oropharynx
989,1,1,Tumor Site,oral cavity
989,1,1,Status,Dead unk disease
989,1,1,Overall Stage,IVa
989,1,1,Clinical lab p16,p16 unknown
989,1,1,Second Failure Type,no known failure
989,1,1,Time to Death,5.7
989,1,1,First Failure Type,locoregional
989,1,1,Tumor Stage,T4a
989,1,1,Research lab p16,p16 unknown
989,1,1,Age at Death,59.0
989,1,1,Time to First Failure,1.3
989,1,1,Date of Death,2008-07-04 00:00:00
989,1,1,First Failure Treatment Modality,Sx
990,1,1,Tumor Stage,T1
990,1,1,Occurrence #,1st primary
990,1,1,Tumor Site,oral cavity
990,1,1,Overall Stage,I
990,1,1,Second Failure Type,no known failure
990,1,1,First Failure Type,no known failure
990,1,1,Age at Death,84.5
990,1,1,Status,Dead unk disease
990,1,1,Date of Death,2008-12-11 00:00:00
990,1,1,Nodal Stage,N0
990,1,1,Metastasis,M0
990,1,1,Research lab HPV,HPV unknown
990,1,1,Time to Death,3.5
990,1,1,Research lab p16,p16 unknown
990,1,1,Clinical lab p16,p16 unknown
990,1,1,Treatment Modality,Sx
991,1,1,Occurrence #,1st primary
991,1,1,Clinical lab p16,p16 unknown
991,1,1,Second Failure Type,no known failure
991,1,1,First Failure Type,no known failure
991,1,1,Research lab p16,p16 unknown
991,1,1,Treatment Modality,Sx
991,1,1,Overall Stage,IVa
991,1,1,Research lab HPV,HPV unknown
991,1,1,Nodal Stage,N0
991,1,1,Metastasis,M0
991,1,1,Tumor Stage,T4a
991,1,1,Status,Alive unk disease
991,1,1,Tumor Site,oral cavity
992,1,1,Status,Alive w/o disease
992,1,1,Overall Stage,II
992,1,1,Nodal Stage,N0
992,1,1,Research lab p16,p16 unknown
992,1,1,Metastasis,M0
992,1,1,Tumor Stage,T2
992,1,1,Treatment Modality,Sx
992,1,1,Occurrence #,1st primary
992,1,1,Clinical lab p16,p16 unknown
992,1,1,Second Failure Type,no known failure
992,1,1,Tumor Site,oral cavity
992,1,1,Research lab HPV,HPV unknown
992,1,1,First Failure Type,no known failure
993,1,1,First Failure Type,no known failure
993,1,1,Tumor Stage,T1
993,1,1,Research lab p16,p16 unknown
993,1,1,Tumor Site,oral cavity
993,1,1,Overall Stage,I
993,1,1,Clinical lab p16,p16 unknown
993,1,1,Treatment Modality,Sx
993,1,1,Nodal Stage,N0
993,1,1,Second Failure Type,no known failure
993,1,1,Status,Alive w/o disease
993,1,1,Metastasis,M0
993,1,1,Research lab HPV,HPV unknown
993,1,1,Occurrence #,1st primary
994,1,1,Tumor Site,oral cavity
994,1,1,First Failure Type,no known failure
994,1,1,Treatment Modality,Sx & CTX-RT
994,1,1,Second Failure Type,no known failure
994,1,1,Nodal Stage,N2
994,1,1,Clinical lab p16,p16 unknown
994,1,1,Occurrence #,1st primary
994,1,1,Metastasis,M0
994,1,1,Research lab p16,p16 unknown
994,1,1,Research lab HPV,HPV unknown
994,1,1,Status,Alive w/o disease
994,1,1,Tumor Stage,T2
994,1,1,Initial Chemotherapy Agent,cis
994,1,1,Radiation Dosage,70.2
994,1,1,Overall Stage,IVa
995,1,1,Occurrence #,1st primary
995,1,1,Treatment Modality,Sx
995,1,1,Clinical lab p16,p16 unknown
995,1,1,Tumor Stage,T1
995,1,1,Overall Stage,I
995,1,1,Research lab p16,p16 unknown
995,1,1,Metastasis,M0
995,1,1,Research lab HPV,HPV unknown
995,1,1,Second Failure Type,no known failure
995,1,1,Nodal Stage,N0
995,1,1,Tumor Site,oral cavity
995,1,1,First Failure Type,no known failure
995,1,1,Status,Alive unk disease
996,1,1,Status,Alive unk disease
996,1,1,Overall Stage,I
996,1,1,Research lab p16,p16 unknown
996,1,1,First Failure Type,no known failure
996,1,1,Tumor Stage,T1
996,1,1,Research lab HPV,HPV unknown
996,1,1,Nodal Stage,N0
996,1,1,Treatment Modality,Sx
996,1,1,Metastasis,M0
996,1,1,Occurrence #,1st primary
996,1,1,Second Failure Type,no known failure
996,1,1,Clinical lab p16,p16 unknown
996,1,1,Tumor Site,oral cavity
997,1,1,First Failure Type,distant
997,1,1,Treatment Modality,Sx & CTX-RT
997,1,1,Overall Stage,IVa
997,1,1,Tumor Stage,T4a
997,1,1,Date of Death,2006-01-17 00:00:00
997,1,1,Radiation Dosage,63
997,1,1,Research lab p16,p16 unknown
997,1,1,Initial Chemotherapy Agent,cis
997,1,1,Metastasis,M0
997,1,1,Tumor Site,oral cavity
997,1,1,Time to Death,0.7
997,1,1,Age at Death,64.2
997,1,1,Occurrence #,1st primary
997,1,1,Second Failure Type,no known failure
997,1,1,Clinical lab p16,p16 unknown
997,1,1,Nodal Stage,N2
997,1,1,Research lab HPV,HPV unknown
997,1,1,Time to First Failure,0.3
997,1,1,Status,Dead w/ disease
998,1,1,Treatment Modality,Sx
998,1,1,Occurrence #,1st primary
998,1,1,Status,Alive unk disease
998,1,1,Research lab p16,p16 unknown
998,1,1,Tumor Site,oral cavity
998,1,1,Overall Stage,IVa
998,1,1,Research lab HPV,HPV unknown
998,1,1,Clinical lab p16,p16 unknown
998,1,1,First Failure Type,no known failure
998,1,1,Nodal Stage,N2
998,1,1,Second Failure Type,no known failure
998,1,1,Tumor Stage,T4a
998,1,1,Metastasis,M0
999,1,1,Status,Alive unk disease
999,1,1,Nodal Stage,N0
999,1,1,Occurrence #,1st primary
999,1,1,Second Failure Type,no known failure
999,1,1,First Failure Type,no known failure
999,1,1,Research lab p16,p16 unknown
999,1,1,Overall Stage,I
999,1,1,Tumor Stage,T1
999,1,1,Metastasis,M0
999,1,1,Clinical lab p16,p16 unknown
999,1,1,Treatment Modality,Sx
999,1,1,Research lab HPV,HPV unknown
999,1,1,Tumor Site,oral cavity
1000,1,1,Nodal Stage,N1
1000,1,1,Date of Death,2007-12-13 00:00:00
1000,1,1,Overall Stage,IVa
1000,1,1,Tumor Site,oral cavity
1000,1,1,Tumor Stage,T4a
1000,1,1,Status,Dead unk disease
1000,1,1,Research lab p16,p16 unknown
1000,1,1,First Failure Type,no known failure
1000,1,1,Metastasis,M0
1000,1,1,Second Failure Type,no known failure
1000,1,1,Occurrence #,1st primary
1000,1,1,Research lab HPV,HPV unknown
1000,1,1,Treatment Modality,Sx
1000,1,1,Clinical lab p16,p16 unknown
1000,1,1,Time to Death,4.3
1000,1,1,Age at Death,91.0
1001,1,1,Time to First Failure,1.3
1001,1,1,Metastasis,M0
1001,1,1,Research lab HPV,HPV unknown
1001,1,1,Occurrence #,other primary
1001,1,1,Tumor Site,oral cavity
1001,1,1,First Failure Treatment Modality,Sx
1001,1,1,Second Failure Type,no known failure
1001,1,1,Date of Death,2007-05-06 00:00:00
1001,1,1,Status,Dead unk disease
1001,1,1,Research lab p16,p16 unknown
1001,1,1,Time to Death,2.3
1001,1,1,Nodal Stage,N0
1001,1,1,Age at Death,78.2
1001,1,1,Treatment Modality,Sx
1001,1,1,First Failure Site,oral cavity
1001,1,1,Clinical lab p16,p16 unknown
1001,1,1,Overall Stage,I
1001,1,1,First Failure Type,locoregional
1001,1,1,Tumor Stage,T1
1003,1,1,Occurrence #,1st primary
1003,1,1,Tumor Site,oral cavity
1003,1,1,Metastasis,Unknown
1003,1,1,Research lab HPV,HPV unknown
1003,1,1,Treatment Modality,Unknown
1003,1,1,Clinical lab p16,p16 unknown
1003,1,1,Tumor Stage,Unknown
1003,1,1,Overall Stage,Unknown
1003,1,1,Research lab p16,p16 unknown
1003,1,1,Status,Alive unk disease
1003,1,1,Second Failure Type,no known failure
1003,1,1,Nodal Stage,Unknown
1003,1,1,First Failure Type,no known failure
1004,1,1,Initial Chemotherapy Agent,cis
1004,1,1,Research lab p16,p16 unknown
1004,1,1,Treatment Modality,Sx & CTX-RT
1004,1,1,Research lab HPV,HPV unknown
1004,1,1,First Failure Type,locoregional and distant
1004,1,1,Tumor Stage,T4a
1004,1,1,Clinical lab p16,p16 unknown
1004,1,1,Nodal Stage,N2
1004,1,1,Occurrence #,1st primary
1004,1,1,Radiation Dosage,52.2
1004,1,1,Tumor Site,oral cavity
1004,1,1,Metastasis,M0
1004,1,1,Date of Death,2009-07-09 00:00:00
1004,1,1,Age at Death,64.2
1004,1,1,Second Failure Type,no known failure
1004,1,1,Status,Dead w/ disease
1004,1,1,Overall Stage,IVa
1004,1,1,Time to Death,1.2
1004,1,1,Time to First Failure,0.7
1005,1,1,Overall Stage,IVa
1005,1,1,First Failure Type,no known failure
1005,1,1,Research lab p16,p16 unknown
1005,1,1,Treatment Modality,Sx & RT
1005,1,1,Clinical lab p16,p16 unknown
1005,1,1,Tumor Site,oral cavity
1005,1,1,Second Failure Type,no known failure
1005,1,1,Metastasis,M0
1005,1,1,Research lab HPV,HPV unknown
1005,1,1,Radiation Dosage,66
1005,1,1,Nodal Stage,N2
1005,1,1,Tumor Stage,T2
1005,1,1,Occurrence #,1st primary
1005,1,1,Status,Alive w/o disease
1006,1,1,Time to First Failure,2.9
1006,1,1,First Failure Site,oral cavity
1006,1,1,Age at Death,77.2
1006,1,1,Occurrence #,recurrence
1006,1,1,Date of Death,2011-04-03 00:00:00
1006,1,1,Time to Death,2.2
1006,1,1,First Failure Treatment Modality,Sx
1006,1,1,Clinical lab p16,p16 unknown
1006,1,1,Second Failure Type,no known failure
1006,1,1,Radiation Dosage,unknown
1006,1,1,First Failure Type,locoregional
1006,1,1,Treatment Modality,Sx & RT
1006,1,1,Tumor Stage,T2
1006,1,1,Research lab HPV,HPV unknown
1006,1,1,Research lab p16,p16 unknown
1006,1,1,Nodal Stage,N0
1006,1,1,Tumor Site,oral cavity
1006,1,1,Metastasis,M0
1006,1,1,Overall Stage,II
1006,1,1,Status,Dead unk disease
1007,1,1,Status,Alive w/o disease
1007,1,1,Initial Chemotherapy Agent,unknown
1007,1,1,Research lab HPV,HPV unknown
1007,1,1,Second Failure Type,no known failure
1007,1,1,Metastasis,M0
1007,1,1,Tumor Site,oral cavity
1007,1,1,Occurrence #,1st primary
1007,1,1,First Failure Type,no known failure
1007,1,1,Tumor Stage,T4a
1007,1,1,Overall Stage,IVa
1007,1,1,Treatment Modality,Sx & CTX
1007,1,1,Research lab p16,p16 unknown
1007,1,1,Nodal Stage,N1
1007,1,1,Clinical lab p16,p16 unknown
1008,1,1,Clinical lab p16,p16 unknown
1008,1,1,Tumor Stage,T1
1008,1,1,Research lab HPV,HPV unknown
1008,1,1,Status,Alive unk disease
1008,1,1,Nodal Stage,N0
1008,1,1,Treatment Modality,Sx
1008,1,1,Occurrence #,1st primary
1008,1,1,First Failure Type,no known failure
1008,1,1,Second Failure Type,no known failure
1008,1,1,Overall Stage,I
1008,1,1,Research lab p16,p16 unknown
1008,1,1,Tumor Site,oral cavity
1008,1,1,Metastasis,M0
1009,1,1,Second Failure Type,no known failure
1009,1,1,Research lab p16,p16 unknown
1009,1,1,First Failure Type,no known failure
1009,1,1,Research lab HPV,HPV unknown
1009,1,1,Clinical lab p16,p16 unknown
1009,1,1,Tumor Site,oral cavity
1009,1,1,Status,Alive w/o disease
1009,1,1,Metastasis,M0
1009,1,1,Occurrence #,1st primary
1009,1,1,Nodal Stage,N0
1009,1,1,Treatment Modality,Sx & RT
1009,1,1,Tumor Stage,T2
1009,1,1,Radiation Dosage,60
1009,1,1,Overall Stage,II
1010,1,1,Metastasis,M0
1010,1,1,Nodal Stage,N0
1010,1,1,Status,Alive w/o disease
1010,1,1,Second Failure Type,no known failure
1010,1,1,Overall Stage,IVa
1010,1,1,Tumor Stage,T4a
1010,1,1,Research lab p16,p16 unknown
1010,1,1,Occurrence #,1st primary
1010,1,1,Clinical lab p16,p16 unknown
1010,1,1,Treatment Modality,Sx
1010,1,1,First Failure Type,no known failure
1010,1,1,Tumor Site,oral cavity
1010,1,1,Research lab HPV,HPV unknown
1011,1,1,Initial Chemotherapy Agent,carbo/PTX
1011,1,1,Tumor Site,oral cavity
1011,1,1,Metastasis,M0
1011,1,1,Occurrence #,other primary
1011,1,1,Overall Stage,I
1011,1,1,First Failure Type,no known failure
1011,1,1,Second Failure Type,no known failure
1011,1,1,Clinical lab p16,p16 unknown
1011,1,1,Nodal Stage,N0
1011,1,1,Radiation Dosage,60
1011,1,1,Tumor Stage,T1
1011,1,1,Research lab p16,p16 unknown
1011,1,1,Treatment Modality,Sx & CTX-RT
1011,1,1,Research lab HPV,HPV unknown
1011,1,1,Status,Alive w/o disease
1012,1,1,Initial Chemotherapy Agent,carbo/PTX
1012,1,1,Tumor Stage,T4a
1012,1,1,Overall Stage,IVa
1012,1,1,Occurrence #,1st primary
1012,1,1,Treatment Modality,Sx & CTX-RT
1012,1,1,Nodal Stage,N2
1012,1,1,Research lab p16,p16 unknown
1012,1,1,First Failure Type,no known failure
1012,1,1,Second Failure Type,no known failure
1012,1,1,Research lab HPV,HPV unknown
1012,1,1,Tumor Site,oral cavity
1012,1,1,Metastasis,M0
1012,1,1,Radiation Dosage,63
1012,1,1,Status,Alive w/o disease
1012,1,1,Clinical lab p16,p16 unknown
1013,1,1,Overall Stage,II
1013,1,1,Radiation Dosage,63
1013,1,1,First Failure Type,no known failure
1013,1,1,Clinical lab p16,p16 unknown
1013,1,1,Nodal Stage,N0
1013,1,1,Occurrence #,1st primary
1013,1,1,Tumor Stage,T2
1013,1,1,Treatment Modality,RT
1013,1,1,Research lab p16,p16 unknown
1013,1,1,Status,Unknown
1013,1,1,Research lab HPV,HPV unknown
1013,1,1,Metastasis,M0
1013,1,1,Second Failure Type,no known failure
1013,1,1,Tumor Site,oral cavity
1014,1,1,First Failure Type,no known failure
1014,1,1,Research lab p16,p16 unknown
1014,1,1,Date of Death,2009-11-06 00:00:00
1014,1,1,Nodal Stage,N0
1014,1,1,Time to Death,7.1
1014,1,1,Age at Death,84.4
1014,1,1,Clinical lab p16,p16 unknown
1014,1,1,Overall Stage,II
1014,1,1,Tumor Stage,T2
1014,1,1,Treatment Modality,Sx
1014,1,1,Occurrence #,1st primary
1014,1,1,Second Failure Type,no known failure
1014,1,1,Tumor Site,oral cavity
1014,1,1,Metastasis,M0
1014,1,1,Research lab HPV,HPV unknown
1014,1,1,Status,Dead unk disease
1015,1,1,Second Failure Type,no known failure
1015,1,1,Metastasis,M0
1015,1,1,Research lab p16,p16 unknown
1015,1,1,Overall Stage,II
1015,1,1,Treatment Modality,Sx & CTX-RT
1015,1,1,Tumor Site,oral cavity
1015,1,1,Status,Alive w/o disease
1015,1,1,Research lab HPV,HPV unknown
1015,1,1,Occurrence #,1st primary
1015,1,1,Radiation Dosage,60
1015,1,1,Nodal Stage,N0
1015,1,1,Initial Chemotherapy Agent,cetux
1015,1,1,First Failure Type,no known failure
1015,1,1,Tumor Stage,T2
1015,1,1,Clinical lab p16,p16 unknown
1016,1,1,Research lab p16,p16 unknown
1016,1,1,Status,Alive unk disease
1016,1,1,Tumor Stage,T2
1016,1,1,Nodal Stage,N2
1016,1,1,Initial Chemotherapy Agent,unknown
1016,1,1,Time to First Failure,-0.1
1016,1,1,Tumor Site,oral cavity
1016,1,1,Radiation Dosage,unknown
1016,1,1,Clinical lab p16,p16 unknown
1016,1,1,Occurrence #,recurrence
1016,1,1,Research lab HPV,HPV unknown
1016,1,1,First Failure Type,locoregional and distant
1016,1,1,Second Failure Type,no known failure
1016,1,1,Metastasis,M0
1016,1,1,Treatment Modality,Sx & CTX-RT
1016,1,1,Overall Stage,IVa
1017,1,1,Clinical lab p16,p16 unknown
1017,1,1,Overall Stage,II
1017,1,1,Treatment Modality,Sx
1017,1,1,Date of Death,2010-01-29 00:00:00
1017,1,1,Research lab p16,p16 unknown
1017,1,1,Tumor Site,oral cavity
1017,1,1,Time to Death,8.4
1017,1,1,Research lab HPV,HPV unknown
1017,1,1,Occurrence #,1st primary
1017,1,1,Metastasis,M0
1017,1,1,First Failure Type,no known failure
1017,1,1,Second Failure Type,no known failure
1017,1,1,Status,Dead unk disease
1017,1,1,Age at Death,64.1
1017,1,1,Tumor Stage,T2
1017,1,1,Nodal Stage,N0
1018,1,1,Treatment Modality,Sx
1018,1,1,Overall Stage,I
1018,1,1,Research lab HPV,HPV unknown
1018,1,1,Occurrence #,1st primary
1018,1,1,Second Failure Type,no known failure
1018,1,1,Clinical lab p16,p16 unknown
1018,1,1,Metastasis,M0
1018,1,1,Tumor Site,oral cavity
1018,1,1,Research lab p16,p16 unknown
1018,1,1,First Failure Type,no known failure
1018,1,1,Tumor Stage,T1
1018,1,1,Nodal Stage,N0
1018,1,1,Status,Alive unk disease
1019,1,1,Research lab p16,p16 unknown
1019,1,1,First Failure Type,no known failure
1019,1,1,Metastasis,M0
1019,1,1,Clinical lab p16,p16 unknown
1019,1,1,Time to Death,2.0
1019,1,1,Treatment Modality,Sx
1019,1,1,Age at Death,86.9
1019,1,1,Occurrence #,1st primary
1019,1,1,Research lab HPV,HPV unknown
1019,1,1,Tumor Stage,T2
1019,1,1,Status,Dead unk disease
1019,1,1,Tumor Site,oral cavity
1019,1,1,Overall Stage,II
1019,1,1,Nodal Stage,N0
1019,1,1,Date of Death,2004-04-30 00:00:00
1019,1,1,Second Failure Type,no known failure
1020,1,1,Status,Alive unk disease
1020,1,1,Overall Stage,IVa
1020,1,1,Research lab HPV,HPV unknown
1020,1,1,Tumor Stage,T2
1020,1,1,Clinical lab p16,p16 unknown
1020,1,1,Research lab p16,p16 unknown
1020,1,1,Second Failure Type,no known failure
1020,1,1,Nodal Stage,N2
1020,1,1,Tumor Site,oral cavity
1020,1,1,Occurrence #,1st primary
1020,1,1,Metastasis,M0
1020,1,1,First Failure Type,no known failure
1020,1,1,Treatment Modality,Sx
1021,1,1,Tumor Stage,T1
1021,1,1,Overall Stage,I
1021,1,1,Tumor Site,oral cavity
1021,1,1,Nodal Stage,N0
1021,1,1,Status,Dead unk disease
1021,1,1,Metastasis,M0
1021,1,1,Age at Death,83.0
1021,1,1,Occurrence #,1st primary
1021,1,1,Treatment Modality,Sx
1021,1,1,Second Failure Type,no known failure
1021,1,1,Research lab HPV,HPV unknown
1021,1,1,Date of Death,2011-01-17 00:00:00
1021,1,1,Time to Death,10.3
1021,1,1,Research lab p16,p16 unknown
1021,1,1,First Failure Type,no known failure
1021,1,1,Clinical lab p16,p16 unknown
1022,1,1,Overall Stage,III
1022,1,1,Clinical lab p16,p16 unknown
1022,1,1,Time to Death,0.8
1022,1,1,Metastasis,M0
1022,1,1,Tumor Stage,T3
1022,1,1,Age at Death,89.3
1022,1,1,Occurrence #,1st primary
1022,1,1,Tumor Site,oral cavity
1022,1,1,Date of Death,2009-02-10 00:00:00
1022,1,1,Research lab p16,p16 unknown
1022,1,1,Second Failure Type,no known failure
1022,1,1,Research lab HPV,HPV unknown
1022,1,1,Status,Dead unk disease
1022,1,1,First Failure Type,no known failure
1022,1,1,Nodal Stage,N1
1022,1,1,Treatment Modality,Sx
1023,1,1,Research lab HPV,HPV unknown
1023,1,1,Tumor Site,oral cavity
1023,1,1,Occurrence #,1st primary
1023,1,1,Metastasis,M0
1023,1,1,Nodal Stage,N0
1023,1,1,Second Failure Type,no known failure
1023,1,1,Clinical lab p16,p16 unknown
1023,1,1,Research lab p16,p16 unknown
1023,1,1,Tumor Stage,T1
1023,1,1,Treatment Modality,Sx
1023,1,1,Status,Alive w/o disease
1023,1,1,Overall Stage,I
1023,1,1,First Failure Type,no known failure
1024,1,1,Research lab p16,p16 unknown
1024,1,1,Tumor Stage,T1
1024,1,1,Nodal Stage,N0
1024,1,1,Research lab HPV,HPV unknown
1024,1,1,Tumor Site,oral cavity
1024,1,1,First Failure Type,no known failure
1024,1,1,Occurrence #,1st primary
1024,1,1,Status,Alive w/o disease
1024,1,1,Treatment Modality,Sx
1024,1,1,Metastasis,M0
1024,1,1,Overall Stage,I
1024,1,1,Clinical lab p16,p16 unknown
1024,1,1,Second Failure Type,no known failure
1025,1,1,Metastasis,M0
1025,1,1,Treatment Modality,Sx
1025,1,1,First Failure Type,no known failure
1025,1,1,Occurrence #,1st primary
1025,1,1,Second Failure Type,no known failure
1025,1,1,Overall Stage,IVa
1025,1,1,Date of Death,2003-10-25 00:00:00
1025,1,1,Status,Dead unk disease
1025,1,1,Research lab HPV,HPV unknown
1025,1,1,Time to Death,2.1
1025,1,1,Nodal Stage,N2
1025,1,1,Age at Death,63.5
1025,1,1,Tumor Stage,T4a
1025,1,1,Research lab p16,p16 unknown
1025,1,1,Tumor Site,oral cavity
1025,1,1,Clinical lab p16,p16 unknown
1026,1,1,Clinical lab p16,p16 unknown
1026,1,1,Treatment Modality,Sx
1026,1,1,Occurrence #,1st primary
1026,1,1,First Failure Type,no known failure
1026,1,1,Tumor Site,oral cavity
1026,1,1,Nodal Stage,N2
1026,1,1,Research lab p16,p16 unknown
1026,1,1,Second Failure Type,no known failure
1026,1,1,Date of Death,2002-03-17 00:00:00
1026,1,1,Metastasis,M0
1026,1,1,Tumor Stage,T4a
1026,1,1,Research lab HPV,HPV unknown
1026,1,1,Status,Dead unk disease
1026,1,1,Time to Death,0.4
1026,1,1,Overall Stage,IVa
1026,1,1,Age at Death,64.1
1027,1,1,Time to Death,1.0
1027,1,1,Research lab HPV,HPV unknown
1027,1,1,Radiation Dosage,70.2
1027,1,1,Time to First Failure,0.3
1027,1,1,First Failure Type,locoregional
1027,1,1,Tumor Site,oral cavity
1027,1,1,Nodal Stage,N2
1027,1,1,Tumor Stage,T4a
1027,1,1,Research lab p16,p16 unknown
1027,1,1,Date of Death,2002-03-03 00:00:00
1027,1,1,Treatment Modality,CTX-RT
1027,1,1,First Failure Site,oral cavity
1027,1,1,Age at Death,46.8
1027,1,1,Metastasis,M0
1027,1,1,Clinical lab p16,p16 unknown
1027,1,1,Occurrence #,1st primary
1027,1,1,Status,Dead unk disease
1027,1,1,Second Failure Type,no known failure
1027,1,1,Overall Stage,IVa
1027,1,1,Initial Chemotherapy Agent,PTX
1028,1,1,Second Failure Type,no known failure
1028,1,1,Status,Alive unk disease
1028,1,1,Tumor Site,oral cavity
1028,1,1,Nodal Stage,N0
1028,1,1,Overall Stage,II
1028,1,1,Clinical lab p16,p16 unknown
1028,1,1,Research lab HPV,HPV unknown
1028,1,1,Occurrence #,1st primary
1028,1,1,First Failure Type,no known failure
1028,1,1,Metastasis,M0
1028,1,1,Treatment Modality,Sx
1028,1,1,Tumor Stage,T2
1028,1,1,Research lab p16,p16 unknown
1029,1,1,Research lab HPV,HPV unknown
1029,1,1,Second Failure Type,no known failure
1029,1,1,Status,Alive unk disease
1029,1,1,Metastasis,M0
1029,1,1,Treatment Modality,Sx
1029,1,1,Overall Stage,II
1029,1,1,Clinical lab p16,p16 unknown
1029,1,1,Occurrence #,1st primary
1029,1,1,Research lab p16,p16 unknown
1029,1,1,Tumor Stage,T2
1029,1,1,Nodal Stage,N0
1029,1,1,Tumor Site,oral cavity
1029,1,1,First Failure Type,no known failure
1030,1,1,Tumor Site,oral cavity
1030,1,1,Occurrence #,1st primary
1030,1,1,Second Failure Type,no known failure
1030,1,1,Research lab HPV,HPV unknown
1030,1,1,Status,Alive unk disease
1030,1,1,Nodal Stage,N0
1030,1,1,First Failure Type,no known failure
1030,1,1,Clinical lab p16,p16 unknown
1030,1,1,Overall Stage,I
1030,1,1,Research lab p16,p16 unknown
1030,1,1,Treatment Modality,Sx
1030,1,1,Metastasis,M0
1030,1,1,Tumor Stage,T1
1031,1,1,Tumor Stage,T4a
1031,1,1,Metastasis,M0
1031,1,1,Status,Alive unk disease
1031,1,1,Clinical lab p16,p16 unknown
1031,1,1,Research lab HPV,HPV unknown
1031,1,1,Overall Stage,IVa
1031,1,1,Second Failure Type,no known failure
1031,1,1,Time to First Failure,3.0
1031,1,1,Research lab p16,p16 unknown
1031,1,1,Tumor Site,oral cavity
1031,1,1,First Failure Type,locoregional
1031,1,1,Nodal Stage,N2
1031,1,1,Occurrence #,recurrence
1031,1,1,Treatment Modality,Sx
1032,1,1,Overall Stage,I
1032,1,1,Tumor Stage,T1
1032,1,1,Nodal Stage,N0
1032,1,1,Tumor Site,oral cavity
1032,1,1,First Failure Type,no known failure
1032,1,1,Research lab p16,p16 unknown
1032,1,1,Occurrence #,1st primary
1032,1,1,Status,Alive w/o disease
1032,1,1,Metastasis,M0
1032,1,1,Clinical lab p16,p16 unknown
1032,1,1,Research lab HPV,HPV unknown
1032,1,1,Second Failure Type,no known failure
1032,1,1,Treatment Modality,Sx
1033,1,1,Radiation Dosage,63
1033,1,1,Nodal Stage,N2
1033,1,1,Overall Stage,IVa
1033,1,1,Research lab p16,p16 unknown
1033,1,1,Tumor Site,oral cavity
1033,1,1,First Failure Type,no known failure
1033,1,1,Clinical lab p16,p16 unknown
1033,1,1,Second Failure Type,no known failure
1033,1,1,Tumor Stage,T4a
1033,1,1,Status,Alive w/o disease
1033,1,1,Metastasis,M0
1033,1,1,Research lab HPV,HPV unknown
1033,1,1,Treatment Modality,Sx & RT
1033,1,1,Occurrence #,1st primary
1034,1,1,Time to First Failure,0.3
1034,1,1,Status,Alive w/o disease
1034,1,1,Research lab p16,p16 unknown
1034,1,1,Radiation Dosage,unknown
1034,1,1,Tumor Site,oral cavity
1034,1,1,Overall Stage,IVa
1034,1,1,Research lab HPV,HPV unknown
1034,1,1,Metastasis,M0
1034,1,1,First Failure Type,locoregional
1034,1,1,Tumor Stage,T4a
1034,1,1,Clinical lab p16,p16 unknown
1034,1,1,Occurrence #,1st primary
1034,1,1,Nodal Stage,N1
1034,1,1,Second Failure Type,no known failure
1034,1,1,Treatment Modality,Sx & RT
1035,1,1,Tumor Stage,T1
1035,1,1,Treatment Modality,Unknown
1035,1,1,Metastasis,M0
1035,1,1,First Failure Type,no known failure
1035,1,1,Time to Death,1.2
1035,1,1,Research lab p16,p16 unknown
1035,1,1,Status,Dead unk disease
1035,1,1,Occurrence #,other primary
1035,1,1,Second Failure Type,no known failure
1035,1,1,Overall Stage,I
1035,1,1,Nodal Stage,N0
1035,1,1,Clinical lab p16,p16 unknown
1035,1,1,Age at Death,70.7
1035,1,1,Date of Death,2010-10-22 00:00:00
1035,1,1,Tumor Site,oral cavity
1035,1,1,Research lab HPV,HPV unknown
1036,1,1,Tumor Site,oral cavity
1036,1,1,Metastasis,M0
1036,1,1,Research lab HPV,HPV unknown
1036,1,1,Status,Alive unk disease
1036,1,1,Clinical lab p16,p16 unknown
1036,1,1,Second Failure Type,no known failure
1036,1,1,Overall Stage,IVa
1036,1,1,Treatment Modality,Sx
1036,1,1,First Failure Type,no known failure
1036,1,1,Nodal Stage,N2
1036,1,1,Research lab p16,p16 unknown
1036,1,1,Occurrence #,1st primary
1036,1,1,Tumor Stage,T4a
1037,1,1,Clinical lab p16,p16 unknown
1037,1,1,Tumor Stage,T4a
1037,1,1,Research lab p16,p16 unknown
1037,1,1,Overall Stage,IVa
1037,1,1,Treatment Modality,Unknown
1037,1,1,Metastasis,M0
1037,1,1,Second Failure Type,no known failure
1037,1,1,Nodal Stage,N1
1037,1,1,Age at Death,66.9
1037,1,1,Date of Death,2002-04-11 00:00:00
1037,1,1,Time to Death,0.8
1037,1,1,Research lab HPV,HPV unknown
1037,1,1,Status,Dead unk disease
1037,1,1,Occurrence #,1st primary
1037,1,1,First Failure Type,no known failure
1037,1,1,Tumor Site,oral cavity
1038,1,1,Metastasis,M0
1038,1,1,Overall Stage,IVa
1038,1,1,Tumor Stage,T4a
1038,1,1,Status,Dead w/ disease
1038,1,1,Occurrence #,1st primary
1038,1,1,Clinical lab p16,p16 unknown
1038,1,1,Second Failure Type,no known failure
1038,1,1,Time to Death,3.7
1038,1,1,First Failure Type,no known failure
1038,1,1,Age at Death,72.7
1038,1,1,Nodal Stage,N0
1038,1,1,Research lab p16,p16 unknown
1038,1,1,Date of Death,2007-10-01 00:00:00
1038,1,1,Tumor Site,oral cavity
1038,1,1,Treatment Modality,Sx
1038,1,1,Research lab HPV,HPV unknown
1039,1,1,Status,Alive unk disease
1039,1,1,First Failure Type,no known failure
1039,1,1,Research lab HPV,HPV unknown
1039,1,1,Metastasis,M0
1039,1,1,Treatment Modality,Sx
1039,1,1,Occurrence #,1st primary
1039,1,1,Research lab p16,p16 unknown
1039,1,1,Nodal Stage,N0
1039,1,1,Tumor Site,oral cavity
1039,1,1,Second Failure Type,no known failure
1039,1,1,Tumor Stage,T1
1039,1,1,Overall Stage,I
1039,1,1,Clinical lab p16,p16 unknown
1040,1,1,Research lab HPV,HPV unknown
1040,1,1,Nodal Stage,N0
1040,1,1,Clinical lab p16,p16 unknown
1040,1,1,Occurrence #,1st primary
1040,1,1,Overall Stage,I
1040,1,1,Age at Death,63.5
1040,1,1,First Failure Type,no known failure
1040,1,1,Second Failure Type,no known failure
1040,1,1,Status,Dead unk disease
1040,1,1,Time to Death,1.0
1040,1,1,Metastasis,M0
1040,1,1,Research lab p16,p16 unknown
1040,1,1,Treatment Modality,Sx
1040,1,1,Tumor Site,oral cavity
1040,1,1,Tumor Stage,T1
1040,1,1,Date of Death,2006-01-09 00:00:00
1041,1,1,Research lab HPV,HPV unknown
1041,1,1,Clinical lab p16,p16 unknown
1041,1,1,First Failure Type,no known failure
1041,1,1,Status,Alive unk disease
1041,1,1,Tumor Site,oral cavity
1041,1,1,Second Failure Type,no known failure
1041,1,1,Tumor Stage,T1
1041,1,1,Overall Stage,I
1041,1,1,Treatment Modality,Sx
1041,1,1,Metastasis,M0
1041,1,1,Nodal Stage,N0
1041,1,1,Research lab p16,p16 unknown
1041,1,1,Occurrence #,1st primary
1042,1,1,Tumor Stage,T4b
1042,1,1,Age at Death,67.3
1042,1,1,Occurrence #,recurrence
1042,1,1,Nodal Stage,N0
1042,1,1,Clinical lab p16,p16 unknown
1042,1,1,Research lab HPV,HPV unknown
1042,1,1,Date of Death,2001-07-04 00:00:00
1042,1,1,Overall Stage,IVb
1042,1,1,Tumor Site,oral cavity
1042,1,1,Metastasis,M0
1042,1,1,Treatment Modality,Sx
1042,1,1,Status,Dead unk disease
1042,1,1,Research lab p16,p16 unknown
1042,1,1,First Failure Type,no known failure
1042,1,1,Time to Death,0.4
1042,1,1,Second Failure Type,no known failure
1043,1,1,Tumor Site,oral cavity
1043,1,1,Overall Stage,IVa
1043,1,1,Clinical lab p16,p16 unknown
1043,1,1,Research lab HPV,HPV unknown
1043,1,1,Nodal Stage,N0
1043,1,1,Radiation Dosage,59.4
1043,1,1,First Failure Type,no known failure
1043,1,1,Occurrence #,1st primary
1043,1,1,Status,Alive w/o disease
1043,1,1,Treatment Modality,Sx & RT
1043,1,1,Metastasis,M0
1043,1,1,Tumor Stage,T4a
1043,1,1,Research lab p16,p16 unknown
1043,1,1,Second Failure Type,no known failure
1044,1,1,Occurrence #,1st primary
1044,1,1,Research lab HPV,HPV unknown
1044,1,1,Nodal Stage,N0
1044,1,1,Clinical lab p16,p16 unknown
1044,1,1,First Failure Type,no known failure
1044,1,1,Research lab p16,p16 unknown
1044,1,1,Treatment Modality,Sx
1044,1,1,Tumor Stage,T2
1044,1,1,Second Failure Type,no known failure
1044,1,1,Metastasis,M0
1044,1,1,Status,Alive w/o disease
1044,1,1,Tumor Site,oral cavity
1044,1,1,Overall Stage,II
1045,1,1,Nodal Stage,N0
1045,1,1,First Failure Type,no known failure
1045,1,1,Clinical lab p16,p16 unknown
1045,1,1,Status,Dead unk disease
1045,1,1,Research lab p16,p16 unknown
1045,1,1,Treatment Modality,Sx
1045,1,1,Tumor Stage,T4a
1045,1,1,Research lab HPV,HPV unknown
1045,1,1,Overall Stage,IVa
1045,1,1,Age at Death,91.1
1045,1,1,Occurrence #,recurrence
1045,1,1,Tumor Site,oral cavity
1045,1,1,Metastasis,M0
1045,1,1,Time to Death,1.3
1045,1,1,Date of Death,2004-01-09 00:00:00
1045,1,1,Second Failure Type,no known failure
1046,1,1,Overall Stage,IVa
1046,1,1,Research lab HPV,HPV unknown
1046,1,1,Time to Death,0.6
1046,1,1,Tumor Stage,T4a
1046,1,1,Tumor Site,oral cavity
1046,1,1,Treatment Modality,CTX-RT
1046,1,1,Occurrence #,1st primary
1046,1,1,Second Failure Type,no known failure
1046,1,1,Date of Death,2009-08-05 00:00:00
1046,1,1,Radiation Dosage,70.2
1046,1,1,Age at Death,88.1
1046,1,1,Nodal Stage,N2
1046,1,1,Initial Chemotherapy Agent,unknown
1046,1,1,Clinical lab p16,p16 unknown
1046,1,1,Metastasis,M0
1046,1,1,Status,Dead unk disease
1046,1,1,Research lab p16,p16 unknown
1046,1,1,First Failure Type,no known failure
1047,1,1,Metastasis,M0
1047,1,1,Status,Alive unk disease
1047,1,1,Second Failure Type,no known failure
1047,1,1,Nodal Stage,N0
1047,1,1,Occurrence #,recurrence
1047,1,1,Clinical lab p16,p16 unknown
1047,1,1,First Failure Type,no known failure
1047,1,1,Research lab p16,p16 unknown
1047,1,1,Overall Stage,I
1047,1,1,Treatment Modality,Unknown
1047,1,1,Tumor Stage,T1
1047,1,1,Research lab HPV,HPV unknown
1047,1,1,Tumor Site,oral cavity
1048,1,1,Overall Stage,II
1048,1,1,Status,Dead unk disease
1048,1,1,Nodal Stage,N0
1048,1,1,Tumor Stage,T2
1048,1,1,Clinical lab p16,p16 unknown
1048,1,1,Treatment Modality,Sx
1048,1,1,First Failure Type,no known failure
1048,1,1,Research lab p16,p16 unknown
1048,1,1,Tumor Site,oral cavity
1048,1,1,Second Failure Type,no known failure
1048,1,1,Date of Death,2010-10-26 00:00:00
1048,1,1,Research lab HPV,HPV unknown
1048,1,1,Time to Death,1.0
1048,1,1,Occurrence #,1st primary
1048,1,1,Age at Death,79.6
1048,1,1,Metastasis,M0
1049,1,1,Tumor Stage,T1
1049,1,1,Overall Stage,I
1049,1,1,Tumor Site,oral cavity
1049,1,1,Second Failure Type,no known failure
1049,1,1,Date of Death,2005-05-02 00:00:00
1049,1,1,Research lab p16,p16 unknown
1049,1,1,First Failure Type,no known failure
1049,1,1,Clinical lab p16,p16 unknown
1049,1,1,Occurrence #,1st primary
1049,1,1,Age at Death,73.2
1049,1,1,Nodal Stage,N0
1049,1,1,Metastasis,M0
1049,1,1,Research lab HPV,HPV unknown
1049,1,1,Status,Dead unk disease
1049,1,1,Time to Death,0.7
1049,1,1,Treatment Modality,Sx
1050,1,1,Overall Stage,I
1050,1,1,Clinical lab p16,p16 unknown
1050,1,1,Status,Alive unk disease
1050,1,1,Treatment Modality,Sx
1050,1,1,Tumor Stage,T1
1050,1,1,Tumor Site,oral cavity
1050,1,1,Research lab HPV,HPV unknown
1050,1,1,Occurrence #,1st primary
1050,1,1,Research lab p16,p16 unknown
1050,1,1,Nodal Stage,N0
1050,1,1,Second Failure Type,no known failure
1050,1,1,Metastasis,M0
1050,1,1,First Failure Type,no known failure
1052,1,1,Tumor Site,oral cavity
1052,1,1,Nodal Stage,N0
1052,1,1,Treatment Modality,Sx
1052,1,1,Time to First Failure,2.0
1052,1,1,First Failure Treatment Modality,Sx
1052,1,1,Overall Stage,I
1052,1,1,Research lab HPV,HPV unknown
1052,1,1,First Failure Site,oral cavity
1052,1,1,Metastasis,M0
1052,1,1,Tumor Stage,T1
1052,1,1,Occurrence #,other primary
1052,1,1,Second Failure Type,no known failure
1052,1,1,First Failure Type,locoregional
1052,1,1,Research lab p16,p16 unknown
1052,1,1,Status,Alive w/o disease
1052,1,1,Clinical lab p16,p16 unknown
1053,1,1,Overall Stage,IVa
1053,1,1,Research lab HPV,HPV unknown
1053,1,1,First Failure Site,oral cavity
1053,1,1,Occurrence #,1st primary
1053,1,1,Second Failure Type,no known failure
1053,1,1,Clinical lab p16,p16 unknown
1053,1,1,Nodal Stage,Unknown
1053,1,1,Tumor Site,oral cavity
1053,1,1,Treatment Modality,Sx
1053,1,1,Tumor Stage,T4a
1053,1,1,Research lab p16,p16 unknown
1053,1,1,Time to First Failure,4.7
1053,1,1,First Failure Treatment Modality,Sx
1053,1,1,First Failure Type,locoregional
1053,1,1,Status,Alive unk disease
1053,1,1,Metastasis,Unknown
1054,1,1,Metastasis,M0
1054,1,1,Research lab p16,p16 unknown
1054,1,1,Second Failure Type,no known failure
1054,1,1,First Failure Site,oral cavity
1054,1,1,Treatment Modality,Sx
1054,1,1,First Failure Type,locoregional
1054,1,1,Occurrence #,recurrence
1054,1,1,Tumor Stage,T2
1054,1,1,Tumor Site,oral cavity
1054,1,1,Time to First Failure,0.3
1054,1,1,First Failure Treatment Modality,Sx
1054,1,1,Status,Alive unk disease
1054,1,1,Overall Stage,II
1054,1,1,Clinical lab p16,p16 unknown
1054,1,1,Nodal Stage,N0
1054,1,1,Research lab HPV,HPV unknown
1055,1,1,Status,Alive w/o disease
1055,1,1,Research lab HPV,HPV unknown
1055,1,1,Tumor Site,oral cavity
1055,1,1,Research lab p16,p16 unknown
1055,1,1,Metastasis,M0
1055,1,1,First Failure Type,no known failure
1055,1,1,Tumor Stage,T1
1055,1,1,Treatment Modality,Sx
1055,1,1,Nodal Stage,N0
1055,1,1,Clinical lab p16,p16 unknown
1055,1,1,Overall Stage,I
1055,1,1,Occurrence #,1st primary
1055,1,1,Second Failure Type,no known failure
1056,1,1,Research lab p16,p16 unknown
1056,1,1,First Failure Site,oral cavity
1056,1,1,Tumor Stage,T1
1056,1,1,Clinical lab p16,p16 unknown
1056,1,1,Date of Death,2008-10-09 00:00:00
1056,1,1,Time to Death,2.9
1056,1,1,Tumor Site,oral cavity
1056,1,1,First Failure Treatment Modality,Sx & RT
1056,1,1,Research lab HPV,HPV unknown
1056,1,1,Age at Death,61.8
1056,1,1,Nodal Stage,N0
1056,1,1,Overall Stage,I
1056,1,1,Treatment Modality,Sx
1056,1,1,Status,Dead w/ disease
1056,1,1,Occurrence #,1st primary
1056,1,1,Second Failure Type,no known failure
1056,1,1,First Failure Radiation Dosage,unknown
1056,1,1,First Failure Type,locoregional
1056,1,1,Time to First Failure,1.4
1056,1,1,Metastasis,M0
1057,1,1,Clinical lab p16,p16 unknown
1057,1,1,Tumor Site,oral cavity
1057,1,1,Overall Stage,I
1057,1,1,Metastasis,M0
1057,1,1,Status,Alive w/o disease
1057,1,1,Tumor Stage,T1
1057,1,1,Research lab HPV,HPV unknown
1057,1,1,Second Failure Type,no known failure
1057,1,1,Research lab p16,p16 unknown
1057,1,1,Occurrence #,1st primary
1057,1,1,First Failure Type,no known failure
1057,1,1,Treatment Modality,Sx
1057,1,1,Nodal Stage,N0
1058,1,1,Age at Death,70.9
1058,1,1,First Failure Type,locoregional
1058,1,1,Research lab p16,p16 unknown
1058,1,1,Status,Dead unk disease
1058,1,1,Research lab HPV,HPV unknown
1058,1,1,Second Failure Type,no known failure
1058,1,1,Nodal Stage,N1
1058,1,1,Clinical lab p16,p16 unknown
1058,1,1,Time to Death,1.6
1058,1,1,Tumor Site,oral cavity
1058,1,1,Date of Death,2008-03-26 00:00:00
1058,1,1,Time to First Failure,0.7
1058,1,1,Metastasis,M0
1058,1,1,Radiation Dosage,63
1058,1,1,Tumor Stage,T3
1058,1,1,Occurrence #,1st primary
1058,1,1,Initial Chemotherapy Agent,cis
1058,1,1,Overall Stage,III
1058,1,1,Treatment Modality,Sx & CTX-RT
1059,1,1,Overall Stage,I
1059,1,1,Tumor Stage,T1
1059,1,1,Status,Alive unk disease
1059,1,1,Tumor Site,oral cavity
1059,1,1,Metastasis,M0
1059,1,1,Research lab p16,p16 unknown
1059,1,1,First Failure Type,no known failure
1059,1,1,Nodal Stage,N0
1059,1,1,Second Failure Type,no known failure
1059,1,1,Occurrence #,1st primary
1059,1,1,Research lab HPV,HPV unknown
1059,1,1,Treatment Modality,Sx
1059,1,1,Clinical lab p16,p16 unknown
1060,1,1,Research lab HPV,HPV unknown
1060,1,1,Metastasis,M0
1060,1,1,Research lab p16,p16 unknown
1060,1,1,Status,Alive w/o disease
1060,1,1,Second Failure Type,no known failure
1060,1,1,First Failure Type,no known failure
1060,1,1,Overall Stage,I
1060,1,1,Treatment Modality,Sx
1060,1,1,Occurrence #,1st primary
1060,1,1,Nodal Stage,N0
1060,1,1,Clinical lab p16,p16 unknown
1060,1,1,Tumor Site,oral cavity
1060,1,1,Tumor Stage,T1
1061,1,1,Clinical lab p16,p16 unknown
1061,1,1,Occurrence #,1st primary
1061,1,1,Nodal Stage,N0
1061,1,1,Second Failure Type,no known failure
1061,1,1,Status,Alive unk disease
1061,1,1,First Failure Type,no known failure
1061,1,1,Tumor Site,oral cavity
1061,1,1,Overall Stage,II
1061,1,1,Treatment Modality,Sx
1061,1,1,Metastasis,M0
1061,1,1,Tumor Stage,T2
1061,1,1,Research lab HPV,HPV unknown
1061,1,1,Research lab p16,p16 unknown
1062,1,1,Second Failure Type,no known failure
1062,1,1,Overall Stage,I
1062,1,1,Status,Alive w/o disease
1062,1,1,First Failure Type,no known failure
1062,1,1,Treatment Modality,Sx
1062,1,1,Occurrence #,1st primary
1062,1,1,Clinical lab p16,p16 unknown
1062,1,1,Research lab p16,p16 unknown
1062,1,1,Tumor Site,oral cavity
1062,1,1,Research lab HPV,HPV unknown
1062,1,1,Nodal Stage,N0
1062,1,1,Tumor Stage,T1
1062,1,1,Metastasis,M0
1063,1,1,Occurrence #,1st primary
1063,1,1,Clinical lab p16,p16 unknown
1063,1,1,Tumor Stage,T4a
1063,1,1,Tumor Site,oral cavity
1063,1,1,Second Failure Type,no known failure
1063,1,1,Metastasis,M0
1063,1,1,Research lab HPV,HPV unknown
1063,1,1,Overall Stage,IVa
1063,1,1,Research lab p16,p16 unknown
1063,1,1,Status,Alive unk disease
1063,1,1,First Failure Type,no known failure
1063,1,1,Nodal Stage,N0
1063,1,1,Treatment Modality,Sx
1064,1,1,Second Failure Type,no known failure
1064,1,1,Occurrence #,1st primary
1064,1,1,Overall Stage,I
1064,1,1,Tumor Stage,T1
1064,1,1,Research lab HPV,HPV unknown
1064,1,1,Research lab p16,p16 unknown
1064,1,1,Clinical lab p16,p16 unknown
1064,1,1,Treatment Modality,Sx
1064,1,1,Status,Alive w/o disease
1064,1,1,Nodal Stage,N0
1064,1,1,First Failure Type,no known failure
1064,1,1,Tumor Site,oral cavity
1064,1,1,Metastasis,M0
1065,1,1,Treatment Modality,Sx & RT
1065,1,1,Age at Death,74.8
1065,1,1,Occurrence #,1st primary
1065,1,1,Metastasis,M0
1065,1,1,Overall Stage,IVa
1065,1,1,Radiation Dosage,unknown
1065,1,1,Tumor Stage,T3
1065,1,1,Research lab p16,p16 unknown
1065,1,1,Date of Death,2004-05-14 00:00:00
1065,1,1,Second Failure Type,no known failure
1065,1,1,Nodal Stage,N2
1065,1,1,First Failure Type,no known failure
1065,1,1,Status,Dead unk disease
1065,1,1,Research lab HPV,HPV unknown
1065,1,1,Time to Death,1.5
1065,1,1,Tumor Site,oral cavity
1065,1,1,Clinical lab p16,p16 unknown
1066,1,1,Metastasis,M0
1066,1,1,Tumor Site,oral cavity
1066,1,1,Nodal Stage,N0
1066,1,1,Treatment Modality,Sx
1066,1,1,First Failure Type,no known failure
1066,1,1,Clinical lab p16,p16 unknown
1066,1,1,Research lab p16,p16 unknown
1066,1,1,Research lab HPV,HPV unknown
1066,1,1,Overall Stage,II
1066,1,1,Occurrence #,1st primary
1066,1,1,Tumor Stage,T2
1066,1,1,Second Failure Type,no known failure
1066,1,1,Status,Alive w/o disease
1067,1,1,Age at Death,78.0
1067,1,1,First Failure Type,no known failure
1067,1,1,Research lab HPV,HPV unknown
1067,1,1,Treatment Modality,RT
1067,1,1,Overall Stage,I
1067,1,1,Occurrence #,1st primary
1067,1,1,Status,Dead w/o disease
1067,1,1,Research lab p16,p16 unknown
1067,1,1,Nodal Stage,N0
1067,1,1,Tumor Site,oral cavity
1067,1,1,Tumor Stage,T1
1067,1,1,Radiation Dosage,66
1067,1,1,Date of Death,2010-12-08 00:00:00
1067,1,1,Metastasis,M0
1067,1,1,Second Failure Type,no known failure
1067,1,1,Clinical lab p16,p16 unknown
1067,1,1,Time to Death,2.6
1068,1,1,Overall Stage,II
1068,1,1,Second Failure Type,no known failure
1068,1,1,Status,Alive w/o disease
1068,1,1,Tumor Stage,T2
1068,1,1,Research lab p16,p16 unknown
1068,1,1,Occurrence #,1st primary
1068,1,1,First Failure Type,no known failure
1068,1,1,Clinical lab p16,p16 unknown
1068,1,1,Radiation Dosage,58
1068,1,1,Metastasis,M0
1068,1,1,Nodal Stage,N0
1068,1,1,Tumor Site,oral cavity
1068,1,1,Treatment Modality,Sx & RT
1068,1,1,Research lab HPV,HPV unknown
1071,1,1,Second Failure Type,no known failure
1071,1,1,Age at Death,93.8
1071,1,1,Status,Dead unk disease
1071,1,1,Overall Stage,I
1071,1,1,First Failure Type,locoregional
1071,1,1,Research lab HPV,HPV unknown
1071,1,1,Metastasis,M0
1071,1,1,First Failure Site,oral cavity
1071,1,1,Time to Death,7.1
1071,1,1,Tumor Stage,T1
1071,1,1,Date of Death,2008-03-12 00:00:00
1071,1,1,Tumor Site,oral cavity
1071,1,1,Nodal Stage,N0
1071,1,1,Occurrence #,1st primary
1071,1,1,First Failure Treatment Modality,Sx
1071,1,1,Research lab p16,p16 unknown
1071,1,1,Treatment Modality,Sx
1071,1,1,Clinical lab p16,p16 unknown
1071,1,1,Time to First Failure,4.5
1072,1,1,Tumor Site,oral cavity
1072,1,1,Time to First Failure,0.6
1072,1,1,First Failure Type,distant
1072,1,1,Nodal Stage,N0
1072,1,1,Research lab p16,p16 unknown
1072,1,1,Status,Dead w/o disease
1072,1,1,Research lab HPV,HPV negative
1072,1,1,Clinical lab p16,p16 negative
1072,1,1,Second Failure Type,no known failure
1072,1,1,Treatment Modality,Sx & RT
1072,1,1,Metastasis,M0
1072,1,1,Occurrence #,1st primary
1072,1,1,Tumor Stage,T2
1072,1,1,Radiation Dosage,60
1072,1,1,Overall Stage,II
1073,1,1,Treatment Modality,Sx
1073,1,1,Research lab p16,p16 unknown
1073,1,1,Nodal Stage,N0
1073,1,1,Clinical lab p16,p16 unknown
1073,1,1,Tumor Stage,T2
1073,1,1,First Failure Type,no known failure
1073,1,1,Date of Death,2009-08-07 00:00:00
1073,1,1,Second Failure Type,no known failure
1073,1,1,Overall Stage,II
1073,1,1,Status,Dead unk disease
1073,1,1,Research lab HPV,HPV unknown
1073,1,1,Occurrence #,1st primary
1073,1,1,Time to Death,6.7
1073,1,1,Tumor Site,oral cavity
1073,1,1,Age at Death,62.2
1073,1,1,Metastasis,M0
1074,1,1,Metastasis,M0
1074,1,1,Occurrence #,1st primary
1074,1,1,First Failure Type,no known failure
1074,1,1,Research lab HPV,HPV unknown
1074,1,1,Initial Chemotherapy Agent,cis
1074,1,1,Time to Death,0.7
1074,1,1,Overall Stage,IVa
1074,1,1,Second Failure Type,no known failure
1074,1,1,Radiation Dosage,74.4
1074,1,1,Nodal Stage,N0
1074,1,1,Research lab p16,p16 unknown
1074,1,1,Treatment Modality,CTX-RT
1074,1,1,Date of Death,2011-08-20 00:00:00
1074,1,1,Clinical lab p16,p16 unknown
1074,1,1,Status,Dead w/ disease
1074,1,1,Tumor Stage,T4a
1074,1,1,Age at Death,53.0
1074,1,1,Tumor Site,oral cavity
1075,1,1,Nodal Stage,N1
1075,1,1,Metastasis,M0
1075,1,1,Treatment Modality,Sx
1075,1,1,Tumor Stage,T3
1075,1,1,First Failure Type,no known failure
1075,1,1,Research lab p16,p16 unknown
1075,1,1,Occurrence #,1st primary
1075,1,1,Research lab HPV,HPV unknown
1075,1,1,Clinical lab p16,p16 unknown
1075,1,1,Second Failure Type,no known failure
1075,1,1,Overall Stage,III
1075,1,1,Tumor Site,oral cavity
1075,1,1,Status,Alive unk disease
1076,1,1,Occurrence #,1st primary
1076,1,1,Research lab p16,p16 unknown
1076,1,1,Treatment Modality,Sx
1076,1,1,Metastasis,M0
1076,1,1,Research lab HPV,HPV unknown
1076,1,1,First Failure Type,no known failure
1076,1,1,Overall Stage,I
1076,1,1,Second Failure Type,no known failure
1076,1,1,Tumor Site,oral cavity
1076,1,1,Nodal Stage,N0
1076,1,1,Clinical lab p16,p16 unknown
1076,1,1,Tumor Stage,T1
1076,1,1,Status,Alive w/o disease
1077,1,1,Tumor Stage,T4a
1077,1,1,Research lab HPV,HPV unknown
1077,1,1,Tumor Site,oral cavity
1077,1,1,Occurrence #,1st primary
1077,1,1,Status,Alive unk disease
1077,1,1,Clinical lab p16,p16 unknown
1077,1,1,Treatment Modality,Sx
1077,1,1,First Failure Type,no known failure
1077,1,1,Overall Stage,IVa
1077,1,1,Research lab p16,p16 unknown
1077,1,1,Nodal Stage,N2
1077,1,1,Metastasis,M0
1077,1,1,Second Failure Type,no known failure
1078,1,1,Treatment Modality,Sx
1078,1,1,Clinical lab p16,p16 unknown
1078,1,1,Occurrence #,1st primary
1078,1,1,Nodal Stage,N0
1078,1,1,Date of Death,2005-03-08 00:00:00
1078,1,1,First Failure Type,no known failure
1078,1,1,Research lab HPV,HPV unknown
1078,1,1,Age at Death,86.8
1078,1,1,Metastasis,M0
1078,1,1,Tumor Site,oral cavity
1078,1,1,Research lab p16,p16 unknown
1078,1,1,Status,Dead unk disease
1078,1,1,Time to Death,1.0
1078,1,1,Second Failure Type,no known failure
1078,1,1,Tumor Stage,T4a
1078,1,1,Overall Stage,IVa
1079,1,1,Tumor Site,oral cavity
1079,1,1,Overall Stage,IVa
1079,1,1,Status,Dead w/ disease
1079,1,1,Date of Death,2010-08-31 00:00:00
1079,1,1,Tumor Stage,T4a
1079,1,1,Second Failure Type,no known failure
1079,1,1,Radiation Dosage,unknown
1079,1,1,First Failure Type,locoregional
1079,1,1,Nodal Stage,N0
1079,1,1,Occurrence #,1st primary
1079,1,1,Metastasis,M0
1079,1,1,Treatment Modality,Sx
1079,1,1,Age at Death,56.8
1079,1,1,Clinical lab p16,p16 unknown
1079,1,1,Research lab HPV,HPV unknown
1079,1,1,Time to First Failure,-0.0
1079,1,1,Research lab p16,p16 unknown
1079,1,1,Time to Death,0.6
1081,1,1,Treatment Modality,Sx
1081,1,1,Tumor Stage,T1
1081,1,1,Time to Death,2.2
1081,1,1,Tumor Site,oral cavity
1081,1,1,Metastasis,M0
1081,1,1,Nodal Stage,N0
1081,1,1,Research lab HPV,HPV unknown
1081,1,1,Research lab p16,p16 unknown
1081,1,1,Time to First Failure,0.4
1081,1,1,Clinical lab p16,p16 unknown
1081,1,1,Age at Death,87.6
1081,1,1,Second Failure Type,no known failure
1081,1,1,Status,Dead unk disease
1081,1,1,Occurrence #,1st primary
1081,1,1,Overall Stage,I
1081,1,1,First Failure Site,oral cavity
1081,1,1,First Failure Treatment Modality,Sx
1081,1,1,Date of Death,2005-11-29 00:00:00
1081,1,1,First Failure Type,locoregional
1082,1,1,Occurrence #,1st primary
1082,1,1,Second Failure Type,no known failure
1082,1,1,Date of Death,2006-04-24 00:00:00
1082,1,1,Metastasis,M0
1082,1,1,Tumor Stage,T2
1082,1,1,Research lab HPV,HPV unknown
1082,1,1,Research lab p16,p16 unknown
1082,1,1,Age at Death,68.7
1082,1,1,Clinical lab p16,p16 unknown
1082,1,1,Treatment Modality,Sx
1082,1,1,Nodal Stage,N2
1082,1,1,Status,Dead unk disease
1082,1,1,First Failure Type,no known failure
1082,1,1,Tumor Site,oral cavity
1082,1,1,Time to Death,1.8
1082,1,1,Overall Stage,IVa
1083,1,1,Overall Stage,II
1083,1,1,Research lab HPV,HPV unknown
1083,1,1,Treatment Modality,Sx & RT
1083,1,1,Tumor Stage,T2
1083,1,1,Metastasis,M0
1083,1,1,Status,Dead unk disease
1083,1,1,Nodal Stage,N0
1083,1,1,First Failure Type,no known failure
1083,1,1,Occurrence #,1st primary
1083,1,1,Research lab p16,p16 unknown
1083,1,1,Date of Death,2003-10-21 00:00:00
1083,1,1,Second Failure Type,no known failure
1083,1,1,Age at Death,57.8
1083,1,1,Radiation Dosage,57.6
1083,1,1,Clinical lab p16,p16 unknown
1083,1,1,Tumor Site,oral cavity
1083,1,1,Time to Death,3.0
1084,1,1,Tumor Site,oral cavity
1084,1,1,Treatment Modality,Sx & RT
1084,1,1,First Failure Type,distant
1084,1,1,Second Failure Type,no known failure
1084,1,1,Radiation Dosage,unknown
1084,1,1,Time to First Failure,6.7
1084,1,1,Research lab p16,p16 unknown
1084,1,1,Metastasis,M0
1084,1,1,Tumor Stage,T2
1084,1,1,Occurrence #,1st primary
1084,1,1,Research lab HPV,HPV unknown
1084,1,1,Status,Alive w/ disease
1084,1,1,Overall Stage,II
1084,1,1,Clinical lab p16,p16 unknown
1084,1,1,Nodal Stage,N0
1085,1,1,Tumor Stage,T1
1085,1,1,Research lab p16,p16 unknown
1085,1,1,First Failure Type,no known failure
1085,1,1,Occurrence #,1st primary
1085,1,1,Nodal Stage,N0
1085,1,1,Metastasis,M0
1085,1,1,Research lab HPV,HPV unknown
1085,1,1,Status,Alive unk disease
1085,1,1,Overall Stage,I
1085,1,1,Clinical lab p16,p16 unknown
1085,1,1,Tumor Site,oral cavity
1085,1,1,Treatment Modality,Sx
1085,1,1,Second Failure Type,no known failure
1086,1,1,Research lab p16,p16 unknown
1086,1,1,First Failure Type,no known failure
1086,1,1,Clinical lab p16,p16 unknown
1086,1,1,Second Failure Type,no known failure
1086,1,1,Tumor Site,oral cavity
1086,1,1,Tumor Stage,T2
1086,1,1,Overall Stage,II
1086,1,1,Metastasis,M0
1086,1,1,Status,Alive unk disease
1086,1,1,Nodal Stage,N0
1086,1,1,Treatment Modality,Sx
1086,1,1,Research lab HPV,HPV unknown
1086,1,1,Occurrence #,1st primary
1087,1,1,Metastasis,M0
1087,1,1,Occurrence #,1st primary
1087,1,1,Time to Death,0.3
1087,1,1,Nodal Stage,N2
1087,1,1,Tumor Site,oral cavity
1087,1,1,Research lab p16,p16 unknown
1087,1,1,Overall Stage,IVa
1087,1,1,Tumor Stage,T4a
1087,1,1,Second Failure Type,no known failure
1087,1,1,Status,Dead unk disease
1087,1,1,Age at Death,52.1
1087,1,1,Date of Death,2006-05-02 00:00:00
1087,1,1,First Failure Type,no known failure
1087,1,1,Research lab HPV,HPV unknown
1087,1,1,Initial Chemotherapy Agent,unknown
1087,1,1,Clinical lab p16,p16 unknown
1087,1,1,Treatment Modality,Sx & CTX
1088,1,1,Tumor Stage,T3
1088,1,1,First Failure Site,oral cavity
1088,1,1,Status,Dead w/ disease
1088,1,1,Overall Stage,IVa
1088,1,1,Treatment Modality,Sx & RT
1088,1,1,Time to First Failure,0.2
1088,1,1,Occurrence #,1st primary
1088,1,1,First Failure Initial Chemotherapy Agent,carbo
1088,1,1,Metastasis,M0
1088,1,1,Second Failure Type,no known failure
1088,1,1,First Failure Treatment Modality,Sx & CTX-RT
1088,1,1,Time to Death,0.7
1088,1,1,Date of Death,2011-09-14 00:00:00
1088,1,1,Radiation Dosage,59.4
1088,1,1,Research lab p16,p16 unknown
1088,1,1,First Failure Radiation Dosage,51.6
1088,1,1,Tumor Site,oral cavity
1088,1,1,Nodal Stage,N2
1088,1,1,Clinical lab p16,p16 unknown
1088,1,1,Age at Death,69.1
1088,1,1,Research lab HPV,HPV unknown
1088,1,1,First Failure Type,locoregional
1089,1,1,Status,Dead unk disease
1089,1,1,Treatment Modality,Sx & RT
1089,1,1,Radiation Dosage,unknown
1089,1,1,Tumor Site,oral cavity
1089,1,1,Clinical lab p16,p16 unknown
1089,1,1,Nodal Stage,N1
1089,1,1,Age at Death,68.5
1089,1,1,Research lab HPV,HPV unknown
1089,1,1,Second Failure Type,no known failure
1089,1,1,First Failure Type,no known failure
1089,1,1,Research lab p16,p16 unknown
1089,1,1,Tumor Stage,T2
1089,1,1,Overall Stage,III
1089,1,1,Occurrence #,1st primary
1089,1,1,Metastasis,M0
1089,1,1,Time to Death,5.6
1089,1,1,Date of Death,2006-04-03 00:00:00
1090,1,1,First Failure Type,no known failure
1090,1,1,Metastasis,M0
1090,1,1,Treatment Modality,Sx
1090,1,1,Clinical lab p16,p16 unknown
1090,1,1,Tumor Stage,T1
1090,1,1,Research lab HPV,HPV unknown
1090,1,1,Status,Dead w/o disease
1090,1,1,Research lab p16,p16 unknown
1090,1,1,Overall Stage,I
1090,1,1,Occurrence #,1st primary
1090,1,1,Second Failure Type,no known failure
1090,1,1,Nodal Stage,N0
1090,1,1,Tumor Site,oral cavity
1091,1,1,Status,Dead unk disease
1091,1,1,Metastasis,M0
1091,1,1,Clinical lab p16,p16 unknown
1091,1,1,Nodal Stage,N1
1091,1,1,Treatment Modality,Sx
1091,1,1,First Failure Type,no known failure
1091,1,1,Age at Death,70.6
1091,1,1,Time to Death,1.5
1091,1,1,Tumor Site,oral cavity
1091,1,1,Second Failure Type,no known failure
1091,1,1,Occurrence #,recurrence
1091,1,1,Research lab p16,p16 unknown
1091,1,1,Tumor Stage,T4a
1091,1,1,Research lab HPV,HPV unknown
1091,1,1,Overall Stage,IVa
1091,1,1,Date of Death,2010-04-03 00:00:00
1092,1,1,Occurrence #,1st primary
1092,1,1,Treatment Modality,Sx
1092,1,1,Overall Stage,IVa
1092,1,1,Metastasis,M0
1092,1,1,Status,Dead w/o disease
1092,1,1,Nodal Stage,N2
1092,1,1,Date of Death,2011-02-13 00:00:00
1092,1,1,Research lab HPV,HPV unknown
1092,1,1,Clinical lab p16,p16 unknown
1092,1,1,Tumor Stage,T4a
1092,1,1,Research lab p16,p16 unknown
1092,1,1,Time to Death,0.8
1092,1,1,Tumor Site,oral cavity
1092,1,1,Age at Death,64.8
1092,1,1,First Failure Type,no known failure
1092,1,1,Second Failure Type,no known failure
1093,1,1,Time to Death,1.0
1093,1,1,Treatment Modality,Sx & CTX-RT
1093,1,1,Age at Death,48.9
1093,1,1,Occurrence #,1st primary
1093,1,1,Nodal Stage,N2
1093,1,1,Second Failure Type,no known failure
1093,1,1,Overall Stage,IVa
1093,1,1,Radiation Dosage,63
1093,1,1,Clinical lab p16,p16 unknown
1093,1,1,Metastasis,M0
1093,1,1,Initial Chemotherapy Agent,cis
1093,1,1,Tumor Stage,T4a
1093,1,1,First Failure Type,locoregional
1093,1,1,Date of Death,2005-07-11 00:00:00
1093,1,1,Research lab HPV,HPV unknown
1093,1,1,Tumor Site,oral cavity
1093,1,1,Status,Dead w/ disease
1093,1,1,Time to First Failure,0.3
1093,1,1,Research lab p16,p16 unknown
1094,1,1,Clinical lab p16,p16 unknown
1094,1,1,Status,Dead w/o disease
1094,1,1,Research lab p16,p16 unknown
1094,1,1,Tumor Stage,T4a
1094,1,1,Overall Stage,IVa
1094,1,1,Second Failure Type,no known failure
1094,1,1,Tumor Site,oral cavity
1094,1,1,Time to Death,1.9
1094,1,1,Treatment Modality,Sx
1094,1,1,Age at Death,75.2
1094,1,1,Nodal Stage,N0
1094,1,1,Occurrence #,1st primary
1094,1,1,First Failure Type,no known failure
1094,1,1,Research lab HPV,HPV unknown
1094,1,1,Date of Death,2011-03-16 00:00:00
1094,1,1,Metastasis,M0
1095,1,1,Metastasis,M0
1095,1,1,Second Failure Type,no known failure
1095,1,1,Status,Alive unk disease
1095,1,1,Treatment Modality,Sx
1095,1,1,First Failure Type,no known failure
1095,1,1,Nodal Stage,N0
1095,1,1,Research lab HPV,HPV unknown
1095,1,1,Tumor Site,oral cavity
1095,1,1,Occurrence #,1st primary
1095,1,1,Tumor Stage,T1
1095,1,1,Overall Stage,I
1095,1,1,Research lab p16,p16 unknown
1095,1,1,Clinical lab p16,p16 unknown
1096,1,1,Occurrence #,1st primary
1096,1,1,Overall Stage,I
1096,1,1,First Failure Type,no known failure
1096,1,1,Second Failure Type,no known failure
1096,1,1,Research lab p16,p16 unknown
1096,1,1,Treatment Modality,Sx
1096,1,1,Clinical lab p16,p16 unknown
1096,1,1,Status,Alive w/o disease
1096,1,1,Tumor Site,oral cavity
1096,1,1,Research lab HPV,HPV unknown
1096,1,1,Tumor Stage,T1
1096,1,1,Nodal Stage,N0
1096,1,1,Metastasis,M0
1097,1,1,Tumor Stage,T1
1097,1,1,Treatment Modality,Sx
1097,1,1,Tumor Site,oral cavity
1097,1,1,Clinical lab p16,p16 unknown
1097,1,1,Status,Alive unk disease
1097,1,1,First Failure Type,no known failure
1097,1,1,Nodal Stage,N0
1097,1,1,Research lab p16,p16 unknown
1097,1,1,Second Failure Type,no known failure
1097,1,1,Overall Stage,I
1097,1,1,Metastasis,M0
1097,1,1,Research lab HPV,HPV unknown
1097,1,1,Occurrence #,1st primary
1098,1,1,Clinical lab p16,p16 unknown
1098,1,1,Research lab p16,p16 unknown
1098,1,1,Research lab HPV,HPV unknown
1098,1,1,Tumor Stage,T4a
1098,1,1,Nodal Stage,N1
1098,1,1,Age at Death,73.9
1098,1,1,Overall Stage,IVa
1098,1,1,Date of Death,2007-10-18 00:00:00
1098,1,1,Radiation Dosage,unknown
1098,1,1,Metastasis,M0
1098,1,1,Occurrence #,1st primary
1098,1,1,Second Failure Type,no known failure
1098,1,1,First Failure Type,no known failure
1098,1,1,Time to Death,0.6
1098,1,1,Tumor Site,oral cavity
1098,1,1,Status,Dead unk disease
1098,1,1,Treatment Modality,Sx & RT
1099,1,1,Clinical lab p16,p16 unknown
1099,1,1,Second Failure Type,no known failure
1099,1,1,Status,Alive unk disease
1099,1,1,Research lab HPV,HPV unknown
1099,1,1,Research lab p16,p16 unknown
1099,1,1,Treatment Modality,Sx
1099,1,1,Occurrence #,1st primary
1099,1,1,Tumor Site,oral cavity
1099,1,1,Nodal Stage,N0
1099,1,1,Tumor Stage,T4a
1099,1,1,Overall Stage,IVa
1099,1,1,First Failure Type,no known failure
1099,1,1,Metastasis,M0
1100,1,1,Treatment Modality,Sx
1100,1,1,Metastasis,M0
1100,1,1,Overall Stage,I
1100,1,1,Occurrence #,1st primary
1100,1,1,Nodal Stage,N0
1100,1,1,Research lab p16,p16 unknown
1100,1,1,Tumor Stage,T1
1100,1,1,First Failure Type,no known failure
1100,1,1,Clinical lab p16,p16 unknown
1100,1,1,Status,Alive unk disease
1100,1,1,Tumor Site,oral cavity
1100,1,1,Second Failure Type,no known failure
1100,1,1,Research lab HPV,HPV unknown
1101,1,1,First Failure Type,no known failure
1101,1,1,Date of Death,2006-02-22 00:00:00
1101,1,1,Occurrence #,1st primary
1101,1,1,Time to Death,0.4
1101,1,1,Tumor Stage,T2
1101,1,1,Clinical lab p16,p16 unknown
1101,1,1,Research lab HPV,HPV unknown
1101,1,1,Research lab p16,p16 unknown
1101,1,1,Tumor Site,oral cavity
1101,1,1,Nodal Stage,N2
1101,1,1,Metastasis,M0
1101,1,1,Treatment Modality,Sx
1101,1,1,Second Failure Type,no known failure
1101,1,1,Status,Dead unk disease
1101,1,1,Overall Stage,IVa
1101,1,1,Age at Death,83.4
1102,1,1,Clinical lab p16,p16 unknown
1102,1,1,Second Failure Type,no known failure
1102,1,1,Tumor Stage,T4a
1102,1,1,Research lab p16,p16 unknown
1102,1,1,Treatment Modality,Sx
1102,1,1,Overall Stage,IVa
1102,1,1,Nodal Stage,Unknown
1102,1,1,First Failure Type,no known failure
1102,1,1,Occurrence #,recurrence
1102,1,1,Date of Death,2009-04-13 00:00:00
1102,1,1,Age at Death,59.0
1102,1,1,Status,Dead unk disease
1102,1,1,Research lab HPV,HPV unknown
1102,1,1,Time to Death,3.0
1102,1,1,Tumor Site,oral cavity
1102,1,1,Metastasis,M0
1103,1,1,Treatment Modality,Sx
1103,1,1,Overall Stage,I
1103,1,1,Metastasis,M0
1103,1,1,Tumor Site,oral cavity
1103,1,1,Research lab p16,p16 unknown
1103,1,1,Tumor Stage,T1
1103,1,1,Research lab HPV,HPV unknown
1103,1,1,Nodal Stage,N0
1103,1,1,Clinical lab p16,p16 unknown
1103,1,1,Status,Alive unk disease
1103,1,1,Occurrence #,1st primary
1103,1,1,Second Failure Type,no known failure
1103,1,1,First Failure Type,no known failure
1104,1,1,Tumor Stage,T2
1104,1,1,Treatment Modality,Sx
1104,1,1,Age at Death,78.1
1104,1,1,Status,Dead unk disease
1104,1,1,Clinical lab p16,p16 unknown
1104,1,1,Metastasis,M0
1104,1,1,Research lab HPV,HPV unknown
1104,1,1,Tumor Site,oral cavity
1104,1,1,Date of Death,2008-02-14 00:00:00
1104,1,1,Nodal Stage,N2
1104,1,1,Time to Death,0.7
1104,1,1,Research lab p16,p16 unknown
1104,1,1,Second Failure Type,no known failure
1104,1,1,Overall Stage,IVa
1104,1,1,First Failure Type,no known failure
1104,1,1,Occurrence #,1st primary
1105,1,1,Metastasis,M0
1105,1,1,Nodal Stage,N0
1105,1,1,Tumor Stage,T2
1105,1,1,Tumor Site,oral cavity
1105,1,1,First Failure Treatment Modality,Sx
1105,1,1,Time to First Failure,7.1
1105,1,1,Overall Stage,II
1105,1,1,Occurrence #,1st primary
1105,1,1,Clinical lab p16,p16 unknown
1105,1,1,First Failure Type,locoregional
1105,1,1,Status,Alive unk disease
1105,1,1,Treatment Modality,Sx
1105,1,1,Research lab p16,p16 unknown
1105,1,1,First Failure Site,oral cavity
1105,1,1,Second Failure Type,no known failure
1105,1,1,Research lab HPV,HPV unknown
1106,1,1,Second Failure Type,no known failure
1106,1,1,Research lab p16,p16 unknown
1106,1,1,Tumor Stage,T4a
1106,1,1,Date of Death,2006-05-13 00:00:00
1106,1,1,Clinical lab p16,p16 unknown
1106,1,1,First Failure Type,no known failure
1106,1,1,Status,Dead unk disease
1106,1,1,Age at Death,74.2
1106,1,1,Research lab HPV,HPV unknown
1106,1,1,Time to Death,0.6
1106,1,1,Tumor Site,oral cavity
1106,1,1,Overall Stage,IVa
1106,1,1,Occurrence #,recurrence
1106,1,1,Treatment Modality,Sx
1106,1,1,Metastasis,M0
1106,1,1,Nodal Stage,N0
1107,1,1,Metastasis,M0
1107,1,1,First Failure Type,no known failure
1107,1,1,Status,Alive unk disease
1107,1,1,Clinical lab p16,p16 unknown
1107,1,1,Treatment Modality,Sx
1107,1,1,Second Failure Type,no known failure
1107,1,1,Overall Stage,IVa
1107,1,1,Occurrence #,1st primary
1107,1,1,Research lab HPV,HPV unknown
1107,1,1,Tumor Stage,T4a
1107,1,1,Research lab p16,p16 unknown
1107,1,1,Tumor Site,oral cavity
1107,1,1,Nodal Stage,N2
1108,1,1,Overall Stage,II
1108,1,1,Radiation Dosage,63
1108,1,1,Status,Alive w/o disease
1108,1,1,Tumor Stage,T2
1108,1,1,Second Failure Type,no known failure
1108,1,1,Treatment Modality,Sx & RT
1108,1,1,Research lab HPV,HPV unknown
1108,1,1,Nodal Stage,N0
1108,1,1,Research lab p16,p16 unknown
1108,1,1,Clinical lab p16,p16 unknown
1108,1,1,Metastasis,M0
1108,1,1,Tumor Site,oral cavity
1108,1,1,First Failure Type,no known failure
1108,1,1,Occurrence #,1st primary
1109,1,1,Second Failure Type,no known failure
1109,1,1,Research lab p16,p16 unknown
1109,1,1,Time to First Failure,4.7
1109,1,1,First Failure Treatment Modality,Sx
1109,1,1,Overall Stage,I
1109,1,1,Occurrence #,1st primary
1109,1,1,Treatment Modality,Sx
1109,1,1,Metastasis,M0
1109,1,1,First Failure Type,locoregional
1109,1,1,Tumor Site,oral cavity
1109,1,1,Research lab HPV,HPV unknown
1109,1,1,Tumor Stage,T1
1109,1,1,Status,Alive unk disease
1109,1,1,Nodal Stage,N0
1109,1,1,First Failure Site,oral cavity
1109,1,1,Clinical lab p16,p16 unknown
1110,1,1,Tumor Site,oral cavity
1110,1,1,Metastasis,M0
1110,1,1,Date of Death,2009-03-20 00:00:00
1110,1,1,Research lab HPV,HPV unknown
1110,1,1,Status,Dead unk disease
1110,1,1,Age at Death,58.1
1110,1,1,Occurrence #,1st primary
1110,1,1,Treatment Modality,Sx
1110,1,1,Nodal Stage,N2
1110,1,1,Research lab p16,p16 unknown
1110,1,1,Second Failure Type,no known failure
1110,1,1,Clinical lab p16,p16 unknown
1110,1,1,Tumor Stage,T4a
1110,1,1,First Failure Type,no known failure
1110,1,1,Time to Death,0.1
1110,1,1,Overall Stage,IVa
1111,1,1,Overall Stage,IVb
1111,1,1,Second Failure Type,no known failure
1111,1,1,Time to First Failure,-0.2
1111,1,1,Metastasis,M0
1111,1,1,First Failure Type,locoregional and distant
1111,1,1,Occurrence #,1st primary
1111,1,1,Research lab HPV,HPV unknown
1111,1,1,Tumor Site,oral cavity
1111,1,1,Radiation Dosage,70.2
1111,1,1,Date of Death,2007-03-27 00:00:00
1111,1,1,Treatment Modality,Sx & CTX-RT
1111,1,1,Nodal Stage,N3
1111,1,1,Research lab p16,p16 unknown
1111,1,1,Tumor Stage,T2
1111,1,1,Age at Death,44.8
1111,1,1,Status,Dead w/ disease
1111,1,1,Initial Chemotherapy Agent,carbo/PTX
1111,1,1,Time to Death,0.5
1111,1,1,Clinical lab p16,p16 unknown
1112,1,1,Tumor Stage,T2
1112,1,1,Overall Stage,II
1112,1,1,Tumor Site,oral cavity
1112,1,1,Treatment Modality,Sx
1112,1,1,Status,Dead w/ disease
1112,1,1,Metastasis,M0
1112,1,1,Occurrence #,recurrence
1112,1,1,Research lab HPV,HPV unknown
1112,1,1,Nodal Stage,N0
1112,1,1,Clinical lab p16,p16 unknown
1112,1,1,Time to First Failure,3.2
1112,1,1,Research lab p16,p16 unknown
1112,1,1,Second Failure Type,no known failure
1112,1,1,First Failure Type,locoregional
1113,1,1,First Failure Type,locoregional
1113,1,1,Research lab HPV,HPV unknown
1113,1,1,Tumor Site,oral cavity
1113,1,1,Treatment Modality,Sx
1113,1,1,Research lab p16,p16 unknown
1113,1,1,Date of Death,2009-08-12 00:00:00
1113,1,1,Nodal Stage,N0
1113,1,1,First Failure Treatment Modality,Sx
1113,1,1,Clinical lab p16,p16 unknown
1113,1,1,Time to First Failure,0.5
1113,1,1,Age at Death,50.0
1113,1,1,Occurrence #,other primary
1113,1,1,Metastasis,M0
1113,1,1,Tumor Stage,T1
1113,1,1,First Failure Site,oral cavity
1113,1,1,Time to Death,0.9
1113,1,1,Status,Dead w/ disease
1113,1,1,Second Failure Type,no known failure
1113,1,1,Overall Stage,I
1114,1,1,Clinical lab p16,p16 unknown
1114,1,1,Date of Death,2010-05-19 00:00:00
1114,1,1,Time to Death,0.5
1114,1,1,Second Failure Type,no known failure
1114,1,1,Occurrence #,recurrence
1114,1,1,Research lab p16,p16 unknown
1114,1,1,Tumor Site,oral cavity
1114,1,1,Nodal Stage,N1
1114,1,1,Research lab HPV,HPV unknown
1114,1,1,Treatment Modality,Sx
1114,1,1,First Failure Treatment Modality,Sx
1114,1,1,Overall Stage,III
1114,1,1,Time to First Failure,0.2
1114,1,1,First Failure Type,locoregional
1114,1,1,Status,Dead unk disease
1114,1,1,First Failure Site,oral cavity
1114,1,1,Tumor Stage,T1
1114,1,1,Metastasis,M0
1114,1,1,Age at Death,55.2
1115,1,1,Nodal Stage,N0
1115,1,1,Treatment Modality,Sx
1115,1,1,Clinical lab p16,p16 unknown
1115,1,1,Second Failure Type,no known failure
1115,1,1,Research lab HPV,HPV unknown
1115,1,1,Overall Stage,I
1115,1,1,First Failure Type,no known failure
1115,1,1,Tumor Stage,T1
1115,1,1,Metastasis,M0
1115,1,1,Research lab p16,p16 unknown
1115,1,1,Status,Alive unk disease
1115,1,1,Occurrence #,recurrence
1115,1,1,Tumor Site,oral cavity
1116,1,1,Occurrence #,recurrence
1116,1,1,Metastasis,M1
1116,1,1,Nodal Stage,N0
1116,1,1,Radiation Dosage,36
1116,1,1,Treatment Modality,Sx & RT
1116,1,1,Age at Death,56.5
1116,1,1,Overall Stage,IVc
1116,1,1,Second Failure Type,no known failure
1116,1,1,Time to Death,1.0
1116,1,1,Status,Dead w/ disease
1116,1,1,Tumor Stage,T4a
1116,1,1,Research lab HPV,HPV unknown
1116,1,1,Tumor Site,oral cavity
1116,1,1,Clinical lab p16,p16 unknown
1116,1,1,First Failure Type,no known failure
1116,1,1,Date of Death,2005-01-24 00:00:00
1116,1,1,Research lab p16,p16 unknown
1117,1,1,Second Failure Type,no known failure
1117,1,1,Occurrence #,1st primary
1117,1,1,Nodal Stage,N2
1117,1,1,Metastasis,M0
1117,1,1,Overall Stage,IVa
1117,1,1,First Failure Type,no known failure
1117,1,1,Treatment Modality,Sx
1117,1,1,Tumor Site,oral cavity
1117,1,1,Research lab HPV,HPV unknown
1117,1,1,Status,Alive unk disease
1117,1,1,Clinical lab p16,p16 unknown
1117,1,1,Tumor Stage,T2
1117,1,1,Research lab p16,p16 unknown
1118,1,1,Time to Death,8.4
1118,1,1,Metastasis,M0
1118,1,1,Overall Stage,I
1118,1,1,Date of Death,2010-12-26 00:00:00
1118,1,1,Second Failure Type,no known failure
1118,1,1,Age at Death,83.3
1118,1,1,Status,Dead unk disease
1118,1,1,Clinical lab p16,p16 unknown
1118,1,1,Treatment Modality,Sx
1118,1,1,Tumor Stage,T1
1118,1,1,Research lab HPV,HPV unknown
1118,1,1,Nodal Stage,N0
1118,1,1,First Failure Type,no known failure
1118,1,1,Tumor Site,oral cavity
1118,1,1,Occurrence #,recurrence
1118,1,1,Research lab p16,p16 unknown
1119,1,1,Clinical lab p16,p16 unknown
1119,1,1,Research lab p16,p16 unknown
1119,1,1,Nodal Stage,N0
1119,1,1,First Failure Type,no known failure
1119,1,1,Treatment Modality,Sx
1119,1,1,Overall Stage,I
1119,1,1,Metastasis,M0
1119,1,1,Tumor Site,oral cavity
1119,1,1,Occurrence #,1st primary
1119,1,1,Research lab HPV,HPV unknown
1119,1,1,Tumor Stage,T1
1119,1,1,Status,Alive w/o disease
1119,1,1,Second Failure Type,no known failure
1120,1,1,Overall Stage,I
1120,1,1,Tumor Stage,T1
1120,1,1,Research lab p16,p16 unknown
1120,1,1,Clinical lab p16,p16 unknown
1120,1,1,Second Failure Type,no known failure
1120,1,1,Status,Alive unk disease
1120,1,1,Research lab HPV,HPV unknown
1120,1,1,Tumor Site,oral cavity
1120,1,1,Metastasis,M0
1120,1,1,First Failure Type,no known failure
1120,1,1,Nodal Stage,N0
1120,1,1,Occurrence #,1st primary
1120,1,1,Treatment Modality,Sx
1121,1,1,First Failure Type,no known failure
1121,1,1,Overall Stage,I
1121,1,1,Treatment Modality,Sx
1121,1,1,Status,Dead w/o disease
1121,1,1,Nodal Stage,N0
1121,1,1,Date of Death,2011-08-27 00:00:00
1121,1,1,Second Failure Type,no known failure
1121,1,1,Time to Death,11.2
1121,1,1,Research lab p16,p16 unknown
1121,1,1,Tumor Stage,T1
1121,1,1,Clinical lab p16,p16 unknown
1121,1,1,Age at Death,79.1
1121,1,1,Occurrence #,1st primary
1121,1,1,Research lab HPV,HPV unknown
1121,1,1,Metastasis,M0
1121,1,1,Tumor Site,oral cavity
1122,1,1,Second Failure Type,no known failure
1122,1,1,First Failure Type,no known failure
1122,1,1,Tumor Stage,T1
1122,1,1,Clinical lab p16,p16 unknown
1122,1,1,Research lab p16,p16 unknown
1122,1,1,Occurrence #,1st primary
1122,1,1,Nodal Stage,N1
1122,1,1,Tumor Site,oral cavity
1122,1,1,Treatment Modality,Sx
1122,1,1,Status,Alive unk disease
1122,1,1,Research lab HPV,HPV unknown
1122,1,1,Metastasis,M0
1122,1,1,Overall Stage,III
1123,1,1,Clinical lab p16,p16 unknown
1123,1,1,Age at Death,75.7
1123,1,1,Tumor Site,oral cavity
1123,1,1,Second Failure Type,no known failure
1123,1,1,Metastasis,M0
1123,1,1,Time to Death,0.2
1123,1,1,Date of Death,2010-06-10 00:00:00
1123,1,1,Research lab HPV,HPV unknown
1123,1,1,Tumor Stage,T4b
1123,1,1,Status,Dead w/o disease
1123,1,1,Nodal Stage,Unknown
1123,1,1,Overall Stage,IVb
1123,1,1,First Failure Type,no known failure
1123,1,1,Occurrence #,1st primary
1123,1,1,Treatment Modality,Sx
1123,1,1,Research lab p16,p16 unknown
1124,1,1,Tumor Site,oral cavity
1124,1,1,Nodal Stage,N1
1124,1,1,Research lab HPV,HPV unknown
1124,1,1,Occurrence #,1st primary
1124,1,1,Status,Alive unk disease
1124,1,1,Overall Stage,III
1124,1,1,Treatment Modality,Sx
1124,1,1,Research lab p16,p16 unknown
1124,1,1,First Failure Type,no known failure
1124,1,1,Tumor Stage,T2
1124,1,1,Metastasis,M0
1124,1,1,Clinical lab p16,p16 unknown
1124,1,1,Second Failure Type,no known failure
1125,1,1,Occurrence #,1st primary
1125,1,1,Tumor Site,oral cavity
1125,1,1,Metastasis,M0
1125,1,1,First Failure Type,no known failure
1125,1,1,Research lab HPV,HPV unknown
1125,1,1,Overall Stage,IVa
1125,1,1,Treatment Modality,Sx
1125,1,1,Clinical lab p16,p16 unknown
1125,1,1,Tumor Stage,T4a
1125,1,1,Research lab p16,p16 unknown
1125,1,1,Second Failure Type,no known failure
1125,1,1,Age at Death,48.7
1125,1,1,Nodal Stage,N0
1125,1,1,Date of Death,2002-07-10 00:00:00
1125,1,1,Time to Death,0.7
1125,1,1,Status,Dead unk disease
1126,1,1,Status,Dead unk disease
1126,1,1,Second Failure Type,no known failure
1126,1,1,Time to Death,1.4
1126,1,1,Tumor Stage,T1
1126,1,1,First Failure Type,locoregional
1126,1,1,Clinical lab p16,p16 unknown
1126,1,1,First Failure Site,oral cavity
1126,1,1,Time to First Failure,0.8
1126,1,1,Research lab p16,p16 unknown
1126,1,1,Date of Death,2003-07-02 00:00:00
1126,1,1,Metastasis,M0
1126,1,1,Nodal Stage,N0
1126,1,1,Tumor Site,oral cavity
1126,1,1,Treatment Modality,Sx
1126,1,1,First Failure Treatment Modality,Sx
1126,1,1,Research lab HPV,HPV unknown
1126,1,1,Overall Stage,I
1126,1,1,Age at Death,44.5
1126,1,1,Occurrence #,1st primary
1127,1,1,Occurrence #,1st primary
1127,1,1,Tumor Stage,T4a
1127,1,1,Tumor Site,oral cavity
1127,1,1,Nodal Stage,N1
1127,1,1,Research lab HPV,HPV unknown
1127,1,1,First Failure Type,no known failure
1127,1,1,Clinical lab p16,p16 unknown
1127,1,1,Treatment Modality,Sx
1127,1,1,Second Failure Type,no known failure
1127,1,1,Metastasis,M0
1127,1,1,Research lab p16,p16 unknown
1127,1,1,Overall Stage,IVa
1127,1,1,Status,Alive unk disease
1128,1,1,Age at Death,59.3
1128,1,1,Nodal Stage,N1
1128,1,1,Tumor Site,oral cavity
1128,1,1,Clinical lab p16,p16 unknown
1128,1,1,Research lab HPV,HPV unknown
1128,1,1,Occurrence #,1st primary
1128,1,1,First Failure Type,locoregional and distant
1128,1,1,Status,Dead w/ disease
1128,1,1,Treatment Modality,Sx & RT
1128,1,1,Date of Death,2009-05-03 00:00:00
1128,1,1,Tumor Stage,T2
1128,1,1,Time to First Failure,0.5
1128,1,1,Overall Stage,III
1128,1,1,Radiation Dosage,unknown
1128,1,1,Time to Death,1.0
1128,1,1,Metastasis,M0
1128,1,1,Research lab p16,p16 unknown
1128,1,1,Second Failure Type,no known failure
1129,1,1,Initial Chemotherapy Agent,carbo/PTX
1129,1,1,Radiation Dosage,70.2
1129,1,1,Tumor Site,oral cavity
1129,1,1,Metastasis,M0
1129,1,1,Nodal Stage,N1
1129,1,1,Status,Alive w/o disease
1129,1,1,Clinical lab p16,p16 unknown
1129,1,1,Tumor Stage,T4a
1129,1,1,Research lab HPV,HPV unknown
1129,1,1,Research lab p16,p16 unknown
1129,1,1,Overall Stage,IVa
1129,1,1,Occurrence #,1st primary
1129,1,1,First Failure Type,no known failure
1129,1,1,Second Failure Type,no known failure
1129,1,1,Treatment Modality,CTX-RT
1130,1,1,Treatment Modality,Sx
1130,1,1,Age at Death,84.7
1130,1,1,First Failure Type,no known failure
1130,1,1,Status,Dead unk disease
1130,1,1,Nodal Stage,N0
1130,1,1,Research lab HPV,HPV unknown
1130,1,1,Research lab p16,p16 unknown
1130,1,1,Date of Death,2009-11-17 00:00:00
1130,1,1,Second Failure Type,no known failure
1130,1,1,Tumor Stage,T1
1130,1,1,Occurrence #,1st primary
1130,1,1,Overall Stage,I
1130,1,1,Tumor Site,oral cavity
1130,1,1,Metastasis,M0
1130,1,1,Clinical lab p16,p16 unknown
1130,1,1,Time to Death,4.4
1131,1,1,Tumor Site,oral cavity
1131,1,1,Research lab HPV,HPV unknown
1131,1,1,Nodal Stage,N2
1131,1,1,Occurrence #,1st primary
1131,1,1,Age at Death,70.3
1131,1,1,Treatment Modality,Sx
1131,1,1,Tumor Stage,T3
1131,1,1,Time to Death,0.6
1131,1,1,Metastasis,M0
1131,1,1,Status,Dead unk disease
1131,1,1,Clinical lab p16,p16 unknown
1131,1,1,Second Failure Type,no known failure
1131,1,1,Date of Death,2009-04-16 00:00:00
1131,1,1,First Failure Type,no known failure
1131,1,1,Research lab p16,p16 unknown
1131,1,1,Overall Stage,IVa
1132,1,1,Clinical lab p16,p16 unknown
1132,1,1,Occurrence #,1st primary
1132,1,1,Tumor Site,oral cavity
1132,1,1,Metastasis,M0
1132,1,1,Research lab p16,p16 unknown
1132,1,1,Second Failure Type,no known failure
1132,1,1,Overall Stage,I
1132,1,1,First Failure Type,no known failure
1132,1,1,Treatment Modality,Sx
1132,1,1,Tumor Stage,T1
1132,1,1,Research lab HPV,HPV unknown
1132,1,1,Status,Alive w/o disease
1132,1,1,Nodal Stage,N0
1133,1,1,Overall Stage,I
1133,1,1,Research lab p16,p16 unknown
1133,1,1,First Failure Type,no known failure
1133,1,1,Research lab HPV,HPV unknown
1133,1,1,Metastasis,M0
1133,1,1,Tumor Site,oral cavity
1133,1,1,Status,Alive unk disease
1133,1,1,Clinical lab p16,p16 unknown
1133,1,1,Occurrence #,1st primary
1133,1,1,Tumor Stage,T1
1133,1,1,Nodal Stage,N0
1133,1,1,Treatment Modality,Sx
1133,1,1,Second Failure Type,no known failure
1134,1,1,Treatment Modality,Sx
1134,1,1,Research lab HPV,HPV unknown
1134,1,1,Research lab p16,p16 unknown
1134,1,1,Age at Death,82.1
1134,1,1,First Failure Type,no known failure
1134,1,1,Overall Stage,II
1134,1,1,Occurrence #,1st primary
1134,1,1,Clinical lab p16,p16 unknown
1134,1,1,Metastasis,M0
1134,1,1,Tumor Stage,T2
1134,1,1,Second Failure Type,no known failure
1134,1,1,Date of Death,2009-12-24 00:00:00
1134,1,1,Status,Dead unk disease
1134,1,1,Time to Death,4.1
1134,1,1,Nodal Stage,N0
1134,1,1,Tumor Site,oral cavity
1135,1,1,Tumor Site,oral cavity
1135,1,1,Tumor Stage,T2
1135,1,1,Occurrence #,1st primary
1135,1,1,Time to Death,1.5
1135,1,1,Treatment Modality,Sx & RT
1135,1,1,Metastasis,M0
1135,1,1,Date of Death,2007-08-07 00:00:00
1135,1,1,Second Failure Type,no known failure
1135,1,1,Clinical lab p16,p16 unknown
1135,1,1,Research lab p16,p16 unknown
1135,1,1,Status,Dead unk disease
1135,1,1,Research lab HPV,HPV unknown
1135,1,1,First Failure Type,no known failure
1135,1,1,Nodal Stage,N0
1135,1,1,Age at Death,59.6
1135,1,1,Radiation Dosage,53
1135,1,1,Overall Stage,II
1136,1,1,Status,Alive w/o disease
1136,1,1,Treatment Modality,Sx & CTX-RT
1136,1,1,First Failure Type,no known failure
1136,1,1,Metastasis,M0
1136,1,1,Clinical lab p16,p16 unknown
1136,1,1,Nodal Stage,N0
1136,1,1,Second Failure Type,no known failure
1136,1,1,Initial Chemotherapy Agent,unknown
1136,1,1,Research lab HPV,HPV unknown
1136,1,1,Research lab p16,p16 unknown
1136,1,1,Radiation Dosage,unknown
1136,1,1,Tumor Site,oral cavity
1136,1,1,Occurrence #,1st primary
1136,1,1,Tumor Stage,T2
1136,1,1,Overall Stage,II
1137,1,1,Second Failure Type,no known failure
1137,1,1,Time to Death,5.5
1137,1,1,Nodal Stage,N0
1137,1,1,Date of Death,2010-12-14 00:00:00
1137,1,1,Age at Death,65.6
1137,1,1,Occurrence #,1st primary
1137,1,1,Research lab p16,p16 unknown
1137,1,1,Treatment Modality,Sx
1137,1,1,Status,Dead w/o disease
1137,1,1,Research lab HPV,HPV unknown
1137,1,1,Tumor Stage,T1
1137,1,1,Overall Stage,I
1137,1,1,First Failure Type,no known failure
1137,1,1,Tumor Site,oral cavity
1137,1,1,Clinical lab p16,p16 unknown
1137,1,1,Metastasis,M0
1138,1,1,Tumor Stage,T4a
1138,1,1,Time to First Failure,0.9
1138,1,1,Metastasis,M0
1138,1,1,Treatment Modality,Sx
1138,1,1,Time to Death,1.2
1138,1,1,First Failure Type,locoregional
1138,1,1,Nodal Stage,N0
1138,1,1,Second Failure Type,no known failure
1138,1,1,Research lab HPV,HPV unknown
1138,1,1,Clinical lab p16,p16 unknown
1138,1,1,Tumor Site,oral cavity
1138,1,1,Age at Death,86.5
1138,1,1,Occurrence #,1st primary
1138,1,1,Overall Stage,IVa
1138,1,1,Date of Death,2008-07-14 00:00:00
1138,1,1,Research lab p16,p16 unknown
1138,1,1,Status,Dead unk disease
1139,1,1,Treatment Modality,Sx
1139,1,1,Overall Stage,III
1139,1,1,Research lab HPV,HPV unknown
1139,1,1,First Failure Type,no known failure
1139,1,1,Tumor Site,oral cavity
1139,1,1,Occurrence #,1st primary
1139,1,1,Tumor Stage,T2
1139,1,1,Research lab p16,p16 unknown
1139,1,1,Metastasis,M0
1139,1,1,Second Failure Type,no known failure
1139,1,1,Status,Alive unk disease
1139,1,1,Clinical lab p16,p16 unknown
1139,1,1,Nodal Stage,N1
1140,1,1,Tumor Stage,T4a
1140,1,1,Second Failure Type,no known failure
1140,1,1,Research lab p16,p16 unknown
1140,1,1,Metastasis,M0
1140,1,1,First Failure Type,no known failure
1140,1,1,Tumor Site,oral cavity
1140,1,1,Radiation Dosage,unknown
1140,1,1,Overall Stage,IVa
1140,1,1,Nodal Stage,N0
1140,1,1,Occurrence #,1st primary
1140,1,1,Status,Alive w/o disease
1140,1,1,Clinical lab p16,p16 unknown
1140,1,1,Research lab HPV,HPV unknown
1140,1,1,Treatment Modality,Sx & RT
1141,1,1,Tumor Stage,T1
1141,1,1,Research lab p16,p16 unknown
1141,1,1,Second Failure Type,no known failure
1141,1,1,Metastasis,M0
1141,1,1,Clinical lab p16,p16 unknown
1141,1,1,Status,Alive w/ disease
1141,1,1,Nodal Stage,N0
1141,1,1,Treatment Modality,Sx
1141,1,1,Research lab HPV,HPV unknown
1141,1,1,Tumor Site,oral cavity
1141,1,1,Occurrence #,recurrence
1141,1,1,First Failure Type,locoregional
1141,1,1,Time to First Failure,0.5
1141,1,1,Overall Stage,I
1142,1,1,Occurrence #,1st primary
1142,1,1,Second Failure Type,no known failure
1142,1,1,Treatment Modality,Sx
1142,1,1,Research lab p16,p16 unknown
1142,1,1,Metastasis,M0
1142,1,1,Status,Alive w/o disease
1142,1,1,Clinical lab p16,p16 unknown
1142,1,1,Nodal Stage,N0
1142,1,1,Research lab HPV,HPV unknown
1142,1,1,Tumor Site,oral cavity
1142,1,1,First Failure Type,no known failure
1142,1,1,Tumor Stage,T4a
1142,1,1,Overall Stage,IVa
1143,1,1,Occurrence #,1st primary
1143,1,1,Clinical lab p16,p16 unknown
1143,1,1,First Failure Type,no known failure
1143,1,1,Second Failure Type,no known failure
1143,1,1,Status,Alive unk disease
1143,1,1,Overall Stage,I
1143,1,1,Research lab HPV,HPV unknown
1143,1,1,Research lab p16,p16 unknown
1143,1,1,Tumor Site,oral cavity
1143,1,1,Metastasis,M0
1143,1,1,Nodal Stage,N0
1143,1,1,Treatment Modality,Sx
1143,1,1,Tumor Stage,T1
1144,1,1,Overall Stage,IVa
1144,1,1,Research lab HPV,HPV unknown
1144,1,1,Tumor Site,oral cavity
1144,1,1,First Failure Type,no known failure
1144,1,1,Clinical lab p16,p16 unknown
1144,1,1,Nodal Stage,N2
1144,1,1,Metastasis,M0
1144,1,1,Research lab p16,p16 unknown
1144,1,1,Tumor Stage,T4a
1144,1,1,Treatment Modality,Sx
1144,1,1,Status,Alive unk disease
1144,1,1,Occurrence #,1st primary
1144,1,1,Second Failure Type,no known failure
1145,1,1,Treatment Modality,Sx
1145,1,1,First Failure Type,no known failure
1145,1,1,Clinical lab p16,p16 unknown
1145,1,1,Metastasis,M0
1145,1,1,Research lab p16,p16 unknown
1145,1,1,Tumor Stage,T3
1145,1,1,Overall Stage,IVa
1145,1,1,Date of Death,2006-07-19 00:00:00
1145,1,1,Status,Dead unk disease
1145,1,1,Time to Death,0.9
1145,1,1,Occurrence #,1st primary
1145,1,1,Nodal Stage,N2
1145,1,1,Tumor Site,oral cavity
1145,1,1,Second Failure Type,no known failure
1145,1,1,Research lab HPV,HPV unknown
1145,1,1,Age at Death,76.9
1146,1,1,Nodal Stage,N2
1146,1,1,Occurrence #,1st primary
1146,1,1,Second Failure Type,no known failure
1146,1,1,Metastasis,M0
1146,1,1,Tumor Stage,T4a
1146,1,1,First Failure Type,no known failure
1146,1,1,Research lab HPV,HPV unknown
1146,1,1,Radiation Dosage,70.2
1146,1,1,Tumor Site,oral cavity
1146,1,1,Overall Stage,IVa
1146,1,1,Initial Chemotherapy Agent,carbo/PTX
1146,1,1,Clinical lab p16,p16 unknown
1146,1,1,Treatment Modality,CTX-RT
1146,1,1,Status,Alive w/o disease
1146,1,1,Research lab p16,p16 unknown
1147,1,1,Clinical lab p16,p16 unknown
1147,1,1,Second Failure Type,no known failure
1147,1,1,Tumor Site,oral cavity
1147,1,1,First Failure Type,no known failure
1147,1,1,Treatment Modality,Sx
1147,1,1,Status,Dead w/ disease
1147,1,1,Research lab p16,p16 unknown
1147,1,1,Research lab HPV,HPV unknown
1147,1,1,Overall Stage,IVa
1147,1,1,Occurrence #,1st primary
1147,1,1,Metastasis,M0
1147,1,1,Tumor Stage,T4a
1147,1,1,Nodal Stage,N2
1148,1,1,Date of Death,2005-10-14 00:00:00
1148,1,1,Metastasis,M0
1148,1,1,Research lab p16,p16 unknown
1148,1,1,Tumor Site,oral cavity
1148,1,1,Overall Stage,II
1148,1,1,Treatment Modality,Sx
1148,1,1,Research lab HPV,HPV unknown
1148,1,1,Age at Death,48.9
1148,1,1,Tumor Stage,T2
1148,1,1,Second Failure Type,no known failure
1148,1,1,Occurrence #,1st primary
1148,1,1,Clinical lab p16,p16 unknown
1148,1,1,Nodal Stage,N0
1148,1,1,Status,Dead w/o disease
1148,1,1,Time to Death,5.4
1148,1,1,First Failure Type,no known failure
1149,1,1,Time to First Failure,0.7
1149,1,1,Occurrence #,recurrence
1149,1,1,Nodal Stage,N0
1149,1,1,Age at Death,81.6
1149,1,1,Treatment Modality,Sx
1149,1,1,Metastasis,M0
1149,1,1,Overall Stage,III
1149,1,1,Research lab p16,p16 unknown
1149,1,1,Research lab HPV,HPV unknown
1149,1,1,Status,Dead unk disease
1149,1,1,Time to Death,0.8
1149,1,1,Tumor Site,oral cavity
1149,1,1,First Failure Type,locoregional
1149,1,1,Second Failure Type,no known failure
1149,1,1,Clinical lab p16,p16 unknown
1149,1,1,Tumor Stage,T3
1149,1,1,Date of Death,2005-02-17 00:00:00
1150,1,1,Research lab HPV,HPV unknown
1150,1,1,Treatment Modality,Sx
1150,1,1,Tumor Site,oral cavity
1150,1,1,Metastasis,M0
1150,1,1,Overall Stage,I
1150,1,1,Clinical lab p16,p16 unknown
1150,1,1,Status,Alive w/o disease
1150,1,1,Tumor Stage,T1
1150,1,1,Research lab p16,p16 unknown
1150,1,1,Occurrence #,1st primary
1150,1,1,Second Failure Type,no known failure
1150,1,1,First Failure Type,no known failure
1150,1,1,Nodal Stage,N0
1151,1,1,Tumor Site,oral cavity
1151,1,1,Age at Death,55.6
1151,1,1,Second Failure Type,no known failure
1151,1,1,Overall Stage,II
1151,1,1,Metastasis,M0
1151,1,1,Research lab p16,p16 unknown
1151,1,1,Time to Death,0.8
1151,1,1,Nodal Stage,N0
1151,1,1,Tumor Stage,T2
1151,1,1,Date of Death,2009-08-23 00:00:00
1151,1,1,First Failure Type,no known failure
1151,1,1,Clinical lab p16,p16 unknown
1151,1,1,Status,Dead unk disease
1151,1,1,Research lab HPV,HPV unknown
1151,1,1,Occurrence #,1st primary
1151,1,1,Treatment Modality,Sx
1152,1,1,Clinical lab p16,p16 unknown
1152,1,1,Metastasis,M0
1152,1,1,Tumor Site,oral cavity
1152,1,1,Treatment Modality,Sx
1152,1,1,Tumor Stage,T1
1152,1,1,Second Failure Type,no known failure
1152,1,1,First Failure Type,no known failure
1152,1,1,Status,Alive unk disease
1152,1,1,Research lab HPV,HPV unknown
1152,1,1,Research lab p16,p16 unknown
1152,1,1,Overall Stage,III
1152,1,1,Nodal Stage,N1
1152,1,1,Occurrence #,1st primary
1153,1,1,Second Failure Type,no known failure
1153,1,1,First Failure Type,no known failure
1153,1,1,Date of Death,2001-01-26 00:00:00
1153,1,1,Nodal Stage,N2
1153,1,1,Status,Dead unk disease
1153,1,1,Tumor Stage,T4a
1153,1,1,Occurrence #,1st primary
1153,1,1,Time to Death,0.6
1153,1,1,Tumor Site,oral cavity
1153,1,1,Clinical lab p16,p16 unknown
1153,1,1,Research lab p16,p16 unknown
1153,1,1,Age at Death,51.3
1153,1,1,Overall Stage,IVa
1153,1,1,Radiation Dosage,59.4
1153,1,1,Metastasis,M0
1153,1,1,Treatment Modality,Sx & RT
1153,1,1,Research lab HPV,HPV unknown
1154,1,1,Tumor Stage,T2
1154,1,1,Treatment Modality,Sx & CTX-RT
1154,1,1,Overall Stage,IVa
1154,1,1,Clinical lab p16,p16 unknown
1154,1,1,Metastasis,M0
1154,1,1,Research lab HPV,HPV unknown
1154,1,1,Occurrence #,1st primary
1154,1,1,First Failure Type,no known failure
1154,1,1,Second Failure Type,no known failure
1154,1,1,Status,Alive w/o disease
1154,1,1,Tumor Site,oral cavity
1154,1,1,Radiation Dosage,unknown
1154,1,1,Research lab p16,p16 unknown
1154,1,1,Nodal Stage,N2
1154,1,1,Initial Chemotherapy Agent,unknown
1155,1,1,Treatment Modality,Sx
1155,1,1,Tumor Site,oral cavity
1155,1,1,Clinical lab p16,p16 unknown
1155,1,1,First Failure Type,no known failure
1155,1,1,Metastasis,M0
1155,1,1,Overall Stage,I
1155,1,1,Second Failure Type,no known failure
1155,1,1,Occurrence #,1st primary
1155,1,1,Research lab HPV,HPV unknown
1155,1,1,Research lab p16,p16 unknown
1155,1,1,Tumor Stage,T1
1155,1,1,Status,Alive unk disease
1155,1,1,Nodal Stage,N0
1156,1,1,Research lab HPV,HPV unknown
1156,1,1,Overall Stage,IVa
1156,1,1,Time to First Failure,0.0
1156,1,1,Occurrence #,recurrence
1156,1,1,Research lab p16,p16 unknown
1156,1,1,Tumor Site,oral cavity
1156,1,1,Time to Death,0.8
1156,1,1,Treatment Modality,Sx & RT
1156,1,1,Second Failure Type,no known failure
1156,1,1,Metastasis,M0
1156,1,1,Date of Death,2004-02-28 00:00:00
1156,1,1,First Failure Type,locoregional
1156,1,1,Clinical lab p16,p16 unknown
1156,1,1,Tumor Stage,T4a
1156,1,1,Nodal Stage,N2
1156,1,1,Status,Dead w/ disease
1156,1,1,Age at Death,64.1
1156,1,1,Radiation Dosage,unknown
1157,1,1,Tumor Site,oral cavity
1157,1,1,Tumor Stage,T2
1157,1,1,Status,Alive w/ disease
1157,1,1,Research lab HPV,HPV unknown
1157,1,1,Research lab p16,p16 unknown
1157,1,1,Occurrence #,1st primary
1157,1,1,Nodal Stage,N0
1157,1,1,Overall Stage,II
1157,1,1,Second Failure Type,no known failure
1157,1,1,Metastasis,M0
1157,1,1,Treatment Modality,Sx
1157,1,1,First Failure Type,no known failure
1157,1,1,Clinical lab p16,p16 unknown
1158,1,1,Time to First Failure,1.1
1158,1,1,Research lab HPV,HPV unknown
1158,1,1,First Failure Type,locoregional
1158,1,1,Occurrence #,1st primary
1158,1,1,Nodal Stage,N2
1158,1,1,Age at Death,65.3
1158,1,1,Overall Stage,IVa
1158,1,1,Initial Chemotherapy Agent,unknown
1158,1,1,Radiation Dosage,unknown
1158,1,1,Clinical lab p16,p16 unknown
1158,1,1,Metastasis,M0
1158,1,1,Second Failure Type,no known failure
1158,1,1,Date of Death,2011-11-02 00:00:00
1158,1,1,Tumor Site,oral cavity
1158,1,1,Tumor Stage,T4a
1158,1,1,Treatment Modality,Sx & CTX-RT
1158,1,1,Time to Death,1.9
1158,1,1,Research lab p16,p16 unknown
1158,1,1,Status,Dead w/ disease
1159,1,1,Overall Stage,I
1159,1,1,Tumor Site,oral cavity
1159,1,1,Metastasis,M0
1159,1,1,Research lab HPV,HPV unknown
1159,1,1,Nodal Stage,N0
1159,1,1,Tumor Stage,T1
1159,1,1,Status,Alive w/o disease
1159,1,1,Research lab p16,p16 unknown
1159,1,1,Occurrence #,1st primary
1159,1,1,First Failure Type,no known failure
1159,1,1,Clinical lab p16,p16 unknown
1159,1,1,Second Failure Type,no known failure
1159,1,1,Treatment Modality,Sx
1160,1,1,Second Failure Type,no known failure
1160,1,1,First Failure Type,no known failure
1160,1,1,Nodal Stage,N0
1160,1,1,Research lab HPV,HPV unknown
1160,1,1,Clinical lab p16,p16 unknown
1160,1,1,Occurrence #,1st primary
1160,1,1,Research lab p16,p16 unknown
1160,1,1,Status,Alive unk disease
1160,1,1,Metastasis,M0
1160,1,1,Tumor Stage,T4a
1160,1,1,Overall Stage,IVa
1160,1,1,Tumor Site,oral cavity
1160,1,1,Treatment Modality,Sx
1161,1,1,Time to Death,5.5
1161,1,1,First Failure Type,no known failure
1161,1,1,Age at Death,91.5
1161,1,1,Nodal Stage,N1
1161,1,1,Metastasis,M0
1161,1,1,Status,Dead unk disease
1161,1,1,Overall Stage,IVa
1161,1,1,Second Failure Type,no known failure
1161,1,1,Research lab HPV,HPV unknown
1161,1,1,Treatment Modality,Sx
1161,1,1,Date of Death,2010-05-23 00:00:00
1161,1,1,Clinical lab p16,p16 unknown
1161,1,1,Occurrence #,1st primary
1161,1,1,Tumor Site,oral cavity
1161,1,1,Research lab p16,p16 unknown
1161,1,1,Tumor Stage,T4a
1162,1,1,First Failure Treatment Modality,Sx
1162,1,1,Research lab p16,p16 unknown
1162,1,1,Time to First Failure,0.5
1162,1,1,Metastasis,M0
1162,1,1,Nodal Stage,N0
1162,1,1,Tumor Stage,T1
1162,1,1,First Failure Site,oral cavity
1162,1,1,Overall Stage,I
1162,1,1,Occurrence #,1st primary
1162,1,1,Status,Dead unk disease
1162,1,1,Clinical lab p16,p16 unknown
1162,1,1,Treatment Modality,Sx
1162,1,1,Time to Death,1.0
1162,1,1,First Failure Type,locoregional
1162,1,1,Second Failure Type,no known failure
1162,1,1,Research lab HPV,HPV unknown
1162,1,1,Tumor Site,oral cavity
1162,1,1,Age at Death,59.6
1162,1,1,Date of Death,2008-03-08 00:00:00
1163,1,1,Nodal Stage,N2
1163,1,1,Age at Death,51.1
1163,1,1,Date of Death,2011-07-06 00:00:00
1163,1,1,Metastasis,M0
1163,1,1,Overall Stage,IVa
1163,1,1,Clinical lab p16,p16 unknown
1163,1,1,Second Failure Type,no known failure
1163,1,1,Status,Dead unk disease
1163,1,1,Treatment Modality,Sx & RT
1163,1,1,Radiation Dosage,unknown
1163,1,1,Tumor Stage,T2
1163,1,1,Research lab p16,p16 unknown
1163,1,1,Time to Death,1.6
1163,1,1,Research lab HPV,HPV unknown
1163,1,1,Occurrence #,1st primary
1163,1,1,Tumor Site,oropharynx
1163,1,1,First Failure Type,locoregional
1163,1,1,Time to First Failure,0.5
1164,1,1,Occurrence #,1st primary
1164,1,1,First Failure Type,no known failure
1164,1,1,Status,Alive w/o disease
1164,1,1,Treatment Modality,Sx
1164,1,1,Overall Stage,I
1164,1,1,Second Failure Type,no known failure
1164,1,1,Research lab HPV,HPV unknown
1164,1,1,Clinical lab p16,p16 unknown
1164,1,1,Nodal Stage,N0
1164,1,1,Metastasis,M0
1164,1,1,Research lab p16,p16 unknown
1164,1,1,Tumor Stage,T1
1164,1,1,Tumor Site,oropharynx
1165,1,1,Age at Death,47.8
1165,1,1,Tumor Stage,T1
1165,1,1,Date of Death,2009-03-08 00:00:00
1165,1,1,Occurrence #,other primary
1165,1,1,Status,Dead w/ disease
1165,1,1,Tumor Site,oropharynx
1165,1,1,Treatment Modality,CTX-RT
1165,1,1,Nodal Stage,N3
1165,1,1,Research lab HPV,HPV unknown
1165,1,1,Initial Chemotherapy Agent,cis/PTX
1165,1,1,Research lab p16,p16 unknown
1165,1,1,Clinical lab p16,p16 unknown
1165,1,1,Second Failure Type,no known failure
1165,1,1,Radiation Dosage,61.6
1165,1,1,First Failure Type,no known failure
1165,1,1,Metastasis,M0
1165,1,1,Overall Stage,IVb
1165,1,1,Time to Death,0.6
1165,1,1,Second Line Chemotherapy Agent,cis/5-FU
1166,1,1,Nodal Stage,N2
1166,1,1,Date of Death,2011-03-05 00:00:00
1166,1,1,First Failure Type,no known failure
1166,1,1,Status,Dead unk disease
1166,1,1,Tumor Stage,T2
1166,1,1,Clinical lab p16,p16 unknown
1166,1,1,Overall Stage,IVa
1166,1,1,Tumor Site,oropharynx
1166,1,1,Metastasis,M0
1166,1,1,Second Failure Type,no known failure
1166,1,1,Occurrence #,recurrence
1166,1,1,Time to Death,0.8
1166,1,1,Age at Death,59.6
1166,1,1,Research lab HPV,HPV unknown
1166,1,1,Treatment Modality,Sx
1166,1,1,Research lab p16,p16 unknown
1167,1,1,Second Failure Type,no known failure
1167,1,1,Treatment Modality,CTX-RT
1167,1,1,Tumor Site,oropharynx
1167,1,1,Tumor Stage,T3
1167,1,1,Second Line Chemotherapy Agent,carbo
1167,1,1,Occurrence #,1st primary
1167,1,1,Initial Chemotherapy Agent,cis
1167,1,1,Radiation Dosage,70.2
1167,1,1,Research lab p16,p16 unknown
1167,1,1,First Failure Type,no known failure
1167,1,1,Nodal Stage,N2
1167,1,1,Clinical lab p16,p16 unknown
1167,1,1,Overall Stage,IVa
1167,1,1,Metastasis,M0
1167,1,1,Status,Alive w/ disease
1167,1,1,Research lab HPV,HPV unknown
1168,1,1,Occurrence #,1st primary
1168,1,1,Nodal Stage,Unknown
1168,1,1,Treatment Modality,Unknown
1168,1,1,Clinical lab p16,p16 unknown
1168,1,1,Metastasis,Unknown
1168,1,1,Tumor Stage,Unknown
1168,1,1,First Failure Type,no known failure
1168,1,1,Status,Alive unk disease
1168,1,1,Second Failure Type,no known failure
1168,1,1,Overall Stage,Unknown
1168,1,1,Research lab p16,p16 unknown
1168,1,1,Research lab HPV,HPV unknown
1168,1,1,Tumor Site,oropharynx
1169,1,1,Status,Alive unk disease
1169,1,1,Occurrence #,1st primary
1169,1,1,Tumor Stage,T4a
1169,1,1,Tumor Site,oropharynx
1169,1,1,Research lab p16,p16 unknown
1169,1,1,Second Failure Type,no known failure
1169,1,1,Overall Stage,IVa
1169,1,1,Clinical lab p16,p16 unknown
1169,1,1,Metastasis,M0
1169,1,1,Research lab HPV,HPV unknown
1169,1,1,First Failure Type,no known failure
1169,1,1,Nodal Stage,N2
1169,1,1,Treatment Modality,Unknown
1170,1,1,Overall Stage,III
1170,1,1,Tumor Site,oropharynx
1170,1,1,Tumor Stage,Unknown
1170,1,1,Initial Chemotherapy Agent,unknown
1170,1,1,First Failure Type,no known failure
1170,1,1,Occurrence #,1st primary
1170,1,1,Second Failure Type,no known failure
1170,1,1,Research lab p16,p16 unknown
1170,1,1,Research lab HPV,HPV unknown
1170,1,1,Treatment Modality,CTX-RT
1170,1,1,Metastasis,M0
1170,1,1,Radiation Dosage,unknown
1170,1,1,Clinical lab p16,p16 unknown
1170,1,1,Nodal Stage,Unknown
1170,1,1,Status,Alive w/o disease
1171,1,1,Radiation Dosage,70.2
1171,1,1,Tumor Site,oropharynx
1171,1,1,Occurrence #,1st primary
1171,1,1,Second Failure Type,no known failure
1171,1,1,Tumor Stage,T2
1171,1,1,Research lab p16,p16 unknown
1171,1,1,Status,Alive w/o disease
1171,1,1,Metastasis,M0
1171,1,1,Nodal Stage,N1
1171,1,1,Clinical lab p16,p16 unknown
1171,1,1,First Failure Type,no known failure
1171,1,1,Initial Chemotherapy Agent,cis
1171,1,1,Treatment Modality,CTX-RT
1171,1,1,Research lab HPV,HPV positive
1171,1,1,Overall Stage,III
1172,1,1,Research lab HPV,HPV unknown
1172,1,1,Research lab p16,p16 unknown
1172,1,1,Overall Stage,III
1172,1,1,Tumor Site,oropharynx
1172,1,1,Nodal Stage,N0
1172,1,1,Radiation Dosage,unknown
1172,1,1,Second Failure Type,no known failure
1172,1,1,Initial Chemotherapy Agent,unknown
1172,1,1,Tumor Stage,T3
1172,1,1,Time to First Failure,0.5
1172,1,1,Treatment Modality,Sx & CTX-RT
1172,1,1,Clinical lab p16,p16 unknown
1172,1,1,Metastasis,M0
1172,1,1,First Failure Type,locoregional
1172,1,1,Occurrence #,1st primary
1172,1,1,Status,Dead w/o disease
1174,1,1,Treatment Modality,Sx & RT
1174,1,1,Clinical lab p16,p16 unknown
1174,1,1,Occurrence #,other primary
1174,1,1,Second Failure Type,no known failure
1174,1,1,Overall Stage,II
1174,1,1,Research lab p16,p16 unknown
1174,1,1,Tumor Site,oropharynx
1174,1,1,Radiation Dosage,63
1174,1,1,Research lab HPV,HPV unknown
1174,1,1,Metastasis,M0
1174,1,1,First Failure Type,no known failure
1174,1,1,Status,Alive unk disease
1174,1,1,Tumor Stage,T2
1174,1,1,Nodal Stage,N0
1175,1,1,Clinical lab p16,p16 unknown
1175,1,1,Radiation Dosage,70.2
1175,1,1,Tumor Site,oropharynx
1175,1,1,Metastasis,M0
1175,1,1,Research lab HPV,HPV unknown
1175,1,1,Treatment Modality,CTX-RT
1175,1,1,Overall Stage,IVa
1175,1,1,First Failure Type,no known failure
1175,1,1,Research lab p16,p16 unknown
1175,1,1,Initial Chemotherapy Agent,carbo
1175,1,1,Status,Alive w/o disease
1175,1,1,Occurrence #,1st primary
1175,1,1,Tumor Stage,T2
1175,1,1,Second Failure Type,no known failure
1175,1,1,Nodal Stage,N2
1176,1,1,Tumor Site,oropharynx
1176,1,1,Treatment Modality,Sx & CTX-RT
1176,1,1,Research lab HPV,HPV unknown
1176,1,1,Time to Death,1.0
1176,1,1,Initial Chemotherapy Agent,carbo/PTX
1176,1,1,Research lab p16,p16 unknown
1176,1,1,Tumor Stage,T2
1176,1,1,Age at Death,63.2
1176,1,1,Radiation Dosage,unknown
1176,1,1,Date of Death,2002-05-26 00:00:00
1176,1,1,First Failure Type,no known failure
1176,1,1,Metastasis,M0
1176,1,1,Occurrence #,recurrence
1176,1,1,Nodal Stage,N0
1176,1,1,Overall Stage,II
1176,1,1,Clinical lab p16,p16 unknown
1176,1,1,Status,Dead w/ disease
1176,1,1,Second Failure Type,no known failure
1177,1,1,Metastasis,Unknown
1177,1,1,Clinical lab p16,p16 unknown
1177,1,1,Nodal Stage,Unknown
1177,1,1,Treatment Modality,Unknown
1177,1,1,Research lab p16,p16 unknown
1177,1,1,Second Failure Type,no known failure
1177,1,1,Tumor Stage,Unknown
1177,1,1,Tumor Site,oropharynx
1177,1,1,Occurrence #,recurrence
1177,1,1,Overall Stage,Unknown
1177,1,1,First Failure Type,no known failure
1177,1,1,Research lab HPV,HPV unknown
1177,1,1,Status,Alive w/ disease
1178,1,1,Second Failure Type,no known failure
1178,1,1,Research lab p16,p16 unknown
1178,1,1,First Failure Type,no known failure
1178,1,1,Metastasis,M0
1178,1,1,Radiation Dosage,64
1178,1,1,Occurrence #,1st primary
1178,1,1,Clinical lab p16,p16 positive
1178,1,1,Tumor Stage,T1
1178,1,1,Research lab HPV,HPV positive
1178,1,1,Overall Stage,III
1178,1,1,Status,Alive w/o disease
1178,1,1,Tumor Site,oropharynx
1178,1,1,Nodal Stage,N1
1178,1,1,Treatment Modality,Sx & RT
1179,1,1,Occurrence #,1st primary
1179,1,1,Tumor Stage,T1
1179,1,1,Research lab p16,p16 unknown
1179,1,1,Tumor Site,oropharynx
1179,1,1,Research lab HPV,HPV unknown
1179,1,1,Overall Stage,I
1179,1,1,Clinical lab p16,p16 unknown
1179,1,1,First Failure Type,no known failure
1179,1,1,Second Failure Type,no known failure
1179,1,1,Nodal Stage,N0
1179,1,1,Treatment Modality,RT
1179,1,1,Radiation Dosage,66
1179,1,1,Metastasis,M0
1179,1,1,Status,Alive w/o disease
1180,1,1,Second Failure Type,no known failure
1180,1,1,First Failure Type,no known failure
1180,1,1,Time to Death,2.4
1180,1,1,Treatment Modality,RT
1180,1,1,Occurrence #,1st primary
1180,1,1,Status,Dead unk disease
1180,1,1,Research lab HPV,HPV unknown
1180,1,1,Nodal Stage,N0
1180,1,1,Metastasis,M0
1180,1,1,Age at Death,72.6
1180,1,1,Tumor Stage,T2
1180,1,1,Radiation Dosage,66.6
1180,1,1,Overall Stage,II
1180,1,1,Tumor Site,oropharynx
1180,1,1,Clinical lab p16,p16 unknown
1180,1,1,Date of Death,2005-01-27 00:00:00
1180,1,1,Research lab p16,p16 unknown
1181,1,1,Date of Death,2008-04-03 00:00:00
1181,1,1,First Failure Type,no known failure
1181,1,1,Nodal Stage,N2
1181,1,1,Second Failure Type,no known failure
1181,1,1,Tumor Site,oropharynx
1181,1,1,Overall Stage,IVa
1181,1,1,Time to Death,0.8
1181,1,1,Treatment Modality,Unknown
1181,1,1,Clinical lab p16,p16 unknown
1181,1,1,Age at Death,55.6
1181,1,1,Metastasis,M0
1181,1,1,Research lab p16,p16 unknown
1181,1,1,Tumor Stage,T3
1181,1,1,Occurrence #,1st primary
1181,1,1,Research lab HPV,HPV unknown
1181,1,1,Status,Dead unk disease
1182,1,1,Tumor Stage,T2
1182,1,1,Status,Dead unk disease
1182,1,1,Treatment Modality,Sx
1182,1,1,Research lab p16,p16 unknown
1182,1,1,Date of Death,2009-10-18 00:00:00
1182,1,1,Age at Death,62.6
1182,1,1,Occurrence #,other primary
1182,1,1,Time to Death,0.3
1182,1,1,Clinical lab p16,p16 unknown
1182,1,1,Second Failure Type,no known failure
1182,1,1,Research lab HPV,HPV unknown
1182,1,1,Tumor Site,oropharynx
1182,1,1,First Failure Type,no known failure
1182,1,1,Metastasis,M0
1182,1,1,Nodal Stage,N0
1182,1,1,Overall Stage,II
1183,1,1,Second Failure Type,no known failure
1183,1,1,Treatment Modality,Unknown
1183,1,1,Clinical lab p16,p16 unknown
1183,1,1,Status,Alive unk disease
1183,1,1,Research lab p16,p16 unknown
1183,1,1,Nodal Stage,N2
1183,1,1,First Failure Type,no known failure
1183,1,1,Research lab HPV,HPV positive
1183,1,1,Tumor Site,oropharynx
1183,1,1,Tumor Stage,T2
1183,1,1,Overall Stage,IVa
1183,1,1,Metastasis,M0
1183,1,1,Occurrence #,1st primary
1184,1,1,Research lab p16,p16 unknown
1184,1,1,First Failure Type,no known failure
1184,1,1,Radiation Dosage,34.2
1184,1,1,Treatment Modality,CTX-RT
1184,1,1,Second Failure Type,no known failure
1184,1,1,Clinical lab p16,p16 unknown
1184,1,1,Tumor Stage,T4a
1184,1,1,Research lab HPV,HPV unknown
1184,1,1,Overall Stage,IVa
1184,1,1,Metastasis,M0
1184,1,1,Occurrence #,1st primary
1184,1,1,Nodal Stage,N2
1184,1,1,Status,Dead w/ disease
1184,1,1,Initial Chemotherapy Agent,unknown
1184,1,1,Age at Death,72.7
1184,1,1,Date of Death,2009-12-29 00:00:00
1184,1,1,Tumor Site,oropharynx
1184,1,1,Time to Death,0.2
1185,1,1,Treatment Modality,Sx
1185,1,1,Second Failure Type,no known failure
1185,1,1,Tumor Stage,T1
1185,1,1,Overall Stage,I
1185,1,1,Tumor Site,oropharynx
1185,1,1,Metastasis,M0
1185,1,1,Occurrence #,other primary
1185,1,1,Nodal Stage,N0
1185,1,1,Research lab HPV,HPV unknown
1185,1,1,Status,Alive unk disease
1185,1,1,Clinical lab p16,p16 unknown
1185,1,1,First Failure Type,no known failure
1185,1,1,Research lab p16,p16 unknown
1186,1,1,Tumor Stage,T1
1186,1,1,Clinical lab p16,p16 unknown
1186,1,1,Research lab p16,p16 unknown
1186,1,1,Research lab HPV,HPV unknown
1186,1,1,Overall Stage,I
1186,1,1,Treatment Modality,Sx
1186,1,1,Metastasis,M0
1186,1,1,Tumor Site,oral cavity
1186,1,1,Occurrence #,1st primary
1186,1,1,Nodal Stage,N0
1186,1,1,Status,Alive unk disease
1186,1,1,First Failure Type,no known failure
1186,1,1,Second Failure Type,no known failure
1187,1,1,Research lab p16,p16 unknown
1187,1,1,Status,Alive w/o disease
1187,1,1,Tumor Stage,T2
1187,1,1,Overall Stage,IVa
1187,1,1,Metastasis,M0
1187,1,1,Occurrence #,1st primary
1187,1,1,Nodal Stage,N2
1187,1,1,Initial Chemotherapy Agent,cis
1187,1,1,Clinical lab p16,p16 unknown
1187,1,1,Research lab HPV,HPV unknown
1187,1,1,Treatment Modality,CTX-RT
1187,1,1,Radiation Dosage,70.2
1187,1,1,First Failure Type,no known failure
1187,1,1,Second Failure Type,no known failure
1187,1,1,Tumor Site,oropharynx
1188,1,1,Tumor Stage,T2
1188,1,1,Second Failure Type,no known failure
1188,1,1,Tumor Site,oropharynx
1188,1,1,Radiation Dosage,70.2
1188,1,1,Metastasis,M0
1188,1,1,Clinical lab p16,p16 unknown
1188,1,1,Research lab p16,p16 unknown
1188,1,1,Status,Alive w/o disease
1188,1,1,First Failure Type,no known failure
1188,1,1,Research lab HPV,HPV unknown
1188,1,1,Nodal Stage,N2
1188,1,1,Initial Chemotherapy Agent,cis
1188,1,1,Occurrence #,1st primary
1188,1,1,Treatment Modality,CTX-RT
1188,1,1,Overall Stage,IVa
1189,1,1,Overall Stage,III
1189,1,1,Tumor Site,oropharynx
1189,1,1,Status,Alive w/o disease
1189,1,1,Second Failure Type,no known failure
1189,1,1,Initial Chemotherapy Agent,cis
1189,1,1,Metastasis,M0
1189,1,1,Occurrence #,1st primary
1189,1,1,First Failure Type,no known failure
1189,1,1,Nodal Stage,N1
1189,1,1,Treatment Modality,CTX-RT
1189,1,1,Clinical lab p16,p16 unknown
1189,1,1,Research lab p16,p16 unknown
1189,1,1,Research lab HPV,HPV unknown
1189,1,1,Radiation Dosage,70.2
1189,1,1,Tumor Stage,T2
1190,1,1,Research lab p16,p16 unknown
1190,1,1,Age at Death,49.3
1190,1,1,Date of Death,2010-12-29 00:00:00
1190,1,1,Nodal Stage,N1
1190,1,1,Metastasis,M0
1190,1,1,Tumor Stage,T3
1190,1,1,Second Failure Type,no known failure
1190,1,1,Overall Stage,III
1190,1,1,Research lab HPV,HPV unknown
1190,1,1,Occurrence #,1st primary
1190,1,1,Tumor Site,oropharynx
1190,1,1,Treatment Modality,CTX-RT
1190,1,1,Initial Chemotherapy Agent,carbo
1190,1,1,First Failure Type,no known failure
1190,1,1,Time to Death,1.0
1190,1,1,Radiation Dosage,unknown
1190,1,1,Status,Dead w/ disease
1190,1,1,Clinical lab p16,p16 unknown
1191,1,1,Tumor Site,oropharynx
1191,1,1,Tumor Stage,T1
1191,1,1,Research lab HPV,HPV unknown
1191,1,1,Clinical lab p16,p16 unknown
1191,1,1,Second Failure Type,no known failure
1191,1,1,Treatment Modality,CTX-RT
1191,1,1,Research lab p16,p16 unknown
1191,1,1,Initial Chemotherapy Agent,carbo/PTX
1191,1,1,Radiation Dosage,72
1191,1,1,Metastasis,M0
1191,1,1,First Failure Type,no known failure
1191,1,1,Nodal Stage,N2
1191,1,1,Status,Alive w/o disease
1191,1,1,Occurrence #,recurrence
1191,1,1,Overall Stage,IVa
1192,1,1,Tumor Stage,T4a
1192,1,1,Clinical lab p16,p16 unknown
1192,1,1,Metastasis,M0
1192,1,1,First Failure Type,locoregional
1192,1,1,Tumor Site,oral cavity
1192,1,1,Nodal Stage,N0
1192,1,1,Second Failure Type,no known failure
1192,1,1,Treatment Modality,Sx
1192,1,1,Research lab p16,p16 unknown
1192,1,1,Overall Stage,IVa
1192,1,1,Research lab HPV,HPV unknown
1192,1,1,Time to First Failure,0.5
1192,1,1,Occurrence #,recurrence
1192,1,1,Status,Dead w/ disease
1193,1,1,Overall Stage,IVa
1193,1,1,First Failure Type,no known failure
1193,1,1,Status,Alive w/o disease
1193,1,1,Nodal Stage,N2
1193,1,1,Tumor Site,oropharynx
1193,1,1,Second Failure Type,no known failure
1193,1,1,Treatment Modality,CTX-RT
1193,1,1,Research lab p16,p16 unknown
1193,1,1,Metastasis,M0
1193,1,1,Initial Chemotherapy Agent,cis
1193,1,1,Tumor Stage,T1
1193,1,1,Radiation Dosage,70.2
1193,1,1,Research lab HPV,HPV positive
1193,1,1,Clinical lab p16,p16 unknown
1193,1,1,Occurrence #,1st primary
1194,1,1,Clinical lab p16,p16 unknown
1194,1,1,Initial Chemotherapy Agent,cis
1194,1,1,First Failure Type,no known failure
1194,1,1,Overall Stage,IVb
1194,1,1,Tumor Stage,T1
1194,1,1,Radiation Dosage,70.2
1194,1,1,Research lab p16,p16 unknown
1194,1,1,Treatment Modality,CTX-RT
1194,1,1,Research lab HPV,HPV unknown
1194,1,1,Nodal Stage,N3
1194,1,1,Occurrence #,1st primary
1194,1,1,Status,Alive unk disease
1194,1,1,Metastasis,M0
1194,1,1,Second Failure Type,no known failure
1194,1,1,Tumor Site,oropharynx
1195,1,1,Overall Stage,Unknown
1195,1,1,Nodal Stage,Unknown
1195,1,1,Research lab HPV,HPV unknown
1195,1,1,Age at Death,75.9
1195,1,1,Clinical lab p16,p16 unknown
1195,1,1,Status,Dead unk disease
1195,1,1,Tumor Site,oropharynx
1195,1,1,Tumor Stage,Unknown
1195,1,1,First Failure Type,no known failure
1195,1,1,Date of Death,2008-04-12 00:00:00
1195,1,1,Metastasis,Unknown
1195,1,1,Time to Death,0.4
1195,1,1,Occurrence #,1st primary
1195,1,1,Second Failure Type,no known failure
1195,1,1,Treatment Modality,Unknown
1195,1,1,Research lab p16,p16 unknown
1196,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1196,1,1,Tumor Stage,T4a
1196,1,1,Status,Dead w/ disease
1196,1,1,Treatment Modality,CTX
1196,1,1,Tumor Site,oropharynx
1196,1,1,Metastasis,M1
1196,1,1,Occurrence #,1st primary
1196,1,1,Time to Death,0.1
1196,1,1,Research lab p16,p16 unknown
1196,1,1,Age at Death,54.9
1196,1,1,Second Failure Type,no known failure
1196,1,1,Clinical lab p16,p16 negative
1196,1,1,Research lab HPV,HPV negative
1196,1,1,Date of Death,2011-01-15 00:00:00
1196,1,1,Nodal Stage,N3
1196,1,1,Overall Stage,IVc
1196,1,1,First Failure Type,no known failure
1197,1,1,Metastasis,M0
1197,1,1,Tumor Stage,T4a
1197,1,1,Radiation Dosage,70.2
1197,1,1,Overall Stage,IVa
1197,1,1,Nodal Stage,N2
1197,1,1,Treatment Modality,CTX-RT
1197,1,1,Tumor Site,oropharynx
1197,1,1,Status,Alive w/o disease
1197,1,1,Research lab p16,p16 unknown
1197,1,1,Research lab HPV,HPV positive
1197,1,1,Second Failure Type,no known failure
1197,1,1,Second Line Chemotherapy Agent,carbo
1197,1,1,Clinical lab p16,p16 unknown
1197,1,1,Initial Chemotherapy Agent,cis
1197,1,1,First Failure Type,no known failure
1197,1,1,Occurrence #,1st primary
1198,1,1,Occurrence #,1st primary
1198,1,1,Tumor Stage,T2
1198,1,1,Research lab HPV,HPV unknown
1198,1,1,Clinical lab p16,p16 unknown
1198,1,1,Tumor Site,oropharynx
1198,1,1,Overall Stage,IVa
1198,1,1,Status,Alive w/o disease
1198,1,1,Treatment Modality,CTX-RT
1198,1,1,Nodal Stage,N2
1198,1,1,Second Failure Type,no known failure
1198,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1198,1,1,Metastasis,M0
1198,1,1,Research lab p16,p16 unknown
1198,1,1,First Failure Type,no known failure
1198,1,1,Radiation Dosage,70.2
1199,1,1,Tumor Site,oropharynx
1199,1,1,Date of Death,2008-09-09 00:00:00
1199,1,1,Nodal Stage,N3
1199,1,1,First Failure Type,no known failure
1199,1,1,Metastasis,M0
1199,1,1,Second Failure Type,no known failure
1199,1,1,Overall Stage,IVb
1199,1,1,Clinical lab p16,p16 unknown
1199,1,1,Treatment Modality,CTX-RT
1199,1,1,Time to Death,1.9
1199,1,1,Research lab p16,p16 unknown
1199,1,1,Initial Chemotherapy Agent,unknown
1199,1,1,Radiation Dosage,70.2
1199,1,1,Research lab HPV,HPV unknown
1199,1,1,Tumor Stage,T3
1199,1,1,Age at Death,64.4
1199,1,1,Status,Dead unk disease
1199,1,1,Occurrence #,1st primary
1200,1,1,First Failure Type,locoregional and distant
1200,1,1,Second Line Chemotherapy Agent,carbo/doce
1200,1,1,Time to Death,1.5
1200,1,1,Research lab HPV,HPV unknown
1200,1,1,Overall Stage,IVb
1200,1,1,Initial Chemotherapy Agent,cis
1200,1,1,Clinical lab p16,p16 unknown
1200,1,1,Nodal Stage,N3
1200,1,1,Research lab p16,p16 unknown
1200,1,1,Time to First Failure,0.2
1200,1,1,Date of Death,2010-12-20 00:00:00
1200,1,1,Second Failure Type,no known failure
1200,1,1,Status,Dead w/ disease
1200,1,1,Radiation Dosage,70.2
1200,1,1,Metastasis,M0
1200,1,1,Tumor Site,oropharynx
1200,1,1,Treatment Modality,Sx & CTX-RT
1200,1,1,Tumor Stage,T3
1200,1,1,Age at Death,62.2
1200,1,1,Occurrence #,1st primary
1201,1,1,Tumor Stage,T3
1201,1,1,Occurrence #,1st primary
1201,1,1,Research lab p16,p16 unknown
1201,1,1,Overall Stage,IVa
1201,1,1,Status,Alive w/o disease
1201,1,1,Radiation Dosage,70.2
1201,1,1,Initial Chemotherapy Agent,carbo/PTX
1201,1,1,Metastasis,M0
1201,1,1,First Failure Type,no known failure
1201,1,1,Clinical lab p16,p16 unknown
1201,1,1,Tumor Site,oropharynx
1201,1,1,Nodal Stage,N2
1201,1,1,Research lab HPV,HPV unknown
1201,1,1,Second Failure Type,no known failure
1201,1,1,Treatment Modality,Sx & CTX-RT
1202,1,1,Time to Death,0.1
1202,1,1,Nodal Stage,Unknown
1202,1,1,Overall Stage,IVc
1202,1,1,Metastasis,M1
1202,1,1,Tumor Site,oropharynx
1202,1,1,Status,Dead w/ disease
1202,1,1,Radiation Dosage,105
1202,1,1,Clinical lab p16,p16 unknown
1202,1,1,Age at Death,50.8
1202,1,1,Treatment Modality,RT
1202,1,1,Occurrence #,1st primary
1202,1,1,First Failure Type,no known failure
1202,1,1,Research lab HPV,HPV unknown
1202,1,1,Research lab p16,p16 unknown
1202,1,1,Date of Death,2010-10-15 00:00:00
1202,1,1,Second Failure Type,no known failure
1202,1,1,Tumor Stage,Unknown
1203,1,1,Nodal Stage,N2
1203,1,1,Overall Stage,IVa
1203,1,1,Metastasis,M0
1203,1,1,Second Failure Type,no known failure
1203,1,1,Research lab p16,p16 unknown
1203,1,1,Treatment Modality,Sx & CTX-RT
1203,1,1,Occurrence #,1st primary
1203,1,1,Initial Chemotherapy Agent,cis
1203,1,1,First Failure Type,no known failure
1203,1,1,Status,Alive w/o disease
1203,1,1,Tumor Stage,T1
1203,1,1,Research lab HPV,HPV positive
1203,1,1,Clinical lab p16,p16 positive
1203,1,1,Tumor Site,oropharynx
1203,1,1,Radiation Dosage,59.4
1204,1,1,Research lab p16,p16 unknown
1204,1,1,Tumor Stage,T1
1204,1,1,Nodal Stage,N2
1204,1,1,Treatment Modality,RT
1204,1,1,Tumor Site,oropharynx
1204,1,1,First Failure Type,no known failure
1204,1,1,Metastasis,M0
1204,1,1,Second Failure Type,no known failure
1204,1,1,Research lab HPV,HPV positive
1204,1,1,Overall Stage,IVa
1204,1,1,Occurrence #,1st primary
1204,1,1,Clinical lab p16,p16 unknown
1204,1,1,Status,Dead w/ disease
1204,1,1,Radiation Dosage,70
1205,1,1,Occurrence #,1st primary
1205,1,1,Clinical lab p16,p16 positive
1205,1,1,Second Failure Type,no known failure
1205,1,1,Overall Stage,IVa
1205,1,1,Metastasis,M0
1205,1,1,First Failure Type,no known failure
1205,1,1,Date of Death,2011-01-17 00:00:00
1205,1,1,Research lab HPV,HPV positive
1205,1,1,Age at Death,59.8
1205,1,1,Nodal Stage,N2
1205,1,1,Treatment Modality,Unknown
1205,1,1,Time to Death,0.1
1205,1,1,Tumor Stage,T3
1205,1,1,Research lab p16,p16 unknown
1205,1,1,Status,Dead w/ disease
1205,1,1,Tumor Site,oropharynx
1206,1,1,Tumor Stage,T2
1206,1,1,First Failure Type,no known failure
1206,1,1,Metastasis,M0
1206,1,1,Overall Stage,IVb
1206,1,1,Research lab p16,p16 unknown
1206,1,1,Clinical lab p16,p16 unknown
1206,1,1,Status,Alive unk disease
1206,1,1,Tumor Site,oropharynx
1206,1,1,Nodal Stage,N3
1206,1,1,Second Failure Type,no known failure
1206,1,1,Occurrence #,1st primary
1206,1,1,Treatment Modality,Unknown
1206,1,1,Research lab HPV,HPV unknown
1207,1,1,First Failure Type,no known failure
1207,1,1,Status,Dead w/o disease
1207,1,1,Occurrence #,1st primary
1207,1,1,Research lab p16,p16 unknown
1207,1,1,Nodal Stage,N2
1207,1,1,Radiation Dosage,70.2
1207,1,1,Initial Chemotherapy Agent,cis
1207,1,1,Clinical lab p16,p16 unknown
1207,1,1,Tumor Stage,T1
1207,1,1,Research lab HPV,HPV unknown
1207,1,1,Treatment Modality,CTX-RT
1207,1,1,Tumor Site,oropharynx
1207,1,1,Second Failure Type,no known failure
1207,1,1,Overall Stage,IVa
1207,1,1,Metastasis,M0
1208,1,1,Status,Alive w/o disease
1208,1,1,Research lab HPV,HPV unknown
1208,1,1,Nodal Stage,N2
1208,1,1,Radiation Dosage,70.2
1208,1,1,Initial Chemotherapy Agent,cis/carbo
1208,1,1,Tumor Site,oropharynx
1208,1,1,Metastasis,M0
1208,1,1,Overall Stage,IVa
1208,1,1,First Failure Type,no known failure
1208,1,1,Research lab p16,p16 unknown
1208,1,1,Second Failure Type,no known failure
1208,1,1,Treatment Modality,Sx & CTX-RT
1208,1,1,Tumor Stage,T1
1208,1,1,Occurrence #,1st primary
1208,1,1,Clinical lab p16,p16 unknown
1209,1,1,Time to Death,0.4
1209,1,1,Tumor Site,oropharynx
1209,1,1,Treatment Modality,Unknown
1209,1,1,First Failure Type,no known failure
1209,1,1,Age at Death,60.6
1209,1,1,Research lab HPV,HPV unknown
1209,1,1,Clinical lab p16,p16 unknown
1209,1,1,Nodal Stage,Unknown
1209,1,1,Research lab p16,p16 unknown
1209,1,1,Second Failure Type,no known failure
1209,1,1,Status,Dead unk disease
1209,1,1,Date of Death,2000-12-12 00:00:00
1209,1,1,Metastasis,Unknown
1209,1,1,Tumor Stage,Unknown
1209,1,1,Occurrence #,1st primary
1209,1,1,Overall Stage,Unknown
1210,1,1,Overall Stage,IVb
1210,1,1,Radiation Dosage,15
1210,1,1,Second Failure Type,no known failure
1210,1,1,Age at Death,46.4
1210,1,1,Occurrence #,1st primary
1210,1,1,Clinical lab p16,p16 unknown
1210,1,1,Nodal Stage,N3
1210,1,1,Tumor Stage,T3
1210,1,1,Research lab p16,p16 unknown
1210,1,1,Initial Chemotherapy Agent,cis/PTX
1210,1,1,Status,Dead w/ disease
1210,1,1,Research lab HPV,HPV unknown
1210,1,1,Date of Death,2010-11-04 00:00:00
1210,1,1,Time to Death,0.2
1210,1,1,Metastasis,M0
1210,1,1,First Failure Type,no known failure
1210,1,1,Tumor Site,oropharynx
1210,1,1,Treatment Modality,CTX-RT
1211,1,1,Clinical lab p16,p16 unknown
1211,1,1,Tumor Stage,T3
1211,1,1,Occurrence #,other primary
1211,1,1,Research lab p16,p16 unknown
1211,1,1,Nodal Stage,N0
1211,1,1,Second Failure Type,no known failure
1211,1,1,Research lab HPV,HPV unknown
1211,1,1,Status,Dead w/o disease
1211,1,1,Metastasis,M0
1211,1,1,Treatment Modality,Sx & CTX
1211,1,1,Tumor Site,oropharynx
1211,1,1,Overall Stage,III
1211,1,1,Initial Chemotherapy Agent,cetux
1211,1,1,Time to First Failure,-0.0
1211,1,1,First Failure Type,locoregional
1212,1,1,Research lab p16,p16 unknown
1212,1,1,Tumor Stage,T1
1212,1,1,Treatment Modality,Sx
1212,1,1,Second Failure Type,no known failure
1212,1,1,Nodal Stage,N0
1212,1,1,Clinical lab p16,p16 unknown
1212,1,1,Research lab HPV,HPV unknown
1212,1,1,Occurrence #,1st primary
1212,1,1,Metastasis,M0
1212,1,1,Age at Death,75.2
1212,1,1,Date of Death,2004-10-27 00:00:00
1212,1,1,First Failure Type,no known failure
1212,1,1,Tumor Site,oropharynx
1212,1,1,Status,Dead unk disease
1212,1,1,Time to Death,1.1
1212,1,1,Overall Stage,I
1213,1,1,Research lab HPV,HPV positive
1213,1,1,Initial Chemotherapy Agent,carbo
1213,1,1,Time to Death,1.2
1213,1,1,Clinical lab p16,p16 unknown
1213,1,1,Nodal Stage,N2
1213,1,1,Status,Dead w/ disease
1213,1,1,First Failure Type,locoregional
1213,1,1,Occurrence #,1st primary
1213,1,1,Metastasis,M0
1213,1,1,Tumor Stage,T2
1213,1,1,Date of Death,2010-12-07 00:00:00
1213,1,1,Time to First Failure,0.3
1213,1,1,Second Failure Type,no known failure
1213,1,1,Radiation Dosage,70.2
1213,1,1,Treatment Modality,CTX-RT
1213,1,1,Tumor Site,oropharynx
1213,1,1,Overall Stage,IVa
1213,1,1,Age at Death,63.1
1213,1,1,Research lab p16,p16 unknown
1214,1,1,Treatment Modality,Sx
1214,1,1,Research lab HPV,HPV unknown
1214,1,1,Occurrence #,recurrence
1214,1,1,First Failure Type,no known failure
1214,1,1,Research lab p16,p16 unknown
1214,1,1,Time to Death,1.1
1214,1,1,Second Failure Type,no known failure
1214,1,1,Clinical lab p16,p16 unknown
1214,1,1,Nodal Stage,N0
1214,1,1,Age at Death,74.8
1214,1,1,Tumor Site,oropharynx
1214,1,1,Status,Dead unk disease
1214,1,1,Tumor Stage,T3
1214,1,1,Date of Death,2011-08-28 00:00:00
1214,1,1,Metastasis,M0
1214,1,1,Overall Stage,III
1215,1,1,Nodal Stage,N1
1215,1,1,Status,Alive w/o disease
1215,1,1,Clinical lab p16,p16 unknown
1215,1,1,Research lab p16,p16 unknown
1215,1,1,Radiation Dosage,70.2
1215,1,1,Research lab HPV,HPV unknown
1215,1,1,Initial Chemotherapy Agent,cis
1215,1,1,Metastasis,M0
1215,1,1,Tumor Stage,T3
1215,1,1,Treatment Modality,CTX-RT
1215,1,1,First Failure Type,no known failure
1215,1,1,Second Failure Type,no known failure
1215,1,1,Overall Stage,III
1215,1,1,Tumor Site,oropharynx
1215,1,1,Occurrence #,1st primary
1216,1,1,First Failure Type,distant
1216,1,1,Age at Death,52.3
1216,1,1,Date of Death,2007-06-13 00:00:00
1216,1,1,Initial Chemotherapy Agent,carbo/PTX
1216,1,1,Overall Stage,IVc
1216,1,1,First Failure Radiation Dosage,40
1216,1,1,Time to First Failure,0.4
1216,1,1,Second Failure Type,no known failure
1216,1,1,Nodal Stage,Unknown
1216,1,1,First Failure Treatment Modality,CTX-RT
1216,1,1,Tumor Site,oropharynx
1216,1,1,Metastasis,M1
1216,1,1,Tumor Stage,Unknown
1216,1,1,First Failure Initial Chemotherapy Agent,HPV/MAGE
1216,1,1,Treatment Modality,CTX
1216,1,1,Clinical lab p16,p16 unknown
1216,1,1,Occurrence #,recurrence
1216,1,1,Research lab p16,p16 unknown
1216,1,1,Time to Death,3.3
1216,1,1,Status,Dead w/ disease
1216,1,1,Research lab HPV,HPV unknown
1217,1,1,Tumor Stage,T1
1217,1,1,Tumor Site,oropharynx
1217,1,1,Metastasis,M0
1217,1,1,Nodal Stage,N2
1217,1,1,Time to First Failure,1.5
1217,1,1,First Failure Treatment Modality,Sx
1217,1,1,Treatment Modality,CTX-RT
1217,1,1,Status,Alive w/ disease
1217,1,1,Research lab HPV,HPV positive
1217,1,1,First Failure Type,locoregional
1217,1,1,Clinical lab p16,p16 unknown
1217,1,1,Second Failure Type,no known failure
1217,1,1,First Failure Site,oropharynx
1217,1,1,Radiation Dosage,unknown
1217,1,1,Occurrence #,1st primary
1217,1,1,Initial Chemotherapy Agent,cetux
1217,1,1,Research lab p16,p16 unknown
1217,1,1,Overall Stage,IVa
1218,1,1,Occurrence #,recurrence
1218,1,1,Time to Death,0.6
1218,1,1,Age at Death,68.0
1218,1,1,Clinical lab p16,p16 unknown
1218,1,1,Treatment Modality,Unknown
1218,1,1,Research lab p16,p16 unknown
1218,1,1,Date of Death,2011-08-02 00:00:00
1218,1,1,Research lab HPV,HPV unknown
1218,1,1,Tumor Site,oropharynx
1218,1,1,Nodal Stage,Unknown
1218,1,1,Metastasis,M1
1218,1,1,Tumor Stage,Unknown
1218,1,1,Overall Stage,IVc
1218,1,1,Second Failure Type,no known failure
1218,1,1,First Failure Type,no known failure
1218,1,1,Status,Dead unk disease
1219,1,1,Radiation Dosage,70.2
1219,1,1,Second Failure Type,no known failure
1219,1,1,Tumor Stage,T1
1219,1,1,Second Line Chemotherapy Agent,carbo/PTX
1219,1,1,Overall Stage,IVa
1219,1,1,Tumor Site,oropharynx
1219,1,1,Research lab p16,p16 unknown
1219,1,1,First Failure Type,no known failure
1219,1,1,Occurrence #,1st primary
1219,1,1,Clinical lab p16,p16 unknown
1219,1,1,Treatment Modality,Sx & CTX-RT
1219,1,1,Status,Alive w/o disease
1219,1,1,Research lab HPV,HPV unknown
1219,1,1,Nodal Stage,N2
1219,1,1,Metastasis,M0
1219,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
1220,1,1,Treatment Modality,CTX-RT
1220,1,1,Radiation Dosage,70.2
1220,1,1,Nodal Stage,N2
1220,1,1,Tumor Site,oropharynx
1220,1,1,Initial Chemotherapy Agent,cis
1220,1,1,Research lab HPV,HPV unknown
1220,1,1,Overall Stage,IVa
1220,1,1,Research lab p16,p16 unknown
1220,1,1,First Failure Type,no known failure
1220,1,1,Occurrence #,1st primary
1220,1,1,Clinical lab p16,p16 unknown
1220,1,1,Status,Alive w/o disease
1220,1,1,Metastasis,M0
1220,1,1,Tumor Stage,T2
1220,1,1,Second Failure Type,no known failure
1221,1,1,Nodal Stage,N1
1221,1,1,First Failure Site,hypopharynx
1221,1,1,Time to First Failure,4.6
1221,1,1,Status,Alive w/o disease
1221,1,1,Tumor Site,oropharynx
1221,1,1,Treatment Modality,Sx
1221,1,1,Occurrence #,1st primary
1221,1,1,Clinical lab p16,p16 unknown
1221,1,1,First Failure Type,locoregional
1221,1,1,Second Failure Type,no known failure
1221,1,1,Overall Stage,IVa
1221,1,1,Research lab p16,p16 unknown
1221,1,1,Research lab HPV,HPV unknown
1221,1,1,Tumor Stage,T4a
1221,1,1,Metastasis,M0
1223,1,1,Tumor Stage,T2
1223,1,1,Overall Stage,II
1223,1,1,Research lab p16,p16 unknown
1223,1,1,First Failure Treatment Modality,Sx
1223,1,1,Time to First Failure,0.7
1223,1,1,Second Failure Type,no known failure
1223,1,1,First Failure Type,locoregional
1223,1,1,Clinical lab p16,p16 negative
1223,1,1,Radiation Dosage,74.4
1223,1,1,Research lab HPV,HPV unknown
1223,1,1,First Failure Site,oropharynx
1223,1,1,Nodal Stage,N0
1223,1,1,Metastasis,M0
1223,1,1,Status,Alive w/ disease
1223,1,1,Tumor Site,oropharynx
1223,1,1,Treatment Modality,RT
1223,1,1,Occurrence #,1st primary
1224,1,1,Tumor Site,oropharynx
1224,1,1,Status,Alive unk disease
1224,1,1,Metastasis,M0
1224,1,1,Occurrence #,1st primary
1224,1,1,Tumor Stage,T1
1224,1,1,Second Failure Type,no known failure
1224,1,1,Overall Stage,IVb
1224,1,1,Clinical lab p16,p16 unknown
1224,1,1,Research lab HPV,HPV unknown
1224,1,1,Nodal Stage,N3
1224,1,1,Research lab p16,p16 unknown
1224,1,1,First Failure Type,no known failure
1224,1,1,Treatment Modality,Sx
1225,1,1,Second Failure Type,no known failure
1225,1,1,Tumor Stage,T4a
1225,1,1,Overall Stage,IVa
1225,1,1,Research lab p16,p16 unknown
1225,1,1,Age at Death,52.5
1225,1,1,Clinical lab p16,p16 unknown
1225,1,1,Status,Dead unk disease
1225,1,1,Metastasis,M0
1225,1,1,Occurrence #,1st primary
1225,1,1,Treatment Modality,Unknown
1225,1,1,Tumor Site,oropharynx
1225,1,1,First Failure Type,no known failure
1225,1,1,Time to Death,4.0
1225,1,1,Research lab HPV,HPV unknown
1225,1,1,Nodal Stage,N2
1225,1,1,Date of Death,2006-02-05 00:00:00
1226,1,1,Occurrence #,1st primary
1226,1,1,Metastasis,M0
1226,1,1,Clinical lab p16,p16 unknown
1226,1,1,Research lab HPV,HPV unknown
1226,1,1,Research lab p16,p16 unknown
1226,1,1,Overall Stage,III
1226,1,1,Treatment Modality,Sx
1226,1,1,Tumor Site,oropharynx
1226,1,1,First Failure Type,no known failure
1226,1,1,Nodal Stage,N1
1226,1,1,Tumor Stage,T2
1226,1,1,Second Failure Type,no known failure
1226,1,1,Status,Alive w/o disease
1227,1,1,Status,Alive w/o disease
1227,1,1,Tumor Stage,Unknown
1227,1,1,Research lab HPV,HPV unknown
1227,1,1,Clinical lab p16,p16 unknown
1227,1,1,First Failure Type,no known failure
1227,1,1,Treatment Modality,Sx
1227,1,1,Nodal Stage,N2
1227,1,1,Second Failure Type,no known failure
1227,1,1,Research lab p16,p16 unknown
1227,1,1,Overall Stage,IVa
1227,1,1,Occurrence #,1st primary
1227,1,1,Metastasis,M0
1227,1,1,Tumor Site,oropharynx
1228,1,1,Clinical lab p16,p16 unknown
1228,1,1,Research lab p16,p16 unknown
1228,1,1,Occurrence #,1st primary
1228,1,1,Second Failure Type,no known failure
1228,1,1,Initial Chemotherapy Agent,cis
1228,1,1,Nodal Stage,N2
1228,1,1,Metastasis,M0
1228,1,1,Tumor Site,oropharynx
1228,1,1,Radiation Dosage,70.2
1228,1,1,Treatment Modality,CTX-RT
1228,1,1,First Failure Type,no known failure
1228,1,1,Overall Stage,IVa
1228,1,1,Status,Alive w/o disease
1228,1,1,Tumor Stage,T4a
1228,1,1,Research lab HPV,HPV unknown
1229,1,1,Research lab p16,p16 unknown
1229,1,1,Status,Dead w/ disease
1229,1,1,Radiation Dosage,70.2
1229,1,1,Occurrence #,1st primary
1229,1,1,Treatment Modality,CTX-RT
1229,1,1,Time to First Failure,0.6
1229,1,1,Clinical lab p16,p16 unknown
1229,1,1,Time to Death,1.5
1229,1,1,Metastasis,M0
1229,1,1,Nodal Stage,N3
1229,1,1,Tumor Site,oropharynx
1229,1,1,Tumor Stage,T2
1229,1,1,Date of Death,2009-04-11 00:00:00
1229,1,1,First Failure Type,distant
1229,1,1,Age at Death,53.0
1229,1,1,Research lab HPV,HPV unknown
1229,1,1,Second Line Chemotherapy Agent,cetux/cis/doce
1229,1,1,Initial Chemotherapy Agent,Carbo/PTX/cetux
1229,1,1,Overall Stage,IVb
1229,1,1,Second Failure Type,no known failure
1230,1,1,Nodal Stage,N0
1230,1,1,Overall Stage,III
1230,1,1,Tumor Site,oropharynx
1230,1,1,Treatment Modality,Sx & CTX-RT
1230,1,1,Occurrence #,1st primary
1230,1,1,Initial Chemotherapy Agent,carbo/cetux
1230,1,1,Research lab p16,p16 unknown
1230,1,1,Clinical lab p16,p16 positive
1230,1,1,Metastasis,M0
1230,1,1,Research lab HPV,HPV positive
1230,1,1,Status,Alive w/o disease
1230,1,1,Second Failure Type,no known failure
1230,1,1,First Failure Type,no known failure
1230,1,1,Tumor Stage,T3
1230,1,1,Radiation Dosage,70.2
1231,1,1,Second Failure Type,no known failure
1231,1,1,Initial Chemotherapy Agent,carbo/PTX
1231,1,1,Research lab HPV,HPV unknown
1231,1,1,Radiation Dosage,70.2
1231,1,1,Overall Stage,IVa
1231,1,1,Time to First Failure,0.6
1231,1,1,Treatment Modality,CTX-RT
1231,1,1,Tumor Stage,T4a
1231,1,1,Nodal Stage,N0
1231,1,1,Age at Death,58.9
1231,1,1,Metastasis,M0
1231,1,1,Time to Death,1.4
1231,1,1,Research lab p16,p16 unknown
1231,1,1,First Failure Type,locoregional
1231,1,1,Tumor Site,oropharynx
1231,1,1,Status,Dead w/ disease
1231,1,1,Date of Death,2007-05-16 00:00:00
1231,1,1,Occurrence #,1st primary
1231,1,1,Clinical lab p16,p16 unknown
1232,1,1,Tumor Stage,T1
1232,1,1,Treatment Modality,Sx & CTX-RT
1232,1,1,Nodal Stage,N2
1232,1,1,Tumor Site,oropharynx
1232,1,1,Metastasis,M0
1232,1,1,Occurrence #,1st primary
1232,1,1,Clinical lab p16,p16 unknown
1232,1,1,Overall Stage,IVa
1232,1,1,Second Failure Type,no known failure
1232,1,1,Research lab p16,p16 unknown
1232,1,1,Research lab HPV,HPV unknown
1232,1,1,Radiation Dosage,70.2
1232,1,1,First Failure Type,no known failure
1232,1,1,Status,Alive unk disease
1232,1,1,Initial Chemotherapy Agent,cis
1234,1,1,Tumor Stage,T2
1234,1,1,Time to Death,0.2
1234,1,1,First Failure Type,no known failure
1234,1,1,Research lab HPV,HPV unknown
1234,1,1,Second Failure Type,no known failure
1234,1,1,Status,Dead w/ disease
1234,1,1,Clinical lab p16,p16 unknown
1234,1,1,Metastasis,M1
1234,1,1,Overall Stage,IVc
1234,1,1,Initial Chemotherapy Agent,cis
1234,1,1,Date of Death,2009-04-23 00:00:00
1234,1,1,Treatment Modality,CTX-RT
1234,1,1,Radiation Dosage,52.2
1234,1,1,Tumor Site,oropharynx
1234,1,1,Age at Death,56.7
1234,1,1,Occurrence #,1st primary
1234,1,1,Nodal Stage,N2
1234,1,1,Research lab p16,p16 unknown
1235,1,1,Time to Death,5.9
1235,1,1,Second Failure Type,no known failure
1235,1,1,Age at Death,70.8
1235,1,1,First Failure Type,no known failure
1235,1,1,Research lab HPV,HPV unknown
1235,1,1,Overall Stage,II
1235,1,1,Clinical lab p16,p16 unknown
1235,1,1,Treatment Modality,Sx & RT
1235,1,1,Occurrence #,1st primary
1235,1,1,Research lab p16,p16 unknown
1235,1,1,Tumor Stage,T2
1235,1,1,Date of Death,2005-12-09 00:00:00
1235,1,1,Status,Dead unk disease
1235,1,1,Tumor Site,oropharynx
1235,1,1,Nodal Stage,N0
1235,1,1,Metastasis,M0
1235,1,1,Radiation Dosage,72
1236,1,1,Age at Death,63.9
1236,1,1,Research lab p16,p16 unknown
1236,1,1,Date of Death,2010-11-27 00:00:00
1236,1,1,Occurrence #,recurrence
1236,1,1,Overall Stage,IVa
1236,1,1,Time to First Failure,0.1
1236,1,1,Treatment Modality,Sx
1236,1,1,Tumor Stage,T4a
1236,1,1,Nodal Stage,Unknown
1236,1,1,Metastasis,M0
1236,1,1,Research lab HPV,HPV unknown
1236,1,1,Time to Death,0.5
1236,1,1,Tumor Site,oropharynx
1236,1,1,Clinical lab p16,p16 unknown
1236,1,1,Second Failure Type,no known failure
1236,1,1,First Failure Type,locoregional
1236,1,1,Status,Dead w/ disease
1237,1,1,Status,Alive unk disease
1237,1,1,Nodal Stage,N2
1237,1,1,First Failure Type,locoregional
1237,1,1,Tumor Site,oropharynx
1237,1,1,First Failure Site,oropharynx
1237,1,1,Time to First Failure,1.9
1237,1,1,Research lab HPV,HPV unknown
1237,1,1,Treatment Modality,CTX-RT
1237,1,1,First Failure Treatment Modality,Sx & CTX-RT
1237,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
1237,1,1,Occurrence #,1st primary
1237,1,1,Radiation Dosage,70.2
1237,1,1,Second Failure Type,no known failure
1237,1,1,Overall Stage,IVa
1237,1,1,First Failure Radiation Dosage,60
1237,1,1,Clinical lab p16,p16 unknown
1237,1,1,Tumor Stage,T3
1237,1,1,Research lab p16,p16 unknown
1237,1,1,Metastasis,M0
1237,1,1,Initial Chemotherapy Agent,cis
1238,1,1,Radiation Dosage,unknown
1238,1,1,Age at Death,49.9
1238,1,1,Metastasis,M1
1238,1,1,Overall Stage,IVc
1238,1,1,First Failure Type,no known failure
1238,1,1,Tumor Site,oropharynx
1238,1,1,Tumor Stage,T4a
1238,1,1,Clinical lab p16,p16 negative
1238,1,1,Date of Death,2011-10-07 00:00:00
1238,1,1,Initial Chemotherapy Agent,unk
1238,1,1,Status,Dead w/ disease
1238,1,1,Research lab HPV,HPV unknown
1238,1,1,Nodal Stage,N2
1238,1,1,Occurrence #,1st primary
1238,1,1,Second Failure Type,no known failure
1238,1,1,Treatment Modality,Sx & CTX-RT
1238,1,1,Time to Death,1.1
1238,1,1,Research lab p16,p16 unknown
1239,1,1,Research lab p16,p16 unknown
1239,1,1,Overall Stage,IVa
1239,1,1,Time to Death,0.1
1239,1,1,Status,Dead w/ disease
1239,1,1,Initial Chemotherapy Agent,carbo/PTX
1239,1,1,Metastasis,M0
1239,1,1,First Failure Type,no known failure
1239,1,1,Nodal Stage,N2
1239,1,1,Date of Death,2010-06-12 00:00:00
1239,1,1,Clinical lab p16,p16 unknown
1239,1,1,Treatment Modality,CTX-RT
1239,1,1,Tumor Site,oropharynx
1239,1,1,Occurrence #,1st primary
1239,1,1,Radiation Dosage,60
1239,1,1,Second Failure Type,no known failure
1239,1,1,Tumor Stage,T3
1239,1,1,Age at Death,70.8
1239,1,1,Research lab HPV,HPV unknown
1240,1,1,Clinical lab p16,p16 unknown
1240,1,1,First Failure Type,locoregional
1240,1,1,Status,Alive w/o disease
1240,1,1,Second Failure Type,no known failure
1240,1,1,Nodal Stage,N2
1240,1,1,Research lab HPV,HPV positive
1240,1,1,Treatment Modality,CTX-RT
1240,1,1,Tumor Site,oropharynx
1240,1,1,Research lab p16,p16 unknown
1240,1,1,Time to First Failure,0.6
1240,1,1,Initial Chemotherapy Agent,cis
1240,1,1,Tumor Stage,T1
1240,1,1,Metastasis,M0
1240,1,1,Occurrence #,1st primary
1240,1,1,Overall Stage,IVa
1240,1,1,Radiation Dosage,70.2
1241,1,1,Treatment Modality,Sx & CTX-RT
1241,1,1,Metastasis,M0
1241,1,1,Research lab p16,p16 unknown
1241,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
1241,1,1,Occurrence #,1st primary
1241,1,1,Research lab HPV,HPV unknown
1241,1,1,Overall Stage,IVa
1241,1,1,Clinical lab p16,p16 unknown
1241,1,1,Tumor Site,oropharynx
1241,1,1,Second Failure Type,no known failure
1241,1,1,Nodal Stage,N2
1241,1,1,First Failure Type,no known failure
1241,1,1,Tumor Stage,T2
1241,1,1,Status,Alive w/o disease
1241,1,1,Radiation Dosage,70.2
1243,1,1,Treatment Modality,Sx & CTX-RT
1243,1,1,Overall Stage,IVa
1243,1,1,Occurrence #,1st primary
1243,1,1,Clinical lab p16,p16 unknown
1243,1,1,First Failure Type,no known failure
1243,1,1,Research lab HPV,HPV unknown
1243,1,1,Second Failure Type,no known failure
1243,1,1,Status,Dead w/o disease
1243,1,1,Nodal Stage,N2
1243,1,1,Date of Death,2009-05-13 00:00:00
1243,1,1,Tumor Stage,T1
1243,1,1,Research lab p16,p16 unknown
1243,1,1,Age at Death,44.9
1243,1,1,Metastasis,M0
1243,1,1,Radiation Dosage,63
1243,1,1,Time to Death,0.8
1243,1,1,Tumor Site,oropharynx
1243,1,1,Initial Chemotherapy Agent,cis
1244,1,1,Clinical lab p16,p16 unknown
1244,1,1,Time to Death,0.7
1244,1,1,Status,Dead w/ disease
1244,1,1,Research lab p16,p16 unknown
1244,1,1,Age at Death,58.8
1244,1,1,Occurrence #,1st primary
1244,1,1,Nodal Stage,N2
1244,1,1,Overall Stage,IVa
1244,1,1,Metastasis,M0
1244,1,1,First Failure Type,no known failure
1244,1,1,Radiation Dosage,70.2
1244,1,1,Tumor Site,oropharynx
1244,1,1,Tumor Stage,T4a
1244,1,1,Initial Chemotherapy Agent,unk
1244,1,1,Second Failure Type,no known failure
1244,1,1,Treatment Modality,CTX-RT
1244,1,1,Date of Death,2011-04-25 00:00:00
1244,1,1,Research lab HPV,HPV unknown
1245,1,1,Initial Chemotherapy Agent,unkn
1245,1,1,Metastasis,M0
1245,1,1,Occurrence #,1st primary
1245,1,1,Status,Dead w/ disease
1245,1,1,Radiation Dosage,70.2
1245,1,1,Nodal Stage,N2
1245,1,1,Date of Death,2011-03-30 00:00:00
1245,1,1,Overall Stage,IVa
1245,1,1,Research lab p16,p16 unknown
1245,1,1,First Failure Type,distant
1245,1,1,Time to First Failure,0.2
1245,1,1,Tumor Stage,T4a
1245,1,1,Clinical lab p16,p16 unknown
1245,1,1,Second Failure Type,no known failure
1245,1,1,Research lab HPV,HPV unknown
1245,1,1,Time to Death,1.3
1245,1,1,Age at Death,55.9
1245,1,1,Treatment Modality,CTX-RT
1245,1,1,Tumor Site,oropharynx
1246,1,1,Radiation Dosage,70.2
1246,1,1,Tumor Site,oropharynx
1246,1,1,Research lab HPV,HPV positive
1246,1,1,Status,Dead w/ disease
1246,1,1,First Failure Type,no known failure
1246,1,1,Research lab p16,p16 unknown
1246,1,1,Overall Stage,IVb
1246,1,1,Occurrence #,1st primary
1246,1,1,Clinical lab p16,p16 positive
1246,1,1,Treatment Modality,CTX-RT
1246,1,1,Second Failure Type,no known failure
1246,1,1,Nodal Stage,N3
1246,1,1,Initial Chemotherapy Agent,doce/cis/5 FU
1246,1,1,Metastasis,M0
1246,1,1,Tumor Stage,T3
1247,1,1,Treatment Modality,Sx & RT
1247,1,1,Occurrence #,1st primary
1247,1,1,Research lab HPV,HPV unknown
1247,1,1,Radiation Dosage,60
1247,1,1,Clinical lab p16,p16 unknown
1247,1,1,Research lab p16,p16 unknown
1247,1,1,Metastasis,M0
1247,1,1,Second Failure Type,no known failure
1247,1,1,Nodal Stage,N0
1247,1,1,Status,Alive w/o disease
1247,1,1,First Failure Type,no known failure
1247,1,1,Tumor Stage,T2
1247,1,1,Overall Stage,II
1247,1,1,Tumor Site,oropharynx
1248,1,1,Tumor Site,oropharynx
1248,1,1,Clinical lab p16,p16 unknown
1248,1,1,Tumor Stage,T1
1248,1,1,Overall Stage,III
1248,1,1,Metastasis,M0
1248,1,1,Occurrence #,1st primary
1248,1,1,Status,Alive w/o disease
1248,1,1,Second Failure Type,no known failure
1248,1,1,Nodal Stage,N1
1248,1,1,First Failure Type,no known failure
1248,1,1,Radiation Dosage,70.2
1248,1,1,Research lab p16,p16 unknown
1248,1,1,Research lab HPV,HPV unknown
1248,1,1,Treatment Modality,RT
1249,1,1,Tumor Site,oropharynx
1249,1,1,Tumor Stage,T1
1249,1,1,First Failure Type,no known failure
1249,1,1,Treatment Modality,Sx
1249,1,1,Time to Death,0.8
1249,1,1,Second Failure Type,no known failure
1249,1,1,Overall Stage,IVc
1249,1,1,Age at Death,67.3
1249,1,1,Date of Death,2011-02-01 00:00:00
1249,1,1,Clinical lab p16,p16 unknown
1249,1,1,Occurrence #,recurrence
1249,1,1,Research lab HPV,HPV unknown
1249,1,1,Metastasis,M1
1249,1,1,Status,Dead w/ disease
1249,1,1,Research lab p16,p16 unknown
1249,1,1,Nodal Stage,N2
1250,1,1,Tumor Site,oropharynx
1250,1,1,Treatment Modality,CTX-RT
1250,1,1,Overall Stage,IVa
1250,1,1,Clinical lab p16,p16 unknown
1250,1,1,Tumor Stage,T2
1250,1,1,Research lab p16,p16 unknown
1250,1,1,Metastasis,M0
1250,1,1,Radiation Dosage,70.2
1250,1,1,Occurrence #,1st primary
1250,1,1,Status,Alive w/o disease
1250,1,1,First Failure Type,no known failure
1250,1,1,Nodal Stage,N2
1250,1,1,Research lab HPV,HPV unknown
1250,1,1,Second Failure Type,no known failure
1250,1,1,Initial Chemotherapy Agent,cis
1251,1,1,Research lab HPV,HPV unknown
1251,1,1,Occurrence #,1st primary
1251,1,1,Metastasis,M0
1251,1,1,Clinical lab p16,p16 unknown
1251,1,1,Radiation Dosage,unknown
1251,1,1,Tumor Stage,T2
1251,1,1,Status,Alive w/o disease
1251,1,1,Second Failure Type,no known failure
1251,1,1,Nodal Stage,N2
1251,1,1,Overall Stage,IVa
1251,1,1,Research lab p16,p16 unknown
1251,1,1,First Failure Type,no known failure
1251,1,1,Initial Chemotherapy Agent,unk
1251,1,1,Treatment Modality,CTX-RT
1251,1,1,Tumor Site,oropharynx
1252,1,1,Overall Stage,III
1252,1,1,Tumor Stage,T3
1252,1,1,Metastasis,M0
1252,1,1,Nodal Stage,N0
1252,1,1,Tumor Site,oropharynx
1252,1,1,Occurrence #,other primary
1252,1,1,First Failure Type,no known failure
1252,1,1,Research lab HPV,HPV unknown
1252,1,1,Second Failure Type,no known failure
1252,1,1,Treatment Modality,Sx
1252,1,1,Date of Death,2011-08-07 00:00:00
1252,1,1,Age at Death,61.4
1252,1,1,Research lab p16,p16 unknown
1252,1,1,Clinical lab p16,p16 unknown
1252,1,1,Status,Dead w/ disease
1253,1,1,First Failure Type,distant
1253,1,1,Clinical lab p16,p16 negative
1253,1,1,Second Failure Type,no known failure
1253,1,1,Radiation Dosage,70.2
1253,1,1,Occurrence #,1st primary
1253,1,1,Metastasis,M0
1253,1,1,Nodal Stage,N2
1253,1,1,Overall Stage,IVa
1253,1,1,Tumor Stage,T3
1253,1,1,Status,Dead w/ disease
1253,1,1,Research lab p16,p16 unknown
1253,1,1,Treatment Modality,CTX-RT
1253,1,1,Time to First Failure,-0.2
1253,1,1,Initial Chemotherapy Agent,cis
1253,1,1,Tumor Site,oropharynx
1253,1,1,Research lab HPV,HPV negative
1254,1,1,Tumor Site,oropharynx
1254,1,1,Tumor Stage,T1
1254,1,1,Second Failure Type,no known failure
1254,1,1,Research lab p16,p16 unknown
1254,1,1,Occurrence #,other primary
1254,1,1,Overall Stage,I
1254,1,1,Metastasis,M0
1254,1,1,Nodal Stage,N0
1254,1,1,Treatment Modality,Sx
1254,1,1,Status,Dead w/o disease
1254,1,1,First Failure Type,no known failure
1254,1,1,Research lab HPV,HPV unknown
1254,1,1,Clinical lab p16,p16 unknown
1255,1,1,Tumor Site,oropharynx
1255,1,1,Clinical lab p16,p16 unknown
1255,1,1,Research lab p16,p16 unknown
1255,1,1,Initial Chemotherapy Agent,cis
1255,1,1,Date of Death,2010-04-19 00:00:00
1255,1,1,Status,Dead w/ disease
1255,1,1,Metastasis,M1
1255,1,1,Second Failure Type,no known failure
1255,1,1,Research lab HPV,HPV unknown
1255,1,1,Radiation Dosage,70.2
1255,1,1,First Failure Type,distant
1255,1,1,Age at Death,54.3
1255,1,1,Tumor Stage,T3
1255,1,1,Time to Death,0.8
1255,1,1,Time to First Failure,-0.2
1255,1,1,Treatment Modality,CTX-RT
1255,1,1,Nodal Stage,N2
1255,1,1,Overall Stage,IVc
1255,1,1,Occurrence #,1st primary
1256,1,1,Nodal Stage,N0
1256,1,1,Date of Death,2011-01-14 00:00:00
1256,1,1,Initial Chemotherapy Agent,carbo
1256,1,1,Clinical lab p16,p16 unknown
1256,1,1,First Failure Type,no known failure
1256,1,1,Status,Dead unk disease
1256,1,1,Overall Stage,IVa
1256,1,1,Treatment Modality,CTX-RT
1256,1,1,Research lab HPV,HPV unknown
1256,1,1,Metastasis,M0
1256,1,1,Radiation Dosage,70.2
1256,1,1,Age at Death,62.5
1256,1,1,Occurrence #,1st primary
1256,1,1,Research lab p16,p16 unknown
1256,1,1,Tumor Stage,T4a
1256,1,1,Tumor Site,oropharynx
1256,1,1,Time to Death,1.3
1256,1,1,Second Failure Type,no known failure
1257,1,1,First Failure Type,no known failure
1257,1,1,Nodal Stage,N1
1257,1,1,Research lab HPV,HPV unknown
1257,1,1,Occurrence #,1st primary
1257,1,1,Clinical lab p16,p16 unknown
1257,1,1,Tumor Site,oropharynx
1257,1,1,Second Failure Type,no known failure
1257,1,1,Radiation Dosage,70.2
1257,1,1,Research lab p16,p16 unknown
1257,1,1,Treatment Modality,CTX-RT
1257,1,1,Initial Chemotherapy Agent,cis
1257,1,1,Status,Alive w/o disease
1257,1,1,Tumor Stage,T2
1257,1,1,Overall Stage,III
1257,1,1,Metastasis,M0
1258,1,1,Research lab p16,p16 unknown
1258,1,1,Tumor Stage,T2
1258,1,1,Second Failure Type,no known failure
1258,1,1,Overall Stage,IVa
1258,1,1,Tumor Site,oropharynx
1258,1,1,Status,Alive w/o disease
1258,1,1,Nodal Stage,N2
1258,1,1,Radiation Dosage,70.2
1258,1,1,Clinical lab p16,p16 positive
1258,1,1,Initial Chemotherapy Agent,cis
1258,1,1,Treatment Modality,CTX-RT
1258,1,1,Metastasis,M0
1258,1,1,First Failure Type,no known failure
1258,1,1,Research lab HPV,HPV positive
1258,1,1,Occurrence #,1st primary
1259,1,1,Overall Stage,Unknown
1259,1,1,Second Failure Type,no known failure
1259,1,1,Treatment Modality,CTX-RT
1259,1,1,Occurrence #,other primary
1259,1,1,Research lab p16,p16 unknown
1259,1,1,First Failure Site,oropharynx
1259,1,1,Status,Dead w/ disease
1259,1,1,First Failure Treatment Modality,Sx & CTX
1259,1,1,Research lab HPV,HPV unknown
1259,1,1,Initial Chemotherapy Agent,carbo/PTX
1259,1,1,Clinical lab p16,p16 unknown
1259,1,1,Radiation Dosage,56.4
1259,1,1,First Failure Type,locoregional
1259,1,1,Tumor Site,oropharynx
1259,1,1,Nodal Stage,N0
1259,1,1,Tumor Stage,Unknown
1259,1,1,First Failure Initial Chemotherapy Agent,HPV/MAGE
1259,1,1,Metastasis,M0
1259,1,1,Time to First Failure,0.4
1260,1,1,Nodal Stage,N2
1260,1,1,Second Failure Type,no known failure
1260,1,1,Occurrence #,1st primary
1260,1,1,Status,Dead w/o disease
1260,1,1,Research lab HPV,HPV unknown
1260,1,1,Research lab p16,p16 unknown
1260,1,1,Date of Death,2003-05-26 00:00:00
1260,1,1,Clinical lab p16,p16 unknown
1260,1,1,Radiation Dosage,66.6
1260,1,1,Tumor Site,oropharynx
1260,1,1,Tumor Stage,T2
1260,1,1,Metastasis,M0
1260,1,1,First Failure Type,no known failure
1260,1,1,Treatment Modality,Sx & RT
1260,1,1,Overall Stage,IVa
1260,1,1,Age at Death,70.0
1260,1,1,Time to Death,2.7
1261,1,1,Occurrence #,1st primary
1261,1,1,First Failure Type,no known failure
1261,1,1,Treatment Modality,Sx
1261,1,1,Status,Alive unk disease
1261,1,1,Overall Stage,IVa
1261,1,1,Tumor Stage,T2
1261,1,1,Research lab p16,p16 unknown
1261,1,1,Tumor Site,oropharynx
1261,1,1,Second Failure Type,no known failure
1261,1,1,Metastasis,M0
1261,1,1,Clinical lab p16,p16 unknown
1261,1,1,Nodal Stage,N2
1261,1,1,Research lab HPV,HPV unknown
1262,1,1,Tumor Stage,T2
1262,1,1,Tumor Site,oropharynx
1262,1,1,First Failure Type,no known failure
1262,1,1,Initial Chemotherapy Agent,carbo/PTX
1262,1,1,Treatment Modality,CTX-RT
1262,1,1,Nodal Stage,N1
1262,1,1,Radiation Dosage,70.2
1262,1,1,Overall Stage,III
1262,1,1,Research lab HPV,HPV unknown
1262,1,1,Occurrence #,1st primary
1262,1,1,Metastasis,M0
1262,1,1,Clinical lab p16,p16 unknown
1262,1,1,Research lab p16,p16 unknown
1262,1,1,Status,Alive unk disease
1262,1,1,Second Failure Type,no known failure
1263,1,1,Status,Dead unk disease
1263,1,1,Research lab p16,p16 unknown
1263,1,1,First Failure Type,no known failure
1263,1,1,Age at Death,58.5
1263,1,1,Nodal Stage,N2
1263,1,1,Date of Death,2007-09-29 00:00:00
1263,1,1,Tumor Site,oropharynx
1263,1,1,Tumor Stage,T2
1263,1,1,Metastasis,M0
1263,1,1,Overall Stage,IVa
1263,1,1,Second Failure Type,no known failure
1263,1,1,Research lab HPV,HPV unknown
1263,1,1,Clinical lab p16,p16 unknown
1263,1,1,Occurrence #,1st primary
1263,1,1,Time to Death,0.2
1263,1,1,Treatment Modality,Unknown
1264,1,1,Status,Alive w/o disease
1264,1,1,Metastasis,M0
1264,1,1,Treatment Modality,CTX-RT
1264,1,1,Tumor Site,oropharynx
1264,1,1,Clinical lab p16,p16 unknown
1264,1,1,Initial Chemotherapy Agent,cis
1264,1,1,Nodal Stage,N1
1264,1,1,First Failure Type,no known failure
1264,1,1,Tumor Stage,T2
1264,1,1,Overall Stage,III
1264,1,1,Occurrence #,1st primary
1264,1,1,Radiation Dosage,70.2
1264,1,1,Research lab p16,p16 unknown
1264,1,1,Second Failure Type,no known failure
1264,1,1,Research lab HPV,HPV unknown
1265,1,1,Status,Alive w/ disease
1265,1,1,Clinical lab p16,p16 unknown
1265,1,1,Research lab HPV,HPV unknown
1265,1,1,Time to First Failure,0.6
1265,1,1,Occurrence #,recurrence
1265,1,1,Metastasis,Unknown
1265,1,1,Nodal Stage,Unknown
1265,1,1,Second Failure Type,no known failure
1265,1,1,Tumor Stage,Unknown
1265,1,1,Research lab p16,p16 unknown
1265,1,1,Overall Stage,Unknown
1265,1,1,Initial Chemotherapy Agent,HPV/MAGE
1265,1,1,Treatment Modality,Unknown
1265,1,1,First Failure Type,locoregional and distant
1265,1,1,Tumor Site,oropharynx
1266,1,1,Treatment Modality,CTX-RT
1266,1,1,Time to First Failure,0.7
1266,1,1,First Failure Treatment Modality,Sx
1266,1,1,Occurrence #,1st primary
1266,1,1,First Failure Type,locoregional
1266,1,1,Nodal Stage,N1
1266,1,1,Research lab HPV,HPV unknown
1266,1,1,Second Failure Type,no known failure
1266,1,1,First Failure Site,oropharynx
1266,1,1,Metastasis,M0
1266,1,1,Overall Stage,III
1266,1,1,Tumor Site,oropharynx
1266,1,1,Tumor Stage,T3
1266,1,1,Radiation Dosage,70.2
1266,1,1,Status,Alive unk disease
1266,1,1,Initial Chemotherapy Agent,cis
1266,1,1,Clinical lab p16,p16 unknown
1266,1,1,Research lab p16,p16 unknown
1267,1,1,Treatment Modality,Unknown
1267,1,1,Time to First Failure,-0.4
1267,1,1,Time to Death,1.7
1267,1,1,Research lab HPV,HPV unknown
1267,1,1,Date of Death,2009-08-01 00:00:00
1267,1,1,Occurrence #,recurrence
1267,1,1,Radiation Dosage,8
1267,1,1,Nodal Stage,N2
1267,1,1,Clinical lab p16,p16 unknown
1267,1,1,First Failure Type,distant
1267,1,1,Research lab p16,p16 unknown
1267,1,1,Age at Death,62.2
1267,1,1,Tumor Stage,T2
1267,1,1,Initial Chemotherapy Agent,dendritic cells
1267,1,1,Metastasis,M0
1267,1,1,Tumor Site,oropharynx
1267,1,1,Overall Stage,IVa
1267,1,1,Second Failure Type,no known failure
1267,1,1,Status,Dead unk disease
1268,1,1,Nodal Stage,N3
1268,1,1,Age at Death,84.5
1268,1,1,Overall Stage,IVb
1268,1,1,Tumor Site,oropharynx
1268,1,1,Date of Death,2002-09-14 00:00:00
1268,1,1,Metastasis,M0
1268,1,1,Research lab HPV,HPV unknown
1268,1,1,Second Failure Type,no known failure
1268,1,1,Radiation Dosage,25.2
1268,1,1,Status,Dead w/ disease
1268,1,1,Research lab p16,p16 unknown
1268,1,1,Time to Death,0.1
1268,1,1,Tumor Stage,T3
1268,1,1,Clinical lab p16,p16 unknown
1268,1,1,Occurrence #,recurrence
1268,1,1,Treatment Modality,RT
1268,1,1,First Failure Type,no known failure
1269,1,1,Second Failure Type,no known failure
1269,1,1,Time to Death,1.2
1269,1,1,First Failure Type,locoregional and distant
1269,1,1,Research lab HPV,HPV unknown
1269,1,1,Initial Chemotherapy Agent,cis/doce/5 FU
1269,1,1,Radiation Dosage,50.4
1269,1,1,Time to First Failure,0.1
1269,1,1,Occurrence #,recurrence
1269,1,1,Research lab p16,p16 unknown
1269,1,1,Metastasis,Unknown
1269,1,1,Treatment Modality,Sx & CTX-RT
1269,1,1,Clinical lab p16,p16 unknown
1269,1,1,Nodal Stage,Unknown
1269,1,1,Overall Stage,Unknown
1269,1,1,Second Line Chemotherapy Agent,carbo
1269,1,1,Age at Death,54.5
1269,1,1,Tumor Site,oropharynx
1269,1,1,Status,Dead w/ disease
1269,1,1,Tumor Stage,Unknown
1269,1,1,Date of Death,2009-02-02 00:00:00
1270,1,1,Clinical lab p16,p16 unknown
1270,1,1,Status,Alive unk disease
1270,1,1,Tumor Site,oropharynx
1270,1,1,Metastasis,M0
1270,1,1,Second Failure Type,no known failure
1270,1,1,Overall Stage,IVa
1270,1,1,First Failure Type,no known failure
1270,1,1,Treatment Modality,Sx
1270,1,1,Research lab p16,p16 unknown
1270,1,1,Occurrence #,recurrence
1270,1,1,Research lab HPV,HPV unknown
1270,1,1,Tumor Stage,T4a
1270,1,1,Nodal Stage,N0
1271,1,1,Overall Stage,IVb
1271,1,1,Age at Death,55.4
1271,1,1,Nodal Stage,N3
1271,1,1,Tumor Stage,T2
1271,1,1,Second Failure Type,no known failure
1271,1,1,Tumor Site,oropharynx
1271,1,1,Radiation Dosage,70.2
1271,1,1,Initial Chemotherapy Agent,cis
1271,1,1,First Failure Type,no known failure
1271,1,1,Research lab HPV,HPV unknown
1271,1,1,Time to Death,2.0
1271,1,1,Treatment Modality,CTX-RT
1271,1,1,Research lab p16,p16 unknown
1271,1,1,Status,Dead unk disease
1271,1,1,Date of Death,2011-07-03 00:00:00
1271,1,1,Occurrence #,1st primary
1271,1,1,Metastasis,M0
1271,1,1,Clinical lab p16,p16 unknown
1272,1,1,Overall Stage,II
1272,1,1,Status,Dead unk disease
1272,1,1,Nodal Stage,N0
1272,1,1,Clinical lab p16,p16 unknown
1272,1,1,Research lab p16,p16 unknown
1272,1,1,First Failure Type,locoregional and distant
1272,1,1,Occurrence #,recurrence
1272,1,1,Time to First Failure,0.0
1272,1,1,Research lab HPV,HPV unknown
1272,1,1,Initial Chemotherapy Agent,dendritic cells
1272,1,1,Treatment Modality,RT
1272,1,1,Time to Death,0.2
1272,1,1,Metastasis,M0
1272,1,1,Second Failure Type,no known failure
1272,1,1,Radiation Dosage,9
1272,1,1,Date of Death,2007-11-12 00:00:00
1272,1,1,Tumor Site,oropharynx
1272,1,1,Tumor Stage,T2
1272,1,1,Age at Death,41.5
1273,1,1,Date of Death,2009-07-12 00:00:00
1273,1,1,Age at Death,61.1
1273,1,1,Tumor Site,oropharynx
1273,1,1,Clinical lab p16,p16 unknown
1273,1,1,Overall Stage,IVb
1273,1,1,Research lab p16,p16 unknown
1273,1,1,Status,Dead w/ disease
1273,1,1,Treatment Modality,CTX-RT
1273,1,1,Occurrence #,1st primary
1273,1,1,Time to Death,1.1
1273,1,1,First Failure Type,distant
1273,1,1,Nodal Stage,N3
1273,1,1,Radiation Dosage,66.6
1273,1,1,Research lab HPV,HPV unknown
1273,1,1,Second Failure Type,no known failure
1273,1,1,Initial Chemotherapy Agent,cis
1273,1,1,Tumor Stage,T1
1273,1,1,Metastasis,M0
1273,1,1,Time to First Failure,0.4
1274,1,1,Second Failure Type,no known failure
1274,1,1,Date of Death,2011-02-08 00:00:00
1274,1,1,Metastasis,M0
1274,1,1,First Failure Type,no known failure
1274,1,1,Overall Stage,III
1274,1,1,Age at Death,49.9
1274,1,1,Research lab HPV,HPV unknown
1274,1,1,Time to Death,0.6
1274,1,1,Treatment Modality,Unknown
1274,1,1,Tumor Stage,T3
1274,1,1,Status,Dead w/ disease
1274,1,1,Occurrence #,1st primary
1274,1,1,Research lab p16,p16 unknown
1274,1,1,Nodal Stage,N0
1274,1,1,Clinical lab p16,p16 unknown
1274,1,1,Tumor Site,oropharynx
1275,1,1,Tumor Site,oropharynx
1275,1,1,Metastasis,M0
1275,1,1,Status,Dead w/ disease
1275,1,1,Clinical lab p16,p16 unknown
1275,1,1,Nodal Stage,N0
1275,1,1,Treatment Modality,Sx
1275,1,1,Second Failure Type,no known failure
1275,1,1,Occurrence #,other primary
1275,1,1,First Failure Type,no known failure
1275,1,1,Research lab HPV,HPV unknown
1275,1,1,Tumor Stage,T1
1275,1,1,Overall Stage,I
1275,1,1,Research lab p16,p16 unknown
1276,1,1,Time to Death,2.0
1276,1,1,Treatment Modality,Sx
1276,1,1,Research lab p16,p16 unknown
1276,1,1,Clinical lab p16,p16 unknown
1276,1,1,Nodal Stage,Unknown
1276,1,1,Time to First Failure,0.6
1276,1,1,Research lab HPV,HPV unknown
1276,1,1,Tumor Site,oropharynx
1276,1,1,Age at Death,48.7
1276,1,1,Overall Stage,IVc
1276,1,1,Tumor Stage,Unknown
1276,1,1,Occurrence #,recurrence
1276,1,1,Metastasis,M1
1276,1,1,Date of Death,2010-10-07 00:00:00
1276,1,1,Status,Dead w/ disease
1276,1,1,First Failure Type,distant
1276,1,1,Second Failure Type,no known failure
1277,1,1,Clinical lab p16,p16 unknown
1277,1,1,Status,Alive w/o disease
1277,1,1,Metastasis,M0
1277,1,1,Tumor Site,oropharynx
1277,1,1,Overall Stage,IVa
1277,1,1,Tumor Stage,T3
1277,1,1,Radiation Dosage,64.8
1277,1,1,Second Failure Type,no known failure
1277,1,1,Nodal Stage,N2
1277,1,1,First Failure Type,no known failure
1277,1,1,Treatment Modality,CTX-RT
1277,1,1,Research lab HPV,HPV positive
1277,1,1,Research lab p16,p16 unknown
1277,1,1,Initial Chemotherapy Agent,cis
1277,1,1,Occurrence #,1st primary
1278,1,1,Radiation Dosage,70.2
1278,1,1,Occurrence #,1st primary
1278,1,1,Tumor Site,oropharynx
1278,1,1,Overall Stage,IVa
1278,1,1,Tumor Stage,T3
1278,1,1,Nodal Stage,N2
1278,1,1,First Failure Type,no known failure
1278,1,1,Treatment Modality,CTX-RT
1278,1,1,Research lab p16,p16 unknown
1278,1,1,Initial Chemotherapy Agent,cis
1278,1,1,Clinical lab p16,p16 unknown
1278,1,1,Status,Alive w/o disease
1278,1,1,Metastasis,M0
1278,1,1,Research lab HPV,HPV positive
1278,1,1,Second Failure Type,no known failure
1279,1,1,Occurrence #,1st primary
1279,1,1,Nodal Stage,N2
1279,1,1,Date of Death,2010-06-25 00:00:00
1279,1,1,Status,Dead w/ disease
1279,1,1,Time to First Failure,0.1
1279,1,1,First Failure Type,distant
1279,1,1,Time to Death,0.6
1279,1,1,Treatment Modality,CTX-RT
1279,1,1,Initial Chemotherapy Agent,carbo
1279,1,1,Research lab HPV,HPV unknown
1279,1,1,Tumor Site,oropharynx
1279,1,1,Clinical lab p16,p16 unknown
1279,1,1,Age at Death,48.7
1279,1,1,Radiation Dosage,70.2
1279,1,1,Overall Stage,IVa
1279,1,1,Metastasis,M0
1279,1,1,Tumor Stage,T2
1279,1,1,Second Failure Type,no known failure
1279,1,1,Research lab p16,p16 unknown
1280,1,1,Status,Alive unk disease
1280,1,1,Second Failure Type,no known failure
1280,1,1,Clinical lab p16,p16 unknown
1280,1,1,First Failure Type,no known failure
1280,1,1,Research lab HPV,HPV unknown
1280,1,1,Nodal Stage,N0
1280,1,1,Tumor Stage,T1
1280,1,1,Overall Stage,I
1280,1,1,Tumor Site,oropharynx
1280,1,1,Research lab p16,p16 unknown
1280,1,1,Treatment Modality,Sx
1280,1,1,Occurrence #,1st primary
1280,1,1,Metastasis,M0
1281,1,1,Initial Chemotherapy Agent,cis
1281,1,1,Occurrence #,1st primary
1281,1,1,Research lab p16,p16 unknown
1281,1,1,Radiation Dosage,70.2
1281,1,1,Overall Stage,IVa
1281,1,1,Clinical lab p16,p16 unknown
1281,1,1,Metastasis,M0
1281,1,1,Second Failure Type,no known failure
1281,1,1,Tumor Stage,T3
1281,1,1,Nodal Stage,N2
1281,1,1,Status,Alive w/o disease
1281,1,1,Research lab HPV,HPV unknown
1281,1,1,First Failure Type,no known failure
1281,1,1,Treatment Modality,CTX-RT
1281,1,1,Tumor Site,oropharynx
1282,1,1,Tumor Stage,T3
1282,1,1,Time to Death,0.7
1282,1,1,Second Failure Type,no known failure
1282,1,1,First Failure Type,locoregional and distant
1282,1,1,Occurrence #,recurrence
1282,1,1,Date of Death,2007-03-06 00:00:00
1282,1,1,Treatment Modality,Sx & CTX-RT
1282,1,1,Radiation Dosage,60
1282,1,1,Research lab p16,p16 unknown
1282,1,1,Initial Chemotherapy Agent,carbo/PTX
1282,1,1,Nodal Stage,N0
1282,1,1,Overall Stage,III
1282,1,1,Time to First Failure,0.2
1282,1,1,Age at Death,47.6
1282,1,1,Tumor Site,oropharynx
1282,1,1,Research lab HPV,HPV unknown
1282,1,1,Status,Dead w/ disease
1282,1,1,Metastasis,M0
1282,1,1,Clinical lab p16,p16 unknown
1283,1,1,Research lab p16,p16 unknown
1283,1,1,Nodal Stage,N0
1283,1,1,Metastasis,M0
1283,1,1,Research lab HPV,HPV unknown
1283,1,1,Treatment Modality,Sx & RT
1283,1,1,First Failure Type,locoregional and distant
1283,1,1,Tumor Site,oropharynx
1283,1,1,Overall Stage,II
1283,1,1,Radiation Dosage,66
1283,1,1,Status,Alive w/ disease
1283,1,1,Occurrence #,1st primary
1283,1,1,Second Failure Type,no known failure
1283,1,1,Time to First Failure,-0.2
1283,1,1,Tumor Stage,T2
1283,1,1,Clinical lab p16,p16 unknown
1284,1,1,Metastasis,M0
1284,1,1,Occurrence #,1st primary
1284,1,1,Tumor Stage,T1
1284,1,1,Research lab HPV,HPV unknown
1284,1,1,Treatment Modality,Sx & CTX-RT
1284,1,1,Status,Alive w/o disease
1284,1,1,Second Failure Type,no known failure
1284,1,1,Research lab p16,p16 unknown
1284,1,1,Overall Stage,IVa
1284,1,1,Nodal Stage,N2
1284,1,1,First Failure Type,no known failure
1284,1,1,Tumor Site,oropharynx
1284,1,1,Clinical lab p16,p16 unknown
1284,1,1,Initial Chemotherapy Agent,cis
1284,1,1,Radiation Dosage,66.6
1285,1,1,Tumor Site,oropharynx
1285,1,1,Overall Stage,IVc
1285,1,1,First Failure Type,no known failure
1285,1,1,Tumor Stage,T2
1285,1,1,Research lab HPV,HPV unknown
1285,1,1,Nodal Stage,N2
1285,1,1,Metastasis,M1
1285,1,1,Research lab p16,p16 unknown
1285,1,1,Status,Alive w/o disease
1285,1,1,Treatment Modality,Sx
1285,1,1,Clinical lab p16,p16 unknown
1285,1,1,Second Failure Type,no known failure
1285,1,1,Occurrence #,recurrence
1286,1,1,First Failure Treatment Modality,Sx
1286,1,1,Second Failure Type,no known failure
1286,1,1,Tumor Site,oropharynx
1286,1,1,Radiation Dosage,unknown
1286,1,1,Status,Dead w/o disease
1286,1,1,Research lab HPV,HPV unknown
1286,1,1,Nodal Stage,N0
1286,1,1,Initial Chemotherapy Agent,cetux
1286,1,1,Occurrence #,1st primary
1286,1,1,Tumor Stage,T4a
1286,1,1,Metastasis,M0
1286,1,1,Time to First Failure,1.0
1286,1,1,First Failure Site,oropharynx
1286,1,1,First Failure Type,locoregional
1286,1,1,Research lab p16,p16 unknown
1286,1,1,Clinical lab p16,p16 unknown
1286,1,1,Overall Stage,IVa
1286,1,1,Treatment Modality,CTX-RT
1287,1,1,Clinical lab p16,p16 unknown
1287,1,1,Nodal Stage,N0
1287,1,1,Research lab HPV,HPV unknown
1287,1,1,Tumor Stage,T1
1287,1,1,Second Failure Type,no known failure
1287,1,1,Radiation Dosage,70.2
1287,1,1,Status,Dead w/ disease
1287,1,1,Age at Death,66.4
1287,1,1,First Failure Type,locoregional
1287,1,1,Time to First Failure,0.9
1287,1,1,Occurrence #,other primary
1287,1,1,Research lab p16,p16 unknown
1287,1,1,Overall Stage,I
1287,1,1,Date of Death,2001-09-23 00:00:00
1287,1,1,Metastasis,M0
1287,1,1,Time to Death,1.5
1287,1,1,Tumor Site,oropharynx
1287,1,1,Treatment Modality,RT
1288,1,1,Time to Death,0.1
1288,1,1,Tumor Stage,T3
1288,1,1,Clinical lab p16,p16 unknown
1288,1,1,First Failure Type,no known failure
1288,1,1,Metastasis,M0
1288,1,1,Date of Death,2010-04-23 00:00:00
1288,1,1,Age at Death,81.5
1288,1,1,Treatment Modality,Unknown
1288,1,1,Status,Dead w/ disease
1288,1,1,Research lab p16,p16 unknown
1288,1,1,Overall Stage,IVa
1288,1,1,Tumor Site,oropharynx
1288,1,1,Research lab HPV,HPV unknown
1288,1,1,Occurrence #,1st primary
1288,1,1,Second Failure Type,no known failure
1288,1,1,Nodal Stage,N2
1289,1,1,Age at Death,56.5
1289,1,1,Nodal Stage,N2
1289,1,1,Date of Death,2007-07-30 00:00:00
1289,1,1,Research lab p16,p16 unknown
1289,1,1,Research lab HPV,HPV unknown
1289,1,1,Metastasis,M1
1289,1,1,Status,Dead w/ disease
1289,1,1,Clinical lab p16,p16 unknown
1289,1,1,Overall Stage,IVc
1289,1,1,Time to Death,0.5
1289,1,1,Second Failure Type,no known failure
1289,1,1,Occurrence #,1st primary
1289,1,1,Tumor Site,oropharynx
1289,1,1,Tumor Stage,T4a
1289,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1289,1,1,First Failure Type,no known failure
1289,1,1,Treatment Modality,CTX
1290,1,1,Metastasis,M0
1290,1,1,Overall Stage,IVa
1290,1,1,Tumor Site,oropharynx
1290,1,1,First Failure Site,oropharynx
1290,1,1,Time to First Failure,0.5
1290,1,1,Research lab HPV,HPV unknown
1290,1,1,Occurrence #,1st primary
1290,1,1,First Failure Type,locoregional
1290,1,1,Treatment Modality,CTX-RT
1290,1,1,First Failure Treatment Modality,Sx
1290,1,1,Second Failure Type,no known failure
1290,1,1,Radiation Dosage,70.2
1290,1,1,Nodal Stage,N2
1290,1,1,Research lab p16,p16 unknown
1290,1,1,Status,Alive w/o disease
1290,1,1,Tumor Stage,T3
1290,1,1,Initial Chemotherapy Agent,doce/5-FU/cis
1290,1,1,Clinical lab p16,p16 unknown
1291,1,1,Clinical lab p16,p16 unknown
1291,1,1,Nodal Stage,N2
1291,1,1,Tumor Site,oropharynx
1291,1,1,Second Failure Type,no known failure
1291,1,1,Metastasis,M0
1291,1,1,Research lab p16,p16 unknown
1291,1,1,Overall Stage,IVa
1291,1,1,Tumor Stage,T3
1291,1,1,Research lab HPV,HPV unknown
1291,1,1,Treatment Modality,CTX-RT
1291,1,1,First Failure Type,no known failure
1291,1,1,Initial Chemotherapy Agent,cis
1291,1,1,Occurrence #,1st primary
1291,1,1,Radiation Dosage,70.2
1291,1,1,Status,Alive w/ disease
1292,1,1,Clinical lab p16,p16 unknown
1292,1,1,Treatment Modality,Unknown
1292,1,1,Time to Death,0.3
1292,1,1,First Failure Type,distant
1292,1,1,Metastasis,M1
1292,1,1,Research lab p16,p16 unknown
1292,1,1,Tumor Stage,Unknown
1292,1,1,Overall Stage,IVc
1292,1,1,Date of Death,2011-04-24 00:00:00
1292,1,1,Status,Dead w/ disease
1292,1,1,Age at Death,54.2
1292,1,1,Tumor Site,oropharynx
1292,1,1,Nodal Stage,Unknown
1292,1,1,Research lab HPV,HPV unknown
1292,1,1,Second Failure Type,no known failure
1292,1,1,Occurrence #,recurrence
1293,1,1,Nodal Stage,N0
1293,1,1,First Failure Type,no known failure
1293,1,1,Research lab p16,p16 unknown
1293,1,1,Overall Stage,II
1293,1,1,Status,Alive w/o disease
1293,1,1,Occurrence #,other primary
1293,1,1,Treatment Modality,Sx
1293,1,1,Clinical lab p16,p16 unknown
1293,1,1,Tumor Stage,T2
1293,1,1,Tumor Site,oropharynx
1293,1,1,Metastasis,M0
1293,1,1,Research lab HPV,HPV unknown
1293,1,1,Second Failure Type,no known failure
1294,1,1,Age at Death,57.2
1294,1,1,Metastasis,M0
1294,1,1,Occurrence #,recurrence
1294,1,1,Status,Dead unk disease
1294,1,1,Date of Death,2010-11-26 00:00:00
1294,1,1,Tumor Site,oropharynx
1294,1,1,Second Failure Type,no known failure
1294,1,1,Overall Stage,III
1294,1,1,Research lab p16,p16 unknown
1294,1,1,Clinical lab p16,p16 unknown
1294,1,1,Tumor Stage,T2
1294,1,1,Research lab HPV,HPV unknown
1294,1,1,Nodal Stage,N1
1294,1,1,Time to Death,0.2
1294,1,1,Treatment Modality,Sx
1294,1,1,First Failure Type,no known failure
1295,1,1,First Failure Treatment Modality,Sx
1295,1,1,Clinical lab p16,p16 unknown
1295,1,1,Second Failure Type,no known failure
1295,1,1,Radiation Dosage,70.2
1295,1,1,Status,Alive unk disease
1295,1,1,Tumor Stage,T3
1295,1,1,First Failure Type,locoregional and distant
1295,1,1,Tumor Site,oropharynx
1295,1,1,Time to First Failure,0.9
1295,1,1,Treatment Modality,CTX-RT
1295,1,1,Nodal Stage,N0
1295,1,1,Research lab p16,p16 unknown
1295,1,1,Overall Stage,III
1295,1,1,Research lab HPV,HPV unknown
1295,1,1,Metastasis,M0
1295,1,1,Initial Chemotherapy Agent,cis
1295,1,1,First Failure Site,oropharynx
1295,1,1,Occurrence #,1st primary
1296,1,1,Time to Death,0.5
1296,1,1,First Failure Initial Chemotherapy Agent,cis/doce/carbo
1296,1,1,Clinical lab p16,p16 unknown
1296,1,1,Tumor Site,oropharynx
1296,1,1,Occurrence #,1st primary
1296,1,1,First Failure Radiation Dosage,50.4
1296,1,1,Metastasis,M0
1296,1,1,Nodal Stage,N2
1296,1,1,Date of Death,2009-04-13 00:00:00
1296,1,1,Research lab HPV,HPV positive
1296,1,1,Second Failure Type,no known failure
1296,1,1,Status,Dead w/ disease
1296,1,1,Age at Death,53.7
1296,1,1,First Failure Treatment Modality,CTX-RT
1296,1,1,First Failure Type,distant
1296,1,1,Time to First Failure,1.3
1296,1,1,Research lab p16,p16 unknown
1296,1,1,Tumor Stage,T1
1296,1,1,Radiation Dosage,67
1296,1,1,Treatment Modality,Sx & CTX-RT
1296,1,1,Overall Stage,IVa
1296,1,1,Initial Chemotherapy Agent,carbo/doce
1297,1,1,Time to First Failure,0.4
1297,1,1,Occurrence #,recurrence
1297,1,1,Research lab HPV,HPV unknown
1297,1,1,Tumor Site,oropharynx
1297,1,1,Research lab p16,p16 unknown
1297,1,1,Nodal Stage,Unknown
1297,1,1,Treatment Modality,Sx
1297,1,1,Clinical lab p16,p16 unknown
1297,1,1,Metastasis,Unknown
1297,1,1,Tumor Stage,Unknown
1297,1,1,First Failure Type,locoregional
1297,1,1,Overall Stage,Unknown
1297,1,1,Status,Alive w/o disease
1297,1,1,Second Failure Type,no known failure
1298,1,1,Nodal Stage,N0
1298,1,1,Clinical lab p16,p16 unknown
1298,1,1,Radiation Dosage,60
1298,1,1,Status,Alive w/o disease
1298,1,1,Treatment Modality,Sx & CTX-RT
1298,1,1,Occurrence #,other primary
1298,1,1,Research lab p16,p16 unknown
1298,1,1,Overall Stage,III
1298,1,1,Metastasis,M0
1298,1,1,Initial Chemotherapy Agent,carbo/PTX
1298,1,1,Research lab HPV,HPV unknown
1298,1,1,Second Failure Type,no known failure
1298,1,1,Tumor Site,oropharynx
1298,1,1,Tumor Stage,T3
1298,1,1,First Failure Type,no known failure
1299,1,1,Treatment Modality,CTX-RT
1299,1,1,Tumor Stage,T2
1299,1,1,Metastasis,M0
1299,1,1,Research lab HPV,HPV unknown
1299,1,1,Initial Chemotherapy Agent,cis
1299,1,1,Clinical lab p16,p16 unknown
1299,1,1,Second Failure Type,no known failure
1299,1,1,Radiation Dosage,70.2
1299,1,1,Nodal Stage,N2
1299,1,1,Overall Stage,IVa
1299,1,1,First Failure Type,no known failure
1299,1,1,Status,Alive w/o disease
1299,1,1,Occurrence #,1st primary
1299,1,1,Tumor Site,oropharynx
1299,1,1,Research lab p16,p16 unknown
1300,1,1,Second Failure Type,no known failure
1300,1,1,Clinical lab p16,p16 unknown
1300,1,1,Overall Stage,IVc
1300,1,1,Nodal Stage,Unknown
1300,1,1,Age at Death,56.5
1300,1,1,First Failure Type,no known failure
1300,1,1,Time to Death,0.0
1300,1,1,Research lab p16,p16 unknown
1300,1,1,Status,Dead w/ disease
1300,1,1,Tumor Site,oropharynx
1300,1,1,Date of Death,2010-09-27 00:00:00
1300,1,1,Tumor Stage,Unknown
1300,1,1,Treatment Modality,Unknown
1300,1,1,Metastasis,M1
1300,1,1,Research lab HPV,HPV unknown
1300,1,1,Occurrence #,recurrence
1301,1,1,Clinical lab p16,p16 unknown
1301,1,1,First Failure Type,no known failure
1301,1,1,Radiation Dosage,70.2
1301,1,1,Overall Stage,IVa
1301,1,1,Metastasis,M0
1301,1,1,Second Failure Type,no known failure
1301,1,1,Treatment Modality,CTX-RT
1301,1,1,Tumor Site,oropharynx
1301,1,1,Nodal Stage,N2
1301,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1301,1,1,Occurrence #,1st primary
1301,1,1,Research lab p16,p16 unknown
1301,1,1,Tumor Stage,T3
1301,1,1,Status,Alive unk disease
1301,1,1,Research lab HPV,HPV unknown
1302,1,1,Metastasis,M0
1302,1,1,Status,Alive w/o disease
1302,1,1,Research lab HPV,HPV unknown
1302,1,1,Tumor Stage,T3
1302,1,1,Occurrence #,1st primary
1302,1,1,Nodal Stage,N0
1302,1,1,Tumor Site,oropharynx
1302,1,1,First Failure Type,no known failure
1302,1,1,Radiation Dosage,70.2
1302,1,1,Second Failure Type,no known failure
1302,1,1,Overall Stage,III
1302,1,1,Treatment Modality,CTX-RT
1302,1,1,Clinical lab p16,p16 unknown
1302,1,1,Initial Chemotherapy Agent,cis
1302,1,1,Research lab p16,p16 unknown
1303,1,1,Overall Stage,III
1303,1,1,Initial Chemotherapy Agent,cis
1303,1,1,Radiation Dosage,70.2
1303,1,1,Research lab p16,p16 unknown
1303,1,1,Metastasis,M0
1303,1,1,Tumor Site,oropharynx
1303,1,1,Research lab HPV,HPV unknown
1303,1,1,Tumor Stage,T1
1303,1,1,Second Line Chemotherapy Agent,Carbo
1303,1,1,Date of Death,2015-06-01 00:00:00
1303,1,1,First Failure Type,distant
1303,1,1,Clinical lab p16,p16 unknown
1303,1,1,Occurrence #,1st primary
1303,1,1,Age at Death,64.1
1303,1,1,Nodal Stage,N1
1303,1,1,Status,Dead w/ disease
1303,1,1,Time to First Failure,4.5
1303,1,1,Time to Death,7.5
1303,1,1,Second Failure Type,no known failure
1303,1,1,Treatment Modality,CTX-RT
1304,1,1,Research lab p16,p16 unknown
1304,1,1,Treatment Modality,CTX-RT
1304,1,1,Occurrence #,1st primary
1304,1,1,Nodal Stage,N2
1304,1,1,First Failure Type,no known failure
1304,1,1,Second Failure Type,no known failure
1304,1,1,Research lab HPV,HPV unknown
1304,1,1,Tumor Stage,T1
1304,1,1,Status,Alive w/o disease
1304,1,1,Radiation Dosage,70.2
1304,1,1,Tumor Site,oropharynx
1304,1,1,Overall Stage,IVa
1304,1,1,Initial Chemotherapy Agent,cis
1304,1,1,Clinical lab p16,p16 unknown
1304,1,1,Second Line Chemotherapy Agent,carbo/PTX
1304,1,1,Metastasis,M0
1305,1,1,Radiation Dosage,70.2
1305,1,1,Clinical lab p16,p16 unknown
1305,1,1,Second Failure Type,no known failure
1305,1,1,Research lab p16,p16 unknown
1305,1,1,Tumor Stage,T3
1305,1,1,Tumor Site,oropharynx
1305,1,1,Metastasis,M0
1305,1,1,Date of Death,2011-06-09 00:00:00
1305,1,1,Treatment Modality,CTX-RT
1305,1,1,Occurrence #,1st primary
1305,1,1,Research lab HPV,HPV unknown
1305,1,1,First Failure Type,no known failure
1305,1,1,Status,Dead w/ disease
1305,1,1,Age at Death,77.1
1305,1,1,Initial Chemotherapy Agent,unknown
1305,1,1,Nodal Stage,N3
1305,1,1,Overall Stage,IVb
1305,1,1,Time to Death,0.3
1306,1,1,Time to First Failure,0.6
1306,1,1,Research lab HPV,HPV unknown
1306,1,1,Nodal Stage,N2
1306,1,1,Status,Dead w/ disease
1306,1,1,Tumor Stage,T2
1306,1,1,Date of Death,2008-10-26 00:00:00
1306,1,1,Overall Stage,II
1306,1,1,Treatment Modality,CTX-RT
1306,1,1,Time to Death,1.2
1306,1,1,Research lab p16,p16 unknown
1306,1,1,Occurrence #,1st primary
1306,1,1,Metastasis,M0
1306,1,1,Tumor Site,oropharynx
1306,1,1,Second Failure Type,no known failure
1306,1,1,Age at Death,63.5
1306,1,1,Clinical lab p16,p16 unknown
1306,1,1,Radiation Dosage,70.2
1306,1,1,First Failure Type,locoregional and distant
1306,1,1,Initial Chemotherapy Agent,cetux/PTX/carbo
1307,1,1,Occurrence #,1st primary
1307,1,1,Age at Death,52.7
1307,1,1,Time to First Failure,6.0
1307,1,1,Tumor Site,oropharynx
1307,1,1,Clinical lab p16,p16 unknown
1307,1,1,Research lab p16,p16 unknown
1307,1,1,Treatment Modality,Sx & CTX-RT
1307,1,1,Time to Death,7.0
1307,1,1,Status,Dead unk disease
1307,1,1,Second Failure Type,no known failure
1307,1,1,Initial Chemotherapy Agent,carbo/PTX
1307,1,1,Overall Stage,IVa
1307,1,1,Metastasis,M0
1307,1,1,Nodal Stage,N0
1307,1,1,First Failure Type,locoregional
1307,1,1,Tumor Stage,T4a
1307,1,1,First Failure Site,oropharynx
1307,1,1,Date of Death,2009-11-13 00:00:00
1307,1,1,First Failure Treatment Modality,Sx
1307,1,1,Radiation Dosage,unknown
1307,1,1,Research lab HPV,HPV unknown
1309,1,1,Tumor Site,oropharynx
1309,1,1,Clinical lab p16,p16 unknown
1309,1,1,First Failure Type,no known failure
1309,1,1,Age at Death,50.7
1309,1,1,Treatment Modality,CTX-RT
1309,1,1,Metastasis,M0
1309,1,1,Time to Death,0.4
1309,1,1,Date of Death,2002-08-13 00:00:00
1309,1,1,Radiation Dosage,unknown
1309,1,1,Nodal Stage,N3
1309,1,1,Status,Dead unk disease
1309,1,1,Initial Chemotherapy Agent,carbo/PTX
1309,1,1,Research lab p16,p16 unknown
1309,1,1,Second Failure Type,no known failure
1309,1,1,Overall Stage,IVb
1309,1,1,Research lab HPV,HPV unknown
1309,1,1,Tumor Stage,T3
1309,1,1,Occurrence #,1st primary
1310,1,1,Metastasis,M0
1310,1,1,Overall Stage,I
1310,1,1,Status,Dead w/o disease
1310,1,1,First Failure Type,no known failure
1310,1,1,Nodal Stage,N0
1310,1,1,Clinical lab p16,p16 unknown
1310,1,1,Tumor Stage,T1
1310,1,1,Treatment Modality,Sx
1310,1,1,Research lab HPV,HPV unknown
1310,1,1,Second Failure Type,no known failure
1310,1,1,Research lab p16,p16 unknown
1310,1,1,Tumor Site,oropharynx
1310,1,1,Occurrence #,recurrence
1311,1,1,First Failure Type,no known failure
1311,1,1,Tumor Site,oropharynx
1311,1,1,Nodal Stage,N0
1311,1,1,Date of Death,2011-06-21 00:00:00
1311,1,1,Time to Death,7.4
1311,1,1,Clinical lab p16,p16 unknown
1311,1,1,Tumor Stage,T4a
1311,1,1,Second Failure Type,no known failure
1311,1,1,Research lab p16,p16 unknown
1311,1,1,Research lab HPV,HPV unknown
1311,1,1,Treatment Modality,Sx
1311,1,1,Overall Stage,IVa
1311,1,1,Occurrence #,other primary
1311,1,1,Age at Death,75.8
1311,1,1,Metastasis,M0
1311,1,1,Status,Dead unk disease
1312,1,1,Date of Death,2010-01-12 00:00:00
1312,1,1,First Failure Type,no known failure
1312,1,1,Time to Death,0.5
1312,1,1,Tumor Stage,T3
1312,1,1,Second Failure Type,no known failure
1312,1,1,Tumor Site,oropharynx
1312,1,1,Metastasis,M0
1312,1,1,Age at Death,82.0
1312,1,1,Clinical lab p16,p16 unknown
1312,1,1,Nodal Stage,N0
1312,1,1,Treatment Modality,Unknown
1312,1,1,Status,Dead w/ disease
1312,1,1,Research lab p16,p16 unknown
1312,1,1,Research lab HPV,HPV unknown
1312,1,1,Occurrence #,1st primary
1312,1,1,Overall Stage,III
1313,1,1,Metastasis,M0
1313,1,1,Overall Stage,IVa
1313,1,1,Tumor Stage,T1
1313,1,1,Initial Chemotherapy Agent,cis/vandetanib
1313,1,1,Second Failure Type,no known failure
1313,1,1,Research lab HPV,HPV unknown
1313,1,1,Research lab p16,p16 unknown
1313,1,1,Occurrence #,1st primary
1313,1,1,Treatment Modality,Sx & CTX-RT
1313,1,1,Clinical lab p16,p16 unknown
1313,1,1,Tumor Site,oropharynx
1313,1,1,Radiation Dosage,62.9
1313,1,1,Status,Alive w/o disease
1313,1,1,First Failure Type,no known failure
1313,1,1,Nodal Stage,N2
1314,1,1,Radiation Dosage,70.2
1314,1,1,Nodal Stage,N3
1314,1,1,Tumor Site,oropharynx
1314,1,1,Status,Alive w/o disease
1314,1,1,Treatment Modality,Sx & CTX-RT
1314,1,1,Initial Chemotherapy Agent,cis
1314,1,1,Occurrence #,1st primary
1314,1,1,Research lab p16,p16 unknown
1314,1,1,First Failure Type,no known failure
1314,1,1,Research lab HPV,HPV unknown
1314,1,1,Clinical lab p16,p16 unknown
1314,1,1,Overall Stage,IVb
1314,1,1,Metastasis,M0
1314,1,1,Second Failure Type,no known failure
1314,1,1,Tumor Stage,T3
1315,1,1,Research lab HPV,HPV unknown
1315,1,1,Clinical lab p16,p16 unknown
1315,1,1,Date of Death,2003-10-10 00:00:00
1315,1,1,Research lab p16,p16 unknown
1315,1,1,Treatment Modality,RT
1315,1,1,Time to First Failure,1.3
1315,1,1,Occurrence #,1st primary
1315,1,1,Status,Dead w/ disease
1315,1,1,Radiation Dosage,unknown
1315,1,1,Nodal Stage,N0
1315,1,1,Age at Death,52.8
1315,1,1,Second Failure Type,no known failure
1315,1,1,Overall Stage,IVa
1315,1,1,First Failure Type,locoregional
1315,1,1,Tumor Site,oropharynx
1315,1,1,Metastasis,M0
1315,1,1,Tumor Stage,T4a
1315,1,1,Time to Death,2.3
1316,1,1,Age at Death,76.4
1316,1,1,Occurrence #,recurrence
1316,1,1,Tumor Stage,T4a
1316,1,1,Second Failure Type,no known failure
1316,1,1,Nodal Stage,N0
1316,1,1,Treatment Modality,Sx
1316,1,1,First Failure Type,no known failure
1316,1,1,Status,Dead unk disease
1316,1,1,Overall Stage,IVa
1316,1,1,Research lab HPV,HPV unknown
1316,1,1,Research lab p16,p16 unknown
1316,1,1,Date of Death,2001-08-23 00:00:00
1316,1,1,Clinical lab p16,p16 unknown
1316,1,1,Time to Death,1.0
1316,1,1,Metastasis,M0
1316,1,1,Tumor Site,oropharynx
1317,1,1,Metastasis,M0
1317,1,1,Occurrence #,1st primary
1317,1,1,Research lab HPV,HPV unknown
1317,1,1,Overall Stage,III
1317,1,1,Research lab p16,p16 unknown
1317,1,1,First Failure Type,no known failure
1317,1,1,Second Failure Type,no known failure
1317,1,1,Tumor Stage,T3
1317,1,1,Tumor Site,oropharynx
1317,1,1,Clinical lab p16,p16 unknown
1317,1,1,Status,Alive w/o disease
1317,1,1,Nodal Stage,N0
1317,1,1,Treatment Modality,Sx
1318,1,1,Tumor Site,oropharynx
1318,1,1,Overall Stage,III
1318,1,1,Occurrence #,1st primary
1318,1,1,Clinical lab p16,p16 unknown
1318,1,1,Research lab HPV,HPV positive
1318,1,1,Second Failure Type,no known failure
1318,1,1,Tumor Stage,T3
1318,1,1,Status,Alive unk disease
1318,1,1,Nodal Stage,N1
1318,1,1,Treatment Modality,Sx
1318,1,1,Research lab p16,p16 unknown
1318,1,1,Metastasis,M0
1318,1,1,First Failure Type,no known failure
1319,1,1,Treatment Modality,RT
1319,1,1,Research lab p16,p16 unknown
1319,1,1,Tumor Site,oropharynx
1319,1,1,Nodal Stage,N0
1319,1,1,Metastasis,M0
1319,1,1,Clinical lab p16,p16 unknown
1319,1,1,First Failure Type,no known failure
1319,1,1,Tumor Stage,T2
1319,1,1,Occurrence #,1st primary
1319,1,1,Radiation Dosage,74.4
1319,1,1,Overall Stage,II
1319,1,1,Research lab HPV,HPV unknown
1319,1,1,Status,Alive w/o disease
1319,1,1,Second Failure Type,no known failure
1320,1,1,First Failure Type,locoregional and distant
1320,1,1,Second Failure Type,no known failure
1320,1,1,Tumor Site,oropharynx
1320,1,1,Date of Death,2009-03-07 00:00:00
1320,1,1,Nodal Stage,Unknown
1320,1,1,Age at Death,89.5
1320,1,1,Tumor Stage,Unknown
1320,1,1,Metastasis,M1
1320,1,1,Radiation Dosage,37.5
1320,1,1,Treatment Modality,RT
1320,1,1,Occurrence #,1st primary
1320,1,1,Time to Death,1.4
1320,1,1,Research lab HPV,HPV unknown
1320,1,1,Status,Dead w/ disease
1320,1,1,Time to First Failure,0.6
1320,1,1,Overall Stage,IVc
1320,1,1,Research lab p16,p16 unknown
1320,1,1,Clinical lab p16,p16 unknown
1322,1,1,Nodal Stage,N2
1322,1,1,First Failure Type,distant
1322,1,1,Second Failure Type,no known failure
1322,1,1,Clinical lab p16,p16 unknown
1322,1,1,Metastasis,M0
1322,1,1,Time to Death,9.8
1322,1,1,Tumor Stage,T4a
1322,1,1,Time to First Failure,9.4
1322,1,1,Overall Stage,IVa
1322,1,1,Research lab HPV,HPV unknown
1322,1,1,Initial Chemotherapy Agent,PTX/cap
1322,1,1,Research lab p16,p16 unknown
1322,1,1,Tumor Site,oropharynx
1322,1,1,Status,Dead w/ disease
1322,1,1,Radiation Dosage,72
1322,1,1,Age at Death,54.3
1322,1,1,Occurrence #,1st primary
1322,1,1,Treatment Modality,CTX-RT
1322,1,1,Date of Death,2010-08-29 00:00:00
1323,1,1,Status,Dead w/o disease
1323,1,1,First Failure Type,no known failure
1323,1,1,Overall Stage,IVa
1323,1,1,Date of Death,2004-11-10 00:00:00
1323,1,1,Radiation Dosage,72
1323,1,1,Tumor Stage,T4a
1323,1,1,Occurrence #,1st primary
1323,1,1,Age at Death,72.0
1323,1,1,Treatment Modality,CTX-RT
1323,1,1,Time to Death,3.2
1323,1,1,Nodal Stage,N0
1323,1,1,Research lab HPV,HPV unknown
1323,1,1,Second Failure Type,no known failure
1323,1,1,Metastasis,M0
1323,1,1,Initial Chemotherapy Agent,unknown
1323,1,1,Research lab p16,p16 unknown
1323,1,1,Clinical lab p16,p16 unknown
1323,1,1,Tumor Site,oropharynx
1324,1,1,Occurrence #,recurrence
1324,1,1,Research lab p16,p16 unknown
1324,1,1,Tumor Stage,T3
1324,1,1,Second Failure Type,no known failure
1324,1,1,Metastasis,Unknown
1324,1,1,Tumor Site,oropharynx
1324,1,1,Date of Death,2011-01-05 00:00:00
1324,1,1,Treatment Modality,Sx
1324,1,1,Overall Stage,Unknown
1324,1,1,Age at Death,92.1
1324,1,1,Status,Dead unk disease
1324,1,1,Clinical lab p16,p16 unknown
1324,1,1,Time to Death,1.4
1324,1,1,First Failure Type,no known failure
1324,1,1,Research lab HPV,HPV unknown
1324,1,1,Nodal Stage,Unknown
1325,1,1,Overall Stage,II
1325,1,1,Research lab p16,p16 unknown
1325,1,1,Tumor Site,oropharynx
1325,1,1,Second Failure Type,no known failure
1325,1,1,Status,Alive w/o disease
1325,1,1,Research lab HPV,HPV unknown
1325,1,1,Radiation Dosage,66.6
1325,1,1,Nodal Stage,N0
1325,1,1,Occurrence #,1st primary
1325,1,1,Clinical lab p16,p16 unknown
1325,1,1,Tumor Stage,T2
1325,1,1,Metastasis,M0
1325,1,1,First Failure Type,no known failure
1325,1,1,Treatment Modality,RT
1326,1,1,Time to Death,0.7
1326,1,1,Clinical lab p16,p16 unknown
1326,1,1,Age at Death,48.3
1326,1,1,Second Failure Type,no known failure
1326,1,1,Nodal Stage,N0
1326,1,1,Research lab HPV,HPV unknown
1326,1,1,Status,Dead w/ disease
1326,1,1,Metastasis,M0
1326,1,1,First Failure Type,no known failure
1326,1,1,Overall Stage,IVa
1326,1,1,Radiation Dosage,9.6
1326,1,1,Date of Death,2009-02-14 00:00:00
1326,1,1,Treatment Modality,CTX-RT
1326,1,1,Tumor Site,oropharynx
1326,1,1,Research lab p16,p16 unknown
1326,1,1,Initial Chemotherapy Agent,doce/carbo/5FU
1326,1,1,Tumor Stage,T4a
1326,1,1,Occurrence #,other primary
1327,1,1,Treatment Modality,Unknown
1327,1,1,Nodal Stage,N2
1327,1,1,Research lab p16,p16 unknown
1327,1,1,Tumor Stage,T2
1327,1,1,Clinical lab p16,p16 unknown
1327,1,1,Occurrence #,1st primary
1327,1,1,Overall Stage,IVa
1327,1,1,Metastasis,M0
1327,1,1,First Failure Type,no known failure
1327,1,1,Research lab HPV,HPV unknown
1327,1,1,Second Failure Type,no known failure
1327,1,1,Tumor Site,oropharynx
1327,1,1,Status,Alive unk disease
1328,1,1,Nodal Stage,N0
1328,1,1,Clinical lab p16,p16 unknown
1328,1,1,First Failure Type,no known failure
1328,1,1,Research lab HPV,HPV unknown
1328,1,1,Treatment Modality,RT
1328,1,1,Research lab p16,p16 unknown
1328,1,1,Tumor Site,larynx
1328,1,1,Second Failure Type,no known failure
1328,1,1,Tumor Stage,T2
1328,1,1,Occurrence #,1st primary
1328,1,1,Status,Alive unk disease
1328,1,1,Overall Stage,II
1328,1,1,Radiation Dosage,70.2
1328,1,1,Metastasis,M0
1329,1,1,Research lab p16,p16 unknown
1329,1,1,Overall Stage,I
1329,1,1,Tumor Site,larynx
1329,1,1,Time to Death,0.7
1329,1,1,First Failure Type,no known failure
1329,1,1,Status,Dead unk disease
1329,1,1,Second Failure Type,no known failure
1329,1,1,Research lab HPV,HPV unknown
1329,1,1,Occurrence #,1st primary
1329,1,1,Age at Death,63.7
1329,1,1,Treatment Modality,RT
1329,1,1,Clinical lab p16,p16 unknown
1329,1,1,Date of Death,2008-07-22 00:00:00
1329,1,1,Radiation Dosage,50
1329,1,1,Metastasis,M0
1329,1,1,Tumor Stage,T1
1329,1,1,Nodal Stage,N0
1330,1,1,Time to Death,9.6
1330,1,1,Metastasis,M0
1330,1,1,Second Failure Type,no known failure
1330,1,1,Treatment Modality,Sx
1330,1,1,First Failure Type,no known failure
1330,1,1,Tumor Stage,T4a
1330,1,1,Date of Death,2009-10-19 00:00:00
1330,1,1,Status,Dead unk disease
1330,1,1,Nodal Stage,N0
1330,1,1,Research lab p16,p16 unknown
1330,1,1,Clinical lab p16,p16 unknown
1330,1,1,Age at Death,59.5
1330,1,1,Occurrence #,1st primary
1330,1,1,Overall Stage,IVa
1330,1,1,Research lab HPV,HPV unknown
1330,1,1,Tumor Site,larynx
1331,1,1,Time to Death,1.0
1331,1,1,Nodal Stage,N2
1331,1,1,Clinical lab p16,p16 unknown
1331,1,1,Tumor Stage,T1
1331,1,1,Overall Stage,IVa
1331,1,1,Status,Dead w/ disease
1331,1,1,Time to First Failure,0.6
1331,1,1,Age at Death,58.1
1331,1,1,Radiation Dosage,unknown
1331,1,1,Date of Death,2001-04-19 00:00:00
1331,1,1,Treatment Modality,Sx & RT
1331,1,1,Occurrence #,1st primary
1331,1,1,Research lab HPV,HPV unknown
1331,1,1,Second Failure Type,no known failure
1331,1,1,First Failure Type,locoregional
1331,1,1,Tumor Site,larynx
1331,1,1,Metastasis,M0
1331,1,1,Research lab p16,p16 unknown
1332,1,1,Research lab HPV,HPV unknown
1332,1,1,Status,Dead w/o disease
1332,1,1,First Failure Type,no known failure
1332,1,1,Second Failure Type,no known failure
1332,1,1,Nodal Stage,N0
1332,1,1,Research lab p16,p16 unknown
1332,1,1,Tumor Site,larynx
1332,1,1,Occurrence #,1st primary
1332,1,1,Treatment Modality,Sx
1332,1,1,Overall Stage,I
1332,1,1,Metastasis,M0
1332,1,1,Tumor Stage,T1
1332,1,1,Clinical lab p16,p16 unknown
1333,1,1,Radiation Dosage,59.4
1333,1,1,Occurrence #,1st primary
1333,1,1,Tumor Site,larynx
1333,1,1,Nodal Stage,N2
1333,1,1,Initial Chemotherapy Agent,cis
1333,1,1,Research lab HPV,HPV unknown
1333,1,1,Clinical lab p16,p16 unknown
1333,1,1,Status,Alive w/o disease
1333,1,1,Tumor Stage,T3
1333,1,1,Overall Stage,IVa
1333,1,1,Second Failure Type,no known failure
1333,1,1,First Failure Type,no known failure
1333,1,1,Treatment Modality,Sx & CTX-RT
1333,1,1,Research lab p16,p16 unknown
1333,1,1,Metastasis,M0
1334,1,1,Occurrence #,1st primary
1334,1,1,First Failure Type,no known failure
1334,1,1,Metastasis,M0
1334,1,1,Time to Death,1.2
1334,1,1,Nodal Stage,N2
1334,1,1,Research lab p16,p16 unknown
1334,1,1,Tumor Site,larynx
1334,1,1,Age at Death,54.2
1334,1,1,Treatment Modality,Sx
1334,1,1,Tumor Stage,T4a
1334,1,1,Second Failure Type,no known failure
1334,1,1,Research lab HPV,HPV unknown
1334,1,1,Clinical lab p16,p16 unknown
1334,1,1,Overall Stage,IVa
1334,1,1,Status,Dead unk disease
1334,1,1,Date of Death,2009-03-19 00:00:00
1335,1,1,Overall Stage,IVa
1335,1,1,Radiation Dosage,unknown
1335,1,1,Tumor Stage,T4a
1335,1,1,Treatment Modality,Sx & RT
1335,1,1,Clinical lab p16,p16 unknown
1335,1,1,First Failure Type,no known failure
1335,1,1,Second Failure Type,no known failure
1335,1,1,Occurrence #,1st primary
1335,1,1,Status,Alive w/o disease
1335,1,1,Research lab p16,p16 unknown
1335,1,1,Metastasis,M0
1335,1,1,Tumor Site,larynx
1335,1,1,Nodal Stage,N0
1335,1,1,Research lab HPV,HPV unknown
1336,1,1,Treatment Modality,RT
1336,1,1,Radiation Dosage,74.4
1336,1,1,Tumor Stage,T3
1336,1,1,Nodal Stage,N0
1336,1,1,Time to Death,1.4
1336,1,1,Occurrence #,1st primary
1336,1,1,Overall Stage,III
1336,1,1,First Failure Type,no known failure
1336,1,1,Metastasis,M0
1336,1,1,Date of Death,2002-05-03 00:00:00
1336,1,1,Clinical lab p16,p16 unknown
1336,1,1,Status,Dead unk disease
1336,1,1,Age at Death,54.6
1336,1,1,Tumor Site,larynx
1336,1,1,Research lab p16,p16 unknown
1336,1,1,Second Failure Type,no known failure
1336,1,1,Research lab HPV,HPV unknown
1337,1,1,Second Failure Type,no known failure
1337,1,1,Overall Stage,II
1337,1,1,Nodal Stage,N0
1337,1,1,Tumor Stage,T2
1337,1,1,Occurrence #,recurrence
1337,1,1,First Failure Type,no known failure
1337,1,1,Status,Alive unk disease
1337,1,1,Research lab HPV,HPV unknown
1337,1,1,Metastasis,M0
1337,1,1,Treatment Modality,Sx
1337,1,1,Clinical lab p16,p16 unknown
1337,1,1,Tumor Site,larynx
1337,1,1,Research lab p16,p16 unknown
1338,1,1,Clinical lab p16,p16 unknown
1338,1,1,First Failure Site,larynx
1338,1,1,Occurrence #,1st primary
1338,1,1,Status,Dead w/ disease
1338,1,1,Time to First Failure,0.8
1338,1,1,Second Failure Type,no known failure
1338,1,1,First Failure Radiation Dosage,60
1338,1,1,Tumor Site,larynx
1338,1,1,Age at Death,63.8
1338,1,1,First Failure Treatment Modality,CTX-RT
1338,1,1,First Failure Type,locoregional
1338,1,1,Radiation Dosage,59.4
1338,1,1,Metastasis,M0
1338,1,1,Overall Stage,IVa
1338,1,1,Time to Death,1.9
1338,1,1,Research lab HPV,HPV unknown
1338,1,1,Nodal Stage,N0
1338,1,1,Research lab p16,p16 unknown
1338,1,1,Tumor Stage,T4a
1338,1,1,Treatment Modality,Sx & RT
1338,1,1,Date of Death,2008-05-03 00:00:00
1338,1,1,First Failure Initial Chemotherapy Agent,carbo
1339,1,1,Research lab HPV,HPV unknown
1339,1,1,Clinical lab p16,p16 unknown
1339,1,1,Research lab p16,p16 unknown
1339,1,1,Tumor Stage,T1
1339,1,1,Status,Dead unk disease
1339,1,1,Tumor Site,larynx
1339,1,1,Date of Death,2008-08-18 00:00:00
1339,1,1,Second Failure Type,no known failure
1339,1,1,Age at Death,79.4
1339,1,1,First Failure Type,no known failure
1339,1,1,Metastasis,M0
1339,1,1,Occurrence #,recurrence
1339,1,1,Treatment Modality,Sx
1339,1,1,Nodal Stage,N0
1339,1,1,Time to Death,0.7
1339,1,1,Overall Stage,I
1340,1,1,Second Failure Type,no known failure
1340,1,1,Clinical lab p16,p16 unknown
1340,1,1,Tumor Stage,T1
1340,1,1,Tumor Site,larynx
1340,1,1,Treatment Modality,RT
1340,1,1,Occurrence #,1st primary
1340,1,1,Research lab HPV,HPV unknown
1340,1,1,Metastasis,M0
1340,1,1,First Failure Type,no known failure
1340,1,1,Status,Alive w/o disease
1340,1,1,Radiation Dosage,63
1340,1,1,Nodal Stage,N0
1340,1,1,Overall Stage,I
1340,1,1,Research lab p16,p16 unknown
1341,1,1,First Failure Type,no known failure
1341,1,1,Second Failure Type,no known failure
1341,1,1,Tumor Stage,T2
1341,1,1,Treatment Modality,RT
1341,1,1,Metastasis,M0
1341,1,1,Tumor Site,larynx
1341,1,1,Occurrence #,1st primary
1341,1,1,Clinical lab p16,p16 unknown
1341,1,1,Nodal Stage,N0
1341,1,1,Status,Alive unk disease
1341,1,1,Overall Stage,II
1341,1,1,Radiation Dosage,63
1341,1,1,Research lab p16,p16 unknown
1341,1,1,Research lab HPV,HPV unknown
1342,1,1,Metastasis,M0
1342,1,1,Second Failure Type,no known failure
1342,1,1,Occurrence #,1st primary
1342,1,1,Tumor Stage,T4a
1342,1,1,Status,Alive unk disease
1342,1,1,First Failure Type,no known failure
1342,1,1,Clinical lab p16,p16 unknown
1342,1,1,Treatment Modality,Sx
1342,1,1,Nodal Stage,N0
1342,1,1,Research lab HPV,HPV unknown
1342,1,1,Overall Stage,IVa
1342,1,1,Research lab p16,p16 unknown
1342,1,1,Tumor Site,larynx
1343,1,1,Occurrence #,recurrence
1343,1,1,First Failure Type,no known failure
1343,1,1,Metastasis,M0
1343,1,1,Research lab p16,p16 unknown
1343,1,1,Research lab HPV,HPV unknown
1343,1,1,Status,Alive unk disease
1343,1,1,Nodal Stage,N0
1343,1,1,Clinical lab p16,p16 unknown
1343,1,1,Tumor Site,larynx
1343,1,1,Overall Stage,III
1343,1,1,Second Failure Type,no known failure
1343,1,1,Treatment Modality,Sx
1343,1,1,Tumor Stage,T3
1344,1,1,First Failure Type,no known failure
1344,1,1,Radiation Dosage,72
1344,1,1,Research lab p16,p16 unknown
1344,1,1,Time to Death,7.0
1344,1,1,Research lab HPV,HPV unknown
1344,1,1,Date of Death,2007-12-12 00:00:00
1344,1,1,Metastasis,M0
1344,1,1,Overall Stage,IVa
1344,1,1,Tumor Site,larynx
1344,1,1,Age at Death,56.6
1344,1,1,Occurrence #,1st primary
1344,1,1,Second Failure Type,no known failure
1344,1,1,Tumor Stage,T3
1344,1,1,Nodal Stage,N2
1344,1,1,Treatment Modality,RT
1344,1,1,Clinical lab p16,p16 unknown
1344,1,1,Status,Dead w/o disease
1345,1,1,Overall Stage,II
1345,1,1,Treatment Modality,RT
1345,1,1,Metastasis,M0
1345,1,1,Occurrence #,1st primary
1345,1,1,First Failure Type,no known failure
1345,1,1,Nodal Stage,N0
1345,1,1,Tumor Site,larynx
1345,1,1,Research lab p16,p16 unknown
1345,1,1,Age at Death,71.9
1345,1,1,Second Failure Type,no known failure
1345,1,1,Research lab HPV,HPV unknown
1345,1,1,Tumor Stage,T2
1345,1,1,Time to Death,4.4
1345,1,1,Clinical lab p16,p16 unknown
1345,1,1,Status,Dead unk disease
1345,1,1,Date of Death,2008-02-18 00:00:00
1345,1,1,Radiation Dosage,unknown
1346,1,1,Research lab p16,p16 unknown
1346,1,1,Research lab HPV,HPV unknown
1346,1,1,Radiation Dosage,unknown
1346,1,1,Nodal Stage,N2
1346,1,1,Metastasis,M0
1346,1,1,Occurrence #,recurrence
1346,1,1,Tumor Site,larynx
1346,1,1,Age at Death,69.6
1346,1,1,Second Failure Type,no known failure
1346,1,1,Time to First Failure,0.6
1346,1,1,Initial Chemotherapy Agent,cis
1346,1,1,Time to Death,0.6
1346,1,1,Overall Stage,IVa
1346,1,1,First Failure Type,distant
1346,1,1,Tumor Stage,T3
1346,1,1,Treatment Modality,Sx & CTX-RT
1346,1,1,Status,Dead w/ disease
1346,1,1,Clinical lab p16,p16 unknown
1346,1,1,Date of Death,2009-03-23 00:00:00
1347,1,1,Age at Death,87.9
1347,1,1,Occurrence #,1st primary
1347,1,1,Treatment Modality,RT
1347,1,1,Tumor Stage,T1
1347,1,1,Radiation Dosage,63
1347,1,1,Status,Dead unk disease
1347,1,1,Clinical lab p16,p16 unknown
1347,1,1,Tumor Site,larynx
1347,1,1,Second Failure Type,no known failure
1347,1,1,Metastasis,M0
1347,1,1,Date of Death,2011-05-07 00:00:00
1347,1,1,Research lab p16,p16 unknown
1347,1,1,Nodal Stage,N0
1347,1,1,First Failure Type,no known failure
1347,1,1,Time to Death,4.6
1347,1,1,Overall Stage,I
1347,1,1,Research lab HPV,HPV unknown
1348,1,1,Research lab HPV,HPV unknown
1348,1,1,First Failure Type,no known failure
1348,1,1,Tumor Site,larynx
1348,1,1,Clinical lab p16,p16 unknown
1348,1,1,Metastasis,M0
1348,1,1,Research lab p16,p16 unknown
1348,1,1,Tumor Stage,T4a
1348,1,1,Status,Alive w/o disease
1348,1,1,Initial Chemotherapy Agent,carbo/PTX
1348,1,1,Second Failure Type,no known failure
1348,1,1,Occurrence #,recurrence
1348,1,1,Treatment Modality,Sx & CTX-RT
1348,1,1,Radiation Dosage,60
1348,1,1,Overall Stage,IVa
1348,1,1,Nodal Stage,N2
1349,1,1,Age at Death,82.6
1349,1,1,Date of Death,2002-02-03 00:00:00
1349,1,1,Tumor Stage,T4a
1349,1,1,Treatment Modality,Sx
1349,1,1,Status,Dead unk disease
1349,1,1,First Failure Type,no known failure
1349,1,1,Metastasis,M0
1349,1,1,Research lab p16,p16 unknown
1349,1,1,Overall Stage,IVa
1349,1,1,Research lab HPV,HPV unknown
1349,1,1,Nodal Stage,N1
1349,1,1,Second Failure Type,no known failure
1349,1,1,Time to Death,0.2
1349,1,1,Clinical lab p16,p16 unknown
1349,1,1,Tumor Site,larynx
1349,1,1,Occurrence #,other primary
1350,1,1,First Failure Treatment Modality,Sx
1350,1,1,Research lab p16,p16 unknown
1350,1,1,First Failure Site,larynx
1350,1,1,First Failure Type,locoregional
1350,1,1,Nodal Stage,N0
1350,1,1,Research lab HPV,HPV unknown
1350,1,1,Radiation Dosage,63
1350,1,1,Second Failure Type,no known failure
1350,1,1,Tumor Stage,T1
1350,1,1,Metastasis,M0
1350,1,1,Overall Stage,I
1350,1,1,Clinical lab p16,p16 unknown
1350,1,1,Treatment Modality,RT
1350,1,1,Status,Alive unk disease
1350,1,1,Time to First Failure,2.1
1350,1,1,Occurrence #,1st primary
1350,1,1,Tumor Site,larynx
1351,1,1,Overall Stage,Unknown
1351,1,1,Nodal Stage,Unknown
1351,1,1,Date of Death,2007-04-18 00:00:00
1351,1,1,Occurrence #,recurrence
1351,1,1,Clinical lab p16,p16 unknown
1351,1,1,Treatment Modality,RT
1351,1,1,Second Failure Type,no known failure
1351,1,1,Tumor Stage,Unknown
1351,1,1,Time to Death,5.2
1351,1,1,Status,Dead unk disease
1351,1,1,Research lab HPV,HPV unknown
1351,1,1,Radiation Dosage,unknown
1351,1,1,Age at Death,84.1
1351,1,1,Tumor Site,larynx
1351,1,1,Research lab p16,p16 unknown
1351,1,1,First Failure Type,no known failure
1351,1,1,Metastasis,Unknown
1352,1,1,Treatment Modality,CTX-RT
1352,1,1,Metastasis,M0
1352,1,1,Occurrence #,1st primary
1352,1,1,Tumor Site,larynx
1352,1,1,Time to Death,0.2
1352,1,1,Second Failure Type,no known failure
1352,1,1,Tumor Stage,T3
1352,1,1,Status,Dead w/ disease
1352,1,1,Radiation Dosage,70.2
1352,1,1,Age at Death,64.5
1352,1,1,Research lab p16,p16 unknown
1352,1,1,First Failure Type,no known failure
1352,1,1,Date of Death,2008-09-16 00:00:00
1352,1,1,Clinical lab p16,p16 unknown
1352,1,1,Research lab HPV,HPV unknown
1352,1,1,Initial Chemotherapy Agent,cis
1352,1,1,Nodal Stage,N0
1352,1,1,Overall Stage,III
1353,1,1,Overall Stage,II
1353,1,1,Status,Alive w/o disease
1353,1,1,First Failure Type,no known failure
1353,1,1,Tumor Site,larynx
1353,1,1,Second Failure Type,no known failure
1353,1,1,Clinical lab p16,p16 unknown
1353,1,1,Research lab HPV,HPV unknown
1353,1,1,Treatment Modality,Sx
1353,1,1,Nodal Stage,N0
1353,1,1,Research lab p16,p16 unknown
1353,1,1,Occurrence #,1st primary
1353,1,1,Tumor Stage,T2
1353,1,1,Metastasis,M0
1354,1,1,Occurrence #,recurrence
1354,1,1,Tumor Site,larynx
1354,1,1,Clinical lab p16,p16 unknown
1354,1,1,Second Failure Type,no known failure
1354,1,1,Tumor Stage,T3
1354,1,1,First Failure Initial Chemotherapy Agent,cis/doce
1354,1,1,First Failure Site,larynx
1354,1,1,Metastasis,M0
1354,1,1,Nodal Stage,N2
1354,1,1,Research lab p16,p16 unknown
1354,1,1,Date of Death,2007-11-23 00:00:00
1354,1,1,First Failure Treatment Modality,CTX
1354,1,1,Time to First Failure,0.6
1354,1,1,Age at Death,60.4
1354,1,1,Time to Death,1.7
1354,1,1,First Failure Type,locoregional
1354,1,1,Status,Dead w/ disease
1354,1,1,Overall Stage,IVa
1354,1,1,Research lab HPV,HPV unknown
1354,1,1,Treatment Modality,Sx
1355,1,1,Research lab HPV,HPV unknown
1355,1,1,Metastasis,M0
1355,1,1,Tumor Stage,T3
1355,1,1,First Failure Type,no known failure
1355,1,1,Age at Death,74.3
1355,1,1,Research lab p16,p16 unknown
1355,1,1,Treatment Modality,Unknown
1355,1,1,Status,Dead unk disease
1355,1,1,Clinical lab p16,p16 unknown
1355,1,1,Tumor Site,larynx
1355,1,1,Occurrence #,1st primary
1355,1,1,Time to Death,2.4
1355,1,1,Nodal Stage,N1
1355,1,1,Second Failure Type,no known failure
1355,1,1,Date of Death,2006-10-15 00:00:00
1355,1,1,Overall Stage,III
1356,1,1,Age at Death,70.5
1356,1,1,Time to Death,4.5
1356,1,1,Clinical lab p16,p16 unknown
1356,1,1,Nodal Stage,N1
1356,1,1,Tumor Stage,T4a
1356,1,1,First Failure Type,no known failure
1356,1,1,Radiation Dosage,unknown
1356,1,1,Second Failure Type,no known failure
1356,1,1,Tumor Site,larynx
1356,1,1,Overall Stage,IVa
1356,1,1,Research lab HPV,HPV unknown
1356,1,1,Metastasis,M0
1356,1,1,Status,Dead unk disease
1356,1,1,Occurrence #,1st primary
1356,1,1,Date of Death,2006-04-14 00:00:00
1356,1,1,Treatment Modality,Sx & RT
1356,1,1,Research lab p16,p16 unknown
1357,1,1,Tumor Site,larynx
1357,1,1,Status,Alive w/o disease
1357,1,1,Occurrence #,1st primary
1357,1,1,Second Failure Type,no known failure
1357,1,1,Radiation Dosage,63
1357,1,1,Tumor Stage,T3
1357,1,1,Research lab HPV,HPV unknown
1357,1,1,Research lab p16,p16 unknown
1357,1,1,Metastasis,M0
1357,1,1,Nodal Stage,N2
1357,1,1,First Failure Type,no known failure
1357,1,1,Overall Stage,IVa
1357,1,1,Clinical lab p16,p16 unknown
1357,1,1,Treatment Modality,Sx & RT
1358,1,1,Research lab p16,p16 unknown
1358,1,1,Status,Alive w/o disease
1358,1,1,Treatment Modality,RT
1358,1,1,First Failure Type,no known failure
1358,1,1,Metastasis,M0
1358,1,1,Tumor Site,larynx
1358,1,1,Overall Stage,I
1358,1,1,Tumor Stage,T1
1358,1,1,Clinical lab p16,p16 unknown
1358,1,1,Research lab HPV,HPV unknown
1358,1,1,Nodal Stage,N0
1358,1,1,Occurrence #,1st primary
1358,1,1,Second Failure Type,no known failure
1358,1,1,Radiation Dosage,63
1359,1,1,Research lab p16,p16 unknown
1359,1,1,Nodal Stage,N2
1359,1,1,Second Failure Type,no known failure
1359,1,1,Date of Death,2010-11-29 00:00:00
1359,1,1,Age at Death,62.0
1359,1,1,Research lab HPV,HPV unknown
1359,1,1,Initial Chemotherapy Agent,unknown
1359,1,1,Occurrence #,1st primary
1359,1,1,Clinical lab p16,p16 unknown
1359,1,1,Tumor Stage,T3
1359,1,1,Metastasis,M0
1359,1,1,Overall Stage,IVa
1359,1,1,Treatment Modality,CTX-RT
1359,1,1,Tumor Site,larynx
1359,1,1,First Failure Type,no known failure
1359,1,1,Status,Dead unk disease
1359,1,1,Time to Death,1.7
1359,1,1,Radiation Dosage,unknown
1360,1,1,Status,Dead w/o disease
1360,1,1,Second Failure Type,no known failure
1360,1,1,Nodal Stage,N0
1360,1,1,Treatment Modality,Sx
1360,1,1,Metastasis,M0
1360,1,1,Tumor Stage,T4a
1360,1,1,Clinical lab p16,p16 unknown
1360,1,1,Time to Death,0.7
1360,1,1,Occurrence #,1st primary
1360,1,1,Tumor Site,larynx
1360,1,1,Date of Death,2009-02-26 00:00:00
1360,1,1,Age at Death,52.7
1360,1,1,First Failure Type,no known failure
1360,1,1,Research lab HPV,HPV unknown
1360,1,1,Research lab p16,p16 unknown
1360,1,1,Overall Stage,IVa
1361,1,1,Radiation Dosage,74.4
1361,1,1,Nodal Stage,N0
1361,1,1,First Failure Type,no known failure
1361,1,1,Overall Stage,III
1361,1,1,Time to Death,1.3
1361,1,1,Occurrence #,1st primary
1361,1,1,Date of Death,2010-03-04 00:00:00
1361,1,1,Second Failure Type,no known failure
1361,1,1,Research lab HPV,HPV unknown
1361,1,1,Metastasis,M0
1361,1,1,Tumor Stage,T3
1361,1,1,Clinical lab p16,p16 unknown
1361,1,1,Treatment Modality,RT
1361,1,1,Tumor Site,larynx
1361,1,1,Status,Dead w/o disease
1361,1,1,Age at Death,82.1
1361,1,1,Research lab p16,p16 unknown
1362,1,1,Clinical lab p16,p16 unknown
1362,1,1,Overall Stage,IVc
1362,1,1,Research lab HPV,HPV unknown
1362,1,1,Occurrence #,1st primary
1362,1,1,Research lab p16,p16 unknown
1362,1,1,First Failure Type,no known failure
1362,1,1,Tumor Site,larynx
1362,1,1,Treatment Modality,CTX
1362,1,1,Metastasis,M1
1362,1,1,Nodal Stage,N3
1362,1,1,Initial Chemotherapy Agent,cis/doce/PTX
1362,1,1,Status,Alive unk disease
1362,1,1,Second Failure Type,no known failure
1362,1,1,Tumor Stage,T3
1363,1,1,Age at Death,48.5
1363,1,1,Tumor Stage,T3
1363,1,1,Initial Chemotherapy Agent,carbo/PTX
1363,1,1,Research lab p16,p16 unknown
1363,1,1,Treatment Modality,CTX-RT
1363,1,1,Metastasis,M0
1363,1,1,Status,Dead unk disease
1363,1,1,Tumor Site,larynx
1363,1,1,Overall Stage,IVa
1363,1,1,Date of Death,2007-05-21 00:00:00
1363,1,1,Occurrence #,1st primary
1363,1,1,Second Failure Type,no known failure
1363,1,1,Clinical lab p16,p16 unknown
1363,1,1,Research lab HPV,HPV unknown
1363,1,1,First Failure Type,no known failure
1363,1,1,Time to Death,0.8
1363,1,1,Nodal Stage,N2
1363,1,1,Radiation Dosage,unknown
1364,1,1,Research lab p16,p16 unknown
1364,1,1,Metastasis,M0
1364,1,1,Status,Alive unk disease
1364,1,1,Research lab HPV,HPV unknown
1364,1,1,Treatment Modality,Sx
1364,1,1,Tumor Site,larynx
1364,1,1,Nodal Stage,N0
1364,1,1,Second Failure Type,no known failure
1364,1,1,Tumor Stage,T1
1364,1,1,Overall Stage,I
1364,1,1,Clinical lab p16,p16 unknown
1364,1,1,Occurrence #,1st primary
1364,1,1,First Failure Type,no known failure
1365,1,1,Age at Death,51.3
1365,1,1,Research lab p16,p16 unknown
1365,1,1,Treatment Modality,Sx
1365,1,1,Nodal Stage,N0
1365,1,1,Tumor Stage,T3
1365,1,1,First Failure Type,no known failure
1365,1,1,Occurrence #,1st primary
1365,1,1,Overall Stage,III
1365,1,1,Date of Death,2008-01-18 00:00:00
1365,1,1,Metastasis,M0
1365,1,1,Status,Dead unk disease
1365,1,1,Tumor Site,larynx
1365,1,1,Time to Death,7.9
1365,1,1,Research lab HPV,HPV unknown
1365,1,1,Second Failure Type,no known failure
1365,1,1,Clinical lab p16,p16 unknown
1366,1,1,Research lab p16,p16 unknown
1366,1,1,First Failure Site,larynx
1366,1,1,Tumor Stage,T2
1366,1,1,Second Failure Type,no known failure
1366,1,1,Tumor Site,larynx
1366,1,1,Clinical lab p16,p16 unknown
1366,1,1,First Failure Treatment Modality,Sx
1366,1,1,First Failure Type,locoregional
1366,1,1,Status,Alive w/o disease
1366,1,1,Radiation Dosage,74.4
1366,1,1,Metastasis,M0
1366,1,1,Treatment Modality,RT
1366,1,1,Nodal Stage,N0
1366,1,1,Occurrence #,1st primary
1366,1,1,Overall Stage,II
1366,1,1,Time to First Failure,0.3
1366,1,1,Research lab HPV,HPV unknown
1367,1,1,Tumor Stage,T2
1367,1,1,Time to Death,1.4
1367,1,1,Metastasis,M0
1367,1,1,Treatment Modality,RT
1367,1,1,Occurrence #,1st primary
1367,1,1,Status,Dead w/o disease
1367,1,1,Tumor Site,larynx
1367,1,1,Radiation Dosage,74.4
1367,1,1,Research lab p16,p16 unknown
1367,1,1,Date of Death,2010-07-15 00:00:00
1367,1,1,Research lab HPV,HPV unknown
1367,1,1,Age at Death,70.3
1367,1,1,Nodal Stage,N0
1367,1,1,Second Failure Type,no known failure
1367,1,1,First Failure Type,no known failure
1367,1,1,Overall Stage,II
1367,1,1,Clinical lab p16,p16 unknown
1368,1,1,First Failure Type,no known failure
1368,1,1,Tumor Stage,T4a
1368,1,1,Overall Stage,IVa
1368,1,1,Radiation Dosage,70.2
1368,1,1,Occurrence #,1st primary
1368,1,1,Nodal Stage,N2
1368,1,1,Research lab p16,p16 unknown
1368,1,1,Research lab HPV,HPV unknown
1368,1,1,Initial Chemotherapy Agent,cis
1368,1,1,Second Failure Type,no known failure
1368,1,1,Clinical lab p16,p16 unknown
1368,1,1,Tumor Site,larynx
1368,1,1,Status,Alive w/o disease
1368,1,1,Metastasis,M0
1368,1,1,Treatment Modality,CTX-RT
1369,1,1,Date of Death,2009-04-29 00:00:00
1369,1,1,Second Failure Type,no known failure
1369,1,1,Occurrence #,1st primary
1369,1,1,Research lab HPV,HPV unknown
1369,1,1,Overall Stage,I
1369,1,1,Tumor Stage,T1
1369,1,1,First Failure Type,no known failure
1369,1,1,Radiation Dosage,63
1369,1,1,Nodal Stage,N0
1369,1,1,Treatment Modality,RT
1369,1,1,Research lab p16,p16 unknown
1369,1,1,Status,Dead unk disease
1369,1,1,Clinical lab p16,p16 unknown
1369,1,1,Age at Death,85.1
1369,1,1,Tumor Site,larynx
1369,1,1,Metastasis,M0
1369,1,1,Time to Death,6.3
1370,1,1,Time to Death,1.9
1370,1,1,Nodal Stage,N0
1370,1,1,Second Failure Type,no known failure
1370,1,1,Clinical lab p16,p16 unknown
1370,1,1,Occurrence #,1st primary
1370,1,1,Research lab HPV,HPV unknown
1370,1,1,First Failure Type,no known failure
1370,1,1,Tumor Stage,T4a
1370,1,1,Overall Stage,IVa
1370,1,1,Treatment Modality,Sx & RT
1370,1,1,Radiation Dosage,unknown
1370,1,1,Tumor Site,larynx
1370,1,1,Status,Dead unk disease
1370,1,1,Research lab p16,p16 unknown
1370,1,1,Metastasis,M0
1370,1,1,Date of Death,2004-07-23 00:00:00
1370,1,1,Age at Death,62.2
1371,1,1,Initial Chemotherapy Agent,cis
1371,1,1,Research lab HPV,HPV unknown
1371,1,1,First Failure Type,no known failure
1371,1,1,Tumor Stage,T3
1371,1,1,Overall Stage,IVa
1371,1,1,Radiation Dosage,70.2
1371,1,1,Nodal Stage,N2
1371,1,1,Treatment Modality,CTX-RT
1371,1,1,Research lab p16,p16 unknown
1371,1,1,Occurrence #,1st primary
1371,1,1,Clinical lab p16,p16 unknown
1371,1,1,Status,Alive w/o disease
1371,1,1,Metastasis,M0
1371,1,1,Second Failure Type,no known failure
1371,1,1,Tumor Site,larynx
1372,1,1,Tumor Stage,T2
1372,1,1,Clinical lab p16,p16 unknown
1372,1,1,First Failure Type,no known failure
1372,1,1,Second Failure Type,no known failure
1372,1,1,Overall Stage,IVa
1372,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1372,1,1,Treatment Modality,CTX-RT
1372,1,1,Radiation Dosage,70.2
1372,1,1,Research lab p16,p16 unknown
1372,1,1,Tumor Site,larynx
1372,1,1,Nodal Stage,N2
1372,1,1,Occurrence #,1st primary
1372,1,1,Status,Alive w/o disease
1372,1,1,Metastasis,M0
1372,1,1,Research lab HPV,HPV unknown
1373,1,1,Status,Alive w/o disease
1373,1,1,Metastasis,M0
1373,1,1,Tumor Site,larynx
1373,1,1,Research lab p16,p16 unknown
1373,1,1,Clinical lab p16,p16 unknown
1373,1,1,Overall Stage,I
1373,1,1,Nodal Stage,N0
1373,1,1,Second Failure Type,no known failure
1373,1,1,Research lab HPV,HPV unknown
1373,1,1,First Failure Type,no known failure
1373,1,1,Occurrence #,1st primary
1373,1,1,Treatment Modality,Sx
1373,1,1,Tumor Stage,T1
1374,1,1,Tumor Stage,T2
1374,1,1,Research lab p16,p16 unknown
1374,1,1,First Failure Type,no known failure
1374,1,1,Radiation Dosage,74.4
1374,1,1,Nodal Stage,N0
1374,1,1,Status,Alive w/o disease
1374,1,1,Treatment Modality,RT
1374,1,1,Overall Stage,II
1374,1,1,Second Failure Type,no known failure
1374,1,1,Occurrence #,1st primary
1374,1,1,Clinical lab p16,p16 unknown
1374,1,1,Research lab HPV,HPV unknown
1374,1,1,Metastasis,M0
1374,1,1,Tumor Site,larynx
1375,1,1,Treatment Modality,Sx & CTX-RT
1375,1,1,Occurrence #,1st primary
1375,1,1,Nodal Stage,N2
1375,1,1,Time to Death,3.1
1375,1,1,Radiation Dosage,70.2
1375,1,1,Research lab HPV,HPV unknown
1375,1,1,Initial Chemotherapy Agent,carbo/PTX
1375,1,1,Date of Death,2005-04-24 00:00:00
1375,1,1,Overall Stage,IVa
1375,1,1,First Failure Type,no known failure
1375,1,1,Tumor Stage,T4a
1375,1,1,Metastasis,M0
1375,1,1,Clinical lab p16,p16 unknown
1375,1,1,Tumor Site,larynx
1375,1,1,Age at Death,49.2
1375,1,1,Research lab p16,p16 unknown
1375,1,1,Status,Dead w/o disease
1375,1,1,Second Failure Type,no known failure
1376,1,1,Tumor Stage,T4a
1376,1,1,Date of Death,2006-07-25 00:00:00
1376,1,1,Status,Dead w/ disease
1376,1,1,Time to Death,1.0
1376,1,1,First Failure Treatment Modality,CTX
1376,1,1,Time to First Failure,-2.5
1376,1,1,Metastasis,M0
1376,1,1,Nodal Stage,N2
1376,1,1,Second Failure Type,no known failure
1376,1,1,First Failure Second Line Chemotherapy Agent,carbo/doce
1376,1,1,Tumor Site,larynx
1376,1,1,First Failure Initial Chemotherapy Agent,cap
1376,1,1,Age at Death,66.6
1376,1,1,Research lab p16,p16 unknown
1376,1,1,Treatment Modality,Sx
1376,1,1,Occurrence #,other primary
1376,1,1,Research lab HPV,HPV unknown
1376,1,1,Overall Stage,IVa
1376,1,1,First Failure Type,locoregional
1376,1,1,Clinical lab p16,p16 unknown
1377,1,1,Overall Stage,IVa
1377,1,1,Tumor Site,larynx
1377,1,1,Clinical lab p16,p16 unknown
1377,1,1,Research lab p16,p16 unknown
1377,1,1,Status,Alive w/o disease
1377,1,1,Research lab HPV,HPV unknown
1377,1,1,Metastasis,M0
1377,1,1,Treatment Modality,Sx & RT
1377,1,1,Tumor Stage,T4a
1377,1,1,First Failure Type,no known failure
1377,1,1,Occurrence #,1st primary
1377,1,1,Radiation Dosage,60
1377,1,1,Nodal Stage,N0
1377,1,1,Second Failure Type,no known failure
1378,1,1,Tumor Site,larynx
1378,1,1,First Failure Type,no known failure
1378,1,1,Clinical lab p16,p16 unknown
1378,1,1,Tumor Stage,T2
1378,1,1,Occurrence #,1st primary
1378,1,1,Research lab HPV,HPV unknown
1378,1,1,Research lab p16,p16 unknown
1378,1,1,Overall Stage,II
1378,1,1,Nodal Stage,N0
1378,1,1,Metastasis,M0
1378,1,1,Treatment Modality,RT
1378,1,1,Status,Alive w/o disease
1378,1,1,Radiation Dosage,74.4
1378,1,1,Second Failure Type,no known failure
1379,1,1,Second Failure Type,no known failure
1379,1,1,Occurrence #,1st primary
1379,1,1,Tumor Stage,T3
1379,1,1,Clinical lab p16,p16 unknown
1379,1,1,Metastasis,M0
1379,1,1,Treatment Modality,Sx
1379,1,1,Nodal Stage,N3
1379,1,1,Date of Death,2006-09-07 00:00:00
1379,1,1,Age at Death,65.9
1379,1,1,Status,Dead unk disease
1379,1,1,Research lab p16,p16 unknown
1379,1,1,Time to Death,1.3
1379,1,1,Tumor Site,larynx
1379,1,1,First Failure Type,no known failure
1379,1,1,Research lab HPV,HPV unknown
1379,1,1,Overall Stage,IVb
1380,1,1,Research lab HPV,HPV unknown
1380,1,1,Date of Death,2007-09-09 00:00:00
1380,1,1,Metastasis,M0
1380,1,1,Overall Stage,III
1380,1,1,First Failure Type,distant
1380,1,1,Second Failure Type,no known failure
1380,1,1,Tumor Stage,T3
1380,1,1,Initial Chemotherapy Agent,cis
1380,1,1,Radiation Dosage,70.2
1380,1,1,Treatment Modality,CTX-RT
1380,1,1,Nodal Stage,N0
1380,1,1,First Failure Initial Chemotherapy Agent,doce
1380,1,1,Occurrence #,1st primary
1380,1,1,Time to First Failure,1.1
1380,1,1,Status,Dead w/ disease
1380,1,1,Time to Death,1.9
1380,1,1,Research lab p16,p16 unknown
1380,1,1,Tumor Site,larynx
1380,1,1,First Failure Site,larynx
1380,1,1,First Failure Treatment Modality,CTX
1380,1,1,Age at Death,68.5
1380,1,1,Clinical lab p16,p16 unknown
1381,1,1,Metastasis,M0
1381,1,1,Status,Dead w/ disease
1381,1,1,Time to Death,1.1
1381,1,1,Tumor Site,larynx
1381,1,1,Tumor Stage,T4a
1381,1,1,Radiation Dosage,64
1381,1,1,Occurrence #,1st primary
1381,1,1,Treatment Modality,Sx & RT
1381,1,1,Age at Death,47.8
1381,1,1,Research lab p16,p16 unknown
1381,1,1,First Failure Type,locoregional and distant
1381,1,1,Second Failure Type,no known failure
1381,1,1,Nodal Stage,N3
1381,1,1,Clinical lab p16,p16 unknown
1381,1,1,Research lab HPV,HPV unknown
1381,1,1,Date of Death,2010-08-23 00:00:00
1381,1,1,Overall Stage,IVb
1381,1,1,Time to First Failure,0.7
1382,1,1,Tumor Stage,T4a
1382,1,1,Treatment Modality,Sx
1382,1,1,Date of Death,2009-10-18 00:00:00
1382,1,1,Clinical lab p16,p16 unknown
1382,1,1,Nodal Stage,N0
1382,1,1,Metastasis,M0
1382,1,1,First Failure Type,no known failure
1382,1,1,Overall Stage,IVa
1382,1,1,Research lab HPV,HPV unknown
1382,1,1,Second Failure Type,no known failure
1382,1,1,Age at Death,62.6
1382,1,1,Research lab p16,p16 unknown
1382,1,1,Occurrence #,recurrence
1382,1,1,Time to Death,0.3
1382,1,1,Tumor Site,larynx
1382,1,1,Status,Dead unk disease
1383,1,1,First Failure Type,no known failure
1383,1,1,Nodal Stage,N2
1383,1,1,Treatment Modality,Sx & RT
1383,1,1,Research lab p16,p16 unknown
1383,1,1,Tumor Site,larynx
1383,1,1,Occurrence #,recurrence
1383,1,1,Research lab HPV,HPV unknown
1383,1,1,Radiation Dosage,63
1383,1,1,Clinical lab p16,p16 unknown
1383,1,1,Second Failure Type,no known failure
1383,1,1,Age at Death,53.9
1383,1,1,Status,Dead unk disease
1383,1,1,Metastasis,M0
1383,1,1,Date of Death,2002-04-13 00:00:00
1383,1,1,Time to Death,1.1
1383,1,1,Overall Stage,IVa
1383,1,1,Tumor Stage,T1
1384,1,1,Occurrence #,1st primary
1384,1,1,Age at Death,55.3
1384,1,1,Overall Stage,IVa
1384,1,1,Clinical lab p16,p16 unknown
1384,1,1,Research lab HPV,HPV unknown
1384,1,1,Second Failure Type,no known failure
1384,1,1,Tumor Stage,T3
1384,1,1,Metastasis,M0
1384,1,1,Time to Death,2.0
1384,1,1,First Failure Type,no known failure
1384,1,1,Date of Death,2005-03-11 00:00:00
1384,1,1,Radiation Dosage,74.4
1384,1,1,Tumor Site,larynx
1384,1,1,Nodal Stage,N2
1384,1,1,Treatment Modality,RT
1384,1,1,Status,Dead unk disease
1384,1,1,Research lab p16,p16 unknown
1385,1,1,Clinical lab p16,p16 unknown
1385,1,1,First Failure Type,no known failure
1385,1,1,Second Failure Type,no known failure
1385,1,1,Tumor Stage,T4a
1385,1,1,Time to Death,0.4
1385,1,1,Overall Stage,IVa
1385,1,1,Age at Death,65.5
1385,1,1,Status,Dead unk disease
1385,1,1,Date of Death,2002-11-30 00:00:00
1385,1,1,Metastasis,M0
1385,1,1,Research lab HPV,HPV unknown
1385,1,1,Nodal Stage,Unknown
1385,1,1,Treatment Modality,Unknown
1385,1,1,Research lab p16,p16 unknown
1385,1,1,Tumor Site,larynx
1385,1,1,Occurrence #,1st primary
1386,1,1,Tumor Stage,T2
1386,1,1,First Failure Type,no known failure
1386,1,1,Nodal Stage,N0
1386,1,1,Status,Alive w/o disease
1386,1,1,Occurrence #,1st primary
1386,1,1,Clinical lab p16,p16 unknown
1386,1,1,Research lab HPV,HPV unknown
1386,1,1,Metastasis,M0
1386,1,1,Tumor Site,larynx
1386,1,1,Second Failure Type,no known failure
1386,1,1,Overall Stage,II
1386,1,1,Research lab p16,p16 unknown
1386,1,1,Radiation Dosage,74.4
1386,1,1,Treatment Modality,RT
1387,1,1,First Failure Type,locoregional
1387,1,1,First Failure Treatment Modality,Sx
1387,1,1,Clinical lab p16,p16 unknown
1387,1,1,Radiation Dosage,70
1387,1,1,Research lab HPV,HPV unknown
1387,1,1,Date of Death,2007-03-14 00:00:00
1387,1,1,Treatment Modality,RT
1387,1,1,Occurrence #,1st primary
1387,1,1,Time to Death,2.3
1387,1,1,Time to First Failure,0.3
1387,1,1,Research lab p16,p16 unknown
1387,1,1,Overall Stage,III
1387,1,1,Tumor Site,larynx
1387,1,1,Age at Death,51.5
1387,1,1,Metastasis,M0
1387,1,1,Nodal Stage,N1
1387,1,1,Tumor Stage,T2
1387,1,1,First Failure Site,larynx
1387,1,1,Status,Dead unk disease
1387,1,1,Second Failure Type,no known failure
1388,1,1,Tumor Site,larynx
1388,1,1,Research lab p16,p16 unknown
1388,1,1,Research lab HPV,HPV unknown
1388,1,1,Date of Death,2007-09-12 00:00:00
1388,1,1,Status,Dead unk disease
1388,1,1,Occurrence #,1st primary
1388,1,1,Second Failure Type,no known failure
1388,1,1,Time to Death,0.6
1388,1,1,Treatment Modality,Sx
1388,1,1,Age at Death,83.4
1388,1,1,Overall Stage,IVa
1388,1,1,First Failure Type,no known failure
1388,1,1,Nodal Stage,N2
1388,1,1,Metastasis,M0
1388,1,1,Tumor Stage,T4a
1388,1,1,Clinical lab p16,p16 unknown
1389,1,1,Treatment Modality,Sx
1389,1,1,Tumor Site,larynx
1389,1,1,Occurrence #,recurrence
1389,1,1,Age at Death,65.4
1389,1,1,Metastasis,M0
1389,1,1,Time to Death,0.0
1389,1,1,Time to First Failure,-0.5
1389,1,1,Nodal Stage,N0
1389,1,1,First Failure Type,locoregional
1389,1,1,Research lab p16,p16 unknown
1389,1,1,Tumor Stage,T4b
1389,1,1,Clinical lab p16,p16 unknown
1389,1,1,Overall Stage,IVb
1389,1,1,Research lab HPV,HPV unknown
1389,1,1,Status,Dead w/ disease
1389,1,1,Date of Death,2007-06-08 00:00:00
1389,1,1,Second Failure Type,no known failure
1390,1,1,Nodal Stage,N0
1390,1,1,Research lab p16,p16 unknown
1390,1,1,Tumor Site,larynx
1390,1,1,Overall Stage,I
1390,1,1,Metastasis,M0
1390,1,1,Occurrence #,recurrence
1390,1,1,Research lab HPV,HPV unknown
1390,1,1,Status,Alive unk disease
1390,1,1,Tumor Stage,T1
1390,1,1,Second Failure Type,no known failure
1390,1,1,Treatment Modality,Sx
1390,1,1,First Failure Type,no known failure
1390,1,1,Clinical lab p16,p16 unknown
1391,1,1,Overall Stage,IVa
1391,1,1,Radiation Dosage,70.2
1391,1,1,Treatment Modality,CTX-RT
1391,1,1,Nodal Stage,N1
1391,1,1,Status,Alive w/o disease
1391,1,1,Metastasis,M0
1391,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1391,1,1,First Failure Type,no known failure
1391,1,1,Tumor Stage,T4a
1391,1,1,Clinical lab p16,p16 unknown
1391,1,1,Research lab HPV,HPV unknown
1391,1,1,Occurrence #,1st primary
1391,1,1,Research lab p16,p16 unknown
1391,1,1,Second Failure Type,no known failure
1391,1,1,Tumor Site,larynx
1392,1,1,Status,Alive w/o disease
1392,1,1,Nodal Stage,N2
1392,1,1,Research lab p16,p16 unknown
1392,1,1,Second Failure Type,no known failure
1392,1,1,Tumor Stage,T3
1392,1,1,Tumor Site,larynx
1392,1,1,Metastasis,M0
1392,1,1,Overall Stage,IVa
1392,1,1,Clinical lab p16,p16 unknown
1392,1,1,Occurrence #,1st primary
1392,1,1,Treatment Modality,Sx & RT
1392,1,1,Radiation Dosage,63
1392,1,1,Research lab HPV,HPV unknown
1392,1,1,First Failure Type,no known failure
1393,1,1,Age at Death,64.4
1393,1,1,First Failure Type,no known failure
1393,1,1,Clinical lab p16,p16 unknown
1393,1,1,Occurrence #,1st primary
1393,1,1,Date of Death,2001-06-03 00:00:00
1393,1,1,Research lab HPV,HPV unknown
1393,1,1,Tumor Site,larynx
1393,1,1,Second Failure Type,no known failure
1393,1,1,Radiation Dosage,63
1393,1,1,Treatment Modality,Sx & RT
1393,1,1,Status,Dead w/ disease
1393,1,1,Overall Stage,IVc
1393,1,1,Metastasis,M1
1393,1,1,Nodal Stage,N2
1393,1,1,Tumor Stage,T4a
1393,1,1,Time to Death,1.1
1393,1,1,Research lab p16,p16 unknown
1394,1,1,Clinical lab p16,p16 unknown
1394,1,1,Initial Chemotherapy Agent,cis
1394,1,1,Metastasis,M0
1394,1,1,Tumor Stage,T3
1394,1,1,First Failure Type,no known failure
1394,1,1,Radiation Dosage,70.2
1394,1,1,Research lab HPV,HPV unknown
1394,1,1,Treatment Modality,CTX-RT
1394,1,1,Overall Stage,III
1394,1,1,Nodal Stage,N0
1394,1,1,Research lab p16,p16 unknown
1394,1,1,Tumor Site,larynx
1394,1,1,Second Failure Type,no known failure
1394,1,1,Occurrence #,1st primary
1394,1,1,Status,Alive w/o disease
1395,1,1,Second Failure Type,no known failure
1395,1,1,Research lab HPV,HPV unknown
1395,1,1,Tumor Stage,T3
1395,1,1,Treatment Modality,Sx & CTX-RT
1395,1,1,Nodal Stage,N0
1395,1,1,Research lab p16,p16 unknown
1395,1,1,Tumor Site,larynx
1395,1,1,Status,Alive w/o disease
1395,1,1,Occurrence #,1st primary
1395,1,1,Radiation Dosage,70.2
1395,1,1,Clinical lab p16,p16 unknown
1395,1,1,First Failure Type,no known failure
1395,1,1,Overall Stage,IVc
1395,1,1,Initial Chemotherapy Agent,carbo/PTX
1395,1,1,Metastasis,M1
1396,1,1,Treatment Modality,RT
1396,1,1,Overall Stage,I
1396,1,1,Research lab HPV,HPV unknown
1396,1,1,Research lab p16,p16 unknown
1396,1,1,Tumor Site,larynx
1396,1,1,Occurrence #,1st primary
1396,1,1,Status,Alive w/o disease
1396,1,1,Radiation Dosage,63
1396,1,1,Clinical lab p16,p16 unknown
1396,1,1,Nodal Stage,N0
1396,1,1,Second Failure Type,no known failure
1396,1,1,First Failure Type,no known failure
1396,1,1,Tumor Stage,T1
1396,1,1,Metastasis,M0
1397,1,1,Initial Chemotherapy Agent,cis/PTX
1397,1,1,Time to Death,1.2
1397,1,1,Second Line Chemotherapy Agent,gemcitabine/doce
1397,1,1,Treatment Modality,CTX
1397,1,1,Tumor Site,larynx
1397,1,1,Second Failure Type,no known failure
1397,1,1,Nodal Stage,N1
1397,1,1,Research lab p16,p16 unknown
1397,1,1,Date of Death,2002-03-12 00:00:00
1397,1,1,Overall Stage,IVc
1397,1,1,Time to First Failure,-0.4
1397,1,1,Age at Death,45.8
1397,1,1,First Failure Type,locoregional
1397,1,1,Metastasis,M1
1397,1,1,Research lab HPV,HPV unknown
1397,1,1,Occurrence #,1st primary
1397,1,1,Status,Dead w/ disease
1397,1,1,Clinical lab p16,p16 unknown
1397,1,1,Tumor Stage,T4a
1398,1,1,Nodal Stage,N0
1398,1,1,Research lab HPV,HPV unknown
1398,1,1,Research lab p16,p16 unknown
1398,1,1,Second Failure Type,no known failure
1398,1,1,Overall Stage,I
1398,1,1,Treatment Modality,Sx & RT
1398,1,1,Clinical lab p16,p16 unknown
1398,1,1,First Failure Type,no known failure
1398,1,1,Tumor Site,larynx
1398,1,1,Occurrence #,1st primary
1398,1,1,Radiation Dosage,63
1398,1,1,Metastasis,M0
1398,1,1,Status,Alive w/o disease
1398,1,1,Tumor Stage,T1
1399,1,1,First Failure Type,no known failure
1399,1,1,Nodal Stage,N0
1399,1,1,Second Failure Type,no known failure
1399,1,1,Tumor Stage,T2
1399,1,1,Metastasis,M0
1399,1,1,Tumor Site,larynx
1399,1,1,Radiation Dosage,63
1399,1,1,Clinical lab p16,p16 unknown
1399,1,1,Treatment Modality,Sx & RT
1399,1,1,Status,Alive w/o disease
1399,1,1,Research lab HPV,HPV unknown
1399,1,1,Overall Stage,II
1399,1,1,Occurrence #,1st primary
1399,1,1,Research lab p16,p16 unknown
1400,1,1,Tumor Site,larynx
1400,1,1,Clinical lab p16,p16 unknown
1400,1,1,Tumor Stage,T1
1400,1,1,Occurrence #,1st primary
1400,1,1,Research lab HPV,HPV unknown
1400,1,1,Metastasis,M0
1400,1,1,First Failure Type,no known failure
1400,1,1,Research lab p16,p16 unknown
1400,1,1,Nodal Stage,N0
1400,1,1,Overall Stage,I
1400,1,1,Radiation Dosage,unknown
1400,1,1,Second Failure Type,no known failure
1400,1,1,Treatment Modality,RT
1400,1,1,Status,Alive w/o disease
1401,1,1,Tumor Site,larynx
1401,1,1,Overall Stage,I
1401,1,1,Treatment Modality,RT
1401,1,1,Radiation Dosage,63
1401,1,1,Second Failure Type,no known failure
1401,1,1,Nodal Stage,N0
1401,1,1,Research lab p16,p16 unknown
1401,1,1,Tumor Stage,T1
1401,1,1,Research lab HPV,HPV unknown
1401,1,1,Metastasis,M0
1401,1,1,First Failure Type,no known failure
1401,1,1,Clinical lab p16,p16 unknown
1401,1,1,Occurrence #,1st primary
1401,1,1,Status,Alive w/o disease
1402,1,1,Nodal Stage,N2
1402,1,1,Treatment Modality,CTX-RT
1402,1,1,Metastasis,M0
1402,1,1,Second Failure Type,no known failure
1402,1,1,Radiation Dosage,70.2
1402,1,1,Clinical lab p16,p16 unknown
1402,1,1,First Failure Type,no known failure
1402,1,1,Tumor Stage,T3
1402,1,1,Status,Alive w/o disease
1402,1,1,Initial Chemotherapy Agent,carbo/PTX
1402,1,1,Research lab HPV,HPV unknown
1402,1,1,Research lab p16,p16 unknown
1402,1,1,Occurrence #,1st primary
1402,1,1,Overall Stage,IVa
1402,1,1,Tumor Site,larynx
1403,1,1,Radiation Dosage,64
1403,1,1,Nodal Stage,N0
1403,1,1,Metastasis,M0
1403,1,1,Clinical lab p16,p16 unknown
1403,1,1,Research lab HPV,HPV unknown
1403,1,1,Second Failure Type,no known failure
1403,1,1,Status,Dead w/o disease
1403,1,1,First Failure Type,no known failure
1403,1,1,Treatment Modality,Sx & RT
1403,1,1,Tumor Stage,T4a
1403,1,1,Overall Stage,IVa
1403,1,1,Tumor Site,larynx
1403,1,1,Occurrence #,1st primary
1403,1,1,Research lab p16,p16 unknown
1404,1,1,Clinical lab p16,p16 unknown
1404,1,1,First Failure Type,no known failure
1404,1,1,Second Failure Type,no known failure
1404,1,1,Status,Dead unk disease
1404,1,1,Date of Death,2009-03-06 00:00:00
1404,1,1,Tumor Stage,T4a
1404,1,1,Research lab p16,p16 unknown
1404,1,1,Metastasis,M0
1404,1,1,Occurrence #,1st primary
1404,1,1,Research lab HPV,HPV unknown
1404,1,1,Time to Death,8.8
1404,1,1,Overall Stage,IVa
1404,1,1,Nodal Stage,N1
1404,1,1,Tumor Site,larynx
1404,1,1,Treatment Modality,Sx
1404,1,1,Age at Death,51.2
1405,1,1,Research lab p16,p16 unknown
1405,1,1,Treatment Modality,RT
1405,1,1,Occurrence #,1st primary
1405,1,1,Radiation Dosage,74.4
1405,1,1,Research lab HPV,HPV unknown
1405,1,1,Overall Stage,II
1405,1,1,Tumor Stage,T2
1405,1,1,Tumor Site,larynx
1405,1,1,First Failure Type,no known failure
1405,1,1,Nodal Stage,N0
1405,1,1,Metastasis,M0
1405,1,1,Clinical lab p16,p16 unknown
1405,1,1,Second Failure Type,no known failure
1405,1,1,Status,Alive w/o disease
1406,1,1,Tumor Site,larynx
1406,1,1,Status,Dead unk disease
1406,1,1,Treatment Modality,RT
1406,1,1,Overall Stage,I
1406,1,1,Research lab p16,p16 unknown
1406,1,1,Second Failure Type,no known failure
1406,1,1,First Failure Type,no known failure
1406,1,1,Nodal Stage,N0
1406,1,1,Metastasis,M0
1406,1,1,Clinical lab p16,p16 unknown
1406,1,1,Age at Death,73.7
1406,1,1,Radiation Dosage,68
1406,1,1,Date of Death,2004-03-22 00:00:00
1406,1,1,Research lab HPV,HPV unknown
1406,1,1,Occurrence #,1st primary
1406,1,1,Tumor Stage,T1
1407,1,1,Treatment Modality,Sx & RT
1407,1,1,Tumor Site,larynx
1407,1,1,Nodal Stage,N1
1407,1,1,Occurrence #,1st primary
1407,1,1,First Failure Type,distant
1407,1,1,Metastasis,M0
1407,1,1,Time to First Failure,0.8
1407,1,1,Research lab HPV,HPV unknown
1407,1,1,Overall Stage,IVa
1407,1,1,Research lab p16,p16 unknown
1407,1,1,Radiation Dosage,59.4
1407,1,1,Second Failure Type,no known failure
1407,1,1,Clinical lab p16,p16 unknown
1407,1,1,Tumor Stage,T4a
1407,1,1,Status,Dead w/ disease
1408,1,1,Research lab p16,p16 unknown
1408,1,1,Tumor Stage,T3
1408,1,1,Tumor Site,larynx
1408,1,1,Time to First Failure,1.0
1408,1,1,Age at Death,50.9
1408,1,1,Metastasis,M0
1408,1,1,Clinical lab p16,p16 unknown
1408,1,1,Research lab HPV,HPV unknown
1408,1,1,Occurrence #,1st primary
1408,1,1,First Failure Type,locoregional
1408,1,1,Time to Death,1.4
1408,1,1,Second Failure Type,no known failure
1408,1,1,Status,Dead w/ disease
1408,1,1,Nodal Stage,N0
1408,1,1,Overall Stage,III
1408,1,1,Radiation Dosage,unknown
1408,1,1,Treatment Modality,CTX-RT
1408,1,1,Initial Chemotherapy Agent,unknown
1408,1,1,Date of Death,2006-04-13 00:00:00
1409,1,1,Tumor Site,larynx
1409,1,1,Nodal Stage,N0
1409,1,1,Time to First Failure,0.5
1409,1,1,Treatment Modality,Sx & RT
1409,1,1,Status,Dead w/ disease
1409,1,1,Age at Death,65.9
1409,1,1,Time to Death,0.9
1409,1,1,First Failure Type,locoregional and distant
1409,1,1,Date of Death,2007-03-20 00:00:00
1409,1,1,Occurrence #,1st primary
1409,1,1,Radiation Dosage,59.4
1409,1,1,Research lab p16,p16 unknown
1409,1,1,Overall Stage,IVa
1409,1,1,Tumor Stage,T4a
1409,1,1,Second Failure Type,no known failure
1409,1,1,Research lab HPV,HPV unknown
1409,1,1,Metastasis,M0
1409,1,1,Clinical lab p16,p16 unknown
1410,1,1,Second Failure Type,no known failure
1410,1,1,Radiation Dosage,unknown
1410,1,1,First Failure Type,no known failure
1410,1,1,Metastasis,M0
1410,1,1,Occurrence #,1st primary
1410,1,1,Status,Alive w/o disease
1410,1,1,Research lab HPV,HPV unknown
1410,1,1,Treatment Modality,Sx & RT
1410,1,1,Overall Stage,II
1410,1,1,Nodal Stage,N0
1410,1,1,Clinical lab p16,p16 unknown
1410,1,1,Tumor Site,larynx
1410,1,1,Tumor Stage,T2
1410,1,1,Research lab p16,p16 unknown
1411,1,1,Age at Death,68.8
1411,1,1,Tumor Stage,T3
1411,1,1,Research lab HPV,HPV unknown
1411,1,1,Occurrence #,1st primary
1411,1,1,Time to First Failure,1.0
1411,1,1,Overall Stage,III
1411,1,1,Nodal Stage,N1
1411,1,1,Tumor Site,larynx
1411,1,1,Treatment Modality,Sx
1411,1,1,First Failure Type,distant
1411,1,1,Metastasis,M0
1411,1,1,Second Failure Type,no known failure
1411,1,1,Status,Dead w/ disease
1411,1,1,Research lab p16,p16 unknown
1411,1,1,Clinical lab p16,p16 unknown
1411,1,1,Time to Death,1.9
1411,1,1,Date of Death,2009-04-17 00:00:00
1412,1,1,Radiation Dosage,74.4
1412,1,1,Occurrence #,1st primary
1412,1,1,Research lab p16,p16 unknown
1412,1,1,Tumor Stage,T3
1412,1,1,Overall Stage,IVa
1412,1,1,Clinical lab p16,p16 unknown
1412,1,1,Status,Alive unk disease
1412,1,1,Metastasis,M0
1412,1,1,Research lab HPV,HPV unknown
1412,1,1,Nodal Stage,N2
1412,1,1,Second Failure Type,no known failure
1412,1,1,Initial Chemotherapy Agent,unknown
1412,1,1,Tumor Site,larynx
1412,1,1,First Failure Type,no known failure
1412,1,1,Treatment Modality,CTX-RT
1413,1,1,Overall Stage,I
1413,1,1,Tumor Site,larynx
1413,1,1,Clinical lab p16,p16 unknown
1413,1,1,Date of Death,2006-08-10 00:00:00
1413,1,1,Metastasis,M0
1413,1,1,Research lab p16,p16 unknown
1413,1,1,First Failure Type,no known failure
1413,1,1,Radiation Dosage,63
1413,1,1,Status,Dead unk disease
1413,1,1,Research lab HPV,HPV unknown
1413,1,1,Treatment Modality,RT
1413,1,1,Nodal Stage,N0
1413,1,1,Tumor Stage,T1
1413,1,1,Second Failure Type,no known failure
1413,1,1,Occurrence #,1st primary
1413,1,1,Time to Death,1.6
1413,1,1,Age at Death,81.8
1414,1,1,Treatment Modality,Sx
1414,1,1,Tumor Stage,T4a
1414,1,1,Date of Death,2011-11-17 00:00:00
1414,1,1,Research lab p16,p16 unknown
1414,1,1,Age at Death,65.5
1414,1,1,Clinical lab p16,p16 unknown
1414,1,1,Metastasis,M0
1414,1,1,Occurrence #,other primary
1414,1,1,First Failure Type,locoregional
1414,1,1,Tumor Site,larynx
1414,1,1,First Failure Site,larynx
1414,1,1,First Failure Initial Chemotherapy Agent,cis/doce
1414,1,1,Second Failure Type,no known failure
1414,1,1,Time to First Failure,0.4
1414,1,1,Nodal Stage,N1
1414,1,1,Time to Death,1.8
1414,1,1,Research lab HPV,HPV unknown
1414,1,1,Status,Dead w/ disease
1414,1,1,First Failure Treatment Modality,CTX
1414,1,1,Overall Stage,IVa
1415,1,1,Status,Dead unk disease
1415,1,1,First Failure Type,no known failure
1415,1,1,Tumor Stage,T1
1415,1,1,Nodal Stage,N3
1415,1,1,Overall Stage,IVb
1415,1,1,Tumor Site,larynx
1415,1,1,Initial Chemotherapy Agent,unknown
1415,1,1,Research lab HPV,HPV unknown
1415,1,1,Occurrence #,1st primary
1415,1,1,Time to Death,0.2
1415,1,1,Treatment Modality,CTX-RT
1415,1,1,Second Failure Type,no known failure
1415,1,1,Clinical lab p16,p16 unknown
1415,1,1,Research lab p16,p16 unknown
1415,1,1,Radiation Dosage,54
1415,1,1,Date of Death,2002-11-13 00:00:00
1415,1,1,Metastasis,M0
1416,1,1,Date of Death,2007-11-11 00:00:00
1416,1,1,Age at Death,70.2
1416,1,1,Occurrence #,1st primary
1416,1,1,Nodal Stage,N2
1416,1,1,First Failure Type,no known failure
1416,1,1,Treatment Modality,Sx
1416,1,1,Clinical lab p16,p16 unknown
1416,1,1,Metastasis,M0
1416,1,1,Research lab p16,p16 unknown
1416,1,1,Second Failure Type,no known failure
1416,1,1,Time to Death,0.4
1416,1,1,Overall Stage,IVa
1416,1,1,Research lab HPV,HPV unknown
1416,1,1,Status,Dead unk disease
1416,1,1,Tumor Stage,T4a
1416,1,1,Tumor Site,larynx
1417,1,1,First Failure Type,no known failure
1417,1,1,Tumor Site,larynx
1417,1,1,Second Failure Type,no known failure
1417,1,1,Tumor Stage,T2
1417,1,1,Research lab p16,p16 unknown
1417,1,1,Nodal Stage,N0
1417,1,1,Radiation Dosage,74.4
1417,1,1,Clinical lab p16,p16 unknown
1417,1,1,Status,Alive w/o disease
1417,1,1,Overall Stage,II
1417,1,1,Occurrence #,1st primary
1417,1,1,Treatment Modality,RT
1417,1,1,Metastasis,M0
1417,1,1,Research lab HPV,HPV unknown
1418,1,1,Second Failure Type,no known failure
1418,1,1,Overall Stage,IVa
1418,1,1,Time to First Failure,0.2
1418,1,1,Research lab p16,p16 unknown
1418,1,1,Tumor Site,larynx
1418,1,1,Metastasis,Unknown
1418,1,1,Tumor Stage,T4a
1418,1,1,Nodal Stage,N0
1418,1,1,Date of Death,2007-10-03 00:00:00
1418,1,1,Status,Dead w/ disease
1418,1,1,First Failure Type,locoregional
1418,1,1,Age at Death,67.6
1418,1,1,Initial Chemotherapy Agent,doce
1418,1,1,Treatment Modality,Sx & CTX
1418,1,1,Research lab HPV,HPV unknown
1418,1,1,Occurrence #,other primary
1418,1,1,Time to Death,1.7
1418,1,1,Clinical lab p16,p16 unknown
1419,1,1,Clinical lab p16,p16 unknown
1419,1,1,Second Failure Type,no known failure
1419,1,1,Tumor Site,larynx
1419,1,1,Nodal Stage,N1
1419,1,1,Status,Dead unk disease
1419,1,1,Metastasis,M0
1419,1,1,Treatment Modality,Sx
1419,1,1,Time to Death,0.7
1419,1,1,Research lab HPV,HPV unknown
1419,1,1,First Failure Type,no known failure
1419,1,1,Date of Death,2010-01-31 00:00:00
1419,1,1,Tumor Stage,T2
1419,1,1,Age at Death,70.9
1419,1,1,Occurrence #,recurrence
1419,1,1,Research lab p16,p16 unknown
1419,1,1,Overall Stage,III
1420,1,1,Second Failure Type,no known failure
1420,1,1,Tumor Site,larynx
1420,1,1,Treatment Modality,CTX-RT
1420,1,1,Radiation Dosage,unknown
1420,1,1,Tumor Stage,Unknown
1420,1,1,Overall Stage,IVa
1420,1,1,Nodal Stage,Unknown
1420,1,1,Initial Chemotherapy Agent,carbo/PTX
1420,1,1,Time to Death,1.2
1420,1,1,Date of Death,2003-06-23 00:00:00
1420,1,1,Age at Death,65.5
1420,1,1,Status,Dead w/ disease
1420,1,1,Research lab p16,p16 unknown
1420,1,1,Research lab HPV,HPV unknown
1420,1,1,First Failure Type,locoregional
1420,1,1,Occurrence #,recurrence
1420,1,1,Clinical lab p16,p16 unknown
1420,1,1,Time to First Failure,-0.0
1420,1,1,Metastasis,M0
1421,1,1,Research lab HPV,HPV unknown
1421,1,1,Overall Stage,IVa
1421,1,1,Nodal Stage,N0
1421,1,1,Status,Alive w/o disease
1421,1,1,Metastasis,M0
1421,1,1,First Failure Type,no known failure
1421,1,1,Treatment Modality,Sx
1421,1,1,Clinical lab p16,p16 unknown
1421,1,1,Occurrence #,recurrence
1421,1,1,Research lab p16,p16 unknown
1421,1,1,Tumor Stage,T4a
1421,1,1,Tumor Site,larynx
1421,1,1,Second Failure Type,no known failure
1422,1,1,First Failure Type,no known failure
1422,1,1,Tumor Stage,T4a
1422,1,1,Initial Chemotherapy Agent,cis
1422,1,1,Metastasis,M0
1422,1,1,Date of Death,2006-09-24 00:00:00
1422,1,1,Second Failure Type,no known failure
1422,1,1,Occurrence #,1st primary
1422,1,1,Tumor Site,larynx
1422,1,1,Research lab p16,p16 unknown
1422,1,1,Clinical lab p16,p16 unknown
1422,1,1,Age at Death,65.9
1422,1,1,Treatment Modality,CTX-RT
1422,1,1,Radiation Dosage,70.2
1422,1,1,Overall Stage,IVa
1422,1,1,Nodal Stage,N2
1422,1,1,Status,Dead w/o disease
1422,1,1,Time to Death,0.6
1422,1,1,Research lab HPV,HPV unknown
1423,1,1,Treatment Modality,Sx
1423,1,1,Metastasis,Unknown
1423,1,1,Research lab HPV,HPV unknown
1423,1,1,Age at Death,84.6
1423,1,1,First Failure Type,no known failure
1423,1,1,Status,Dead unk disease
1423,1,1,Overall Stage,Unknown
1423,1,1,Tumor Stage,Unknown
1423,1,1,Time to Death,0.2
1423,1,1,Date of Death,2006-08-26 00:00:00
1423,1,1,Nodal Stage,Unknown
1423,1,1,Tumor Site,larynx
1423,1,1,Occurrence #,recurrence
1423,1,1,Clinical lab p16,p16 unknown
1423,1,1,Research lab p16,p16 unknown
1423,1,1,Second Failure Type,no known failure
1424,1,1,Metastasis,M0
1424,1,1,Tumor Site,larynx
1424,1,1,Research lab p16,p16 unknown
1424,1,1,Overall Stage,III
1424,1,1,Treatment Modality,Sx
1424,1,1,First Failure Type,no known failure
1424,1,1,Research lab HPV,HPV unknown
1424,1,1,Clinical lab p16,p16 unknown
1424,1,1,Occurrence #,1st primary
1424,1,1,Second Failure Type,no known failure
1424,1,1,Tumor Stage,T3
1424,1,1,Nodal Stage,N0
1424,1,1,Status,Alive unk disease
1425,1,1,Second Failure Type,no known failure
1425,1,1,Treatment Modality,Sx & RT
1425,1,1,Status,Alive w/o disease
1425,1,1,Nodal Stage,N1
1425,1,1,First Failure Type,no known failure
1425,1,1,Radiation Dosage,59.9
1425,1,1,Research lab HPV,HPV unknown
1425,1,1,Clinical lab p16,p16 unknown
1425,1,1,Occurrence #,1st primary
1425,1,1,Research lab p16,p16 unknown
1425,1,1,Tumor Stage,T3
1425,1,1,Tumor Site,larynx
1425,1,1,Overall Stage,III
1425,1,1,Metastasis,M0
1426,1,1,Tumor Stage,T2
1426,1,1,Tumor Site,larynx
1426,1,1,Clinical lab p16,p16 unknown
1426,1,1,Nodal Stage,N0
1426,1,1,Second Failure Type,no known failure
1426,1,1,Research lab p16,p16 unknown
1426,1,1,Occurrence #,1st primary
1426,1,1,First Failure Type,no known failure
1426,1,1,Metastasis,M0
1426,1,1,Status,Alive w/o disease
1426,1,1,Overall Stage,II
1426,1,1,Treatment Modality,Sx
1426,1,1,Research lab HPV,HPV unknown
1427,1,1,First Failure Site,oropharynx
1427,1,1,Date of Death,2011-02-06 00:00:00
1427,1,1,Status,Dead unk disease
1427,1,1,Time to First Failure,0.2
1427,1,1,First Failure Initial Chemotherapy Agent,unknown
1427,1,1,Research lab p16,p16 unknown
1427,1,1,Time to Death,9.6
1427,1,1,Metastasis,M0
1427,1,1,Research lab HPV,HPV unknown
1427,1,1,Tumor Site,larynx
1427,1,1,Tumor Stage,T3
1427,1,1,Overall Stage,III
1427,1,1,Occurrence #,1st primary
1427,1,1,Clinical lab p16,p16 unknown
1427,1,1,Nodal Stage,N0
1427,1,1,First Failure Radiation Dosage,72
1427,1,1,Age at Death,83.2
1427,1,1,First Failure Type,locoregional
1427,1,1,Second Failure Type,no known failure
1427,1,1,Treatment Modality,Sx
1427,1,1,First Failure Treatment Modality,Sx & CTX-RT
1428,1,1,Tumor Site,larynx
1428,1,1,Research lab HPV,HPV unknown
1428,1,1,Occurrence #,recurrence
1428,1,1,Second Failure Type,no known failure
1428,1,1,Status,Alive w/ disease
1428,1,1,Treatment Modality,Sx
1428,1,1,Time to First Failure,-0.7
1428,1,1,Clinical lab p16,p16 unknown
1428,1,1,First Failure Type,distant
1428,1,1,Overall Stage,I
1428,1,1,Metastasis,M0
1428,1,1,Research lab p16,p16 unknown
1428,1,1,Tumor Stage,T1
1428,1,1,Nodal Stage,N0
1429,1,1,Second Failure Type,no known failure
1429,1,1,First Failure Type,no known failure
1429,1,1,Radiation Dosage,70.2
1429,1,1,Tumor Stage,T3
1429,1,1,Nodal Stage,N0
1429,1,1,Clinical lab p16,p16 unknown
1429,1,1,Treatment Modality,CTX-RT
1429,1,1,Overall Stage,III
1429,1,1,Status,Alive unk disease
1429,1,1,Initial Chemotherapy Agent,cis
1429,1,1,Metastasis,M0
1429,1,1,Research lab p16,p16 unknown
1429,1,1,Occurrence #,1st primary
1429,1,1,Tumor Site,larynx
1429,1,1,Research lab HPV,HPV unknown
1430,1,1,Age at Death,54.4
1430,1,1,Second Failure Type,no known failure
1430,1,1,Treatment Modality,Sx
1430,1,1,Research lab HPV,HPV unknown
1430,1,1,Nodal Stage,N1
1430,1,1,Occurrence #,1st primary
1430,1,1,Tumor Site,larynx
1430,1,1,Time to Death,0.7
1430,1,1,Research lab p16,p16 unknown
1430,1,1,Date of Death,2007-06-29 00:00:00
1430,1,1,Metastasis,M0
1430,1,1,First Failure Type,no known failure
1430,1,1,Tumor Stage,T2
1430,1,1,Clinical lab p16,p16 unknown
1430,1,1,Status,Dead unk disease
1430,1,1,Overall Stage,III
1431,1,1,Radiation Dosage,74.4
1431,1,1,First Failure Type,no known failure
1431,1,1,Treatment Modality,RT
1431,1,1,Nodal Stage,N0
1431,1,1,Metastasis,M0
1431,1,1,Overall Stage,II
1431,1,1,Status,Alive w/o disease
1431,1,1,Research lab HPV,HPV unknown
1431,1,1,Clinical lab p16,p16 unknown
1431,1,1,Research lab p16,p16 unknown
1431,1,1,Occurrence #,1st primary
1431,1,1,Second Failure Type,no known failure
1431,1,1,Tumor Stage,T2
1431,1,1,Tumor Site,larynx
1432,1,1,Overall Stage,I
1432,1,1,Occurrence #,1st primary
1432,1,1,Second Failure Type,no known failure
1432,1,1,Treatment Modality,Sx
1432,1,1,Nodal Stage,N0
1432,1,1,Clinical lab p16,p16 unknown
1432,1,1,First Failure Type,no known failure
1432,1,1,Research lab HPV,HPV unknown
1432,1,1,Tumor Site,larynx
1432,1,1,Tumor Stage,T1
1432,1,1,Metastasis,M0
1432,1,1,Research lab p16,p16 unknown
1432,1,1,Status,Alive w/o disease
1433,1,1,Occurrence #,1st primary
1433,1,1,Tumor Site,larynx
1433,1,1,Nodal Stage,N0
1433,1,1,Metastasis,M0
1433,1,1,Research lab p16,p16 unknown
1433,1,1,First Failure Type,no known failure
1433,1,1,Radiation Dosage,63
1433,1,1,Clinical lab p16,p16 unknown
1433,1,1,Tumor Stage,T1
1433,1,1,Treatment Modality,RT
1433,1,1,Overall Stage,I
1433,1,1,Second Failure Type,no known failure
1433,1,1,Status,Alive w/o disease
1433,1,1,Research lab HPV,HPV unknown
1434,1,1,Status,Dead unk disease
1434,1,1,Date of Death,2005-01-19 00:00:00
1434,1,1,Tumor Site,larynx
1434,1,1,Time to Death,2.0
1434,1,1,Research lab p16,p16 unknown
1434,1,1,Research lab HPV,HPV unknown
1434,1,1,Nodal Stage,N0
1434,1,1,Occurrence #,1st primary
1434,1,1,Treatment Modality,Unknown
1434,1,1,Second Failure Type,no known failure
1434,1,1,Metastasis,M0
1434,1,1,Overall Stage,III
1434,1,1,Age at Death,59.1
1434,1,1,Clinical lab p16,p16 unknown
1434,1,1,Tumor Stage,T3
1434,1,1,First Failure Type,no known failure
1435,1,1,Nodal Stage,N0
1435,1,1,Initial Chemotherapy Agent,cis
1435,1,1,First Failure Type,no known failure
1435,1,1,Tumor Stage,T3
1435,1,1,Research lab p16,p16 unknown
1435,1,1,Overall Stage,III
1435,1,1,Occurrence #,1st primary
1435,1,1,Research lab HPV,HPV unknown
1435,1,1,Clinical lab p16,p16 unknown
1435,1,1,Status,Alive w/o disease
1435,1,1,Treatment Modality,CTX-RT
1435,1,1,Tumor Site,larynx
1435,1,1,Radiation Dosage,43.2
1435,1,1,Second Failure Type,no known failure
1435,1,1,Metastasis,M0
1436,1,1,Age at Death,52.4
1436,1,1,Date of Death,2008-12-07 00:00:00
1436,1,1,Clinical lab p16,p16 unknown
1436,1,1,Occurrence #,1st primary
1436,1,1,Second Failure Type,no known failure
1436,1,1,Tumor Site,larynx
1436,1,1,Overall Stage,IVa
1436,1,1,Time to Death,0.2
1436,1,1,Nodal Stage,N1
1436,1,1,Metastasis,M0
1436,1,1,Treatment Modality,Unknown
1436,1,1,Research lab p16,p16 unknown
1436,1,1,First Failure Type,no known failure
1436,1,1,Research lab HPV,HPV unknown
1436,1,1,Tumor Stage,T4a
1436,1,1,Status,Dead w/ disease
1437,1,1,Occurrence #,1st primary
1437,1,1,Status,Alive w/o disease
1437,1,1,First Failure Type,locoregional
1437,1,1,Clinical lab p16,p16 unknown
1437,1,1,Tumor Site,larynx
1437,1,1,First Failure Initial Chemotherapy Agent,cis/doce
1437,1,1,Time to First Failure,4.8
1437,1,1,First Failure Treatment Modality,Sx & CTX
1437,1,1,Second Failure Type,no known failure
1437,1,1,First Failure Site,larynx
1437,1,1,Research lab HPV,HPV unknown
1437,1,1,Overall Stage,IVa
1437,1,1,Treatment Modality,Sx & RT
1437,1,1,Research lab p16,p16 unknown
1437,1,1,Radiation Dosage,unknown
1437,1,1,Tumor Stage,T3
1437,1,1,First Failure Second Line Chemotherapy Agent,doxycycline/doce
1437,1,1,Metastasis,M0
1437,1,1,Nodal Stage,N2
1438,1,1,Tumor Stage,T4a
1438,1,1,Date of Death,2007-07-11 00:00:00
1438,1,1,First Failure Treatment Modality,Sx
1438,1,1,Overall Stage,IVa
1438,1,1,Time to Death,1.9
1438,1,1,Age at Death,53.8
1438,1,1,Nodal Stage,N2
1438,1,1,Metastasis,M0
1438,1,1,Time to First Failure,0.4
1438,1,1,Tumor Site,larynx
1438,1,1,Second Line Chemotherapy Agent,carbo/doce
1438,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1438,1,1,Radiation Dosage,70.2
1438,1,1,Treatment Modality,CTX-RT
1438,1,1,Research lab p16,p16 unknown
1438,1,1,First Failure Site,larynx
1438,1,1,Status,Dead w/ disease
1438,1,1,Occurrence #,1st primary
1438,1,1,Second Failure Type,no known failure
1438,1,1,Clinical lab p16,p16 unknown
1438,1,1,Research lab HPV,HPV unknown
1438,1,1,First Failure Type,locoregional
1439,1,1,Status,Alive w/o disease
1439,1,1,Tumor Site,larynx
1439,1,1,Occurrence #,recurrence
1439,1,1,Treatment Modality,Sx
1439,1,1,Research lab HPV,HPV unknown
1439,1,1,Second Failure Type,no known failure
1439,1,1,Clinical lab p16,p16 unknown
1439,1,1,Research lab p16,p16 unknown
1439,1,1,First Failure Type,no known failure
1439,1,1,Tumor Stage,T4a
1439,1,1,Nodal Stage,N0
1439,1,1,Overall Stage,IVa
1439,1,1,Metastasis,M0
1440,1,1,First Failure Type,distant
1440,1,1,Time to First Failure,-0.0
1440,1,1,Treatment Modality,Sx
1440,1,1,Tumor Site,larynx
1440,1,1,Research lab HPV,HPV unknown
1440,1,1,Second Failure Type,no known failure
1440,1,1,Clinical lab p16,p16 unknown
1440,1,1,Research lab p16,p16 unknown
1440,1,1,Date of Death,2011-01-22 00:00:00
1440,1,1,Overall Stage,IVc
1440,1,1,Metastasis,M1
1440,1,1,Time to Death,1.3
1440,1,1,Nodal Stage,N2
1440,1,1,Tumor Stage,T2
1440,1,1,Status,Dead w/ disease
1440,1,1,Age at Death,67.7
1440,1,1,Occurrence #,recurrence
1441,1,1,Status,Dead w/ disease
1441,1,1,Nodal Stage,Unknown
1441,1,1,Overall Stage,Unknown
1441,1,1,Time to Death,0.0
1441,1,1,First Failure Type,no known failure
1441,1,1,Date of Death,2001-11-10 00:00:00
1441,1,1,Second Failure Type,no known failure
1441,1,1,Research lab p16,p16 unknown
1441,1,1,Research lab HPV,HPV unknown
1441,1,1,Occurrence #,1st primary
1441,1,1,Tumor Site,larynx
1441,1,1,Treatment Modality,Unknown
1441,1,1,Metastasis,Unknown
1441,1,1,Age at Death,80.5
1441,1,1,Clinical lab p16,p16 unknown
1441,1,1,Tumor Stage,Unknown
1442,1,1,Nodal Stage,N0
1442,1,1,Occurrence #,1st primary
1442,1,1,Research lab p16,p16 unknown
1442,1,1,Status,Alive w/o disease
1442,1,1,Clinical lab p16,p16 unknown
1442,1,1,Treatment Modality,RT
1442,1,1,Tumor Site,larynx
1442,1,1,Research lab HPV,HPV unknown
1442,1,1,First Failure Type,no known failure
1442,1,1,Radiation Dosage,74.4
1442,1,1,Second Failure Type,no known failure
1442,1,1,Overall Stage,II
1442,1,1,Tumor Stage,T2
1442,1,1,Metastasis,M0
1443,1,1,Research lab p16,p16 unknown
1443,1,1,Overall Stage,I
1443,1,1,Second Failure Type,no known failure
1443,1,1,Time to Death,6.2
1443,1,1,First Failure Type,no known failure
1443,1,1,Tumor Stage,T1
1443,1,1,Research lab HPV,HPV unknown
1443,1,1,Age at Death,76.9
1443,1,1,Tumor Site,larynx
1443,1,1,Treatment Modality,Sx
1443,1,1,Clinical lab p16,p16 unknown
1443,1,1,Occurrence #,1st primary
1443,1,1,Status,Dead unk disease
1443,1,1,Date of Death,2011-02-23 00:00:00
1443,1,1,Nodal Stage,N0
1443,1,1,Metastasis,M0
1444,1,1,Tumor Stage,T2
1444,1,1,Metastasis,M0
1444,1,1,Radiation Dosage,unknown
1444,1,1,Status,Alive w/o disease
1444,1,1,Clinical lab p16,p16 unknown
1444,1,1,Tumor Site,larynx
1444,1,1,Second Failure Type,no known failure
1444,1,1,Research lab HPV,HPV unknown
1444,1,1,Treatment Modality,CTX-RT
1444,1,1,Nodal Stage,N0
1444,1,1,First Failure Type,no known failure
1444,1,1,Overall Stage,II
1444,1,1,Research lab p16,p16 unknown
1444,1,1,Initial Chemotherapy Agent,unknown
1444,1,1,Occurrence #,1st primary
1445,1,1,Treatment Modality,Sx
1445,1,1,Tumor Site,larynx
1445,1,1,Clinical lab p16,p16 unknown
1445,1,1,Status,Alive unk disease
1445,1,1,Second Failure Type,no known failure
1445,1,1,Research lab HPV,HPV unknown
1445,1,1,First Failure Type,no known failure
1445,1,1,Overall Stage,II
1445,1,1,Tumor Stage,T2
1445,1,1,Occurrence #,1st primary
1445,1,1,Research lab p16,p16 unknown
1445,1,1,Nodal Stage,N0
1445,1,1,Metastasis,M0
1446,1,1,Time to Death,0.2
1446,1,1,Nodal Stage,N0
1446,1,1,Second Failure Type,no known failure
1446,1,1,Research lab HPV,HPV unknown
1446,1,1,Tumor Stage,T3
1446,1,1,Status,Dead w/ disease
1446,1,1,Clinical lab p16,p16 unknown
1446,1,1,Tumor Site,larynx
1446,1,1,Overall Stage,III
1446,1,1,Occurrence #,1st primary
1446,1,1,Treatment Modality,CTX-RT
1446,1,1,Date of Death,2006-10-10 00:00:00
1446,1,1,Initial Chemotherapy Agent,cis
1446,1,1,Age at Death,68.7
1446,1,1,Radiation Dosage,28.8
1446,1,1,Research lab p16,p16 unknown
1446,1,1,Metastasis,M0
1446,1,1,First Failure Type,no known failure
1447,1,1,Research lab p16,p16 unknown
1447,1,1,Clinical lab p16,p16 unknown
1447,1,1,Second Failure Type,no known failure
1447,1,1,Tumor Site,larynx
1447,1,1,Metastasis,M0
1447,1,1,Overall Stage,IVa
1447,1,1,Research lab HPV,HPV unknown
1447,1,1,Occurrence #,recurrence
1447,1,1,Tumor Stage,T4a
1447,1,1,First Failure Type,no known failure
1447,1,1,Status,Alive unk disease
1447,1,1,Treatment Modality,Sx
1447,1,1,Nodal Stage,N0
1448,1,1,Status,Alive w/o disease
1448,1,1,Time to First Failure,2.1
1448,1,1,First Failure Type,distant
1448,1,1,First Failure Site,larynx
1448,1,1,Tumor Stage,T4a
1448,1,1,Overall Stage,IVa
1448,1,1,Occurrence #,1st primary
1448,1,1,Research lab HPV,HPV unknown
1448,1,1,Second Failure Type,no known failure
1448,1,1,First Failure Treatment Modality,Sx
1448,1,1,Metastasis,M0
1448,1,1,Clinical lab p16,p16 unknown
1448,1,1,Tumor Site,larynx
1448,1,1,Treatment Modality,Sx & RT
1448,1,1,Research lab p16,p16 unknown
1448,1,1,Nodal Stage,N0
1448,1,1,Radiation Dosage,63
1449,1,1,Overall Stage,IVa
1449,1,1,Occurrence #,1st primary
1449,1,1,Radiation Dosage,70.2
1449,1,1,Metastasis,M0
1449,1,1,Research lab HPV,HPV unknown
1449,1,1,Treatment Modality,CTX-RT
1449,1,1,Age at Death,76.2
1449,1,1,Tumor Site,larynx
1449,1,1,Tumor Stage,T2
1449,1,1,Initial Chemotherapy Agent,cis
1449,1,1,First Failure Type,distant
1449,1,1,Research lab p16,p16 unknown
1449,1,1,Status,Dead w/ disease
1449,1,1,Clinical lab p16,p16 unknown
1449,1,1,Time to First Failure,0.7
1449,1,1,Date of Death,2009-03-31 00:00:00
1449,1,1,Time to Death,1.6
1449,1,1,Second Failure Type,no known failure
1449,1,1,Nodal Stage,N2
1450,1,1,Nodal Stage,N0
1450,1,1,Time to Death,6.8
1450,1,1,Tumor Stage,T4a
1450,1,1,Status,Dead w/o disease
1450,1,1,First Failure Type,no known failure
1450,1,1,Metastasis,M0
1450,1,1,Research lab HPV,HPV unknown
1450,1,1,Clinical lab p16,p16 unknown
1450,1,1,Second Failure Type,no known failure
1450,1,1,Occurrence #,1st primary
1450,1,1,Treatment Modality,Sx
1450,1,1,Tumor Site,larynx
1450,1,1,Research lab p16,p16 unknown
1450,1,1,Date of Death,2009-02-21 00:00:00
1450,1,1,Age at Death,66.6
1450,1,1,Overall Stage,IVa
1451,1,1,Status,Alive w/o disease
1451,1,1,Metastasis,M0
1451,1,1,Tumor Stage,T2
1451,1,1,First Failure Type,no known failure
1451,1,1,Occurrence #,1st primary
1451,1,1,Radiation Dosage,74.4
1451,1,1,Overall Stage,II
1451,1,1,Tumor Site,larynx
1451,1,1,Research lab p16,p16 unknown
1451,1,1,Second Failure Type,no known failure
1451,1,1,Clinical lab p16,p16 unknown
1451,1,1,Research lab HPV,HPV unknown
1451,1,1,Treatment Modality,RT
1451,1,1,Nodal Stage,N0
1452,1,1,Occurrence #,1st primary
1452,1,1,Tumor Site,larynx
1452,1,1,Status,Dead w/ disease
1452,1,1,Research lab HPV,HPV unknown
1452,1,1,Radiation Dosage,63
1452,1,1,Tumor Stage,T1
1452,1,1,Treatment Modality,RT
1452,1,1,First Failure Type,no known failure
1452,1,1,Clinical lab p16,p16 unknown
1452,1,1,Second Failure Type,no known failure
1452,1,1,Research lab p16,p16 unknown
1452,1,1,Metastasis,M0
1452,1,1,Nodal Stage,N0
1452,1,1,Overall Stage,I
1453,1,1,First Failure Type,no known failure
1453,1,1,Status,Alive unk disease
1453,1,1,Occurrence #,1st primary
1453,1,1,Tumor Stage,T4a
1453,1,1,Nodal Stage,N0
1453,1,1,Metastasis,M0
1453,1,1,Overall Stage,IVa
1453,1,1,Tumor Site,larynx
1453,1,1,Research lab p16,p16 unknown
1453,1,1,Second Failure Type,no known failure
1453,1,1,Clinical lab p16,p16 unknown
1453,1,1,Research lab HPV,HPV unknown
1453,1,1,Treatment Modality,RT
1453,1,1,Radiation Dosage,70.2
1454,1,1,Age at Death,62.9
1454,1,1,Date of Death,2003-11-24 00:00:00
1454,1,1,Time to Death,0.3
1454,1,1,Second Failure Type,no known failure
1454,1,1,Status,Dead w/ disease
1454,1,1,Clinical lab p16,p16 unknown
1454,1,1,Nodal Stage,N3
1454,1,1,Treatment Modality,Unknown
1454,1,1,Research lab HPV,HPV unknown
1454,1,1,Overall Stage,IVb
1454,1,1,Research lab p16,p16 unknown
1454,1,1,Metastasis,M0
1454,1,1,First Failure Type,no known failure
1454,1,1,Occurrence #,1st primary
1454,1,1,Tumor Site,larynx
1454,1,1,Tumor Stage,T4a
1455,1,1,Date of Death,2010-05-23 00:00:00
1455,1,1,Age at Death,77.5
1455,1,1,Status,Dead w/o disease
1455,1,1,Treatment Modality,RT
1455,1,1,Research lab p16,p16 unknown
1455,1,1,Tumor Stage,T1
1455,1,1,Overall Stage,I
1455,1,1,Nodal Stage,N0
1455,1,1,Time to Death,5.6
1455,1,1,Occurrence #,other primary
1455,1,1,First Failure Type,no known failure
1455,1,1,Second Failure Type,no known failure
1455,1,1,Clinical lab p16,p16 unknown
1455,1,1,Radiation Dosage,60
1455,1,1,Tumor Site,larynx
1455,1,1,Metastasis,M0
1455,1,1,Research lab HPV,HPV unknown
1456,1,1,Metastasis,M0
1456,1,1,First Failure Type,no known failure
1456,1,1,Tumor Site,larynx
1456,1,1,Time to Death,0.9
1456,1,1,Tumor Stage,T2
1456,1,1,Age at Death,67.5
1456,1,1,Research lab p16,p16 unknown
1456,1,1,Radiation Dosage,67.2
1456,1,1,Research lab HPV,HPV unknown
1456,1,1,Nodal Stage,N0
1456,1,1,Treatment Modality,RT
1456,1,1,Status,Dead unk disease
1456,1,1,Clinical lab p16,p16 unknown
1456,1,1,Overall Stage,II
1456,1,1,Second Failure Type,no known failure
1456,1,1,Date of Death,2007-06-29 00:00:00
1456,1,1,Occurrence #,1st primary
1457,1,1,First Failure Type,no known failure
1457,1,1,Overall Stage,IVa
1457,1,1,Research lab HPV,HPV unknown
1457,1,1,Clinical lab p16,p16 unknown
1457,1,1,Second Failure Type,no known failure
1457,1,1,Research lab p16,p16 unknown
1457,1,1,Treatment Modality,Sx
1457,1,1,Nodal Stage,N0
1457,1,1,Tumor Site,larynx
1457,1,1,Tumor Stage,T4a
1457,1,1,Occurrence #,1st primary
1457,1,1,Metastasis,M0
1457,1,1,Status,Alive unk disease
1458,1,1,Nodal Stage,N0
1458,1,1,Research lab HPV,HPV unknown
1458,1,1,First Failure Site,larynx
1458,1,1,Tumor Site,larynx
1458,1,1,Time to First Failure,0.9
1458,1,1,Treatment Modality,RT
1458,1,1,Age at Death,66.2
1458,1,1,Metastasis,M0
1458,1,1,Second Failure Type,no known failure
1458,1,1,Radiation Dosage,74.4
1458,1,1,Tumor Stage,T2
1458,1,1,Status,Dead unk disease
1458,1,1,First Failure Type,locoregional
1458,1,1,Overall Stage,II
1458,1,1,Time to Death,1.8
1458,1,1,Clinical lab p16,p16 unknown
1458,1,1,Occurrence #,1st primary
1458,1,1,Research lab p16,p16 unknown
1458,1,1,Date of Death,2008-10-20 00:00:00
1458,1,1,First Failure Treatment Modality,Sx
1459,1,1,Metastasis,M0
1459,1,1,Overall Stage,IVa
1459,1,1,First Failure Type,no known failure
1459,1,1,Research lab p16,p16 unknown
1459,1,1,Tumor Site,larynx
1459,1,1,Research lab HPV,HPV unknown
1459,1,1,Occurrence #,recurrence
1459,1,1,Status,Alive w/o disease
1459,1,1,Tumor Stage,T4a
1459,1,1,Second Failure Type,no known failure
1459,1,1,Treatment Modality,Sx
1459,1,1,Clinical lab p16,p16 unknown
1459,1,1,Nodal Stage,N0
1460,1,1,Clinical lab p16,p16 unknown
1460,1,1,Time to Death,0.6
1460,1,1,First Failure Type,no known failure
1460,1,1,Research lab HPV,HPV unknown
1460,1,1,Status,Dead unk disease
1460,1,1,Metastasis,M0
1460,1,1,Nodal Stage,N1
1460,1,1,Radiation Dosage,63
1460,1,1,Date of Death,2006-04-25 00:00:00
1460,1,1,Initial Chemotherapy Agent,unknown
1460,1,1,Occurrence #,1st primary
1460,1,1,Age at Death,65.1
1460,1,1,Tumor Stage,T4a
1460,1,1,Research lab p16,p16 unknown
1460,1,1,Treatment Modality,Sx & CTX-RT
1460,1,1,Tumor Site,larynx
1460,1,1,Second Failure Type,no known failure
1460,1,1,Overall Stage,IVa
1461,1,1,Overall Stage,II
1461,1,1,Treatment Modality,Sx
1461,1,1,Nodal Stage,N0
1461,1,1,Metastasis,M0
1461,1,1,First Failure Type,no known failure
1461,1,1,Status,Alive unk disease
1461,1,1,Research lab HPV,HPV unknown
1461,1,1,Second Failure Type,no known failure
1461,1,1,Occurrence #,recurrence
1461,1,1,Tumor Stage,T2
1461,1,1,Tumor Site,larynx
1461,1,1,Clinical lab p16,p16 unknown
1461,1,1,Research lab p16,p16 unknown
1462,1,1,Age at Death,71.8
1462,1,1,First Failure Site,larynx
1462,1,1,Clinical lab p16,p16 unknown
1462,1,1,Time to First Failure,1.6
1462,1,1,Status,Dead unk disease
1462,1,1,Tumor Site,larynx
1462,1,1,Date of Death,2006-01-30 00:00:00
1462,1,1,First Failure Type,locoregional
1462,1,1,First Failure Treatment Modality,Sx
1462,1,1,Research lab p16,p16 unknown
1462,1,1,Overall Stage,I
1462,1,1,Treatment Modality,RT
1462,1,1,Tumor Stage,T1
1462,1,1,Occurrence #,1st primary
1462,1,1,Second Failure Type,no known failure
1462,1,1,Radiation Dosage,66
1462,1,1,Research lab HPV,HPV unknown
1462,1,1,Metastasis,M0
1462,1,1,Time to Death,4.4
1462,1,1,Nodal Stage,N0
1463,1,1,Overall Stage,IVa
1463,1,1,Clinical lab p16,p16 unknown
1463,1,1,Tumor Site,larynx
1463,1,1,Research lab HPV,HPV unknown
1463,1,1,Tumor Stage,T2
1463,1,1,First Failure Type,no known failure
1463,1,1,Metastasis,M0
1463,1,1,Occurrence #,recurrence
1463,1,1,Date of Death,2001-06-01 00:00:00
1463,1,1,Nodal Stage,N2
1463,1,1,Second Failure Type,no known failure
1463,1,1,Treatment Modality,Sx
1463,1,1,Time to Death,0.2
1463,1,1,Status,Dead unk disease
1463,1,1,Research lab p16,p16 unknown
1463,1,1,Age at Death,69.3
1464,1,1,Tumor Site,larynx
1464,1,1,Clinical lab p16,p16 unknown
1464,1,1,Date of Death,2002-12-17 00:00:00
1464,1,1,Metastasis,M0
1464,1,1,Second Failure Type,no known failure
1464,1,1,Occurrence #,1st primary
1464,1,1,Radiation Dosage,70.2
1464,1,1,First Failure Type,no known failure
1464,1,1,Research lab HPV,HPV unknown
1464,1,1,Initial Chemotherapy Agent,unknown
1464,1,1,Status,Dead unk disease
1464,1,1,Research lab p16,p16 unknown
1464,1,1,Age at Death,64.2
1464,1,1,Tumor Stage,T3
1464,1,1,Treatment Modality,CTX-RT
1464,1,1,Overall Stage,III
1464,1,1,Time to Death,0.6
1464,1,1,Nodal Stage,N1
1465,1,1,First Failure Treatment Modality,Sx
1465,1,1,Status,Dead w/ disease
1465,1,1,Second Failure Type,no known failure
1465,1,1,Nodal Stage,N0
1465,1,1,Research lab p16,p16 unknown
1465,1,1,First Failure Site,larynx
1465,1,1,First Failure Type,locoregional
1465,1,1,Date of Death,2005-03-24 00:00:00
1465,1,1,Metastasis,M0
1465,1,1,Occurrence #,1st primary
1465,1,1,Radiation Dosage,64.5
1465,1,1,Time to First Failure,1.3
1465,1,1,Tumor Stage,T1
1465,1,1,Time to Death,4.8
1465,1,1,Tumor Site,larynx
1465,1,1,Clinical lab p16,p16 unknown
1465,1,1,Overall Stage,I
1465,1,1,Research lab HPV,HPV unknown
1465,1,1,Age at Death,73.9
1465,1,1,Treatment Modality,RT
1466,1,1,Date of Death,2004-01-08 00:00:00
1466,1,1,Age at Death,63.3
1466,1,1,Second Failure Type,no known failure
1466,1,1,Tumor Site,larynx
1466,1,1,First Failure Type,no known failure
1466,1,1,Metastasis,M0
1466,1,1,Occurrence #,1st primary
1466,1,1,Time to Death,3.0
1466,1,1,Treatment Modality,Unknown
1466,1,1,Research lab HPV,HPV unknown
1466,1,1,Overall Stage,III
1466,1,1,Status,Dead unk disease
1466,1,1,Tumor Stage,T3
1466,1,1,Clinical lab p16,p16 unknown
1466,1,1,Research lab p16,p16 unknown
1466,1,1,Nodal Stage,N1
1467,1,1,Overall Stage,III
1467,1,1,First Failure Type,no known failure
1467,1,1,Age at Death,50.2
1467,1,1,Occurrence #,1st primary
1467,1,1,Research lab HPV,HPV unknown
1467,1,1,Second Failure Type,no known failure
1467,1,1,Initial Chemotherapy Agent,unknown
1467,1,1,Clinical lab p16,p16 unknown
1467,1,1,Research lab p16,p16 unknown
1467,1,1,Status,Dead unk disease
1467,1,1,Tumor Site,larynx
1467,1,1,Treatment Modality,CTX-RT
1467,1,1,Tumor Stage,T3
1467,1,1,Nodal Stage,N1
1467,1,1,Time to Death,1.7
1467,1,1,Radiation Dosage,70
1467,1,1,Metastasis,M0
1467,1,1,Date of Death,2008-07-19 00:00:00
1468,1,1,Tumor Stage,T4a
1468,1,1,Overall Stage,IVa
1468,1,1,First Failure Site,larynx
1468,1,1,Tumor Site,larynx
1468,1,1,Time to Death,0.5
1468,1,1,Research lab HPV,HPV unknown
1468,1,1,Research lab p16,p16 unknown
1468,1,1,Time to First Failure,0.3
1468,1,1,First Failure Type,locoregional
1468,1,1,Occurrence #,recurrence
1468,1,1,Metastasis,M0
1468,1,1,Second Failure Type,no known failure
1468,1,1,Age at Death,41.4
1468,1,1,Date of Death,2003-01-20 00:00:00
1468,1,1,Clinical lab p16,p16 unknown
1468,1,1,First Failure Treatment Modality,Sx
1468,1,1,Nodal Stage,N1
1468,1,1,Treatment Modality,Sx
1468,1,1,Status,Dead w/ disease
1469,1,1,Time to Death,1.7
1469,1,1,Clinical lab p16,p16 unknown
1469,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
1469,1,1,Metastasis,M0
1469,1,1,Second Failure Type,no known failure
1469,1,1,Age at Death,62.2
1469,1,1,Research lab p16,p16 unknown
1469,1,1,Radiation Dosage,unknown
1469,1,1,Date of Death,2005-01-01 00:00:00
1469,1,1,Time to First Failure,0.5
1469,1,1,First Failure Type,distant
1469,1,1,Initial Chemotherapy Agent,carbo/PTX/amifostine
1469,1,1,Research lab HPV,HPV positive
1469,1,1,Tumor Site,larynx
1469,1,1,Status,Dead w/ disease
1469,1,1,First Failure Site,larynx
1469,1,1,First Failure Treatment Modality,Sx & CTX
1469,1,1,Occurrence #,1st primary
1469,1,1,Nodal Stage,Unknown
1469,1,1,Treatment Modality,CTX-RT
1469,1,1,Tumor Stage,T4a
1469,1,1,Overall Stage,IVa
1469,1,1,First Failure Second Line Chemotherapy Agent,pemetrexed
1470,1,1,Second Failure Type,no known failure
1470,1,1,Metastasis,Unknown
1470,1,1,Tumor Stage,Unknown
1470,1,1,Research lab p16,p16 unknown
1470,1,1,Date of Death,2003-08-15 00:00:00
1470,1,1,Clinical lab p16,p16 unknown
1470,1,1,First Failure Type,no known failure
1470,1,1,Nodal Stage,Unknown
1470,1,1,Treatment Modality,Unknown
1470,1,1,Overall Stage,Unknown
1470,1,1,Time to Death,0.1
1470,1,1,Occurrence #,1st primary
1470,1,1,Research lab HPV,HPV unknown
1470,1,1,Age at Death,77.9
1470,1,1,Status,Dead unk disease
1470,1,1,Tumor Site,larynx
1471,1,1,Clinical lab p16,p16 unknown
1471,1,1,Tumor Stage,Unknown
1471,1,1,Age at Death,56.6
1471,1,1,Nodal Stage,Unknown
1471,1,1,Status,Dead w/ disease
1471,1,1,Occurrence #,recurrence
1471,1,1,Tumor Site,larynx
1471,1,1,Treatment Modality,Unknown
1471,1,1,First Failure Type,no known failure
1471,1,1,Research lab p16,p16 unknown
1471,1,1,Research lab HPV,HPV unknown
1471,1,1,Metastasis,Unknown
1471,1,1,Second Failure Type,no known failure
1471,1,1,Time to Death,0.2
1471,1,1,Date of Death,2010-09-03 00:00:00
1471,1,1,Overall Stage,Unknown
1472,1,1,Date of Death,2008-04-21 00:00:00
1472,1,1,Age at Death,61.0
1472,1,1,Treatment Modality,Sx
1472,1,1,Status,Dead unk disease
1472,1,1,Clinical lab p16,p16 unknown
1472,1,1,Occurrence #,1st primary
1472,1,1,Second Failure Type,no known failure
1472,1,1,First Failure Type,no known failure
1472,1,1,Research lab HPV,HPV unknown
1472,1,1,Metastasis,M0
1472,1,1,Time to Death,7.8
1472,1,1,Overall Stage,I
1472,1,1,Tumor Site,larynx
1472,1,1,Tumor Stage,T1
1472,1,1,Research lab p16,p16 unknown
1472,1,1,Nodal Stage,N0
1473,1,1,Occurrence #,1st primary
1473,1,1,Time to Death,4.8
1473,1,1,Nodal Stage,N0
1473,1,1,Metastasis,M0
1473,1,1,Research lab HPV,HPV unknown
1473,1,1,Clinical lab p16,p16 unknown
1473,1,1,Tumor Site,larynx
1473,1,1,Overall Stage,III
1473,1,1,Age at Death,39.4
1473,1,1,Date of Death,2007-12-21 00:00:00
1473,1,1,Status,Dead unk disease
1473,1,1,Treatment Modality,Unknown
1473,1,1,Research lab p16,p16 unknown
1473,1,1,Tumor Stage,T3
1473,1,1,Second Failure Type,no known failure
1473,1,1,First Failure Type,no known failure
1474,1,1,Status,Dead w/ disease
1474,1,1,Nodal Stage,N0
1474,1,1,Tumor Site,larynx
1474,1,1,Occurrence #,1st primary
1474,1,1,First Failure Type,distant
1474,1,1,Tumor Stage,T4a
1474,1,1,Research lab HPV,HPV unknown
1474,1,1,Overall Stage,IVa
1474,1,1,Treatment Modality,Sx & RT
1474,1,1,Radiation Dosage,59.4
1474,1,1,Age at Death,52.6
1474,1,1,Date of Death,2010-09-11 00:00:00
1474,1,1,Research lab p16,p16 unknown
1474,1,1,Clinical lab p16,p16 unknown
1474,1,1,Second Failure Type,no known failure
1474,1,1,Metastasis,M0
1474,1,1,Time to Death,1.2
1474,1,1,Time to First Failure,0.3
1475,1,1,Time to First Failure,0.9
1475,1,1,Overall Stage,III
1475,1,1,Research lab p16,p16 unknown
1475,1,1,Metastasis,M0
1475,1,1,Initial Chemotherapy Agent,cis
1475,1,1,Treatment Modality,CTX-RT
1475,1,1,Radiation Dosage,70.2
1475,1,1,Status,Dead w/ disease
1475,1,1,Tumor Site,larynx
1475,1,1,Tumor Stage,T3
1475,1,1,Nodal Stage,N0
1475,1,1,Occurrence #,1st primary
1475,1,1,Second Failure Type,no known failure
1475,1,1,Research lab HPV,HPV unknown
1475,1,1,First Failure Type,locoregional
1475,1,1,Clinical lab p16,p16 unknown
1476,1,1,Radiation Dosage,74.4
1476,1,1,Occurrence #,1st primary
1476,1,1,Status,Alive w/o disease
1476,1,1,Nodal Stage,N0
1476,1,1,Tumor Site,larynx
1476,1,1,Second Failure Type,no known failure
1476,1,1,Treatment Modality,RT
1476,1,1,Clinical lab p16,p16 unknown
1476,1,1,Metastasis,M0
1476,1,1,First Failure Type,no known failure
1476,1,1,Tumor Stage,T2
1476,1,1,Overall Stage,II
1476,1,1,Research lab p16,p16 unknown
1476,1,1,Research lab HPV,HPV unknown
1477,1,1,Tumor Stage,T2
1477,1,1,Nodal Stage,N2
1477,1,1,Tumor Site,larynx
1477,1,1,Age at Death,48.2
1477,1,1,Status,Dead unk disease
1477,1,1,Metastasis,M0
1477,1,1,Second Failure Type,no known failure
1477,1,1,Treatment Modality,CTX-RT
1477,1,1,Date of Death,2010-03-13 00:00:00
1477,1,1,Research lab p16,p16 unknown
1477,1,1,Radiation Dosage,70.2
1477,1,1,Research lab HPV,HPV unknown
1477,1,1,Time to Death,1.4
1477,1,1,Initial Chemotherapy Agent,cis
1477,1,1,First Failure Type,no known failure
1477,1,1,Occurrence #,1st primary
1477,1,1,Clinical lab p16,p16 unknown
1477,1,1,Overall Stage,IVa
1478,1,1,Metastasis,M0
1478,1,1,Second Failure Type,no known failure
1478,1,1,Research lab p16,p16 unknown
1478,1,1,Clinical lab p16,p16 unknown
1478,1,1,Tumor Site,larynx
1478,1,1,Treatment Modality,CTX-RT
1478,1,1,Initial Chemotherapy Agent,cis
1478,1,1,Research lab HPV,HPV unknown
1478,1,1,First Failure Type,no known failure
1478,1,1,Nodal Stage,N0
1478,1,1,Status,Alive w/o disease
1478,1,1,Tumor Stage,T4a
1478,1,1,Overall Stage,IVa
1478,1,1,Radiation Dosage,70.2
1478,1,1,Occurrence #,1st primary
1479,1,1,Research lab p16,p16 unknown
1479,1,1,Age at Death,58.3
1479,1,1,Overall Stage,Unknown
1479,1,1,Research lab HPV,HPV unknown
1479,1,1,Treatment Modality,Unknown
1479,1,1,Time to Death,0.6
1479,1,1,Date of Death,2006-03-28 00:00:00
1479,1,1,Second Failure Type,no known failure
1479,1,1,Tumor Site,larynx
1479,1,1,Nodal Stage,Unknown
1479,1,1,Metastasis,Unknown
1479,1,1,Occurrence #,1st primary
1479,1,1,Status,Dead unk disease
1479,1,1,Clinical lab p16,p16 unknown
1479,1,1,Tumor Stage,Unknown
1479,1,1,First Failure Type,no known failure
1480,1,1,Tumor Stage,T4a
1480,1,1,Occurrence #,1st primary
1480,1,1,Age at Death,65.6
1480,1,1,Clinical lab p16,p16 unknown
1480,1,1,Second Failure Type,no known failure
1480,1,1,First Failure Type,no known failure
1480,1,1,Research lab HPV,HPV unknown
1480,1,1,Overall Stage,IVb
1480,1,1,Metastasis,M0
1480,1,1,Status,Dead unk disease
1480,1,1,Treatment Modality,Sx
1480,1,1,Date of Death,2008-03-20 00:00:00
1480,1,1,Research lab p16,p16 unknown
1480,1,1,Tumor Site,larynx
1480,1,1,Time to Death,0.9
1480,1,1,Nodal Stage,N3
1481,1,1,Research lab p16,p16 unknown
1481,1,1,Clinical lab p16,p16 unknown
1481,1,1,First Failure Type,no known failure
1481,1,1,Overall Stage,I
1481,1,1,Status,Alive w/o disease
1481,1,1,Tumor Site,larynx
1481,1,1,Nodal Stage,N0
1481,1,1,Tumor Stage,T1
1481,1,1,Second Failure Type,no known failure
1481,1,1,Research lab HPV,HPV unknown
1481,1,1,Treatment Modality,Sx
1481,1,1,Occurrence #,1st primary
1481,1,1,Metastasis,M0
1482,1,1,Tumor Stage,T2
1482,1,1,First Failure Type,no known failure
1482,1,1,Occurrence #,1st primary
1482,1,1,Overall Stage,II
1482,1,1,Nodal Stage,N0
1482,1,1,Research lab HPV,HPV unknown
1482,1,1,Clinical lab p16,p16 unknown
1482,1,1,Second Failure Type,no known failure
1482,1,1,Research lab p16,p16 unknown
1482,1,1,Metastasis,M0
1482,1,1,Tumor Site,larynx
1482,1,1,Treatment Modality,Sx
1482,1,1,Status,Alive w/o disease
1483,1,1,Research lab p16,p16 unknown
1483,1,1,Tumor Site,larynx
1483,1,1,Research lab HPV,HPV unknown
1483,1,1,Second Failure Type,no known failure
1483,1,1,Tumor Stage,T3
1483,1,1,Clinical lab p16,p16 unknown
1483,1,1,Metastasis,M0
1483,1,1,First Failure Type,no known failure
1483,1,1,Occurrence #,1st primary
1483,1,1,Overall Stage,III
1483,1,1,Treatment Modality,Sx & RT
1483,1,1,Nodal Stage,N0
1483,1,1,Status,Alive unk disease
1483,1,1,Radiation Dosage,59.4
1484,1,1,First Failure Type,no known failure
1484,1,1,Metastasis,M0
1484,1,1,Nodal Stage,N2
1484,1,1,Status,Alive w/o disease
1484,1,1,Second Failure Type,no known failure
1484,1,1,Treatment Modality,CTX-RT
1484,1,1,Tumor Site,larynx
1484,1,1,Tumor Stage,T3
1484,1,1,Research lab p16,p16 unknown
1484,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1484,1,1,Overall Stage,IVa
1484,1,1,Radiation Dosage,70.2
1484,1,1,Clinical lab p16,p16 unknown
1484,1,1,Research lab HPV,HPV unknown
1484,1,1,Occurrence #,1st primary
1485,1,1,Research lab p16,p16 unknown
1485,1,1,Second Failure Type,no known failure
1485,1,1,Treatment Modality,Unknown
1485,1,1,Overall Stage,IVa
1485,1,1,Age at Death,52.8
1485,1,1,Research lab HPV,HPV unknown
1485,1,1,Occurrence #,recurrence
1485,1,1,Date of Death,2001-03-21 00:00:00
1485,1,1,Metastasis,Unknown
1485,1,1,Status,Dead w/ disease
1485,1,1,Tumor Site,larynx
1485,1,1,First Failure Type,no known failure
1485,1,1,Time to Death,0.2
1485,1,1,Tumor Stage,T4a
1485,1,1,Clinical lab p16,p16 unknown
1485,1,1,Nodal Stage,Unknown
1486,1,1,Tumor Stage,T2
1486,1,1,Nodal Stage,N2
1486,1,1,Research lab HPV,HPV unknown
1486,1,1,Clinical lab p16,p16 unknown
1486,1,1,Time to Death,2.4
1486,1,1,Date of Death,2004-03-18 00:00:00
1486,1,1,Research lab p16,p16 unknown
1486,1,1,Second Failure Type,no known failure
1486,1,1,First Failure Type,locoregional
1486,1,1,Initial Chemotherapy Agent,gemcitabine/PTX/cap
1486,1,1,Metastasis,M0
1486,1,1,Time to First Failure,-0.0
1486,1,1,Status,Dead w/ disease
1486,1,1,Treatment Modality,Sx & CTX
1486,1,1,Overall Stage,IVa
1486,1,1,Occurrence #,recurrence
1486,1,1,Age at Death,57.4
1486,1,1,Tumor Site,larynx
1487,1,1,Status,Alive w/o disease
1487,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
1487,1,1,First Failure Treatment Modality,Sx & CTX-RT
1487,1,1,Metastasis,M0
1487,1,1,Research lab p16,p16 unknown
1487,1,1,Initial Chemotherapy Agent,cis
1487,1,1,Occurrence #,1st primary
1487,1,1,Radiation Dosage,70.2
1487,1,1,Clinical lab p16,p16 unknown
1487,1,1,Research lab HPV,HPV unknown
1487,1,1,Nodal Stage,N0
1487,1,1,Tumor Site,larynx
1487,1,1,First Failure Site,larynx
1487,1,1,Overall Stage,III
1487,1,1,Second Failure Type,no known failure
1487,1,1,Time to First Failure,1.2
1487,1,1,Treatment Modality,CTX-RT
1487,1,1,First Failure Radiation Dosage,60
1487,1,1,Tumor Stage,T3
1487,1,1,First Failure Type,locoregional
1488,1,1,Date of Death,2011-08-29 00:00:00
1488,1,1,Radiation Dosage,63
1488,1,1,Tumor Stage,T4a
1488,1,1,Nodal Stage,N0
1488,1,1,Overall Stage,IVa
1488,1,1,Treatment Modality,Sx & RT
1488,1,1,Research lab p16,p16 unknown
1488,1,1,Status,Dead unk disease
1488,1,1,Tumor Site,larynx
1488,1,1,Second Failure Type,no known failure
1488,1,1,First Failure Type,no known failure
1488,1,1,Time to Death,7.7
1488,1,1,Metastasis,M0
1488,1,1,Clinical lab p16,p16 unknown
1488,1,1,Age at Death,82.8
1488,1,1,Research lab HPV,HPV unknown
1488,1,1,Occurrence #,1st primary
1489,1,1,Research lab p16,p16 unknown
1489,1,1,Overall Stage,III
1489,1,1,Status,Dead w/o disease
1489,1,1,Second Failure Type,no known failure
1489,1,1,First Failure Type,no known failure
1489,1,1,Clinical lab p16,p16 unknown
1489,1,1,Time to Death,6.0
1489,1,1,Tumor Stage,T3
1489,1,1,Nodal Stage,N0
1489,1,1,Research lab HPV,HPV unknown
1489,1,1,Treatment Modality,Sx
1489,1,1,Age at Death,64.0
1489,1,1,Tumor Site,larynx
1489,1,1,Metastasis,M0
1489,1,1,Date of Death,2007-03-05 00:00:00
1489,1,1,Occurrence #,1st primary
1490,1,1,Second Failure Type,no known failure
1490,1,1,Nodal Stage,N0
1490,1,1,Status,Alive w/o disease
1490,1,1,Research lab p16,p16 unknown
1490,1,1,Clinical lab p16,p16 unknown
1490,1,1,Metastasis,M0
1490,1,1,Overall Stage,III
1490,1,1,First Failure Type,no known failure
1490,1,1,Occurrence #,1st primary
1490,1,1,Tumor Site,larynx
1490,1,1,Treatment Modality,Sx
1490,1,1,Research lab HPV,HPV unknown
1490,1,1,Tumor Stage,T3
1491,1,1,Initial Chemotherapy Agent,cis
1491,1,1,Radiation Dosage,70.2
1491,1,1,Status,Dead w/o disease
1491,1,1,Research lab HPV,HPV unknown
1491,1,1,Occurrence #,1st primary
1491,1,1,Metastasis,M0
1491,1,1,Overall Stage,IVa
1491,1,1,Nodal Stage,N2
1491,1,1,Treatment Modality,CTX-RT
1491,1,1,Tumor Stage,T3
1491,1,1,Research lab p16,p16 unknown
1491,1,1,Clinical lab p16,p16 unknown
1491,1,1,Tumor Site,larynx
1491,1,1,First Failure Type,no known failure
1491,1,1,Second Failure Type,no known failure
1492,1,1,Nodal Stage,N0
1492,1,1,Metastasis,M0
1492,1,1,Treatment Modality,Sx
1492,1,1,Research lab HPV,HPV unknown
1492,1,1,Status,Alive w/o disease
1492,1,1,Second Failure Type,no known failure
1492,1,1,Tumor Stage,T1
1492,1,1,Occurrence #,1st primary
1492,1,1,Overall Stage,I
1492,1,1,Tumor Site,larynx
1492,1,1,Clinical lab p16,p16 unknown
1492,1,1,Research lab p16,p16 unknown
1492,1,1,First Failure Type,no known failure
1493,1,1,Clinical lab p16,p16 unknown
1493,1,1,Status,Alive w/o disease
1493,1,1,Initial Chemotherapy Agent,cis
1493,1,1,Research lab p16,p16 unknown
1493,1,1,Tumor Stage,T3
1493,1,1,First Failure Type,no known failure
1493,1,1,Metastasis,M0
1493,1,1,Overall Stage,III
1493,1,1,Second Failure Type,no known failure
1493,1,1,Nodal Stage,N0
1493,1,1,Tumor Site,larynx
1493,1,1,Occurrence #,1st primary
1493,1,1,Radiation Dosage,70.2
1493,1,1,Treatment Modality,CTX-RT
1493,1,1,Research lab HPV,HPV unknown
1494,1,1,Research lab p16,p16 unknown
1494,1,1,Status,Dead w/ disease
1494,1,1,Metastasis,M0
1494,1,1,Time to First Failure,0.4
1494,1,1,First Failure Type,distant
1494,1,1,Second Failure Type,no known failure
1494,1,1,Occurrence #,recurrence
1494,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
1494,1,1,Time to Death,1.2
1494,1,1,Tumor Site,larynx
1494,1,1,Clinical lab p16,p16 unknown
1494,1,1,First Failure Site,larynx
1494,1,1,Initial Chemotherapy Agent,unknown
1494,1,1,First Failure Radiation Dosage,50.4
1494,1,1,Nodal Stage,N1
1494,1,1,Overall Stage,III
1494,1,1,Radiation Dosage,63
1494,1,1,Date of Death,2004-09-10 00:00:00
1494,1,1,Age at Death,58.5
1494,1,1,Tumor Stage,T3
1494,1,1,First Failure Treatment Modality,CTX-RT
1494,1,1,Treatment Modality,Sx & CTX-RT
1494,1,1,Research lab HPV,HPV unknown
1495,1,1,Metastasis,M0
1495,1,1,Research lab HPV,HPV unknown
1495,1,1,Time to Death,0.0
1495,1,1,Occurrence #,1st primary
1495,1,1,Nodal Stage,N2
1495,1,1,Second Failure Type,no known failure
1495,1,1,Overall Stage,IVa
1495,1,1,First Failure Type,no known failure
1495,1,1,Tumor Site,larynx
1495,1,1,Tumor Stage,T4a
1495,1,1,Research lab p16,p16 unknown
1495,1,1,Treatment Modality,Sx
1495,1,1,Status,Dead unk disease
1495,1,1,Clinical lab p16,p16 unknown
1495,1,1,Age at Death,68.0
1495,1,1,Date of Death,2003-07-13 00:00:00
1496,1,1,Second Failure Type,no known failure
1496,1,1,Radiation Dosage,70
1496,1,1,Nodal Stage,N0
1496,1,1,Clinical lab p16,p16 unknown
1496,1,1,Occurrence #,1st primary
1496,1,1,Tumor Stage,T2
1496,1,1,Metastasis,M0
1496,1,1,Status,Alive w/o disease
1496,1,1,Research lab HPV,HPV unknown
1496,1,1,First Failure Type,no known failure
1496,1,1,Research lab p16,p16 unknown
1496,1,1,Tumor Site,larynx
1496,1,1,Overall Stage,II
1496,1,1,Treatment Modality,RT
1497,1,1,Radiation Dosage,63
1497,1,1,Treatment Modality,RT
1497,1,1,Nodal Stage,N0
1497,1,1,Second Failure Type,no known failure
1497,1,1,Status,Dead w/o disease
1497,1,1,First Failure Type,no known failure
1497,1,1,Age at Death,73.1
1497,1,1,Overall Stage,I
1497,1,1,Tumor Site,larynx
1497,1,1,Occurrence #,1st primary
1497,1,1,Tumor Stage,T1
1497,1,1,Clinical lab p16,p16 unknown
1497,1,1,Research lab HPV,HPV unknown
1497,1,1,Metastasis,M0
1497,1,1,Time to Death,2.7
1497,1,1,Date of Death,2007-02-25 00:00:00
1497,1,1,Research lab p16,p16 unknown
1498,1,1,Status,Dead w/ disease
1498,1,1,First Failure Type,no known failure
1498,1,1,Overall Stage,Unknown
1498,1,1,Tumor Site,larynx
1498,1,1,Research lab HPV,HPV unknown
1498,1,1,Second Failure Type,no known failure
1498,1,1,Treatment Modality,Unknown
1498,1,1,Nodal Stage,Unknown
1498,1,1,Research lab p16,p16 unknown
1498,1,1,Tumor Stage,Unknown
1498,1,1,Age at Death,72.8
1498,1,1,Date of Death,2002-04-06 00:00:00
1498,1,1,Time to Death,0.1
1498,1,1,Occurrence #,1st primary
1498,1,1,Metastasis,Unknown
1498,1,1,Clinical lab p16,p16 unknown
1499,1,1,Research lab p16,p16 unknown
1499,1,1,Treatment Modality,Unknown
1499,1,1,Tumor Site,larynx
1499,1,1,Date of Death,2005-08-31 00:00:00
1499,1,1,Research lab HPV,HPV unknown
1499,1,1,Metastasis,M0
1499,1,1,Tumor Stage,T2
1499,1,1,Time to Death,0.7
1499,1,1,Age at Death,89.8
1499,1,1,Clinical lab p16,p16 unknown
1499,1,1,Overall Stage,II
1499,1,1,Nodal Stage,N0
1499,1,1,Status,Dead unk disease
1499,1,1,Second Failure Type,no known failure
1499,1,1,Occurrence #,1st primary
1499,1,1,First Failure Type,no known failure
1500,1,1,Overall Stage,IVa
1500,1,1,Occurrence #,recurrence
1500,1,1,First Failure Type,locoregional and distant
1500,1,1,Age at Death,58.7
1500,1,1,Time to First Failure,0.2
1500,1,1,Status,Dead w/ disease
1500,1,1,Treatment Modality,CTX-RT
1500,1,1,Initial Chemotherapy Agent,cis
1500,1,1,Metastasis,M0
1500,1,1,Time to Death,1.6
1500,1,1,Tumor Site,larynx
1500,1,1,Research lab p16,p16 unknown
1500,1,1,Clinical lab p16,p16 unknown
1500,1,1,Tumor Stage,T3
1500,1,1,Research lab HPV,HPV unknown
1500,1,1,Second Failure Type,no known failure
1500,1,1,Radiation Dosage,70.2
1500,1,1,Nodal Stage,N2
1500,1,1,Date of Death,2010-07-01 00:00:00
1501,1,1,Metastasis,M0
1501,1,1,Time to First Failure,1.3
1501,1,1,Nodal Stage,N0
1501,1,1,Tumor Site,larynx
1501,1,1,Tumor Stage,T1
1501,1,1,Occurrence #,1st primary
1501,1,1,First Failure Treatment Modality,Sx
1501,1,1,Second Failure Type,no known failure
1501,1,1,First Failure Type,locoregional
1501,1,1,Overall Stage,I
1501,1,1,Research lab HPV,HPV unknown
1501,1,1,Research lab p16,p16 unknown
1501,1,1,Radiation Dosage,66
1501,1,1,First Failure Site,larynx
1501,1,1,Treatment Modality,RT
1501,1,1,Status,Alive w/o disease
1501,1,1,Clinical lab p16,p16 unknown
1502,1,1,Tumor Stage,Unknown
1502,1,1,Clinical lab p16,p16 unknown
1502,1,1,Research lab HPV,HPV unknown
1502,1,1,Status,Dead unk disease
1502,1,1,Metastasis,Unknown
1502,1,1,Second Failure Type,no known failure
1502,1,1,First Failure Type,no known failure
1502,1,1,Time to Death,0.9
1502,1,1,Tumor Site,larynx
1502,1,1,Treatment Modality,Unknown
1502,1,1,Age at Death,79.1
1502,1,1,Occurrence #,recurrence
1502,1,1,Nodal Stage,Unknown
1502,1,1,Date of Death,2003-10-15 00:00:00
1502,1,1,Research lab p16,p16 unknown
1502,1,1,Overall Stage,Unknown
1503,1,1,Occurrence #,1st primary
1503,1,1,Second Failure Type,no known failure
1503,1,1,Clinical lab p16,p16 unknown
1503,1,1,Research lab HPV,HPV unknown
1503,1,1,Tumor Stage,T2
1503,1,1,Status,Dead w/o disease
1503,1,1,Nodal Stage,N0
1503,1,1,First Failure Type,no known failure
1503,1,1,Overall Stage,II
1503,1,1,Tumor Site,larynx
1503,1,1,Metastasis,M0
1503,1,1,Research lab p16,p16 unknown
1503,1,1,Treatment Modality,Sx
1504,1,1,Radiation Dosage,unknown
1504,1,1,Nodal Stage,Unknown
1504,1,1,Overall Stage,Unknown
1504,1,1,Tumor Site,larynx
1504,1,1,Occurrence #,1st primary
1504,1,1,Tumor Stage,Unknown
1504,1,1,Research lab HPV,HPV unknown
1504,1,1,Second Failure Type,no known failure
1504,1,1,First Failure Type,no known failure
1504,1,1,Status,Alive unk disease
1504,1,1,Metastasis,Unknown
1504,1,1,Clinical lab p16,p16 unknown
1504,1,1,Treatment Modality,Sx & RT
1504,1,1,Research lab p16,p16 unknown
1505,1,1,Overall Stage,II
1505,1,1,Status,Alive unk disease
1505,1,1,Research lab p16,p16 unknown
1505,1,1,Occurrence #,1st primary
1505,1,1,Clinical lab p16,p16 unknown
1505,1,1,Nodal Stage,N0
1505,1,1,Treatment Modality,RT
1505,1,1,Second Failure Type,no known failure
1505,1,1,Radiation Dosage,74.4
1505,1,1,Tumor Stage,T2
1505,1,1,Tumor Site,larynx
1505,1,1,Research lab HPV,HPV unknown
1505,1,1,Metastasis,M0
1505,1,1,First Failure Type,no known failure
1506,1,1,Status,Dead w/ disease
1506,1,1,Research lab p16,p16 unknown
1506,1,1,Treatment Modality,CTX
1506,1,1,Clinical lab p16,p16 unknown
1506,1,1,First Failure Type,locoregional and distant
1506,1,1,Overall Stage,IVc
1506,1,1,Metastasis,M1
1506,1,1,Research lab HPV,HPV unknown
1506,1,1,Second Failure Type,no known failure
1506,1,1,Time to First Failure,-0.0
1506,1,1,Occurrence #,recurrence
1506,1,1,Tumor Stage,Unknown
1506,1,1,Initial Chemotherapy Agent,erlotinib/bev
1506,1,1,Age at Death,52.8
1506,1,1,Tumor Site,larynx
1506,1,1,Time to Death,0.9
1506,1,1,Nodal Stage,Unknown
1506,1,1,Date of Death,2007-07-28 00:00:00
1506,1,1,Second Line Chemotherapy Agent,cap
1507,1,1,Age at Death,89.8
1507,1,1,Nodal Stage,N2
1507,1,1,Occurrence #,1st primary
1507,1,1,Tumor Stage,T4a
1507,1,1,Overall Stage,IVa
1507,1,1,Clinical lab p16,p16 unknown
1507,1,1,Treatment Modality,Unknown
1507,1,1,Research lab HPV,HPV unknown
1507,1,1,Metastasis,M0
1507,1,1,Status,Dead w/ disease
1507,1,1,Tumor Site,larynx
1507,1,1,Second Failure Type,no known failure
1507,1,1,First Failure Type,no known failure
1507,1,1,Date of Death,2001-10-26 00:00:00
1507,1,1,Time to Death,0.2
1507,1,1,Research lab p16,p16 unknown
1508,1,1,Age at Death,91.2
1508,1,1,Research lab p16,p16 unknown
1508,1,1,Tumor Stage,T3
1508,1,1,Second Failure Type,no known failure
1508,1,1,Tumor Site,larynx
1508,1,1,Radiation Dosage,70.2
1508,1,1,Research lab HPV,HPV unknown
1508,1,1,Status,Dead w/ disease
1508,1,1,Time to Death,0.9
1508,1,1,Treatment Modality,RT
1508,1,1,Nodal Stage,N0
1508,1,1,Clinical lab p16,p16 unknown
1508,1,1,Date of Death,2010-11-10 00:00:00
1508,1,1,Overall Stage,III
1508,1,1,Occurrence #,1st primary
1508,1,1,First Failure Type,locoregional
1508,1,1,Time to First Failure,0.2
1508,1,1,Metastasis,M0
1509,1,1,Time to Death,2.4
1509,1,1,Treatment Modality,CTX-RT
1509,1,1,Nodal Stage,N2
1509,1,1,Radiation Dosage,70.2
1509,1,1,Overall Stage,IVa
1509,1,1,Second Failure Type,no known failure
1509,1,1,Age at Death,79.9
1509,1,1,First Failure Type,no known failure
1509,1,1,Research lab HPV,HPV unknown
1509,1,1,Research lab p16,p16 unknown
1509,1,1,Metastasis,M0
1509,1,1,Occurrence #,1st primary
1509,1,1,Tumor Site,larynx
1509,1,1,Status,Dead w/o disease
1509,1,1,Date of Death,2010-10-26 00:00:00
1509,1,1,Clinical lab p16,p16 unknown
1509,1,1,Initial Chemotherapy Agent,cetux
1509,1,1,Tumor Stage,T3
1510,1,1,Clinical lab p16,p16 unknown
1510,1,1,Treatment Modality,Sx
1510,1,1,Tumor Stage,Unknown
1510,1,1,Tumor Site,larynx
1510,1,1,Overall Stage,IVa
1510,1,1,Research lab p16,p16 unknown
1510,1,1,Date of Death,2009-06-26 00:00:00
1510,1,1,First Failure Type,no known failure
1510,1,1,Metastasis,M0
1510,1,1,Occurrence #,recurrence
1510,1,1,Second Failure Type,no known failure
1510,1,1,Time to Death,2.5
1510,1,1,Nodal Stage,N2
1510,1,1,Status,Dead unk disease
1510,1,1,Age at Death,80.0
1510,1,1,Research lab HPV,HPV unknown
1511,1,1,Research lab p16,p16 unknown
1511,1,1,Occurrence #,1st primary
1511,1,1,Tumor Stage,T3
1511,1,1,First Failure Type,no known failure
1511,1,1,Radiation Dosage,70.2
1511,1,1,Second Failure Type,no known failure
1511,1,1,Tumor Site,larynx
1511,1,1,Status,Alive w/o disease
1511,1,1,Research lab HPV,HPV unknown
1511,1,1,Nodal Stage,N0
1511,1,1,Initial Chemotherapy Agent,cis
1511,1,1,Treatment Modality,CTX-RT
1511,1,1,Overall Stage,III
1511,1,1,Metastasis,M0
1511,1,1,Clinical lab p16,p16 unknown
1512,1,1,Metastasis,M0
1512,1,1,Research lab p16,p16 unknown
1512,1,1,Occurrence #,1st primary
1512,1,1,Overall Stage,II
1512,1,1,Nodal Stage,N0
1512,1,1,Status,Alive unk disease
1512,1,1,Tumor Stage,T2
1512,1,1,Treatment Modality,Unknown
1512,1,1,Clinical lab p16,p16 unknown
1512,1,1,Tumor Site,larynx
1512,1,1,First Failure Type,no known failure
1512,1,1,Second Failure Type,no known failure
1512,1,1,Research lab HPV,HPV unknown
1513,1,1,Time to Death,6.9
1513,1,1,Research lab HPV,HPV unknown
1513,1,1,Treatment Modality,RT
1513,1,1,Occurrence #,1st primary
1513,1,1,Nodal Stage,N0
1513,1,1,Clinical lab p16,p16 unknown
1513,1,1,Age at Death,66.2
1513,1,1,Date of Death,2008-12-11 00:00:00
1513,1,1,Radiation Dosage,70
1513,1,1,Metastasis,M0
1513,1,1,Second Failure Type,no known failure
1513,1,1,First Failure Type,no known failure
1513,1,1,Overall Stage,II
1513,1,1,Tumor Stage,T2
1513,1,1,Tumor Site,larynx
1513,1,1,Research lab p16,p16 unknown
1513,1,1,Status,Alive unk disease
1514,1,1,Tumor Stage,T4a
1514,1,1,Status,Dead w/o disease
1514,1,1,Age at Death,74.1
1514,1,1,Date of Death,2009-01-05 00:00:00
1514,1,1,Overall Stage,IVa
1514,1,1,Occurrence #,1st primary
1514,1,1,Research lab p16,p16 unknown
1514,1,1,Tumor Site,larynx
1514,1,1,Research lab HPV,HPV unknown
1514,1,1,Metastasis,M0
1514,1,1,Second Failure Type,no known failure
1514,1,1,Nodal Stage,N0
1514,1,1,First Failure Type,no known failure
1514,1,1,Treatment Modality,Sx
1514,1,1,Time to Death,6.1
1514,1,1,Clinical lab p16,p16 unknown
1515,1,1,Clinical lab p16,p16 unknown
1515,1,1,Research lab HPV,HPV unknown
1515,1,1,Overall Stage,III
1515,1,1,Radiation Dosage,59.4
1515,1,1,Status,Dead unk disease
1515,1,1,Second Failure Type,no known failure
1515,1,1,First Failure Type,no known failure
1515,1,1,Tumor Site,larynx
1515,1,1,Treatment Modality,Sx & RT
1515,1,1,Occurrence #,1st primary
1515,1,1,Time to Death,5.6
1515,1,1,Research lab p16,p16 unknown
1515,1,1,Tumor Stage,T3
1515,1,1,Metastasis,M0
1515,1,1,Date of Death,2006-03-24 00:00:00
1515,1,1,Age at Death,67.0
1515,1,1,Nodal Stage,N1
1516,1,1,Research lab p16,p16 unknown
1516,1,1,Tumor Site,larynx
1516,1,1,First Failure Type,no known failure
1516,1,1,Overall Stage,II
1516,1,1,Treatment Modality,Sx
1516,1,1,Tumor Stage,T2
1516,1,1,Occurrence #,1st primary
1516,1,1,Research lab HPV,HPV unknown
1516,1,1,Nodal Stage,N0
1516,1,1,Clinical lab p16,p16 unknown
1516,1,1,Metastasis,M0
1516,1,1,Second Failure Type,no known failure
1516,1,1,Status,Alive unk disease
1517,1,1,Occurrence #,1st primary
1517,1,1,Metastasis,M0
1517,1,1,Research lab HPV,HPV unknown
1517,1,1,Status,Dead unk disease
1517,1,1,Nodal Stage,N0
1517,1,1,First Failure Type,no known failure
1517,1,1,Overall Stage,II
1517,1,1,Date of Death,2008-07-18 00:00:00
1517,1,1,Time to Death,0.6
1517,1,1,Tumor Site,larynx
1517,1,1,Clinical lab p16,p16 unknown
1517,1,1,Research lab p16,p16 unknown
1517,1,1,Age at Death,69.8
1517,1,1,Radiation Dosage,70.4
1517,1,1,Second Failure Type,no known failure
1517,1,1,Tumor Stage,T2
1517,1,1,Treatment Modality,RT
1518,1,1,Nodal Stage,N0
1518,1,1,Second Failure Type,no known failure
1518,1,1,Metastasis,M0
1518,1,1,Clinical lab p16,p16 unknown
1518,1,1,Tumor Site,larynx
1518,1,1,Status,Dead w/ disease
1518,1,1,Time to First Failure,1.0
1518,1,1,Treatment Modality,Sx
1518,1,1,Research lab HPV,HPV unknown
1518,1,1,Tumor Stage,T1
1518,1,1,Occurrence #,recurrence
1518,1,1,Research lab p16,p16 unknown
1518,1,1,First Failure Type,locoregional
1518,1,1,Overall Stage,I
1519,1,1,Treatment Modality,RT
1519,1,1,Occurrence #,1st primary
1519,1,1,Tumor Stage,T2
1519,1,1,Metastasis,M0
1519,1,1,Nodal Stage,N0
1519,1,1,Research lab p16,p16 unknown
1519,1,1,Clinical lab p16,p16 unknown
1519,1,1,First Failure Type,no known failure
1519,1,1,Radiation Dosage,74.4
1519,1,1,Overall Stage,II
1519,1,1,Research lab HPV,HPV unknown
1519,1,1,Tumor Site,larynx
1519,1,1,Second Failure Type,no known failure
1519,1,1,Status,Alive w/o disease
1520,1,1,Tumor Stage,T1
1520,1,1,First Failure Type,no known failure
1520,1,1,Research lab p16,p16 unknown
1520,1,1,Clinical lab p16,p16 unknown
1520,1,1,Nodal Stage,N0
1520,1,1,Research lab HPV,HPV unknown
1520,1,1,Second Failure Type,no known failure
1520,1,1,Treatment Modality,RT
1520,1,1,Occurrence #,1st primary
1520,1,1,Status,Alive w/o disease
1520,1,1,Tumor Site,larynx
1520,1,1,Metastasis,M0
1520,1,1,Radiation Dosage,63
1520,1,1,Overall Stage,I
1521,1,1,Status,Alive w/o disease
1521,1,1,First Failure Type,no known failure
1521,1,1,Metastasis,M0
1521,1,1,Overall Stage,I
1521,1,1,Treatment Modality,Sx
1521,1,1,Research lab p16,p16 unknown
1521,1,1,Tumor Site,larynx
1521,1,1,Tumor Stage,T1
1521,1,1,Clinical lab p16,p16 unknown
1521,1,1,Nodal Stage,N0
1521,1,1,Second Failure Type,no known failure
1521,1,1,Occurrence #,recurrence
1521,1,1,Research lab HPV,HPV unknown
1522,1,1,Clinical lab p16,p16 unknown
1522,1,1,Time to First Failure,0.1
1522,1,1,First Failure Type,locoregional and distant
1522,1,1,Date of Death,2011-05-08 00:00:00
1522,1,1,Research lab HPV,HPV unknown
1522,1,1,Radiation Dosage,59.4
1522,1,1,Overall Stage,IVa
1522,1,1,Status,Dead w/ disease
1522,1,1,Tumor Stage,T4a
1522,1,1,Nodal Stage,N2
1522,1,1,Second Failure Type,no known failure
1522,1,1,Time to Death,1.8
1522,1,1,Research lab p16,p16 unknown
1522,1,1,Age at Death,59.0
1522,1,1,Occurrence #,1st primary
1522,1,1,Metastasis,M0
1522,1,1,Treatment Modality,Sx & RT
1522,1,1,Tumor Site,larynx
1523,1,1,Tumor Stage,T2
1523,1,1,Research lab HPV,HPV unknown
1523,1,1,First Failure Type,no known failure
1523,1,1,Overall Stage,II
1523,1,1,Clinical lab p16,p16 unknown
1523,1,1,Radiation Dosage,74.4
1523,1,1,Metastasis,M0
1523,1,1,Treatment Modality,RT
1523,1,1,Second Failure Type,no known failure
1523,1,1,Tumor Site,larynx
1523,1,1,Status,Alive w/o disease
1523,1,1,Nodal Stage,N0
1523,1,1,Occurrence #,1st primary
1523,1,1,Research lab p16,p16 unknown
1524,1,1,Second Failure Type,no known failure
1524,1,1,Initial Chemotherapy Agent,cis
1524,1,1,Tumor Stage,T2
1524,1,1,Time to First Failure,5.9
1524,1,1,Research lab HPV,HPV unknown
1524,1,1,First Failure Treatment Modality,Sx
1524,1,1,Clinical lab p16,p16 unknown
1524,1,1,Status,Dead w/o disease
1524,1,1,Radiation Dosage,70.2
1524,1,1,Metastasis,M0
1524,1,1,Second Line Chemotherapy Agent,carbo
1524,1,1,Occurrence #,1st primary
1524,1,1,First Failure Site,larynx
1524,1,1,Tumor Site,larynx
1524,1,1,Date of Death,2016-10-10 00:00:00
1524,1,1,Treatment Modality,CTX-RT
1524,1,1,Overall Stage,III
1524,1,1,Research lab p16,p16 unknown
1524,1,1,First Failure Type,locoregional
1524,1,1,Nodal Stage,N1
1524,1,1,Age at Death,57.5
1524,1,1,Time to Death,7.6
1525,1,1,Nodal Stage,N0
1525,1,1,Tumor Site,larynx
1525,1,1,Second Failure Type,no known failure
1525,1,1,Metastasis,M0
1525,1,1,Occurrence #,1st primary
1525,1,1,Research lab p16,p16 unknown
1525,1,1,Radiation Dosage,63
1525,1,1,Status,Alive w/o disease
1525,1,1,First Failure Type,no known failure
1525,1,1,Research lab HPV,HPV unknown
1525,1,1,Tumor Stage,T1
1525,1,1,Treatment Modality,RT
1525,1,1,Clinical lab p16,p16 unknown
1525,1,1,Overall Stage,I
1526,1,1,Age at Death,69.9
1526,1,1,Tumor Stage,T2
1526,1,1,Treatment Modality,Sx & CTX-RT
1526,1,1,Nodal Stage,N2
1526,1,1,Second Failure Type,no known failure
1526,1,1,Time to Death,2.1
1526,1,1,Occurrence #,1st primary
1526,1,1,Metastasis,M0
1526,1,1,Tumor Site,larynx
1526,1,1,Status,Dead unk disease
1526,1,1,Clinical lab p16,p16 unknown
1526,1,1,Date of Death,2007-05-08 00:00:00
1526,1,1,Overall Stage,IVa
1526,1,1,Research lab p16,p16 unknown
1526,1,1,First Failure Type,no known failure
1526,1,1,Radiation Dosage,unknown
1526,1,1,Initial Chemotherapy Agent,unknown
1526,1,1,Research lab HPV,HPV unknown
1527,1,1,Nodal Stage,N0
1527,1,1,Occurrence #,recurrence
1527,1,1,Metastasis,M0
1527,1,1,Research lab HPV,HPV unknown
1527,1,1,Clinical lab p16,p16 unknown
1527,1,1,Second Failure Type,no known failure
1527,1,1,Date of Death,2009-03-28 00:00:00
1527,1,1,Tumor Site,larynx
1527,1,1,Age at Death,60.1
1527,1,1,Status,Alive unk disease
1527,1,1,Time to Death,1.2
1527,1,1,Research lab p16,p16 unknown
1527,1,1,First Failure Type,no known failure
1527,1,1,Tumor Stage,T4a
1527,1,1,Overall Stage,IVa
1527,1,1,Treatment Modality,Sx
1528,1,1,Initial Chemotherapy Agent,cis/PTX
1528,1,1,Age at Death,60.5
1528,1,1,Time to Death,2.3
1528,1,1,Second Failure Type,no known failure
1528,1,1,Nodal Stage,N2
1528,1,1,Clinical lab p16,p16 unknown
1528,1,1,Treatment Modality,CTX-RT
1528,1,1,Occurrence #,1st primary
1528,1,1,Metastasis,M1
1528,1,1,Tumor Site,larynx
1528,1,1,Radiation Dosage,70.2
1528,1,1,Research lab HPV,HPV unknown
1528,1,1,Overall Stage,IVc
1528,1,1,Tumor Stage,T2
1528,1,1,Time to First Failure,0.3
1528,1,1,First Failure Type,distant
1528,1,1,Date of Death,2010-02-25 00:00:00
1528,1,1,Status,Dead w/ disease
1528,1,1,Research lab p16,p16 unknown
1529,1,1,Clinical lab p16,p16 unknown
1529,1,1,Research lab HPV,HPV unknown
1529,1,1,First Failure Type,no known failure
1529,1,1,Metastasis,M0
1529,1,1,Time to Death,2.7
1529,1,1,Nodal Stage,N0
1529,1,1,Occurrence #,1st primary
1529,1,1,Tumor Site,larynx
1529,1,1,Status,Dead w/o disease
1529,1,1,Date of Death,2007-06-10 00:00:00
1529,1,1,Overall Stage,II
1529,1,1,Radiation Dosage,74.4
1529,1,1,Treatment Modality,RT
1529,1,1,Age at Death,71.3
1529,1,1,Tumor Stage,T2
1529,1,1,Second Failure Type,no known failure
1529,1,1,Research lab p16,p16 unknown
1530,1,1,Overall Stage,IVa
1530,1,1,Date of Death,2000-05-11 00:00:00
1530,1,1,Research lab p16,p16 unknown
1530,1,1,Treatment Modality,RT
1530,1,1,Clinical lab p16,p16 unknown
1530,1,1,First Failure Type,no known failure
1530,1,1,Metastasis,M0
1530,1,1,Occurrence #,1st primary
1530,1,1,Tumor Stage,T4a
1530,1,1,Radiation Dosage,41.4
1530,1,1,Age at Death,55.7
1530,1,1,Research lab HPV,HPV unknown
1530,1,1,Second Failure Type,no known failure
1530,1,1,Nodal Stage,N2
1530,1,1,Status,Dead unk disease
1530,1,1,Time to Death,0.2
1530,1,1,Tumor Site,larynx
1531,1,1,First Failure Type,no known failure
1531,1,1,Metastasis,M0
1531,1,1,Status,Alive w/o disease
1531,1,1,Tumor Stage,T3
1531,1,1,Nodal Stage,N1
1531,1,1,Clinical lab p16,p16 unknown
1531,1,1,Occurrence #,1st primary
1531,1,1,Research lab HPV,HPV unknown
1531,1,1,Second Failure Type,no known failure
1531,1,1,Radiation Dosage,unknown
1531,1,1,Initial Chemotherapy Agent,unknown
1531,1,1,Treatment Modality,CTX-RT
1531,1,1,Research lab p16,p16 unknown
1531,1,1,Tumor Site,larynx
1531,1,1,Overall Stage,III
1532,1,1,Second Failure Type,no known failure
1532,1,1,Time to Death,10.4
1532,1,1,Radiation Dosage,63
1532,1,1,Occurrence #,1st primary
1532,1,1,Status,Dead unk disease
1532,1,1,Nodal Stage,N0
1532,1,1,First Failure Type,no known failure
1532,1,1,Tumor Site,larynx
1532,1,1,Overall Stage,I
1532,1,1,Treatment Modality,RT
1532,1,1,Research lab p16,p16 unknown
1532,1,1,Tumor Stage,T1
1532,1,1,Metastasis,M0
1532,1,1,Research lab HPV,HPV unknown
1532,1,1,Age at Death,78.9
1532,1,1,Clinical lab p16,p16 unknown
1532,1,1,Date of Death,2011-05-19 00:00:00
1533,1,1,Status,Dead w/o disease
1533,1,1,Overall Stage,I
1533,1,1,Tumor Site,larynx
1533,1,1,Radiation Dosage,66
1533,1,1,Nodal Stage,N0
1533,1,1,Tumor Stage,T1
1533,1,1,Metastasis,M0
1533,1,1,Research lab p16,p16 unknown
1533,1,1,Clinical lab p16,p16 unknown
1533,1,1,Second Failure Type,no known failure
1533,1,1,First Failure Type,no known failure
1533,1,1,Occurrence #,1st primary
1533,1,1,Treatment Modality,RT
1533,1,1,Research lab HPV,HPV unknown
1534,1,1,Date of Death,2006-08-02 00:00:00
1534,1,1,Status,Dead w/o disease
1534,1,1,Tumor Stage,T2
1534,1,1,Metastasis,M0
1534,1,1,Tumor Site,larynx
1534,1,1,Occurrence #,1st primary
1534,1,1,Overall Stage,II
1534,1,1,Time to Death,2.1
1534,1,1,Second Failure Type,no known failure
1534,1,1,Nodal Stage,N0
1534,1,1,First Failure Type,no known failure
1534,1,1,Clinical lab p16,p16 unknown
1534,1,1,Research lab p16,p16 unknown
1534,1,1,Treatment Modality,RT
1534,1,1,Research lab HPV,HPV unknown
1534,1,1,Age at Death,74.3
1534,1,1,Radiation Dosage,74.4
1535,1,1,Tumor Stage,Unknown
1535,1,1,Research lab HPV,HPV unknown
1535,1,1,Second Failure Type,no known failure
1535,1,1,Research lab p16,p16 unknown
1535,1,1,Treatment Modality,Unknown
1535,1,1,Date of Death,2004-08-27 00:00:00
1535,1,1,Overall Stage,Unknown
1535,1,1,Time to Death,0.4
1535,1,1,Age at Death,63.2
1535,1,1,Nodal Stage,Unknown
1535,1,1,Status,Dead w/ disease
1535,1,1,Metastasis,Unknown
1535,1,1,First Failure Type,no known failure
1535,1,1,Clinical lab p16,p16 unknown
1535,1,1,Occurrence #,recurrence
1535,1,1,Tumor Site,larynx
1536,1,1,Status,Alive w/o disease
1536,1,1,Second Failure Type,no known failure
1536,1,1,Overall Stage,IVa
1536,1,1,First Failure Type,no known failure
1536,1,1,Research lab HPV,HPV unknown
1536,1,1,Tumor Site,larynx
1536,1,1,Tumor Stage,T4a
1536,1,1,Treatment Modality,Sx & CTX-RT
1536,1,1,Nodal Stage,N1
1536,1,1,Radiation Dosage,70.2
1536,1,1,Initial Chemotherapy Agent,cis
1536,1,1,Metastasis,M0
1536,1,1,Clinical lab p16,p16 unknown
1536,1,1,Occurrence #,1st primary
1536,1,1,Research lab p16,p16 unknown
1537,1,1,Overall Stage,I
1537,1,1,Research lab p16,p16 unknown
1537,1,1,Treatment Modality,Sx
1537,1,1,Status,Alive unk disease
1537,1,1,Clinical lab p16,p16 unknown
1537,1,1,Tumor Stage,T1
1537,1,1,Nodal Stage,N0
1537,1,1,Metastasis,M0
1537,1,1,First Failure Type,no known failure
1537,1,1,Second Failure Type,no known failure
1537,1,1,Occurrence #,1st primary
1537,1,1,Tumor Site,larynx
1537,1,1,Research lab HPV,HPV unknown
1538,1,1,Second Failure Type,no known failure
1538,1,1,Overall Stage,III
1538,1,1,Metastasis,M0
1538,1,1,Research lab p16,p16 unknown
1538,1,1,Radiation Dosage,70.2
1538,1,1,Nodal Stage,N1
1538,1,1,Research lab HPV,HPV unknown
1538,1,1,Tumor Stage,T3
1538,1,1,Tumor Site,larynx
1538,1,1,Clinical lab p16,p16 unknown
1538,1,1,Status,Alive w/o disease
1538,1,1,Treatment Modality,CTX-RT
1538,1,1,Occurrence #,1st primary
1538,1,1,First Failure Type,no known failure
1538,1,1,Initial Chemotherapy Agent,unknown
1539,1,1,Treatment Modality,RT
1539,1,1,Clinical lab p16,p16 unknown
1539,1,1,Research lab p16,p16 unknown
1539,1,1,Research lab HPV,HPV unknown
1539,1,1,First Failure Type,no known failure
1539,1,1,Status,Alive w/o disease
1539,1,1,Occurrence #,1st primary
1539,1,1,Metastasis,M0
1539,1,1,Tumor Site,larynx
1539,1,1,Overall Stage,I
1539,1,1,Nodal Stage,N0
1539,1,1,Tumor Stage,T1
1539,1,1,Second Failure Type,no known failure
1539,1,1,Radiation Dosage,65.25
1540,1,1,Tumor Site,larynx
1540,1,1,Status,Alive w/o disease
1540,1,1,Overall Stage,IVa
1540,1,1,Research lab HPV,HPV unknown
1540,1,1,First Failure Type,no known failure
1540,1,1,Treatment Modality,CTX-RT
1540,1,1,Clinical lab p16,p16 unknown
1540,1,1,Tumor Stage,T3
1540,1,1,Research lab p16,p16 unknown
1540,1,1,Radiation Dosage,70.2
1540,1,1,Nodal Stage,N2
1540,1,1,Metastasis,M0
1540,1,1,Second Failure Type,no known failure
1540,1,1,Initial Chemotherapy Agent,carbo/PTX
1540,1,1,Occurrence #,1st primary
1541,1,1,Status,Dead w/o disease
1541,1,1,Nodal Stage,N0
1541,1,1,Time to Death,3.6
1541,1,1,Tumor Stage,T3
1541,1,1,Overall Stage,III
1541,1,1,First Failure Type,no known failure
1541,1,1,Metastasis,M0
1541,1,1,Research lab p16,p16 unknown
1541,1,1,Second Failure Type,no known failure
1541,1,1,Age at Death,61.4
1541,1,1,Research lab HPV,HPV unknown
1541,1,1,Tumor Site,larynx
1541,1,1,Occurrence #,recurrence
1541,1,1,Clinical lab p16,p16 unknown
1541,1,1,Date of Death,2011-08-07 00:00:00
1541,1,1,Treatment Modality,Sx
1542,1,1,Research lab p16,p16 unknown
1542,1,1,Treatment Modality,Sx & RT
1542,1,1,Research lab HPV,HPV unknown
1542,1,1,Nodal Stage,N0
1542,1,1,Tumor Stage,T1
1542,1,1,Metastasis,M0
1542,1,1,First Failure Type,no known failure
1542,1,1,Clinical lab p16,p16 unknown
1542,1,1,Second Failure Type,no known failure
1542,1,1,Status,Alive unk disease
1542,1,1,Overall Stage,I
1542,1,1,Radiation Dosage,63.6
1542,1,1,Tumor Site,larynx
1542,1,1,Occurrence #,1st primary
1543,1,1,Tumor Site,larynx
1543,1,1,Date of Death,2005-10-16 00:00:00
1543,1,1,Initial Chemotherapy Agent,PTX/cap
1543,1,1,First Failure Type,no known failure
1543,1,1,Status,Dead w/o disease
1543,1,1,Research lab p16,p16 unknown
1543,1,1,Time to Death,4.9
1543,1,1,Clinical lab p16,p16 unknown
1543,1,1,Second Failure Type,no known failure
1543,1,1,Research lab HPV,HPV unknown
1543,1,1,Occurrence #,1st primary
1543,1,1,Radiation Dosage,70.2
1543,1,1,Overall Stage,IVa
1543,1,1,Metastasis,M0
1543,1,1,Nodal Stage,N1
1543,1,1,Treatment Modality,CTX-RT
1543,1,1,Age at Death,56.3
1543,1,1,Tumor Stage,T4a
1544,1,1,First Failure Treatment Modality,Sx
1544,1,1,Clinical lab p16,p16 unknown
1544,1,1,Time to Death,1.4
1544,1,1,Tumor Stage,T4a
1544,1,1,Occurrence #,1st primary
1544,1,1,Second Failure Type,no known failure
1544,1,1,Tumor Site,larynx
1544,1,1,Research lab HPV,HPV unknown
1544,1,1,Research lab p16,p16 unknown
1544,1,1,Treatment Modality,Sx
1544,1,1,Time to First Failure,0.9
1544,1,1,Status,Dead unk disease
1544,1,1,Age at Death,58.0
1544,1,1,First Failure Site,larynx
1544,1,1,Date of Death,2003-02-16 00:00:00
1544,1,1,First Failure Type,locoregional
1544,1,1,Nodal Stage,N0
1544,1,1,Overall Stage,IVa
1544,1,1,Metastasis,M0
1545,1,1,Metastasis,M0
1545,1,1,Second Failure Type,no known failure
1545,1,1,Tumor Site,larynx
1545,1,1,Research lab p16,p16 unknown
1545,1,1,First Failure Type,no known failure
1545,1,1,Clinical lab p16,p16 unknown
1545,1,1,Radiation Dosage,63
1545,1,1,Nodal Stage,N0
1545,1,1,Occurrence #,1st primary
1545,1,1,Tumor Stage,T1
1545,1,1,Research lab HPV,HPV unknown
1545,1,1,Overall Stage,I
1545,1,1,Status,Alive w/o disease
1545,1,1,Treatment Modality,RT
1546,1,1,Time to First Failure,0.6
1546,1,1,Age at Death,52.3
1546,1,1,Metastasis,M0
1546,1,1,Overall Stage,IVa
1546,1,1,Treatment Modality,Sx
1546,1,1,Tumor Stage,T4a
1546,1,1,Tumor Site,larynx
1546,1,1,Date of Death,2005-03-22 00:00:00
1546,1,1,Nodal Stage,N2
1546,1,1,First Failure Type,locoregional
1546,1,1,Time to Death,0.6
1546,1,1,Status,Dead w/ disease
1546,1,1,Clinical lab p16,p16 unknown
1546,1,1,Research lab HPV,HPV unknown
1546,1,1,Second Failure Type,no known failure
1546,1,1,Research lab p16,p16 unknown
1546,1,1,Occurrence #,1st primary
1547,1,1,First Failure Site,larynx
1547,1,1,Nodal Stage,N0
1547,1,1,Tumor Site,larynx
1547,1,1,First Failure Treatment Modality,Sx & RT
1547,1,1,Overall Stage,I
1547,1,1,Metastasis,M0
1547,1,1,First Failure Type,locoregional
1547,1,1,Status,Dead w/ disease
1547,1,1,Time to First Failure,0.5
1547,1,1,Clinical lab p16,p16 unknown
1547,1,1,Age at Death,50.8
1547,1,1,Occurrence #,1st primary
1547,1,1,Second Failure Type,no known failure
1547,1,1,First Failure Radiation Dosage,unknown
1547,1,1,Radiation Dosage,63
1547,1,1,Date of Death,2001-03-20 00:00:00
1547,1,1,Research lab p16,p16 unknown
1547,1,1,Tumor Stage,T1
1547,1,1,Treatment Modality,RT
1547,1,1,Research lab HPV,HPV unknown
1547,1,1,Time to Death,0.4
1548,1,1,Research lab HPV,HPV unknown
1548,1,1,Age at Death,76.1
1548,1,1,Occurrence #,1st primary
1548,1,1,Clinical lab p16,p16 unknown
1548,1,1,Research lab p16,p16 unknown
1548,1,1,Initial Chemotherapy Agent,carbo/PTX
1548,1,1,Status,Dead w/ disease
1548,1,1,Time to Death,3.6
1548,1,1,Time to First Failure,2.6
1548,1,1,Second Failure Type,no known failure
1548,1,1,First Failure Type,distant
1548,1,1,Treatment Modality,CTX-RT
1548,1,1,Overall Stage,II
1548,1,1,Date of Death,2009-10-12 00:00:00
1548,1,1,Metastasis,M0
1548,1,1,Nodal Stage,N0
1548,1,1,Radiation Dosage,50.4
1548,1,1,Tumor Stage,T2
1548,1,1,Tumor Site,larynx
1549,1,1,Metastasis,M0
1549,1,1,Nodal Stage,N2
1549,1,1,Second Failure Type,no known failure
1549,1,1,Research lab HPV,HPV unknown
1549,1,1,Overall Stage,IVa
1549,1,1,Date of Death,2002-07-05 00:00:00
1549,1,1,Treatment Modality,Sx & RT
1549,1,1,Clinical lab p16,p16 unknown
1549,1,1,Radiation Dosage,63
1549,1,1,Tumor Site,larynx
1549,1,1,Status,Dead unk disease
1549,1,1,First Failure Type,no known failure
1549,1,1,Occurrence #,1st primary
1549,1,1,Research lab p16,p16 unknown
1549,1,1,Age at Death,65.2
1549,1,1,Time to Death,1.1
1549,1,1,Tumor Stage,T4a
1550,1,1,Tumor Stage,T3
1550,1,1,Date of Death,2010-07-13 00:00:00
1550,1,1,Overall Stage,III
1550,1,1,Status,Dead w/ disease
1550,1,1,Tumor Site,larynx
1550,1,1,Age at Death,72.4
1550,1,1,Time to Death,8.5
1550,1,1,Research lab HPV,HPV unknown
1550,1,1,Metastasis,M0
1550,1,1,Clinical lab p16,p16 unknown
1550,1,1,Treatment Modality,Sx
1550,1,1,Nodal Stage,N0
1550,1,1,First Failure Type,no known failure
1550,1,1,Second Failure Type,no known failure
1550,1,1,Occurrence #,1st primary
1550,1,1,Research lab p16,p16 unknown
1551,1,1,Clinical lab p16,p16 unknown
1551,1,1,Age at Death,69.8
1551,1,1,Treatment Modality,Unknown
1551,1,1,Time to Death,0.7
1551,1,1,Overall Stage,Unknown
1551,1,1,First Failure Type,no known failure
1551,1,1,Tumor Stage,Unknown
1551,1,1,Metastasis,Unknown
1551,1,1,Status,Dead unk disease
1551,1,1,Research lab p16,p16 unknown
1551,1,1,Occurrence #,1st primary
1551,1,1,Date of Death,2009-01-28 00:00:00
1551,1,1,Research lab HPV,HPV unknown
1551,1,1,Nodal Stage,Unknown
1551,1,1,Tumor Site,larynx
1551,1,1,Second Failure Type,no known failure
1552,1,1,Treatment Modality,Sx
1552,1,1,Tumor Stage,T4a
1552,1,1,Overall Stage,IVa
1552,1,1,Tumor Site,larynx
1552,1,1,Nodal Stage,N0
1552,1,1,Occurrence #,1st primary
1552,1,1,Metastasis,M0
1552,1,1,First Failure Type,no known failure
1552,1,1,Research lab p16,p16 unknown
1552,1,1,Clinical lab p16,p16 unknown
1552,1,1,Second Failure Type,no known failure
1552,1,1,Research lab HPV,HPV unknown
1552,1,1,Age at Death,74.1
1552,1,1,Status,Dead unk disease
1552,1,1,Time to Death,0.3
1552,1,1,Date of Death,2002-06-23 00:00:00
1553,1,1,Overall Stage,IVa
1553,1,1,Tumor Site,larynx
1553,1,1,Nodal Stage,N2
1553,1,1,Occurrence #,1st primary
1553,1,1,Radiation Dosage,72
1553,1,1,Metastasis,M0
1553,1,1,Clinical lab p16,p16 unknown
1553,1,1,Second Failure Type,no known failure
1553,1,1,Research lab HPV,HPV unknown
1553,1,1,First Failure Treatment Modality,Sx
1553,1,1,Status,Dead unk disease
1553,1,1,Time to Death,4.3
1553,1,1,Treatment Modality,RT
1553,1,1,First Failure Site,larynx
1553,1,1,First Failure Type,locoregional
1553,1,1,Age at Death,60.0
1553,1,1,Research lab p16,p16 unknown
1553,1,1,Date of Death,2005-05-25 00:00:00
1553,1,1,Tumor Stage,T3
1553,1,1,Time to First Failure,3.0
1554,1,1,Nodal Stage,N2
1554,1,1,Research lab p16,p16 unknown
1554,1,1,Initial Chemotherapy Agent,unknown
1554,1,1,Tumor Stage,T2
1554,1,1,Radiation Dosage,unknown
1554,1,1,Metastasis,M0
1554,1,1,Overall Stage,IVa
1554,1,1,Clinical lab p16,p16 unknown
1554,1,1,Treatment Modality,Sx & CTX-RT
1554,1,1,Research lab HPV,HPV unknown
1554,1,1,Status,Alive w/o disease
1554,1,1,Second Failure Type,no known failure
1554,1,1,Tumor Site,larynx
1554,1,1,Occurrence #,1st primary
1554,1,1,First Failure Type,no known failure
1555,1,1,Nodal Stage,N0
1555,1,1,Clinical lab p16,p16 unknown
1555,1,1,Research lab HPV,HPV unknown
1555,1,1,Overall Stage,IVa
1555,1,1,Tumor Stage,T4a
1555,1,1,Date of Death,2005-02-14 00:00:00
1555,1,1,Tumor Site,larynx
1555,1,1,Treatment Modality,Unknown
1555,1,1,Research lab p16,p16 unknown
1555,1,1,Time to Death,0.2
1555,1,1,First Failure Type,no known failure
1555,1,1,Status,Dead w/ disease
1555,1,1,Metastasis,M0
1555,1,1,Second Failure Type,no known failure
1555,1,1,Age at Death,69.1
1555,1,1,Occurrence #,1st primary
1556,1,1,Research lab HPV,HPV unknown
1556,1,1,Treatment Modality,RT
1556,1,1,First Failure Type,no known failure
1556,1,1,Tumor Stage,T1
1556,1,1,Overall Stage,I
1556,1,1,Clinical lab p16,p16 unknown
1556,1,1,Research lab p16,p16 unknown
1556,1,1,Status,Alive w/o disease
1556,1,1,Occurrence #,1st primary
1556,1,1,Metastasis,M0
1556,1,1,Tumor Site,larynx
1556,1,1,Radiation Dosage,66
1556,1,1,Second Failure Type,no known failure
1556,1,1,Nodal Stage,N0
1557,1,1,Occurrence #,1st primary
1557,1,1,Tumor Stage,Unknown
1557,1,1,Overall Stage,Unknown
1557,1,1,Research lab p16,p16 unknown
1557,1,1,Clinical lab p16,p16 unknown
1557,1,1,Metastasis,Unknown
1557,1,1,Nodal Stage,Unknown
1557,1,1,Status,Alive w/ disease
1557,1,1,Tumor Site,larynx
1557,1,1,First Failure Type,no known failure
1557,1,1,Research lab HPV,HPV unknown
1557,1,1,Second Failure Type,no known failure
1557,1,1,Treatment Modality,Unknown
1558,1,1,First Failure Treatment Modality,Sx
1558,1,1,Nodal Stage,N2
1558,1,1,Treatment Modality,CTX-RT
1558,1,1,Status,Dead w/ disease
1558,1,1,Date of Death,2008-08-22 00:00:00
1558,1,1,Research lab HPV,HPV unknown
1558,1,1,Radiation Dosage,70.2
1558,1,1,Tumor Site,larynx
1558,1,1,Age at Death,62.1
1558,1,1,Metastasis,M0
1558,1,1,Overall Stage,IVa
1558,1,1,First Failure Type,locoregional and distant
1558,1,1,Research lab p16,p16 unknown
1558,1,1,Occurrence #,1st primary
1558,1,1,Tumor Stage,T3
1558,1,1,Clinical lab p16,p16 unknown
1558,1,1,First Failure Site,larynx
1558,1,1,Time to First Failure,0.5
1558,1,1,Time to Death,1.4
1558,1,1,Initial Chemotherapy Agent,cis
1558,1,1,Second Failure Type,no known failure
1559,1,1,Status,Dead unk disease
1559,1,1,Metastasis,M0
1559,1,1,Second Failure Type,no known failure
1559,1,1,Time to Death,0.6
1559,1,1,Age at Death,79.8
1559,1,1,Occurrence #,1st primary
1559,1,1,Research lab HPV,HPV unknown
1559,1,1,Clinical lab p16,p16 unknown
1559,1,1,First Failure Type,no known failure
1559,1,1,Tumor Stage,T4a
1559,1,1,Research lab p16,p16 unknown
1559,1,1,Overall Stage,IVa
1559,1,1,Nodal Stage,N0
1559,1,1,Tumor Site,larynx
1559,1,1,Treatment Modality,Sx
1559,1,1,Date of Death,2003-03-15 00:00:00
1560,1,1,Nodal Stage,N2
1560,1,1,Research lab HPV,HPV unknown
1560,1,1,Tumor Site,larynx
1560,1,1,Clinical lab p16,p16 unknown
1560,1,1,Status,Dead w/ disease
1560,1,1,Tumor Stage,T1
1560,1,1,Treatment Modality,RT
1560,1,1,Age at Death,56.9
1560,1,1,Radiation Dosage,50
1560,1,1,Date of Death,2006-01-12 00:00:00
1560,1,1,Metastasis,M0
1560,1,1,Overall Stage,IVa
1560,1,1,Time to First Failure,1.1
1560,1,1,Occurrence #,1st primary
1560,1,1,Second Failure Type,no known failure
1560,1,1,Research lab p16,p16 unknown
1560,1,1,First Failure Type,locoregional
1560,1,1,Time to Death,2.3
1561,1,1,Tumor Site,larynx
1561,1,1,First Failure Type,no known failure
1561,1,1,Date of Death,2009-09-07 00:00:00
1561,1,1,Nodal Stage,N0
1561,1,1,Research lab p16,p16 unknown
1561,1,1,Tumor Stage,T2
1561,1,1,Second Failure Type,no known failure
1561,1,1,Metastasis,M0
1561,1,1,Research lab HPV,HPV unknown
1561,1,1,Time to Death,8.4
1561,1,1,Clinical lab p16,p16 unknown
1561,1,1,Overall Stage,II
1561,1,1,Status,Dead unk disease
1561,1,1,Occurrence #,other primary
1561,1,1,Age at Death,57.8
1561,1,1,Treatment Modality,Sx
1562,1,1,Time to Death,0.6
1562,1,1,Overall Stage,III
1562,1,1,Research lab p16,p16 unknown
1562,1,1,Treatment Modality,RT
1562,1,1,Tumor Site,larynx
1562,1,1,First Failure Type,no known failure
1562,1,1,Clinical lab p16,p16 unknown
1562,1,1,Nodal Stage,N1
1562,1,1,Date of Death,2008-05-12 00:00:00
1562,1,1,Radiation Dosage,70.2
1562,1,1,Metastasis,M0
1562,1,1,Second Failure Type,no known failure
1562,1,1,Occurrence #,1st primary
1562,1,1,Age at Death,69.5
1562,1,1,Research lab HPV,HPV unknown
1562,1,1,Status,Dead unk disease
1562,1,1,Tumor Stage,T3
1563,1,1,Date of Death,2010-12-26 00:00:00
1563,1,1,Tumor Stage,T3
1563,1,1,Time to Death,1.8
1563,1,1,First Failure Type,no known failure
1563,1,1,Overall Stage,IVa
1563,1,1,Tumor Site,larynx
1563,1,1,Research lab HPV,HPV unknown
1563,1,1,Age at Death,70.7
1563,1,1,Treatment Modality,Unknown
1563,1,1,Occurrence #,1st primary
1563,1,1,Nodal Stage,N2
1563,1,1,Second Failure Type,no known failure
1563,1,1,Metastasis,M0
1563,1,1,Research lab p16,p16 unknown
1563,1,1,Status,Dead unk disease
1563,1,1,Clinical lab p16,p16 unknown
1564,1,1,Nodal Stage,N0
1564,1,1,Tumor Site,larynx
1564,1,1,Treatment Modality,RT
1564,1,1,Tumor Stage,T2
1564,1,1,Radiation Dosage,74.4
1564,1,1,Occurrence #,1st primary
1564,1,1,Metastasis,M0
1564,1,1,Second Failure Type,no known failure
1564,1,1,Research lab HPV,HPV unknown
1564,1,1,Clinical lab p16,p16 unknown
1564,1,1,First Failure Type,no known failure
1564,1,1,Status,Alive w/o disease
1564,1,1,Research lab p16,p16 unknown
1564,1,1,Overall Stage,II
1565,1,1,Tumor Site,larynx
1565,1,1,Clinical lab p16,p16 unknown
1565,1,1,Metastasis,M0
1565,1,1,Occurrence #,1st primary
1565,1,1,Nodal Stage,N0
1565,1,1,Overall Stage,II
1565,1,1,Second Failure Type,no known failure
1565,1,1,Radiation Dosage,74.4
1565,1,1,Tumor Stage,T2
1565,1,1,Research lab HPV,HPV unknown
1565,1,1,First Failure Type,no known failure
1565,1,1,Treatment Modality,RT
1565,1,1,Research lab p16,p16 unknown
1565,1,1,Status,Alive w/o disease
1566,1,1,Age at Death,49.2
1566,1,1,Occurrence #,1st primary
1566,1,1,Initial Chemotherapy Agent,unknown
1566,1,1,Time to Death,2.7
1566,1,1,Radiation Dosage,unknown
1566,1,1,Clinical lab p16,p16 unknown
1566,1,1,First Failure Site,larynx
1566,1,1,Date of Death,2006-05-01 00:00:00
1566,1,1,Nodal Stage,N2
1566,1,1,First Failure Type,locoregional
1566,1,1,Tumor Stage,T2
1566,1,1,Treatment Modality,Sx & CTX-RT
1566,1,1,Research lab HPV,HPV unknown
1566,1,1,Research lab p16,p16 unknown
1566,1,1,Status,Dead w/ disease
1566,1,1,Time to First Failure,1.2
1566,1,1,Tumor Site,larynx
1566,1,1,Second Failure Type,no known failure
1566,1,1,Metastasis,M0
1566,1,1,First Failure Treatment Modality,Sx
1566,1,1,Overall Stage,IVa
1567,1,1,Research lab HPV,HPV unknown
1567,1,1,Second Failure Type,no known failure
1567,1,1,Occurrence #,1st primary
1567,1,1,Tumor Stage,T2
1567,1,1,First Failure Type,no known failure
1567,1,1,Time to Death,3.6
1567,1,1,Date of Death,2004-11-16 00:00:00
1567,1,1,Nodal Stage,N0
1567,1,1,Tumor Site,larynx
1567,1,1,Overall Stage,II
1567,1,1,Metastasis,M0
1567,1,1,Status,Dead unk disease
1567,1,1,Clinical lab p16,p16 unknown
1567,1,1,Treatment Modality,Sx
1567,1,1,Age at Death,72.2
1567,1,1,Research lab p16,p16 unknown
1568,1,1,Time to First Failure,0.2
1568,1,1,Tumor Stage,T3
1568,1,1,Treatment Modality,CTX-RT
1568,1,1,Tumor Site,larynx
1568,1,1,Research lab p16,p16 unknown
1568,1,1,Second Failure Type,no known failure
1568,1,1,Overall Stage,IVa
1568,1,1,Research lab HPV,HPV unknown
1568,1,1,Occurrence #,1st primary
1568,1,1,Clinical lab p16,p16 unknown
1568,1,1,Status,Dead w/ disease
1568,1,1,Initial Chemotherapy Agent,cis
1568,1,1,Age at Death,74.3
1568,1,1,Time to Death,3.2
1568,1,1,First Failure Type,distant
1568,1,1,Nodal Stage,N2
1568,1,1,Date of Death,2010-07-09 00:00:00
1568,1,1,Radiation Dosage,70.2
1568,1,1,Metastasis,M0
1569,1,1,First Failure Type,no known failure
1569,1,1,Clinical lab p16,p16 unknown
1569,1,1,Tumor Stage,T1
1569,1,1,Status,Alive w/o disease
1569,1,1,Treatment Modality,Sx
1569,1,1,Metastasis,M0
1569,1,1,Research lab HPV,HPV unknown
1569,1,1,Overall Stage,I
1569,1,1,Tumor Site,larynx
1569,1,1,Nodal Stage,N0
1569,1,1,Occurrence #,1st primary
1569,1,1,Second Failure Type,no known failure
1569,1,1,Research lab p16,p16 unknown
1570,1,1,Age at Death,64.4
1570,1,1,Occurrence #,1st primary
1570,1,1,Metastasis,M0
1570,1,1,Treatment Modality,CTX-RT
1570,1,1,Time to Death,6.2
1570,1,1,Research lab HPV,HPV unknown
1570,1,1,Research lab p16,p16 unknown
1570,1,1,Tumor Site,larynx
1570,1,1,Nodal Stage,N0
1570,1,1,Date of Death,2010-12-12 00:00:00
1570,1,1,First Failure Type,no known failure
1570,1,1,Radiation Dosage,72
1570,1,1,Clinical lab p16,p16 unknown
1570,1,1,Tumor Stage,T3
1570,1,1,Overall Stage,III
1570,1,1,Status,Dead w/ disease
1570,1,1,Initial Chemotherapy Agent,cis
1570,1,1,Second Failure Type,no known failure
1571,1,1,Metastasis,M0
1571,1,1,Second Failure Type,no known failure
1571,1,1,Research lab HPV,HPV unknown
1571,1,1,Radiation Dosage,70.2
1571,1,1,First Failure Type,no known failure
1571,1,1,Research lab p16,p16 unknown
1571,1,1,Tumor Site,larynx
1571,1,1,Nodal Stage,N1
1571,1,1,Clinical lab p16,p16 unknown
1571,1,1,Status,Alive w/o disease
1571,1,1,Treatment Modality,CTX-RT
1571,1,1,Tumor Stage,T3
1571,1,1,Overall Stage,III
1571,1,1,Initial Chemotherapy Agent,cis
1571,1,1,Occurrence #,1st primary
1572,1,1,Occurrence #,1st primary
1572,1,1,Treatment Modality,Sx & RT
1572,1,1,Clinical lab p16,p16 unknown
1572,1,1,Second Failure Type,no known failure
1572,1,1,Radiation Dosage,63
1572,1,1,Nodal Stage,N2
1572,1,1,Research lab p16,p16 unknown
1572,1,1,Status,Alive w/o disease
1572,1,1,Overall Stage,IVa
1572,1,1,Tumor Site,larynx
1572,1,1,Metastasis,M0
1572,1,1,Research lab HPV,HPV unknown
1572,1,1,First Failure Type,no known failure
1572,1,1,Tumor Stage,T3
1573,1,1,Clinical lab p16,p16 unknown
1573,1,1,Status,Alive w/o disease
1573,1,1,Treatment Modality,RT
1573,1,1,Tumor Stage,T2
1573,1,1,Occurrence #,1st primary
1573,1,1,Radiation Dosage,74.4
1573,1,1,Research lab p16,p16 unknown
1573,1,1,First Failure Type,no known failure
1573,1,1,Nodal Stage,N0
1573,1,1,Research lab HPV,HPV unknown
1573,1,1,Tumor Site,larynx
1573,1,1,Second Failure Type,no known failure
1573,1,1,Overall Stage,II
1573,1,1,Metastasis,M0
1574,1,1,Nodal Stage,N0
1574,1,1,Tumor Site,larynx
1574,1,1,Clinical lab p16,p16 unknown
1574,1,1,Occurrence #,1st primary
1574,1,1,Research lab HPV,HPV unknown
1574,1,1,Tumor Stage,T4a
1574,1,1,Initial Chemotherapy Agent,cis
1574,1,1,Status,Alive w/o disease
1574,1,1,Radiation Dosage,70.2
1574,1,1,Metastasis,M0
1574,1,1,Overall Stage,IVa
1574,1,1,Treatment Modality,CTX-RT
1574,1,1,Second Failure Type,no known failure
1574,1,1,Research lab p16,p16 unknown
1574,1,1,First Failure Type,no known failure
1575,1,1,Time to First Failure,1.2
1575,1,1,Metastasis,M0
1575,1,1,Research lab p16,p16 unknown
1575,1,1,Occurrence #,recurrence
1575,1,1,Treatment Modality,Sx
1575,1,1,First Failure Site,larynx
1575,1,1,First Failure Initial Chemotherapy Agent,unknown
1575,1,1,Tumor Stage,T2
1575,1,1,First Failure Treatment Modality,Sx & CTX-RT
1575,1,1,Tumor Site,larynx
1575,1,1,Clinical lab p16,p16 unknown
1575,1,1,First Failure Type,locoregional
1575,1,1,Second Failure Type,no known failure
1575,1,1,Nodal Stage,N0
1575,1,1,Status,Dead w/ disease
1575,1,1,First Failure Radiation Dosage,60
1575,1,1,Research lab HPV,HPV unknown
1575,1,1,Overall Stage,II
1576,1,1,Time to Death,4.9
1576,1,1,Initial Chemotherapy Agent,carbo/PTX
1576,1,1,Research lab p16,p16 unknown
1576,1,1,Age at Death,59.1
1576,1,1,Tumor Site,larynx
1576,1,1,First Failure Type,no known failure
1576,1,1,Research lab HPV,HPV unknown
1576,1,1,Nodal Stage,N3
1576,1,1,Overall Stage,IVb
1576,1,1,Status,Dead w/o disease
1576,1,1,Occurrence #,1st primary
1576,1,1,Radiation Dosage,70.2
1576,1,1,Treatment Modality,Sx & CTX-RT
1576,1,1,Date of Death,2010-01-08 00:00:00
1576,1,1,Clinical lab p16,p16 unknown
1576,1,1,Metastasis,M0
1576,1,1,Tumor Stage,T2
1576,1,1,Second Failure Type,no known failure
1577,1,1,First Failure Type,no known failure
1577,1,1,Research lab p16,p16 unknown
1577,1,1,Occurrence #,1st primary
1577,1,1,Radiation Dosage,70.2
1577,1,1,Nodal Stage,N0
1577,1,1,Second Failure Type,no known failure
1577,1,1,Clinical lab p16,p16 unknown
1577,1,1,Tumor Stage,T2
1577,1,1,Overall Stage,II
1577,1,1,Treatment Modality,RT
1577,1,1,Status,Alive w/o disease
1577,1,1,Research lab HPV,HPV unknown
1577,1,1,Metastasis,M0
1577,1,1,Tumor Site,larynx
1578,1,1,Overall Stage,I
1578,1,1,Nodal Stage,N0
1578,1,1,Tumor Site,larynx
1578,1,1,Clinical lab p16,p16 unknown
1578,1,1,Research lab HPV,HPV unknown
1578,1,1,Research lab p16,p16 unknown
1578,1,1,Radiation Dosage,63
1578,1,1,Second Failure Type,no known failure
1578,1,1,First Failure Type,no known failure
1578,1,1,Metastasis,M0
1578,1,1,Treatment Modality,RT
1578,1,1,Status,Alive w/o disease
1578,1,1,Tumor Stage,T1
1578,1,1,Occurrence #,1st primary
1579,1,1,Clinical lab p16,p16 unknown
1579,1,1,Tumor Site,larynx
1579,1,1,Second Failure Type,no known failure
1579,1,1,Overall Stage,III
1579,1,1,Date of Death,2011-01-09 00:00:00
1579,1,1,Tumor Stage,T3
1579,1,1,First Failure Type,no known failure
1579,1,1,Initial Chemotherapy Agent,unknown
1579,1,1,Research lab HPV,HPV unknown
1579,1,1,Occurrence #,1st primary
1579,1,1,Treatment Modality,CTX-RT
1579,1,1,Metastasis,M0
1579,1,1,Nodal Stage,N1
1579,1,1,Radiation Dosage,70.2
1579,1,1,Research lab p16,p16 unknown
1579,1,1,Age at Death,64.4
1579,1,1,Status,Dead unk disease
1579,1,1,Time to Death,2.2
1580,1,1,Research lab p16,p16 unknown
1580,1,1,First Failure Type,distant
1580,1,1,Overall Stage,IVa
1580,1,1,Research lab HPV,HPV unknown
1580,1,1,Treatment Modality,CTX-RT
1580,1,1,Occurrence #,1st primary
1580,1,1,Date of Death,2010-03-03 00:00:00
1580,1,1,Status,Dead unk disease
1580,1,1,Second Failure Type,no known failure
1580,1,1,Radiation Dosage,70.2
1580,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1580,1,1,Time to Death,3.8
1580,1,1,Metastasis,M0
1580,1,1,Nodal Stage,N2
1580,1,1,Clinical lab p16,p16 unknown
1580,1,1,Tumor Site,larynx
1580,1,1,Age at Death,69.6
1580,1,1,Time to First Failure,0.4
1580,1,1,Tumor Stage,T2
1581,1,1,Metastasis,M0
1581,1,1,Tumor Site,larynx
1581,1,1,Nodal Stage,N0
1581,1,1,Research lab p16,p16 unknown
1581,1,1,First Failure Site,larynx
1581,1,1,Occurrence #,other primary
1581,1,1,Status,Alive w/ disease
1581,1,1,Clinical lab p16,p16 unknown
1581,1,1,Tumor Stage,T1
1581,1,1,Overall Stage,I
1581,1,1,First Failure Type,locoregional
1581,1,1,Radiation Dosage,unknown
1581,1,1,Time to First Failure,1.6
1581,1,1,Second Failure Type,no known failure
1581,1,1,Research lab HPV,HPV unknown
1581,1,1,Treatment Modality,RT
1581,1,1,First Failure Treatment Modality,Sx
1582,1,1,Research lab HPV,HPV unknown
1582,1,1,Tumor Stage,T1
1582,1,1,Status,Alive w/o disease
1582,1,1,First Failure Type,no known failure
1582,1,1,Overall Stage,I
1582,1,1,Research lab p16,p16 unknown
1582,1,1,Treatment Modality,RT
1582,1,1,Radiation Dosage,66
1582,1,1,Nodal Stage,N0
1582,1,1,Second Failure Type,no known failure
1582,1,1,Occurrence #,1st primary
1582,1,1,Metastasis,M0
1582,1,1,Tumor Site,larynx
1582,1,1,Clinical lab p16,p16 unknown
1583,1,1,Second Failure Type,no known failure
1583,1,1,Clinical lab p16,p16 unknown
1583,1,1,Tumor Stage,T3
1583,1,1,Tumor Site,larynx
1583,1,1,Research lab p16,p16 unknown
1583,1,1,Age at Death,56.1
1583,1,1,Occurrence #,1st primary
1583,1,1,Nodal Stage,N0
1583,1,1,Time to Death,3.5
1583,1,1,Treatment Modality,RT
1583,1,1,First Failure Type,no known failure
1583,1,1,Overall Stage,III
1583,1,1,Status,Dead w/o disease
1583,1,1,Radiation Dosage,70.2
1583,1,1,Metastasis,M0
1583,1,1,Date of Death,2004-04-02 00:00:00
1583,1,1,Research lab HPV,HPV unknown
1584,1,1,Tumor Stage,T1
1584,1,1,Nodal Stage,N3
1584,1,1,Radiation Dosage,70.2
1584,1,1,Research lab HPV,HPV unknown
1584,1,1,Treatment Modality,CTX-RT
1584,1,1,Clinical lab p16,p16 unknown
1584,1,1,Second Failure Type,no known failure
1584,1,1,Occurrence #,1st primary
1584,1,1,Initial Chemotherapy Agent,carbo/PTX/5-FU
1584,1,1,First Failure Type,no known failure
1584,1,1,Overall Stage,IVb
1584,1,1,Metastasis,M0
1584,1,1,Status,Alive w/o disease
1584,1,1,Research lab p16,p16 unknown
1584,1,1,Tumor Site,larynx
1585,1,1,First Failure Type,no known failure
1585,1,1,Date of Death,2002-06-02 00:00:00
1585,1,1,Research lab HPV,HPV unknown
1585,1,1,Treatment Modality,Sx & CTX
1585,1,1,Overall Stage,IVc
1585,1,1,Initial Chemotherapy Agent,gemcetabine/PTX/cap
1585,1,1,Age at Death,55.5
1585,1,1,Second Failure Type,no known failure
1585,1,1,Nodal Stage,N0
1585,1,1,Clinical lab p16,p16 unknown
1585,1,1,Metastasis,M1
1585,1,1,Research lab p16,p16 unknown
1585,1,1,Occurrence #,1st primary
1585,1,1,Time to Death,0.7
1585,1,1,Tumor Site,larynx
1585,1,1,Tumor Stage,T4a
1585,1,1,Status,Dead w/ disease
1586,1,1,Tumor Site,larynx
1586,1,1,Status,Alive unk disease
1586,1,1,Second Failure Type,no known failure
1586,1,1,Overall Stage,IVa
1586,1,1,Metastasis,M0
1586,1,1,Tumor Stage,T4a
1586,1,1,First Failure Type,no known failure
1586,1,1,Research lab p16,p16 unknown
1586,1,1,Occurrence #,1st primary
1586,1,1,Nodal Stage,N0
1586,1,1,Treatment Modality,Sx
1586,1,1,Research lab HPV,HPV unknown
1586,1,1,Clinical lab p16,p16 unknown
1587,1,1,Metastasis,M0
1587,1,1,Second Failure Type,no known failure
1587,1,1,Time to Death,1.4
1587,1,1,Clinical lab p16,p16 unknown
1587,1,1,Tumor Stage,T4a
1587,1,1,Treatment Modality,CTX-RT
1587,1,1,Radiation Dosage,70.2
1587,1,1,Status,Dead w/ disease
1587,1,1,Initial Chemotherapy Agent,carbo/PTX
1587,1,1,Nodal Stage,N2
1587,1,1,Occurrence #,1st primary
1587,1,1,Research lab p16,p16 unknown
1587,1,1,First Failure Type,locoregional
1587,1,1,Date of Death,2002-09-14 00:00:00
1587,1,1,Overall Stage,IVa
1587,1,1,Age at Death,48.6
1587,1,1,Research lab HPV,HPV unknown
1587,1,1,Tumor Site,larynx
1587,1,1,Time to First Failure,0.2
1588,1,1,Research lab p16,p16 unknown
1588,1,1,Clinical lab p16,p16 unknown
1588,1,1,Radiation Dosage,63
1588,1,1,Nodal Stage,N0
1588,1,1,Occurrence #,1st primary
1588,1,1,Research lab HPV,HPV unknown
1588,1,1,First Failure Type,no known failure
1588,1,1,Tumor Stage,T1
1588,1,1,Metastasis,M0
1588,1,1,Overall Stage,I
1588,1,1,Tumor Site,larynx
1588,1,1,Status,Alive w/o disease
1588,1,1,Treatment Modality,RT
1588,1,1,Second Failure Type,no known failure
1589,1,1,Status,Alive unk disease
1589,1,1,Tumor Stage,Unknown
1589,1,1,Research lab HPV,HPV unknown
1589,1,1,Metastasis,Unknown
1589,1,1,Overall Stage,Unknown
1589,1,1,Occurrence #,1st primary
1589,1,1,First Failure Type,no known failure
1589,1,1,Treatment Modality,Unknown
1589,1,1,Clinical lab p16,p16 unknown
1589,1,1,Nodal Stage,Unknown
1589,1,1,Tumor Site,larynx
1589,1,1,Research lab p16,p16 unknown
1589,1,1,Second Failure Type,no known failure
1590,1,1,Treatment Modality,Sx & RT
1590,1,1,Metastasis,M0
1590,1,1,Tumor Site,larynx
1590,1,1,Research lab p16,p16 unknown
1590,1,1,Radiation Dosage,unknown
1590,1,1,Nodal Stage,N0
1590,1,1,Occurrence #,1st primary
1590,1,1,Overall Stage,IVa
1590,1,1,Second Failure Type,no known failure
1590,1,1,First Failure Type,no known failure
1590,1,1,Clinical lab p16,p16 unknown
1590,1,1,Tumor Stage,T4a
1590,1,1,Research lab HPV,HPV unknown
1590,1,1,Status,Alive w/o disease
1591,1,1,Overall Stage,I
1591,1,1,Occurrence #,1st primary
1591,1,1,Status,Alive w/o disease
1591,1,1,Research lab p16,p16 unknown
1591,1,1,Metastasis,M0
1591,1,1,First Failure Type,no known failure
1591,1,1,Research lab HPV,HPV unknown
1591,1,1,Second Failure Type,no known failure
1591,1,1,Radiation Dosage,63
1591,1,1,Treatment Modality,RT
1591,1,1,Tumor Stage,T1
1591,1,1,Tumor Site,larynx
1591,1,1,Clinical lab p16,p16 unknown
1591,1,1,Nodal Stage,N0
1592,1,1,Treatment Modality,Sx
1592,1,1,Overall Stage,I
1592,1,1,Second Failure Type,no known failure
1592,1,1,Nodal Stage,N0
1592,1,1,Research lab HPV,HPV unknown
1592,1,1,Status,Alive w/o disease
1592,1,1,Tumor Stage,T1
1592,1,1,Occurrence #,1st primary
1592,1,1,Metastasis,M0
1592,1,1,First Failure Type,no known failure
1592,1,1,Research lab p16,p16 unknown
1592,1,1,Clinical lab p16,p16 unknown
1592,1,1,Tumor Site,larynx
1593,1,1,Tumor Site,larynx
1593,1,1,First Failure Type,no known failure
1593,1,1,Research lab HPV,HPV unknown
1593,1,1,Occurrence #,1st primary
1593,1,1,Nodal Stage,N0
1593,1,1,Date of Death,2007-01-17 00:00:00
1593,1,1,Status,Dead unk disease
1593,1,1,Treatment Modality,Sx
1593,1,1,Metastasis,M0
1593,1,1,Second Failure Type,no known failure
1593,1,1,Age at Death,87.5
1593,1,1,Tumor Stage,T1
1593,1,1,Time to Death,1.7
1593,1,1,Overall Stage,I
1593,1,1,Clinical lab p16,p16 unknown
1593,1,1,Research lab p16,p16 unknown
1594,1,1,Tumor Stage,T3
1594,1,1,Initial Chemotherapy Agent,cis
1594,1,1,Status,Alive w/o disease
1594,1,1,Metastasis,M0
1594,1,1,First Failure Type,no known failure
1594,1,1,Overall Stage,III
1594,1,1,Clinical lab p16,p16 unknown
1594,1,1,Research lab p16,p16 unknown
1594,1,1,Treatment Modality,CTX-RT
1594,1,1,Radiation Dosage,70.2
1594,1,1,Second Failure Type,no known failure
1594,1,1,Nodal Stage,N0
1594,1,1,Research lab HPV,HPV unknown
1594,1,1,Occurrence #,1st primary
1594,1,1,Tumor Site,larynx
1595,1,1,First Failure Type,no known failure
1595,1,1,Status,Dead w/ disease
1595,1,1,Occurrence #,1st primary
1595,1,1,Tumor Site,larynx
1595,1,1,Second Failure Type,no known failure
1595,1,1,Radiation Dosage,43.2
1595,1,1,Clinical lab p16,p16 unknown
1595,1,1,Metastasis,M0
1595,1,1,Tumor Stage,T4a
1595,1,1,Nodal Stage,N0
1595,1,1,Research lab p16,p16 unknown
1595,1,1,Date of Death,2005-09-22 00:00:00
1595,1,1,Treatment Modality,RT
1595,1,1,Research lab HPV,HPV unknown
1595,1,1,Overall Stage,IVa
1595,1,1,Age at Death,49.1
1595,1,1,Time to Death,0.4
1596,1,1,Second Failure Type,no known failure
1596,1,1,Status,Dead w/ disease
1596,1,1,Research lab HPV,HPV unknown
1596,1,1,Tumor Site,larynx
1596,1,1,Occurrence #,1st primary
1596,1,1,Radiation Dosage,48.6
1596,1,1,Clinical lab p16,p16 unknown
1596,1,1,Age at Death,57.7
1596,1,1,Metastasis,M0
1596,1,1,Tumor Stage,T4a
1596,1,1,Overall Stage,IVa
1596,1,1,Time to Death,1.1
1596,1,1,Treatment Modality,Sx & CTX-RT
1596,1,1,Initial Chemotherapy Agent,carbo/PTX/amifostine
1596,1,1,Time to First Failure,0.5
1596,1,1,First Failure Type,distant
1596,1,1,Research lab p16,p16 unknown
1596,1,1,Date of Death,2006-05-02 00:00:00
1596,1,1,Nodal Stage,N2
1597,1,1,Time to Death,4.8
1597,1,1,Date of Death,2011-12-11 00:00:00
1597,1,1,Clinical lab p16,p16 unknown
1597,1,1,Research lab HPV,HPV unknown
1597,1,1,Treatment Modality,Sx
1597,1,1,First Failure Site,larynx
1597,1,1,Nodal Stage,N0
1597,1,1,Tumor Site,larynx
1597,1,1,Age at Death,72.0
1597,1,1,Overall Stage,I
1597,1,1,Second Failure Type,no known failure
1597,1,1,First Failure Type,locoregional
1597,1,1,Status,Dead w/ disease
1597,1,1,First Failure Treatment Modality,Sx & RT
1597,1,1,Research lab p16,p16 unknown
1597,1,1,Tumor Stage,T1
1597,1,1,First Failure Radiation Dosage,69.6
1597,1,1,Metastasis,M0
1597,1,1,Time to First Failure,1.3
1597,1,1,Occurrence #,1st primary
1598,1,1,Clinical lab p16,p16 unknown
1598,1,1,Research lab p16,p16 unknown
1598,1,1,Metastasis,M0
1598,1,1,Overall Stage,I
1598,1,1,Status,Alive unk disease
1598,1,1,Nodal Stage,N0
1598,1,1,Tumor Stage,T1
1598,1,1,Second Failure Type,no known failure
1598,1,1,Occurrence #,1st primary
1598,1,1,Research lab HPV,HPV unknown
1598,1,1,Treatment Modality,Sx
1598,1,1,Tumor Site,larynx
1598,1,1,First Failure Type,no known failure
1599,1,1,Research lab p16,p16 unknown
1599,1,1,First Failure Type,locoregional
1599,1,1,Overall Stage,III
1599,1,1,Second Failure Type,no known failure
1599,1,1,Clinical lab p16,p16 unknown
1599,1,1,Research lab HPV,HPV unknown
1599,1,1,Treatment Modality,RT
1599,1,1,Metastasis,M0
1599,1,1,Time to First Failure,0.4
1599,1,1,Radiation Dosage,unknown
1599,1,1,Status,Alive w/o disease
1599,1,1,First Failure Site,larynx
1599,1,1,Nodal Stage,N0
1599,1,1,First Failure Treatment Modality,Sx
1599,1,1,Tumor Stage,T3
1599,1,1,Tumor Site,larynx
1599,1,1,Occurrence #,1st primary
1600,1,1,Tumor Stage,T2
1600,1,1,Age at Death,70.7
1600,1,1,Metastasis,M0
1600,1,1,Date of Death,2011-02-09 00:00:00
1600,1,1,Nodal Stage,N0
1600,1,1,Treatment Modality,RT
1600,1,1,Time to Death,0.3
1600,1,1,Research lab HPV,HPV unknown
1600,1,1,Second Failure Type,no known failure
1600,1,1,Clinical lab p16,p16 unknown
1600,1,1,Tumor Site,larynx
1600,1,1,Status,Dead w/ disease
1600,1,1,Research lab p16,p16 unknown
1600,1,1,Overall Stage,II
1600,1,1,Radiation Dosage,41.4
1600,1,1,Occurrence #,1st primary
1600,1,1,First Failure Type,no known failure
1601,1,1,Tumor Stage,T2
1601,1,1,Metastasis,M0
1601,1,1,Nodal Stage,N2
1601,1,1,Treatment Modality,Sx
1601,1,1,Research lab p16,p16 unknown
1601,1,1,Research lab HPV,HPV unknown
1601,1,1,Second Failure Type,no known failure
1601,1,1,Clinical lab p16,p16 unknown
1601,1,1,Occurrence #,1st primary
1601,1,1,Tumor Site,larynx
1601,1,1,Status,Alive unk disease
1601,1,1,First Failure Type,no known failure
1601,1,1,Overall Stage,IVa
1602,1,1,Tumor Stage,T4a
1602,1,1,Age at Death,71.5
1602,1,1,Metastasis,M0
1602,1,1,Nodal Stage,N0
1602,1,1,Treatment Modality,Sx
1602,1,1,Overall Stage,IVa
1602,1,1,Occurrence #,1st primary
1602,1,1,Time to Death,1.6
1602,1,1,Research lab HPV,HPV unknown
1602,1,1,Second Failure Type,no known failure
1602,1,1,Clinical lab p16,p16 unknown
1602,1,1,Tumor Site,larynx
1602,1,1,Status,Dead unk disease
1602,1,1,First Failure Type,no known failure
1602,1,1,Research lab p16,p16 unknown
1602,1,1,Date of Death,2005-02-02 00:00:00
1603,1,1,Tumor Stage,T3
1603,1,1,Research lab p16,p16 unknown
1603,1,1,Overall Stage,IVa
1603,1,1,Initial Chemotherapy Agent,cis
1603,1,1,Clinical lab p16,p16 unknown
1603,1,1,Treatment Modality,CTX-RT
1603,1,1,Tumor Site,larynx
1603,1,1,Occurrence #,1st primary
1603,1,1,Second Line Chemotherapy Agent,carbo/doce
1603,1,1,Nodal Stage,N2
1603,1,1,Radiation Dosage,70.2
1603,1,1,Second Failure Type,no known failure
1603,1,1,Research lab HPV,HPV unknown
1603,1,1,Metastasis,M0
1603,1,1,Status,Alive w/o disease
1603,1,1,First Failure Type,no known failure
1604,1,1,Date of Death,2011-01-10 00:00:00
1604,1,1,Age at Death,45.9
1604,1,1,Overall Stage,III
1604,1,1,Treatment Modality,CTX-RT
1604,1,1,Status,Dead unk disease
1604,1,1,Nodal Stage,N1
1604,1,1,Research lab p16,p16 unknown
1604,1,1,Clinical lab p16,p16 unknown
1604,1,1,Tumor Site,larynx
1604,1,1,Metastasis,M0
1604,1,1,Tumor Stage,T2
1604,1,1,First Failure Type,no known failure
1604,1,1,Radiation Dosage,unknown
1604,1,1,Initial Chemotherapy Agent,unknown
1604,1,1,Time to Death,3.4
1604,1,1,Second Failure Type,no known failure
1604,1,1,Research lab HPV,HPV unknown
1604,1,1,Occurrence #,1st primary
1605,1,1,Research lab p16,p16 unknown
1605,1,1,Status,Alive unk disease
1605,1,1,Clinical lab p16,p16 unknown
1605,1,1,Research lab HPV,HPV unknown
1605,1,1,Second Failure Type,no known failure
1605,1,1,Tumor Site,larynx
1605,1,1,Overall Stage,III
1605,1,1,First Failure Type,no known failure
1605,1,1,Nodal Stage,N0
1605,1,1,Metastasis,M0
1605,1,1,Treatment Modality,Sx
1605,1,1,Occurrence #,recurrence
1605,1,1,Tumor Stage,T3
1606,1,1,Second Failure Type,no known failure
1606,1,1,Overall Stage,IVa
1606,1,1,Treatment Modality,CTX-RT
1606,1,1,Age at Death,58.4
1606,1,1,Tumor Site,larynx
1606,1,1,Metastasis,M0
1606,1,1,First Failure Type,no known failure
1606,1,1,Initial Chemotherapy Agent,unknown
1606,1,1,Time to Death,0.3
1606,1,1,Clinical lab p16,p16 unknown
1606,1,1,Occurrence #,1st primary
1606,1,1,Radiation Dosage,70.2
1606,1,1,Research lab HPV,HPV unknown
1606,1,1,Tumor Stage,T3
1606,1,1,Research lab p16,p16 unknown
1606,1,1,Status,Alive unk disease
1606,1,1,Nodal Stage,N2
1606,1,1,Date of Death,2005-06-24 00:00:00
1607,1,1,Occurrence #,1st primary
1607,1,1,Tumor Site,larynx
1607,1,1,Tumor Stage,T4a
1607,1,1,Metastasis,M0
1607,1,1,Research lab p16,p16 unknown
1607,1,1,Treatment Modality,Sx & RT
1607,1,1,First Failure Type,no known failure
1607,1,1,Status,Alive unk disease
1607,1,1,Research lab HPV,HPV unknown
1607,1,1,Overall Stage,IVa
1607,1,1,Second Failure Type,no known failure
1607,1,1,Radiation Dosage,63
1607,1,1,Nodal Stage,N2
1607,1,1,Clinical lab p16,p16 unknown
1608,1,1,Metastasis,M0
1608,1,1,Occurrence #,1st primary
1608,1,1,Tumor Stage,T1
1608,1,1,Research lab HPV,HPV unknown
1608,1,1,Overall Stage,I
1608,1,1,Radiation Dosage,63
1608,1,1,Clinical lab p16,p16 unknown
1608,1,1,First Failure Type,no known failure
1608,1,1,Nodal Stage,N0
1608,1,1,Treatment Modality,RT
1608,1,1,Second Failure Type,no known failure
1608,1,1,Status,Alive w/o disease
1608,1,1,Tumor Site,larynx
1608,1,1,Research lab p16,p16 unknown
1609,1,1,Status,Alive unk disease
1609,1,1,Tumor Site,larynx
1609,1,1,Treatment Modality,Sx
1609,1,1,First Failure Type,no known failure
1609,1,1,Research lab HPV,HPV unknown
1609,1,1,Clinical lab p16,p16 unknown
1609,1,1,Overall Stage,IVa
1609,1,1,Metastasis,M0
1609,1,1,Occurrence #,1st primary
1609,1,1,Second Failure Type,no known failure
1609,1,1,Tumor Stage,T4a
1609,1,1,Research lab p16,p16 unknown
1609,1,1,Nodal Stage,N0
1610,1,1,Time to Death,6.6
1610,1,1,Clinical lab p16,p16 unknown
1610,1,1,Research lab HPV,HPV unknown
1610,1,1,Status,Dead unk disease
1610,1,1,Radiation Dosage,unknown
1610,1,1,Metastasis,M0
1610,1,1,Tumor Site,larynx
1610,1,1,Occurrence #,1st primary
1610,1,1,Treatment Modality,RT
1610,1,1,Research lab p16,p16 unknown
1610,1,1,Tumor Stage,T3
1610,1,1,Second Failure Type,no known failure
1610,1,1,Nodal Stage,N0
1610,1,1,First Failure Type,no known failure
1610,1,1,Date of Death,2009-05-04 00:00:00
1610,1,1,Age at Death,82.9
1610,1,1,Overall Stage,III
1611,1,1,First Failure Type,no known failure
1611,1,1,Tumor Stage,T1
1611,1,1,Second Failure Type,no known failure
1611,1,1,Metastasis,M0
1611,1,1,Age at Death,94.8
1611,1,1,Radiation Dosage,63
1611,1,1,Nodal Stage,N0
1611,1,1,Status,Dead w/o disease
1611,1,1,Tumor Site,larynx
1611,1,1,Clinical lab p16,p16 unknown
1611,1,1,Treatment Modality,RT
1611,1,1,Overall Stage,I
1611,1,1,Research lab p16,p16 unknown
1611,1,1,Time to Death,7.9
1611,1,1,Occurrence #,1st primary
1611,1,1,Research lab HPV,HPV unknown
1611,1,1,Date of Death,2009-07-04 00:00:00
1612,1,1,Tumor Site,larynx
1612,1,1,Status,Alive w/o disease
1612,1,1,Clinical lab p16,p16 unknown
1612,1,1,Metastasis,M0
1612,1,1,Research lab p16,p16 unknown
1612,1,1,Treatment Modality,Sx
1612,1,1,Nodal Stage,N0
1612,1,1,Second Failure Type,no known failure
1612,1,1,Tumor Stage,T1
1612,1,1,Research lab HPV,HPV unknown
1612,1,1,Occurrence #,recurrence
1612,1,1,Overall Stage,I
1612,1,1,First Failure Type,no known failure
1613,1,1,Tumor Stage,T4a
1613,1,1,Nodal Stage,N1
1613,1,1,Overall Stage,IVa
1613,1,1,Age at Death,73.9
1613,1,1,Occurrence #,1st primary
1613,1,1,Metastasis,M0
1613,1,1,Tumor Site,larynx
1613,1,1,Second Failure Type,no known failure
1613,1,1,Research lab p16,p16 unknown
1613,1,1,Treatment Modality,Sx
1613,1,1,Research lab HPV,HPV unknown
1613,1,1,Status,Dead unk disease
1613,1,1,Time to Death,2.2
1613,1,1,First Failure Type,no known failure
1613,1,1,Clinical lab p16,p16 unknown
1613,1,1,Date of Death,2004-03-23 00:00:00
1614,1,1,Status,Dead w/ disease
1614,1,1,Second Failure Type,no known failure
1614,1,1,Overall Stage,IVa
1614,1,1,Clinical lab p16,p16 unknown
1614,1,1,Metastasis,M0
1614,1,1,Time to First Failure,1.7
1614,1,1,First Failure Type,locoregional
1614,1,1,Age at Death,50.8
1614,1,1,Time to Death,2.4
1614,1,1,Nodal Stage,N2
1614,1,1,Date of Death,2002-08-23 00:00:00
1614,1,1,Research lab p16,p16 unknown
1614,1,1,Radiation Dosage,52.4
1614,1,1,Tumor Stage,T2
1614,1,1,Treatment Modality,Sx & RT
1614,1,1,Tumor Site,larynx
1614,1,1,Research lab HPV,HPV unknown
1614,1,1,Occurrence #,1st primary
1615,1,1,Nodal Stage,N0
1615,1,1,First Failure Type,no known failure
1615,1,1,Tumor Site,larynx
1615,1,1,Tumor Stage,T3
1615,1,1,Status,Alive unk disease
1615,1,1,Metastasis,M0
1615,1,1,Research lab HPV,HPV unknown
1615,1,1,Second Failure Type,no known failure
1615,1,1,Overall Stage,III
1615,1,1,Occurrence #,1st primary
1615,1,1,Clinical lab p16,p16 unknown
1615,1,1,Research lab p16,p16 unknown
1615,1,1,Treatment Modality,Unknown
1616,1,1,Date of Death,2002-05-05 00:00:00
1616,1,1,Clinical lab p16,p16 unknown
1616,1,1,Treatment Modality,Unknown
1616,1,1,Metastasis,M0
1616,1,1,Age at Death,63.2
1616,1,1,Second Failure Type,no known failure
1616,1,1,Research lab HPV,HPV unknown
1616,1,1,Status,Dead unk disease
1616,1,1,First Failure Type,no known failure
1616,1,1,Nodal Stage,N0
1616,1,1,Research lab p16,p16 unknown
1616,1,1,Occurrence #,1st primary
1616,1,1,Overall Stage,III
1616,1,1,Time to Death,0.5
1616,1,1,Tumor Stage,T3
1616,1,1,Tumor Site,larynx
1617,1,1,Research lab p16,p16 unknown
1617,1,1,Research lab HPV,HPV unknown
1617,1,1,Overall Stage,IVa
1617,1,1,Occurrence #,recurrence
1617,1,1,Metastasis,M0
1617,1,1,Date of Death,2009-10-10 00:00:00
1617,1,1,Age at Death,56.8
1617,1,1,Second Failure Type,no known failure
1617,1,1,Treatment Modality,Sx
1617,1,1,Time to Death,0.8
1617,1,1,First Failure Type,no known failure
1617,1,1,Tumor Stage,T4a
1617,1,1,Tumor Site,larynx
1617,1,1,Clinical lab p16,p16 unknown
1617,1,1,Status,Dead unk disease
1617,1,1,Nodal Stage,N0
1618,1,1,Second Failure Type,no known failure
1618,1,1,Clinical lab p16,p16 unknown
1618,1,1,Date of Death,2004-05-28 00:00:00
1618,1,1,Research lab p16,p16 unknown
1618,1,1,Occurrence #,1st primary
1618,1,1,Metastasis,M0
1618,1,1,Time to Death,0.2
1618,1,1,Nodal Stage,N0
1618,1,1,First Failure Type,no known failure
1618,1,1,Age at Death,84.5
1618,1,1,Treatment Modality,Unknown
1618,1,1,Tumor Site,larynx
1618,1,1,Tumor Stage,T4a
1618,1,1,Status,Dead w/ disease
1618,1,1,Overall Stage,IVa
1618,1,1,Research lab HPV,HPV unknown
1619,1,1,Treatment Modality,Sx & RT
1619,1,1,Occurrence #,1st primary
1619,1,1,Time to Death,2.5
1619,1,1,Nodal Stage,N2
1619,1,1,Time to First Failure,1.3
1619,1,1,Age at Death,68.6
1619,1,1,Metastasis,M0
1619,1,1,Research lab p16,p16 unknown
1619,1,1,Second Failure Type,no known failure
1619,1,1,Date of Death,2003-11-20 00:00:00
1619,1,1,Research lab HPV,HPV unknown
1619,1,1,Tumor Stage,T4a
1619,1,1,Tumor Site,larynx
1619,1,1,Clinical lab p16,p16 unknown
1619,1,1,Overall Stage,IVa
1619,1,1,Status,Dead w/ disease
1619,1,1,First Failure Type,distant
1619,1,1,Radiation Dosage,unknown
1620,1,1,First Failure Type,no known failure
1620,1,1,Radiation Dosage,66
1620,1,1,Second Failure Type,no known failure
1620,1,1,Clinical lab p16,p16 unknown
1620,1,1,Time to Death,4.5
1620,1,1,Metastasis,M0
1620,1,1,Treatment Modality,RT
1620,1,1,Date of Death,2006-05-17 00:00:00
1620,1,1,Research lab HPV,HPV unknown
1620,1,1,Tumor Stage,T1
1620,1,1,Age at Death,87.2
1620,1,1,Research lab p16,p16 unknown
1620,1,1,Occurrence #,1st primary
1620,1,1,Tumor Site,larynx
1620,1,1,Nodal Stage,N0
1620,1,1,Status,Dead w/o disease
1620,1,1,Overall Stage,I
1621,1,1,Nodal Stage,N0
1621,1,1,Metastasis,M0
1621,1,1,Occurrence #,1st primary
1621,1,1,Overall Stage,III
1621,1,1,Research lab HPV,HPV unknown
1621,1,1,Time to Death,3.3
1621,1,1,Clinical lab p16,p16 unknown
1621,1,1,Treatment Modality,RT
1621,1,1,Tumor Site,larynx
1621,1,1,Status,Dead unk disease
1621,1,1,Research lab p16,p16 unknown
1621,1,1,Second Failure Type,no known failure
1621,1,1,Tumor Stage,T3
1621,1,1,Radiation Dosage,70.2
1621,1,1,First Failure Type,no known failure
1621,1,1,Age at Death,65.3
1621,1,1,Date of Death,2005-11-17 00:00:00
1622,1,1,Status,Dead w/o disease
1622,1,1,Overall Stage,IVa
1622,1,1,Treatment Modality,Sx & RT
1622,1,1,Research lab p16,p16 unknown
1622,1,1,Occurrence #,1st primary
1622,1,1,Nodal Stage,N0
1622,1,1,Tumor Stage,T4a
1622,1,1,First Failure Type,no known failure
1622,1,1,Clinical lab p16,p16 unknown
1622,1,1,Time to Death,8.3
1622,1,1,Date of Death,2011-01-27 00:00:00
1622,1,1,Metastasis,M0
1622,1,1,Radiation Dosage,59.4
1622,1,1,Research lab HPV,HPV unknown
1622,1,1,Age at Death,69.0
1622,1,1,Second Failure Type,no known failure
1622,1,1,Tumor Site,larynx
1623,1,1,Tumor Site,larynx
1623,1,1,Metastasis,M0
1623,1,1,First Failure Type,locoregional
1623,1,1,Status,Dead w/ disease
1623,1,1,Research lab HPV,HPV unknown
1623,1,1,Radiation Dosage,unknown
1623,1,1,Tumor Stage,T4a
1623,1,1,Research lab p16,p16 unknown
1623,1,1,Time to First Failure,0.6
1623,1,1,Treatment Modality,Sx & RT
1623,1,1,Second Failure Type,no known failure
1623,1,1,Date of Death,2001-08-08 00:00:00
1623,1,1,Clinical lab p16,p16 unknown
1623,1,1,Age at Death,48.9
1623,1,1,Occurrence #,1st primary
1623,1,1,Nodal Stage,N1
1623,1,1,Time to Death,1.1
1623,1,1,Overall Stage,IVa
1624,1,1,Research lab p16,p16 unknown
1624,1,1,Nodal Stage,N0
1624,1,1,Treatment Modality,Sx
1624,1,1,Tumor Site,larynx
1624,1,1,Research lab HPV,HPV unknown
1624,1,1,Tumor Stage,T2
1624,1,1,Metastasis,M0
1624,1,1,Second Failure Type,no known failure
1624,1,1,Occurrence #,1st primary
1624,1,1,Clinical lab p16,p16 unknown
1624,1,1,First Failure Type,no known failure
1624,1,1,Status,Alive w/o disease
1624,1,1,Overall Stage,II
1625,1,1,Second Failure Type,no known failure
1625,1,1,Occurrence #,recurrence
1625,1,1,Overall Stage,I
1625,1,1,First Failure Type,no known failure
1625,1,1,Clinical lab p16,p16 unknown
1625,1,1,Nodal Stage,N0
1625,1,1,Metastasis,M0
1625,1,1,Research lab HPV,HPV unknown
1625,1,1,Treatment Modality,Sx
1625,1,1,Tumor Stage,T1
1625,1,1,Tumor Site,larynx
1625,1,1,Status,Alive w/o disease
1625,1,1,Research lab p16,p16 unknown
1626,1,1,Research lab HPV,HPV unknown
1626,1,1,Radiation Dosage,70.2
1626,1,1,Time to Death,1.2
1626,1,1,Tumor Stage,T4a
1626,1,1,Time to First Failure,0.4
1626,1,1,Research lab p16,p16 unknown
1626,1,1,Overall Stage,IVa
1626,1,1,Status,Dead unk disease
1626,1,1,Metastasis,M0
1626,1,1,First Failure Type,locoregional
1626,1,1,Age at Death,63.4
1626,1,1,Treatment Modality,CTX-RT
1626,1,1,Initial Chemotherapy Agent,carbo/PTX
1626,1,1,Second Failure Type,no known failure
1626,1,1,Occurrence #,1st primary
1626,1,1,Clinical lab p16,p16 unknown
1626,1,1,Nodal Stage,N1
1626,1,1,Tumor Site,larynx
1626,1,1,Date of Death,2005-01-16 00:00:00
1627,1,1,Treatment Modality,Sx & CTX-RT
1627,1,1,Radiation Dosage,59.4
1627,1,1,Tumor Site,larynx
1627,1,1,Initial Chemotherapy Agent,cis
1627,1,1,Tumor Stage,T4a
1627,1,1,Research lab p16,p16 unknown
1627,1,1,Second Failure Type,no known failure
1627,1,1,Nodal Stage,N2
1627,1,1,First Failure Type,no known failure
1627,1,1,Occurrence #,1st primary
1627,1,1,Metastasis,M0
1627,1,1,Clinical lab p16,p16 unknown
1627,1,1,Overall Stage,IVa
1627,1,1,Research lab HPV,HPV unknown
1627,1,1,Status,Alive w/o disease
1628,1,1,First Failure Treatment Modality,Sx
1628,1,1,Time to First Failure,5.5
1628,1,1,Research lab HPV,HPV unknown
1628,1,1,Treatment Modality,RT
1628,1,1,Tumor Stage,T1
1628,1,1,Metastasis,M0
1628,1,1,Status,Alive w/o disease
1628,1,1,Occurrence #,1st primary
1628,1,1,Clinical lab p16,p16 unknown
1628,1,1,Second Failure Type,no known failure
1628,1,1,First Failure Site,larynx
1628,1,1,Overall Stage,I
1628,1,1,Nodal Stage,N0
1628,1,1,Radiation Dosage,63
1628,1,1,Research lab p16,p16 unknown
1628,1,1,Tumor Site,larynx
1628,1,1,First Failure Type,locoregional
1629,1,1,Tumor Stage,T2
1629,1,1,Overall Stage,II
1629,1,1,Treatment Modality,RT
1629,1,1,Metastasis,M0
1629,1,1,Occurrence #,1st primary
1629,1,1,Status,Alive w/o disease
1629,1,1,Nodal Stage,N0
1629,1,1,First Failure Type,no known failure
1629,1,1,Research lab p16,p16 unknown
1629,1,1,Radiation Dosage,74.4
1629,1,1,Clinical lab p16,p16 unknown
1629,1,1,Research lab HPV,HPV unknown
1629,1,1,Second Failure Type,no known failure
1629,1,1,Tumor Site,larynx
1630,1,1,Radiation Dosage,59.4
1630,1,1,First Failure Type,no known failure
1630,1,1,Tumor Stage,T3
1630,1,1,Nodal Stage,N0
1630,1,1,Second Failure Type,no known failure
1630,1,1,Date of Death,2000-12-01 00:00:00
1630,1,1,Time to Death,0.3
1630,1,1,Metastasis,M0
1630,1,1,Research lab p16,p16 unknown
1630,1,1,Status,Dead unk disease
1630,1,1,Research lab HPV,HPV unknown
1630,1,1,Overall Stage,III
1630,1,1,Tumor Site,larynx
1630,1,1,Occurrence #,1st primary
1630,1,1,Treatment Modality,Sx & RT
1630,1,1,Clinical lab p16,p16 unknown
1631,1,1,Age at Death,58.3
1631,1,1,Time to First Failure,1.4
1631,1,1,Date of Death,2005-09-18 00:00:00
1631,1,1,First Failure Type,locoregional
1631,1,1,Research lab HPV,HPV unknown
1631,1,1,Overall Stage,IVa
1631,1,1,Research lab p16,p16 unknown
1631,1,1,Tumor Site,larynx
1631,1,1,Time to Death,1.6
1631,1,1,Treatment Modality,Sx
1631,1,1,Nodal Stage,N0
1631,1,1,Status,Dead w/ disease
1631,1,1,Second Failure Type,no known failure
1631,1,1,Tumor Stage,T4a
1631,1,1,Metastasis,M0
1631,1,1,Clinical lab p16,p16 unknown
1631,1,1,Occurrence #,recurrence
1632,1,1,Status,Alive unk disease
1632,1,1,Overall Stage,III
1632,1,1,Clinical lab p16,p16 unknown
1632,1,1,Nodal Stage,N0
1632,1,1,Tumor Stage,T3
1632,1,1,First Failure Type,no known failure
1632,1,1,Research lab HPV,HPV unknown
1632,1,1,Research lab p16,p16 unknown
1632,1,1,Tumor Site,larynx
1632,1,1,Radiation Dosage,66.6
1632,1,1,Occurrence #,1st primary
1632,1,1,Metastasis,M0
1632,1,1,Second Failure Type,no known failure
1632,1,1,Treatment Modality,Sx & RT
1633,1,1,Date of Death,2010-01-26 00:00:00
1633,1,1,Treatment Modality,Unknown
1633,1,1,Metastasis,Unknown
1633,1,1,Time to Death,1.1
1633,1,1,Tumor Stage,Unknown
1633,1,1,Research lab p16,p16 unknown
1633,1,1,Nodal Stage,Unknown
1633,1,1,Second Failure Type,no known failure
1633,1,1,Clinical lab p16,p16 unknown
1633,1,1,Status,Dead unk disease
1633,1,1,Research lab HPV,HPV unknown
1633,1,1,First Failure Type,no known failure
1633,1,1,Age at Death,65.2
1633,1,1,Occurrence #,1st primary
1633,1,1,Tumor Site,larynx
1633,1,1,Overall Stage,Unknown
1634,1,1,Radiation Dosage,70.2
1634,1,1,Second Failure Type,no known failure
1634,1,1,Tumor Site,larynx
1634,1,1,Occurrence #,1st primary
1634,1,1,Research lab p16,p16 unknown
1634,1,1,Overall Stage,III
1634,1,1,Nodal Stage,N0
1634,1,1,Treatment Modality,CTX-RT
1634,1,1,Tumor Stage,T3
1634,1,1,Research lab HPV,HPV unknown
1634,1,1,First Failure Type,no known failure
1634,1,1,Initial Chemotherapy Agent,cis
1634,1,1,Status,Alive w/o disease
1634,1,1,Clinical lab p16,p16 unknown
1634,1,1,Metastasis,M0
1635,1,1,First Failure Radiation Dosage,unknown
1635,1,1,Second Failure Type,no known failure
1635,1,1,Status,Dead w/ disease
1635,1,1,Metastasis,M0
1635,1,1,Research lab HPV,HPV unknown
1635,1,1,First Failure Treatment Modality,Sx & RT
1635,1,1,Date of Death,2004-03-08 00:00:00
1635,1,1,Overall Stage,III
1635,1,1,Tumor Stage,T3
1635,1,1,Nodal Stage,N0
1635,1,1,Time to First Failure,1.0
1635,1,1,Age at Death,75.9
1635,1,1,Occurrence #,1st primary
1635,1,1,Research lab p16,p16 unknown
1635,1,1,First Failure Site,larynx
1635,1,1,Treatment Modality,Sx & RT
1635,1,1,Clinical lab p16,p16 unknown
1635,1,1,Radiation Dosage,70.2
1635,1,1,Tumor Site,larynx
1635,1,1,First Failure Type,locoregional
1635,1,1,Time to Death,3.3
1636,1,1,Date of Death,2003-05-01 00:00:00
1636,1,1,Clinical lab p16,p16 unknown
1636,1,1,Tumor Stage,T4a
1636,1,1,Research lab p16,p16 unknown
1636,1,1,Status,Dead w/ disease
1636,1,1,Treatment Modality,Sx & RT
1636,1,1,Age at Death,56.1
1636,1,1,First Failure Type,locoregional
1636,1,1,Time to First Failure,0.9
1636,1,1,First Failure Treatment Modality,CTX
1636,1,1,Second Failure Type,no known failure
1636,1,1,Radiation Dosage,70.2
1636,1,1,First Failure Initial Chemotherapy Agent,gemcitabine/doce/cap
1636,1,1,Research lab HPV,HPV unknown
1636,1,1,Occurrence #,1st primary
1636,1,1,First Failure Site,larynx
1636,1,1,Metastasis,M0
1636,1,1,Overall Stage,IVa
1636,1,1,Nodal Stage,N0
1636,1,1,Time to Death,1.8
1636,1,1,Tumor Site,larynx
1637,1,1,Tumor Site,larynx
1637,1,1,Overall Stage,III
1637,1,1,Date of Death,2008-03-16 00:00:00
1637,1,1,Treatment Modality,CTX
1637,1,1,Nodal Stage,N1
1637,1,1,Research lab p16,p16 unknown
1637,1,1,Occurrence #,1st primary
1637,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1637,1,1,Age at Death,61.3
1637,1,1,Research lab HPV,HPV unknown
1637,1,1,Metastasis,M0
1637,1,1,Clinical lab p16,p16 unknown
1637,1,1,Second Failure Type,no known failure
1637,1,1,Time to Death,0.2
1637,1,1,Tumor Stage,T3
1637,1,1,Status,Dead unk disease
1637,1,1,First Failure Type,no known failure
1638,1,1,Second Failure Type,no known failure
1638,1,1,Age at Death,82.4
1638,1,1,Tumor Site,larynx
1638,1,1,Date of Death,2010-06-11 00:00:00
1638,1,1,Time to First Failure,1.7
1638,1,1,Overall Stage,II
1638,1,1,Radiation Dosage,70
1638,1,1,Metastasis,M0
1638,1,1,Status,Dead w/ disease
1638,1,1,First Failure Type,distant
1638,1,1,Occurrence #,1st primary
1638,1,1,Research lab HPV,HPV unknown
1638,1,1,Research lab p16,p16 unknown
1638,1,1,Nodal Stage,N0
1638,1,1,Clinical lab p16,p16 unknown
1638,1,1,Time to Death,2.3
1638,1,1,Tumor Stage,T2
1638,1,1,Treatment Modality,RT
1639,1,1,Research lab HPV,HPV unknown
1639,1,1,Date of Death,2005-09-21 00:00:00
1639,1,1,Clinical lab p16,p16 unknown
1639,1,1,Status,Dead w/ disease
1639,1,1,Treatment Modality,CTX-RT
1639,1,1,Tumor Stage,T4b
1639,1,1,Occurrence #,recurrence
1639,1,1,Time to Death,2.9
1639,1,1,Tumor Site,larynx
1639,1,1,Nodal Stage,N0
1639,1,1,First Failure Type,no known failure
1639,1,1,Age at Death,62.5
1639,1,1,Initial Chemotherapy Agent,carbo/PTX
1639,1,1,Metastasis,M0
1639,1,1,Second Failure Type,no known failure
1639,1,1,Overall Stage,IVb
1639,1,1,Radiation Dosage,60
1639,1,1,Research lab p16,p16 unknown
1640,1,1,Radiation Dosage,63
1640,1,1,Treatment Modality,RT
1640,1,1,Second Failure Type,no known failure
1640,1,1,Status,Alive w/o disease
1640,1,1,Tumor Site,larynx
1640,1,1,Overall Stage,I
1640,1,1,Nodal Stage,N0
1640,1,1,Tumor Stage,T1
1640,1,1,Research lab HPV,HPV unknown
1640,1,1,Clinical lab p16,p16 unknown
1640,1,1,Research lab p16,p16 unknown
1640,1,1,Occurrence #,1st primary
1640,1,1,First Failure Type,no known failure
1640,1,1,Metastasis,M0
1641,1,1,Metastasis,M1
1641,1,1,Initial Chemotherapy Agent,carbo/PTX
1641,1,1,Research lab p16,p16 unknown
1641,1,1,Overall Stage,IVc
1641,1,1,Tumor Stage,T4a
1641,1,1,Nodal Stage,N2
1641,1,1,Time to Death,0.3
1641,1,1,Research lab HPV,HPV unknown
1641,1,1,Tumor Site,larynx
1641,1,1,Clinical lab p16,p16 unknown
1641,1,1,Status,Dead unk disease
1641,1,1,Treatment Modality,Sx & CTX-RT
1641,1,1,Occurrence #,1st primary
1641,1,1,Radiation Dosage,33
1641,1,1,Second Failure Type,no known failure
1641,1,1,Date of Death,2001-08-26 00:00:00
1641,1,1,First Failure Type,no known failure
1641,1,1,Age at Death,44.1
1642,1,1,Clinical lab p16,p16 unknown
1642,1,1,First Failure Type,no known failure
1642,1,1,Tumor Stage,T1
1642,1,1,Radiation Dosage,66
1642,1,1,Overall Stage,I
1642,1,1,Tumor Site,larynx
1642,1,1,Second Failure Type,no known failure
1642,1,1,Status,Alive w/o disease
1642,1,1,Metastasis,M0
1642,1,1,Research lab p16,p16 unknown
1642,1,1,Treatment Modality,RT
1642,1,1,Research lab HPV,HPV unknown
1642,1,1,Occurrence #,1st primary
1642,1,1,Nodal Stage,N0
1643,1,1,Metastasis,M0
1643,1,1,Treatment Modality,Sx
1643,1,1,Second Failure Type,no known failure
1643,1,1,Overall Stage,IVa
1643,1,1,Date of Death,2004-11-01 00:00:00
1643,1,1,Time to Death,4.6
1643,1,1,Tumor Stage,T4a
1643,1,1,Nodal Stage,N0
1643,1,1,Tumor Site,larynx
1643,1,1,Clinical lab p16,p16 unknown
1643,1,1,Research lab HPV,HPV unknown
1643,1,1,Occurrence #,1st primary
1643,1,1,First Failure Type,no known failure
1643,1,1,Research lab p16,p16 unknown
1643,1,1,Status,Dead w/o disease
1643,1,1,Age at Death,59.3
1644,1,1,Status,Dead w/ disease
1644,1,1,Age at Death,62.1
1644,1,1,Time to First Failure,0.4
1644,1,1,Treatment Modality,Sx
1644,1,1,Time to Death,0.6
1644,1,1,Tumor Site,larynx
1644,1,1,Occurrence #,1st primary
1644,1,1,Second Failure Type,no known failure
1644,1,1,Tumor Stage,T4a
1644,1,1,Research lab p16,p16 unknown
1644,1,1,First Failure Type,distant
1644,1,1,Clinical lab p16,p16 unknown
1644,1,1,Research lab HPV,HPV unknown
1644,1,1,Date of Death,2002-02-01 00:00:00
1644,1,1,Nodal Stage,N2
1644,1,1,Overall Stage,IVc
1644,1,1,Metastasis,M1
1645,1,1,Tumor Stage,T1
1645,1,1,Radiation Dosage,66
1645,1,1,Status,Dead unk disease
1645,1,1,Occurrence #,1st primary
1645,1,1,Clinical lab p16,p16 unknown
1645,1,1,Nodal Stage,N0
1645,1,1,Overall Stage,I
1645,1,1,Research lab HPV,HPV unknown
1645,1,1,Time to Death,0.6
1645,1,1,Tumor Site,larynx
1645,1,1,First Failure Type,no known failure
1645,1,1,Second Failure Type,no known failure
1645,1,1,Metastasis,M0
1645,1,1,Date of Death,2003-04-26 00:00:00
1645,1,1,Research lab p16,p16 unknown
1645,1,1,Treatment Modality,RT
1645,1,1,Age at Death,83.4
1646,1,1,Tumor Site,larynx
1646,1,1,Occurrence #,recurrence
1646,1,1,Research lab HPV,HPV unknown
1646,1,1,Second Failure Type,no known failure
1646,1,1,Tumor Stage,T3
1646,1,1,Clinical lab p16,p16 unknown
1646,1,1,Nodal Stage,N0
1646,1,1,Overall Stage,III
1646,1,1,First Failure Type,no known failure
1646,1,1,Metastasis,M0
1646,1,1,Status,Alive w/o disease
1646,1,1,Research lab p16,p16 unknown
1646,1,1,Treatment Modality,Sx
1647,1,1,First Failure Radiation Dosage,9
1647,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
1647,1,1,Overall Stage,IVa
1647,1,1,Radiation Dosage,63
1647,1,1,First Failure Site,larynx
1647,1,1,Clinical lab p16,p16 unknown
1647,1,1,Age at Death,70.5
1647,1,1,Research lab HPV,HPV unknown
1647,1,1,First Failure Treatment Modality,CTX-RT
1647,1,1,Metastasis,M0
1647,1,1,Tumor Stage,T4a
1647,1,1,Nodal Stage,N1
1647,1,1,First Failure Type,locoregional and distant
1647,1,1,Second Failure Type,no known failure
1647,1,1,Status,Dead w/ disease
1647,1,1,Date of Death,2006-01-30 00:00:00
1647,1,1,Tumor Site,larynx
1647,1,1,Research lab p16,p16 unknown
1647,1,1,Time to Death,2.5
1647,1,1,Treatment Modality,Sx & RT
1647,1,1,Time to First Failure,1.9
1647,1,1,Occurrence #,1st primary
1648,1,1,First Failure Type,no known failure
1648,1,1,Occurrence #,1st primary
1648,1,1,Nodal Stage,N2
1648,1,1,Research lab p16,p16 unknown
1648,1,1,Metastasis,M0
1648,1,1,Overall Stage,IVa
1648,1,1,Research lab HPV,HPV positive
1648,1,1,Status,Dead unk disease
1648,1,1,Treatment Modality,Unknown
1648,1,1,Tumor Site,larynx
1648,1,1,Second Failure Type,no known failure
1648,1,1,Time to Death,5.7
1648,1,1,Date of Death,2011-03-16 00:00:00
1648,1,1,Clinical lab p16,p16 positive
1648,1,1,Age at Death,63.0
1648,1,1,Tumor Stage,T2
1649,1,1,Research lab p16,p16 unknown
1649,1,1,First Failure Type,no known failure
1649,1,1,Status,Dead unk disease
1649,1,1,Research lab HPV,HPV unknown
1649,1,1,Treatment Modality,Sx & CTX
1649,1,1,Nodal Stage,N2
1649,1,1,Occurrence #,1st primary
1649,1,1,Second Failure Type,no known failure
1649,1,1,Overall Stage,IVa
1649,1,1,Metastasis,M0
1649,1,1,Time to Death,0.8
1649,1,1,Tumor Stage,T4a
1649,1,1,Date of Death,2001-04-13 00:00:00
1649,1,1,Clinical lab p16,p16 unknown
1649,1,1,Initial Chemotherapy Agent,cis/PTX
1649,1,1,Tumor Site,larynx
1649,1,1,Age at Death,47.5
1650,1,1,Treatment Modality,CTX-RT
1650,1,1,Initial Chemotherapy Agent,carbo/PTX
1650,1,1,First Failure Type,locoregional
1650,1,1,Occurrence #,1st primary
1650,1,1,Research lab HPV,HPV unknown
1650,1,1,Research lab p16,p16 unknown
1650,1,1,Clinical lab p16,p16 unknown
1650,1,1,Radiation Dosage,72
1650,1,1,Overall Stage,IVa
1650,1,1,Age at Death,50.3
1650,1,1,Tumor Site,larynx
1650,1,1,Time to First Failure,0.2
1650,1,1,Nodal Stage,N0
1650,1,1,Status,Dead unk disease
1650,1,1,Tumor Stage,T4a
1650,1,1,Date of Death,2002-12-16 00:00:00
1650,1,1,Second Failure Type,no known failure
1650,1,1,Metastasis,M0
1650,1,1,First Failure Site,larynx
1650,1,1,Time to Death,1.4
1650,1,1,First Failure Treatment Modality,Sx
1651,1,1,Second Failure Type,no known failure
1651,1,1,Research lab HPV,HPV unknown
1651,1,1,Tumor Site,larynx
1651,1,1,Radiation Dosage,70.2
1651,1,1,Treatment Modality,CTX-RT
1651,1,1,Status,Dead w/o disease
1651,1,1,Occurrence #,1st primary
1651,1,1,First Failure Type,no known failure
1651,1,1,Metastasis,M0
1651,1,1,Clinical lab p16,p16 unknown
1651,1,1,Overall Stage,III
1651,1,1,Initial Chemotherapy Agent,cis
1651,1,1,Research lab p16,p16 unknown
1651,1,1,Nodal Stage,N1
1651,1,1,Tumor Stage,T2
1652,1,1,Date of Death,2009-09-11 00:00:00
1652,1,1,Second Failure Type,no known failure
1652,1,1,Initial Chemotherapy Agent,unknown
1652,1,1,Time to Death,2.2
1652,1,1,Occurrence #,recurrence
1652,1,1,Metastasis,M1
1652,1,1,First Failure Type,no known failure
1652,1,1,Treatment Modality,CTX-RT
1652,1,1,Nodal Stage,Unknown
1652,1,1,Overall Stage,IVc
1652,1,1,Research lab p16,p16 unknown
1652,1,1,Age at Death,62.6
1652,1,1,Tumor Stage,Unknown
1652,1,1,Radiation Dosage,18
1652,1,1,Tumor Site,larynx
1652,1,1,Status,Dead w/ disease
1652,1,1,Research lab HPV,HPV unknown
1652,1,1,Clinical lab p16,p16 unknown
1653,1,1,Treatment Modality,Sx
1653,1,1,Tumor Stage,T2
1653,1,1,Clinical lab p16,p16 unknown
1653,1,1,Tumor Site,larynx
1653,1,1,Overall Stage,II
1653,1,1,Research lab HPV,HPV unknown
1653,1,1,Second Failure Type,no known failure
1653,1,1,Occurrence #,1st primary
1653,1,1,Status,Alive w/o disease
1653,1,1,Research lab p16,p16 unknown
1653,1,1,Metastasis,M0
1653,1,1,Nodal Stage,N0
1653,1,1,First Failure Type,no known failure
1654,1,1,Nodal Stage,N0
1654,1,1,Clinical lab p16,p16 unknown
1654,1,1,Occurrence #,1st primary
1654,1,1,Overall Stage,I
1654,1,1,Tumor Stage,T1
1654,1,1,Second Failure Type,no known failure
1654,1,1,Metastasis,M0
1654,1,1,Radiation Dosage,63
1654,1,1,Research lab HPV,HPV unknown
1654,1,1,Treatment Modality,RT
1654,1,1,Research lab p16,p16 unknown
1654,1,1,Status,Alive unk disease
1654,1,1,First Failure Type,no known failure
1654,1,1,Tumor Site,larynx
1655,1,1,Age at Death,58.1
1655,1,1,First Failure Type,no known failure
1655,1,1,Clinical lab p16,p16 unknown
1655,1,1,Tumor Site,larynx
1655,1,1,Metastasis,M0
1655,1,1,Occurrence #,recurrence
1655,1,1,Tumor Stage,T2
1655,1,1,Research lab HPV,HPV unknown
1655,1,1,Treatment Modality,Sx
1655,1,1,Date of Death,2008-02-09 00:00:00
1655,1,1,Time to Death,7.5
1655,1,1,Research lab p16,p16 unknown
1655,1,1,Nodal Stage,N0
1655,1,1,Second Failure Type,no known failure
1655,1,1,Overall Stage,II
1655,1,1,Status,Dead unk disease
1656,1,1,Research lab p16,p16 unknown
1656,1,1,Tumor Site,larynx
1656,1,1,Clinical lab p16,p16 unknown
1656,1,1,Treatment Modality,Sx
1656,1,1,Tumor Stage,T1
1656,1,1,Metastasis,M0
1656,1,1,Research lab HPV,HPV unknown
1656,1,1,First Failure Type,no known failure
1656,1,1,Second Failure Type,no known failure
1656,1,1,Occurrence #,1st primary
1656,1,1,Overall Stage,I
1656,1,1,Status,Alive unk disease
1656,1,1,Nodal Stage,N0
1657,1,1,Nodal Stage,N0
1657,1,1,Research lab p16,p16 unknown
1657,1,1,Treatment Modality,Sx
1657,1,1,Tumor Site,larynx
1657,1,1,Occurrence #,recurrence
1657,1,1,Tumor Stage,T1
1657,1,1,Clinical lab p16,p16 unknown
1657,1,1,Second Failure Type,no known failure
1657,1,1,First Failure Type,no known failure
1657,1,1,Status,Alive w/o disease
1657,1,1,Research lab HPV,HPV unknown
1657,1,1,Overall Stage,I
1657,1,1,Metastasis,M0
1658,1,1,Second Failure Type,no known failure
1658,1,1,Tumor Site,larynx
1658,1,1,Nodal Stage,N0
1658,1,1,Occurrence #,recurrence
1658,1,1,Overall Stage,III
1658,1,1,First Failure Type,no known failure
1658,1,1,Tumor Stage,T3
1658,1,1,Status,Alive unk disease
1658,1,1,Research lab HPV,HPV unknown
1658,1,1,Metastasis,M0
1658,1,1,Clinical lab p16,p16 unknown
1658,1,1,Research lab p16,p16 unknown
1658,1,1,Treatment Modality,Sx
1659,1,1,Research lab p16,p16 unknown
1659,1,1,Occurrence #,1st primary
1659,1,1,Treatment Modality,Sx & RT
1659,1,1,Clinical lab p16,p16 unknown
1659,1,1,Research lab HPV,HPV unknown
1659,1,1,Date of Death,2008-08-08 00:00:00
1659,1,1,Tumor Site,larynx
1659,1,1,First Failure Type,no known failure
1659,1,1,Overall Stage,I
1659,1,1,Status,Dead unk disease
1659,1,1,Tumor Stage,T1
1659,1,1,Metastasis,M0
1659,1,1,Age at Death,49.8
1659,1,1,Nodal Stage,N0
1659,1,1,Time to Death,5.8
1659,1,1,Radiation Dosage,unknown
1659,1,1,Second Failure Type,no known failure
1660,1,1,Research lab HPV,HPV unknown
1660,1,1,Radiation Dosage,66
1660,1,1,Clinical lab p16,p16 unknown
1660,1,1,Status,Alive unk disease
1660,1,1,Treatment Modality,RT
1660,1,1,Metastasis,M0
1660,1,1,First Failure Type,no known failure
1660,1,1,Tumor Site,larynx
1660,1,1,Nodal Stage,N0
1660,1,1,Overall Stage,I
1660,1,1,Occurrence #,1st primary
1660,1,1,Tumor Stage,T1
1660,1,1,Research lab p16,p16 unknown
1660,1,1,Second Failure Type,no known failure
1661,1,1,First Failure Type,no known failure
1661,1,1,Overall Stage,IVa
1661,1,1,Age at Death,51.3
1661,1,1,Date of Death,2002-09-10 00:00:00
1661,1,1,Occurrence #,recurrence
1661,1,1,Nodal Stage,N1
1661,1,1,Clinical lab p16,p16 unknown
1661,1,1,Tumor Stage,T4a
1661,1,1,Tumor Site,larynx
1661,1,1,Research lab p16,p16 unknown
1661,1,1,Time to Death,0.0
1661,1,1,Treatment Modality,Sx
1661,1,1,Status,Dead unk disease
1661,1,1,Metastasis,M0
1661,1,1,Research lab HPV,HPV unknown
1661,1,1,Second Failure Type,no known failure
1662,1,1,Overall Stage,IVa
1662,1,1,Date of Death,2004-08-24 00:00:00
1662,1,1,Tumor Site,larynx
1662,1,1,Time to Death,2.0
1662,1,1,Second Failure Type,no known failure
1662,1,1,Research lab p16,p16 unknown
1662,1,1,Occurrence #,1st primary
1662,1,1,Nodal Stage,N0
1662,1,1,Treatment Modality,RT
1662,1,1,Radiation Dosage,72
1662,1,1,Clinical lab p16,p16 unknown
1662,1,1,First Failure Type,locoregional and distant
1662,1,1,Research lab HPV,HPV unknown
1662,1,1,Tumor Stage,T4a
1662,1,1,Age at Death,75.1
1662,1,1,Metastasis,M0
1662,1,1,Status,Dead w/ disease
1662,1,1,Time to First Failure,1.7
1663,1,1,Age at Death,80.1
1663,1,1,Nodal Stage,N2
1663,1,1,Second Failure Type,no known failure
1663,1,1,Occurrence #,1st primary
1663,1,1,Tumor Site,larynx
1663,1,1,Tumor Stage,T3
1663,1,1,Clinical lab p16,p16 unknown
1663,1,1,Metastasis,M0
1663,1,1,Time to Death,0.2
1663,1,1,Overall Stage,IVa
1663,1,1,Initial Chemotherapy Agent,unknown
1663,1,1,Treatment Modality,CTX-RT
1663,1,1,Research lab HPV,HPV unknown
1663,1,1,Status,Dead unk disease
1663,1,1,Radiation Dosage,34
1663,1,1,Date of Death,2008-03-05 00:00:00
1663,1,1,First Failure Type,no known failure
1663,1,1,Research lab p16,p16 unknown
1664,1,1,Date of Death,2005-11-24 00:00:00
1664,1,1,Time to Death,1.6
1664,1,1,Nodal Stage,N0
1664,1,1,Tumor Stage,T1
1664,1,1,Research lab HPV,HPV unknown
1664,1,1,Tumor Site,larynx
1664,1,1,Metastasis,M0
1664,1,1,Status,Alive unk disease
1664,1,1,Overall Stage,I
1664,1,1,Radiation Dosage,63
1664,1,1,Occurrence #,1st primary
1664,1,1,Second Failure Type,no known failure
1664,1,1,Research lab p16,p16 unknown
1664,1,1,Treatment Modality,RT
1664,1,1,Clinical lab p16,p16 unknown
1664,1,1,First Failure Type,no known failure
1664,1,1,Age at Death,67.7
1665,1,1,Initial Chemotherapy Agent,cis
1665,1,1,Second Failure Type,no known failure
1665,1,1,Research lab p16,p16 unknown
1665,1,1,Tumor Stage,T3
1665,1,1,Metastasis,M0
1665,1,1,Status,Alive w/o disease
1665,1,1,First Failure Type,no known failure
1665,1,1,Clinical lab p16,p16 unknown
1665,1,1,Radiation Dosage,70.2
1665,1,1,Nodal Stage,N1
1665,1,1,Overall Stage,III
1665,1,1,Tumor Site,larynx
1665,1,1,Research lab HPV,HPV unknown
1665,1,1,Occurrence #,1st primary
1665,1,1,Treatment Modality,CTX-RT
1666,1,1,Research lab HPV,HPV unknown
1666,1,1,Age at Death,64.3
1666,1,1,Occurrence #,1st primary
1666,1,1,Nodal Stage,N2
1666,1,1,First Failure Type,locoregional
1666,1,1,Time to Death,1.4
1666,1,1,Metastasis,M0
1666,1,1,Date of Death,2004-09-21 00:00:00
1666,1,1,Time to First Failure,1.0
1666,1,1,Treatment Modality,Sx
1666,1,1,Second Failure Type,no known failure
1666,1,1,Status,Dead w/ disease
1666,1,1,Overall Stage,IVa
1666,1,1,Tumor Stage,T4a
1666,1,1,Tumor Site,larynx
1666,1,1,Clinical lab p16,p16 unknown
1666,1,1,Research lab p16,p16 unknown
1667,1,1,Tumor Stage,T2
1667,1,1,Metastasis,M0
1667,1,1,Treatment Modality,RT
1667,1,1,Status,Alive w/o disease
1667,1,1,Clinical lab p16,p16 unknown
1667,1,1,First Failure Type,no known failure
1667,1,1,Overall Stage,II
1667,1,1,Occurrence #,1st primary
1667,1,1,Nodal Stage,N0
1667,1,1,Tumor Site,larynx
1667,1,1,Second Failure Type,no known failure
1667,1,1,Research lab p16,p16 unknown
1667,1,1,Radiation Dosage,74.4
1667,1,1,Research lab HPV,HPV unknown
1668,1,1,Treatment Modality,Sx
1668,1,1,Time to First Failure,0.8
1668,1,1,Status,Dead w/ disease
1668,1,1,Occurrence #,recurrence
1668,1,1,First Failure Site,larynx
1668,1,1,Clinical lab p16,p16 unknown
1668,1,1,Second Failure Type,no known failure
1668,1,1,Date of Death,2007-12-09 00:00:00
1668,1,1,First Failure Type,locoregional
1668,1,1,Research lab p16,p16 unknown
1668,1,1,Age at Death,63.7
1668,1,1,Overall Stage,IVa
1668,1,1,First Failure Initial Chemotherapy Agent,cetux
1668,1,1,Tumor Stage,T4a
1668,1,1,First Failure Treatment Modality,CTX
1668,1,1,Metastasis,M0
1668,1,1,Time to Death,2.5
1668,1,1,Nodal Stage,N0
1668,1,1,Tumor Site,larynx
1668,1,1,Research lab HPV,HPV unknown
1669,1,1,Overall Stage,IVa
1669,1,1,Status,Dead w/ disease
1669,1,1,Occurrence #,1st primary
1669,1,1,Radiation Dosage,63
1669,1,1,Tumor Stage,T3
1669,1,1,Nodal Stage,N2
1669,1,1,First Failure Treatment Modality,RT
1669,1,1,Age at Death,56.0
1669,1,1,First Failure Radiation Dosage,19
1669,1,1,Clinical lab p16,p16 unknown
1669,1,1,Metastasis,M0
1669,1,1,Second Failure Type,no known failure
1669,1,1,First Failure Site,larynx
1669,1,1,Time to First Failure,1.0
1669,1,1,Date of Death,2005-05-01 00:00:00
1669,1,1,Time to Death,1.5
1669,1,1,Treatment Modality,Sx & RT
1669,1,1,Tumor Site,larynx
1669,1,1,Research lab p16,p16 unknown
1669,1,1,Research lab HPV,HPV unknown
1669,1,1,First Failure Type,distant
1670,1,1,Occurrence #,1st primary
1670,1,1,Radiation Dosage,63
1670,1,1,Research lab HPV,HPV unknown
1670,1,1,Nodal Stage,N0
1670,1,1,Metastasis,M0
1670,1,1,Second Failure Type,no known failure
1670,1,1,Clinical lab p16,p16 unknown
1670,1,1,Treatment Modality,RT
1670,1,1,Status,Alive w/o disease
1670,1,1,Research lab p16,p16 unknown
1670,1,1,First Failure Type,no known failure
1670,1,1,Tumor Stage,T1
1670,1,1,Tumor Site,larynx
1670,1,1,Overall Stage,I
1671,1,1,Research lab p16,p16 unknown
1671,1,1,Research lab HPV,HPV unknown
1671,1,1,Date of Death,2008-09-27 00:00:00
1671,1,1,Tumor Site,larynx
1671,1,1,Occurrence #,1st primary
1671,1,1,Second Failure Type,no known failure
1671,1,1,Treatment Modality,CTX
1671,1,1,Nodal Stage,N2
1671,1,1,Time to Death,1.9
1671,1,1,Clinical lab p16,p16 unknown
1671,1,1,Status,Dead w/ disease
1671,1,1,First Failure Type,locoregional
1671,1,1,Tumor Stage,T3
1671,1,1,Overall Stage,IVc
1671,1,1,Metastasis,M1
1671,1,1,Time to First Failure,0.8
1671,1,1,Initial Chemotherapy Agent,cis/PTX
1671,1,1,Age at Death,68.0
1672,1,1,Metastasis,M0
1672,1,1,Clinical lab p16,p16 unknown
1672,1,1,Tumor Stage,T3
1672,1,1,Tumor Site,larynx
1672,1,1,Treatment Modality,Sx
1672,1,1,Second Failure Type,no known failure
1672,1,1,Occurrence #,1st primary
1672,1,1,Nodal Stage,N0
1672,1,1,Research lab p16,p16 unknown
1672,1,1,First Failure Type,no known failure
1672,1,1,Overall Stage,III
1672,1,1,Research lab HPV,HPV unknown
1672,1,1,Status,Alive unk disease
1673,1,1,Clinical lab p16,p16 unknown
1673,1,1,Status,Dead w/ disease
1673,1,1,Tumor Site,larynx
1673,1,1,Overall Stage,IVc
1673,1,1,Time to Death,0.6
1673,1,1,First Failure Type,no known failure
1673,1,1,Second Failure Type,no known failure
1673,1,1,Occurrence #,1st primary
1673,1,1,Metastasis,M1
1673,1,1,Research lab p16,p16 unknown
1673,1,1,Research lab HPV,HPV unknown
1673,1,1,Age at Death,58.9
1673,1,1,Treatment Modality,Unknown
1673,1,1,Date of Death,2009-05-16 00:00:00
1673,1,1,Tumor Stage,T3
1673,1,1,Nodal Stage,N0
1674,1,1,Status,Dead unk disease
1674,1,1,Research lab HPV,HPV unknown
1674,1,1,Date of Death,2006-06-01 00:00:00
1674,1,1,Research lab p16,p16 unknown
1674,1,1,Treatment Modality,Unknown
1674,1,1,Tumor Site,larynx
1674,1,1,Second Failure Type,no known failure
1674,1,1,Occurrence #,1st primary
1674,1,1,Time to Death,0.3
1674,1,1,Clinical lab p16,p16 unknown
1674,1,1,First Failure Type,no known failure
1674,1,1,Overall Stage,IVa
1674,1,1,Nodal Stage,N2
1674,1,1,Tumor Stage,T4a
1674,1,1,Metastasis,M0
1674,1,1,Age at Death,59.1
1675,1,1,Occurrence #,1st primary
1675,1,1,Clinical lab p16,p16 unknown
1675,1,1,Tumor Site,larynx
1675,1,1,Metastasis,M0
1675,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1675,1,1,Radiation Dosage,59.4
1675,1,1,Age at Death,53.3
1675,1,1,Second Line Chemotherapy Agent,carbo/cetux
1675,1,1,Research lab p16,p16 unknown
1675,1,1,Second Failure Type,no known failure
1675,1,1,Treatment Modality,CTX-RT
1675,1,1,Research lab HPV,HPV unknown
1675,1,1,Time to Death,0.4
1675,1,1,Date of Death,2009-08-27 00:00:00
1675,1,1,Status,Dead w/ disease
1675,1,1,Nodal Stage,N3
1675,1,1,Tumor Stage,T1
1675,1,1,First Failure Type,distant
1675,1,1,Time to First Failure,0.0
1675,1,1,Overall Stage,IVb
1676,1,1,Occurrence #,1st primary
1676,1,1,Tumor Stage,T2
1676,1,1,Age at Death,77.3
1676,1,1,Nodal Stage,N0
1676,1,1,Date of Death,2008-03-13 00:00:00
1676,1,1,Second Failure Type,no known failure
1676,1,1,Metastasis,M0
1676,1,1,Treatment Modality,Unknown
1676,1,1,Research lab p16,p16 unknown
1676,1,1,Time to Death,2.8
1676,1,1,Tumor Site,larynx
1676,1,1,Clinical lab p16,p16 unknown
1676,1,1,First Failure Type,no known failure
1676,1,1,Research lab HPV,HPV unknown
1676,1,1,Overall Stage,II
1676,1,1,Status,Dead unk disease
1677,1,1,Status,Dead unk disease
1677,1,1,Date of Death,2011-08-18 00:00:00
1677,1,1,Radiation Dosage,70
1677,1,1,Initial Chemotherapy Agent,carbo/PTX
1677,1,1,Research lab p16,p16 unknown
1677,1,1,Research lab HPV,HPV unknown
1677,1,1,Tumor Stage,T3
1677,1,1,Time to Death,7.0
1677,1,1,Clinical lab p16,p16 unknown
1677,1,1,Occurrence #,1st primary
1677,1,1,Age at Death,62.8
1677,1,1,Tumor Site,larynx
1677,1,1,Treatment Modality,CTX-RT
1677,1,1,Overall Stage,III
1677,1,1,Metastasis,M0
1677,1,1,Nodal Stage,N0
1677,1,1,First Failure Type,no known failure
1677,1,1,Second Failure Type,no known failure
1678,1,1,Treatment Modality,RT
1678,1,1,First Failure Type,no known failure
1678,1,1,Tumor Site,larynx
1678,1,1,Research lab HPV,HPV unknown
1678,1,1,Overall Stage,II
1678,1,1,Clinical lab p16,p16 unknown
1678,1,1,Nodal Stage,N0
1678,1,1,Occurrence #,1st primary
1678,1,1,Tumor Stage,T2
1678,1,1,Status,Alive w/o disease
1678,1,1,Radiation Dosage,74.4
1678,1,1,Metastasis,M0
1678,1,1,Research lab p16,p16 unknown
1678,1,1,Second Failure Type,no known failure
1679,1,1,Status,Dead w/ disease
1679,1,1,Nodal Stage,N0
1679,1,1,Time to Death,0.3
1679,1,1,Tumor Stage,T4a
1679,1,1,First Failure Type,no known failure
1679,1,1,Age at Death,55.5
1679,1,1,Clinical lab p16,p16 unknown
1679,1,1,Research lab HPV,HPV unknown
1679,1,1,Overall Stage,IVa
1679,1,1,Metastasis,M0
1679,1,1,Second Failure Type,no known failure
1679,1,1,Date of Death,2011-03-27 00:00:00
1679,1,1,Occurrence #,recurrence
1679,1,1,Treatment Modality,Sx
1679,1,1,Tumor Site,larynx
1679,1,1,Research lab p16,p16 unknown
1680,1,1,Occurrence #,1st primary
1680,1,1,Tumor Stage,T1
1680,1,1,Second Failure Type,no known failure
1680,1,1,Research lab HPV,HPV unknown
1680,1,1,Metastasis,M0
1680,1,1,Clinical lab p16,p16 unknown
1680,1,1,Status,Alive w/o disease
1680,1,1,Overall Stage,I
1680,1,1,First Failure Type,no known failure
1680,1,1,Tumor Site,larynx
1680,1,1,Treatment Modality,Sx
1680,1,1,Nodal Stage,N0
1680,1,1,Research lab p16,p16 unknown
1681,1,1,Tumor Stage,T3
1681,1,1,Time to First Failure,0.7
1681,1,1,Time to Death,2.8
1681,1,1,Clinical lab p16,p16 unknown
1681,1,1,First Failure Site,larynx
1681,1,1,Date of Death,2003-11-27 00:00:00
1681,1,1,Research lab p16,p16 unknown
1681,1,1,Age at Death,54.9
1681,1,1,First Failure Initial Chemotherapy Agent,unknown
1681,1,1,Radiation Dosage,unknown
1681,1,1,Research lab HPV,HPV unknown
1681,1,1,First Failure Type,locoregional
1681,1,1,Metastasis,M0
1681,1,1,Second Failure Type,no known failure
1681,1,1,Tumor Site,larynx
1681,1,1,Nodal Stage,N1
1681,1,1,Occurrence #,1st primary
1681,1,1,First Failure Treatment Modality,Sx & CTX
1681,1,1,Treatment Modality,Sx & RT
1681,1,1,Overall Stage,III
1681,1,1,Status,Dead unk disease
1682,1,1,Nodal Stage,N0
1682,1,1,First Failure Type,no known failure
1682,1,1,Clinical lab p16,p16 unknown
1682,1,1,Time to Death,2.0
1682,1,1,Overall Stage,IVa
1682,1,1,Occurrence #,1st primary
1682,1,1,Tumor Site,larynx
1682,1,1,Research lab HPV,HPV unknown
1682,1,1,Research lab p16,p16 unknown
1682,1,1,Treatment Modality,Sx
1682,1,1,Status,Dead unk disease
1682,1,1,Second Failure Type,no known failure
1682,1,1,Metastasis,M0
1682,1,1,Tumor Stage,T4a
1682,1,1,Age at Death,62.5
1682,1,1,Date of Death,2008-05-23 00:00:00
1683,1,1,Research lab HPV,HPV unknown
1683,1,1,Status,Dead w/o disease
1683,1,1,Occurrence #,1st primary
1683,1,1,Radiation Dosage,63
1683,1,1,Research lab p16,p16 unknown
1683,1,1,Tumor Stage,T1
1683,1,1,Metastasis,M0
1683,1,1,Nodal Stage,N0
1683,1,1,Treatment Modality,RT
1683,1,1,Age at Death,70.6
1683,1,1,Clinical lab p16,p16 unknown
1683,1,1,Time to Death,1.2
1683,1,1,First Failure Type,no known failure
1683,1,1,Overall Stage,I
1683,1,1,Tumor Site,larynx
1683,1,1,Date of Death,2008-01-28 00:00:00
1683,1,1,Second Failure Type,no known failure
1684,1,1,Date of Death,2011-03-31 00:00:00
1684,1,1,Treatment Modality,CTX-RT
1684,1,1,Research lab p16,p16 unknown
1684,1,1,Radiation Dosage,70.2
1684,1,1,Status,Dead w/ disease
1684,1,1,Second Failure Type,no known failure
1684,1,1,Metastasis,M0
1684,1,1,Initial Chemotherapy Agent,cis
1684,1,1,Age at Death,57.3
1684,1,1,Occurrence #,1st primary
1684,1,1,Nodal Stage,N2
1684,1,1,Clinical lab p16,p16 unknown
1684,1,1,Time to Death,2.6
1684,1,1,Time to First Failure,2.1
1684,1,1,Overall Stage,IVa
1684,1,1,Research lab HPV,HPV unknown
1684,1,1,First Failure Type,distant
1684,1,1,Tumor Site,larynx
1684,1,1,Tumor Stage,T3
1685,1,1,Research lab HPV,HPV unknown
1685,1,1,Tumor Stage,T1
1685,1,1,Status,Alive w/o disease
1685,1,1,Second Failure Type,no known failure
1685,1,1,Nodal Stage,N0
1685,1,1,Research lab p16,p16 unknown
1685,1,1,Tumor Site,larynx
1685,1,1,Clinical lab p16,p16 unknown
1685,1,1,Overall Stage,I
1685,1,1,First Failure Type,no known failure
1685,1,1,Treatment Modality,RT
1685,1,1,Radiation Dosage,63
1685,1,1,Occurrence #,1st primary
1685,1,1,Metastasis,M0
1686,1,1,Tumor Stage,T2
1686,1,1,Time to Death,2.5
1686,1,1,Radiation Dosage,50
1686,1,1,Second Failure Type,no known failure
1686,1,1,Metastasis,M1
1686,1,1,Nodal Stage,N2
1686,1,1,Research lab p16,p16 unknown
1686,1,1,Age at Death,68.3
1686,1,1,Tumor Site,larynx
1686,1,1,Initial Chemotherapy Agent,cis/5-FU
1686,1,1,Clinical lab p16,p16 unknown
1686,1,1,Date of Death,2008-08-24 00:00:00
1686,1,1,First Failure Type,no known failure
1686,1,1,Occurrence #,1st primary
1686,1,1,Status,Dead unk disease
1686,1,1,Research lab HPV,HPV unknown
1686,1,1,Treatment Modality,Sx & CTX-RT
1686,1,1,Overall Stage,IVc
1687,1,1,Research lab p16,p16 unknown
1687,1,1,Time to First Failure,1.9
1687,1,1,Time to Death,3.1
1687,1,1,First Failure Type,locoregional and distant
1687,1,1,Initial Chemotherapy Agent,cis
1687,1,1,Metastasis,M0
1687,1,1,Tumor Site,larynx
1687,1,1,First Failure Site,larynx
1687,1,1,First Failure Treatment Modality,CTX-RT
1687,1,1,Overall Stage,IVa
1687,1,1,Clinical lab p16,p16 unknown
1687,1,1,Second Failure Type,no known failure
1687,1,1,Treatment Modality,Sx & CTX-RT
1687,1,1,Date of Death,2007-08-15 00:00:00
1687,1,1,Nodal Stage,N2
1687,1,1,Radiation Dosage,63
1687,1,1,First Failure Radiation Dosage,37.5
1687,1,1,Occurrence #,1st primary
1687,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
1687,1,1,Age at Death,53.3
1687,1,1,Tumor Stage,T4a
1687,1,1,Status,Dead w/ disease
1687,1,1,Research lab HPV,HPV unknown
1688,1,1,Research lab p16,p16 unknown
1688,1,1,Status,Dead w/ disease
1688,1,1,First Failure Type,locoregional
1688,1,1,Occurrence #,1st primary
1688,1,1,Second Failure Type,no known failure
1688,1,1,Date of Death,2007-02-27 00:00:00
1688,1,1,Overall Stage,II
1688,1,1,Tumor Site,larynx
1688,1,1,Nodal Stage,N0
1688,1,1,Clinical lab p16,p16 unknown
1688,1,1,Research lab HPV,HPV unknown
1688,1,1,Treatment Modality,Sx
1688,1,1,Tumor Stage,T2
1688,1,1,Age at Death,68.6
1688,1,1,Time to First Failure,0.2
1688,1,1,Time to Death,2.1
1688,1,1,Metastasis,M0
1689,1,1,Clinical lab p16,p16 unknown
1689,1,1,First Failure Treatment Modality,Sx & CTX-RT
1689,1,1,Status,Alive w/o disease
1689,1,1,Nodal Stage,N2
1689,1,1,Overall Stage,IVa
1689,1,1,First Failure Radiation Dosage,67.2
1689,1,1,Research lab p16,p16 unknown
1689,1,1,Metastasis,M0
1689,1,1,Tumor Stage,T3
1689,1,1,Radiation Dosage,70.2
1689,1,1,Second Failure Type,no known failure
1689,1,1,First Failure Initial Chemotherapy Agent,cis
1689,1,1,First Failure Type,no known failure
1689,1,1,First Failure Site,oral cavity
1689,1,1,Treatment Modality,CTX-RT
1689,1,1,Occurrence #,1st primary
1689,1,1,Research lab HPV,HPV unknown
1689,1,1,Initial Chemotherapy Agent,cis
1689,1,1,Tumor Site,larynx
1690,1,1,First Failure Type,no known failure
1690,1,1,Occurrence #,1st primary
1690,1,1,Date of Death,2008-08-13 00:00:00
1690,1,1,Overall Stage,I
1690,1,1,Time to Death,2.4
1690,1,1,Treatment Modality,RT
1690,1,1,Research lab HPV,HPV unknown
1690,1,1,Status,Dead unk disease
1690,1,1,Second Failure Type,no known failure
1690,1,1,Tumor Site,larynx
1690,1,1,Radiation Dosage,63
1690,1,1,Metastasis,M0
1690,1,1,Tumor Stage,T1
1690,1,1,Nodal Stage,N0
1690,1,1,Age at Death,79.7
1690,1,1,Clinical lab p16,p16 unknown
1690,1,1,Research lab p16,p16 unknown
1691,1,1,Age at Death,80.9
1691,1,1,Treatment Modality,Sx
1691,1,1,Status,Dead w/ disease
1691,1,1,Date of Death,2005-03-05 00:00:00
1691,1,1,Nodal Stage,N0
1691,1,1,Clinical lab p16,p16 unknown
1691,1,1,Metastasis,M0
1691,1,1,Time to Death,0.9
1691,1,1,First Failure Treatment Modality,Sx
1691,1,1,Overall Stage,III
1691,1,1,First Failure Site,larynx
1691,1,1,Research lab HPV,HPV unknown
1691,1,1,Occurrence #,recurrence
1691,1,1,Tumor Site,larynx
1691,1,1,Time to First Failure,0.4
1691,1,1,Research lab p16,p16 unknown
1691,1,1,First Failure Type,locoregional
1691,1,1,Second Failure Type,no known failure
1691,1,1,Tumor Stage,T3
1692,1,1,Tumor Site,larynx
1692,1,1,Clinical lab p16,p16 unknown
1692,1,1,Radiation Dosage,63
1692,1,1,Status,Dead unk disease
1692,1,1,Second Failure Type,no known failure
1692,1,1,Metastasis,M0
1692,1,1,Time to First Failure,0.3
1692,1,1,Nodal Stage,N0
1692,1,1,Occurrence #,1st primary
1692,1,1,Research lab p16,p16 unknown
1692,1,1,Research lab HPV,HPV unknown
1692,1,1,Date of Death,2006-03-08 00:00:00
1692,1,1,Age at Death,84.8
1692,1,1,Tumor Stage,T1
1692,1,1,Treatment Modality,RT
1692,1,1,Overall Stage,I
1692,1,1,Time to Death,1.6
1692,1,1,First Failure Type,locoregional
1693,1,1,First Failure Type,no known failure
1693,1,1,Tumor Site,larynx
1693,1,1,Research lab p16,p16 unknown
1693,1,1,Tumor Stage,T2
1693,1,1,Treatment Modality,CTX-RT
1693,1,1,Nodal Stage,N2
1693,1,1,Second Failure Type,no known failure
1693,1,1,Radiation Dosage,unknown
1693,1,1,Initial Chemotherapy Agent,unknown
1693,1,1,Metastasis,M0
1693,1,1,Status,Alive w/o disease
1693,1,1,Occurrence #,1st primary
1693,1,1,Overall Stage,IVa
1693,1,1,Clinical lab p16,p16 unknown
1693,1,1,Research lab HPV,HPV unknown
1694,1,1,Research lab HPV,HPV unknown
1694,1,1,Status,Alive w/o disease
1694,1,1,Second Failure Type,no known failure
1694,1,1,Tumor Stage,T2
1694,1,1,Tumor Site,larynx
1694,1,1,Metastasis,M0
1694,1,1,Initial Chemotherapy Agent,cis/doce/ 5 FU
1694,1,1,Occurrence #,1st primary
1694,1,1,Second Line Chemotherapy Agent,carbo
1694,1,1,Treatment Modality,CTX-RT
1694,1,1,Nodal Stage,N2
1694,1,1,Radiation Dosage,70.2
1694,1,1,Research lab p16,p16 unknown
1694,1,1,First Failure Type,no known failure
1694,1,1,Clinical lab p16,p16 unknown
1694,1,1,Overall Stage,IVa
1695,1,1,Research lab HPV,HPV unknown
1695,1,1,Overall Stage,I
1695,1,1,Tumor Stage,T1
1695,1,1,Treatment Modality,RT
1695,1,1,First Failure Type,no known failure
1695,1,1,Radiation Dosage,63
1695,1,1,Research lab p16,p16 unknown
1695,1,1,Second Failure Type,no known failure
1695,1,1,Tumor Site,larynx
1695,1,1,Nodal Stage,N0
1695,1,1,Metastasis,M0
1695,1,1,Occurrence #,1st primary
1695,1,1,Status,Alive w/o disease
1695,1,1,Clinical lab p16,p16 unknown
1696,1,1,First Failure Type,no known failure
1696,1,1,Metastasis,M0
1696,1,1,Occurrence #,1st primary
1696,1,1,Date of Death,2001-11-03 00:00:00
1696,1,1,Status,Dead unk disease
1696,1,1,Time to Death,1.7
1696,1,1,Nodal Stage,N2
1696,1,1,Research lab p16,p16 unknown
1696,1,1,Second Failure Type,no known failure
1696,1,1,Clinical lab p16,p16 unknown
1696,1,1,Tumor Site,larynx
1696,1,1,Age at Death,67.4
1696,1,1,Research lab HPV,HPV unknown
1696,1,1,Treatment Modality,Sx
1696,1,1,Overall Stage,IVa
1696,1,1,Tumor Stage,T4a
1697,1,1,Overall Stage,IVa
1697,1,1,Treatment Modality,Sx & RT
1697,1,1,Metastasis,M0
1697,1,1,Occurrence #,1st primary
1697,1,1,Clinical lab p16,p16 unknown
1697,1,1,Tumor Site,larynx
1697,1,1,Nodal Stage,N2
1697,1,1,Research lab HPV,HPV unknown
1697,1,1,Tumor Stage,T4a
1697,1,1,Status,Alive w/o disease
1697,1,1,Second Failure Type,no known failure
1697,1,1,First Failure Type,no known failure
1697,1,1,Radiation Dosage,63
1697,1,1,Research lab p16,p16 unknown
1698,1,1,Nodal Stage,N0
1698,1,1,Research lab HPV,HPV unknown
1698,1,1,Occurrence #,1st primary
1698,1,1,First Failure Type,no known failure
1698,1,1,Overall Stage,I
1698,1,1,Second Failure Type,no known failure
1698,1,1,Tumor Site,larynx
1698,1,1,Age at Death,70.3
1698,1,1,Metastasis,M0
1698,1,1,Clinical lab p16,p16 unknown
1698,1,1,Status,Dead unk disease
1698,1,1,Radiation Dosage,63
1698,1,1,Treatment Modality,RT
1698,1,1,Date of Death,2008-01-29 00:00:00
1698,1,1,Tumor Stage,T1
1698,1,1,Research lab p16,p16 unknown
1698,1,1,Time to Death,3.5
1699,1,1,First Failure Site,hypopharynx
1699,1,1,Research lab HPV,HPV unknown
1699,1,1,Time to First Failure,0.0
1699,1,1,Overall Stage,IVa
1699,1,1,Tumor Site,hypopharynx
1699,1,1,Status,Dead w/ disease
1699,1,1,Tumor Stage,T2
1699,1,1,Treatment Modality,Sx & CTX-RT
1699,1,1,First Failure Type,distant
1699,1,1,Clinical lab p16,p16 unknown
1699,1,1,Initial Chemotherapy Agent,cis
1699,1,1,Nodal Stage,N2
1699,1,1,Radiation Dosage,70.2
1699,1,1,Research lab p16,p16 unknown
1699,1,1,First Failure Treatment Modality,Sx
1699,1,1,Second Failure Type,no known failure
1699,1,1,Occurrence #,1st primary
1699,1,1,Metastasis,M0
1700,1,1,Tumor Site,hypopharynx
1700,1,1,Second Failure Type,no known failure
1700,1,1,Overall Stage,IVa
1700,1,1,Occurrence #,1st primary
1700,1,1,Status,Dead w/ disease
1700,1,1,Tumor Stage,T4a
1700,1,1,Treatment Modality,RT
1700,1,1,Research lab HPV,HPV unknown
1700,1,1,First Failure Type,no known failure
1700,1,1,Clinical lab p16,p16 unknown
1700,1,1,Age at Death,54.6
1700,1,1,Time to Death,0.4
1700,1,1,Nodal Stage,Unknown
1700,1,1,Date of Death,2006-07-23 00:00:00
1700,1,1,Radiation Dosage,30
1700,1,1,Metastasis,Unknown
1700,1,1,Research lab p16,p16 unknown
1701,1,1,Status,Dead w/ disease
1701,1,1,Overall Stage,IVa
1701,1,1,Age at Death,51.9
1701,1,1,Tumor Stage,T3
1701,1,1,Nodal Stage,N2
1701,1,1,Time to Death,0.7
1701,1,1,Date of Death,2006-02-11 00:00:00
1701,1,1,Research lab p16,p16 unknown
1701,1,1,Occurrence #,recurrence
1701,1,1,Treatment Modality,Sx
1701,1,1,Metastasis,M0
1701,1,1,Research lab HPV,HPV unknown
1701,1,1,Tumor Site,hypopharynx
1701,1,1,First Failure Type,no known failure
1701,1,1,Second Failure Type,no known failure
1701,1,1,Clinical lab p16,p16 unknown
1702,1,1,Occurrence #,1st primary
1702,1,1,Clinical lab p16,p16 unknown
1702,1,1,Status,Dead w/ disease
1702,1,1,Research lab HPV,HPV unknown
1702,1,1,Metastasis,M0
1702,1,1,First Failure Type,no known failure
1702,1,1,Treatment Modality,Sx
1702,1,1,Tumor Stage,T3
1702,1,1,Nodal Stage,N2
1702,1,1,Second Failure Type,no known failure
1702,1,1,Tumor Site,hypopharynx
1702,1,1,Overall Stage,IVa
1702,1,1,Research lab p16,p16 unknown
1703,1,1,Tumor Site,hypopharynx
1703,1,1,Metastasis,M0
1703,1,1,Research lab HPV,HPV unknown
1703,1,1,Initial Chemotherapy Agent,cis/doce
1703,1,1,Clinical lab p16,p16 unknown
1703,1,1,Second Failure Type,no known failure
1703,1,1,Radiation Dosage,70.2
1703,1,1,First Failure Type,no known failure
1703,1,1,Occurrence #,1st primary
1703,1,1,Research lab p16,p16 unknown
1703,1,1,Treatment Modality,CTX-RT
1703,1,1,Tumor Stage,T3
1703,1,1,Nodal Stage,N0
1703,1,1,Overall Stage,III
1703,1,1,Status,Alive unk disease
1704,1,1,Clinical lab p16,p16 unknown
1704,1,1,Time to Death,1.3
1704,1,1,Age at Death,63.9
1704,1,1,Metastasis,M0
1704,1,1,Date of Death,2009-01-05 00:00:00
1704,1,1,Research lab p16,p16 unknown
1704,1,1,Nodal Stage,N2
1704,1,1,Second Failure Type,no known failure
1704,1,1,Treatment Modality,Sx
1704,1,1,Occurrence #,recurrence
1704,1,1,First Failure Treatment Modality,CTX
1704,1,1,Tumor Stage,T4a
1704,1,1,Overall Stage,IVa
1704,1,1,Research lab HPV,HPV unknown
1704,1,1,First Failure Initial Chemotherapy Agent,MAGE-3 vaccine
1704,1,1,First Failure Second Line Chemotherapy Agent,cis/doce
1704,1,1,Status,Dead w/ disease
1704,1,1,Time to First Failure,0.7
1704,1,1,First Failure Site,hypopharynx
1704,1,1,Tumor Site,hypopharynx
1704,1,1,First Failure Type,locoregional
1705,1,1,Occurrence #,1st primary
1705,1,1,Radiation Dosage,70.2
1705,1,1,Tumor Site,hypopharynx
1705,1,1,Overall Stage,IVa
1705,1,1,Research lab p16,p16 unknown
1705,1,1,Nodal Stage,N2
1705,1,1,Initial Chemotherapy Agent,carbo/PTX
1705,1,1,Metastasis,M0
1705,1,1,Status,Alive w/o disease
1705,1,1,Second Failure Type,no known failure
1705,1,1,First Failure Type,no known failure
1705,1,1,Tumor Stage,T3
1705,1,1,Research lab HPV,HPV unknown
1705,1,1,Treatment Modality,CTX-RT
1705,1,1,Clinical lab p16,p16 unknown
1706,1,1,Research lab p16,p16 unknown
1706,1,1,Tumor Stage,T3
1706,1,1,Nodal Stage,N0
1706,1,1,Tumor Site,hypopharynx
1706,1,1,Second Failure Type,no known failure
1706,1,1,Age at Death,58.9
1706,1,1,Overall Stage,III
1706,1,1,Treatment Modality,Sx
1706,1,1,First Failure Type,no known failure
1706,1,1,Occurrence #,other primary
1706,1,1,Metastasis,M0
1706,1,1,Time to Death,0.4
1706,1,1,Clinical lab p16,p16 unknown
1706,1,1,Research lab HPV,HPV unknown
1706,1,1,Date of Death,2004-06-26 00:00:00
1706,1,1,Status,Dead unk disease
1707,1,1,Tumor Stage,T3
1707,1,1,Initial Chemotherapy Agent,unknown
1707,1,1,Metastasis,M0
1707,1,1,First Failure Type,no known failure
1707,1,1,Radiation Dosage,70.2
1707,1,1,Tumor Site,hypopharynx
1707,1,1,Second Failure Type,no known failure
1707,1,1,Nodal Stage,N0
1707,1,1,Treatment Modality,CTX-RT
1707,1,1,Research lab HPV,HPV unknown
1707,1,1,Occurrence #,1st primary
1707,1,1,Research lab p16,p16 unknown
1707,1,1,Clinical lab p16,p16 unknown
1707,1,1,Overall Stage,III
1707,1,1,Status,Alive w/o disease
1708,1,1,Treatment Modality,CTX-RT
1708,1,1,Date of Death,2002-09-30 00:00:00
1708,1,1,Tumor Site,hypopharynx
1708,1,1,Metastasis,M0
1708,1,1,First Failure Type,no known failure
1708,1,1,Age at Death,57.7
1708,1,1,Radiation Dosage,70.2
1708,1,1,Clinical lab p16,p16 unknown
1708,1,1,Research lab HPV,HPV unknown
1708,1,1,Tumor Stage,T3
1708,1,1,Research lab p16,p16 unknown
1708,1,1,Nodal Stage,N1
1708,1,1,Occurrence #,1st primary
1708,1,1,Time to Death,0.6
1708,1,1,Second Failure Type,no known failure
1708,1,1,Overall Stage,III
1708,1,1,Initial Chemotherapy Agent,carbo/PTX
1708,1,1,Status,Dead w/o disease
1709,1,1,Metastasis,M0
1709,1,1,Second Failure Type,no known failure
1709,1,1,Nodal Stage,N0
1709,1,1,Occurrence #,other primary
1709,1,1,Time to Death,2.4
1709,1,1,Tumor Site,hypopharynx
1709,1,1,Overall Stage,II
1709,1,1,Tumor Stage,T2
1709,1,1,Research lab p16,p16 unknown
1709,1,1,Status,Dead w/ disease
1709,1,1,Research lab HPV,HPV unknown
1709,1,1,Treatment Modality,Sx
1709,1,1,Clinical lab p16,p16 unknown
1709,1,1,Time to First Failure,1.3
1709,1,1,Age at Death,66.0
1709,1,1,Date of Death,2011-06-07 00:00:00
1709,1,1,First Failure Type,locoregional
1710,1,1,Age at Death,50.2
1710,1,1,Overall Stage,IVa
1710,1,1,Treatment Modality,RT
1710,1,1,Metastasis,M0
1710,1,1,Status,Dead w/ disease
1710,1,1,Nodal Stage,N2
1710,1,1,Occurrence #,1st primary
1710,1,1,Tumor Stage,T3
1710,1,1,Clinical lab p16,p16 unknown
1710,1,1,Research lab p16,p16 unknown
1710,1,1,Second Failure Type,no known failure
1710,1,1,Research lab HPV,HPV unknown
1710,1,1,Date of Death,2006-08-29 00:00:00
1710,1,1,First Failure Type,locoregional and distant
1710,1,1,Radiation Dosage,42
1710,1,1,Tumor Site,hypopharynx
1710,1,1,Time to Death,1.8
1710,1,1,Time to First Failure,0.8
1711,1,1,Treatment Modality,CTX-RT
1711,1,1,Clinical lab p16,p16 unknown
1711,1,1,Status,Dead unk disease
1711,1,1,First Failure Type,no known failure
1711,1,1,Tumor Stage,T3
1711,1,1,Initial Chemotherapy Agent,doce/PTX
1711,1,1,Date of Death,2004-04-10 00:00:00
1711,1,1,Research lab HPV,HPV unknown
1711,1,1,Time to Death,3.1
1711,1,1,Radiation Dosage,72
1711,1,1,Nodal Stage,N0
1711,1,1,Second Failure Type,no known failure
1711,1,1,Tumor Site,hypopharynx
1711,1,1,Metastasis,M0
1711,1,1,Occurrence #,1st primary
1711,1,1,Age at Death,64.7
1711,1,1,Overall Stage,III
1711,1,1,Research lab p16,p16 unknown
1712,1,1,Initial Chemotherapy Agent,carbo/PTX
1712,1,1,Research lab p16,p16 unknown
1712,1,1,Occurrence #,recurrence
1712,1,1,First Failure Type,locoregional
1712,1,1,Research lab HPV,HPV unknown
1712,1,1,Time to First Failure,0.8
1712,1,1,Date of Death,2009-11-15 00:00:00
1712,1,1,Status,Dead w/ disease
1712,1,1,Second Failure Type,no known failure
1712,1,1,Treatment Modality,CTX-RT
1712,1,1,Overall Stage,IVa
1712,1,1,Tumor Stage,T4a
1712,1,1,Tumor Site,hypopharynx
1712,1,1,Radiation Dosage,60
1712,1,1,Time to Death,1.3
1712,1,1,Nodal Stage,N2
1712,1,1,Metastasis,M0
1712,1,1,Age at Death,77.0
1712,1,1,Clinical lab p16,p16 unknown
1713,1,1,Overall Stage,III
1713,1,1,Occurrence #,1st primary
1713,1,1,Age at Death,59.5
1713,1,1,Status,Dead w/ disease
1713,1,1,Research lab HPV,HPV unknown
1713,1,1,Time to Death,2.8
1713,1,1,Tumor Site,hypopharynx
1713,1,1,Time to First Failure,0.3
1713,1,1,Treatment Modality,CTX-RT
1713,1,1,Date of Death,2011-03-19 00:00:00
1713,1,1,Research lab p16,p16 unknown
1713,1,1,Initial Chemotherapy Agent,carbo/PTX
1713,1,1,Metastasis,M0
1713,1,1,Radiation Dosage,70.2
1713,1,1,Clinical lab p16,p16 unknown
1713,1,1,Tumor Stage,T3
1713,1,1,Second Failure Type,no known failure
1713,1,1,Nodal Stage,N0
1713,1,1,First Failure Type,locoregional
1714,1,1,Date of Death,2009-12-02 00:00:00
1714,1,1,Research lab p16,p16 unknown
1714,1,1,Treatment Modality,CTX-RT
1714,1,1,Radiation Dosage,70.2
1714,1,1,Overall Stage,IVa
1714,1,1,Time to Death,6.4
1714,1,1,Tumor Stage,T2
1714,1,1,Second Failure Type,no known failure
1714,1,1,First Failure Type,no known failure
1714,1,1,Metastasis,M0
1714,1,1,Initial Chemotherapy Agent,carbo/PTX
1714,1,1,Research lab HPV,HPV unknown
1714,1,1,Occurrence #,1st primary
1714,1,1,Tumor Site,hypopharynx
1714,1,1,Age at Death,60.8
1714,1,1,Status,Dead unk disease
1714,1,1,Nodal Stage,N3
1714,1,1,Clinical lab p16,p16 unknown
1715,1,1,Tumor Site,hypopharynx
1715,1,1,Second Failure Type,no known failure
1715,1,1,Metastasis,M0
1715,1,1,Radiation Dosage,51.2
1715,1,1,Research lab p16,p16 unknown
1715,1,1,Research lab HPV,HPV unknown
1715,1,1,Age at Death,57.0
1715,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
1715,1,1,First Failure Radiation Dosage,60
1715,1,1,First Failure Treatment Modality,CTX-RT
1715,1,1,Overall Stage,IVa
1715,1,1,Clinical lab p16,p16 unknown
1715,1,1,Tumor Stage,T3
1715,1,1,Time to First Failure,2.9
1715,1,1,Date of Death,2008-12-24 00:00:00
1715,1,1,First Failure Site,hypopharynx
1715,1,1,First Failure Type,locoregional
1715,1,1,Occurrence #,1st primary
1715,1,1,Status,Dead w/ disease
1715,1,1,Treatment Modality,Sx & RT
1715,1,1,Time to Death,0.4
1715,1,1,Nodal Stage,N2
1716,1,1,Occurrence #,recurrence
1716,1,1,Overall Stage,III
1716,1,1,First Failure Type,no known failure
1716,1,1,Research lab HPV,HPV unknown
1716,1,1,Tumor Site,hypopharynx
1716,1,1,Tumor Stage,T3
1716,1,1,Second Failure Type,no known failure
1716,1,1,Clinical lab p16,p16 unknown
1716,1,1,Metastasis,M0
1716,1,1,Age at Death,86.5
1716,1,1,Status,Dead unk disease
1716,1,1,Research lab p16,p16 unknown
1716,1,1,Time to Death,2.7
1716,1,1,Treatment Modality,Sx
1716,1,1,Date of Death,2005-02-16 00:00:00
1716,1,1,Nodal Stage,N0
1717,1,1,Time to First Failure,0.8
1717,1,1,Tumor Stage,T4b
1717,1,1,Research lab p16,p16 unknown
1717,1,1,Nodal Stage,N2
1717,1,1,Clinical lab p16,p16 unknown
1717,1,1,Second Failure Type,no known failure
1717,1,1,Time to Death,1.1
1717,1,1,Tumor Site,hypopharynx
1717,1,1,Metastasis,M0
1717,1,1,Occurrence #,1st primary
1717,1,1,Research lab HPV,HPV unknown
1717,1,1,Radiation Dosage,70.2
1717,1,1,Age at Death,59.6
1717,1,1,Date of Death,2006-06-06 00:00:00
1717,1,1,Status,Dead w/ disease
1717,1,1,Overall Stage,IVb
1717,1,1,Treatment Modality,CTX-RT
1717,1,1,First Failure Type,locoregional and distant
1717,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1718,1,1,Second Failure Type,no known failure
1718,1,1,Radiation Dosage,70.2
1718,1,1,Date of Death,2009-06-02 00:00:00
1718,1,1,Occurrence #,1st primary
1718,1,1,Time to Death,3.2
1718,1,1,Nodal Stage,N2
1718,1,1,Research lab p16,p16 unknown
1718,1,1,Treatment Modality,CTX-RT
1718,1,1,First Failure Type,no known failure
1718,1,1,Initial Chemotherapy Agent,carbo/PTX
1718,1,1,Status,Dead w/o disease
1718,1,1,Research lab HPV,HPV unknown
1718,1,1,Age at Death,54.5
1718,1,1,Metastasis,M0
1718,1,1,Overall Stage,IVa
1718,1,1,Clinical lab p16,p16 unknown
1718,1,1,Tumor Site,hypopharynx
1718,1,1,Tumor Stage,T2
1719,1,1,Status,Alive unk disease
1719,1,1,Nodal Stage,N0
1719,1,1,Tumor Stage,T3
1719,1,1,Clinical lab p16,p16 unknown
1719,1,1,Tumor Site,hypopharynx
1719,1,1,Treatment Modality,Sx
1719,1,1,Second Failure Type,no known failure
1719,1,1,Metastasis,M0
1719,1,1,Overall Stage,III
1719,1,1,First Failure Type,no known failure
1719,1,1,Research lab HPV,HPV unknown
1719,1,1,Occurrence #,1st primary
1719,1,1,Research lab p16,p16 unknown
1720,1,1,Treatment Modality,CTX-RT
1720,1,1,First Failure Type,no known failure
1720,1,1,Research lab p16,p16 unknown
1720,1,1,Metastasis,M0
1720,1,1,Tumor Site,hypopharynx
1720,1,1,Nodal Stage,N2
1720,1,1,Research lab HPV,HPV unknown
1720,1,1,Occurrence #,1st primary
1720,1,1,Overall Stage,IVa
1720,1,1,Status,Alive w/o disease
1720,1,1,Clinical lab p16,p16 unknown
1720,1,1,Second Failure Type,no known failure
1720,1,1,Radiation Dosage,70.2
1720,1,1,Tumor Stage,T2
1720,1,1,Initial Chemotherapy Agent,carbo/PTX
1721,1,1,Clinical lab p16,p16 unknown
1721,1,1,Tumor Site,hypopharynx
1721,1,1,Research lab p16,p16 unknown
1721,1,1,Metastasis,M0
1721,1,1,Overall Stage,IVa
1721,1,1,Initial Chemotherapy Agent,PTX/doce/gemcitabine
1721,1,1,Treatment Modality,Sx & CTX
1721,1,1,Occurrence #,recurrence
1721,1,1,Nodal Stage,N2
1721,1,1,First Failure Type,no known failure
1721,1,1,Status,Dead unk disease
1721,1,1,Tumor Stage,T4a
1721,1,1,Time to Death,0.6
1721,1,1,Research lab HPV,HPV unknown
1721,1,1,Date of Death,2001-11-20 00:00:00
1721,1,1,Second Failure Type,no known failure
1721,1,1,Age at Death,38.9
1722,1,1,Research lab p16,p16 unknown
1722,1,1,Research lab HPV,HPV unknown
1722,1,1,Initial Chemotherapy Agent,cis
1722,1,1,Overall Stage,IVa
1722,1,1,Occurrence #,1st primary
1722,1,1,Tumor Stage,T4a
1722,1,1,Status,Alive w/o disease
1722,1,1,Radiation Dosage,60
1722,1,1,Treatment Modality,Sx & CTX-RT
1722,1,1,Tumor Site,hypopharynx
1722,1,1,Metastasis,M0
1722,1,1,First Failure Type,no known failure
1722,1,1,Second Failure Type,no known failure
1722,1,1,Nodal Stage,N2
1722,1,1,Clinical lab p16,p16 unknown
1723,1,1,Second Failure Type,no known failure
1723,1,1,First Failure Type,no known failure
1723,1,1,Status,Dead unk disease
1723,1,1,Research lab HPV,HPV unknown
1723,1,1,Tumor Stage,T2
1723,1,1,Date of Death,2001-08-29 00:00:00
1723,1,1,Treatment Modality,Unknown
1723,1,1,Time to Death,0.3
1723,1,1,Metastasis,M0
1723,1,1,Occurrence #,1st primary
1723,1,1,Clinical lab p16,p16 unknown
1723,1,1,Research lab p16,p16 unknown
1723,1,1,Nodal Stage,N0
1723,1,1,Tumor Site,hypopharynx
1723,1,1,Overall Stage,II
1723,1,1,Age at Death,60.4
1724,1,1,Nodal Stage,N0
1724,1,1,Research lab HPV,HPV unknown
1724,1,1,Research lab p16,p16 unknown
1724,1,1,Clinical lab p16,p16 unknown
1724,1,1,Second Failure Type,no known failure
1724,1,1,Metastasis,M0
1724,1,1,Status,Alive w/o disease
1724,1,1,Tumor Site,hypopharynx
1724,1,1,Treatment Modality,CTX-RT
1724,1,1,Initial Chemotherapy Agent,carbo/PTX
1724,1,1,Tumor Stage,T2
1724,1,1,Occurrence #,other primary
1724,1,1,Radiation Dosage,59.4
1724,1,1,First Failure Type,no known failure
1724,1,1,Overall Stage,II
1725,1,1,Clinical lab p16,p16 unknown
1725,1,1,Nodal Stage,N0
1725,1,1,Tumor Stage,T3
1725,1,1,Research lab p16,p16 unknown
1725,1,1,Second Failure Type,no known failure
1725,1,1,Overall Stage,III
1725,1,1,Treatment Modality,Sx
1725,1,1,First Failure Type,no known failure
1725,1,1,Metastasis,M0
1725,1,1,Status,Alive w/o disease
1725,1,1,Tumor Site,hypopharynx
1725,1,1,Research lab HPV,HPV unknown
1725,1,1,Occurrence #,1st primary
1726,1,1,Metastasis,M0
1726,1,1,Second Failure Type,no known failure
1726,1,1,Tumor Site,hypopharynx
1726,1,1,Occurrence #,1st primary
1726,1,1,Research lab p16,p16 unknown
1726,1,1,Treatment Modality,Sx & CTX-RT
1726,1,1,Time to Death,4.8
1726,1,1,Radiation Dosage,unknown
1726,1,1,Nodal Stage,N3
1726,1,1,Tumor Stage,T3
1726,1,1,Research lab HPV,HPV unknown
1726,1,1,Clinical lab p16,p16 unknown
1726,1,1,Age at Death,57.6
1726,1,1,First Failure Type,no known failure
1726,1,1,Date of Death,2009-07-19 00:00:00
1726,1,1,Overall Stage,IVb
1726,1,1,Initial Chemotherapy Agent,unknown
1726,1,1,Status,Dead unk disease
1727,1,1,Treatment Modality,Sx & CTX-RT
1727,1,1,Occurrence #,1st primary
1727,1,1,Research lab p16,p16 unknown
1727,1,1,Metastasis,M0
1727,1,1,Initial Chemotherapy Agent,unknown
1727,1,1,Tumor Site,hypopharynx
1727,1,1,Radiation Dosage,unknown
1727,1,1,Research lab HPV,HPV unknown
1727,1,1,Second Failure Type,no known failure
1727,1,1,Status,Dead unk disease
1727,1,1,Age at Death,69.3
1727,1,1,Tumor Stage,T2
1727,1,1,Overall Stage,IVa
1727,1,1,Time to Death,1.4
1727,1,1,First Failure Type,no known failure
1727,1,1,Nodal Stage,N2
1727,1,1,Date of Death,2009-09-28 00:00:00
1727,1,1,Clinical lab p16,p16 unknown
1728,1,1,Metastasis,M0
1728,1,1,Status,Dead w/o disease
1728,1,1,Occurrence #,1st primary
1728,1,1,Research lab p16,p16 unknown
1728,1,1,Tumor Stage,T4a
1728,1,1,Age at Death,61.7
1728,1,1,Treatment Modality,CTX-RT
1728,1,1,First Failure Type,no known failure
1728,1,1,Radiation Dosage,70.2
1728,1,1,Initial Chemotherapy Agent,carbo/PTX
1728,1,1,Overall Stage,IVa
1728,1,1,Tumor Site,hypopharynx
1728,1,1,Date of Death,2003-02-03 00:00:00
1728,1,1,Second Failure Type,no known failure
1728,1,1,Research lab HPV,HPV unknown
1728,1,1,Nodal Stage,N0
1728,1,1,Time to Death,1.3
1728,1,1,Clinical lab p16,p16 unknown
1729,1,1,Research lab HPV,HPV unknown
1729,1,1,Status,Dead unk disease
1729,1,1,Overall Stage,IVa
1729,1,1,Date of Death,2001-07-10 00:00:00
1729,1,1,Clinical lab p16,p16 unknown
1729,1,1,Metastasis,M0
1729,1,1,Radiation Dosage,70.2
1729,1,1,Second Failure Type,no known failure
1729,1,1,Tumor Stage,T1
1729,1,1,Occurrence #,1st primary
1729,1,1,Tumor Site,hypopharynx
1729,1,1,Treatment Modality,RT
1729,1,1,Time to Death,0.3
1729,1,1,Age at Death,53.6
1729,1,1,First Failure Type,no known failure
1729,1,1,Nodal Stage,N2
1729,1,1,Research lab p16,p16 unknown
1730,1,1,Tumor Site,hypopharynx
1730,1,1,Research lab p16,p16 unknown
1730,1,1,Research lab HPV,HPV unknown
1730,1,1,Overall Stage,I
1730,1,1,Nodal Stage,N0
1730,1,1,Date of Death,2010-02-10 00:00:00
1730,1,1,Second Failure Type,no known failure
1730,1,1,Clinical lab p16,p16 unknown
1730,1,1,Treatment Modality,Sx
1730,1,1,Status,Dead unk disease
1730,1,1,Metastasis,M0
1730,1,1,Time to Death,9.9
1730,1,1,Occurrence #,1st primary
1730,1,1,Age at Death,61.1
1730,1,1,First Failure Type,no known failure
1730,1,1,Tumor Stage,T1
1731,1,1,Overall Stage,Unknown
1731,1,1,Research lab HPV,HPV unknown
1731,1,1,Nodal Stage,Unknown
1731,1,1,Second Failure Type,no known failure
1731,1,1,Age at Death,53.6
1731,1,1,Date of Death,2003-07-26 00:00:00
1731,1,1,Treatment Modality,Unknown
1731,1,1,Status,Dead w/ disease
1731,1,1,First Failure Type,no known failure
1731,1,1,Clinical lab p16,p16 unknown
1731,1,1,Metastasis,Unknown
1731,1,1,Research lab p16,p16 unknown
1731,1,1,Tumor Site,hypopharynx
1731,1,1,Tumor Stage,Unknown
1731,1,1,Time to Death,0.2
1731,1,1,Occurrence #,1st primary
1732,1,1,First Failure Type,distant
1732,1,1,Time to Death,1.3
1732,1,1,Clinical lab p16,p16 unknown
1732,1,1,Treatment Modality,CTX-RT
1732,1,1,Status,Dead w/ disease
1732,1,1,Tumor Stage,T3
1732,1,1,Tumor Site,hypopharynx
1732,1,1,Time to First Failure,0.2
1732,1,1,Research lab p16,p16 unknown
1732,1,1,Date of Death,2007-04-03 00:00:00
1732,1,1,Second Line Chemotherapy Agent,cap
1732,1,1,Research lab HPV,HPV unknown
1732,1,1,Initial Chemotherapy Agent,cis
1732,1,1,Radiation Dosage,70.2
1732,1,1,Occurrence #,1st primary
1732,1,1,Metastasis,M1
1732,1,1,Nodal Stage,N2
1732,1,1,Overall Stage,IVc
1732,1,1,Second Failure Type,no known failure
1732,1,1,Age at Death,57.7
1733,1,1,Status,Alive unk disease
1733,1,1,Overall Stage,II
1733,1,1,Tumor Stage,T2
1733,1,1,Occurrence #,1st primary
1733,1,1,Initial Chemotherapy Agent,unknown
1733,1,1,Tumor Site,hypopharynx
1733,1,1,Clinical lab p16,p16 unknown
1733,1,1,Radiation Dosage,unknown
1733,1,1,Metastasis,M0
1733,1,1,Nodal Stage,N0
1733,1,1,Research lab p16,p16 unknown
1733,1,1,Treatment Modality,CTX-RT
1733,1,1,First Failure Type,no known failure
1733,1,1,Research lab HPV,HPV unknown
1733,1,1,Second Failure Type,no known failure
1734,1,1,Initial Chemotherapy Agent,carbo/PTX
1734,1,1,Metastasis,M0
1734,1,1,Radiation Dosage,70.2
1734,1,1,Occurrence #,1st primary
1734,1,1,Tumor Stage,T3
1734,1,1,First Failure Type,no known failure
1734,1,1,Research lab HPV,HPV unknown
1734,1,1,Time to Death,1.2
1734,1,1,Tumor Site,hypopharynx
1734,1,1,Nodal Stage,N2
1734,1,1,Clinical lab p16,p16 unknown
1734,1,1,Date of Death,2001-08-24 00:00:00
1734,1,1,Second Failure Type,no known failure
1734,1,1,Overall Stage,IVa
1734,1,1,Treatment Modality,CTX-RT
1734,1,1,Age at Death,49.8
1734,1,1,Status,Dead unk disease
1734,1,1,Research lab p16,p16 unknown
1735,1,1,First Failure Type,no known failure
1735,1,1,Research lab p16,p16 unknown
1735,1,1,Research lab HPV,HPV unknown
1735,1,1,Radiation Dosage,66
1735,1,1,Tumor Stage,T1
1735,1,1,Tumor Site,hypopharynx
1735,1,1,Clinical lab p16,p16 unknown
1735,1,1,Treatment Modality,RT
1735,1,1,Metastasis,M0
1735,1,1,Second Failure Type,no known failure
1735,1,1,Occurrence #,recurrence
1735,1,1,Overall Stage,I
1735,1,1,Status,Alive w/o disease
1735,1,1,Nodal Stage,N0
1736,1,1,Second Failure Type,no known failure
1736,1,1,Initial Chemotherapy Agent,cis/doce
1736,1,1,Tumor Stage,T4a
1736,1,1,Time to Death,0.3
1736,1,1,Tumor Site,hypopharynx
1736,1,1,Clinical lab p16,p16 unknown
1736,1,1,Date of Death,2008-09-06 00:00:00
1736,1,1,Treatment Modality,CTX
1736,1,1,Overall Stage,IVa
1736,1,1,Age at Death,62.7
1736,1,1,Status,Dead w/ disease
1736,1,1,Occurrence #,1st primary
1736,1,1,First Failure Type,no known failure
1736,1,1,Metastasis,M0
1736,1,1,Research lab HPV,HPV unknown
1736,1,1,Research lab p16,p16 unknown
1736,1,1,Nodal Stage,N1
1737,1,1,Age at Death,61.8
1737,1,1,Status,Dead w/o disease
1737,1,1,Treatment Modality,CTX-RT
1737,1,1,Second Failure Type,no known failure
1737,1,1,Research lab p16,p16 unknown
1737,1,1,Overall Stage,III
1737,1,1,Nodal Stage,N0
1737,1,1,Date of Death,2008-07-20 00:00:00
1737,1,1,Clinical lab p16,p16 unknown
1737,1,1,Tumor Site,hypopharynx
1737,1,1,Time to Death,3.5
1737,1,1,Research lab HPV,HPV unknown
1737,1,1,Tumor Stage,T3
1737,1,1,Occurrence #,1st primary
1737,1,1,Radiation Dosage,70
1737,1,1,First Failure Type,no known failure
1737,1,1,Metastasis,M0
1737,1,1,Initial Chemotherapy Agent,cis
1738,1,1,Research lab HPV,HPV unknown
1738,1,1,Time to Death,2.4
1738,1,1,Treatment Modality,CTX-RT
1738,1,1,First Failure Type,no known failure
1738,1,1,Tumor Site,hypopharynx
1738,1,1,Metastasis,M0
1738,1,1,Clinical lab p16,p16 unknown
1738,1,1,Research lab p16,p16 unknown
1738,1,1,Age at Death,64.6
1738,1,1,Date of Death,2002-08-27 00:00:00
1738,1,1,Nodal Stage,N0
1738,1,1,Occurrence #,other primary
1738,1,1,Initial Chemotherapy Agent,carbo/PTX
1738,1,1,Radiation Dosage,70.2
1738,1,1,Tumor Stage,T4a
1738,1,1,Status,Dead unk disease
1738,1,1,Overall Stage,IVa
1738,1,1,Second Failure Type,no known failure
1739,1,1,Research lab HPV,HPV unknown
1739,1,1,Radiation Dosage,unknown
1739,1,1,Date of Death,2004-03-15 00:00:00
1739,1,1,Tumor Stage,T4a
1739,1,1,Metastasis,M0
1739,1,1,Status,Dead w/ disease
1739,1,1,Initial Chemotherapy Agent,carbo/PTX
1739,1,1,Clinical lab p16,p16 unknown
1739,1,1,Tumor Site,hypopharynx
1739,1,1,First Failure Type,no known failure
1739,1,1,Time to Death,0.3
1739,1,1,Overall Stage,IVa
1739,1,1,Occurrence #,recurrence
1739,1,1,Second Failure Type,no known failure
1739,1,1,Age at Death,70.1
1739,1,1,Treatment Modality,CTX-RT
1739,1,1,Nodal Stage,N1
1739,1,1,Research lab p16,p16 unknown
1740,1,1,Clinical lab p16,p16 unknown
1740,1,1,Initial Chemotherapy Agent,cis/PTX
1740,1,1,Tumor Site,hypopharynx
1740,1,1,First Failure Type,locoregional
1740,1,1,Treatment Modality,Sx & CTX-RT
1740,1,1,Research lab HPV,HPV unknown
1740,1,1,First Failure Initial Chemotherapy Agent,cis/cetux
1740,1,1,Time to First Failure,1.0
1740,1,1,Occurrence #,1st primary
1740,1,1,Tumor Stage,T2
1740,1,1,Research lab p16,p16 unknown
1740,1,1,Second Failure Type,no known failure
1740,1,1,Radiation Dosage,70.2
1740,1,1,Nodal Stage,N2
1740,1,1,First Failure Site,hypopharynx
1740,1,1,Status,Dead w/ disease
1740,1,1,Metastasis,M0
1740,1,1,Time to Death,2.6
1740,1,1,First Failure Second Line Chemotherapy Agent,doce
1740,1,1,Overall Stage,IVa
1740,1,1,First Failure Treatment Modality,Sx & CTX-RT
1740,1,1,Age at Death,56.3
1740,1,1,Date of Death,2010-04-02 00:00:00
1740,1,1,First Failure Radiation Dosage,60
1741,1,1,Tumor Site,hypopharynx
1741,1,1,Nodal Stage,N3
1741,1,1,Time to Death,0.4
1741,1,1,Research lab p16,p16 unknown
1741,1,1,Second Failure Type,no known failure
1741,1,1,Age at Death,55.8
1741,1,1,Occurrence #,1st primary
1741,1,1,Tumor Stage,T2
1741,1,1,Date of Death,2010-12-12 00:00:00
1741,1,1,Metastasis,M1
1741,1,1,Treatment Modality,Sx
1741,1,1,Clinical lab p16,p16 unknown
1741,1,1,First Failure Type,locoregional and distant
1741,1,1,Time to First Failure,0.2
1741,1,1,Status,Dead w/ disease
1741,1,1,Research lab HPV,HPV unknown
1741,1,1,Overall Stage,IVc
1742,1,1,Tumor Stage,T3
1742,1,1,Radiation Dosage,70.2
1742,1,1,Second Failure Type,no known failure
1742,1,1,Overall Stage,IVb
1742,1,1,Research lab HPV,HPV unknown
1742,1,1,Status,Dead w/ disease
1742,1,1,Time to First Failure,0.2
1742,1,1,Nodal Stage,N3
1742,1,1,Age at Death,58.8
1742,1,1,Date of Death,2003-03-12 00:00:00
1742,1,1,Treatment Modality,CTX-RT
1742,1,1,Time to Death,0.5
1742,1,1,Initial Chemotherapy Agent,carbo/PTX/amifistine
1742,1,1,Clinical lab p16,p16 unknown
1742,1,1,Research lab p16,p16 unknown
1742,1,1,First Failure Type,distant
1742,1,1,Occurrence #,1st primary
1742,1,1,Metastasis,M0
1742,1,1,Tumor Site,hypopharynx
1743,1,1,Treatment Modality,Sx
1743,1,1,First Failure Type,no known failure
1743,1,1,Status,Dead unk disease
1743,1,1,Research lab HPV,HPV unknown
1743,1,1,Overall Stage,IVa
1743,1,1,Second Failure Type,no known failure
1743,1,1,Tumor Site,hypopharynx
1743,1,1,Tumor Stage,T4a
1743,1,1,Metastasis,M0
1743,1,1,Occurrence #,other primary
1743,1,1,Research lab p16,p16 unknown
1743,1,1,Age at Death,79.6
1743,1,1,Date of Death,2005-03-21 00:00:00
1743,1,1,Clinical lab p16,p16 unknown
1743,1,1,Nodal Stage,N0
1743,1,1,Time to Death,0.4
1744,1,1,Research lab HPV,HPV unknown
1744,1,1,Research lab p16,p16 unknown
1744,1,1,Nodal Stage,N1
1744,1,1,First Failure Type,no known failure
1744,1,1,Occurrence #,1st primary
1744,1,1,Time to Death,0.2
1744,1,1,Tumor Site,hypopharynx
1744,1,1,Date of Death,2000-07-31 00:00:00
1744,1,1,Overall Stage,IVa
1744,1,1,Tumor Stage,T4a
1744,1,1,Age at Death,69.0
1744,1,1,Treatment Modality,Unknown
1744,1,1,Clinical lab p16,p16 unknown
1744,1,1,Status,Dead w/ disease
1744,1,1,Metastasis,M0
1744,1,1,Second Failure Type,no known failure
1745,1,1,First Failure Type,no known failure
1745,1,1,Nodal Stage,N2
1745,1,1,Initial Chemotherapy Agent,PTX/cap
1745,1,1,Date of Death,2004-07-28 00:00:00
1745,1,1,Overall Stage,IVa
1745,1,1,Research lab p16,p16 unknown
1745,1,1,Occurrence #,1st primary
1745,1,1,Metastasis,M0
1745,1,1,Treatment Modality,CTX-RT
1745,1,1,Second Failure Type,no known failure
1745,1,1,Age at Death,70.2
1745,1,1,Radiation Dosage,72
1745,1,1,Tumor Stage,T4a
1745,1,1,Tumor Site,hypopharynx
1745,1,1,Status,Dead unk disease
1745,1,1,Research lab HPV,HPV unknown
1745,1,1,Clinical lab p16,p16 unknown
1745,1,1,Time to Death,1.1
1746,1,1,Time to Death,5.2
1746,1,1,Research lab HPV,HPV unknown
1746,1,1,Treatment Modality,CTX-RT
1746,1,1,Research lab p16,p16 unknown
1746,1,1,Metastasis,M0
1746,1,1,Nodal Stage,N2
1746,1,1,Second Failure Type,no known failure
1746,1,1,Clinical lab p16,p16 unknown
1746,1,1,Occurrence #,recurrence
1746,1,1,Radiation Dosage,60
1746,1,1,Tumor Stage,T2
1746,1,1,Initial Chemotherapy Agent,carbo/PTX
1746,1,1,First Failure Type,no known failure
1746,1,1,Date of Death,2009-01-16 00:00:00
1746,1,1,Status,Dead unk disease
1746,1,1,Overall Stage,IVa
1746,1,1,Tumor Site,hypopharynx
1746,1,1,Age at Death,64.7
1747,1,1,Research lab HPV,HPV unknown
1747,1,1,Second Failure Type,no known failure
1747,1,1,Time to Death,0.9
1747,1,1,Tumor Site,hypopharynx
1747,1,1,Treatment Modality,Sx & CTX-RT
1747,1,1,Tumor Stage,T3
1747,1,1,Initial Chemotherapy Agent,carbo/PTX
1747,1,1,Status,Dead w/ disease
1747,1,1,Nodal Stage,N3
1747,1,1,Age at Death,53.9
1747,1,1,Clinical lab p16,p16 unknown
1747,1,1,Radiation Dosage,70.2
1747,1,1,Overall Stage,IVb
1747,1,1,Occurrence #,1st primary
1747,1,1,First Failure Type,distant
1747,1,1,Time to First Failure,0.2
1747,1,1,Metastasis,M0
1747,1,1,Research lab p16,p16 unknown
1747,1,1,Date of Death,2006-07-24 00:00:00
1748,1,1,Tumor Site,hypopharynx
1748,1,1,Status,Dead unk disease
1748,1,1,Research lab p16,p16 unknown
1748,1,1,Second Failure Type,no known failure
1748,1,1,Tumor Stage,T4a
1748,1,1,Occurrence #,1st primary
1748,1,1,Date of Death,2010-08-31 00:00:00
1748,1,1,Metastasis,M0
1748,1,1,Research lab HPV,HPV unknown
1748,1,1,First Failure Type,no known failure
1748,1,1,Radiation Dosage,unknown
1748,1,1,Age at Death,48.8
1748,1,1,Overall Stage,IVa
1748,1,1,Clinical lab p16,p16 unknown
1748,1,1,Treatment Modality,Sx & CTX-RT
1748,1,1,Initial Chemotherapy Agent,cis
1748,1,1,Time to Death,1.3
1748,1,1,Nodal Stage,N2
1749,1,1,Date of Death,2015-10-20 00:00:00
1749,1,1,Research lab HPV,HPV unknown
1749,1,1,Research lab p16,p16 unknown
1749,1,1,Time to Death,5.0
1749,1,1,Clinical lab p16,p16 unknown
1749,1,1,Age at Death,57.7
1749,1,1,Occurrence #,1st primary
1749,1,1,Metastasis,M0
1749,1,1,First Failure Type,no known failure
1749,1,1,Nodal Stage,N2
1749,1,1,Radiation Dosage,70.2
1749,1,1,Overall Stage,IVa
1749,1,1,Initial Chemotherapy Agent,cis
1749,1,1,Treatment Modality,CTX-RT
1749,1,1,Status,Dead w/o disease
1749,1,1,Second Failure Type,no known failure
1749,1,1,Tumor Stage,T3
1749,1,1,Tumor Site,hypopharynx
1750,1,1,Age at Death,89.4
1750,1,1,Date of Death,2006-05-26 00:00:00
1750,1,1,First Failure Type,no known failure
1750,1,1,Time to Death,0.5
1750,1,1,Tumor Stage,T3
1750,1,1,Clinical lab p16,p16 unknown
1750,1,1,Research lab p16,p16 unknown
1750,1,1,Treatment Modality,RT
1750,1,1,Radiation Dosage,70.2
1750,1,1,Overall Stage,IVa
1750,1,1,Occurrence #,1st primary
1750,1,1,Tumor Site,hypopharynx
1750,1,1,Metastasis,M0
1750,1,1,Nodal Stage,N2
1750,1,1,Research lab HPV,HPV unknown
1750,1,1,Second Failure Type,no known failure
1750,1,1,Status,Dead w/ disease
1751,1,1,First Failure Site,hypopharynx
1751,1,1,Radiation Dosage,70.2
1751,1,1,Status,Dead unk disease
1751,1,1,Age at Death,78.2
1751,1,1,First Failure Type,locoregional
1751,1,1,Time to First Failure,0.3
1751,1,1,Metastasis,M0
1751,1,1,Nodal Stage,N1
1751,1,1,Treatment Modality,CTX-RT
1751,1,1,Tumor Stage,T4a
1751,1,1,Initial Chemotherapy Agent,cis
1751,1,1,Occurrence #,1st primary
1751,1,1,First Failure Treatment Modality,Sx
1751,1,1,Clinical lab p16,p16 unknown
1751,1,1,Second Failure Type,no known failure
1751,1,1,Date of Death,2006-09-06 00:00:00
1751,1,1,Tumor Site,hypopharynx
1751,1,1,Research lab HPV,HPV unknown
1751,1,1,Time to Death,1.1
1751,1,1,Research lab p16,p16 unknown
1751,1,1,Overall Stage,IVa
1752,1,1,Date of Death,2007-06-30 00:00:00
1752,1,1,Tumor Site,hypopharynx
1752,1,1,Nodal Stage,N0
1752,1,1,Initial Chemotherapy Agent,carbo/5-FU
1752,1,1,Status,Dead w/ disease
1752,1,1,Clinical lab p16,p16 unknown
1752,1,1,Treatment Modality,Sx & CTX
1752,1,1,Overall Stage,III
1752,1,1,Second Failure Type,no known failure
1752,1,1,Time to First Failure,0.7
1752,1,1,Metastasis,M0
1752,1,1,Time to Death,1.3
1752,1,1,Research lab HPV,HPV unknown
1752,1,1,Occurrence #,other primary
1752,1,1,Age at Death,60.0
1752,1,1,Tumor Stage,T3
1752,1,1,First Failure Type,locoregional
1752,1,1,Research lab p16,p16 unknown
1753,1,1,Second Failure Type,no known failure
1753,1,1,Treatment Modality,RT
1753,1,1,Metastasis,M0
1753,1,1,Date of Death,2015-07-03 00:00:00
1753,1,1,Overall Stage,II
1753,1,1,First Failure Site,hypopharynx
1753,1,1,Tumor Site,hypopharynx
1753,1,1,Research lab p16,p16 unknown
1753,1,1,Research lab HPV,HPV unknown
1753,1,1,Clinical lab p16,p16 unknown
1753,1,1,Status,Dead w/ disease
1753,1,1,Occurrence #,1st primary
1753,1,1,Tumor Stage,T2
1753,1,1,Nodal Stage,N0
1753,1,1,Time to First Failure,5.1
1753,1,1,Radiation Dosage,74.4
1753,1,1,First Failure Type,locoregional
1753,1,1,Time to Death,5.6
1753,1,1,Age at Death,69.8
1754,1,1,Age at Death,61.2
1754,1,1,Research lab HPV,HPV unknown
1754,1,1,Radiation Dosage,70.2
1754,1,1,First Failure Type,locoregional and distant
1754,1,1,Research lab p16,p16 unknown
1754,1,1,Metastasis,M0
1754,1,1,Overall Stage,IVa
1754,1,1,Occurrence #,1st primary
1754,1,1,Second Failure Type,no known failure
1754,1,1,Tumor Site,hypopharynx
1754,1,1,Nodal Stage,N2
1754,1,1,Tumor Stage,T2
1754,1,1,Clinical lab p16,p16 unknown
1754,1,1,Time to First Failure,-0.2
1754,1,1,Treatment Modality,CTX-RT
1754,1,1,Status,Dead w/ disease
1754,1,1,Date of Death,2010-06-24 00:00:00
1754,1,1,Initial Chemotherapy Agent,cis
1754,1,1,Time to Death,1.6
1755,1,1,Overall Stage,I
1755,1,1,Status,Alive w/o disease
1755,1,1,Metastasis,M0
1755,1,1,Treatment Modality,RT
1755,1,1,First Failure Site,hypopharynx
1755,1,1,Radiation Dosage,66
1755,1,1,Nodal Stage,N0
1755,1,1,First Failure Treatment Modality,Sx
1755,1,1,Clinical lab p16,p16 unknown
1755,1,1,Tumor Stage,T1
1755,1,1,Time to First Failure,6.8
1755,1,1,Tumor Site,hypopharynx
1755,1,1,Research lab HPV,HPV unknown
1755,1,1,First Failure Type,locoregional
1755,1,1,Occurrence #,1st primary
1755,1,1,Research lab p16,p16 unknown
1755,1,1,Second Failure Type,no known failure
1756,1,1,Metastasis,M0
1756,1,1,First Failure Type,no known failure
1756,1,1,Tumor Stage,T1
1756,1,1,Status,Dead unk disease
1756,1,1,Time to Death,1.6
1756,1,1,Clinical lab p16,p16 unknown
1756,1,1,Treatment Modality,CTX-RT
1756,1,1,Overall Stage,IVa
1756,1,1,Date of Death,2002-01-29 00:00:00
1756,1,1,Research lab HPV,HPV unknown
1756,1,1,Occurrence #,1st primary
1756,1,1,Initial Chemotherapy Agent,carbo/PTX
1756,1,1,Age at Death,53.8
1756,1,1,Nodal Stage,N2
1756,1,1,Second Failure Type,no known failure
1756,1,1,Tumor Site,hypopharynx
1756,1,1,Research lab p16,p16 unknown
1756,1,1,Radiation Dosage,70.2
1757,1,1,Treatment Modality,Unknown
1757,1,1,Research lab p16,p16 unknown
1757,1,1,Research lab HPV,HPV unknown
1757,1,1,Overall Stage,IVa
1757,1,1,Second Failure Type,no known failure
1757,1,1,Time to Death,0.1
1757,1,1,Tumor Stage,T4a
1757,1,1,Age at Death,52.6
1757,1,1,Occurrence #,1st primary
1757,1,1,First Failure Type,no known failure
1757,1,1,Date of Death,2001-04-01 00:00:00
1757,1,1,Tumor Site,hypopharynx
1757,1,1,Metastasis,M0
1757,1,1,Nodal Stage,N1
1757,1,1,Status,Dead w/ disease
1757,1,1,Clinical lab p16,p16 unknown
1758,1,1,First Failure Site,hypopharynx
1758,1,1,Radiation Dosage,70.2
1758,1,1,Overall Stage,IVb
1758,1,1,Status,Dead w/ disease
1758,1,1,Time to First Failure,0.1
1758,1,1,Metastasis,M0
1758,1,1,Time to Death,1.9
1758,1,1,Second Failure Type,no known failure
1758,1,1,First Failure Type,locoregional and distant
1758,1,1,First Failure Initial Chemotherapy Agent,unknown
1758,1,1,Nodal Stage,N3
1758,1,1,First Failure Treatment Modality,Sx & CTX-RT
1758,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1758,1,1,Occurrence #,1st primary
1758,1,1,Research lab HPV,HPV unknown
1758,1,1,Tumor Site,hypopharynx
1758,1,1,Date of Death,2008-08-02 00:00:00
1758,1,1,Tumor Stage,T1
1758,1,1,Clinical lab p16,p16 unknown
1758,1,1,Research lab p16,p16 unknown
1758,1,1,First Failure Radiation Dosage,60
1758,1,1,Age at Death,68.0
1758,1,1,Treatment Modality,CTX-RT
1759,1,1,Tumor Site,hypopharynx
1759,1,1,Age at Death,43.4
1759,1,1,Occurrence #,other primary
1759,1,1,Tumor Stage,T4b
1759,1,1,Time to Death,0.0
1759,1,1,Second Failure Type,no known failure
1759,1,1,First Failure Type,no known failure
1759,1,1,Treatment Modality,Unknown
1759,1,1,Research lab p16,p16 unknown
1759,1,1,Date of Death,2001-08-26 00:00:00
1759,1,1,Research lab HPV,HPV unknown
1759,1,1,Overall Stage,IVb
1759,1,1,Metastasis,M0
1759,1,1,Status,Dead w/ disease
1759,1,1,Clinical lab p16,p16 unknown
1759,1,1,Nodal Stage,Unknown
1760,1,1,Date of Death,2006-09-02 00:00:00
1760,1,1,Initial Chemotherapy Agent,cis/PTX
1760,1,1,Occurrence #,1st primary
1760,1,1,First Failure Treatment Modality,CTX
1760,1,1,First Failure Type,locoregional
1760,1,1,Time to Death,1.3
1760,1,1,Age at Death,47.4
1760,1,1,Treatment Modality,CTX-RT
1760,1,1,Clinical lab p16,p16 unknown
1760,1,1,Metastasis,M0
1760,1,1,Research lab p16,p16 unknown
1760,1,1,Research lab HPV,HPV unknown
1760,1,1,Nodal Stage,N2
1760,1,1,Overall Stage,IVb
1760,1,1,Second Failure Type,no known failure
1760,1,1,Tumor Stage,T4b
1760,1,1,Status,Dead w/ disease
1760,1,1,Second Line Chemotherapy Agent,carbo/doce
1760,1,1,First Failure Site,hypopharynx
1760,1,1,Tumor Site,hypopharynx
1760,1,1,First Failure Initial Chemotherapy Agent,cap
1760,1,1,Radiation Dosage,70.2
1760,1,1,Time to First Failure,0.2
1761,1,1,Clinical lab p16,p16 unknown
1761,1,1,First Failure Type,no known failure
1761,1,1,Occurrence #,1st primary
1761,1,1,Tumor Site,hypopharynx
1761,1,1,Tumor Stage,T2
1761,1,1,Research lab HPV,HPV unknown
1761,1,1,Radiation Dosage,72
1761,1,1,Metastasis,M0
1761,1,1,Research lab p16,p16 unknown
1761,1,1,Overall Stage,IVa
1761,1,1,Treatment Modality,CTX-RT
1761,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1761,1,1,Status,Alive w/o disease
1761,1,1,Nodal Stage,N2
1761,1,1,Second Failure Type,no known failure
1762,1,1,Occurrence #,other primary
1762,1,1,Age at Death,69.5
1762,1,1,Date of Death,2004-02-23 00:00:00
1762,1,1,Tumor Site,hypopharynx
1762,1,1,Time to Death,1.5
1762,1,1,Treatment Modality,RT
1762,1,1,First Failure Type,locoregional
1762,1,1,Tumor Stage,T4a
1762,1,1,Overall Stage,IVa
1762,1,1,Research lab HPV,HPV unknown
1762,1,1,Status,Dead w/ disease
1762,1,1,Radiation Dosage,60
1762,1,1,Metastasis,M0
1762,1,1,Nodal Stage,N0
1762,1,1,Research lab p16,p16 unknown
1762,1,1,Second Failure Type,no known failure
1762,1,1,Time to First Failure,0.6
1762,1,1,Clinical lab p16,p16 unknown
1763,1,1,Time to Death,0.6
1763,1,1,Research lab HPV,HPV unknown
1763,1,1,Status,Dead unk disease
1763,1,1,First Failure Type,no known failure
1763,1,1,Tumor Site,hypopharynx
1763,1,1,Occurrence #,1st primary
1763,1,1,Treatment Modality,Sx
1763,1,1,Metastasis,M0
1763,1,1,Second Failure Type,no known failure
1763,1,1,Date of Death,2007-07-08 00:00:00
1763,1,1,Age at Death,64.5
1763,1,1,Tumor Stage,T2
1763,1,1,Research lab p16,p16 unknown
1763,1,1,Nodal Stage,N3
1763,1,1,Clinical lab p16,p16 unknown
1763,1,1,Overall Stage,IVb
1764,1,1,Radiation Dosage,70.2
1764,1,1,Status,Dead w/ disease
1764,1,1,Age at Death,58.2
1764,1,1,Occurrence #,1st primary
1764,1,1,Time to Death,1.2
1764,1,1,Treatment Modality,RT
1764,1,1,Second Failure Type,no known failure
1764,1,1,Overall Stage,III
1764,1,1,Tumor Site,hypopharynx
1764,1,1,Tumor Stage,T3
1764,1,1,Clinical lab p16,p16 unknown
1764,1,1,Research lab HPV,HPV unknown
1764,1,1,Nodal Stage,N1
1764,1,1,Research lab p16,p16 unknown
1764,1,1,First Failure Type,locoregional and distant
1764,1,1,Metastasis,M0
1764,1,1,Date of Death,2001-10-16 00:00:00
1764,1,1,Time to First Failure,0.8
1765,1,1,First Failure Type,no known failure
1765,1,1,Nodal Stage,N3
1765,1,1,Date of Death,2009-05-18 00:00:00
1765,1,1,Overall Stage,IVb
1765,1,1,Time to Death,0.4
1765,1,1,Second Failure Type,no known failure
1765,1,1,Metastasis,M0
1765,1,1,Tumor Stage,T2
1765,1,1,Occurrence #,1st primary
1765,1,1,Treatment Modality,Unknown
1765,1,1,Research lab HPV,HPV unknown
1765,1,1,Clinical lab p16,p16 unknown
1765,1,1,Research lab p16,p16 unknown
1765,1,1,Age at Death,59.5
1765,1,1,Tumor Site,hypopharynx
1765,1,1,Status,Dead unk disease
1766,1,1,Tumor Site,hypopharynx
1766,1,1,Date of Death,2003-05-31 00:00:00
1766,1,1,Time to First Failure,0.1
1766,1,1,Overall Stage,IVb
1766,1,1,Research lab HPV,HPV unknown
1766,1,1,Occurrence #,1st primary
1766,1,1,Metastasis,M0
1766,1,1,Second Failure Type,no known failure
1766,1,1,Age at Death,53.2
1766,1,1,First Failure Type,locoregional
1766,1,1,Nodal Stage,N3
1766,1,1,Time to Death,1.0
1766,1,1,Initial Chemotherapy Agent,carbo/PTX
1766,1,1,Clinical lab p16,p16 unknown
1766,1,1,Radiation Dosage,70.2
1766,1,1,Research lab p16,p16 unknown
1766,1,1,Status,Dead w/ disease
1766,1,1,Tumor Stage,T3
1766,1,1,Treatment Modality,CTX-RT
1767,1,1,Metastasis,M1
1767,1,1,Status,Dead unk disease
1767,1,1,Nodal Stage,Unknown
1767,1,1,Research lab HPV,HPV unknown
1767,1,1,Treatment Modality,Sx
1767,1,1,Tumor Site,hypopharynx
1767,1,1,Age at Death,56.7
1767,1,1,Date of Death,2003-04-08 00:00:00
1767,1,1,First Failure Type,no known failure
1767,1,1,Second Failure Type,no known failure
1767,1,1,Research lab p16,p16 unknown
1767,1,1,Time to Death,0.7
1767,1,1,Clinical lab p16,p16 unknown
1767,1,1,Occurrence #,recurrence
1767,1,1,Tumor Stage,Unknown
1767,1,1,Overall Stage,IVc
1768,1,1,Tumor Site,hypopharynx
1768,1,1,Radiation Dosage,70.2
1768,1,1,Tumor Stage,T4a
1768,1,1,Overall Stage,IVa
1768,1,1,Status,Dead w/o disease
1768,1,1,Research lab p16,p16 unknown
1768,1,1,Metastasis,M0
1768,1,1,Nodal Stage,N2
1768,1,1,Age at Death,66.7
1768,1,1,Occurrence #,1st primary
1768,1,1,Second Failure Type,no known failure
1768,1,1,Date of Death,2007-08-16 00:00:00
1768,1,1,Time to Death,3.5
1768,1,1,Research lab HPV,HPV unknown
1768,1,1,Initial Chemotherapy Agent,carbo/PTX
1768,1,1,Treatment Modality,CTX-RT
1768,1,1,First Failure Type,no known failure
1768,1,1,Clinical lab p16,p16 unknown
1769,1,1,Occurrence #,1st primary
1769,1,1,Research lab p16,p16 unknown
1769,1,1,Nodal Stage,N2
1769,1,1,Tumor Stage,T2
1769,1,1,Radiation Dosage,70.2
1769,1,1,Metastasis,M0
1769,1,1,Time to Death,1.5
1769,1,1,Second Failure Type,no known failure
1769,1,1,Age at Death,70.5
1769,1,1,Treatment Modality,CTX-RT
1769,1,1,First Failure Type,distant
1769,1,1,Status,Dead w/ disease
1769,1,1,Date of Death,2009-06-08 00:00:00
1769,1,1,Time to First Failure,1.0
1769,1,1,Initial Chemotherapy Agent,cis
1769,1,1,Clinical lab p16,p16 unknown
1769,1,1,Overall Stage,IVa
1769,1,1,Research lab HPV,HPV unknown
1769,1,1,Tumor Site,hypopharynx
1770,1,1,Clinical lab p16,p16 unknown
1770,1,1,Tumor Stage,T1
1770,1,1,Time to Death,2.4
1770,1,1,Second Failure Type,no known failure
1770,1,1,First Failure Treatment Modality,RT
1770,1,1,Date of Death,2011-04-30 00:00:00
1770,1,1,Research lab HPV,HPV unknown
1770,1,1,Time to First Failure,4.1
1770,1,1,Metastasis,M0
1770,1,1,Overall Stage,III
1770,1,1,Status,Dead w/ disease
1770,1,1,Research lab p16,p16 unknown
1770,1,1,Age at Death,82.9
1770,1,1,Treatment Modality,Sx
1770,1,1,First Failure Site,oropharynx
1770,1,1,First Failure Type,locoregional
1770,1,1,Nodal Stage,N1
1770,1,1,First Failure Radiation Dosage,35
1770,1,1,Tumor Site,hypopharynx
1770,1,1,Occurrence #,other primary
1771,1,1,Tumor Site,hypopharynx
1771,1,1,Second Failure Type,no known failure
1771,1,1,First Failure Type,no known failure
1771,1,1,Occurrence #,recurrence
1771,1,1,Nodal Stage,Unknown
1771,1,1,Overall Stage,Unknown
1771,1,1,Research lab p16,p16 unknown
1771,1,1,Metastasis,Unknown
1771,1,1,Status,Alive unk disease
1771,1,1,Treatment Modality,Unknown
1771,1,1,Research lab HPV,HPV unknown
1771,1,1,Clinical lab p16,p16 unknown
1771,1,1,Tumor Stage,Unknown
1772,1,1,Status,Dead unk disease
1772,1,1,Tumor Site,hypopharynx
1772,1,1,Metastasis,M0
1772,1,1,Research lab p16,p16 unknown
1772,1,1,Treatment Modality,Sx
1772,1,1,Time to Death,0.9
1772,1,1,Age at Death,48.0
1772,1,1,Clinical lab p16,p16 unknown
1772,1,1,First Failure Type,no known failure
1772,1,1,Occurrence #,other primary
1772,1,1,Research lab HPV,HPV unknown
1772,1,1,Date of Death,2003-11-02 00:00:00
1772,1,1,Second Failure Type,no known failure
1772,1,1,Tumor Stage,T4a
1772,1,1,Nodal Stage,N2
1772,1,1,Overall Stage,IVa
1773,1,1,Time to First Failure,1.7
1773,1,1,Status,Dead w/ disease
1773,1,1,Metastasis,M0
1773,1,1,Date of Death,2011-02-09 00:00:00
1773,1,1,First Failure Type,distant
1773,1,1,Tumor Stage,T3
1773,1,1,Research lab p16,p16 unknown
1773,1,1,Overall Stage,III
1773,1,1,Initial Chemotherapy Agent,cis
1773,1,1,Research lab HPV,HPV unknown
1773,1,1,Occurrence #,1st primary
1773,1,1,Radiation Dosage,70.2
1773,1,1,Nodal Stage,N1
1773,1,1,Clinical lab p16,p16 unknown
1773,1,1,Treatment Modality,Sx & CTX-RT
1773,1,1,Time to Death,2.3
1773,1,1,Second Failure Type,no known failure
1773,1,1,Age at Death,60.5
1773,1,1,Tumor Site,hypopharynx
1774,1,1,Tumor Stage,T3
1774,1,1,Occurrence #,other primary
1774,1,1,Tumor Site,hypopharynx
1774,1,1,Treatment Modality,CTX-RT
1774,1,1,Time to First Failure,0.3
1774,1,1,Date of Death,2011-08-27 00:00:00
1774,1,1,Overall Stage,IVa
1774,1,1,Nodal Stage,N2
1774,1,1,Clinical lab p16,p16 unknown
1774,1,1,Initial Chemotherapy Agent,cetux
1774,1,1,Second Failure Type,no known failure
1774,1,1,First Failure Type,locoregional
1774,1,1,Time to Death,0.7
1774,1,1,Age at Death,79.1
1774,1,1,Research lab HPV,HPV unknown
1774,1,1,Status,Dead w/ disease
1774,1,1,Metastasis,M0
1774,1,1,Research lab p16,p16 unknown
1774,1,1,Radiation Dosage,70.2
1775,1,1,First Failure Type,locoregional
1775,1,1,Time to First Failure,0.0
1775,1,1,Second Failure Type,no known failure
1775,1,1,Tumor Site,hypopharynx
1775,1,1,Nodal Stage,N2
1775,1,1,Date of Death,2005-12-03 00:00:00
1775,1,1,Metastasis,M0
1775,1,1,Overall Stage,IVa
1775,1,1,Status,Dead w/ disease
1775,1,1,Clinical lab p16,p16 unknown
1775,1,1,Research lab p16,p16 unknown
1775,1,1,Time to Death,0.4
1775,1,1,Research lab HPV,HPV unknown
1775,1,1,Treatment Modality,RT
1775,1,1,Tumor Stage,T4a
1775,1,1,Occurrence #,1st primary
1775,1,1,Age at Death,60.9
1775,1,1,Radiation Dosage,10
1776,1,1,Research lab HPV,HPV unknown
1776,1,1,Age at Death,52.8
1776,1,1,Overall Stage,III
1776,1,1,Tumor Site,hypopharynx
1776,1,1,Research lab p16,p16 unknown
1776,1,1,Initial Chemotherapy Agent,cis
1776,1,1,Status,Dead w/o disease
1776,1,1,Occurrence #,1st primary
1776,1,1,Second Failure Type,no known failure
1776,1,1,Nodal Stage,N1
1776,1,1,Radiation Dosage,70.2
1776,1,1,Time to Death,0.8
1776,1,1,Second Line Chemotherapy Agent,carbo/doce
1776,1,1,First Failure Type,no known failure
1776,1,1,Clinical lab p16,p16 unknown
1776,1,1,Date of Death,2009-08-02 00:00:00
1776,1,1,Tumor Stage,T2
1776,1,1,Treatment Modality,CTX-RT
1776,1,1,Metastasis,M0
1777,1,1,Metastasis,M0
1777,1,1,Research lab p16,p16 unknown
1777,1,1,Radiation Dosage,46.8
1777,1,1,Tumor Stage,T4a
1777,1,1,Research lab HPV,HPV unknown
1777,1,1,Age at Death,63.9
1777,1,1,Treatment Modality,CTX-RT
1777,1,1,Occurrence #,1st primary
1777,1,1,Tumor Site,hypopharynx
1777,1,1,Status,Dead unk disease
1777,1,1,Date of Death,2002-08-20 00:00:00
1777,1,1,Nodal Stage,N3
1777,1,1,Initial Chemotherapy Agent,carbo/PTX
1777,1,1,Clinical lab p16,p16 unknown
1777,1,1,Time to Death,0.3
1777,1,1,First Failure Type,no known failure
1777,1,1,Second Failure Type,no known failure
1777,1,1,Overall Stage,IVb
1778,1,1,Treatment Modality,RT
1778,1,1,Nodal Stage,N2
1778,1,1,Clinical lab p16,p16 unknown
1778,1,1,Radiation Dosage,70.2
1778,1,1,Tumor Site,hypopharynx
1778,1,1,Time to Death,0.5
1778,1,1,First Failure Type,no known failure
1778,1,1,Age at Death,47.9
1778,1,1,Metastasis,M0
1778,1,1,Occurrence #,1st primary
1778,1,1,Overall Stage,IVa
1778,1,1,Date of Death,2008-09-27 00:00:00
1778,1,1,Research lab HPV,HPV unknown
1778,1,1,Research lab p16,p16 unknown
1778,1,1,Status,Dead unk disease
1778,1,1,Tumor Stage,T4a
1778,1,1,Second Failure Type,no known failure
1779,1,1,Date of Death,2010-04-02 00:00:00
1779,1,1,Radiation Dosage,60
1779,1,1,First Failure Type,locoregional
1779,1,1,Initial Chemotherapy Agent,carbo/PTX
1779,1,1,Time to Death,1.5
1779,1,1,Occurrence #,other primary
1779,1,1,Time to First Failure,0.3
1779,1,1,Overall Stage,II
1779,1,1,Metastasis,M0
1779,1,1,Tumor Stage,T2
1779,1,1,Clinical lab p16,p16 unknown
1779,1,1,Nodal Stage,N0
1779,1,1,Research lab HPV,HPV unknown
1779,1,1,Age at Death,61.1
1779,1,1,Status,Dead w/ disease
1779,1,1,Second Failure Type,no known failure
1779,1,1,Research lab p16,p16 unknown
1779,1,1,Treatment Modality,Sx & CTX-RT
1779,1,1,Tumor Site,hypopharynx
1780,1,1,First Failure Type,no known failure
1780,1,1,Occurrence #,recurrence
1780,1,1,Second Failure Type,no known failure
1780,1,1,Overall Stage,III
1780,1,1,Metastasis,M0
1780,1,1,Tumor Stage,T3
1780,1,1,Tumor Site,hypopharynx
1780,1,1,Research lab p16,p16 unknown
1780,1,1,Status,Alive w/o disease
1780,1,1,Treatment Modality,Sx
1780,1,1,Nodal Stage,N0
1780,1,1,Clinical lab p16,p16 unknown
1780,1,1,Research lab HPV,HPV unknown
1781,1,1,Research lab p16,p16 unknown
1781,1,1,Age at Death,50.2
1781,1,1,Status,Dead w/ disease
1781,1,1,Second Failure Type,no known failure
1781,1,1,Time to Death,1.2
1781,1,1,Date of Death,2002-06-08 00:00:00
1781,1,1,Overall Stage,IVb
1781,1,1,Research lab HPV,HPV unknown
1781,1,1,Clinical lab p16,p16 unknown
1781,1,1,Tumor Stage,T4a
1781,1,1,Time to First Failure,0.0
1781,1,1,Radiation Dosage,70
1781,1,1,Nodal Stage,N3
1781,1,1,Initial Chemotherapy Agent,carbo/PTX
1781,1,1,Occurrence #,1st primary
1781,1,1,Metastasis,M0
1781,1,1,First Failure Type,distant
1781,1,1,Treatment Modality,Sx & CTX-RT
1781,1,1,Tumor Site,hypopharynx
1782,1,1,Date of Death,2006-02-01 00:00:00
1782,1,1,First Failure Type,no known failure
1782,1,1,Time to Death,1.0
1782,1,1,Status,Dead unk disease
1782,1,1,Tumor Stage,T2
1782,1,1,Research lab p16,p16 unknown
1782,1,1,Nodal Stage,N0
1782,1,1,Clinical lab p16,p16 unknown
1782,1,1,Treatment Modality,Sx & CTX-RT
1782,1,1,Research lab HPV,HPV unknown
1782,1,1,Second Failure Type,no known failure
1782,1,1,Overall Stage,II
1782,1,1,Initial Chemotherapy Agent,carbo/PTX
1782,1,1,Tumor Site,hypopharynx
1782,1,1,Occurrence #,recurrence
1782,1,1,Age at Death,57.2
1782,1,1,Metastasis,M0
1782,1,1,Radiation Dosage,60
1783,1,1,Overall Stage,IVa
1783,1,1,First Failure Type,no known failure
1783,1,1,Status,Alive unk disease
1783,1,1,Treatment Modality,CTX-RT
1783,1,1,Tumor Site,hypopharynx
1783,1,1,Research lab HPV,HPV unknown
1783,1,1,Tumor Stage,T4a
1783,1,1,Nodal Stage,N0
1783,1,1,Initial Chemotherapy Agent,unknown
1783,1,1,Research lab p16,p16 unknown
1783,1,1,Second Failure Type,no known failure
1783,1,1,Clinical lab p16,p16 unknown
1783,1,1,Occurrence #,1st primary
1783,1,1,Radiation Dosage,70.2
1783,1,1,Metastasis,M0
1784,1,1,Second Failure Type,no known failure
1784,1,1,Clinical lab p16,p16 unknown
1784,1,1,Tumor Site,hypopharynx
1784,1,1,Research lab p16,p16 unknown
1784,1,1,Age at Death,49.8
1784,1,1,Nodal Stage,N0
1784,1,1,Research lab HPV,HPV unknown
1784,1,1,Tumor Stage,T4a
1784,1,1,Date of Death,2004-08-29 00:00:00
1784,1,1,Treatment Modality,Unknown
1784,1,1,Status,Dead unk disease
1784,1,1,First Failure Type,no known failure
1784,1,1,Time to Death,1.3
1784,1,1,Overall Stage,IVa
1784,1,1,Metastasis,M0
1784,1,1,Occurrence #,1st primary
1785,1,1,Second Failure Type,no known failure
1785,1,1,Treatment Modality,Sx & CTX-RT
1785,1,1,Time to First Failure,8.1
1785,1,1,Research lab HPV,HPV unknown
1785,1,1,Tumor Site,oral cavity
1785,1,1,Overall Stage,IVa
1785,1,1,Occurrence #,1st primary
1785,1,1,Clinical lab p16,p16 unknown
1785,1,1,Status,Alive w/ disease
1785,1,1,Radiation Dosage,unknown
1785,1,1,First Failure Site,oral cavity
1785,1,1,Tumor Stage,T2
1785,1,1,Initial Chemotherapy Agent,cis
1785,1,1,First Failure Type,locoregional
1785,1,1,Nodal Stage,N2
1785,1,1,Research lab p16,p16 unknown
1785,1,1,Metastasis,M0
1786,1,1,Clinical lab p16,p16 unknown
1786,1,1,Second Failure Type,no known failure
1786,1,1,Time to Death,2.5
1786,1,1,Research lab p16,p16 unknown
1786,1,1,Treatment Modality,Sx
1786,1,1,Status,Dead unk disease
1786,1,1,Nodal Stage,N0
1786,1,1,First Failure Type,no known failure
1786,1,1,Tumor Stage,T1
1786,1,1,Overall Stage,I
1786,1,1,Tumor Site,oral cavity
1786,1,1,Occurrence #,1st primary
1786,1,1,Age at Death,91.5
1786,1,1,Date of Death,2011-04-02 00:00:00
1786,1,1,Research lab HPV,HPV unknown
1786,1,1,Metastasis,M0
1789,1,1,First Failure Type,no known failure
1789,1,1,Occurrence #,1st primary
1789,1,1,Treatment Modality,CTX-RT
1789,1,1,Nodal Stage,N3
1789,1,1,Overall Stage,IVb
1789,1,1,Tumor Stage,T2
1789,1,1,Tumor Site,oropharynx
1789,1,1,Initial Chemotherapy Agent,cis
1789,1,1,Metastasis,M0
1789,1,1,Status,Alive w/o disease
1789,1,1,Research lab HPV,HPV positive
1789,1,1,Clinical lab p16,p16 unknown
1789,1,1,Research lab p16,p16 unknown
1789,1,1,Radiation Dosage,70.2
1789,1,1,Second Failure Type,no known failure
1790,1,1,Clinical lab p16,p16 unknown
1790,1,1,Overall Stage,IVa
1790,1,1,Radiation Dosage,70.2
1790,1,1,Nodal Stage,N2
1790,1,1,Research lab p16,p16 unknown
1790,1,1,Status,Dead w/ disease
1790,1,1,Initial Chemotherapy Agent,Carbo/doce
1790,1,1,Age at Death,61.8
1790,1,1,Research lab HPV,HPV unknown
1790,1,1,Date of Death,2008-06-12 00:00:00
1790,1,1,Time to First Failure,1.1
1790,1,1,Occurrence #,1st primary
1790,1,1,Treatment Modality,Sx & CTX-RT
1790,1,1,Tumor Stage,T3
1790,1,1,Time to Death,0.7
1790,1,1,Metastasis,M0
1790,1,1,First Failure Type,locoregional and distant
1790,1,1,Tumor Site,oropharynx
1790,1,1,Second Failure Type,no known failure
1791,1,1,Second Failure Type,no known failure
1791,1,1,Status,Alive w/o disease
1791,1,1,Clinical lab p16,p16 positive
1791,1,1,Research lab HPV,HPV positive
1791,1,1,Radiation Dosage,70.2
1791,1,1,Research lab p16,p16 unknown
1791,1,1,Metastasis,M0
1791,1,1,Overall Stage,IVa
1791,1,1,First Failure Type,no known failure
1791,1,1,Nodal Stage,N2
1791,1,1,Tumor Stage,T1
1791,1,1,Treatment Modality,CTX-RT
1791,1,1,Tumor Site,oropharynx
1791,1,1,Initial Chemotherapy Agent,cis
1791,1,1,Occurrence #,1st primary
1792,1,1,Occurrence #,1st primary
1792,1,1,Overall Stage,IVb
1792,1,1,Research lab p16,p16 unknown
1792,1,1,Metastasis,M0
1792,1,1,Research lab HPV,HPV unknown
1792,1,1,Nodal Stage,N1
1792,1,1,Date of Death,2008-05-09 00:00:00
1792,1,1,Time to Death,0.4
1792,1,1,Tumor Site,oropharynx
1792,1,1,Age at Death,57.8
1792,1,1,Tumor Stage,T4b
1792,1,1,Treatment Modality,Unknown
1792,1,1,Second Failure Type,no known failure
1792,1,1,First Failure Type,no known failure
1792,1,1,Clinical lab p16,p16 unknown
1792,1,1,Status,Dead unk disease
1793,1,1,Radiation Dosage,70.2
1793,1,1,Time to Death,0.2
1793,1,1,Clinical lab p16,p16 unknown
1793,1,1,Date of Death,2007-12-26 00:00:00
1793,1,1,Metastasis,M0
1793,1,1,Research lab HPV,HPV unknown
1793,1,1,Tumor Stage,T4a
1793,1,1,Nodal Stage,N2
1793,1,1,Treatment Modality,CTX-RT
1793,1,1,Research lab p16,p16 unknown
1793,1,1,Tumor Site,oropharynx
1793,1,1,Age at Death,68.5
1793,1,1,Overall Stage,IVa
1793,1,1,First Failure Type,no known failure
1793,1,1,Initial Chemotherapy Agent,carbo/doce
1793,1,1,Occurrence #,1st primary
1793,1,1,Status,Dead unk disease
1793,1,1,Second Failure Type,no known failure
1794,1,1,First Failure Type,no known failure
1794,1,1,Nodal Stage,N2
1794,1,1,Metastasis,M0
1794,1,1,Clinical lab p16,p16 unknown
1794,1,1,Overall Stage,IVa
1794,1,1,Research lab HPV,HPV unknown
1794,1,1,Treatment Modality,Sx & RT
1794,1,1,Research lab p16,p16 unknown
1794,1,1,Status,Alive w/o disease
1794,1,1,Radiation Dosage,63
1794,1,1,Occurrence #,1st primary
1794,1,1,Tumor Site,oropharynx
1794,1,1,Tumor Stage,T1
1794,1,1,Second Failure Type,no known failure
1795,1,1,First Failure Type,no known failure
1795,1,1,Occurrence #,1st primary
1795,1,1,Metastasis,M0
1795,1,1,Tumor Site,oropharynx
1795,1,1,Treatment Modality,CTX-RT
1795,1,1,Second Failure Type,no known failure
1795,1,1,Initial Chemotherapy Agent,cis
1795,1,1,Overall Stage,III
1795,1,1,Status,Alive w/o disease
1795,1,1,Research lab p16,p16 unknown
1795,1,1,Tumor Stage,T3
1795,1,1,Radiation Dosage,70.2
1795,1,1,Clinical lab p16,p16 unknown
1795,1,1,Research lab HPV,HPV unknown
1795,1,1,Nodal Stage,N1
1796,1,1,Metastasis,M0
1796,1,1,Tumor Site,oropharynx
1796,1,1,Treatment Modality,Unknown
1796,1,1,Age at Death,61.3
1796,1,1,First Failure Type,no known failure
1796,1,1,Nodal Stage,N2
1796,1,1,Tumor Stage,T4a
1796,1,1,Status,Dead w/ disease
1796,1,1,Research lab HPV,HPV unknown
1796,1,1,Second Failure Type,no known failure
1796,1,1,Occurrence #,recurrence
1796,1,1,Research lab p16,p16 unknown
1796,1,1,Date of Death,2010-03-25 00:00:00
1796,1,1,Overall Stage,IVa
1796,1,1,Clinical lab p16,p16 unknown
1796,1,1,Time to Death,0.2
1797,1,1,Radiation Dosage,unknown
1797,1,1,Initial Chemotherapy Agent,unk
1797,1,1,Occurrence #,1st primary
1797,1,1,Research lab p16,p16 unknown
1797,1,1,Tumor Site,oropharynx
1797,1,1,Nodal Stage,N2
1797,1,1,Second Failure Type,no known failure
1797,1,1,Treatment Modality,Sx & CTX-RT
1797,1,1,Clinical lab p16,p16 unknown
1797,1,1,Overall Stage,IVa
1797,1,1,First Failure Type,no known failure
1797,1,1,Status,Alive w/o disease
1797,1,1,Research lab HPV,HPV unknown
1797,1,1,Metastasis,M0
1797,1,1,Tumor Stage,T1
1798,1,1,Overall Stage,IVa
1798,1,1,Treatment Modality,Sx & CTX-RT
1798,1,1,Nodal Stage,N2
1798,1,1,Initial Chemotherapy Agent,unknown
1798,1,1,Occurrence #,1st primary
1798,1,1,Status,Alive w/o disease
1798,1,1,Second Failure Type,no known failure
1798,1,1,First Failure Type,no known failure
1798,1,1,Metastasis,M0
1798,1,1,Radiation Dosage,63
1798,1,1,Tumor Site,oropharynx
1798,1,1,Research lab p16,p16 unknown
1798,1,1,Clinical lab p16,p16 unknown
1798,1,1,Tumor Stage,T1
1798,1,1,Research lab HPV,HPV unknown
1799,1,1,Overall Stage,IVa
1799,1,1,Research lab HPV,HPV unknown
1799,1,1,First Failure Type,no known failure
1799,1,1,Occurrence #,1st primary
1799,1,1,Radiation Dosage,70.2
1799,1,1,Research lab p16,p16 unknown
1799,1,1,Initial Chemotherapy Agent,cis
1799,1,1,Nodal Stage,N2
1799,1,1,Tumor Site,oropharynx
1799,1,1,Tumor Stage,T3
1799,1,1,Treatment Modality,CTX-RT
1799,1,1,Second Failure Type,no known failure
1799,1,1,Clinical lab p16,p16 unknown
1799,1,1,Metastasis,M0
1799,1,1,Status,Alive w/o disease
1800,1,1,Clinical lab p16,p16 unknown
1800,1,1,Treatment Modality,RT
1800,1,1,First Failure Type,no known failure
1800,1,1,Overall Stage,I
1800,1,1,Metastasis,M0
1800,1,1,Tumor Stage,T1
1800,1,1,Second Failure Type,no known failure
1800,1,1,Research lab p16,p16 unknown
1800,1,1,Research lab HPV,HPV unknown
1800,1,1,Tumor Site,oropharynx
1800,1,1,Status,Alive w/o disease
1800,1,1,Occurrence #,1st primary
1800,1,1,Nodal Stage,N0
1800,1,1,Radiation Dosage,66
1801,1,1,Metastasis,M0
1801,1,1,Treatment Modality,Unknown
1801,1,1,First Failure Type,no known failure
1801,1,1,Occurrence #,1st primary
1801,1,1,Overall Stage,II
1801,1,1,Status,Alive unk disease
1801,1,1,Second Failure Type,no known failure
1801,1,1,Research lab HPV,HPV unknown
1801,1,1,Tumor Site,oropharynx
1801,1,1,Clinical lab p16,p16 unknown
1801,1,1,Tumor Stage,T2
1801,1,1,Research lab p16,p16 unknown
1801,1,1,Nodal Stage,N0
1802,1,1,Research lab p16,p16 unknown
1802,1,1,Overall Stage,IVa
1802,1,1,Research lab HPV,HPV unknown
1802,1,1,Tumor Stage,T2
1802,1,1,Metastasis,M0
1802,1,1,Second Failure Type,no known failure
1802,1,1,Occurrence #,1st primary
1802,1,1,Treatment Modality,CTX-RT
1802,1,1,Clinical lab p16,p16 unknown
1802,1,1,Status,Alive w/o disease
1802,1,1,Tumor Site,oropharynx
1802,1,1,Nodal Stage,N2
1802,1,1,First Failure Type,no known failure
1803,1,1,Nodal Stage,N2
1803,1,1,Occurrence #,other primary
1803,1,1,Age at Death,57.3
1803,1,1,Status,Dead w/o disease
1803,1,1,First Failure Type,no known failure
1803,1,1,Tumor Stage,T1
1803,1,1,Clinical lab p16,p16 unknown
1803,1,1,Radiation Dosage,60
1803,1,1,Research lab HPV,HPV unknown
1803,1,1,Date of Death,2002-07-25 00:00:00
1803,1,1,Second Failure Type,no known failure
1803,1,1,Research lab p16,p16 unknown
1803,1,1,Initial Chemotherapy Agent,unknown
1803,1,1,Treatment Modality,Sx & CTX-RT
1803,1,1,Metastasis,M0
1803,1,1,Time to Death,1.3
1803,1,1,Overall Stage,IVa
1803,1,1,Tumor Site,hypopharynx
1804,1,1,Research lab p16,p16 unknown
1804,1,1,Tumor Site,hypopharynx
1804,1,1,Overall Stage,II
1804,1,1,Research lab HPV,HPV unknown
1804,1,1,Age at Death,69.9
1804,1,1,Metastasis,M0
1804,1,1,Nodal Stage,N0
1804,1,1,First Failure Type,no known failure
1804,1,1,Treatment Modality,Sx
1804,1,1,Time to Death,8.8
1804,1,1,Clinical lab p16,p16 unknown
1804,1,1,Second Failure Type,no known failure
1804,1,1,Occurrence #,other primary
1804,1,1,Status,Dead w/o disease
1804,1,1,Date of Death,2010-10-03 00:00:00
1804,1,1,Tumor Stage,T2
1805,1,1,Overall Stage,III
1805,1,1,Tumor Stage,Unknown
1805,1,1,First Failure Type,no known failure
1805,1,1,Occurrence #,other primary
1805,1,1,Date of Death,2011-08-25 00:00:00
1805,1,1,Tumor Site,hypopharynx
1805,1,1,Status,Dead unk disease
1805,1,1,Age at Death,66.5
1805,1,1,Second Failure Type,no known failure
1805,1,1,Treatment Modality,Sx
1805,1,1,Nodal Stage,N1
1805,1,1,Metastasis,Unknown
1805,1,1,Clinical lab p16,p16 unknown
1805,1,1,Research lab p16,p16 unknown
1805,1,1,Research lab HPV,HPV unknown
1805,1,1,Time to Death,4.4
1806,1,1,Date of Death,2010-08-20 00:00:00
1806,1,1,Research lab p16,p16 unknown
1806,1,1,First Failure Treatment Modality,Sx
1806,1,1,Time to First Failure,1.2
1806,1,1,Tumor Stage,T2
1806,1,1,Research lab HPV,HPV unknown
1806,1,1,Radiation Dosage,unknown
1806,1,1,Clinical lab p16,p16 unknown
1806,1,1,Tumor Site,oropharynx
1806,1,1,Metastasis,M0
1806,1,1,Treatment Modality,RT
1806,1,1,Overall Stage,II
1806,1,1,Second Failure Type,no known failure
1806,1,1,Age at Death,66.5
1806,1,1,Occurrence #,other primary
1806,1,1,First Failure Site,oropharynx
1806,1,1,Time to Death,1.9
1806,1,1,Nodal Stage,N0
1806,1,1,First Failure Type,locoregional
1806,1,1,Status,Dead w/ disease
1807,1,1,Research lab HPV,HPV negative
1807,1,1,Second Failure Type,no known failure
1807,1,1,Age at Death,50.7
1807,1,1,Research lab p16,p16 negative
1807,1,1,Date of Death,2007-07-01 00:00:00
1807,1,1,Tumor Site,oropharynx
1807,1,1,Nodal Stage,N1
1807,1,1,Metastasis,M0
1807,1,1,Time to Death,0.5
1807,1,1,Radiation Dosage,unknown
1807,1,1,First Failure Type,no known failure
1807,1,1,Status,Dead unk disease
1807,1,1,Overall Stage,IVb
1807,1,1,Treatment Modality,RT
1807,1,1,Tumor Stage,T4b
1807,1,1,Clinical lab p16,p16 unknown
1807,1,1,Occurrence #,other primary
1808,1,1,Metastasis,M0
1808,1,1,Research lab p16,p16 unknown
1808,1,1,Treatment Modality,Sx & CTX
1808,1,1,Occurrence #,other primary
1808,1,1,Tumor Site,oral cavity
1808,1,1,First Failure Type,locoregional
1808,1,1,Second Failure Type,no known failure
1808,1,1,Clinical lab p16,p16 unknown
1808,1,1,Time to First Failure,0.0
1808,1,1,Status,Dead w/ disease
1808,1,1,Research lab HPV,HPV unknown
1808,1,1,Date of Death,2007-04-10 00:00:00
1808,1,1,Initial Chemotherapy Agent,cis/PTX
1808,1,1,Age at Death,82.8
1808,1,1,Overall Stage,I
1808,1,1,Tumor Stage,T1
1808,1,1,Nodal Stage,N0
1809,1,1,Second Failure Type,no known failure
1809,1,1,Time to Death,0.2
1809,1,1,Nodal Stage,N0
1809,1,1,Occurrence #,recurrence
1809,1,1,Tumor Site,oropharynx
1809,1,1,Clinical lab p16,p16 unknown
1809,1,1,Tumor Stage,T3
1809,1,1,Research lab HPV,HPV negative
1809,1,1,Treatment Modality,Unknown
1809,1,1,First Failure Type,no known failure
1809,1,1,Status,Dead w/ disease
1809,1,1,Overall Stage,III
1809,1,1,Metastasis,M0
1809,1,1,Age at Death,55.1
1809,1,1,Research lab p16,p16 negative
1809,1,1,Date of Death,2006-03-03 00:00:00
1810,1,1,Tumor Stage,T4a
1810,1,1,Occurrence #,1st primary
1810,1,1,Status,Dead w/o disease
1810,1,1,Nodal Stage,N0
1810,1,1,First Failure Type,no known failure
1810,1,1,Age at Death,56.5
1810,1,1,Metastasis,M0
1810,1,1,Research lab HPV,HPV unknown
1810,1,1,Treatment Modality,CTX-RT
1810,1,1,Overall Stage,IVa
1810,1,1,Initial Chemotherapy Agent,carbo/PTX
1810,1,1,Time to Death,0.5
1810,1,1,Date of Death,2005-07-28 00:00:00
1810,1,1,Research lab p16,p16 unknown
1810,1,1,Radiation Dosage,70.2
1810,1,1,Second Failure Type,no known failure
1810,1,1,Tumor Site,larynx
1810,1,1,Clinical lab p16,p16 unknown
1811,1,1,Tumor Site,larynx
1811,1,1,Metastasis,M0
1811,1,1,Time to Death,2.4
1811,1,1,Overall Stage,IVa
1811,1,1,Initial Chemotherapy Agent,carbo/PTX
1811,1,1,Status,Dead unk disease
1811,1,1,First Failure Type,no known failure
1811,1,1,Treatment Modality,CTX-RT
1811,1,1,Date of Death,2003-04-13 00:00:00
1811,1,1,Research lab p16,p16 unknown
1811,1,1,Tumor Stage,T4a
1811,1,1,Age at Death,56.3
1811,1,1,Research lab HPV,HPV unknown
1811,1,1,Occurrence #,other primary
1811,1,1,Radiation Dosage,70.2
1811,1,1,Nodal Stage,N1
1811,1,1,Clinical lab p16,p16 unknown
1811,1,1,Second Failure Type,no known failure
1812,1,1,Status,Dead unk disease
1812,1,1,Time to Death,6.0
1812,1,1,Age at Death,46.5
1812,1,1,Second Failure Type,no known failure
1812,1,1,Tumor Site,oral cavity
1812,1,1,Time to First Failure,0.3
1812,1,1,First Failure Type,locoregional
1812,1,1,Tumor Stage,T2
1812,1,1,Occurrence #,other primary
1812,1,1,Clinical lab p16,p16 unknown
1812,1,1,Research lab HPV,HPV unknown
1812,1,1,Metastasis,M0
1812,1,1,Nodal Stage,N0
1812,1,1,Research lab p16,p16 unknown
1812,1,1,Overall Stage,II
1812,1,1,Treatment Modality,Sx
1812,1,1,Date of Death,1999-07-18 00:00:00
2222,1,1,Overall Stage,III
2222,1,1,Tumor Site,oral cavity
2222,1,1,Occurrence #,1st primary
2222,1,1,Metastasis,M0
2222,1,1,Nodal Stage,N0
2222,1,1,Second Failure Type,no known failure
2222,1,1,Status,Dead w/o disease
2222,1,1,Tumor Stage,T3
2222,1,1,First Failure Type,no known failure
2222,1,1,Clinical lab p16,p16 positive
2222,1,1,Research lab HPV,HPV positive
2222,1,1,Treatment Modality,Sx
2222,1,1,Research lab p16,p16 unknown
2223,1,1,Tumor Stage,T2
2223,1,1,Overall Stage,III
2223,1,1,Time to First Failure,0.3
2223,1,1,Treatment Modality,Sx
2223,1,1,First Failure Type,locoregional
2223,1,1,Nodal Stage,N2
2223,1,1,Occurrence #,recurrence
2223,1,1,Clinical lab p16,p16 positive
2223,1,1,Research lab HPV,HPV positive
2223,1,1,Tumor Site,oropharynx
2223,1,1,Metastasis,M0
2223,1,1,Status,Alive w/ disease
2223,1,1,Second Failure Type,no known failure
2223,1,1,Research lab p16,p16 unknown
3000,1,1,Occurrence #,1st primary
3000,1,1,Radiation Dosage,70.2
3000,1,1,Metastasis,M0
3000,1,1,Nodal Stage,N2
3000,1,1,Clinical lab p16,p16 positive
3000,1,1,Initial Chemotherapy Agent,Carbo
3000,1,1,Overall Stage,IVa
3000,1,1,Research lab HPV,HPV positive
3000,1,1,Treatment Modality,CTX-RT
3000,1,1,Tumor Stage,T1
3000,1,1,Tumor Site,oropharynx
3000,1,1,Research lab p16,p16 unknown
3000,1,1,Second Failure Type,no known failure
3000,1,1,Status,Alive w/o disease
3000,1,1,First Failure Type,no known failure
3001,1,1,Nodal Stage,N2
3001,1,1,Clinical lab p16,p16 positive
3001,1,1,Initial Chemotherapy Agent,cis
3001,1,1,Research lab HPV,HPV positive
3001,1,1,Treatment Modality,CTX-RT
3001,1,1,Second Failure Type,no known failure
3001,1,1,Research lab p16,p16 unknown
3001,1,1,Occurrence #,1st primary
3001,1,1,Metastasis,M0
3001,1,1,Status,Alive w/o disease
3001,1,1,Tumor Stage,T1
3001,1,1,Tumor Site,oropharynx
3001,1,1,Overall Stage,IVa
3001,1,1,First Failure Type,no known failure
3001,1,1,Radiation Dosage,70.2
3002,1,1,Status,Alive w/ disease
3002,1,1,Research lab HPV,HPV positive
3002,1,1,Treatment Modality,Sx
3002,1,1,Tumor Stage,T1
3002,1,1,Second Failure Type,no known failure
3002,1,1,Research lab p16,p16 unknown
3002,1,1,Tumor Site,oropharynx
3002,1,1,Metastasis,M0
3002,1,1,Clinical lab p16,p16 positive
3002,1,1,Nodal Stage,N2
3002,1,1,Overall Stage,IVa
3002,1,1,Occurrence #,1st primary
3002,1,1,First Failure Type,no known failure
3003,1,1,Metastasis,M0
3003,1,1,Overall Stage,I
3003,1,1,Treatment Modality,Sx & RT
3003,1,1,Tumor Site,oropharynx
3003,1,1,Research lab p16,p16 unknown
3003,1,1,Tumor Stage,T1
3003,1,1,Clinical lab p16,p16 positive
3003,1,1,Research lab HPV,HPV positive
3003,1,1,Status,Alive w/o disease
3003,1,1,Second Failure Type,no known failure
3003,1,1,First Failure Type,no known failure
3003,1,1,Radiation Dosage,unknown
3003,1,1,Occurrence #,1st primary
3003,1,1,Nodal Stage,N0
3004,1,1,Clinical lab p16,p16 positive
3004,1,1,Tumor Stage,T1
3004,1,1,Second Failure Type,no known failure
3004,1,1,Research lab HPV,HPV positive
3004,1,1,Research lab p16,p16 unknown
3004,1,1,Metastasis,M0
3004,1,1,First Failure Type,no known failure
3004,1,1,Initial Chemotherapy Agent,cis
3004,1,1,Nodal Stage,N2
3004,1,1,Overall Stage,IVa
3004,1,1,Occurrence #,1st primary
3004,1,1,Status,Alive w/o disease
3004,1,1,Tumor Site,oropharynx
3004,1,1,Radiation Dosage,70.2
3004,1,1,Treatment Modality,CTX-RT
3005,1,1,Clinical lab p16,p16 positive
3005,1,1,Treatment Modality,Sx & CTX-RT
3005,1,1,First Failure Type,no known failure
3005,1,1,Initial Chemotherapy Agent,Carbo
3005,1,1,Metastasis,M0
3005,1,1,Occurrence #,1st primary
3005,1,1,Nodal Stage,N3
3005,1,1,Overall Stage,IVb
3005,1,1,Status,Alive w/o disease
3005,1,1,Tumor Site,oropharynx
3005,1,1,Second Failure Type,no known failure
3005,1,1,Research lab HPV,HPV positive
3005,1,1,Tumor Stage,T2
3005,1,1,Radiation Dosage,70.2
3005,1,1,Research lab p16,p16 unknown
3006,1,1,Status,Alive unk disease
3006,1,1,Tumor Site,oropharynx
3006,1,1,Initial Chemotherapy Agent,cis
3006,1,1,Second Failure Type,no known failure
3006,1,1,Tumor Stage,T1
3006,1,1,Clinical lab p16,p16 positive
3006,1,1,Treatment Modality,Sx & CTX-RT
3006,1,1,Radiation Dosage,70.2
3006,1,1,Research lab p16,p16 unknown
3006,1,1,Research lab HPV,HPV positive
3006,1,1,First Failure Type,no known failure
3006,1,1,Occurrence #,1st primary
3006,1,1,Overall Stage,IVa
3006,1,1,Nodal Stage,N2
3006,1,1,Metastasis,M0
3007,1,1,First Failure Type,no known failure
3007,1,1,Status,Alive w/o disease
3007,1,1,Nodal Stage,N0
3007,1,1,Tumor Stage,T2
3007,1,1,Research lab HPV,HPV positive
3007,1,1,Overall Stage,II
3007,1,1,Treatment Modality,Sx
3007,1,1,Clinical lab p16,p16 positive
3007,1,1,Tumor Site,oropharynx
3007,1,1,Metastasis,M0
3007,1,1,Occurrence #,1st primary
3007,1,1,Research lab p16,p16 unknown
3007,1,1,Second Failure Type,no known failure
3008,1,1,Research lab HPV,HPV positive
3008,1,1,First Failure Radiation Dosage,palliative
3008,1,1,Occurrence #,1st primary
3008,1,1,Status,Alive w/ disease
3008,1,1,First Failure Initial Chemotherapy Agent,Carbo/doce
3008,1,1,Time to First Failure,2.9
3008,1,1,Clinical lab p16,p16 positive
3008,1,1,First Failure Second Line Chemotherapy Agent,Treme.+MEDI
3008,1,1,First Failure Type,distant
3008,1,1,Tumor Stage,T2
3008,1,1,Overall Stage,IVa
3008,1,1,Nodal Stage,N2
3008,1,1,Radiation Dosage,70.2
3008,1,1,Metastasis,M0
3008,1,1,Initial Chemotherapy Agent,Carbo/cetux
3008,1,1,Treatment Modality,Sx & CTX-RT
3008,1,1,Tumor Site,oropharynx
3008,1,1,Research lab p16,p16 unknown
3008,1,1,First Failure Treatment Modality,Sx & CTX
3008,1,1,Second Failure Type,no known failure
3009,1,1,Clinical lab p16,p16 positive
3009,1,1,Status,Alive w/o disease
3009,1,1,First Failure Type,no known failure
3009,1,1,Second Failure Type,no known failure
3009,1,1,Overall Stage,IVa
3009,1,1,Tumor Site,oropharynx
3009,1,1,Nodal Stage,N0
3009,1,1,Research lab p16,p16 unknown
3009,1,1,Radiation Dosage,70.2
3009,1,1,Initial Chemotherapy Agent,cis
3009,1,1,Research lab HPV,HPV positive
3009,1,1,Tumor Stage,T4a
3009,1,1,Treatment Modality,CTX-RT
3009,1,1,Metastasis,M0
3009,1,1,Occurrence #,1st primary
3010,1,1,Tumor Stage,T1
3010,1,1,Occurrence #,1st primary
3010,1,1,First Failure Type,no known failure
3010,1,1,Research lab p16,p16 unknown
3010,1,1,Radiation Dosage,70.2
3010,1,1,Status,Alive w/o disease
3010,1,1,Research lab HPV,HPV positive
3010,1,1,Overall Stage,IVa
3010,1,1,Initial Chemotherapy Agent,cis
3010,1,1,Metastasis,M0
3010,1,1,Nodal Stage,N2
3010,1,1,Tumor Site,oropharynx
3010,1,1,Second Failure Type,no known failure
3010,1,1,Clinical lab p16,p16 positive
3010,1,1,Treatment Modality,CTX-RT
3011,1,1,Metastasis,M0
3011,1,1,Treatment Modality,Sx
3011,1,1,Nodal Stage,N0
3011,1,1,Overall Stage,I
3011,1,1,Occurrence #,1st primary
3011,1,1,Status,Alive w/o disease
3011,1,1,Tumor Site,oral cavity
3011,1,1,First Failure Type,no known failure
3011,1,1,Research lab p16,p16 unknown
3011,1,1,Tumor Stage,T1
3011,1,1,Clinical lab p16,p16 positive
3011,1,1,Second Failure Type,no known failure
3011,1,1,Research lab HPV,HPV positive
3012,1,1,Radiation Dosage,68.4
3012,1,1,Research lab HPV,HPV positive
3012,1,1,Research lab p16,p16 unknown
3012,1,1,Treatment Modality,CTX-RT
3012,1,1,Initial Chemotherapy Agent,cis
3012,1,1,Status,Alive w/o disease
3012,1,1,Second Failure Type,no known failure
3012,1,1,Occurrence #,1st primary
3012,1,1,Tumor Site,oropharynx
3012,1,1,Metastasis,M0
3012,1,1,Overall Stage,IVa
3012,1,1,Clinical lab p16,p16 positive
3012,1,1,First Failure Type,no known failure
3012,1,1,Tumor Stage,T1
3012,1,1,Nodal Stage,N2
3013,1,1,Metastasis,M0
3013,1,1,Research lab p16,p16 unknown
3013,1,1,First Failure Type,no known failure
3013,1,1,Nodal Stage,N2
3013,1,1,Second Failure Type,no known failure
3013,1,1,Clinical lab p16,p16 positive
3013,1,1,Occurrence #,1st primary
3013,1,1,Treatment Modality,CTX-RT
3013,1,1,Overall Stage,IVa
3013,1,1,Tumor Site,oropharynx
3013,1,1,Status,Alive w/o disease
3013,1,1,Initial Chemotherapy Agent,cis
3013,1,1,Tumor Stage,T1
3013,1,1,Radiation Dosage,70.2
3013,1,1,Research lab HPV,HPV positive
3014,1,1,First Failure Treatment Modality,Sx
3014,1,1,Initial Chemotherapy Agent,carbo
3014,1,1,Metastasis,M0
3014,1,1,Clinical lab p16,p16 positive
3014,1,1,Radiation Dosage,70.2
3014,1,1,Treatment Modality,CTX-RT
3014,1,1,Tumor Site,oropharynx
3014,1,1,Overall Stage,III
3014,1,1,First Failure Site,oropharynx
3014,1,1,Nodal Stage,N1
3014,1,1,Tumor Stage,T2
3014,1,1,Research lab p16,p16 unknown
3014,1,1,Occurrence #,1st primary
3014,1,1,Research lab HPV,HPV positive
3014,1,1,Second Failure Type,no known failure
3014,1,1,Status,Alive w/o disease
3014,1,1,First Failure Type,no known failure
3015,1,1,Second Failure Type,no known failure
3015,1,1,Status,Alive w/o disease
3015,1,1,Metastasis,M0
3015,1,1,First Failure Type,no known failure
3015,1,1,Tumor Stage,T1
3015,1,1,Overall Stage,IVa
3015,1,1,Initial Chemotherapy Agent,cis
3015,1,1,Tumor Site,oropharynx
3015,1,1,Research lab p16,p16 unknown
3015,1,1,Occurrence #,1st primary
3015,1,1,Research lab HPV,HPV positive
3015,1,1,Treatment Modality,CTX-RT
3015,1,1,Nodal Stage,N2
3015,1,1,Radiation Dosage,70.2
3015,1,1,Clinical lab p16,p16 positive
3016,1,1,Metastasis,M0
3016,1,1,Status,Alive w/o disease
3016,1,1,Tumor Site,oropharynx
3016,1,1,Overall Stage,III
3016,1,1,Research lab HPV,HPV positive
3016,1,1,Nodal Stage,N1
3016,1,1,Tumor Stage,T2
3016,1,1,First Failure Type,no known failure
3016,1,1,Occurrence #,1st primary
3016,1,1,Initial Chemotherapy Agent,cis
3016,1,1,Clinical lab p16,p16 positive
3016,1,1,Radiation Dosage,70.2
3016,1,1,Second Failure Type,no known failure
3016,1,1,Research lab p16,p16 unknown
3016,1,1,Treatment Modality,Sx & CTX-RT
3017,1,1,Treatment Modality,Sx & CTX-RT
3017,1,1,Overall Stage,I
3017,1,1,Status,Alive w/o disease
3017,1,1,Metastasis,M0
3017,1,1,Radiation Dosage,66
3017,1,1,Research lab HPV,HPV positive
3017,1,1,Initial Chemotherapy Agent,Cis
3017,1,1,First Failure Type,no known failure
3017,1,1,Occurrence #,1st primary
3017,1,1,Research lab p16,p16 unknown
3017,1,1,Second Failure Type,no known failure
3017,1,1,Nodal Stage,N0
3017,1,1,Tumor Stage,T1
3017,1,1,Clinical lab p16,p16 positive
3017,1,1,Tumor Site,oropharynx
3018,1,1,Second Failure Type,no known failure
3018,1,1,Occurrence #,other primary
3018,1,1,First Failure Site,multiple
3018,1,1,Clinical lab p16,p16 positive
3018,1,1,Metastasis,M1
3018,1,1,Research lab p16,p16 unknown
3018,1,1,Treatment Modality,CTX-RT
3018,1,1,Tumor Site,oropharynx
3018,1,1,Initial Chemotherapy Agent,cis
3018,1,1,Research lab HPV,HPV positive
3018,1,1,First Failure Initial Chemotherapy Agent,cetux
3018,1,1,Tumor Stage,T2
3018,1,1,Status,Dead w/ disease
3018,1,1,Overall Stage,IVc
3018,1,1,Radiation Dosage,70.2
3018,1,1,First Failure Treatment Modality,Sx & CTX
3018,1,1,Nodal Stage,N2
3018,1,1,First Failure Type,no known failure
3019,1,1,Radiation Dosage,70.2
3019,1,1,Research lab HPV,HPV positive
3019,1,1,Overall Stage,IVa
3019,1,1,Clinical lab p16,p16 positive
3019,1,1,Research lab p16,p16 unknown
3019,1,1,Status,Dead w/o disease
3019,1,1,Occurrence #,1st primary
3019,1,1,First Failure Type,no known failure
3019,1,1,Nodal Stage,N2
3019,1,1,Tumor Stage,T1
3019,1,1,Initial Chemotherapy Agent,Carbo
3019,1,1,Second Failure Type,no known failure
3019,1,1,Treatment Modality,CTX-RT
3019,1,1,Metastasis,M0
3019,1,1,Tumor Site,oropharynx
3020,1,1,Tumor Site,oropharynx
3020,1,1,Nodal Stage,N2
3020,1,1,Metastasis,M0
3020,1,1,Research lab HPV,HPV positive
3020,1,1,Treatment Modality,CTX-RT
3020,1,1,First Failure Type,no known failure
3020,1,1,Overall Stage,IVa
3020,1,1,Clinical lab p16,p16 positive
3020,1,1,Research lab p16,p16 unknown
3020,1,1,Tumor Stage,T2
3020,1,1,Status,Dead w/ disease
3020,1,1,Initial Chemotherapy Agent,cis
3020,1,1,Radiation Dosage,70.2
3020,1,1,Second Failure Type,no known failure
3020,1,1,Occurrence #,1st primary
3021,1,1,Nodal Stage,N2
3021,1,1,First Failure Type,no known failure
3021,1,1,Research lab HPV,HPV positive
3021,1,1,Tumor Site,oropharynx
3021,1,1,Overall Stage,IVa
3021,1,1,Metastasis,M0
3021,1,1,Initial Chemotherapy Agent,carbo
3021,1,1,Radiation Dosage,14
3021,1,1,Tumor Stage,T2
3021,1,1,Research lab p16,p16 unknown
3021,1,1,Clinical lab p16,p16 positive
3021,1,1,Second Failure Type,no known failure
3021,1,1,Status,Dead w/ disease
3021,1,1,Occurrence #,1st primary
3021,1,1,Treatment Modality,CTX-RT
3022,1,1,Initial Chemotherapy Agent,cis
3022,1,1,Research lab HPV,HPV positive
3022,1,1,Second Failure Type,no known failure
3022,1,1,Metastasis,M0
3022,1,1,Radiation Dosage,70.2
3022,1,1,Overall Stage,IVa
3022,1,1,Research lab p16,p16 unknown
3022,1,1,Tumor Stage,T2
3022,1,1,Treatment Modality,Sx & CTX-RT
3022,1,1,Clinical lab p16,p16 positive
3022,1,1,Status,Alive w/o disease
3022,1,1,First Failure Type,no known failure
3022,1,1,Nodal Stage,N2
3022,1,1,Second Line Chemotherapy Agent,Carbo
3022,1,1,Tumor Site,oropharynx
3022,1,1,Occurrence #,1st primary
3023,1,1,Radiation Dosage,70.2
3023,1,1,Nodal Stage,N1
3023,1,1,Initial Chemotherapy Agent,cis
3023,1,1,Clinical lab p16,p16 positive
3023,1,1,Second Failure Type,no known failure
3023,1,1,Research lab HPV,HPV positive
3023,1,1,Status,Alive w/o disease
3023,1,1,Research lab p16,p16 unknown
3023,1,1,Occurrence #,1st primary
3023,1,1,Treatment Modality,CTX-RT
3023,1,1,Tumor Site,oropharynx
3023,1,1,First Failure Type,no known failure
3023,1,1,Metastasis,M0
3023,1,1,Overall Stage,III
3023,1,1,Tumor Stage,T2
3024,1,1,Tumor Stage,T1
3024,1,1,Overall Stage,I
3024,1,1,First Failure Type,no known failure
3024,1,1,Clinical lab p16,p16 positive
3024,1,1,Occurrence #,1st primary
3024,1,1,Status,Alive w/o disease
3024,1,1,Tumor Site,oral cavity
3024,1,1,Nodal Stage,N0
3024,1,1,Research lab HPV,HPV positive
3024,1,1,Treatment Modality,Sx
3024,1,1,Metastasis,M0
3024,1,1,Second Failure Type,no known failure
3024,1,1,Research lab p16,p16 unknown
3025,1,1,Tumor Site,oral cavity
3025,1,1,Tumor Stage,T4a
3025,1,1,First Failure Type,no known failure
3025,1,1,Overall Stage,IVa
3025,1,1,Treatment Modality,Sx & RT
3025,1,1,Metastasis,M0
3025,1,1,Occurrence #,1st primary
3025,1,1,Status,Alive w/o disease
3025,1,1,Clinical lab p16,p16 positive
3025,1,1,Nodal Stage,N0
3025,1,1,Research lab p16,p16 unknown
3025,1,1,Research lab HPV,HPV positive
3025,1,1,Second Failure Type,no known failure
3025,1,1,Radiation Dosage,59.4
3026,1,1,Treatment Modality,Sx & CTX-RT
3026,1,1,Research lab HPV,HPV positive
3026,1,1,Research lab p16,p16 unknown
3026,1,1,Metastasis,M0
3026,1,1,Overall Stage,III
3026,1,1,First Failure Treatment Modality,Sx
3026,1,1,Second Line Chemotherapy Agent,carbo
3026,1,1,Occurrence #,1st primary
3026,1,1,First Failure Type,no known failure
3026,1,1,Nodal Stage,N1
3026,1,1,Status,Alive w/o disease
3026,1,1,First Failure Site,oral cavity
3026,1,1,Second Failure Type,no known failure
3026,1,1,Radiation Dosage,63
3026,1,1,Initial Chemotherapy Agent,Cis
3026,1,1,Tumor Site,oral cavity
3026,1,1,Tumor Stage,T1
3026,1,1,Clinical lab p16,p16 positive
3027,1,1,Occurrence #,1st primary
3027,1,1,Clinical lab p16,p16 positive
3027,1,1,First Failure Type,no known failure
3027,1,1,Overall Stage,IVa
3027,1,1,Metastasis,M0
3027,1,1,Tumor Stage,T3
3027,1,1,Tumor Site,oropharynx
3027,1,1,Nodal Stage,N2
3027,1,1,Treatment Modality,CTX-RT
3027,1,1,Research lab p16,p16 unknown
3027,1,1,Research lab HPV,HPV positive
3027,1,1,Status,Alive w/o disease
3027,1,1,Initial Chemotherapy Agent,cis
3027,1,1,Radiation Dosage,70.2
3027,1,1,Second Failure Type,no known failure
3028,1,1,Occurrence #,1st primary
3028,1,1,Overall Stage,IVa
3028,1,1,Status,Alive w/o disease
3028,1,1,Metastasis,M0
3028,1,1,Research lab p16,p16 unknown
3028,1,1,Radiation Dosage,70.2
3028,1,1,Clinical lab p16,p16 positive
3028,1,1,Nodal Stage,N2
3028,1,1,Second Failure Type,no known failure
3028,1,1,Treatment Modality,Sx & CTX-RT
3028,1,1,Tumor Site,oropharynx
3028,1,1,Initial Chemotherapy Agent,cis
3028,1,1,First Failure Type,no known failure
3028,1,1,Tumor Stage,T3
3028,1,1,Research lab HPV,HPV positive
3029,1,1,Treatment Modality,Sx
3029,1,1,First Failure Type,no known failure
3029,1,1,Clinical lab p16,p16 positive
3029,1,1,Occurrence #,1st primary
3029,1,1,Status,Alive w/o disease
3029,1,1,Research lab p16,p16 unknown
3029,1,1,Metastasis,M0
3029,1,1,Nodal Stage,N0
3029,1,1,Research lab HPV,HPV positive
3029,1,1,Tumor Stage,T2
3029,1,1,Overall Stage,II
3029,1,1,Second Failure Type,no known failure
3029,1,1,Tumor Site,oropharynx
3030,1,1,Second Line Chemotherapy Agent,Cis
3030,1,1,Metastasis,M0
3030,1,1,Clinical lab p16,p16 positive
3030,1,1,Tumor Stage,T2
3030,1,1,Second Failure Type,no known failure
3030,1,1,First Failure Type,no known failure
3030,1,1,Status,Alive w/o disease
3030,1,1,Tumor Site,oropharynx
3030,1,1,Research lab HPV,HPV positive
3030,1,1,Radiation Dosage,63
3030,1,1,Overall Stage,IVb
3030,1,1,Research lab p16,p16 unknown
3030,1,1,Treatment Modality,Sx & CTX-RT
3030,1,1,Occurrence #,1st primary
3030,1,1,Nodal Stage,N3
3030,1,1,Initial Chemotherapy Agent,carbo/doce
3031,1,1,Metastasis,M0
3031,1,1,Nodal Stage,N2
3031,1,1,Radiation Dosage,63
3031,1,1,Research lab p16,p16 unknown
3031,1,1,Status,Alive w/o disease
3031,1,1,First Failure Type,no known failure
3031,1,1,Treatment Modality,Sx & CTX-RT
3031,1,1,Occurrence #,1st primary
3031,1,1,Research lab HPV,HPV positive
3031,1,1,Tumor Stage,T4a
3031,1,1,Initial Chemotherapy Agent,cis
3031,1,1,Tumor Site,oropharynx
3031,1,1,Clinical lab p16,p16 positive
3031,1,1,Overall Stage,IVa
3031,1,1,Second Failure Type,no known failure
3032,1,1,Research lab HPV,HPV positive
3032,1,1,Initial Chemotherapy Agent,Cis
3032,1,1,Treatment Modality,Sx & CTX-RT
3032,1,1,Research lab p16,p16 unknown
3032,1,1,Overall Stage,IVa
3032,1,1,Nodal Stage,N1
3032,1,1,First Failure Type,no known failure
3032,1,1,Radiation Dosage,72
3032,1,1,Clinical lab p16,p16 positive
3032,1,1,Occurrence #,1st primary
3032,1,1,Second Failure Type,no known failure
3032,1,1,Status,Alive w/o disease
3032,1,1,Metastasis,M0
3032,1,1,Tumor Stage,T4a
3032,1,1,Tumor Site,oropharynx
3033,1,1,Tumor Stage,T2
3033,1,1,Occurrence #,1st primary
3033,1,1,Metastasis,M0
3033,1,1,Research lab HPV,HPV positive
3033,1,1,Overall Stage,II
3033,1,1,Nodal Stage,N0
3033,1,1,First Failure Type,no known failure
3033,1,1,Research lab p16,p16 unknown
3033,1,1,Treatment Modality,Sx
3033,1,1,Tumor Site,oral cavity
3033,1,1,Second Failure Type,no known failure
3033,1,1,Status,Alive w/o disease
3033,1,1,Clinical lab p16,p16 positive
3034,1,1,Metastasis,M0
3034,1,1,Clinical lab p16,p16 positive
3034,1,1,Treatment Modality,CTX-RT
3034,1,1,Overall Stage,IVa
3034,1,1,Radiation Dosage,70.2
3034,1,1,Status,Alive w/o disease
3034,1,1,Initial Chemotherapy Agent,cis
3034,1,1,Tumor Stage,T1
3034,1,1,Tumor Site,oropharynx
3034,1,1,Research lab p16,p16 unknown
3034,1,1,Research lab HPV,HPV positive
3034,1,1,Second Failure Type,no known failure
3034,1,1,Occurrence #,1st primary
3034,1,1,First Failure Type,no known failure
3034,1,1,Nodal Stage,N2
3035,1,1,Status,Alive w/o disease
3035,1,1,Overall Stage,I
3035,1,1,Treatment Modality,Sx
3035,1,1,Research lab p16,p16 unknown
3035,1,1,Second Failure Type,no known failure
3035,1,1,Nodal Stage,N0
3035,1,1,Metastasis,M0
3035,1,1,Tumor Site,oral cavity
3035,1,1,Research lab HPV,HPV positive
3035,1,1,First Failure Type,no known failure
3035,1,1,Clinical lab p16,p16 positive
3035,1,1,Occurrence #,1st primary
3035,1,1,Tumor Stage,T1
3036,1,1,Research lab HPV,HPV positive
3036,1,1,Treatment Modality,CTX-RT
3036,1,1,Metastasis,M0
3036,1,1,Radiation Dosage,70.2
3036,1,1,Tumor Site,oropharynx
3036,1,1,Tumor Stage,T1
3036,1,1,Second Failure Type,no known failure
3036,1,1,Research lab p16,p16 unknown
3036,1,1,Status,Alive w/o disease
3036,1,1,First Failure Type,no known failure
3036,1,1,Nodal Stage,N2
3036,1,1,Occurrence #,1st primary
3036,1,1,Initial Chemotherapy Agent,Cis/carbo
3036,1,1,Overall Stage,IVa
3036,1,1,Clinical lab p16,p16 positive
3037,1,1,Treatment Modality,Sx
3037,1,1,Metastasis,M0
3037,1,1,First Failure Type,no known failure
3037,1,1,Second Failure Type,no known failure
3037,1,1,Tumor Stage,T1
3037,1,1,Research lab p16,p16 unknown
3037,1,1,Occurrence #,1st primary
3037,1,1,Tumor Site,oral cavity
3037,1,1,Overall Stage,I
3037,1,1,Clinical lab p16,p16 positive
3037,1,1,Research lab HPV,HPV positive
3037,1,1,Nodal Stage,N0
3037,1,1,Status,Alive w/ disease
3038,1,1,Second Failure Type,no known failure
3038,1,1,Overall Stage,III
3038,1,1,First Failure Type,no known failure
3038,1,1,Nodal Stage,N1
3038,1,1,Research lab p16,p16 unknown
3038,1,1,Initial Chemotherapy Agent,cis
3038,1,1,Occurrence #,1st primary
3038,1,1,Radiation Dosage,70.2
3038,1,1,Metastasis,M0
3038,1,1,Clinical lab p16,p16 positive
3038,1,1,Research lab HPV,HPV positive
3038,1,1,Treatment Modality,CTX-RT
3038,1,1,Tumor Stage,T3
3038,1,1,Tumor Site,oropharynx
3038,1,1,Status,Alive w/o disease
3039,1,1,Treatment Modality,Sx
3039,1,1,Clinical lab p16,p16 positive
3039,1,1,Status,Alive w/o disease
3039,1,1,Nodal Stage,N0
3039,1,1,Overall Stage,I
3039,1,1,First Failure Treatment Modality,Sx
3039,1,1,Research lab HPV,HPV positive
3039,1,1,Tumor Site,oral cavity
3039,1,1,Metastasis,M0
3039,1,1,Research lab p16,p16 unknown
3039,1,1,Tumor Stage,T1
3039,1,1,Second Failure Type,no known failure
3039,1,1,First Failure Type,no known failure
3039,1,1,Occurrence #,1st primary
3039,1,1,First Failure Site,oral cavity
3040,1,1,Nodal Stage,N2
3040,1,1,Second Failure Type,no known failure
3040,1,1,Occurrence #,1st primary
3040,1,1,Research lab HPV,HPV positive
3040,1,1,Clinical lab p16,p16 positive
3040,1,1,Tumor Stage,T1
3040,1,1,Overall Stage,IVa
3040,1,1,Tumor Site,oropharynx
3040,1,1,Metastasis,M0
3040,1,1,Research lab p16,p16 unknown
3040,1,1,First Failure Type,no known failure
3040,1,1,Radiation Dosage,63
3040,1,1,Status,Alive w/o disease
3040,1,1,Treatment Modality,Sx & CTX-RT
3040,1,1,Initial Chemotherapy Agent,cis
3041,1,1,Radiation Dosage,63
3041,1,1,Metastasis,M0
3041,1,1,Nodal Stage,N2
3041,1,1,Clinical lab p16,p16 positive
3041,1,1,Overall Stage,IVa
3041,1,1,Tumor Stage,T2
3041,1,1,Status,Dead w/o disease
3041,1,1,Tumor Site,oral cavity
3041,1,1,Second Failure Type,no known failure
3041,1,1,Initial Chemotherapy Agent,carbo
3041,1,1,First Failure Type,no known failure
3041,1,1,Occurrence #,1st primary
3041,1,1,Treatment Modality,Sx & CTX-RT
3041,1,1,Research lab p16,p16 unknown
3041,1,1,Research lab HPV,HPV positive
3042,1,1,Nodal Stage,N2
3042,1,1,Overall Stage,IVa
3042,1,1,Status,Dead w/o disease
3042,1,1,First Failure Type,no known failure
3042,1,1,Metastasis,M0
3042,1,1,Research lab p16,p16 unknown
3042,1,1,Tumor Stage,T2
3042,1,1,Clinical lab p16,p16 positive
3042,1,1,Occurrence #,1st primary
3042,1,1,Treatment Modality,Sx
3042,1,1,Research lab HPV,HPV positive
3042,1,1,Second Failure Type,no known failure
3042,1,1,Tumor Site,oral cavity
3043,1,1,Clinical lab p16,p16 positive
3043,1,1,Tumor Site,oral cavity
3043,1,1,Second Failure Type,no known failure
3043,1,1,First Failure Treatment Modality,Sx & CTX-RT
3043,1,1,First Failure Type,no known failure
3043,1,1,Treatment Modality,Sx & CTX-RT
3043,1,1,Research lab HPV,HPV positive
3043,1,1,Tumor Stage,T3
3043,1,1,Status,Dead w/o disease
3043,1,1,Overall Stage,IVa
3043,1,1,Metastasis,M0
3043,1,1,Research lab p16,p16 unknown
3043,1,1,First Failure Radiation Dosage,60
3043,1,1,Radiation Dosage,64
3043,1,1,First Failure Second Line Chemotherapy Agent,Nivo
3043,1,1,Initial Chemotherapy Agent,cis
3043,1,1,Nodal Stage,N2
3043,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
3043,1,1,Occurrence #,1st primary
3044,1,1,Research lab HPV,HPV positive
3044,1,1,Treatment Modality,CTX-RT
3044,1,1,Clinical lab p16,p16 positive
3044,1,1,Overall Stage,IVa
3044,1,1,Initial Chemotherapy Agent,cis
3044,1,1,Radiation Dosage,70.2
3044,1,1,Research lab p16,p16 unknown
3044,1,1,Second Failure Type,no known failure
3044,1,1,First Failure Type,no known failure
3044,1,1,Status,Dead w/o disease
3044,1,1,Occurrence #,1st primary
3044,1,1,Tumor Stage,T4a
3044,1,1,Tumor Site,oropharynx
3044,1,1,Nodal Stage,N2
3044,1,1,Metastasis,M0
3045,1,1,Overall Stage,IVa
3045,1,1,Clinical lab p16,p16 positive
3045,1,1,Tumor Site,oral cavity
3045,1,1,Metastasis,M0
3045,1,1,Research lab HPV,HPV positive
3045,1,1,First Failure Type,no known failure
3045,1,1,Occurrence #,1st primary
3045,1,1,Tumor Stage,T4a
3045,1,1,Nodal Stage,N1
3045,1,1,Second Failure Type,no known failure
3045,1,1,Status,Dead w/ disease
3045,1,1,Treatment Modality,Sx
3045,1,1,Research lab p16,p16 unknown
3046,1,1,First Failure Site,oropharynx
3046,1,1,Second Failure Type,no known failure
3046,1,1,Tumor Site,oropharynx
3046,1,1,Clinical lab p16,p16 positive
3046,1,1,First Failure Treatment Modality,Sx & RT
3046,1,1,Occurrence #,1st primary
3046,1,1,Research lab HPV,HPV positive
3046,1,1,First Failure Radiation Dosage,66
3046,1,1,Treatment Modality,Sx
3046,1,1,Status,Dead w/o disease
3046,1,1,Overall Stage,I
3046,1,1,Nodal Stage,N0
3046,1,1,First Failure Type,no known failure
3046,1,1,Tumor Stage,T1
3046,1,1,Research lab p16,p16 unknown
3046,1,1,Metastasis,M0
3047,1,1,Nodal Stage,N0
3047,1,1,Research lab HPV,HPV positive
3047,1,1,Status,Dead w/o disease
3047,1,1,Occurrence #,recurrence
3047,1,1,First Failure Treatment Modality,Sx
3047,1,1,Clinical lab p16,p16 positive
3047,1,1,Treatment Modality,Sx & RT
3047,1,1,Overall Stage,I
3047,1,1,Tumor Site,oral cavity
3047,1,1,Tumor Stage,T1
3047,1,1,Research lab p16,p16 unknown
3047,1,1,Second Failure Type,no known failure
3047,1,1,First Failure Site,larynx
3047,1,1,Metastasis,M0
3047,1,1,First Failure Type,no known failure
3048,1,1,Status,Alive w/o disease
3048,1,1,Nodal Stage,N0
3048,1,1,Overall Stage,II
3048,1,1,Tumor Site,oropharynx
3048,1,1,Research lab HPV,HPV positive
3048,1,1,Initial Chemotherapy Agent,cis
3048,1,1,Clinical lab p16,p16 positive
3048,1,1,Research lab p16,p16 unknown
3048,1,1,First Failure Type,no known failure
3048,1,1,Second Failure Type,no known failure
3048,1,1,Occurrence #,1st primary
3048,1,1,Tumor Stage,T2
3048,1,1,Treatment Modality,CTX-RT
3048,1,1,Radiation Dosage,71.4
3048,1,1,Metastasis,M0
3049,1,1,Treatment Modality,CTX-RT
3049,1,1,Tumor Site,oropharynx
3049,1,1,Metastasis,M0
3049,1,1,First Failure Treatment Modality,Sx
3049,1,1,Overall Stage,IVa
3049,1,1,Status,Alive w/o disease
3049,1,1,Clinical lab p16,p16 positive
3049,1,1,First Failure Type,no known failure
3049,1,1,Radiation Dosage,70.2
3049,1,1,Occurrence #,1st primary
3049,1,1,Nodal Stage,N2
3049,1,1,Second Failure Type,no known failure
3049,1,1,Initial Chemotherapy Agent,cis
3049,1,1,Research lab p16,p16 unknown
3049,1,1,Tumor Stage,T2
3049,1,1,Research lab HPV,HPV positive
3050,1,1,Nodal Stage,N0
3050,1,1,Overall Stage,I
3050,1,1,Status,Alive w/o disease
3050,1,1,Second Failure Type,no known failure
3050,1,1,Research lab p16,p16 unknown
3050,1,1,Clinical lab p16,p16 positive
3050,1,1,First Failure Type,no known failure
3050,1,1,Occurrence #,1st primary
3050,1,1,Metastasis,M0
3050,1,1,Tumor Stage,T1
3050,1,1,Tumor Site,oral cavity
3050,1,1,Treatment Modality,Sx
3050,1,1,Research lab HPV,HPV positive
3051,1,1,First Failure Type,no known failure
3051,1,1,Tumor Stage,T2
3051,1,1,Metastasis,M0
3051,1,1,Treatment Modality,Sx
3051,1,1,Research lab HPV,HPV positive
3051,1,1,Clinical lab p16,p16 positive
3051,1,1,Tumor Site,oropharynx
3051,1,1,Nodal Stage,N2
3051,1,1,Research lab p16,p16 unknown
3051,1,1,Occurrence #,1st primary
3051,1,1,Overall Stage,IVa
3051,1,1,Second Failure Type,no known failure
3051,1,1,Status,Alive w/ disease
3052,1,1,Radiation Dosage,70.2
3052,1,1,Status,Alive w/o disease
3052,1,1,First Failure Type,no known failure
3052,1,1,Second Line Chemotherapy Agent,Carbo
3052,1,1,Overall Stage,IVa
3052,1,1,Tumor Site,oropharynx
3052,1,1,Research lab HPV,HPV positive
3052,1,1,Tumor Stage,T1
3052,1,1,Metastasis,M0
3052,1,1,Second Failure Type,no known failure
3052,1,1,Treatment Modality,CTX-RT
3052,1,1,Clinical lab p16,p16 positive
3052,1,1,Research lab p16,p16 unknown
3052,1,1,Initial Chemotherapy Agent,cis
3052,1,1,Nodal Stage,N2
3052,1,1,Occurrence #,1st primary
3053,1,1,Tumor Site,oropharynx
3053,1,1,Status,Alive w/o disease
3053,1,1,Treatment Modality,CTX-RT
3053,1,1,Second Failure Type,no known failure
3053,1,1,Overall Stage,III
3053,1,1,Tumor Stage,T2
3053,1,1,Nodal Stage,N1
3053,1,1,Metastasis,M0
3053,1,1,Radiation Dosage,68
3053,1,1,Research lab HPV,HPV positive
3053,1,1,Clinical lab p16,p16 positive
3053,1,1,Initial Chemotherapy Agent,cis
3053,1,1,Occurrence #,1st primary
3053,1,1,Research lab p16,p16 unknown
3053,1,1,First Failure Type,no known failure
3054,1,1,Nodal Stage,N0
3054,1,1,Overall Stage,I
3054,1,1,Tumor Site,oral cavity
3054,1,1,Research lab p16,p16 unknown
3054,1,1,Metastasis,M0
3054,1,1,Treatment Modality,Sx
3054,1,1,Tumor Stage,T1
3054,1,1,Occurrence #,1st primary
3054,1,1,First Failure Type,no known failure
3054,1,1,Research lab HPV,HPV positive
3054,1,1,Second Failure Type,no known failure
3054,1,1,Status,Alive w/o disease
3054,1,1,Clinical lab p16,p16 positive
3055,1,1,First Failure Treatment Modality,Sx
3055,1,1,Research lab p16,p16 unknown
3055,1,1,Occurrence #,other primary
3055,1,1,Research lab HPV,HPV positive
3055,1,1,First Failure Type,no known failure
3055,1,1,Clinical lab p16,p16 positive
3055,1,1,Treatment Modality,Sx
3055,1,1,Second Failure Type,no known failure
3055,1,1,Tumor Site,oral cavity
3055,1,1,Tumor Stage,T1
3055,1,1,First Failure Site,oral cavity
3055,1,1,Overall Stage,I
3055,1,1,Nodal Stage,N0
3055,1,1,Status,Alive w/o disease
3055,1,1,Metastasis,M0
3056,1,1,Radiation Dosage,70.2
3056,1,1,Treatment Modality,CTX-RT
3056,1,1,Research lab HPV,HPV positive
3056,1,1,Metastasis,M0
3056,1,1,Occurrence #,1st primary
3056,1,1,First Failure Type,no known failure
3056,1,1,Initial Chemotherapy Agent,cis
3056,1,1,Clinical lab p16,p16 positive
3056,1,1,Second Failure Type,no known failure
3056,1,1,Second Line Chemotherapy Agent,Carbo
3056,1,1,Overall Stage,IVa
3056,1,1,Tumor Stage,T1
3056,1,1,Status,Alive w/o disease
3056,1,1,Nodal Stage,N2
3056,1,1,Research lab p16,p16 unknown
3056,1,1,Tumor Site,oropharynx
3057,1,1,Research lab p16,p16 unknown
3057,1,1,Treatment Modality,CTX-RT
3057,1,1,Second Failure Type,no known failure
3057,1,1,Radiation Dosage,70.2
3057,1,1,Occurrence #,1st primary
3057,1,1,Tumor Stage,T4a
3057,1,1,Clinical lab p16,p16 positive
3057,1,1,Overall Stage,IVa
3057,1,1,Tumor Site,oropharynx
3057,1,1,Status,Alive w/o disease
3057,1,1,Nodal Stage,N2
3057,1,1,Initial Chemotherapy Agent,Carbo/doce
3057,1,1,Metastasis,M0
3057,1,1,Research lab HPV,HPV positive
3057,1,1,First Failure Type,no known failure
3058,1,1,Status,Alive w/o disease
3058,1,1,Overall Stage,III
3058,1,1,Clinical lab p16,p16 positive
3058,1,1,Second Failure Type,no known failure
3058,1,1,Initial Chemotherapy Agent,cis
3058,1,1,First Failure Type,no known failure
3058,1,1,Nodal Stage,N0
3058,1,1,Research lab p16,p16 unknown
3058,1,1,Radiation Dosage,70.2
3058,1,1,Metastasis,M0
3058,1,1,Occurrence #,1st primary
3058,1,1,Tumor Stage,T3
3058,1,1,Treatment Modality,Sx & CTX-RT
3058,1,1,Tumor Site,oropharynx
3058,1,1,Research lab HPV,HPV positive
3059,1,1,Treatment Modality,Sx
3059,1,1,Clinical lab p16,p16 positive
3059,1,1,Second Failure Type,no known failure
3059,1,1,Metastasis,M0
3059,1,1,Tumor Stage,T1
3059,1,1,Tumor Site,oropharynx
3059,1,1,Research lab HPV,HPV positive
3059,1,1,Research lab p16,p16 unknown
3059,1,1,Nodal Stage,N0
3059,1,1,Overall Stage,I
3059,1,1,First Failure Type,no known failure
3059,1,1,Occurrence #,1st primary
3059,1,1,Status,Dead w/ disease
3060,1,1,Tumor Stage,T1
3060,1,1,Occurrence #,1st primary
3060,1,1,Research lab HPV,HPV positive
3060,1,1,Clinical lab p16,p16 positive
3060,1,1,Second Failure Type,no known failure
3060,1,1,Nodal Stage,N2
3060,1,1,Treatment Modality,Sx
3060,1,1,First Failure Type,no known failure
3060,1,1,Status,Dead w/ disease
3060,1,1,Research lab p16,p16 unknown
3060,1,1,Metastasis,M0
3060,1,1,Tumor Site,oral cavity
3060,1,1,Overall Stage,IVa
3061,1,1,Tumor Site,oropharynx
3061,1,1,Research lab p16,p16 unknown
3061,1,1,Tumor Stage,T2
3061,1,1,First Failure Type,no known failure
3061,1,1,Initial Chemotherapy Agent,carbo
3061,1,1,Status,Alive w/o disease
3061,1,1,Occurrence #,1st primary
3061,1,1,Research lab HPV,HPV positive
3061,1,1,Overall Stage,IVa
3061,1,1,Radiation Dosage,70.2
3061,1,1,Second Failure Type,no known failure
3061,1,1,Treatment Modality,CTX-RT
3061,1,1,Metastasis,M0
3061,1,1,Nodal Stage,N2
3061,1,1,Clinical lab p16,p16 unknown
3062,1,1,Nodal Stage,N2
3062,1,1,Initial Chemotherapy Agent,Carbo/PTX
3062,1,1,Treatment Modality,CTX-RT
3062,1,1,Radiation Dosage,70
3062,1,1,Tumor Site,oropharynx
3062,1,1,Overall Stage,IVa
3062,1,1,Metastasis,M0
3062,1,1,Research lab HPV,HPV positive
3062,1,1,Status,Alive w/o disease
3062,1,1,Clinical lab p16,p16 unknown
3062,1,1,Research lab p16,p16 unknown
3062,1,1,First Failure Type,no known failure
3062,1,1,Tumor Stage,T3
3062,1,1,Second Failure Type,no known failure
3062,1,1,Occurrence #,1st primary
3063,1,1,Tumor Site,oropharynx
3063,1,1,Research lab p16,p16 unknown
3063,1,1,Nodal Stage,N2
3063,1,1,Metastasis,M0
3063,1,1,Initial Chemotherapy Agent,cis
3063,1,1,Radiation Dosage,70.2
3063,1,1,Overall Stage,IVb
3063,1,1,Treatment Modality,CTX-RT
3063,1,1,Occurrence #,1st primary
3063,1,1,First Failure Type,no known failure
3063,1,1,Clinical lab p16,p16 unknown
3063,1,1,Status,Dead w/ disease
3063,1,1,Tumor Stage,T4a
3063,1,1,Second Failure Type,no known failure
3063,1,1,Research lab HPV,HPV positive
3064,1,1,Nodal Stage,N2
3064,1,1,Tumor Stage,T2
3064,1,1,Metastasis,M0
3064,1,1,Clinical lab p16,p16 negative
3064,1,1,Overall Stage,IVa
3064,1,1,Radiation Dosage,70.2
3064,1,1,Treatment Modality,Sx & CTX-RT
3064,1,1,Research lab HPV,HPV negative
3064,1,1,Initial Chemotherapy Agent,Carbo
3064,1,1,First Failure Treatment Modality,Sx
3064,1,1,First Failure Type,no known failure
3064,1,1,Research lab p16,p16 unknown
3064,1,1,First Failure Radiation Dosage,30
3064,1,1,Second Failure Type,no known failure
3064,1,1,Status,Dead w/ disease
3064,1,1,Tumor Site,oropharynx
3064,1,1,Occurrence #,other primary
3065,1,1,Nodal Stage,Unknown
3065,1,1,Status,Alive w/o disease
3065,1,1,Overall Stage,Unknown
3065,1,1,Research lab HPV,HPV negative
3065,1,1,Occurrence #,other primary
3065,1,1,Treatment Modality,Sx
3065,1,1,Second Failure Type,no known failure
3065,1,1,Tumor Site,oral cavity
3065,1,1,Tumor Stage,Unknown
3065,1,1,First Failure Type,no known failure
3065,1,1,Metastasis,Unknown
3065,1,1,Clinical lab p16,p16 negative
3065,1,1,Research lab p16,p16 unknown
3066,1,1,Overall Stage,Unknown
3066,1,1,First Failure Type,no known failure
3066,1,1,Occurrence #,1st primary
3066,1,1,Tumor Site,oral cavity
3066,1,1,Second Failure Type,no known failure
3066,1,1,Treatment Modality,Sx
3066,1,1,Tumor Stage,Unknown
3066,1,1,Status,Alive w/o disease
3066,1,1,Metastasis,Unknown
3066,1,1,Research lab p16,p16 unknown
3066,1,1,Research lab HPV,HPV negative
3066,1,1,Nodal Stage,Unknown
3066,1,1,Clinical lab p16,p16 negative
3067,1,1,Treatment Modality,Sx
3067,1,1,Second Failure Type,no known failure
3067,1,1,Clinical lab p16,p16 negative
3067,1,1,First Failure Type,no known failure
3067,1,1,Overall Stage,Unknown
3067,1,1,Research lab HPV,HPV negative
3067,1,1,Nodal Stage,Unknown
3067,1,1,Status,Alive w/o disease
3067,1,1,Tumor Site,oral cavity
3067,1,1,Tumor Stage,Unknown
3067,1,1,Metastasis,Unknown
3067,1,1,Research lab p16,p16 unknown
3067,1,1,Occurrence #,1st primary
3068,1,1,Second Failure Type,no known failure
3068,1,1,Overall Stage,Unknown
3068,1,1,Tumor Site,oral cavity
3068,1,1,Status,Alive w/o disease
3068,1,1,Occurrence #,1st primary
3068,1,1,Tumor Stage,Unknown
3068,1,1,Clinical lab p16,p16 negative
3068,1,1,Nodal Stage,Unknown
3068,1,1,Research lab p16,p16 unknown
3068,1,1,Treatment Modality,Sx
3068,1,1,Research lab HPV,HPV negative
3068,1,1,Metastasis,Unknown
3068,1,1,First Failure Type,no known failure
3069,1,1,First Failure Type,locoregional
3069,1,1,Metastasis,M0
3069,1,1,Treatment Modality,Sx
3069,1,1,Nodal Stage,N0
3069,1,1,Research lab p16,p16 unknown
3069,1,1,Time to First Failure,0.0
3069,1,1,Overall Stage,I
3069,1,1,Tumor Stage,T1
3069,1,1,Research lab HPV,HPV negative
3069,1,1,Clinical lab p16,p16 negative
3069,1,1,Status,Alive w/ disease
3069,1,1,Tumor Site,oral cavity
3069,1,1,Occurrence #,recurrence
3069,1,1,Second Failure Type,no known failure
3070,1,1,Occurrence #,1st primary
3070,1,1,Research lab p16,p16 unknown
3070,1,1,Status,Alive w/o disease
3070,1,1,Nodal Stage,N0
3070,1,1,First Failure Type,no known failure
3070,1,1,Tumor Site,oral cavity
3070,1,1,Metastasis,M0
3070,1,1,Tumor Stage,T1
3070,1,1,Research lab HPV,HPV negative
3070,1,1,Clinical lab p16,p16 negative
3070,1,1,Treatment Modality,Sx
3070,1,1,Second Failure Type,no known failure
3070,1,1,Overall Stage,I
3071,1,1,Clinical lab p16,p16 negative
3071,1,1,Research lab HPV,HPV negative
3071,1,1,Status,Alive w/o disease
3071,1,1,Metastasis,M0
3071,1,1,Overall Stage,I
3071,1,1,Tumor Site,oral cavity
3071,1,1,Treatment Modality,Sx
3071,1,1,Occurrence #,1st primary
3071,1,1,Research lab p16,p16 unknown
3071,1,1,Tumor Stage,T1
3071,1,1,Nodal Stage,N0
3071,1,1,First Failure Type,no known failure
3071,1,1,Second Failure Type,no known failure
3072,1,1,First Failure Type,no known failure
3072,1,1,Tumor Stage,Unknown
3072,1,1,Status,Alive w/o disease
3072,1,1,Second Failure Type,no known failure
3072,1,1,Tumor Site,oral cavity
3072,1,1,Treatment Modality,Sx
3072,1,1,Research lab HPV,HPV negative
3072,1,1,Nodal Stage,Unknown
3072,1,1,Clinical lab p16,p16 negative
3072,1,1,Research lab p16,p16 unknown
3072,1,1,Metastasis,Unknown
3072,1,1,Overall Stage,Unknown
3072,1,1,Occurrence #,1st primary
3073,1,1,Nodal Stage,N2
3073,1,1,Tumor Stage,T1
3073,1,1,Treatment Modality,Sx & CTX-RT
3073,1,1,Initial Chemotherapy Agent,Cis
3073,1,1,Clinical lab p16,p16 negative
3073,1,1,Tumor Site,oral cavity
3073,1,1,Status,Alive w/o disease
3073,1,1,Research lab HPV,HPV negative
3073,1,1,Second Failure Type,no known failure
3073,1,1,Occurrence #,1st primary
3073,1,1,Research lab p16,p16 unknown
3073,1,1,Radiation Dosage,66
3073,1,1,First Failure Type,no known failure
3073,1,1,Metastasis,M0
3073,1,1,Overall Stage,IVa
3074,1,1,Overall Stage,II
3074,1,1,Occurrence #,1st primary
3074,1,1,Second Failure Type,no known failure
3074,1,1,Tumor Site,oral cavity
3074,1,1,Clinical lab p16,p16 negative
3074,1,1,Tumor Stage,T2
3074,1,1,Metastasis,M0
3074,1,1,Research lab p16,p16 unknown
3074,1,1,First Failure Site,oral cavity
3074,1,1,Nodal Stage,N0
3074,1,1,Status,Alive w/o disease
3074,1,1,First Failure Treatment Modality,Sx
3074,1,1,Research lab HPV,HPV negative
3074,1,1,First Failure Type,no known failure
3074,1,1,Treatment Modality,Sx
3075,1,1,Second Failure Type,no known failure
3075,1,1,Tumor Site,oral cavity
3075,1,1,Research lab HPV,HPV negative
3075,1,1,Status,Alive w/o disease
3075,1,1,Tumor Stage,Unknown
3075,1,1,Overall Stage,Unknown
3075,1,1,Metastasis,Unknown
3075,1,1,Occurrence #,1st primary
3075,1,1,Research lab p16,p16 unknown
3075,1,1,First Failure Type,no known failure
3075,1,1,Nodal Stage,Unknown
3075,1,1,Clinical lab p16,p16 negative
3075,1,1,Treatment Modality,Sx
3076,1,1,Treatment Modality,Sx
3076,1,1,Tumor Stage,Unknown
3076,1,1,Tumor Site,oral cavity
3076,1,1,Metastasis,Unknown
3076,1,1,Overall Stage,Unknown
3076,1,1,Occurrence #,1st primary
3076,1,1,Second Failure Type,no known failure
3076,1,1,Research lab p16,p16 unknown
3076,1,1,Research lab HPV,HPV negative
3076,1,1,Nodal Stage,Unknown
3076,1,1,Clinical lab p16,p16 negative
3076,1,1,Status,Alive w/o disease
3076,1,1,First Failure Type,no known failure
3077,1,1,Status,Alive w/o disease
3077,1,1,Nodal Stage,Unknown
3077,1,1,Research lab p16,p16 unknown
3077,1,1,Occurrence #,1st primary
3077,1,1,Research lab HPV,HPV negative
3077,1,1,Second Failure Type,no known failure
3077,1,1,Overall Stage,Unknown
3077,1,1,Treatment Modality,Sx
3077,1,1,Tumor Stage,Unknown
3077,1,1,First Failure Type,no known failure
3077,1,1,Metastasis,Unknown
3077,1,1,Tumor Site,oral cavity
3077,1,1,Clinical lab p16,p16 negative
3078,1,1,Treatment Modality,Sx
3078,1,1,Clinical lab p16,p16 negative
3078,1,1,Status,Alive w/o disease
3078,1,1,Nodal Stage,Unknown
3078,1,1,Tumor Stage,Unknown
3078,1,1,First Failure Type,no known failure
3078,1,1,Research lab p16,p16 unknown
3078,1,1,Overall Stage,Unknown
3078,1,1,Occurrence #,1st primary
3078,1,1,Metastasis,Unknown
3078,1,1,Second Failure Type,no known failure
3078,1,1,Tumor Site,oral cavity
3078,1,1,Research lab HPV,HPV negative
3079,1,1,Research lab p16,p16 unknown
3079,1,1,Overall Stage,II
3079,1,1,Nodal Stage,N0
3079,1,1,Research lab HPV,HPV negative
3079,1,1,First Failure Type,no known failure
3079,1,1,Occurrence #,1st primary
3079,1,1,Metastasis,M0
3079,1,1,Radiation Dosage,60
3079,1,1,Tumor Stage,T2
3079,1,1,Tumor Site,oropharynx
3079,1,1,Status,Dead w/o disease
3079,1,1,Clinical lab p16,p16 negative
3079,1,1,Treatment Modality,Sx & RT
3079,1,1,Second Failure Type,no known failure
3080,1,1,Occurrence #,1st primary
3080,1,1,First Failure Type,no known failure
3080,1,1,Second Failure Type,no known failure
3080,1,1,Metastasis,M0
3080,1,1,Tumor Site,oral cavity
3080,1,1,Status,Dead w/ disease
3080,1,1,Treatment Modality,CTX
3080,1,1,Overall Stage,IVa
3080,1,1,Nodal Stage,N2
3080,1,1,Initial Chemotherapy Agent,PTX/Ifosfamide/carbo
3080,1,1,Research lab HPV,HPV negative
3080,1,1,Tumor Stage,T4a
3080,1,1,Clinical lab p16,p16 negative
3080,1,1,Research lab p16,p16 unknown
3081,1,1,Overall Stage,IVa
3081,1,1,Radiation Dosage,75.9
3081,1,1,Nodal Stage,N2
3081,1,1,Second Failure Type,no known failure
3081,1,1,First Failure Type,locoregional and distant
3081,1,1,Treatment Modality,CTX-RT
3081,1,1,Tumor Stage,T4a
3081,1,1,Metastasis,M0
3081,1,1,Clinical lab p16,p16 negative
3081,1,1,Second Line Chemotherapy Agent,Carbo
3081,1,1,Occurrence #,1st primary
3081,1,1,Tumor Site,oral cavity
3081,1,1,Research lab HPV,HPV negative
3081,1,1,Time to First Failure,-0.1
3081,1,1,Initial Chemotherapy Agent,Cis/doce/5FU
3081,1,1,Status,Dead w/ disease
3081,1,1,Research lab p16,p16 unknown
3082,1,1,First Failure Type,no known failure
3082,1,1,Nodal Stage,N0
3082,1,1,Tumor Stage,T2
3082,1,1,Clinical lab p16,p16 negative
3082,1,1,Research lab p16,p16 unknown
3082,1,1,Second Failure Type,no known failure
3082,1,1,Occurrence #,1st primary
3082,1,1,Overall Stage,II
3082,1,1,Metastasis,M0
3082,1,1,Treatment Modality,Sx
3082,1,1,Status,Dead w/ disease
3082,1,1,Research lab HPV,HPV negative
3082,1,1,Tumor Site,oral cavity
3083,1,1,Tumor Site,oropharynx
3083,1,1,Research lab HPV,HPV negative
3083,1,1,First Failure Type,no known failure
3083,1,1,Age at Death,57.3
3083,1,1,Date of Death,2012-01-31 00:00:00
3083,1,1,Tumor Stage,T4a
3083,1,1,Clinical lab p16,p16 negative
3083,1,1,Metastasis,M0
3083,1,1,Treatment Modality,Unknown
3083,1,1,Second Failure Type,no known failure
3083,1,1,Occurrence #,1st primary
3083,1,1,Overall Stage,IVb
3083,1,1,Nodal Stage,N2
3083,1,1,Research lab p16,p16 unknown
3083,1,1,Status,Dead w/ disease
3083,1,1,Time to Death,0.1
3084,1,1,Metastasis,M0
3084,1,1,Treatment Modality,Sx
3084,1,1,Clinical lab p16,p16 negative
3084,1,1,Overall Stage,I
3084,1,1,Tumor Stage,T1
3084,1,1,Occurrence #,1st primary
3084,1,1,Status,Alive w/o disease
3084,1,1,Tumor Site,oral cavity
3084,1,1,Research lab HPV,HPV negative
3084,1,1,First Failure Type,no known failure
3084,1,1,Research lab p16,p16 unknown
3084,1,1,Second Failure Type,no known failure
3084,1,1,Nodal Stage,N0
3085,1,1,Initial Chemotherapy Agent,TPF/5FU
3085,1,1,First Failure Type,locoregional
3085,1,1,Treatment Modality,CTX
3085,1,1,Second Failure Type,no known failure
3085,1,1,Clinical lab p16,p16 negative
3085,1,1,Overall Stage,IVb
3085,1,1,Metastasis,M0
3085,1,1,Second Line Chemotherapy Agent,Carbo
3085,1,1,Date of Death,2013-04-15 00:00:00
3085,1,1,Occurrence #,1st primary
3085,1,1,Nodal Stage,N3
3085,1,1,Research lab p16,p16 unknown
3085,1,1,Status,Dead w/ disease
3085,1,1,Time to First Failure,0.2
3085,1,1,Research lab HPV,HPV negative
3085,1,1,Time to Death,0.4
3085,1,1,Tumor Site,oropharynx
3085,1,1,Age at Death,43.1
3085,1,1,Tumor Stage,T4a
3086,1,1,Treatment Modality,CTX-RT
3086,1,1,Initial Chemotherapy Agent,carbo
3086,1,1,Nodal Stage,N2
3086,1,1,Age at Death,52.5
3086,1,1,Time to Death,0.9
3086,1,1,Date of Death,2013-08-13 00:00:00
3086,1,1,Research lab HPV,HPV negative
3086,1,1,Second Failure Type,no known failure
3086,1,1,Clinical lab p16,p16 negative
3086,1,1,Research lab p16,p16 unknown
3086,1,1,First Failure Type,no known failure
3086,1,1,Metastasis,M0
3086,1,1,Overall Stage,IVa
3086,1,1,Tumor Stage,T4a
3086,1,1,Occurrence #,1st primary
3086,1,1,Tumor Site,oropharynx
3086,1,1,Status,Dead w/o disease
3087,1,1,Treatment Modality,CTX-RT
3087,1,1,Tumor Stage,T2
3087,1,1,Date of Death,2015-04-26 00:00:00
3087,1,1,Status,Dead w/ disease
3087,1,1,Second Line Chemotherapy Agent,Cis/5FU
3087,1,1,Research lab p16,p16 unknown
3087,1,1,Radiation Dosage,60
3087,1,1,Age at Death,49.2
3087,1,1,Overall Stage,IVc
3087,1,1,First Failure Type,distant
3087,1,1,Metastasis,M1
3087,1,1,Tumor Site,oropharynx
3087,1,1,Second Failure Type,no known failure
3087,1,1,Clinical lab p16,p16 negative
3087,1,1,Occurrence #,1st primary
3087,1,1,Time to First Failure,0.4
3087,1,1,Nodal Stage,N2
3087,1,1,Initial Chemotherapy Agent,Cis/doce/5FU
3087,1,1,Research lab HPV,HPV negative
3087,1,1,Time to Death,2.8
3088,1,1,Clinical lab p16,p16 negative
3088,1,1,Tumor Stage,T4a
3088,1,1,Research lab HPV,HPV negative
3088,1,1,Metastasis,M0
3088,1,1,Time to Death,0.3
3088,1,1,Treatment Modality,Sx
3088,1,1,Research lab p16,p16 unknown
3088,1,1,Second Failure Type,no known failure
3088,1,1,Nodal Stage,N2
3088,1,1,Date of Death,2014-02-01 00:00:00
3088,1,1,Tumor Site,oropharynx
3088,1,1,Occurrence #,other primary
3088,1,1,Status,Dead w/ disease
3088,1,1,Age at Death,61.8
3088,1,1,First Failure Type,no known failure
3088,1,1,Overall Stage,IVa
3089,1,1,Tumor Site,oropharynx
3089,1,1,Overall Stage,IVa
3089,1,1,Research lab HPV,HPV negative
3089,1,1,Clinical lab p16,p16 negative
3089,1,1,Occurrence #,1st primary
3089,1,1,First Failure Type,no known failure
3089,1,1,Tumor Stage,T4a
3089,1,1,Metastasis,M0
3089,1,1,Time to Death,0.0
3089,1,1,Treatment Modality,CTX-RT
3089,1,1,Research lab p16,p16 unknown
3089,1,1,Initial Chemotherapy Agent,cis
3089,1,1,Radiation Dosage,70.2
3089,1,1,Status,Dead w/ disease
3089,1,1,Age at Death,36.9
3089,1,1,Date of Death,2011-02-24 00:00:00
3089,1,1,Nodal Stage,N2
3089,1,1,Second Failure Type,no known failure
3090,1,1,Research lab HPV,HPV negative
3090,1,1,Tumor Site,oral cavity
3090,1,1,Research lab p16,p16 unknown
3090,1,1,First Failure Site,oropharynx
3090,1,1,Status,Alive w/ disease
3090,1,1,Treatment Modality,Sx
3090,1,1,Nodal Stage,N0
3090,1,1,Second Failure Type,no known failure
3090,1,1,Time to First Failure,2.2
3090,1,1,Overall Stage,IVa
3090,1,1,First Failure Type,locoregional
3090,1,1,Metastasis,M0
3090,1,1,Tumor Stage,T4a
3090,1,1,Clinical lab p16,p16 negative
3090,1,1,Occurrence #,1st primary
3091,1,1,Occurrence #,1st primary
3091,1,1,First Failure Type,no known failure
3091,1,1,Nodal Stage,N0
3091,1,1,Overall Stage,II
3091,1,1,Second Failure Type,no known failure
3091,1,1,Status,Alive w/o disease
3091,1,1,Metastasis,M0
3091,1,1,Research lab p16,p16 unknown
3091,1,1,Tumor Stage,T2
3091,1,1,Research lab HPV,HPV negative
3091,1,1,Clinical lab p16,p16 negative
3091,1,1,Tumor Site,oral cavity
3091,1,1,Treatment Modality,Sx
3092,1,1,Status,Alive w/o disease
3092,1,1,Nodal Stage,N2
3092,1,1,Research lab HPV,HPV negative
3092,1,1,Initial Chemotherapy Agent,cis
3092,1,1,Research lab p16,p16 unknown
3092,1,1,Occurrence #,1st primary
3092,1,1,Overall Stage,IVa
3092,1,1,Metastasis,M0
3092,1,1,Tumor Stage,T1
3092,1,1,Clinical lab p16,p16 negative
3092,1,1,Tumor Site,oral cavity
3092,1,1,Treatment Modality,Sx & CTX-RT
3092,1,1,Radiation Dosage,60
3092,1,1,Second Failure Type,no known failure
3092,1,1,First Failure Type,no known failure
3093,1,1,Nodal Stage,N2
3093,1,1,Metastasis,M0
3093,1,1,First Failure Type,no known failure
3093,1,1,First Failure Site,oropharynx
3093,1,1,First Failure Treatment Modality,Sx & RT
3093,1,1,Clinical lab p16,p16 negative
3093,1,1,Overall Stage,IVa
3093,1,1,Second Failure Type,no known failure
3093,1,1,Initial Chemotherapy Agent,cis
3093,1,1,Tumor Stage,T4a
3093,1,1,First Failure Second Line Chemotherapy Agent,Carbo/AUC
3093,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
3093,1,1,Treatment Modality,Sx & CTX-RT
3093,1,1,Research lab p16,p16 unknown
3093,1,1,Radiation Dosage,70.2
3093,1,1,Status,Alive w/ disease
3093,1,1,Occurrence #,1st primary
3093,1,1,Research lab HPV,HPV negative
3093,1,1,Tumor Site,oropharynx
3094,1,1,Occurrence #,1st primary
3094,1,1,Tumor Stage,T2
3094,1,1,Metastasis,M0
3094,1,1,Research lab p16,p16 unknown
3094,1,1,Clinical lab p16,p16 negative
3094,1,1,First Failure Type,no known failure
3094,1,1,Radiation Dosage,unknown
3094,1,1,Status,Alive w/o disease
3094,1,1,Research lab HPV,HPV negative
3094,1,1,Overall Stage,II
3094,1,1,Nodal Stage,N0
3094,1,1,Treatment Modality,Sx & RT
3094,1,1,Second Failure Type,no known failure
3094,1,1,Tumor Site,oral cavity
3095,1,1,Tumor Stage,T4a
3095,1,1,Occurrence #,1st primary
3095,1,1,Overall Stage,IVb
3095,1,1,Clinical lab p16,p16 negative
3095,1,1,Second Failure Type,no known failure
3095,1,1,Radiation Dosage,70.2
3095,1,1,Tumor Site,oropharynx
3095,1,1,Research lab p16,p16 unknown
3095,1,1,First Failure Type,no known failure
3095,1,1,Metastasis,M0
3095,1,1,Treatment Modality,CTX-RT
3095,1,1,Initial Chemotherapy Agent,cis
3095,1,1,Status,Alive w/o disease
3095,1,1,Nodal Stage,N3
3095,1,1,Research lab HPV,HPV negative
3096,1,1,Status,Dead w/ disease
3096,1,1,Tumor Stage,T1
3096,1,1,Treatment Modality,Sx
3096,1,1,Research lab p16,p16 unknown
3096,1,1,Research lab HPV,HPV negative
3096,1,1,Tumor Site,oropharynx
3096,1,1,Metastasis,M0
3096,1,1,Second Failure Type,no known failure
3096,1,1,Overall Stage,I
3096,1,1,First Failure Type,no known failure
3096,1,1,Clinical lab p16,p16 negative
3096,1,1,Occurrence #,1st primary
3096,1,1,Nodal Stage,N0
3097,1,1,Treatment Modality,CTX-RT
3097,1,1,Tumor Site,oropharynx
3097,1,1,Second Failure Type,no known failure
3097,1,1,Radiation Dosage,70.2
3097,1,1,Occurrence #,1st primary
3097,1,1,Nodal Stage,N2
3097,1,1,First Failure Type,no known failure
3097,1,1,Metastasis,M0
3097,1,1,Research lab p16,p16 unknown
3097,1,1,Clinical lab p16,p16 negative
3097,1,1,Overall Stage,IVa
3097,1,1,Tumor Stage,T3
3097,1,1,Research lab HPV,HPV negative
3097,1,1,Status,Dead w/ disease
3097,1,1,Initial Chemotherapy Agent,cis
3098,1,1,Occurrence #,1st primary
3098,1,1,Status,Dead w/ disease
3098,1,1,First Failure Type,no known failure
3098,1,1,Clinical lab p16,p16 negative
3098,1,1,Nodal Stage,N0
3098,1,1,Tumor Stage,T2
3098,1,1,Metastasis,M0
3098,1,1,Research lab p16,p16 unknown
3098,1,1,Treatment Modality,Sx
3098,1,1,Overall Stage,II
3098,1,1,Second Failure Type,no known failure
3098,1,1,Research lab HPV,HPV negative
3098,1,1,Tumor Site,oral cavity
3099,1,1,First Failure Initial Chemotherapy Agent,cis
3099,1,1,Research lab HPV,HPV negative
3099,1,1,Metastasis,M0
3099,1,1,First Failure Type,no known failure
3099,1,1,First Failure Treatment Modality,Sx & CTX-RT
3099,1,1,Nodal Stage,N2
3099,1,1,Status,Dead w/ disease
3099,1,1,Overall Stage,IVa
3099,1,1,Second Failure Type,no known failure
3099,1,1,Treatment Modality,Sx
3099,1,1,Tumor Site,oral cavity
3099,1,1,Research lab p16,p16 unknown
3099,1,1,Tumor Stage,T4a
3099,1,1,Occurrence #,1st primary
3099,1,1,Clinical lab p16,p16 negative
3099,1,1,First Failure Site,oral cavity
3100,1,1,Overall Stage,IVa
3100,1,1,Research lab HPV,HPV negative
3100,1,1,Occurrence #,1st primary
3100,1,1,Tumor Site,oral cavity
3100,1,1,Metastasis,M0
3100,1,1,Clinical lab p16,p16 negative
3100,1,1,Treatment Modality,Sx
3100,1,1,Second Failure Type,no known failure
3100,1,1,Tumor Stage,T2
3100,1,1,First Failure Type,no known failure
3100,1,1,Status,Dead w/o disease
3100,1,1,Nodal Stage,N2
3100,1,1,Research lab p16,p16 unknown
3101,1,1,First Failure Type,no known failure
3101,1,1,Research lab p16,p16 unknown
3101,1,1,Radiation Dosage,60
3101,1,1,Clinical lab p16,p16 negative
3101,1,1,Tumor Stage,T2
3101,1,1,Treatment Modality,Sx & CTX-RT
3101,1,1,Second Failure Type,no known failure
3101,1,1,Metastasis,M0
3101,1,1,Occurrence #,1st primary
3101,1,1,Status,Dead w/ disease
3101,1,1,Nodal Stage,N2
3101,1,1,Overall Stage,IVa
3101,1,1,Tumor Site,oral cavity
3101,1,1,Research lab HPV,HPV negative
3101,1,1,Initial Chemotherapy Agent,Carbo
3102,1,1,Status,Dead w/o disease
3102,1,1,First Failure Type,no known failure
3102,1,1,Research lab p16,p16 unknown
3102,1,1,Nodal Stage,N2
3102,1,1,Overall Stage,IVa
3102,1,1,Metastasis,M0
3102,1,1,Second Failure Type,no known failure
3102,1,1,Treatment Modality,Sx
3102,1,1,Clinical lab p16,p16 negative
3102,1,1,Tumor Stage,T3
3102,1,1,Research lab HPV,HPV negative
3102,1,1,Occurrence #,1st primary
3102,1,1,Tumor Site,oral cavity
3103,1,1,Research lab p16,p16 unknown
3103,1,1,Status,Dead w/ disease
3103,1,1,Treatment Modality,CTX-RT
3103,1,1,First Failure Type,no known failure
3103,1,1,Metastasis,M0
3103,1,1,Tumor Stage,T4a
3103,1,1,Second Failure Type,no known failure
3103,1,1,Radiation Dosage,70.2
3103,1,1,Overall Stage,IVa
3103,1,1,Research lab HPV,HPV negative
3103,1,1,Tumor Site,oropharynx
3103,1,1,Initial Chemotherapy Agent,cis
3103,1,1,Occurrence #,1st primary
3103,1,1,Nodal Stage,N2
3103,1,1,Clinical lab p16,p16 negative
3104,1,1,Overall Stage,IVc
3104,1,1,Status,Dead w/ disease
3104,1,1,Nodal Stage,N2
3104,1,1,Clinical lab p16,p16 negative
3104,1,1,Tumor Stage,T4a
3104,1,1,Occurrence #,other primary
3104,1,1,First Failure Type,no known failure
3104,1,1,Research lab p16,p16 unknown
3104,1,1,Radiation Dosage,70
3104,1,1,Second Failure Type,no known failure
3104,1,1,Research lab HPV,HPV negative
3104,1,1,Treatment Modality,CTX-RT
3104,1,1,Metastasis,M1
3104,1,1,Initial Chemotherapy Agent,cis
3104,1,1,Tumor Site,oropharynx
3105,1,1,Metastasis,M1
3105,1,1,Age at Death,77.4
3105,1,1,Tumor Site,oropharynx
3105,1,1,Clinical lab p16,p16 negative
3105,1,1,Nodal Stage,N2
3105,1,1,Date of Death,2015-01-15 00:00:00
3105,1,1,Occurrence #,1st primary
3105,1,1,Initial Chemotherapy Agent,Carbo/doce
3105,1,1,Status,Dead w/ disease
3105,1,1,First Failure Second Line Chemotherapy Agent,cetux
3105,1,1,First Failure Initial Chemotherapy Agent,carbo/pemetrexed
3105,1,1,Time to First Failure,0.1
3105,1,1,Tumor Stage,T3
3105,1,1,Overall Stage,IVc
3105,1,1,Time to Death,1.0
3105,1,1,Research lab HPV,HPV negative
3105,1,1,Treatment Modality,CTX
3105,1,1,First Failure Type,distant
3105,1,1,Research lab p16,p16 unknown
3105,1,1,Second Failure Type,no known failure
3106,1,1,Tumor Site,oral cavity
3106,1,1,Overall Stage,IVa
3106,1,1,Date of Death,2015-04-08 00:00:00
3106,1,1,Occurrence #,1st primary
3106,1,1,Status,Dead w/ disease
3106,1,1,First Failure Treatment Modality,Sx & CTX
3106,1,1,Clinical lab p16,p16 negative
3106,1,1,Metastasis,M0
3106,1,1,Research lab p16,p16 unknown
3106,1,1,Radiation Dosage,63
3106,1,1,Age at Death,53.7
3106,1,1,First Failure Type,locoregional
3106,1,1,Treatment Modality,Sx & CTX-RT
3106,1,1,Second Failure Type,no known failure
3106,1,1,Research lab HPV,HPV negative
3106,1,1,Time to First Failure,0.3
3106,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
3106,1,1,Tumor Stage,T1
3106,1,1,Time to Death,1.0
3106,1,1,Nodal Stage,N2
3106,1,1,Initial Chemotherapy Agent,cis
3107,1,1,Research lab HPV,HPV negative
3107,1,1,Nodal Stage,N0
3107,1,1,Date of Death,2015-09-10 00:00:00
3107,1,1,Research lab p16,p16 unknown
3107,1,1,Metastasis,M0
3107,1,1,First Failure Treatment Modality,Sx
3107,1,1,First Failure Type,locoregional
3107,1,1,Time to First Failure,0.9
3107,1,1,First Failure Initial Chemotherapy Agent,cis
3107,1,1,Clinical lab p16,p16 negative
3107,1,1,Tumor Stage,T2
3107,1,1,Overall Stage,II
3107,1,1,Treatment Modality,Sx
3107,1,1,Status,Dead w/ disease
3107,1,1,Second Failure Type,no known failure
3107,1,1,Tumor Site,oral cavity
3107,1,1,Time to Death,1.8
3107,1,1,Age at Death,82.3
3107,1,1,First Failure Radiation Dosage,60
3107,1,1,First Failure Site,oral cavity
3107,1,1,Occurrence #,recurrence
3108,1,1,Nodal Stage,N0
3108,1,1,Age at Death,77.7
3108,1,1,Research lab HPV,HPV negative
3108,1,1,Second Failure Type,no known failure
3108,1,1,Treatment Modality,Sx
3108,1,1,First Failure Type,no known failure
3108,1,1,Date of Death,2014-01-09 00:00:00
3108,1,1,Tumor Stage,T1
3108,1,1,Metastasis,M0
3108,1,1,Time to Death,0.3
3108,1,1,Tumor Site,oropharynx
3108,1,1,Overall Stage,I
3108,1,1,Status,Dead w/ disease
3108,1,1,Clinical lab p16,p16 negative
3108,1,1,Research lab p16,p16 unknown
3108,1,1,Occurrence #,recurrence
3109,1,1,Research lab p16,p16 unknown
3109,1,1,Status,Alive w/o disease
3109,1,1,Nodal Stage,N0
3109,1,1,Occurrence #,1st primary
3109,1,1,Second Failure Type,no known failure
3109,1,1,Metastasis,M0
3109,1,1,Research lab HPV,HPV negative
3109,1,1,Tumor Site,oral cavity
3109,1,1,Overall Stage,I
3109,1,1,Clinical lab p16,p16 negative
3109,1,1,Treatment Modality,Sx
3109,1,1,Tumor Stage,T1
3109,1,1,First Failure Type,no known failure
3110,1,1,Clinical lab p16,p16 negative
3110,1,1,Research lab p16,p16 unknown
3110,1,1,Status,Alive w/o disease
3110,1,1,Radiation Dosage,66
3110,1,1,Metastasis,M0
3110,1,1,Research lab HPV,HPV negative
3110,1,1,Occurrence #,Unknown
3110,1,1,Nodal Stage,N0
3110,1,1,Second Failure Type,no known failure
3110,1,1,Treatment Modality,RT
3110,1,1,First Failure Type,no known failure
3110,1,1,Tumor Stage,T2
3110,1,1,Tumor Site,oropharynx
3110,1,1,Overall Stage,II
3111,1,1,Overall Stage,IVa
3111,1,1,Second Failure Type,no known failure
3111,1,1,Treatment Modality,Sx & CTX-RT
3111,1,1,Occurrence #,other primary
3111,1,1,Tumor Stage,T4a
3111,1,1,Tumor Site,oral cavity
3111,1,1,Research lab HPV,HPV negative
3111,1,1,Status,Alive w/o disease
3111,1,1,Clinical lab p16,p16 negative
3111,1,1,Metastasis,M0
3111,1,1,Research lab p16,p16 unknown
3111,1,1,Nodal Stage,N1
3111,1,1,First Failure Type,no known failure
3112,1,1,Tumor Site,oral cavity
3112,1,1,Research lab p16,p16 unknown
3112,1,1,First Failure Type,no known failure
3112,1,1,Occurrence #,1st primary
3112,1,1,Metastasis,M0
3112,1,1,Nodal Stage,N2
3112,1,1,Overall Stage,IVa
3112,1,1,Tumor Stage,T4a
3112,1,1,Initial Chemotherapy Agent,cis
3112,1,1,Radiation Dosage,71.4
3112,1,1,Second Failure Type,no known failure
3112,1,1,Clinical lab p16,p16 negative
3112,1,1,Second Line Chemotherapy Agent,Carbo
3112,1,1,Research lab HPV,HPV negative
3112,1,1,Treatment Modality,Sx & CTX-RT
3112,1,1,Status,Alive w/o disease
3113,1,1,Metastasis,M0
3113,1,1,Clinical lab p16,p16 negative
3113,1,1,Status,Alive w/o disease
3113,1,1,Research lab HPV,HPV negative
3113,1,1,Tumor Site,oral cavity
3113,1,1,Nodal Stage,N0
3113,1,1,Second Failure Type,no known failure
3113,1,1,Overall Stage,II
3113,1,1,Treatment Modality,Sx
3113,1,1,Tumor Stage,T2
3113,1,1,First Failure Type,no known failure
3113,1,1,Research lab p16,p16 unknown
3113,1,1,Occurrence #,1st primary
3114,1,1,Research lab p16,p16 unknown
3114,1,1,Tumor Stage,T1
3114,1,1,Metastasis,M0
3114,1,1,Nodal Stage,N0
3114,1,1,Second Failure Type,no known failure
3114,1,1,Status,Alive w/o disease
3114,1,1,Treatment Modality,Sx
3114,1,1,Occurrence #,1st primary
3114,1,1,Tumor Site,oral cavity
3114,1,1,Clinical lab p16,p16 negative
3114,1,1,Overall Stage,I
3114,1,1,Research lab HPV,HPV negative
3114,1,1,First Failure Type,no known failure
3115,1,1,Tumor Stage,T1
3115,1,1,Occurrence #,1st primary
3115,1,1,Research lab p16,p16 unknown
3115,1,1,Status,Alive w/o disease
3115,1,1,Overall Stage,I
3115,1,1,Tumor Site,oral cavity
3115,1,1,Treatment Modality,Sx
3115,1,1,Second Failure Type,no known failure
3115,1,1,Nodal Stage,N0
3115,1,1,First Failure Type,no known failure
3115,1,1,Research lab HPV,HPV negative
3115,1,1,Metastasis,M0
3115,1,1,Clinical lab p16,p16 negative
3116,1,1,Metastasis,M0
3116,1,1,Tumor Site,oral cavity
3116,1,1,Overall Stage,I
3116,1,1,Second Failure Type,no known failure
3116,1,1,Research lab HPV,HPV negative
3116,1,1,Research lab p16,p16 unknown
3116,1,1,Tumor Stage,T1
3116,1,1,Treatment Modality,Sx
3116,1,1,First Failure Type,no known failure
3116,1,1,Clinical lab p16,p16 negative
3116,1,1,Occurrence #,1st primary
3116,1,1,Nodal Stage,N0
3116,1,1,Status,Alive w/o disease
3117,1,1,Metastasis,M0
3117,1,1,Research lab p16,p16 unknown
3117,1,1,Second Failure Type,no known failure
3117,1,1,Status,Alive w/ disease
3117,1,1,Tumor Stage,T3
3117,1,1,Treatment Modality,Sx
3117,1,1,First Failure Type,no known failure
3117,1,1,Occurrence #,1st primary
3117,1,1,Nodal Stage,N2
3117,1,1,Research lab HPV,HPV negative
3117,1,1,Tumor Site,oral cavity
3117,1,1,Clinical lab p16,p16 negative
3117,1,1,Overall Stage,IVa
3118,1,1,Research lab p16,p16 unknown
3118,1,1,Research lab HPV,HPV negative
3118,1,1,Tumor Stage,T2
3118,1,1,Occurrence #,1st primary
3118,1,1,Treatment Modality,Sx
3118,1,1,Clinical lab p16,p16 negative
3118,1,1,Metastasis,M0
3118,1,1,Overall Stage,II
3118,1,1,Status,Alive w/o disease
3118,1,1,Nodal Stage,N0
3118,1,1,Tumor Site,oral cavity
3118,1,1,Second Failure Type,no known failure
3118,1,1,First Failure Type,no known failure
3119,1,1,Clinical lab p16,p16 negative
3119,1,1,Tumor Stage,T1
3119,1,1,Nodal Stage,N0
3119,1,1,Tumor Site,oral cavity
3119,1,1,Second Failure Type,no known failure
3119,1,1,Status,Alive w/o disease
3119,1,1,Overall Stage,I
3119,1,1,Treatment Modality,Sx
3119,1,1,First Failure Type,no known failure
3119,1,1,Research lab HPV,HPV negative
3119,1,1,Research lab p16,p16 unknown
3119,1,1,Occurrence #,1st primary
3119,1,1,Metastasis,M0
3120,1,1,Status,Alive w/o disease
3120,1,1,Treatment Modality,Sx
3120,1,1,Research lab p16,p16 unknown
3120,1,1,Overall Stage,IVa
3120,1,1,Tumor Site,oral cavity
3120,1,1,Second Failure Type,no known failure
3120,1,1,Nodal Stage,N0
3120,1,1,Clinical lab p16,p16 negative
3120,1,1,Metastasis,M0
3120,1,1,Occurrence #,1st primary
3120,1,1,First Failure Type,no known failure
3120,1,1,Tumor Stage,T4a
3120,1,1,Research lab HPV,HPV negative
3121,1,1,Overall Stage,IVa
3121,1,1,Tumor Site,oral cavity
3121,1,1,Occurrence #,1st primary
3121,1,1,Research lab p16,p16 unknown
3121,1,1,Research lab HPV,HPV negative
3121,1,1,Tumor Stage,T4a
3121,1,1,Metastasis,M0
3121,1,1,Clinical lab p16,p16 negative
3121,1,1,Second Failure Type,no known failure
3121,1,1,Treatment Modality,Sx
3121,1,1,Nodal Stage,N0
3121,1,1,First Failure Type,no known failure
3121,1,1,Status,Alive w/o disease
3122,1,1,Status,Alive w/o disease
3122,1,1,Tumor Stage,T1
3122,1,1,Nodal Stage,N0
3122,1,1,Tumor Site,oropharynx
3122,1,1,First Failure Treatment Modality,Sx
3122,1,1,Overall Stage,I
3122,1,1,Second Failure Type,no known failure
3122,1,1,Treatment Modality,Sx
3122,1,1,Research lab HPV,HPV negative
3122,1,1,Clinical lab p16,p16 negative
3122,1,1,Metastasis,M0
3122,1,1,First Failure Site,oral cavity
3122,1,1,Research lab p16,p16 unknown
3122,1,1,First Failure Type,no known failure
3122,1,1,Occurrence #,1st primary
3123,1,1,Research lab HPV,HPV negative
3123,1,1,Treatment Modality,Sx & RT
3123,1,1,Clinical lab p16,p16 negative
3123,1,1,Tumor Stage,T2
3123,1,1,Status,Alive w/o disease
3123,1,1,Metastasis,M0
3123,1,1,Overall Stage,II
3123,1,1,Nodal Stage,N0
3123,1,1,Occurrence #,1st primary
3123,1,1,Tumor Site,oral cavity
3123,1,1,Radiation Dosage,59.4
3123,1,1,Second Failure Type,no known failure
3123,1,1,First Failure Type,no known failure
3123,1,1,Research lab p16,p16 unknown
3124,1,1,Research lab HPV,HPV negative
3124,1,1,Tumor Site,oral cavity
3124,1,1,Research lab p16,p16 unknown
3124,1,1,Metastasis,M0
3124,1,1,First Failure Type,no known failure
3124,1,1,Overall Stage,I
3124,1,1,Treatment Modality,Sx
3124,1,1,Occurrence #,other primary
3124,1,1,Nodal Stage,N0
3124,1,1,Tumor Stage,T1
3124,1,1,Clinical lab p16,p16 negative
3124,1,1,Second Failure Type,no known failure
3124,1,1,Status,Alive w/o disease
3125,1,1,Tumor Site,oral cavity
3125,1,1,Radiation Dosage,63
3125,1,1,Nodal Stage,N0
3125,1,1,Status,Alive w/o disease
3125,1,1,Research lab HPV,HPV negative
3125,1,1,First Failure Type,no known failure
3125,1,1,Tumor Stage,T2
3125,1,1,Second Failure Type,no known failure
3125,1,1,Occurrence #,1st primary
3125,1,1,Clinical lab p16,p16 negative
3125,1,1,Treatment Modality,Sx & RT
3125,1,1,Research lab p16,p16 unknown
3125,1,1,Metastasis,M0
3125,1,1,Overall Stage,II
3126,1,1,Metastasis,M0
3126,1,1,Research lab p16,p16 unknown
3126,1,1,Tumor Stage,T4a
3126,1,1,First Failure Type,no known failure
3126,1,1,Initial Chemotherapy Agent,Unk
3126,1,1,Occurrence #,1st primary
3126,1,1,Overall Stage,IVa
3126,1,1,Research lab HPV,HPV negative
3126,1,1,Clinical lab p16,p16 negative
3126,1,1,Tumor Site,oral cavity
3126,1,1,Status,Alive w/o disease
3126,1,1,Radiation Dosage,Unknown
3126,1,1,Second Failure Type,no known failure
3126,1,1,Treatment Modality,Sx & CTX-RT
3126,1,1,Nodal Stage,N0
3127,1,1,Treatment Modality,Sx
3127,1,1,Metastasis,M0
3127,1,1,Overall Stage,I
3127,1,1,Second Failure Type,no known failure
3127,1,1,Tumor Stage,T1
3127,1,1,First Failure Type,locoregional
3127,1,1,Research lab HPV,HPV negative
3127,1,1,Occurrence #,other primary
3127,1,1,Clinical lab p16,p16 negative
3127,1,1,Status,Alive w/o disease
3127,1,1,Research lab p16,p16 unknown
3127,1,1,Time to First Failure,2.6
3127,1,1,First Failure Site,oral cavity
3127,1,1,First Failure Treatment Modality,Sx
3127,1,1,Nodal Stage,N0
3127,1,1,Tumor Site,oral cavity
3128,1,1,Clinical lab p16,p16 negative
3128,1,1,Occurrence #,1st primary
3128,1,1,Status,Alive w/o disease
3128,1,1,Research lab HPV,HPV negative
3128,1,1,Tumor Stage,T1
3128,1,1,Tumor Site,oral cavity
3128,1,1,Nodal Stage,N0
3128,1,1,First Failure Site,oral cavity
3128,1,1,Metastasis,M0
3128,1,1,First Failure Type,no known failure
3128,1,1,Overall Stage,I
3128,1,1,Research lab p16,p16 unknown
3128,1,1,First Failure Treatment Modality,Sx
3128,1,1,Second Failure Type,no known failure
3128,1,1,Treatment Modality,Sx
3129,1,1,Clinical lab p16,p16 negative
3129,1,1,Overall Stage,II
3129,1,1,Nodal Stage,N0
3129,1,1,Treatment Modality,Sx
3129,1,1,Research lab HPV,HPV negative
3129,1,1,First Failure Type,no known failure
3129,1,1,Second Failure Type,no known failure
3129,1,1,Status,Alive w/o disease
3129,1,1,Research lab p16,p16 unknown
3129,1,1,Occurrence #,1st primary
3129,1,1,Tumor Site,oral cavity
3129,1,1,Metastasis,M0
3129,1,1,Tumor Stage,T2
3130,1,1,Overall Stage,I
3130,1,1,Clinical lab p16,p16 negative
3130,1,1,First Failure Type,no known failure
3130,1,1,Tumor Site,oral cavity
3130,1,1,Status,Alive w/o disease
3130,1,1,Nodal Stage,N0
3130,1,1,Occurrence #,1st primary
3130,1,1,Research lab p16,p16 unknown
3130,1,1,Tumor Stage,T1
3130,1,1,Metastasis,M0
3130,1,1,Radiation Dosage,66.6
3130,1,1,Second Failure Type,no known failure
3130,1,1,Treatment Modality,Sx & RT
3130,1,1,Research lab HPV,HPV negative
3131,1,1,Occurrence #,1st primary
3131,1,1,Treatment Modality,Sx
3131,1,1,Metastasis,M0
3131,1,1,First Failure Type,no known failure
3131,1,1,Second Failure Type,no known failure
3131,1,1,Overall Stage,I
3131,1,1,Nodal Stage,N0
3131,1,1,Research lab p16,p16 unknown
3131,1,1,Status,Alive w/o disease
3131,1,1,Clinical lab p16,p16 negative
3131,1,1,Tumor Stage,T1
3131,1,1,Tumor Site,oral cavity
3131,1,1,Research lab HPV,HPV negative
3132,1,1,Overall Stage,II
3132,1,1,Research lab HPV,HPV negative
3132,1,1,First Failure Type,no known failure
3132,1,1,Treatment Modality,Sx
3132,1,1,Tumor Site,oral cavity
3132,1,1,Clinical lab p16,p16 negative
3132,1,1,Nodal Stage,N0
3132,1,1,Status,Alive w/o disease
3132,1,1,Research lab p16,p16 unknown
3132,1,1,Tumor Stage,T2
3132,1,1,Metastasis,M0
3132,1,1,Occurrence #,1st primary
3132,1,1,Second Failure Type,no known failure
3133,1,1,Overall Stage,IVa
3133,1,1,First Failure Treatment Modality,CTX
3133,1,1,Occurrence #,1st primary
3133,1,1,Time to First Failure,1.2
3133,1,1,Initial Chemotherapy Agent,Carbo
3133,1,1,Research lab HPV,HPV negative
3133,1,1,Status,Dead w/ disease
3133,1,1,Tumor Stage,T2
3133,1,1,Radiation Dosage,70.2
3133,1,1,Clinical lab p16,p16 negative
3133,1,1,First Failure Initial Chemotherapy Agent,carbo/doce
3133,1,1,Tumor Site,oropharynx
3133,1,1,Research lab p16,p16 unknown
3133,1,1,Treatment Modality,CTX-RT
3133,1,1,First Failure Type,distant
3133,1,1,Nodal Stage,N2
3133,1,1,Metastasis,M0
3133,1,1,Second Failure Type,no known failure
3134,1,1,Second Failure Type,no known failure
3134,1,1,Treatment Modality,Sx & CTX-RT
3134,1,1,Metastasis,M0
3134,1,1,Occurrence #,1st primary
3134,1,1,Tumor Stage,T4a
3134,1,1,Radiation Dosage,63
3134,1,1,Clinical lab p16,p16 negative
3134,1,1,First Failure Type,no known failure
3134,1,1,Nodal Stage,N2
3134,1,1,Overall Stage,IVa
3134,1,1,Status,Dead w/o disease
3134,1,1,Initial Chemotherapy Agent,cis
3134,1,1,Research lab HPV,HPV negative
3134,1,1,Tumor Site,oral cavity
3134,1,1,Research lab p16,p16 unknown
3135,1,1,Second Failure Type,no known failure
3135,1,1,Status,Dead w/o disease
3135,1,1,Overall Stage,IVa
3135,1,1,Metastasis,M0
3135,1,1,Clinical lab p16,p16 negative
3135,1,1,First Failure Type,locoregional
3135,1,1,Tumor Site,oral cavity
3135,1,1,Time to Death,4.0
3135,1,1,Treatment Modality,Sx
3135,1,1,First Failure Treatment Modality,Sx
3135,1,1,Research lab p16,p16 unknown
3135,1,1,Age at Death,69.6
3135,1,1,Occurrence #,1st primary
3135,1,1,First Failure Site,oral cavity
3135,1,1,Date of Death,2016-04-20 00:00:00
3135,1,1,Research lab HPV,HPV negative
3135,1,1,Time to First Failure,3.0
3135,1,1,Nodal Stage,N2
3135,1,1,Tumor Stage,T4a
3136,1,1,Clinical lab p16,p16 negative
3136,1,1,Research lab HPV,HPV negative
3136,1,1,Status,Dead w/ disease
3136,1,1,Treatment Modality,Sx
3136,1,1,Second Failure Type,no known failure
3136,1,1,Occurrence #,1st primary
3136,1,1,Tumor Stage,T1
3136,1,1,Nodal Stage,N0
3136,1,1,First Failure Type,no known failure
3136,1,1,Metastasis,M0
3136,1,1,Tumor Site,oral cavity
3136,1,1,Overall Stage,I
3136,1,1,Research lab p16,p16 unknown
3137,1,1,Research lab p16,p16 unknown
3137,1,1,Tumor Stage,T4a
3137,1,1,Status,Dead w/o disease
3137,1,1,Research lab HPV,HPV negative
3137,1,1,Nodal Stage,N2
3137,1,1,Initial Chemotherapy Agent,cis
3137,1,1,Occurrence #,1st primary
3137,1,1,First Failure Type,no known failure
3137,1,1,Metastasis,M0
3137,1,1,Second Failure Type,no known failure
3137,1,1,Overall Stage,IVa
3137,1,1,Tumor Site,oropharynx
3137,1,1,Treatment Modality,Sx & CTX
3137,1,1,Clinical lab p16,p16 negative
3138,1,1,Tumor Stage,T4a
3138,1,1,Tumor Site,oral cavity
3138,1,1,Clinical lab p16,p16 negative
3138,1,1,Overall Stage,IVa
3138,1,1,Status,Dead w/o disease
3138,1,1,Research lab HPV,HPV negative
3138,1,1,Nodal Stage,N0
3138,1,1,Occurrence #,1st primary
3138,1,1,First Failure Type,no known failure
3138,1,1,Treatment Modality,Sx
3138,1,1,Second Failure Type,no known failure
3138,1,1,Metastasis,M0
3138,1,1,Research lab p16,p16 unknown
3139,1,1,Status,Dead w/o disease
3139,1,1,Second Failure Type,no known failure
3139,1,1,Tumor Site,oral cavity
3139,1,1,Nodal Stage,N0
3139,1,1,Overall Stage,I
3139,1,1,Clinical lab p16,p16 negative
3139,1,1,Treatment Modality,Sx
3139,1,1,First Failure Type,no known failure
3139,1,1,Research lab p16,p16 unknown
3139,1,1,Research lab HPV,HPV negative
3139,1,1,Tumor Stage,T1
3139,1,1,Occurrence #,1st primary
3139,1,1,Metastasis,M0
3140,1,1,Overall Stage,IVa
3140,1,1,Treatment Modality,Sx & CTX-RT
3140,1,1,Nodal Stage,N2
3140,1,1,Metastasis,M0
3140,1,1,Research lab p16,p16 unknown
3140,1,1,Second Failure Type,no known failure
3140,1,1,First Failure Type,no known failure
3140,1,1,Tumor Stage,T2
3140,1,1,Occurrence #,1st primary
3140,1,1,Research lab HPV,HPV negative
3140,1,1,Status,Dead w/o disease
3140,1,1,Clinical lab p16,p16 negative
3140,1,1,Tumor Site,oral cavity
3141,1,1,Metastasis,M0
3141,1,1,First Failure Type,no known failure
3141,1,1,Nodal Stage,N0
3141,1,1,Second Failure Type,no known failure
3141,1,1,Tumor Site,oral cavity
3141,1,1,Tumor Stage,T1
3141,1,1,Status,Dead w/ disease
3141,1,1,Clinical lab p16,p16 negative
3141,1,1,Research lab HPV,HPV negative
3141,1,1,Overall Stage,I
3141,1,1,Treatment Modality,Sx & RT
3141,1,1,Occurrence #,1st primary
3141,1,1,Research lab p16,p16 unknown
3141,1,1,Radiation Dosage,66
3142,1,1,Status,Dead w/o disease
3142,1,1,Overall Stage,IVa
3142,1,1,Second Failure Type,no known failure
3142,1,1,Research lab p16,p16 unknown
3142,1,1,Nodal Stage,N2
3142,1,1,Occurrence #,1st primary
3142,1,1,First Failure Site,larynx
3142,1,1,Tumor Stage,T4a
3142,1,1,Treatment Modality,Sx
3142,1,1,Research lab HPV,HPV negative
3142,1,1,Tumor Site,oral cavity
3142,1,1,Clinical lab p16,p16 negative
3142,1,1,Metastasis,M0
3142,1,1,First Failure Type,no known failure
3142,1,1,First Failure Treatment Modality,Sx
3143,1,1,Metastasis,M0
3143,1,1,Second Failure Type,no known failure
3143,1,1,Treatment Modality,Sx & CTX-RT
3143,1,1,Research lab p16,p16 unknown
3143,1,1,Research lab HPV,HPV negative
3143,1,1,Tumor Site,oral cavity
3143,1,1,Initial Chemotherapy Agent,Carbo
3143,1,1,Nodal Stage,N2
3143,1,1,Tumor Stage,T4a
3143,1,1,Overall Stage,IVa
3143,1,1,Status,Dead w/ disease
3143,1,1,Clinical lab p16,p16 negative
3143,1,1,First Failure Type,no known failure
3143,1,1,Occurrence #,recurrence
3143,1,1,Radiation Dosage,63
3144,1,1,Second Line Chemotherapy Agent,Carbo/PTX
3144,1,1,Metastasis,M0
3144,1,1,Tumor Site,oropharynx
3144,1,1,First Failure Type,locoregional
3144,1,1,Nodal Stage,N2
3144,1,1,Second Failure Type,no known failure
3144,1,1,Status,Dead w/ disease
3144,1,1,Research lab p16,p16 unknown
3144,1,1,Initial Chemotherapy Agent,Carbo
3144,1,1,Occurrence #,1st primary
3144,1,1,Time to First Failure,0.5
3144,1,1,Radiation Dosage,70.2
3144,1,1,Research lab HPV,HPV negative
3144,1,1,Tumor Stage,T2
3144,1,1,Treatment Modality,CTX-RT
3144,1,1,Clinical lab p16,p16 negative
3144,1,1,Overall Stage,IVa
3145,1,1,Research lab p16,p16 unknown
3145,1,1,Status,Dead w/ disease
3145,1,1,Clinical lab p16,p16 negative
3145,1,1,Second Failure Type,no known failure
3145,1,1,Nodal Stage,N0
3145,1,1,Tumor Stage,T1
3145,1,1,Overall Stage,I
3145,1,1,First Failure Type,no known failure
3145,1,1,Tumor Site,oral cavity
3145,1,1,Research lab HPV,HPV negative
3145,1,1,Treatment Modality,Sx
3145,1,1,First Failure Treatment Modality,Sx
3145,1,1,Metastasis,M0
3145,1,1,Occurrence #,1st primary
3146,1,1,Nodal Stage,N0
3146,1,1,First Failure Type,no known failure
3146,1,1,Status,Alive w/o disease
3146,1,1,Clinical lab p16,p16 unknown
3146,1,1,Tumor Stage,T1
3146,1,1,Treatment Modality,Sx
3146,1,1,Tumor Site,oral cavity
3146,1,1,Research lab HPV,HPV unknown
3146,1,1,Occurrence #,1st primary
3146,1,1,Second Failure Type,no known failure
3146,1,1,Metastasis,M0
3146,1,1,Overall Stage,I
3146,1,1,Research lab p16,p16 unknown
3147,1,1,Research lab p16,p16 unknown
3147,1,1,Nodal Stage,N1
3147,1,1,Treatment Modality,Sx & RT
3147,1,1,First Failure Type,no known failure
3147,1,1,Second Failure Type,no known failure
3147,1,1,Clinical lab p16,p16 unknown
3147,1,1,Tumor Stage,T2
3147,1,1,Status,Alive w/o disease
3147,1,1,Tumor Site,oral cavity
3147,1,1,Radiation Dosage,63
3147,1,1,Overall Stage,III
3147,1,1,Metastasis,M0
3147,1,1,Research lab HPV,HPV unknown
3147,1,1,Occurrence #,1st primary
3148,1,1,Clinical lab p16,p16 negative
3148,1,1,Initial Chemotherapy Agent,cis
3148,1,1,Occurrence #,1st primary
3148,1,1,Age at Death,49.9
3148,1,1,Research lab HPV,HPV unknown
3148,1,1,Overall Stage,IVb
3148,1,1,Treatment Modality,Sx & CTX-RT
3148,1,1,Research lab p16,p16 unknown
3148,1,1,Tumor Site,oral cavity
3148,1,1,Tumor Stage,T4a
3148,1,1,Second Failure Type,no known failure
3148,1,1,Nodal Stage,N2
3148,1,1,Date of Death,2013-01-03 00:00:00
3148,1,1,Status,Dead w/ disease
3148,1,1,Time to Death,0.5
3148,1,1,First Failure Type,no known failure
3148,1,1,Radiation Dosage,52.2
3148,1,1,Metastasis,M0
3149,1,1,Nodal Stage,N0
3149,1,1,Status,Alive w/o disease
3149,1,1,Metastasis,M0
3149,1,1,Overall Stage,I
3149,1,1,First Failure Type,no known failure
3149,1,1,Research lab p16,p16 unknown
3149,1,1,Research lab HPV,HPV unknown
3149,1,1,Treatment Modality,Sx
3149,1,1,Second Failure Type,no known failure
3149,1,1,Tumor Stage,T1
3149,1,1,Occurrence #,1st primary
3149,1,1,Tumor Site,oral cavity
3149,1,1,Clinical lab p16,p16 negative
3150,1,1,Metastasis,M0
3150,1,1,Overall Stage,II
3150,1,1,Second Failure Type,no known failure
3150,1,1,Research lab HPV,HPV unknown
3150,1,1,Occurrence #,1st primary
3150,1,1,Tumor Site,oral cavity
3150,1,1,Research lab p16,p16 unknown
3150,1,1,Tumor Stage,T2
3150,1,1,Clinical lab p16,p16 negative
3150,1,1,Nodal Stage,N0
3150,1,1,First Failure Type,no known failure
3150,1,1,Status,Alive w/o disease
3150,1,1,Treatment Modality,Sx
3151,1,1,Tumor Stage,T4a
3151,1,1,Tumor Site,oral cavity
3151,1,1,Overall Stage,IVa
3151,1,1,Nodal Stage,N1
3151,1,1,First Failure Type,no known failure
3151,1,1,Metastasis,M0
3151,1,1,Occurrence #,1st primary
3151,1,1,Clinical lab p16,p16 negative
3151,1,1,Research lab HPV,HPV unknown
3151,1,1,Treatment Modality,Sx
3151,1,1,Status,Alive w/o disease
3151,1,1,Second Failure Type,no known failure
3151,1,1,Research lab p16,p16 unknown
3152,1,1,Status,Alive w/o disease
3152,1,1,Tumor Stage,T1
3152,1,1,Second Failure Type,no known failure
3152,1,1,Tumor Site,oral cavity
3152,1,1,Occurrence #,recurrence
3152,1,1,Time to First Failure,1.2
3152,1,1,Research lab HPV,HPV unknown
3152,1,1,Metastasis,M0
3152,1,1,Nodal Stage,N0
3152,1,1,Research lab p16,p16 unknown
3152,1,1,Overall Stage,I
3152,1,1,Clinical lab p16,p16 negative
3152,1,1,First Failure Type,locoregional
3152,1,1,Treatment Modality,Sx
3152,1,1,First Failure Site,oral cavity
3152,1,1,First Failure Treatment Modality,Sx
3153,1,1,Status,Alive w/o disease
3153,1,1,Metastasis,M0
3153,1,1,Second Failure Type,no known failure
3153,1,1,Clinical lab p16,p16 unknown
3153,1,1,First Failure Treatment Modality,Sx
3153,1,1,Tumor Stage,T1
3153,1,1,Occurrence #,1st primary
3153,1,1,Tumor Site,oral cavity
3153,1,1,First Failure Type,no known failure
3153,1,1,Overall Stage,I
3153,1,1,Nodal Stage,N0
3153,1,1,Research lab p16,p16 unknown
3153,1,1,Treatment Modality,Sx
3153,1,1,First Failure Site,oral cavity
3153,1,1,Research lab HPV,HPV unknown
3154,1,1,Status,Alive w/o disease
3154,1,1,Treatment Modality,Sx & CTX-RT
3154,1,1,Tumor Stage,T4a
3154,1,1,Overall Stage,IVc
3154,1,1,Clinical lab p16,p16 unknown
3154,1,1,Second Line Chemotherapy Agent,2/26/14
3154,1,1,Initial Chemotherapy Agent,cis
3154,1,1,Research lab p16,p16 unknown
3154,1,1,Metastasis,M1
3154,1,1,Nodal Stage,N2
3154,1,1,Radiation Dosage,64
3154,1,1,Second Failure Type,no known failure
3154,1,1,Research lab HPV,HPV unknown
3154,1,1,First Failure Type,no known failure
3154,1,1,Occurrence #,other primary
3154,1,1,Tumor Site,hypopharynx
3155,1,1,First Failure Type,no known failure
3155,1,1,Metastasis,M0
3155,1,1,Tumor Site,oral cavity
3155,1,1,Second Failure Type,no known failure
3155,1,1,Research lab p16,p16 unknown
3155,1,1,Research lab HPV,HPV unknown
3155,1,1,Nodal Stage,N0
3155,1,1,Overall Stage,I
3155,1,1,Tumor Stage,T1
3155,1,1,Clinical lab p16,p16 unknown
3155,1,1,Status,Alive w/o disease
3155,1,1,Occurrence #,1st primary
3155,1,1,Treatment Modality,Sx
3156,1,1,Research lab p16,p16 unknown
3156,1,1,Tumor Site,oropharynx
3156,1,1,Treatment Modality,CTX-RT
3156,1,1,Clinical lab p16,p16 unknown
3156,1,1,Research lab HPV,HPV unknown
3156,1,1,Occurrence #,1st primary
3156,1,1,Initial Chemotherapy Agent,cis
3156,1,1,Nodal Stage,N1
3156,1,1,Radiation Dosage,70.2
3156,1,1,Status,Alive w/o disease
3156,1,1,Second Failure Type,no known failure
3156,1,1,Tumor Stage,T2
3156,1,1,Overall Stage,III
3156,1,1,First Failure Type,no known failure
3156,1,1,Metastasis,M0
3157,1,1,Research lab HPV,HPV unknown
3157,1,1,Second Line Chemotherapy Agent,Carbo
3157,1,1,Radiation Dosage,70.2
3157,1,1,Research lab p16,p16 unknown
3157,1,1,First Failure Type,no known failure
3157,1,1,Treatment Modality,Sx & CTX-RT
3157,1,1,Overall Stage,IVa
3157,1,1,Occurrence #,1st primary
3157,1,1,Clinical lab p16,p16 unknown
3157,1,1,Initial Chemotherapy Agent,cis
3157,1,1,Metastasis,M0
3157,1,1,Status,Alive w/o disease
3157,1,1,Tumor Stage,T4a
3157,1,1,Nodal Stage,N1
3157,1,1,Tumor Site,oropharynx
3157,1,1,Second Failure Type,no known failure
3158,1,1,Treatment Modality,Sx
3158,1,1,Occurrence #,1st primary
3158,1,1,Tumor Stage,T1
3158,1,1,Metastasis,M0
3158,1,1,First Failure Type,no known failure
3158,1,1,Second Failure Type,no known failure
3158,1,1,Overall Stage,I
3158,1,1,Research lab p16,p16 unknown
3158,1,1,Tumor Site,oral cavity
3158,1,1,Research lab HPV,HPV unknown
3158,1,1,Status,Alive w/o disease
3158,1,1,Nodal Stage,N0
3158,1,1,Clinical lab p16,p16 unknown
3159,1,1,Second Failure Type,no known failure
3159,1,1,Tumor Stage,T2
3159,1,1,Initial Chemotherapy Agent,carbo/PTX
3159,1,1,Status,Alive w/o disease
3159,1,1,Occurrence #,1st primary
3159,1,1,Research lab p16,p16 unknown
3159,1,1,Nodal Stage,N2
3159,1,1,Clinical lab p16,p16 unknown
3159,1,1,Metastasis,M0
3159,1,1,Treatment Modality,CTX-RT
3159,1,1,Radiation Dosage,70.2
3159,1,1,Overall Stage,IVa
3159,1,1,First Failure Type,no known failure
3159,1,1,Research lab HPV,HPV unknown
3159,1,1,Tumor Site,oropharynx
3160,1,1,Tumor Stage,T4a
3160,1,1,Status,Alive w/o disease
3160,1,1,Tumor Site,oropharynx
3160,1,1,Research lab HPV,HPV unknown
3160,1,1,Occurrence #,1st primary
3160,1,1,First Failure Type,no known failure
3160,1,1,Second Failure Type,no known failure
3160,1,1,Radiation Dosage,unknown
3160,1,1,Nodal Stage,N3
3160,1,1,Clinical lab p16,p16 unknown
3160,1,1,Research lab p16,p16 unknown
3160,1,1,Metastasis,M0
3160,1,1,Initial Chemotherapy Agent,unknown
3160,1,1,Overall Stage,IVb
3160,1,1,Treatment Modality,Sx & CTX-RT
3161,1,1,Treatment Modality,Sx
3161,1,1,Second Failure Type,no known failure
3161,1,1,Nodal Stage,N2
3161,1,1,Overall Stage,IVa
3161,1,1,Tumor Site,oral cavity
3161,1,1,Research lab p16,p16 unknown
3161,1,1,First Failure Type,no known failure
3161,1,1,Research lab HPV,HPV unknown
3161,1,1,Metastasis,M0
3161,1,1,Tumor Stage,T2
3161,1,1,Status,Alive w/o disease
3161,1,1,Clinical lab p16,p16 unknown
3161,1,1,Occurrence #,1st primary
3162,1,1,First Failure Type,locoregional
3162,1,1,Research lab p16,p16 unknown
3162,1,1,Metastasis,M0
3162,1,1,First Failure Initial Chemotherapy Agent,Cis
3162,1,1,First Failure Site,oral cavity
3162,1,1,Occurrence #,1st primary
3162,1,1,Status,Alive unk disease
3162,1,1,Tumor Site,oral cavity
3162,1,1,Nodal Stage,N0
3162,1,1,Treatment Modality,Sx
3162,1,1,Overall Stage,I
3162,1,1,Time to First Failure,0.7
3162,1,1,Tumor Stage,T1
3162,1,1,First Failure Treatment Modality,Sx & CTX-RT
3162,1,1,Research lab HPV,HPV unknown
3162,1,1,Clinical lab p16,p16 unknown
3162,1,1,Second Failure Type,no known failure
3163,1,1,Research lab HPV,HPV unknown
3163,1,1,Occurrence #,1st primary
3163,1,1,Research lab p16,p16 unknown
3163,1,1,Overall Stage,I
3163,1,1,Metastasis,M0
3163,1,1,Nodal Stage,N0
3163,1,1,Treatment Modality,Sx
3163,1,1,Tumor Site,oral cavity
3163,1,1,Status,Alive w/o disease
3163,1,1,First Failure Type,no known failure
3163,1,1,Second Failure Type,no known failure
3163,1,1,Clinical lab p16,p16 unknown
3163,1,1,Tumor Stage,T1
3164,1,1,Research lab HPV,HPV unknown
3164,1,1,Treatment Modality,Sx
3164,1,1,Tumor Site,oral cavity
3164,1,1,Metastasis,M0
3164,1,1,Occurrence #,1st primary
3164,1,1,Status,Alive w/o disease
3164,1,1,Overall Stage,IVa
3164,1,1,Second Failure Type,no known failure
3164,1,1,Tumor Stage,T4a
3164,1,1,Clinical lab p16,p16 unknown
3164,1,1,Research lab p16,p16 unknown
3164,1,1,First Failure Type,no known failure
3164,1,1,Nodal Stage,N0
3165,1,1,Research lab p16,p16 unknown
3165,1,1,Research lab HPV,HPV unknown
3165,1,1,Clinical lab p16,p16 unknown
3165,1,1,Tumor Stage,T4a
3165,1,1,Occurrence #,1st primary
3165,1,1,Second Failure Type,no known failure
3165,1,1,Status,Alive w/o disease
3165,1,1,Metastasis,M0
3165,1,1,Treatment Modality,Sx
3165,1,1,Nodal Stage,N2
3165,1,1,Overall Stage,IVa
3165,1,1,Tumor Site,oral cavity
3165,1,1,First Failure Type,no known failure
3166,1,1,Second Failure Type,no known failure
3166,1,1,Clinical lab p16,p16 unknown
3166,1,1,Occurrence #,1st primary
3166,1,1,Tumor Stage,T2
3166,1,1,Tumor Site,oropharynx
3166,1,1,Metastasis,M0
3166,1,1,Research lab p16,p16 unknown
3166,1,1,Initial Chemotherapy Agent,Cis
3166,1,1,Treatment Modality,CTX-RT
3166,1,1,Radiation Dosage,70.2
3166,1,1,Nodal Stage,N2
3166,1,1,Overall Stage,IVa
3166,1,1,Research lab HPV,HPV unknown
3166,1,1,First Failure Type,no known failure
3166,1,1,Status,Dead w/ disease
3167,1,1,First Failure Type,no known failure
3167,1,1,Occurrence #,1st primary
3167,1,1,Research lab p16,p16 unknown
3167,1,1,Nodal Stage,N2
3167,1,1,Treatment Modality,Sx
3167,1,1,Status,Dead w/o disease
3167,1,1,Tumor Stage,T3
3167,1,1,Metastasis,M0
3167,1,1,Clinical lab p16,p16 unknown
3167,1,1,Overall Stage,IVa
3167,1,1,Research lab HPV,HPV unknown
3167,1,1,Second Failure Type,no known failure
3167,1,1,Tumor Site,oral cavity
3168,1,1,Occurrence #,1st primary
3168,1,1,Research lab HPV,HPV unknown
3168,1,1,Treatment Modality,Sx
3168,1,1,Tumor Stage,T4a
3168,1,1,Metastasis,M0
3168,1,1,First Failure Type,no known failure
3168,1,1,Tumor Site,oral cavity
3168,1,1,First Failure Site,oral cavity
3168,1,1,Nodal Stage,N2
3168,1,1,Clinical lab p16,p16 unknown
3168,1,1,Status,Dead w/o disease
3168,1,1,Research lab p16,p16 unknown
3168,1,1,Second Failure Type,no known failure
3168,1,1,Overall Stage,IVa
3168,1,1,First Failure Treatment Modality,Sx
3169,1,1,Tumor Site,oral cavity
3169,1,1,First Failure Type,no known failure
3169,1,1,Metastasis,M0
3169,1,1,Research lab p16,p16 unknown
3169,1,1,Tumor Stage,T1
3169,1,1,Second Failure Type,no known failure
3169,1,1,Occurrence #,1st primary
3169,1,1,Nodal Stage,N2
3169,1,1,Clinical lab p16,p16 unknown
3169,1,1,Status,Dead w/o disease
3169,1,1,Research lab HPV,HPV unknown
3169,1,1,Overall Stage,IVa
3169,1,1,Treatment Modality,Sx
3170,1,1,Research lab HPV,HPV unknown
3170,1,1,Occurrence #,1st primary
3170,1,1,Overall Stage,IVa
3170,1,1,Research lab p16,p16 unknown
3170,1,1,Clinical lab p16,p16 unknown
3170,1,1,First Failure Type,no known failure
3170,1,1,Treatment Modality,Sx
3170,1,1,Tumor Stage,T1
3170,1,1,Status,Dead w/ disease
3170,1,1,Tumor Site,oral cavity
3170,1,1,Metastasis,M0
3170,1,1,Nodal Stage,N3
3170,1,1,Second Failure Type,no known failure
3171,1,1,Age at Death,55.6
3171,1,1,Treatment Modality,Sx & CTX-RT
3171,1,1,First Failure Site,oral cavity
3171,1,1,Research lab p16,p16 unknown
3171,1,1,Nodal Stage,N2
3171,1,1,Radiation Dosage,72
3171,1,1,Overall Stage,IVa
3171,1,1,Initial Chemotherapy Agent,doce/cap
3171,1,1,Research lab HPV,HPV unknown
3171,1,1,Time to Death,0.1
3171,1,1,Clinical lab p16,p16 unknown
3171,1,1,Occurrence #,1st primary
3171,1,1,First Failure Treatment Modality,Sx
3171,1,1,Second Failure Type,no known failure
3171,1,1,Status,Dead w/ disease
3171,1,1,Metastasis,M0
3171,1,1,Tumor Site,oropharynx
3171,1,1,First Failure Type,no known failure
3171,1,1,Tumor Stage,T4a
3171,1,1,Date of Death,2011-06-27 00:00:00
3172,1,1,Nodal Stage,N1
3172,1,1,Second Failure Type,no known failure
3172,1,1,Occurrence #,1st primary
3172,1,1,Research lab p16,p16 unknown
3172,1,1,Clinical lab p16,p16 unknown
3172,1,1,Overall Stage,III
3172,1,1,Time to Death,0.4
3172,1,1,Initial Chemotherapy Agent,carbo/doce
3172,1,1,Research lab HPV,HPV unknown
3172,1,1,Status,Dead w/ disease
3172,1,1,Date of Death,2015-03-14 00:00:00
3172,1,1,Treatment Modality,CTX
3172,1,1,Tumor Site,oral cavity
3172,1,1,First Failure Type,no known failure
3172,1,1,Tumor Stage,T2
3172,1,1,Age at Death,60.3
3172,1,1,Metastasis,M0
3173,1,1,Date of Death,2014-06-18 00:00:00
3173,1,1,Tumor Site,oral cavity
3173,1,1,Overall Stage,IVa
3173,1,1,Clinical lab p16,p16 unknown
3173,1,1,Time to Death,1.2
3173,1,1,Radiation Dosage,unknown
3173,1,1,Research lab HPV,HPV unknown
3173,1,1,Metastasis,M0
3173,1,1,Occurrence #,1st primary
3173,1,1,Research lab p16,p16 unknown
3173,1,1,Second Failure Type,no known failure
3173,1,1,Status,Dead w/o disease
3173,1,1,Age at Death,79.8
3173,1,1,Nodal Stage,N1
3173,1,1,Tumor Stage,T4a
3173,1,1,Treatment Modality,Sx & RT
3173,1,1,First Failure Type,no known failure
3174,1,1,Status,Dead w/ disease
3174,1,1,Research lab p16,p16 unknown
3174,1,1,Tumor Site,oral cavity
3174,1,1,Nodal Stage,N2
3174,1,1,First Failure Treatment Modality,Sx
3174,1,1,First Failure Site,oral cavity
3174,1,1,First Failure Type,locoregional
3174,1,1,Time to Death,1.0
3174,1,1,Research lab HPV,HPV unknown
3174,1,1,Clinical lab p16,p16 unknown
3174,1,1,Occurrence #,1st primary
3174,1,1,Second Failure Type,no known failure
3174,1,1,Overall Stage,IVa
3174,1,1,Metastasis,M0
3174,1,1,Tumor Stage,T3
3174,1,1,Treatment Modality,Sx
3174,1,1,Time to First Failure,0.6
3174,1,1,Date of Death,2014-04-18 00:00:00
3174,1,1,Age at Death,58.1
3175,1,1,Research lab HPV,HPV unknown
3175,1,1,Time to Death,1.3
3175,1,1,Tumor Site,oral cavity
3175,1,1,Age at Death,65.7
3175,1,1,Date of Death,2014-12-05 00:00:00
3175,1,1,Overall Stage,I
3175,1,1,Metastasis,M0
3175,1,1,Tumor Stage,T1
3175,1,1,Second Failure Type,no known failure
3175,1,1,Nodal Stage,N0
3175,1,1,Occurrence #,1st primary
3175,1,1,Clinical lab p16,p16 unknown
3175,1,1,Research lab p16,p16 unknown
3175,1,1,Status,Dead w/o disease
3175,1,1,Treatment Modality,Sx & CTX-RT
3175,1,1,Initial Chemotherapy Agent,carbo
3175,1,1,First Failure Type,no known failure
3175,1,1,Radiation Dosage,30
3176,1,1,Age at Death,84.9
3176,1,1,Tumor Site,oropharynx
3176,1,1,Overall Stage,IVa
3176,1,1,Date of Death,2012-12-03 00:00:00
3176,1,1,Nodal Stage,N2
3176,1,1,Metastasis,M0
3176,1,1,Treatment Modality,RT
3176,1,1,Research lab p16,p16 unknown
3176,1,1,Status,Dead w/ disease
3176,1,1,First Failure Type,no known failure
3176,1,1,Time to Death,0.3
3176,1,1,Research lab HPV,HPV unknown
3176,1,1,Clinical lab p16,p16 unknown
3176,1,1,Occurrence #,1st primary
3176,1,1,Radiation Dosage,70.2
3176,1,1,Second Failure Type,no known failure
3176,1,1,Tumor Stage,T4a
3177,1,1,Occurrence #,1st primary
3177,1,1,Tumor Stage,T1
3177,1,1,First Failure Type,no known failure
3177,1,1,Metastasis,M0
3177,1,1,Research lab HPV,HPV unknown
3177,1,1,Tumor Site,oral cavity
3177,1,1,Clinical lab p16,p16 unknown
3177,1,1,Second Failure Type,no known failure
3177,1,1,Time to Death,0.2
3177,1,1,Radiation Dosage,11
3177,1,1,Date of Death,2011-07-26 00:00:00
3177,1,1,Treatment Modality,Sx & RT
3177,1,1,Research lab p16,p16 unknown
3177,1,1,Status,Dead w/ disease
3177,1,1,Overall Stage,IVa
3177,1,1,Age at Death,47.1
3177,1,1,Nodal Stage,N2
3178,1,1,Research lab p16,p16 unknown
3178,1,1,Treatment Modality,Sx
3178,1,1,Time to Death,0.1
3178,1,1,Status,Dead w/ disease
3178,1,1,Tumor Site,oral cavity
3178,1,1,Overall Stage,IVa
3178,1,1,Date of Death,2014-07-13 00:00:00
3178,1,1,Nodal Stage,N2
3178,1,1,Second Failure Type,no known failure
3178,1,1,Clinical lab p16,p16 unknown
3178,1,1,Tumor Stage,T4a
3178,1,1,First Failure Type,no known failure
3178,1,1,Metastasis,M0
3178,1,1,Occurrence #,1st primary
3178,1,1,Research lab HPV,HPV unknown
3178,1,1,Age at Death,79.1
3179,1,1,Occurrence #,1st primary
3179,1,1,Nodal Stage,N2
3179,1,1,Initial Chemotherapy Agent,cis
3179,1,1,Research lab p16,p16 unknown
3179,1,1,Time to Death,0.7
3179,1,1,Metastasis,M0
3179,1,1,Tumor Site,oral cavity
3179,1,1,First Failure Treatment Modality,Sx
3179,1,1,Date of Death,2013-10-31 00:00:00
3179,1,1,Age at Death,54.6
3179,1,1,First Failure Type,no known failure
3179,1,1,Second Line Chemotherapy Agent,Carbo
3179,1,1,Second Failure Type,no known failure
3179,1,1,Research lab HPV,HPV unknown
3179,1,1,First Failure Site,oral cavity
3179,1,1,Status,Dead w/ disease
3179,1,1,Tumor Stage,T4a
3179,1,1,Clinical lab p16,p16 unknown
3179,1,1,Overall Stage,IVa
3179,1,1,Radiation Dosage,66.6
3179,1,1,Treatment Modality,Sx & CTX-RT
3180,1,1,Clinical lab p16,p16 unknown
3180,1,1,Time to Death,0.0
3180,1,1,Status,Dead w/ disease
3180,1,1,Research lab HPV,HPV unknown
3180,1,1,First Failure Type,no known failure
3180,1,1,Date of Death,2011-08-31 00:00:00
3180,1,1,Occurrence #,1st primary
3180,1,1,Second Failure Type,no known failure
3180,1,1,Treatment Modality,Sx
3180,1,1,Tumor Site,oral cavity
3180,1,1,Research lab p16,p16 unknown
3180,1,1,Overall Stage,I
3180,1,1,Nodal Stage,N0
3180,1,1,Age at Death,86.4
3180,1,1,Tumor Stage,T1
3180,1,1,Metastasis,M0
3181,1,1,First Failure Type,no known failure
3181,1,1,Research lab HPV,HPV unknown
3181,1,1,Treatment Modality,Unknown
3181,1,1,Tumor Stage,Unknown
3181,1,1,Clinical lab p16,p16 unknown
3181,1,1,Second Failure Type,no known failure
3181,1,1,Occurrence #,Unknown
3181,1,1,Overall Stage,Unknown
3181,1,1,Research lab p16,p16 unknown
3181,1,1,Tumor Site,Unknown
3181,1,1,Status,Unknown
3181,1,1,Metastasis,Unknown
3181,1,1,Nodal Stage,Unknown
3182,1,1,Research lab HPV,HPV unknown
3182,1,1,Status,Alive w/o disease
3182,1,1,Treatment Modality,Sx
3182,1,1,Nodal Stage,N0
3182,1,1,Tumor Stage,T3
3182,1,1,Metastasis,M0
3182,1,1,Tumor Site,oral cavity
3182,1,1,Second Failure Type,no known failure
3182,1,1,Clinical lab p16,p16 unknown
3182,1,1,First Failure Type,no known failure
3182,1,1,Research lab p16,p16 unknown
3182,1,1,Occurrence #,1st primary
3182,1,1,Overall Stage,III
3183,1,1,Nodal Stage,N0
3183,1,1,Metastasis,M0
3183,1,1,First Failure Type,no known failure
3183,1,1,Overall Stage,I
3183,1,1,Treatment Modality,Sx
3183,1,1,Research lab p16,p16 unknown
3183,1,1,Research lab HPV,HPV unknown
3183,1,1,Clinical lab p16,p16 unknown
3183,1,1,Tumor Stage,T1
3183,1,1,Tumor Site,oral cavity
3183,1,1,Occurrence #,1st primary
3183,1,1,Second Failure Type,no known failure
3183,1,1,Status,Alive w/o disease
3184,1,1,Overall Stage,IVa
3184,1,1,Treatment Modality,Sx
3184,1,1,First Failure Type,no known failure
3184,1,1,Tumor Site,oral cavity
3184,1,1,Clinical lab p16,p16 unknown
3184,1,1,Tumor Stage,T4a
3184,1,1,Occurrence #,1st primary
3184,1,1,Status,Alive w/ disease
3184,1,1,Metastasis,M0
3184,1,1,Research lab HPV,HPV unknown
3184,1,1,Second Failure Type,no known failure
3184,1,1,Research lab p16,p16 unknown
3184,1,1,Nodal Stage,N0
3185,1,1,Occurrence #,1st primary
3185,1,1,Research lab HPV,HPV unknown
3185,1,1,First Failure Type,no known failure
3185,1,1,Tumor Site,oral cavity
3185,1,1,Radiation Dosage,60
3185,1,1,Second Failure Type,no known failure
3185,1,1,Treatment Modality,Sx & RT
3185,1,1,Research lab p16,p16 unknown
3185,1,1,Overall Stage,III
3185,1,1,Clinical lab p16,p16 unknown
3185,1,1,Tumor Stage,T1
3185,1,1,Status,Alive w/o disease
3185,1,1,Nodal Stage,N1
3185,1,1,Metastasis,M0
3186,1,1,Clinical lab p16,p16 unknown
3186,1,1,First Failure Type,no known failure
3186,1,1,Metastasis,M0
3186,1,1,Treatment Modality,Sx
3186,1,1,Occurrence #,1st primary
3186,1,1,Research lab p16,p16 unknown
3186,1,1,Tumor Stage,T1
3186,1,1,Research lab HPV,HPV unknown
3186,1,1,Nodal Stage,N0
3186,1,1,Tumor Site,oral cavity
3186,1,1,Status,Alive w/o disease
3186,1,1,Second Failure Type,no known failure
3186,1,1,Overall Stage,I
3187,1,1,Occurrence #,other primary
3187,1,1,Tumor Stage,T1
3187,1,1,Metastasis,M0
3187,1,1,Tumor Site,oral cavity
3187,1,1,Second Failure Type,no known failure
3187,1,1,Status,Alive w/o disease
3187,1,1,Overall Stage,I
3187,1,1,Research lab HPV,HPV unknown
3187,1,1,First Failure Type,no known failure
3187,1,1,Research lab p16,p16 unknown
3187,1,1,Nodal Stage,N0
3187,1,1,Treatment Modality,Sx
3187,1,1,Clinical lab p16,p16 unknown
3188,1,1,First Failure Type,no known failure
3188,1,1,Second Failure Type,no known failure
3188,1,1,Treatment Modality,Sx
3188,1,1,Nodal Stage,Unknown
3188,1,1,Status,Alive w/o disease
3188,1,1,Occurrence #,1st primary
3188,1,1,Tumor Site,oral cavity
3188,1,1,Research lab p16,p16 unknown
3188,1,1,Metastasis,Unknown
3188,1,1,Tumor Stage,Unknown
3188,1,1,Clinical lab p16,p16 unknown
3188,1,1,Overall Stage,Unknown
3188,1,1,Research lab HPV,HPV unknown
3189,1,1,Research lab p16,p16 unknown
3189,1,1,Nodal Stage,Unknown
3189,1,1,First Failure Type,no known failure
3189,1,1,Status,Alive w/o disease
3189,1,1,Clinical lab p16,p16 unknown
3189,1,1,Treatment Modality,Sx
3189,1,1,Overall Stage,Unknown
3189,1,1,Occurrence #,1st primary
3189,1,1,Tumor Stage,Unknown
3189,1,1,Metastasis,Unknown
3189,1,1,Research lab HPV,HPV unknown
3189,1,1,Tumor Site,oral cavity
3189,1,1,Second Failure Type,no known failure
3190,1,1,Overall Stage,I
3190,1,1,Tumor Site,oral cavity
3190,1,1,Tumor Stage,T1
3190,1,1,Status,Alive w/o disease
3190,1,1,Clinical lab p16,p16 unknown
3190,1,1,Second Failure Type,no known failure
3190,1,1,First Failure Type,no known failure
3190,1,1,Research lab p16,p16 unknown
3190,1,1,Nodal Stage,N0
3190,1,1,Treatment Modality,Sx
3190,1,1,Research lab HPV,HPV unknown
3190,1,1,Metastasis,M0
3190,1,1,Occurrence #,1st primary
3191,1,1,Research lab p16,p16 unknown
3191,1,1,Clinical lab p16,p16 unknown
3191,1,1,Nodal Stage,N0
3191,1,1,Status,Alive w/ disease
3191,1,1,Research lab HPV,HPV unknown
3191,1,1,Second Failure Type,no known failure
3191,1,1,Metastasis,M0
3191,1,1,Treatment Modality,Sx
3191,1,1,Overall Stage,I
3191,1,1,First Failure Type,no known failure
3191,1,1,Tumor Site,oral cavity
3191,1,1,Occurrence #,1st primary
3191,1,1,Tumor Stage,T1
3192,1,1,Status,Alive w/o disease
3192,1,1,Clinical lab p16,p16 unknown
3192,1,1,Research lab HPV,HPV unknown
3192,1,1,Tumor Site,oral cavity
3192,1,1,Metastasis,M0
3192,1,1,Treatment Modality,Sx
3192,1,1,First Failure Type,no known failure
3192,1,1,Research lab p16,p16 unknown
3192,1,1,Occurrence #,1st primary
3192,1,1,Second Failure Type,no known failure
3192,1,1,Tumor Stage,T1
3192,1,1,Nodal Stage,N0
3192,1,1,Overall Stage,I
3193,1,1,Clinical lab p16,p16 unknown
3193,1,1,Nodal Stage,N0
3193,1,1,Second Failure Type,no known failure
3193,1,1,Occurrence #,1st primary
3193,1,1,Metastasis,M0
3193,1,1,Tumor Site,oral cavity
3193,1,1,Overall Stage,I
3193,1,1,Status,Alive w/o disease
3193,1,1,Treatment Modality,Sx
3193,1,1,Research lab HPV,HPV unknown
3193,1,1,First Failure Type,no known failure
3193,1,1,Research lab p16,p16 unknown
3193,1,1,Tumor Stage,T1
3194,1,1,Status,Alive w/o disease
3194,1,1,First Failure Type,no known failure
3194,1,1,Treatment Modality,Sx
3194,1,1,Metastasis,M0
3194,1,1,Second Failure Type,no known failure
3194,1,1,Clinical lab p16,p16 unknown
3194,1,1,Occurrence #,1st primary
3194,1,1,Research lab HPV,HPV unknown
3194,1,1,Nodal Stage,N0
3194,1,1,Research lab p16,p16 unknown
3194,1,1,Tumor Stage,T1
3194,1,1,Overall Stage,I
3194,1,1,Tumor Site,oral cavity
3195,1,1,First Failure Type,no known failure
3195,1,1,Research lab HPV,HPV unknown
3195,1,1,Overall Stage,I
3195,1,1,Metastasis,M0
3195,1,1,Tumor Site,oral cavity
3195,1,1,Second Failure Type,no known failure
3195,1,1,Nodal Stage,N0
3195,1,1,Tumor Stage,T1
3195,1,1,Treatment Modality,Sx
3195,1,1,Research lab p16,p16 unknown
3195,1,1,Occurrence #,1st primary
3195,1,1,Clinical lab p16,p16 unknown
3195,1,1,Status,Alive w/o disease
3196,1,1,Occurrence #,1st primary
3196,1,1,Overall Stage,I
3196,1,1,Second Failure Type,no known failure
3196,1,1,Clinical lab p16,p16 unknown
3196,1,1,Research lab HPV,HPV unknown
3196,1,1,Treatment Modality,Sx
3196,1,1,Research lab p16,p16 unknown
3196,1,1,Metastasis,M0
3196,1,1,Status,Alive w/o disease
3196,1,1,Nodal Stage,N0
3196,1,1,Tumor Site,oral cavity
3196,1,1,First Failure Type,no known failure
3196,1,1,Tumor Stage,T1
3197,1,1,Occurrence #,recurrence
3197,1,1,Research lab p16,p16 unknown
3197,1,1,Tumor Stage,T4a
3197,1,1,Status,Alive w/o disease
3197,1,1,Second Failure Type,no known failure
3197,1,1,First Failure Type,no known failure
3197,1,1,Nodal Stage,N1
3197,1,1,Initial Chemotherapy Agent,cis
3197,1,1,Metastasis,M0
3197,1,1,Clinical lab p16,p16 unknown
3197,1,1,Treatment Modality,Sx & CTX-RT
3197,1,1,Tumor Site,oral cavity
3197,1,1,Radiation Dosage,66
3197,1,1,Overall Stage,IVa
3197,1,1,Research lab HPV,HPV unknown
3198,1,1,Research lab p16,p16 unknown
3198,1,1,Nodal Stage,N3
3198,1,1,Second Failure Type,no known failure
3198,1,1,Research lab HPV,HPV unknown
3198,1,1,Tumor Site,oropharynx
3198,1,1,Occurrence #,1st primary
3198,1,1,Clinical lab p16,p16 unknown
3198,1,1,Status,Alive w/o disease
3198,1,1,First Failure Type,no known failure
3198,1,1,Metastasis,M0
3198,1,1,Treatment Modality,Sx & CTX-RT
3198,1,1,Overall Stage,IVb
3198,1,1,Tumor Stage,T1
3199,1,1,Treatment Modality,Sx
3199,1,1,Status,Alive w/o disease
3199,1,1,Nodal Stage,N0
3199,1,1,First Failure Type,no known failure
3199,1,1,Metastasis,M0
3199,1,1,Second Failure Type,no known failure
3199,1,1,Research lab p16,p16 unknown
3199,1,1,Occurrence #,1st primary
3199,1,1,Overall Stage,I
3199,1,1,Tumor Site,oral cavity
3199,1,1,Tumor Stage,T1
3199,1,1,Research lab HPV,HPV unknown
3199,1,1,Clinical lab p16,p16 unknown
3200,1,1,Second Failure Type,no known failure
3200,1,1,Occurrence #,1st primary
3200,1,1,Clinical lab p16,p16 unknown
3200,1,1,Tumor Site,oral cavity
3200,1,1,Nodal Stage,Unknown
3200,1,1,Tumor Stage,T1
3200,1,1,Radiation Dosage,60
3200,1,1,Metastasis,M0
3200,1,1,Status,Alive w/o disease
3200,1,1,First Failure Type,no known failure
3200,1,1,Treatment Modality,Sx & RT
3200,1,1,Overall Stage,Unknown
3200,1,1,Research lab p16,p16 unknown
3200,1,1,Research lab HPV,HPV unknown
3201,1,1,Metastasis,M0
3201,1,1,Tumor Stage,T2
3201,1,1,Overall Stage,II
3201,1,1,Research lab HPV,HPV unknown
3201,1,1,First Failure Type,no known failure
3201,1,1,Status,Alive w/o disease
3201,1,1,Research lab p16,p16 unknown
3201,1,1,Nodal Stage,N0
3201,1,1,Treatment Modality,Sx
3201,1,1,Second Failure Type,no known failure
3201,1,1,Tumor Site,oral cavity
3201,1,1,Occurrence #,1st primary
3201,1,1,Clinical lab p16,p16 unknown
3202,1,1,Tumor Site,oral cavity
3202,1,1,Status,Alive w/o disease
3202,1,1,Tumor Stage,T1
3202,1,1,Treatment Modality,Sx
3202,1,1,Metastasis,M0
3202,1,1,First Failure Type,no known failure
3202,1,1,Occurrence #,1st primary
3202,1,1,Research lab HPV,HPV unknown
3202,1,1,Clinical lab p16,p16 unknown
3202,1,1,Nodal Stage,N0
3202,1,1,Second Failure Type,no known failure
3202,1,1,Overall Stage,I
3202,1,1,Research lab p16,p16 unknown
3203,1,1,Treatment Modality,Sx
3203,1,1,Research lab HPV,HPV unknown
3203,1,1,Nodal Stage,N0
3203,1,1,Tumor Stage,T1
3203,1,1,Second Failure Type,no known failure
3203,1,1,Clinical lab p16,p16 unknown
3203,1,1,Tumor Site,oral cavity
3203,1,1,Research lab p16,p16 unknown
3203,1,1,First Failure Type,no known failure
3203,1,1,Status,Alive w/o disease
3203,1,1,Overall Stage,I
3203,1,1,Occurrence #,1st primary
3203,1,1,Metastasis,M0
3204,1,1,Initial Chemotherapy Agent,Doce/cis/5Fu
3204,1,1,Treatment Modality,Unknown
3204,1,1,Clinical lab p16,p16 unknown
3204,1,1,Occurrence #,1st primary
3204,1,1,Second Failure Type,no known failure
3204,1,1,Overall Stage,Unknown
3204,1,1,Status,Alive w/ disease
3204,1,1,Metastasis,Unknown
3204,1,1,First Failure Type,no known failure
3204,1,1,Tumor Site,oropharynx
3204,1,1,Tumor Stage,Unknown
3204,1,1,Nodal Stage,Unknown
3204,1,1,Research lab p16,p16 unknown
3204,1,1,Research lab HPV,HPV unknown
3205,1,1,Tumor Stage,T1
3205,1,1,Second Failure Type,no known failure
3205,1,1,First Failure Type,no known failure
3205,1,1,Research lab HPV,HPV unknown
3205,1,1,Tumor Site,oral cavity
3205,1,1,Nodal Stage,N0
3205,1,1,Research lab p16,p16 unknown
3205,1,1,Overall Stage,I
3205,1,1,Status,Alive w/o disease
3205,1,1,Treatment Modality,Sx
3205,1,1,Clinical lab p16,p16 unknown
3205,1,1,Occurrence #,1st primary
3205,1,1,Metastasis,M0
3206,1,1,Research lab p16,p16 unknown
3206,1,1,Nodal Stage,N0
3206,1,1,Initial Chemotherapy Agent,cis
3206,1,1,First Failure Type,no known failure
3206,1,1,Research lab HPV,HPV unknown
3206,1,1,Second Failure Type,no known failure
3206,1,1,Overall Stage,III
3206,1,1,Metastasis,M0
3206,1,1,Treatment Modality,Sx & CTX-RT
3206,1,1,Radiation Dosage,70.2
3206,1,1,Status,Alive w/o disease
3206,1,1,Tumor Site,oral cavity
3206,1,1,Clinical lab p16,p16 unknown
3206,1,1,Occurrence #,1st primary
3206,1,1,Tumor Stage,T3
3207,1,1,Tumor Site,oral cavity
3207,1,1,Tumor Stage,Unknown
3207,1,1,Research lab HPV,HPV unknown
3207,1,1,Occurrence #,1st primary
3207,1,1,Treatment Modality,Sx
3207,1,1,Metastasis,Unknown
3207,1,1,Nodal Stage,Unknown
3207,1,1,Second Failure Type,no known failure
3207,1,1,First Failure Type,no known failure
3207,1,1,Status,Alive w/o disease
3207,1,1,Research lab p16,p16 unknown
3207,1,1,Overall Stage,Unknown
3207,1,1,Clinical lab p16,p16 unknown
3208,1,1,Radiation Dosage,unknown
3208,1,1,Metastasis,M0
3208,1,1,Treatment Modality,Sx & RT
3208,1,1,Tumor Site,oral cavity
3208,1,1,Overall Stage,IVa
3208,1,1,Clinical lab p16,p16 unknown
3208,1,1,Nodal Stage,N2
3208,1,1,Research lab p16,p16 unknown
3208,1,1,Tumor Stage,T4a
3208,1,1,Research lab HPV,HPV unknown
3208,1,1,Occurrence #,1st primary
3208,1,1,Second Failure Type,no known failure
3208,1,1,Status,Alive w/o disease
3208,1,1,First Failure Type,no known failure
3209,1,1,Nodal Stage,N0
3209,1,1,Status,Alive w/o disease
3209,1,1,Overall Stage,II
3209,1,1,Research lab p16,p16 unknown
3209,1,1,Second Failure Type,no known failure
3209,1,1,Occurrence #,1st primary
3209,1,1,Tumor Site,oral cavity
3209,1,1,Clinical lab p16,p16 unknown
3209,1,1,First Failure Treatment Modality,Sx
3209,1,1,Tumor Stage,T2
3209,1,1,Treatment Modality,Sx
3209,1,1,First Failure Type,no known failure
3209,1,1,First Failure Site,oropharynx
3209,1,1,Metastasis,M0
3209,1,1,Research lab HPV,HPV unknown
3210,1,1,Clinical lab p16,p16 unknown
3210,1,1,Treatment Modality,Sx
3210,1,1,Research lab p16,p16 unknown
3210,1,1,Overall Stage,I
3210,1,1,Status,Alive w/o disease
3210,1,1,Tumor Stage,T1
3210,1,1,First Failure Type,no known failure
3210,1,1,Metastasis,M0
3210,1,1,Research lab HPV,HPV unknown
3210,1,1,Tumor Site,oral cavity
3210,1,1,Nodal Stage,N0
3210,1,1,Second Failure Type,no known failure
3210,1,1,Occurrence #,1st primary
3211,1,1,Occurrence #,1st primary
3211,1,1,Research lab HPV,HPV unknown
3211,1,1,Clinical lab p16,p16 unknown
3211,1,1,Treatment Modality,Sx
3211,1,1,Second Failure Type,no known failure
3211,1,1,Research lab p16,p16 unknown
3211,1,1,Tumor Stage,T2
3211,1,1,Status,Alive w/o disease
3211,1,1,First Failure Type,no known failure
3211,1,1,Overall Stage,III
3211,1,1,Tumor Site,oral cavity
3211,1,1,Metastasis,M0
3211,1,1,Nodal Stage,N1
3212,1,1,Second Failure Type,no known failure
3212,1,1,Research lab HPV,HPV unknown
3212,1,1,Occurrence #,1st primary
3212,1,1,Tumor Site,oral cavity
3212,1,1,Tumor Stage,T1
3212,1,1,Overall Stage,I
3212,1,1,Clinical lab p16,p16 unknown
3212,1,1,Treatment Modality,Sx
3212,1,1,First Failure Type,no known failure
3212,1,1,Nodal Stage,N0
3212,1,1,Metastasis,M0
3212,1,1,Status,Alive w/o disease
3212,1,1,Research lab p16,p16 unknown
3213,1,1,Tumor Site,oral cavity
3213,1,1,First Failure Type,no known failure
3213,1,1,Overall Stage,I
3213,1,1,Nodal Stage,N0
3213,1,1,Research lab HPV,HPV unknown
3213,1,1,Second Failure Type,no known failure
3213,1,1,Occurrence #,1st primary
3213,1,1,Status,Alive w/o disease
3213,1,1,Metastasis,M0
3213,1,1,Treatment Modality,Sx
3213,1,1,Clinical lab p16,p16 unknown
3213,1,1,Tumor Stage,T1
3213,1,1,Research lab p16,p16 unknown
3214,1,1,Tumor Site,oral cavity
3214,1,1,Metastasis,M0
3214,1,1,Research lab HPV,HPV unknown
3214,1,1,Second Failure Type,no known failure
3214,1,1,Status,Alive w/o disease
3214,1,1,Occurrence #,1st primary
3214,1,1,Overall Stage,IVa
3214,1,1,Research lab p16,p16 unknown
3214,1,1,Tumor Stage,T2
3214,1,1,First Failure Type,no known failure
3214,1,1,Treatment Modality,Sx
3214,1,1,Nodal Stage,N2
3214,1,1,Clinical lab p16,p16 unknown
3215,1,1,First Failure Type,no known failure
3215,1,1,Overall Stage,I
3215,1,1,Clinical lab p16,p16 unknown
3215,1,1,Research lab p16,p16 unknown
3215,1,1,Treatment Modality,Sx
3215,1,1,Second Failure Type,no known failure
3215,1,1,Research lab HPV,HPV unknown
3215,1,1,Occurrence #,1st primary
3215,1,1,First Failure Treatment Modality,Sx
3215,1,1,Tumor Stage,T1
3215,1,1,Metastasis,M0
3215,1,1,Nodal Stage,N0
3215,1,1,Status,Alive w/o disease
3215,1,1,Tumor Site,oral cavity
3216,1,1,Nodal Stage,N2
3216,1,1,Tumor Stage,T1
3216,1,1,Second Failure Type,no known failure
3216,1,1,Research lab p16,p16 unknown
3216,1,1,Initial Chemotherapy Agent,carbo/PTX
3216,1,1,Overall Stage,IVa
3216,1,1,First Failure Type,no known failure
3216,1,1,Radiation Dosage,70.2
3216,1,1,Metastasis,M0
3216,1,1,Research lab HPV,HPV unknown
3216,1,1,Tumor Site,oropharynx
3216,1,1,Treatment Modality,CTX-RT
3216,1,1,Occurrence #,1st primary
3216,1,1,Status,Alive w/o disease
3216,1,1,Clinical lab p16,p16 unknown
3217,1,1,Radiation Dosage,70.2
3217,1,1,Metastasis,M0
3217,1,1,Research lab p16,p16 unknown
3217,1,1,Clinical lab p16,p16 unknown
3217,1,1,Status,Alive w/o disease
3217,1,1,Nodal Stage,N2
3217,1,1,Tumor Stage,T2
3217,1,1,Occurrence #,1st primary
3217,1,1,Treatment Modality,CTX-RT
3217,1,1,Overall Stage,IVa
3217,1,1,Second Failure Type,no known failure
3217,1,1,Research lab HPV,HPV unknown
3217,1,1,Tumor Site,oropharynx
3217,1,1,Initial Chemotherapy Agent,cis
3217,1,1,First Failure Type,no known failure
3218,1,1,Nodal Stage,N0
3218,1,1,Tumor Stage,T1
3218,1,1,Clinical lab p16,p16 unknown
3218,1,1,Occurrence #,1st primary
3218,1,1,Research lab p16,p16 unknown
3218,1,1,Research lab HPV,HPV unknown
3218,1,1,Status,Alive w/o disease
3218,1,1,Second Failure Type,no known failure
3218,1,1,Metastasis,M0
3218,1,1,Tumor Site,oral cavity
3218,1,1,First Failure Type,no known failure
3218,1,1,Overall Stage,I
3218,1,1,Treatment Modality,Sx
3219,1,1,Research lab HPV,HPV unknown
3219,1,1,Status,Alive w/o disease
3219,1,1,Nodal Stage,Unknown
3219,1,1,Clinical lab p16,p16 unknown
3219,1,1,Occurrence #,1st primary
3219,1,1,Tumor Site,oral cavity
3219,1,1,Treatment Modality,Sx
3219,1,1,Tumor Stage,Unknown
3219,1,1,First Failure Type,no known failure
3219,1,1,Metastasis,Unknown
3219,1,1,Overall Stage,Unknown
3219,1,1,Second Failure Type,no known failure
3219,1,1,Research lab p16,p16 unknown
3220,1,1,Overall Stage,I
3220,1,1,First Failure Type,no known failure
3220,1,1,Second Failure Type,no known failure
3220,1,1,Research lab HPV,HPV unknown
3220,1,1,Tumor Site,oral cavity
3220,1,1,Tumor Stage,T1
3220,1,1,Occurrence #,1st primary
3220,1,1,Research lab p16,p16 unknown
3220,1,1,Nodal Stage,N0
3220,1,1,Clinical lab p16,p16 unknown
3220,1,1,Status,Alive w/o disease
3220,1,1,Treatment Modality,Sx
3220,1,1,Metastasis,M0
3221,1,1,Research lab HPV,HPV unknown
3221,1,1,Tumor Site,oral cavity
3221,1,1,Overall Stage,IVa
3221,1,1,Nodal Stage,N2
3221,1,1,First Failure Type,no known failure
3221,1,1,Tumor Stage,T3
3221,1,1,Occurrence #,1st primary
3221,1,1,Radiation Dosage,60
3221,1,1,Metastasis,M0
3221,1,1,Clinical lab p16,p16 unknown
3221,1,1,Treatment Modality,Sx & RT
3221,1,1,Status,Alive w/o disease
3221,1,1,Second Failure Type,no known failure
3221,1,1,Research lab p16,p16 unknown
3222,1,1,Research lab p16,p16 unknown
3222,1,1,First Failure Type,no known failure
3222,1,1,Nodal Stage,Unknown
3222,1,1,Research lab HPV,HPV unknown
3222,1,1,Tumor Stage,Unknown
3222,1,1,Occurrence #,1st primary
3222,1,1,Metastasis,Unknown
3222,1,1,Clinical lab p16,p16 unknown
3222,1,1,Treatment Modality,Sx
3222,1,1,Status,Alive w/o disease
3222,1,1,Tumor Site,oral cavity
3222,1,1,Second Failure Type,no known failure
3222,1,1,Overall Stage,Unknown
3223,1,1,Tumor Site,oral cavity
3223,1,1,Tumor Stage,T1
3223,1,1,Occurrence #,1st primary
3223,1,1,Overall Stage,I
3223,1,1,Second Failure Type,no known failure
3223,1,1,Treatment Modality,Sx
3223,1,1,First Failure Type,no known failure
3223,1,1,Research lab HPV,HPV unknown
3223,1,1,Status,Alive w/o disease
3223,1,1,Research lab p16,p16 unknown
3223,1,1,Metastasis,M0
3223,1,1,Clinical lab p16,p16 unknown
3223,1,1,Nodal Stage,N0
3224,1,1,Overall Stage,I
3224,1,1,Metastasis,M0
3224,1,1,First Failure Site,multiple
3224,1,1,Status,Alive w/o disease
3224,1,1,Occurrence #,1st primary
3224,1,1,Tumor Stage,T1
3224,1,1,Treatment Modality,Sx
3224,1,1,First Failure Type,no known failure
3224,1,1,Tumor Site,oral cavity
3224,1,1,Second Failure Type,no known failure
3224,1,1,Clinical lab p16,p16 unknown
3224,1,1,Research lab HPV,HPV unknown
3224,1,1,Nodal Stage,N0
3224,1,1,Research lab p16,p16 unknown
3225,1,1,Research lab HPV,HPV unknown
3225,1,1,Second Failure Type,no known failure
3225,1,1,Research lab p16,p16 unknown
3225,1,1,Tumor Site,oral cavity
3225,1,1,Treatment Modality,Sx
3225,1,1,Tumor Stage,T4a
3225,1,1,Clinical lab p16,p16 unknown
3225,1,1,Status,Alive w/o disease
3225,1,1,First Failure Type,no known failure
3225,1,1,Overall Stage,IVa
3225,1,1,Nodal Stage,N0
3225,1,1,Occurrence #,1st primary
3225,1,1,Metastasis,M0
3226,1,1,Research lab p16,p16 unknown
3226,1,1,Status,Alive w/o disease
3226,1,1,Tumor Stage,T3
3226,1,1,Tumor Site,oral cavity
3226,1,1,Treatment Modality,Sx & RT
3226,1,1,First Failure Type,no known failure
3226,1,1,Overall Stage,III
3226,1,1,Nodal Stage,N0
3226,1,1,Metastasis,M0
3226,1,1,Research lab HPV,HPV unknown
3226,1,1,Second Failure Type,no known failure
3226,1,1,Clinical lab p16,p16 unknown
3226,1,1,Occurrence #,1st primary
3227,1,1,Metastasis,M0
3227,1,1,Research lab p16,p16 unknown
3227,1,1,Tumor Site,oral cavity
3227,1,1,Treatment Modality,Sx & CTX-RT
3227,1,1,Radiation Dosage,60
3227,1,1,Research lab HPV,HPV unknown
3227,1,1,Second Failure Type,no known failure
3227,1,1,Occurrence #,recurrence
3227,1,1,Tumor Stage,T2
3227,1,1,Nodal Stage,N1
3227,1,1,Status,Alive w/o disease
3227,1,1,First Failure Type,no known failure
3227,1,1,Initial Chemotherapy Agent,Carbo
3227,1,1,Clinical lab p16,p16 unknown
3227,1,1,Overall Stage,IVa
3228,1,1,Nodal Stage,N1
3228,1,1,Research lab HPV,HPV unknown
3228,1,1,Clinical lab p16,p16 unknown
3228,1,1,First Failure Type,no known failure
3228,1,1,Tumor Stage,T2
3228,1,1,Metastasis,M0
3228,1,1,Second Failure Type,no known failure
3228,1,1,Status,Alive w/ disease
3228,1,1,Research lab p16,p16 unknown
3228,1,1,Tumor Site,oral cavity
3228,1,1,Treatment Modality,Sx
3228,1,1,Overall Stage,III
3228,1,1,Occurrence #,1st primary
3229,1,1,Research lab p16,p16 unknown
3229,1,1,Nodal Stage,N0
3229,1,1,Status,Alive w/o disease
3229,1,1,First Failure Type,no known failure
3229,1,1,Clinical lab p16,p16 unknown
3229,1,1,Second Failure Type,no known failure
3229,1,1,Tumor Site,oral cavity
3229,1,1,Treatment Modality,Sx
3229,1,1,Occurrence #,1st primary
3229,1,1,Tumor Stage,T4a
3229,1,1,Research lab HPV,HPV unknown
3229,1,1,Overall Stage,IVa
3229,1,1,Metastasis,M0
3230,1,1,Tumor Site,oral cavity
3230,1,1,Second Failure Type,no known failure
3230,1,1,Occurrence #,1st primary
3230,1,1,First Failure Type,no known failure
3230,1,1,Overall Stage,I
3230,1,1,Clinical lab p16,p16 unknown
3230,1,1,Status,Alive w/o disease
3230,1,1,Treatment Modality,Sx
3230,1,1,Research lab p16,p16 unknown
3230,1,1,Tumor Stage,T1
3230,1,1,Nodal Stage,N0
3230,1,1,Research lab HPV,HPV unknown
3230,1,1,Metastasis,M0
3231,1,1,Research lab HPV,HPV unknown
3231,1,1,First Failure Type,no known failure
3231,1,1,Treatment Modality,Sx
3231,1,1,Tumor Stage,T3
3231,1,1,Second Failure Type,no known failure
3231,1,1,Tumor Site,oral cavity
3231,1,1,Clinical lab p16,p16 unknown
3231,1,1,Overall Stage,III
3231,1,1,Nodal Stage,N0
3231,1,1,Occurrence #,1st primary
3231,1,1,Status,Alive w/o disease
3231,1,1,Metastasis,M0
3231,1,1,Research lab p16,p16 unknown
3232,1,1,Research lab p16,p16 unknown
3232,1,1,Overall Stage,I
3232,1,1,Clinical lab p16,p16 unknown
3232,1,1,Occurrence #,1st primary
3232,1,1,Time to First Failure,1.3
3232,1,1,Treatment Modality,Sx
3232,1,1,Second Failure Type,no known failure
3232,1,1,Tumor Site,oral cavity
3232,1,1,First Failure Site,oral cavity
3232,1,1,Status,Alive w/o disease
3232,1,1,Nodal Stage,N0
3232,1,1,First Failure Type,locoregional
3232,1,1,Research lab HPV,HPV unknown
3232,1,1,First Failure Treatment Modality,Sx
3232,1,1,Metastasis,M0
3232,1,1,Tumor Stage,T1
3233,1,1,First Failure Type,no known failure
3233,1,1,Tumor Stage,T4a
3233,1,1,Research lab p16,p16 unknown
3233,1,1,Research lab HPV,HPV unknown
3233,1,1,Tumor Site,oral cavity
3233,1,1,Nodal Stage,N0
3233,1,1,Metastasis,M0
3233,1,1,Treatment Modality,Sx
3233,1,1,Status,Alive w/o disease
3233,1,1,Overall Stage,IVa
3233,1,1,Second Failure Type,no known failure
3233,1,1,Clinical lab p16,p16 unknown
3233,1,1,Occurrence #,1st primary
3234,1,1,Research lab p16,p16 unknown
3234,1,1,Occurrence #,1st primary
3234,1,1,Tumor Stage,Unknown
3234,1,1,Overall Stage,Unknown
3234,1,1,Nodal Stage,Unknown
3234,1,1,Status,Alive w/o disease
3234,1,1,Metastasis,Unknown
3234,1,1,Clinical lab p16,p16 unknown
3234,1,1,Treatment Modality,Sx
3234,1,1,Tumor Site,oral cavity
3234,1,1,Research lab HPV,HPV unknown
3234,1,1,Second Failure Type,no known failure
3234,1,1,First Failure Type,no known failure
3235,1,1,Nodal Stage,N0
3235,1,1,Overall Stage,I
3235,1,1,Occurrence #,1st primary
3235,1,1,Treatment Modality,Sx
3235,1,1,Research lab HPV,HPV unknown
3235,1,1,First Failure Type,no known failure
3235,1,1,Second Failure Type,no known failure
3235,1,1,Status,Alive w/o disease
3235,1,1,Metastasis,M0
3235,1,1,Tumor Site,oral cavity
3235,1,1,Tumor Stage,T1
3235,1,1,Research lab p16,p16 unknown
3235,1,1,Clinical lab p16,p16 unknown
3236,1,1,Occurrence #,1st primary
3236,1,1,Tumor Stage,T1
3236,1,1,Second Failure Type,no known failure
3236,1,1,Clinical lab p16,p16 unknown
3236,1,1,Status,Alive w/o disease
3236,1,1,Treatment Modality,Sx
3236,1,1,First Failure Type,no known failure
3236,1,1,Overall Stage,I
3236,1,1,Research lab p16,p16 unknown
3236,1,1,Research lab HPV,HPV unknown
3236,1,1,Tumor Site,oral cavity
3236,1,1,Metastasis,M0
3236,1,1,Nodal Stage,N0
3237,1,1,Research lab p16,p16 unknown
3237,1,1,Second Failure Type,no known failure
3237,1,1,Status,Alive w/o disease
3237,1,1,Occurrence #,1st primary
3237,1,1,Nodal Stage,N0
3237,1,1,Metastasis,M0
3237,1,1,Tumor Stage,T2
3237,1,1,Overall Stage,II
3237,1,1,Treatment Modality,Sx
3237,1,1,Clinical lab p16,p16 unknown
3237,1,1,First Failure Type,no known failure
3237,1,1,Research lab HPV,HPV unknown
3237,1,1,Tumor Site,oral cavity
3238,1,1,Tumor Site,oral cavity
3238,1,1,Tumor Stage,Unknown
3238,1,1,Treatment Modality,Sx
3238,1,1,Nodal Stage,Unknown
3238,1,1,Metastasis,Unknown
3238,1,1,Research lab HPV,HPV unknown
3238,1,1,First Failure Type,no known failure
3238,1,1,Research lab p16,p16 unknown
3238,1,1,Overall Stage,Unknown
3238,1,1,Status,Alive w/o disease
3238,1,1,Clinical lab p16,p16 unknown
3238,1,1,Second Failure Type,no known failure
3238,1,1,Occurrence #,1st primary
3239,1,1,Status,Alive w/o disease
3239,1,1,Research lab HPV,HPV unknown
3239,1,1,Clinical lab p16,p16 unknown
3239,1,1,Nodal Stage,N0
3239,1,1,Occurrence #,1st primary
3239,1,1,Metastasis,M0
3239,1,1,First Failure Type,no known failure
3239,1,1,Second Failure Type,no known failure
3239,1,1,Research lab p16,p16 unknown
3239,1,1,Overall Stage,I
3239,1,1,Tumor Stage,T1
3239,1,1,Treatment Modality,Sx
3239,1,1,Tumor Site,oral cavity
3240,1,1,Initial Chemotherapy Agent,cis
3240,1,1,Research lab p16,p16 unknown
3240,1,1,Nodal Stage,N1
3240,1,1,First Failure Type,no known failure
3240,1,1,Status,Alive w/ disease
3240,1,1,Research lab HPV,HPV unknown
3240,1,1,Treatment Modality,Sx & CTX-RT
3240,1,1,Overall Stage,IVa
3240,1,1,Second Failure Type,no known failure
3240,1,1,Clinical lab p16,p16 unknown
3240,1,1,Tumor Site,oral cavity
3240,1,1,Occurrence #,1st primary
3240,1,1,Tumor Stage,T4a
3240,1,1,Metastasis,M0
3241,1,1,Research lab p16,p16 unknown
3241,1,1,Metastasis,Unknown
3241,1,1,First Failure Type,no known failure
3241,1,1,Second Failure Type,no known failure
3241,1,1,Overall Stage,Unknown
3241,1,1,Status,Alive w/o disease
3241,1,1,Clinical lab p16,p16 unknown
3241,1,1,Tumor Stage,Unknown
3241,1,1,Treatment Modality,Sx
3241,1,1,Research lab HPV,HPV unknown
3241,1,1,Tumor Site,Unknown
3241,1,1,Occurrence #,1st primary
3241,1,1,Nodal Stage,Unknown
3242,1,1,First Failure Type,no known failure
3242,1,1,Clinical lab p16,p16 unknown
3242,1,1,Nodal Stage,N0
3242,1,1,Tumor Site,oral cavity
3242,1,1,Tumor Stage,T1
3242,1,1,Treatment Modality,Sx
3242,1,1,Research lab p16,p16 unknown
3242,1,1,Second Failure Type,no known failure
3242,1,1,Status,Alive w/o disease
3242,1,1,Research lab HPV,HPV unknown
3242,1,1,Metastasis,M0
3242,1,1,Overall Stage,I
3242,1,1,Occurrence #,1st primary
3243,1,1,Clinical lab p16,p16 unknown
3243,1,1,First Failure Type,no known failure
3243,1,1,Tumor Stage,T1
3243,1,1,Tumor Site,oral cavity
3243,1,1,Overall Stage,I
3243,1,1,Nodal Stage,N0
3243,1,1,Treatment Modality,Sx
3243,1,1,Second Failure Type,no known failure
3243,1,1,Metastasis,M0
3243,1,1,Status,Alive w/o disease
3243,1,1,Research lab HPV,HPV unknown
3243,1,1,Occurrence #,1st primary
3243,1,1,Research lab p16,p16 unknown
3244,1,1,Treatment Modality,Sx
3244,1,1,First Failure Type,no known failure
3244,1,1,Clinical lab p16,p16 unknown
3244,1,1,Overall Stage,I
3244,1,1,Tumor Site,oral cavity
3244,1,1,Research lab HPV,HPV unknown
3244,1,1,Occurrence #,1st primary
3244,1,1,Status,Alive w/o disease
3244,1,1,Metastasis,M0
3244,1,1,Nodal Stage,N0
3244,1,1,Second Failure Type,no known failure
3244,1,1,Tumor Stage,T1
3244,1,1,Research lab p16,p16 unknown
3245,1,1,Nodal Stage,N0
3245,1,1,Research lab p16,p16 unknown
3245,1,1,Overall Stage,I
3245,1,1,Status,Alive w/o disease
3245,1,1,Metastasis,M0
3245,1,1,Second Failure Type,no known failure
3245,1,1,Treatment Modality,Sx
3245,1,1,Tumor Stage,T1
3245,1,1,First Failure Type,no known failure
3245,1,1,Research lab HPV,HPV unknown
3245,1,1,Clinical lab p16,p16 unknown
3245,1,1,Occurrence #,1st primary
3245,1,1,Tumor Site,oral cavity
3246,1,1,Clinical lab p16,p16 unknown
3246,1,1,Treatment Modality,Sx
3246,1,1,Tumor Site,oral cavity
3246,1,1,Status,Alive w/ disease
3246,1,1,Occurrence #,1st primary
3246,1,1,Overall Stage,I
3246,1,1,First Failure Type,no known failure
3246,1,1,Research lab p16,p16 unknown
3246,1,1,Metastasis,M0
3246,1,1,Tumor Stage,T1
3246,1,1,Research lab HPV,HPV unknown
3246,1,1,Second Failure Type,no known failure
3246,1,1,Nodal Stage,N0
3247,1,1,Clinical lab p16,p16 unknown
3247,1,1,Nodal Stage,N1
3247,1,1,Research lab p16,p16 unknown
3247,1,1,Overall Stage,III
3247,1,1,Treatment Modality,Sx
3247,1,1,First Failure Type,no known failure
3247,1,1,Status,Alive w/o disease
3247,1,1,Research lab HPV,HPV unknown
3247,1,1,Tumor Stage,T2
3247,1,1,Occurrence #,1st primary
3247,1,1,Metastasis,M0
3247,1,1,Second Failure Type,no known failure
3247,1,1,Tumor Site,oral cavity
3248,1,1,Overall Stage,II
3248,1,1,Research lab p16,p16 unknown
3248,1,1,Occurrence #,1st primary
3248,1,1,First Failure Type,no known failure
3248,1,1,Clinical lab p16,p16 unknown
3248,1,1,Treatment Modality,Sx
3248,1,1,Status,Alive w/o disease
3248,1,1,Research lab HPV,HPV unknown
3248,1,1,Metastasis,M0
3248,1,1,Second Failure Type,no known failure
3248,1,1,Nodal Stage,N0
3248,1,1,Tumor Site,oral cavity
3248,1,1,Tumor Stage,T2
3249,1,1,Nodal Stage,N0
3249,1,1,First Failure Type,no known failure
3249,1,1,Overall Stage,II
3249,1,1,Status,Alive w/o disease
3249,1,1,Metastasis,M0
3249,1,1,Research lab HPV,HPV unknown
3249,1,1,Treatment Modality,Sx & RT
3249,1,1,Second Failure Type,no known failure
3249,1,1,Radiation Dosage,66
3249,1,1,Tumor Site,oral cavity
3249,1,1,Clinical lab p16,p16 unknown
3249,1,1,Occurrence #,1st primary
3249,1,1,Research lab p16,p16 unknown
3249,1,1,Tumor Stage,T2
3250,1,1,Tumor Site,oral cavity
3250,1,1,Occurrence #,1st primary
3250,1,1,Research lab HPV,HPV unknown
3250,1,1,Overall Stage,I
3250,1,1,Second Failure Type,no known failure
3250,1,1,Treatment Modality,Sx
3250,1,1,Status,Alive w/o disease
3250,1,1,Clinical lab p16,p16 unknown
3250,1,1,Research lab p16,p16 unknown
3250,1,1,Nodal Stage,N0
3250,1,1,First Failure Type,no known failure
3250,1,1,Metastasis,M0
3250,1,1,Tumor Stage,T1
3251,1,1,Second Failure Type,no known failure
3251,1,1,Metastasis,M0
3251,1,1,Tumor Site,oropharynx
3251,1,1,Clinical lab p16,p16 unknown
3251,1,1,Tumor Stage,T1
3251,1,1,Nodal Stage,N0
3251,1,1,Research lab p16,p16 unknown
3251,1,1,Treatment Modality,Sx
3251,1,1,Overall Stage,I
3251,1,1,Status,Alive w/o disease
3251,1,1,First Failure Type,no known failure
3251,1,1,Research lab HPV,HPV unknown
3251,1,1,Occurrence #,1st primary
3252,1,1,Occurrence #,recurrence
3252,1,1,Second Failure Type,no known failure
3252,1,1,First Failure Type,no known failure
3252,1,1,Status,Alive w/ disease
3252,1,1,Clinical lab p16,p16 unknown
3252,1,1,Overall Stage,IVa
3252,1,1,Research lab p16,p16 unknown
3252,1,1,Tumor Site,oral cavity
3252,1,1,Nodal Stage,N2
3252,1,1,Metastasis,M0
3252,1,1,Tumor Stage,T4a
3252,1,1,Treatment Modality,Sx
3252,1,1,Research lab HPV,HPV unknown
3253,1,1,Tumor Site,oral cavity
3253,1,1,Treatment Modality,Sx & CTX-RT
3253,1,1,Second Failure Type,no known failure
3253,1,1,Metastasis,M0
3253,1,1,Initial Chemotherapy Agent,unk
3253,1,1,Radiation Dosage,unknown
3253,1,1,Overall Stage,IVa
3253,1,1,Status,Alive w/o disease
3253,1,1,Tumor Stage,T4a
3253,1,1,First Failure Type,no known failure
3253,1,1,Clinical lab p16,p16 unknown
3253,1,1,Research lab HPV,HPV unknown
3253,1,1,Nodal Stage,N2
3253,1,1,Research lab p16,p16 unknown
3253,1,1,Occurrence #,1st primary
3254,1,1,Metastasis,Unknown
3254,1,1,Treatment Modality,Sx
3254,1,1,Tumor Stage,Unknown
3254,1,1,Second Failure Type,no known failure
3254,1,1,First Failure Type,no known failure
3254,1,1,Overall Stage,Unknown
3254,1,1,Occurrence #,1st primary
3254,1,1,Research lab p16,p16 unknown
3254,1,1,Research lab HPV,HPV unknown
3254,1,1,Tumor Site,oral cavity
3254,1,1,Nodal Stage,Unknown
3254,1,1,Clinical lab p16,p16 unknown
3254,1,1,Status,Alive w/o disease
3255,1,1,Nodal Stage,N0
3255,1,1,Research lab p16,p16 unknown
3255,1,1,Occurrence #,1st primary
3255,1,1,Status,Alive w/o disease
3255,1,1,Treatment Modality,Sx
3255,1,1,Second Failure Type,no known failure
3255,1,1,Clinical lab p16,p16 unknown
3255,1,1,Research lab HPV,HPV unknown
3255,1,1,First Failure Type,no known failure
3255,1,1,Metastasis,M0
3255,1,1,Tumor Site,oral cavity
3255,1,1,Overall Stage,I
3255,1,1,Tumor Stage,T1
3256,1,1,Overall Stage,IVa
3256,1,1,Metastasis,M0
3256,1,1,Occurrence #,1st primary
3256,1,1,Nodal Stage,N0
3256,1,1,Tumor Site,oral cavity
3256,1,1,Second Failure Type,no known failure
3256,1,1,Clinical lab p16,p16 unknown
3256,1,1,Treatment Modality,Sx
3256,1,1,Research lab HPV,HPV unknown
3256,1,1,Status,Alive w/ disease
3256,1,1,Tumor Stage,T4a
3256,1,1,First Failure Type,no known failure
3256,1,1,Research lab p16,p16 unknown
3257,1,1,Second Failure Type,no known failure
3257,1,1,Clinical lab p16,p16 unknown
3257,1,1,Research lab HPV,HPV unknown
3257,1,1,Overall Stage,I
3257,1,1,Treatment Modality,Sx
3257,1,1,Tumor Stage,T1
3257,1,1,Tumor Site,oral cavity
3257,1,1,Metastasis,M0
3257,1,1,Research lab p16,p16 unknown
3257,1,1,Nodal Stage,N0
3257,1,1,First Failure Type,no known failure
3257,1,1,Status,Alive w/o disease
3257,1,1,Occurrence #,1st primary
3258,1,1,Tumor Stage,T2
3258,1,1,Status,Alive w/o disease
3258,1,1,Overall Stage,II
3258,1,1,Occurrence #,1st primary
3258,1,1,Research lab HPV,HPV unknown
3258,1,1,Nodal Stage,N0
3258,1,1,Clinical lab p16,p16 unknown
3258,1,1,Research lab p16,p16 unknown
3258,1,1,First Failure Type,no known failure
3258,1,1,Metastasis,M0
3258,1,1,Tumor Site,oral cavity
3258,1,1,Second Failure Type,no known failure
3258,1,1,Treatment Modality,Sx
3259,1,1,Occurrence #,1st primary
3259,1,1,Second Line Chemotherapy Agent,Carbo
3259,1,1,Metastasis,M0
3259,1,1,Initial Chemotherapy Agent,cis
3259,1,1,First Failure Type,no known failure
3259,1,1,Overall Stage,IVa
3259,1,1,Tumor Stage,T4a
3259,1,1,Tumor Site,oral cavity
3259,1,1,Radiation Dosage,63
3259,1,1,Research lab p16,p16 unknown
3259,1,1,Clinical lab p16,p16 unknown
3259,1,1,Status,Alive w/o disease
3259,1,1,Research lab HPV,HPV unknown
3259,1,1,Second Failure Type,no known failure
3259,1,1,Treatment Modality,Sx & CTX-RT
3259,1,1,Nodal Stage,N2
3260,1,1,Metastasis,M0
3260,1,1,Tumor Stage,T1
3260,1,1,Clinical lab p16,p16 unknown
3260,1,1,Status,Alive w/o disease
3260,1,1,Nodal Stage,N0
3260,1,1,Tumor Site,oropharynx
3260,1,1,Overall Stage,I
3260,1,1,Second Failure Type,no known failure
3260,1,1,First Failure Type,no known failure
3260,1,1,Treatment Modality,Sx
3260,1,1,Research lab HPV,HPV unknown
3260,1,1,Occurrence #,recurrence
3260,1,1,Research lab p16,p16 unknown
3261,1,1,First Failure Type,no known failure
3261,1,1,Tumor Stage,T2
3261,1,1,Status,Alive w/o disease
3261,1,1,Treatment Modality,Sx
3261,1,1,Second Failure Type,no known failure
3261,1,1,Metastasis,M0
3261,1,1,Tumor Site,oral cavity
3261,1,1,Overall Stage,II
3261,1,1,Clinical lab p16,p16 unknown
3261,1,1,Occurrence #,1st primary
3261,1,1,Research lab HPV,HPV unknown
3261,1,1,Research lab p16,p16 unknown
3261,1,1,Nodal Stage,N0
3262,1,1,Treatment Modality,Sx
3262,1,1,Tumor Stage,Unknown
3262,1,1,Occurrence #,1st primary
3262,1,1,First Failure Treatment Modality,Sx
3262,1,1,Metastasis,Unknown
3262,1,1,First Failure Site,oropharynx
3262,1,1,First Failure Type,no known failure
3262,1,1,Second Failure Type,no known failure
3262,1,1,Status,Alive w/o disease
3262,1,1,Overall Stage,Unknown
3262,1,1,Tumor Site,oropharynx
3262,1,1,Nodal Stage,Unknown
3262,1,1,Clinical lab p16,p16 unknown
3262,1,1,Research lab HPV,HPV unknown
3262,1,1,Research lab p16,p16 unknown
3263,1,1,Treatment Modality,Sx
3263,1,1,Tumor Stage,T1
3263,1,1,Second Failure Type,no known failure
3263,1,1,Clinical lab p16,p16 unknown
3263,1,1,Nodal Stage,N0
3263,1,1,Overall Stage,I
3263,1,1,Research lab HPV,HPV unknown
3263,1,1,Research lab p16,p16 unknown
3263,1,1,Metastasis,M0
3263,1,1,Tumor Site,oral cavity
3263,1,1,Status,Alive w/o disease
3263,1,1,First Failure Type,no known failure
3263,1,1,Occurrence #,recurrence
3264,1,1,Occurrence #,1st primary
3264,1,1,First Failure Type,no known failure
3264,1,1,Status,Alive w/o disease
3264,1,1,Research lab p16,p16 unknown
3264,1,1,Clinical lab p16,p16 unknown
3264,1,1,Second Failure Type,no known failure
3264,1,1,Treatment Modality,Sx
3264,1,1,Metastasis,M0
3264,1,1,Tumor Site,oral cavity
3264,1,1,Overall Stage,I
3264,1,1,Nodal Stage,N0
3264,1,1,Tumor Stage,T1
3264,1,1,Research lab HPV,HPV unknown
3265,1,1,Treatment Modality,Sx
3265,1,1,Metastasis,M0
3265,1,1,Research lab p16,p16 unknown
3265,1,1,Tumor Site,oral cavity
3265,1,1,Clinical lab p16,p16 unknown
3265,1,1,Occurrence #,1st primary
3265,1,1,Nodal Stage,N1
3265,1,1,Tumor Stage,T1
3265,1,1,First Failure Type,no known failure
3265,1,1,Overall Stage,III
3265,1,1,Research lab HPV,HPV unknown
3265,1,1,Second Failure Type,no known failure
3265,1,1,Status,Alive w/o disease
3266,1,1,First Failure Type,no known failure
3266,1,1,Clinical lab p16,p16 unknown
3266,1,1,Occurrence #,1st primary
3266,1,1,Metastasis,Unknown
3266,1,1,Tumor Site,oral cavity
3266,1,1,Overall Stage,Unknown
3266,1,1,Research lab HPV,HPV unknown
3266,1,1,Treatment Modality,Sx
3266,1,1,Status,Alive w/o disease
3266,1,1,Second Failure Type,no known failure
3266,1,1,Research lab p16,p16 unknown
3266,1,1,Tumor Stage,Unknown
3266,1,1,Nodal Stage,Unknown
3267,1,1,Tumor Stage,T1
3267,1,1,Occurrence #,1st primary
3267,1,1,Clinical lab p16,p16 unknown
3267,1,1,First Failure Type,no known failure
3267,1,1,Status,Alive w/o disease
3267,1,1,Tumor Site,oropharynx
3267,1,1,Nodal Stage,N0
3267,1,1,Second Failure Type,no known failure
3267,1,1,Research lab p16,p16 unknown
3267,1,1,Overall Stage,I
3267,1,1,Research lab HPV,HPV unknown
3267,1,1,Treatment Modality,Sx
3267,1,1,Metastasis,M0
3268,1,1,First Failure Type,no known failure
3268,1,1,Research lab HPV,HPV unknown
3268,1,1,Overall Stage,I
3268,1,1,Second Failure Type,no known failure
3268,1,1,Research lab p16,p16 unknown
3268,1,1,Occurrence #,1st primary
3268,1,1,Clinical lab p16,p16 unknown
3268,1,1,Tumor Site,oral cavity
3268,1,1,Tumor Stage,T1
3268,1,1,Nodal Stage,N0
3268,1,1,Treatment Modality,Sx
3268,1,1,Metastasis,M0
3268,1,1,Status,Alive w/o disease
3269,1,1,Status,Alive w/o disease
3269,1,1,Overall Stage,III
3269,1,1,Treatment Modality,Sx
3269,1,1,First Failure Type,no known failure
3269,1,1,Clinical lab p16,p16 unknown
3269,1,1,Occurrence #,1st primary
3269,1,1,Tumor Stage,T3
3269,1,1,Nodal Stage,N1
3269,1,1,Tumor Site,oral cavity
3269,1,1,Research lab HPV,HPV unknown
3269,1,1,Second Failure Type,no known failure
3269,1,1,Research lab p16,p16 unknown
3269,1,1,Metastasis,M0
3270,1,1,Overall Stage,I
3270,1,1,Metastasis,M0
3270,1,1,Research lab HPV,HPV unknown
3270,1,1,Treatment Modality,Sx
3270,1,1,Clinical lab p16,p16 unknown
3270,1,1,Second Failure Type,no known failure
3270,1,1,Research lab p16,p16 unknown
3270,1,1,Tumor Stage,T1
3270,1,1,Occurrence #,1st primary
3270,1,1,Tumor Site,oral cavity
3270,1,1,First Failure Type,no known failure
3270,1,1,Status,Alive w/o disease
3270,1,1,Nodal Stage,N0
3271,1,1,Occurrence #,1st primary
3271,1,1,Status,Alive w/ disease
3271,1,1,Clinical lab p16,p16 unknown
3271,1,1,Second Failure Type,no known failure
3271,1,1,Research lab HPV,HPV unknown
3271,1,1,Nodal Stage,N2
3271,1,1,Tumor Stage,T4a
3271,1,1,First Failure Type,no known failure
3271,1,1,Tumor Site,oral cavity
3271,1,1,Treatment Modality,Sx
3271,1,1,Metastasis,M0
3271,1,1,Overall Stage,IVa
3271,1,1,Research lab p16,p16 unknown
3272,1,1,Tumor Site,oral cavity
3272,1,1,Occurrence #,1st primary
3272,1,1,Nodal Stage,N0
3272,1,1,Metastasis,M0
3272,1,1,Tumor Stage,T2
3272,1,1,Second Failure Type,no known failure
3272,1,1,Research lab HPV,HPV unknown
3272,1,1,Research lab p16,p16 unknown
3272,1,1,Overall Stage,II
3272,1,1,Status,Alive w/o disease
3272,1,1,First Failure Type,no known failure
3272,1,1,Clinical lab p16,p16 unknown
3272,1,1,Treatment Modality,Sx
3273,1,1,Nodal Stage,N0
3273,1,1,Time to First Failure,2.1
3273,1,1,Clinical lab p16,p16 unknown
3273,1,1,Tumor Stage,T1
3273,1,1,Overall Stage,I
3273,1,1,Research lab p16,p16 unknown
3273,1,1,Research lab HPV,HPV unknown
3273,1,1,First Failure Site,oral cavity
3273,1,1,Second Failure Type,no known failure
3273,1,1,Status,Alive w/o disease
3273,1,1,Treatment Modality,Sx
3273,1,1,First Failure Type,locoregional
3273,1,1,First Failure Treatment Modality,Sx
3273,1,1,Occurrence #,1st primary
3273,1,1,Tumor Site,oral cavity
3273,1,1,Metastasis,M0
3274,1,1,First Failure Type,no known failure
3274,1,1,Tumor Stage,T1
3274,1,1,Metastasis,M0
3274,1,1,Tumor Site,oral cavity
3274,1,1,Treatment Modality,Sx
3274,1,1,Overall Stage,I
3274,1,1,Occurrence #,1st primary
3274,1,1,Status,Alive w/o disease
3274,1,1,Nodal Stage,N0
3274,1,1,Research lab HPV,HPV unknown
3274,1,1,Second Failure Type,no known failure
3274,1,1,Research lab p16,p16 unknown
3274,1,1,Clinical lab p16,p16 unknown
3275,1,1,Overall Stage,I
3275,1,1,Occurrence #,1st primary
3275,1,1,Metastasis,M0
3275,1,1,Tumor Site,oral cavity
3275,1,1,Research lab HPV,HPV unknown
3275,1,1,Research lab p16,p16 unknown
3275,1,1,First Failure Type,no known failure
3275,1,1,Status,Alive w/o disease
3275,1,1,Nodal Stage,N0
3275,1,1,Second Failure Type,no known failure
3275,1,1,Treatment Modality,Sx
3275,1,1,Tumor Stage,T1
3275,1,1,Clinical lab p16,p16 unknown
3276,1,1,Occurrence #,1st primary
3276,1,1,Status,Alive w/o disease
3276,1,1,Research lab p16,p16 unknown
3276,1,1,Research lab HPV,HPV unknown
3276,1,1,Treatment Modality,Sx
3276,1,1,Nodal Stage,N0
3276,1,1,First Failure Type,no known failure
3276,1,1,Overall Stage,I
3276,1,1,Tumor Site,oral cavity
3276,1,1,Metastasis,M0
3276,1,1,Tumor Stage,T1
3276,1,1,Second Failure Type,no known failure
3276,1,1,Clinical lab p16,p16 unknown
3277,1,1,Research lab HPV,HPV unknown
3277,1,1,Status,Alive w/o disease
3277,1,1,Clinical lab p16,p16 unknown
3277,1,1,Occurrence #,1st primary
3277,1,1,Tumor Site,oral cavity
3277,1,1,Research lab p16,p16 unknown
3277,1,1,Second Failure Type,no known failure
3277,1,1,Treatment Modality,Sx
3277,1,1,First Failure Type,no known failure
3277,1,1,Nodal Stage,Unknown
3277,1,1,Tumor Stage,Unknown
3277,1,1,Overall Stage,Unknown
3277,1,1,Metastasis,Unknown
3278,1,1,Research lab HPV,HPV unknown
3278,1,1,Clinical lab p16,p16 unknown
3278,1,1,First Failure Type,no known failure
3278,1,1,Status,Alive w/o disease
3278,1,1,Overall Stage,I
3278,1,1,Second Failure Type,no known failure
3278,1,1,Nodal Stage,N0
3278,1,1,Tumor Stage,T1
3278,1,1,Treatment Modality,Sx
3278,1,1,Metastasis,M0
3278,1,1,Research lab p16,p16 unknown
3278,1,1,Tumor Site,oral cavity
3278,1,1,Occurrence #,1st primary
3279,1,1,Occurrence #,1st primary
3279,1,1,Status,Alive w/o disease
3279,1,1,First Failure Type,no known failure
3279,1,1,Tumor Site,oral cavity
3279,1,1,Nodal Stage,N0
3279,1,1,Overall Stage,I
3279,1,1,Tumor Stage,T1
3279,1,1,Second Failure Type,no known failure
3279,1,1,Research lab p16,p16 unknown
3279,1,1,Clinical lab p16,p16 unknown
3279,1,1,Treatment Modality,Sx
3279,1,1,Research lab HPV,HPV unknown
3279,1,1,Metastasis,M0
3280,1,1,First Failure Type,no known failure
3280,1,1,Tumor Stage,T1
3280,1,1,Tumor Site,oral cavity
3280,1,1,Metastasis,M0
3280,1,1,Overall Stage,I
3280,1,1,Research lab p16,p16 unknown
3280,1,1,Nodal Stage,N0
3280,1,1,Status,Alive w/o disease
3280,1,1,Second Failure Type,no known failure
3280,1,1,Research lab HPV,HPV unknown
3280,1,1,Treatment Modality,Sx & RT
3280,1,1,Occurrence #,other primary
3280,1,1,Clinical lab p16,p16 unknown
3281,1,1,Research lab HPV,HPV unknown
3281,1,1,Nodal Stage,N0
3281,1,1,Tumor Site,oral cavity
3281,1,1,Metastasis,M0
3281,1,1,Occurrence #,1st primary
3281,1,1,Status,Alive w/o disease
3281,1,1,Clinical lab p16,p16 unknown
3281,1,1,Tumor Stage,T1
3281,1,1,Treatment Modality,Sx
3281,1,1,First Failure Type,no known failure
3281,1,1,Research lab p16,p16 unknown
3281,1,1,Second Failure Type,no known failure
3281,1,1,Overall Stage,I
3282,1,1,Treatment Modality,Sx
3282,1,1,Research lab p16,p16 unknown
3282,1,1,Nodal Stage,N2
3282,1,1,Status,Alive w/o disease
3282,1,1,Tumor Stage,T4a
3282,1,1,Metastasis,M0
3282,1,1,Clinical lab p16,p16 unknown
3282,1,1,Overall Stage,IVa
3282,1,1,Second Failure Type,no known failure
3282,1,1,Tumor Site,oral cavity
3282,1,1,Occurrence #,1st primary
3282,1,1,Research lab HPV,HPV unknown
3282,1,1,First Failure Type,no known failure
3283,1,1,Treatment Modality,Sx
3283,1,1,Clinical lab p16,p16 unknown
3283,1,1,Tumor Stage,T4a
3283,1,1,First Failure Site,oral cavity
3283,1,1,Research lab HPV,HPV unknown
3283,1,1,First Failure Treatment Modality,Sx
3283,1,1,Occurrence #,1st primary
3283,1,1,Tumor Site,oral cavity
3283,1,1,First Failure Type,no known failure
3283,1,1,Research lab p16,p16 unknown
3283,1,1,Metastasis,M0
3283,1,1,Overall Stage,IVa
3283,1,1,Status,Alive w/o disease
3283,1,1,Second Failure Type,no known failure
3283,1,1,Nodal Stage,N0
3284,1,1,Status,Alive w/o disease
3284,1,1,Research lab p16,p16 unknown
3284,1,1,Tumor Stage,T4a
3284,1,1,Occurrence #,1st primary
3284,1,1,Second Failure Type,no known failure
3284,1,1,Tumor Site,oral cavity
3284,1,1,Metastasis,M0
3284,1,1,Overall Stage,IVa
3284,1,1,Research lab HPV,HPV unknown
3284,1,1,Nodal Stage,N0
3284,1,1,Treatment Modality,Sx
3284,1,1,First Failure Type,no known failure
3284,1,1,Clinical lab p16,p16 unknown
3285,1,1,First Failure Type,no known failure
3285,1,1,Research lab HPV,HPV unknown
3285,1,1,Overall Stage,III
3285,1,1,Tumor Stage,T2
3285,1,1,Occurrence #,1st primary
3285,1,1,Treatment Modality,Sx
3285,1,1,Tumor Site,oral cavity
3285,1,1,Nodal Stage,N1
3285,1,1,Metastasis,M0
3285,1,1,Second Failure Type,no known failure
3285,1,1,Research lab p16,p16 unknown
3285,1,1,Clinical lab p16,p16 unknown
3285,1,1,Status,Alive w/o disease
3286,1,1,Treatment Modality,Sx
3286,1,1,Status,Alive w/o disease
3286,1,1,Nodal Stage,N0
3286,1,1,Research lab p16,p16 unknown
3286,1,1,Metastasis,M0
3286,1,1,Clinical lab p16,p16 unknown
3286,1,1,Tumor Site,oral cavity
3286,1,1,Second Failure Type,no known failure
3286,1,1,Overall Stage,I
3286,1,1,Research lab HPV,HPV unknown
3286,1,1,First Failure Type,no known failure
3286,1,1,Tumor Stage,T1
3286,1,1,Occurrence #,other primary
3287,1,1,Overall Stage,Unknown
3287,1,1,Clinical lab p16,p16 unknown
3287,1,1,First Failure Type,no known failure
3287,1,1,Research lab HPV,HPV unknown
3287,1,1,Metastasis,Unknown
3287,1,1,Occurrence #,1st primary
3287,1,1,Research lab p16,p16 unknown
3287,1,1,Second Failure Type,no known failure
3287,1,1,Tumor Site,oral cavity
3287,1,1,Nodal Stage,Unknown
3287,1,1,Treatment Modality,Unknown
3287,1,1,Tumor Stage,Unknown
3287,1,1,Status,Alive w/o disease
3288,1,1,Nodal Stage,N0
3288,1,1,Treatment Modality,Sx
3288,1,1,Research lab p16,p16 unknown
3288,1,1,Tumor Site,oral cavity
3288,1,1,Occurrence #,1st primary
3288,1,1,Clinical lab p16,p16 unknown
3288,1,1,Metastasis,M0
3288,1,1,Tumor Stage,T2
3288,1,1,First Failure Type,no known failure
3288,1,1,Research lab HPV,HPV unknown
3288,1,1,Overall Stage,II
3288,1,1,Status,Alive w/o disease
3288,1,1,Second Failure Type,no known failure
3289,1,1,Occurrence #,1st primary
3289,1,1,Status,Alive w/o disease
3289,1,1,First Failure Type,no known failure
3289,1,1,Clinical lab p16,p16 unknown
3289,1,1,Tumor Site,oral cavity
3289,1,1,Overall Stage,Unknown
3289,1,1,Research lab p16,p16 unknown
3289,1,1,Second Failure Type,no known failure
3289,1,1,Metastasis,Unknown
3289,1,1,Research lab HPV,HPV unknown
3289,1,1,Nodal Stage,Unknown
3289,1,1,Tumor Stage,Unknown
3289,1,1,Treatment Modality,Sx
3290,1,1,Occurrence #,1st primary
3290,1,1,Second Failure Type,no known failure
3290,1,1,Research lab HPV,HPV unknown
3290,1,1,Status,Alive w/o disease
3290,1,1,First Failure Type,locoregional
3290,1,1,Tumor Stage,T1
3290,1,1,Overall Stage,I
3290,1,1,Time to First Failure,2.1
3290,1,1,Treatment Modality,Sx
3290,1,1,First Failure Site,oral cavity
3290,1,1,Metastasis,M0
3290,1,1,Research lab p16,p16 unknown
3290,1,1,Tumor Site,oral cavity
3290,1,1,First Failure Treatment Modality,Sx
3290,1,1,Clinical lab p16,p16 unknown
3290,1,1,Nodal Stage,N0
3291,1,1,Research lab HPV,HPV unknown
3291,1,1,First Failure Type,no known failure
3291,1,1,Clinical lab p16,p16 unknown
3291,1,1,Tumor Stage,T2
3291,1,1,Nodal Stage,N0
3291,1,1,Metastasis,M0
3291,1,1,Research lab p16,p16 unknown
3291,1,1,Second Failure Type,no known failure
3291,1,1,Tumor Site,oral cavity
3291,1,1,Overall Stage,II
3291,1,1,Occurrence #,1st primary
3291,1,1,Status,Alive w/o disease
3291,1,1,Treatment Modality,Sx
3292,1,1,Status,Alive w/o disease
3292,1,1,Overall Stage,I
3292,1,1,Research lab p16,p16 unknown
3292,1,1,Clinical lab p16,p16 unknown
3292,1,1,Occurrence #,1st primary
3292,1,1,Research lab HPV,HPV unknown
3292,1,1,Nodal Stage,N0
3292,1,1,Tumor Site,oral cavity
3292,1,1,Metastasis,M0
3292,1,1,Second Failure Type,no known failure
3292,1,1,Tumor Stage,T1
3292,1,1,First Failure Type,no known failure
3292,1,1,Treatment Modality,Sx
3293,1,1,Research lab HPV,HPV unknown
3293,1,1,Tumor Site,oral cavity
3293,1,1,Second Failure Type,no known failure
3293,1,1,Clinical lab p16,p16 unknown
3293,1,1,Nodal Stage,N0
3293,1,1,Research lab p16,p16 unknown
3293,1,1,Treatment Modality,Sx
3293,1,1,First Failure Type,no known failure
3293,1,1,Occurrence #,1st primary
3293,1,1,Tumor Stage,T1
3293,1,1,Metastasis,M0
3293,1,1,Overall Stage,I
3293,1,1,Status,Alive w/o disease
3294,1,1,Occurrence #,1st primary
3294,1,1,Treatment Modality,Sx
3294,1,1,Clinical lab p16,p16 unknown
3294,1,1,Nodal Stage,N0
3294,1,1,Tumor Site,oral cavity
3294,1,1,Tumor Stage,T1
3294,1,1,Research lab p16,p16 unknown
3294,1,1,Status,Alive w/o disease
3294,1,1,Second Failure Type,no known failure
3294,1,1,Metastasis,M0
3294,1,1,First Failure Type,no known failure
3294,1,1,Research lab HPV,HPV unknown
3294,1,1,Overall Stage,I
3295,1,1,Overall Stage,I
3295,1,1,First Failure Type,no known failure
3295,1,1,Status,Alive w/o disease
3295,1,1,Treatment Modality,Sx
3295,1,1,Tumor Stage,T1
3295,1,1,Occurrence #,1st primary
3295,1,1,Nodal Stage,N0
3295,1,1,Tumor Site,oral cavity
3295,1,1,Clinical lab p16,p16 unknown
3295,1,1,Metastasis,M0
3295,1,1,Research lab p16,p16 unknown
3295,1,1,Second Failure Type,no known failure
3295,1,1,Research lab HPV,HPV unknown
3296,1,1,Status,Alive w/o disease
3296,1,1,Overall Stage,IVa
3296,1,1,Nodal Stage,N2
3296,1,1,Research lab HPV,HPV unknown
3296,1,1,Clinical lab p16,p16 unknown
3296,1,1,Treatment Modality,Sx
3296,1,1,Tumor Site,oral cavity
3296,1,1,First Failure Type,no known failure
3296,1,1,Second Failure Type,no known failure
3296,1,1,Tumor Stage,T3
3296,1,1,Research lab p16,p16 unknown
3296,1,1,Metastasis,M0
3296,1,1,Occurrence #,1st primary
3297,1,1,Occurrence #,1st primary
3297,1,1,Metastasis,M0
3297,1,1,Treatment Modality,Sx
3297,1,1,Research lab HPV,HPV unknown
3297,1,1,Overall Stage,I
3297,1,1,Tumor Site,oral cavity
3297,1,1,Status,Alive w/o disease
3297,1,1,Tumor Stage,T1
3297,1,1,Clinical lab p16,p16 unknown
3297,1,1,Research lab p16,p16 unknown
3297,1,1,Nodal Stage,N0
3297,1,1,Second Failure Type,no known failure
3297,1,1,First Failure Type,no known failure
3298,1,1,Tumor Site,oral cavity
3298,1,1,Nodal Stage,N0
3298,1,1,Metastasis,M0
3298,1,1,Tumor Stage,T1
3298,1,1,Second Failure Type,no known failure
3298,1,1,Research lab HPV,HPV unknown
3298,1,1,Status,Alive w/o disease
3298,1,1,First Failure Type,no known failure
3298,1,1,Research lab p16,p16 unknown
3298,1,1,Treatment Modality,Sx
3298,1,1,Occurrence #,1st primary
3298,1,1,Overall Stage,I
3298,1,1,Clinical lab p16,p16 unknown
3299,1,1,Treatment Modality,Sx & RT
3299,1,1,Tumor Site,oral cavity
3299,1,1,Occurrence #,recurrence
3299,1,1,Nodal Stage,N0
3299,1,1,Tumor Stage,T3
3299,1,1,First Failure Type,no known failure
3299,1,1,Research lab p16,p16 unknown
3299,1,1,Radiation Dosage,40
3299,1,1,Status,Dead w/o disease
3299,1,1,Overall Stage,III
3299,1,1,Research lab HPV,HPV unknown
3299,1,1,Metastasis,M0
3299,1,1,Second Failure Type,no known failure
3299,1,1,Clinical lab p16,p16 unknown
3300,1,1,Research lab p16,p16 unknown
3300,1,1,Occurrence #,recurrence
3300,1,1,Overall Stage,II
3300,1,1,Tumor Stage,T1
3300,1,1,First Failure Type,no known failure
3300,1,1,Second Failure Type,no known failure
3300,1,1,Tumor Site,oral cavity
3300,1,1,Research lab HPV,HPV unknown
3300,1,1,Metastasis,M0
3300,1,1,Clinical lab p16,p16 unknown
3300,1,1,Nodal Stage,N0
3300,1,1,Status,Alive w/o disease
3300,1,1,Treatment Modality,Sx
3301,1,1,Research lab p16,p16 unknown
3301,1,1,First Failure Type,no known failure
3301,1,1,Occurrence #,1st primary
3301,1,1,Second Failure Type,no known failure
3301,1,1,Tumor Site,oral cavity
3301,1,1,Tumor Stage,T2
3301,1,1,Metastasis,M0
3301,1,1,Status,Alive w/o disease
3301,1,1,Treatment Modality,Sx
3301,1,1,Nodal Stage,N1
3301,1,1,Overall Stage,III
3301,1,1,Clinical lab p16,p16 unknown
3301,1,1,Research lab HPV,HPV unknown
3302,1,1,Research lab p16,p16 unknown
3302,1,1,Status,Alive w/o disease
3302,1,1,Metastasis,M0
3302,1,1,First Failure Type,no known failure
3302,1,1,Research lab HPV,HPV unknown
3302,1,1,Tumor Stage,T1
3302,1,1,Clinical lab p16,p16 unknown
3302,1,1,Treatment Modality,Sx
3302,1,1,Nodal Stage,N0
3302,1,1,Occurrence #,1st primary
3302,1,1,First Failure Treatment Modality,Sx
3302,1,1,Overall Stage,I
3302,1,1,Second Failure Type,no known failure
3302,1,1,Tumor Site,oral cavity
3303,1,1,Second Failure Type,no known failure
3303,1,1,Overall Stage,III
3303,1,1,Occurrence #,1st primary
3303,1,1,Research lab HPV,HPV unknown
3303,1,1,Status,Alive w/o disease
3303,1,1,Tumor Stage,T3
3303,1,1,Treatment Modality,Sx
3303,1,1,Clinical lab p16,p16 unknown
3303,1,1,Research lab p16,p16 unknown
3303,1,1,Nodal Stage,N0
3303,1,1,Metastasis,M0
3303,1,1,First Failure Type,no known failure
3303,1,1,Tumor Site,oral cavity
3304,1,1,Research lab HPV,HPV unknown
3304,1,1,Treatment Modality,Sx
3304,1,1,Metastasis,M0
3304,1,1,Nodal Stage,N0
3304,1,1,Status,Alive w/o disease
3304,1,1,Tumor Stage,T1
3304,1,1,Occurrence #,1st primary
3304,1,1,Tumor Site,oral cavity
3304,1,1,First Failure Type,no known failure
3304,1,1,Overall Stage,I
3304,1,1,Research lab p16,p16 unknown
3304,1,1,Clinical lab p16,p16 unknown
3304,1,1,Second Failure Type,no known failure
3305,1,1,Nodal Stage,N0
3305,1,1,First Failure Type,no known failure
3305,1,1,Tumor Site,oral cavity
3305,1,1,Metastasis,M0
3305,1,1,Clinical lab p16,p16 unknown
3305,1,1,First Failure Treatment Modality,Sx
3305,1,1,Treatment Modality,Sx
3305,1,1,Research lab p16,p16 unknown
3305,1,1,Tumor Stage,T1
3305,1,1,Overall Stage,I
3305,1,1,Occurrence #,1st primary
3305,1,1,Second Failure Type,no known failure
3305,1,1,Research lab HPV,HPV unknown
3305,1,1,First Failure Site,oral cavity
3305,1,1,Status,Alive w/o disease
3306,1,1,First Failure Treatment Modality,Sx
3306,1,1,Treatment Modality,Sx
3306,1,1,Clinical lab p16,p16 unknown
3306,1,1,Overall Stage,III
3306,1,1,Second Failure Type,no known failure
3306,1,1,Nodal Stage,N0
3306,1,1,Metastasis,M0
3306,1,1,Occurrence #,1st primary
3306,1,1,Research lab p16,p16 unknown
3306,1,1,First Failure Site,oral cavity
3306,1,1,Status,Alive w/o disease
3306,1,1,Tumor Stage,T3
3306,1,1,Tumor Site,oral cavity
3306,1,1,First Failure Type,no known failure
3306,1,1,Research lab HPV,HPV unknown
3307,1,1,Clinical lab p16,p16 unknown
3307,1,1,Metastasis,M0
3307,1,1,Tumor Stage,T3
3307,1,1,Nodal Stage,N2
3307,1,1,Research lab HPV,HPV unknown
3307,1,1,Tumor Site,oral cavity
3307,1,1,Second Failure Type,no known failure
3307,1,1,First Failure Type,no known failure
3307,1,1,Status,Alive w/o disease
3307,1,1,Occurrence #,1st primary
3307,1,1,Overall Stage,IVa
3307,1,1,Radiation Dosage,63
3307,1,1,Initial Chemotherapy Agent,Carbo
3307,1,1,Treatment Modality,Sx & CTX-RT
3307,1,1,Research lab p16,p16 unknown
3308,1,1,Research lab p16,p16 unknown
3308,1,1,Tumor Stage,T1
3308,1,1,Tumor Site,oral cavity
3308,1,1,Second Failure Type,no known failure
3308,1,1,First Failure Type,no known failure
3308,1,1,Nodal Stage,N0
3308,1,1,Status,Alive w/o disease
3308,1,1,Research lab HPV,HPV unknown
3308,1,1,Occurrence #,1st primary
3308,1,1,Metastasis,M0
3308,1,1,Treatment Modality,Sx
3308,1,1,Clinical lab p16,p16 unknown
3308,1,1,Overall Stage,I
3309,1,1,Nodal Stage,N0
3309,1,1,Occurrence #,1st primary
3309,1,1,Clinical lab p16,p16 unknown
3309,1,1,Tumor Stage,T2
3309,1,1,Research lab HPV,HPV unknown
3309,1,1,Metastasis,M0
3309,1,1,Treatment Modality,Sx
3309,1,1,Overall Stage,II
3309,1,1,Status,Alive w/o disease
3309,1,1,First Failure Type,no known failure
3309,1,1,Second Failure Type,no known failure
3309,1,1,Tumor Site,oral cavity
3309,1,1,Research lab p16,p16 unknown
3310,1,1,Metastasis,M0
3310,1,1,Research lab HPV,HPV unknown
3310,1,1,Occurrence #,1st primary
3310,1,1,Second Failure Type,no known failure
3310,1,1,First Failure Type,no known failure
3310,1,1,Overall Stage,I
3310,1,1,Tumor Stage,T1
3310,1,1,Tumor Site,oral cavity
3310,1,1,Status,Alive w/o disease
3310,1,1,Treatment Modality,Sx
3310,1,1,Clinical lab p16,p16 unknown
3310,1,1,Nodal Stage,N0
3310,1,1,Research lab p16,p16 unknown
3311,1,1,Treatment Modality,Sx
3311,1,1,Tumor Site,oral cavity
3311,1,1,Overall Stage,III
3311,1,1,First Failure Type,no known failure
3311,1,1,Occurrence #,1st primary
3311,1,1,Nodal Stage,N1
3311,1,1,Tumor Stage,T2
3311,1,1,Research lab p16,p16 unknown
3311,1,1,Research lab HPV,HPV unknown
3311,1,1,Second Failure Type,no known failure
3311,1,1,Clinical lab p16,p16 unknown
3311,1,1,Metastasis,M0
3311,1,1,Status,Alive w/o disease
3312,1,1,Nodal Stage,N0
3312,1,1,Tumor Stage,T1
3312,1,1,Occurrence #,1st primary
3312,1,1,Clinical lab p16,p16 unknown
3312,1,1,First Failure Type,no known failure
3312,1,1,Status,Alive w/o disease
3312,1,1,Second Failure Type,no known failure
3312,1,1,Research lab p16,p16 unknown
3312,1,1,Overall Stage,I
3312,1,1,Tumor Site,oral cavity
3312,1,1,Treatment Modality,Sx
3312,1,1,Research lab HPV,HPV unknown
3312,1,1,Metastasis,M0
3313,1,1,Status,Alive w/o disease
3313,1,1,First Failure Type,locoregional
3313,1,1,Tumor Stage,T2
3313,1,1,First Failure Site,oral cavity
3313,1,1,Metastasis,M0
3313,1,1,Time to First Failure,0.3
3313,1,1,Clinical lab p16,p16 unknown
3313,1,1,Research lab p16,p16 unknown
3313,1,1,Research lab HPV,HPV unknown
3313,1,1,Occurrence #,1st primary
3313,1,1,Overall Stage,II
3313,1,1,Tumor Site,oral cavity
3313,1,1,Second Failure Type,no known failure
3313,1,1,Nodal Stage,N0
3313,1,1,First Failure Treatment Modality,Sx
3313,1,1,Treatment Modality,Sx
3314,1,1,Treatment Modality,Sx
3314,1,1,Research lab p16,p16 unknown
3314,1,1,Status,Alive w/o disease
3314,1,1,Second Failure Type,no known failure
3314,1,1,First Failure Type,no known failure
3314,1,1,Research lab HPV,HPV unknown
3314,1,1,Clinical lab p16,p16 unknown
3314,1,1,Tumor Site,oral cavity
3314,1,1,Occurrence #,1st primary
3314,1,1,Metastasis,M0
3314,1,1,Overall Stage,I
3314,1,1,Tumor Stage,T1
3314,1,1,Nodal Stage,N0
3315,1,1,Metastasis,M0
3315,1,1,Second Failure Type,no known failure
3315,1,1,Tumor Stage,T3
3315,1,1,Research lab p16,p16 unknown
3315,1,1,First Failure Type,no known failure
3315,1,1,Tumor Site,oral cavity
3315,1,1,Research lab HPV,HPV unknown
3315,1,1,Clinical lab p16,p16 unknown
3315,1,1,Treatment Modality,Sx
3315,1,1,Occurrence #,1st primary
3315,1,1,Status,Alive w/o disease
3315,1,1,Nodal Stage,N0
3315,1,1,Overall Stage,III
3316,1,1,Nodal Stage,Unknown
3316,1,1,Second Failure Type,no known failure
3316,1,1,Treatment Modality,Sx
3316,1,1,Research lab HPV,HPV unknown
3316,1,1,Overall Stage,Unknown
3316,1,1,Clinical lab p16,p16 unknown
3316,1,1,Status,Alive w/o disease
3316,1,1,Tumor Site,oral cavity
3316,1,1,Occurrence #,1st primary
3316,1,1,First Failure Type,no known failure
3316,1,1,Tumor Stage,Unknown
3316,1,1,Metastasis,Unknown
3316,1,1,Research lab p16,p16 unknown
3317,1,1,Nodal Stage,N1
3317,1,1,Second Failure Type,no known failure
3317,1,1,Tumor Site,oral cavity
3317,1,1,Treatment Modality,Sx
3317,1,1,Overall Stage,III
3317,1,1,Status,Alive w/o disease
3317,1,1,Clinical lab p16,p16 unknown
3317,1,1,Research lab HPV,HPV unknown
3317,1,1,Tumor Stage,T2
3317,1,1,Occurrence #,1st primary
3317,1,1,First Failure Type,no known failure
3317,1,1,Research lab p16,p16 unknown
3317,1,1,Metastasis,M0
3318,1,1,Status,Alive w/o disease
3318,1,1,Research lab HPV,HPV unknown
3318,1,1,Second Failure Type,no known failure
3318,1,1,Clinical lab p16,p16 unknown
3318,1,1,Metastasis,M0
3318,1,1,First Failure Type,no known failure
3318,1,1,Occurrence #,1st primary
3318,1,1,Tumor Stage,T2
3318,1,1,Nodal Stage,N2
3318,1,1,Treatment Modality,Sx
3318,1,1,Tumor Site,oral cavity
3318,1,1,Overall Stage,IVa
3318,1,1,Research lab p16,p16 unknown
3319,1,1,Status,Alive w/o disease
3319,1,1,Research lab p16,p16 unknown
3319,1,1,Overall Stage,III
3319,1,1,Research lab HPV,HPV unknown
3319,1,1,First Failure Type,no known failure
3319,1,1,Nodal Stage,N1
3319,1,1,Tumor Stage,T2
3319,1,1,Treatment Modality,Sx
3319,1,1,Tumor Site,oral cavity
3319,1,1,Clinical lab p16,p16 unknown
3319,1,1,Metastasis,M0
3319,1,1,Occurrence #,1st primary
3319,1,1,Second Failure Type,no known failure
3320,1,1,First Failure Site,oral cavity
3320,1,1,Occurrence #,1st primary
3320,1,1,Clinical lab p16,p16 unknown
3320,1,1,First Failure Treatment Modality,Sx
3320,1,1,Status,Alive w/o disease
3320,1,1,Metastasis,M0
3320,1,1,Tumor Stage,T2
3320,1,1,First Failure Type,no known failure
3320,1,1,Research lab HPV,HPV unknown
3320,1,1,Tumor Site,oral cavity
3320,1,1,Second Failure Type,no known failure
3320,1,1,Nodal Stage,N1
3320,1,1,Overall Stage,III
3320,1,1,Research lab p16,p16 unknown
3320,1,1,Treatment Modality,Sx
3321,1,1,Second Failure Type,no known failure
3321,1,1,Status,Alive w/o disease
3321,1,1,Research lab HPV,HPV unknown
3321,1,1,Clinical lab p16,p16 unknown
3321,1,1,Research lab p16,p16 unknown
3321,1,1,First Failure Type,no known failure
3321,1,1,Tumor Site,oral cavity
3321,1,1,Treatment Modality,Sx
3321,1,1,Tumor Stage,T2
3321,1,1,Nodal Stage,N2
3321,1,1,Occurrence #,1st primary
3321,1,1,Metastasis,M0
3321,1,1,Overall Stage,IVa
3322,1,1,Research lab HPV,HPV unknown
3322,1,1,Clinical lab p16,p16 unknown
3322,1,1,Status,Alive w/o disease
3322,1,1,Research lab p16,p16 unknown
3322,1,1,Second Failure Type,no known failure
3322,1,1,Tumor Site,oral cavity
3322,1,1,Radiation Dosage,63
3322,1,1,Nodal Stage,N0
3322,1,1,Overall Stage,I
3322,1,1,Treatment Modality,Sx & RT
3322,1,1,Metastasis,M0
3322,1,1,First Failure Type,no known failure
3322,1,1,Occurrence #,1st primary
3322,1,1,Tumor Stage,T1
3322,1,1,First Failure Treatment Modality,Sx
3322,1,1,First Failure Site,oral cavity
3323,1,1,Second Line Chemotherapy Agent,Carbo
3323,1,1,Overall Stage,IVc
3323,1,1,Clinical lab p16,p16 unknown
3323,1,1,Tumor Site,oral cavity
3323,1,1,Research lab p16,p16 unknown
3323,1,1,Radiation Dosage,70.2
3323,1,1,Metastasis,M1
3323,1,1,Initial Chemotherapy Agent,doce/cis/cdetux
3323,1,1,Second Failure Type,no known failure
3323,1,1,Status,Alive w/o disease
3323,1,1,Research lab HPV,HPV unknown
3323,1,1,Tumor Stage,T4a
3323,1,1,First Failure Type,no known failure
3323,1,1,Treatment Modality,CTX-RT
3323,1,1,Occurrence #,1st primary
3323,1,1,Nodal Stage,N2
3324,1,1,First Failure Type,no known failure
3324,1,1,Research lab p16,p16 unknown
3324,1,1,Second Failure Type,no known failure
3324,1,1,Occurrence #,1st primary
3324,1,1,Metastasis,M0
3324,1,1,Treatment Modality,Sx
3324,1,1,Nodal Stage,N0
3324,1,1,Tumor Stage,T4a
3324,1,1,Overall Stage,IVa
3324,1,1,Tumor Site,oral cavity
3324,1,1,Clinical lab p16,p16 unknown
3324,1,1,Status,Alive w/o disease
3324,1,1,Research lab HPV,HPV unknown
3325,1,1,Treatment Modality,Sx
3325,1,1,Overall Stage,I
3325,1,1,Research lab HPV,HPV unknown
3325,1,1,Occurrence #,1st primary
3325,1,1,Nodal Stage,N0
3325,1,1,Clinical lab p16,p16 unknown
3325,1,1,Tumor Site,oral cavity
3325,1,1,Status,Alive w/o disease
3325,1,1,Research lab p16,p16 unknown
3325,1,1,First Failure Type,no known failure
3325,1,1,Second Failure Type,no known failure
3325,1,1,Metastasis,M0
3325,1,1,Tumor Stage,T1
3326,1,1,Second Failure Type,no known failure
3326,1,1,Tumor Stage,T1
3326,1,1,Occurrence #,1st primary
3326,1,1,Metastasis,M0
3326,1,1,Treatment Modality,Sx
3326,1,1,First Failure Type,no known failure
3326,1,1,Research lab p16,p16 unknown
3326,1,1,Tumor Site,oral cavity
3326,1,1,Nodal Stage,N0
3326,1,1,Research lab HPV,HPV unknown
3326,1,1,Status,Alive w/o disease
3326,1,1,Overall Stage,I
3326,1,1,Clinical lab p16,p16 unknown
3327,1,1,Status,Alive w/o disease
3327,1,1,Occurrence #,1st primary
3327,1,1,Tumor Stage,T1
3327,1,1,Nodal Stage,N0
3327,1,1,Clinical lab p16,p16 unknown
3327,1,1,Overall Stage,I
3327,1,1,Treatment Modality,Sx
3327,1,1,First Failure Type,no known failure
3327,1,1,Second Failure Type,no known failure
3327,1,1,Tumor Site,oral cavity
3327,1,1,Research lab HPV,HPV unknown
3327,1,1,Research lab p16,p16 unknown
3327,1,1,Metastasis,M0
3328,1,1,Clinical lab p16,p16 unknown
3328,1,1,Metastasis,M0
3328,1,1,Research lab HPV,HPV unknown
3328,1,1,Status,Alive w/o disease
3328,1,1,Research lab p16,p16 unknown
3328,1,1,Tumor Site,oral cavity
3328,1,1,Nodal Stage,N0
3328,1,1,Overall Stage,II
3328,1,1,Treatment Modality,Sx
3328,1,1,First Failure Type,no known failure
3328,1,1,Occurrence #,1st primary
3328,1,1,Tumor Stage,T2
3328,1,1,Second Failure Type,no known failure
3329,1,1,Tumor Site,oral cavity
3329,1,1,Second Failure Type,no known failure
3329,1,1,Metastasis,M0
3329,1,1,Research lab p16,p16 unknown
3329,1,1,Status,Alive w/o disease
3329,1,1,Research lab HPV,HPV unknown
3329,1,1,Nodal Stage,N2
3329,1,1,Treatment Modality,Sx
3329,1,1,Clinical lab p16,p16 unknown
3329,1,1,Tumor Stage,T2
3329,1,1,First Failure Type,no known failure
3329,1,1,Occurrence #,1st primary
3329,1,1,Overall Stage,IVa
3330,1,1,Status,Alive w/o disease
3330,1,1,Occurrence #,1st primary
3330,1,1,Second Failure Type,no known failure
3330,1,1,Treatment Modality,Sx & CTX-RT
3330,1,1,Research lab HPV,HPV unknown
3330,1,1,Research lab p16,p16 unknown
3330,1,1,Metastasis,M0
3330,1,1,Initial Chemotherapy Agent,cis
3330,1,1,Radiation Dosage,64
3330,1,1,Tumor Stage,T4a
3330,1,1,Tumor Site,oral cavity
3330,1,1,Clinical lab p16,p16 unknown
3330,1,1,Nodal Stage,N2
3330,1,1,First Failure Type,no known failure
3330,1,1,Overall Stage,IVa
3331,1,1,Tumor Stage,T1
3331,1,1,Metastasis,M0
3331,1,1,Second Failure Type,no known failure
3331,1,1,Status,Alive w/o disease
3331,1,1,Treatment Modality,Sx
3331,1,1,Overall Stage,I
3331,1,1,Clinical lab p16,p16 unknown
3331,1,1,First Failure Type,no known failure
3331,1,1,Occurrence #,1st primary
3331,1,1,Tumor Site,oral cavity
3331,1,1,Research lab HPV,HPV unknown
3331,1,1,Research lab p16,p16 unknown
3331,1,1,Nodal Stage,N0
3332,1,1,Status,Alive w/o disease
3332,1,1,Research lab HPV,HPV unknown
3332,1,1,Metastasis,M0
3332,1,1,Occurrence #,1st primary
3332,1,1,Tumor Site,oral cavity
3332,1,1,Nodal Stage,N0
3332,1,1,Tumor Stage,T1
3332,1,1,First Failure Type,no known failure
3332,1,1,Overall Stage,I
3332,1,1,Treatment Modality,Sx
3332,1,1,Research lab p16,p16 unknown
3332,1,1,Clinical lab p16,p16 unknown
3332,1,1,Second Failure Type,no known failure
3333,1,1,Metastasis,M0
3333,1,1,Overall Stage,III
3333,1,1,Research lab p16,p16 unknown
3333,1,1,First Failure Type,no known failure
3333,1,1,Clinical lab p16,p16 unknown
3333,1,1,Nodal Stage,N1
3333,1,1,Tumor Site,oral cavity
3333,1,1,Research lab HPV,HPV unknown
3333,1,1,Treatment Modality,Sx
3333,1,1,Second Failure Type,no known failure
3333,1,1,Status,Alive w/o disease
3333,1,1,Occurrence #,1st primary
3333,1,1,Tumor Stage,T2
3334,1,1,Treatment Modality,Sx
3334,1,1,Occurrence #,1st primary
3334,1,1,Research lab HPV,HPV unknown
3334,1,1,Clinical lab p16,p16 unknown
3334,1,1,Nodal Stage,N0
3334,1,1,Tumor Site,oral cavity
3334,1,1,First Failure Type,no known failure
3334,1,1,Overall Stage,I
3334,1,1,Second Failure Type,no known failure
3334,1,1,Tumor Stage,T1
3334,1,1,Metastasis,M0
3334,1,1,Research lab p16,p16 unknown
3334,1,1,Status,Alive w/o disease
3335,1,1,Status,Alive w/o disease
3335,1,1,Clinical lab p16,p16 unknown
3335,1,1,First Failure Type,no known failure
3335,1,1,Nodal Stage,N0
3335,1,1,Tumor Site,oropharynx
3335,1,1,Second Failure Type,no known failure
3335,1,1,Tumor Stage,T1
3335,1,1,Research lab HPV,HPV unknown
3335,1,1,Metastasis,M0
3335,1,1,Research lab p16,p16 unknown
3335,1,1,Treatment Modality,Sx
3335,1,1,Overall Stage,I
3335,1,1,Occurrence #,1st primary
3336,1,1,Status,Alive w/o disease
3336,1,1,Treatment Modality,CTX-RT
3336,1,1,Occurrence #,1st primary
3336,1,1,Tumor Site,oropharynx
3336,1,1,Initial Chemotherapy Agent,cis
3336,1,1,Research lab p16,p16 unknown
3336,1,1,Tumor Stage,T2
3336,1,1,Radiation Dosage,70.2
3336,1,1,Nodal Stage,N2
3336,1,1,First Failure Type,no known failure
3336,1,1,Metastasis,M0
3336,1,1,Research lab HPV,HPV unknown
3336,1,1,Second Failure Type,no known failure
3336,1,1,Overall Stage,IVa
3336,1,1,Clinical lab p16,p16 unknown
3337,1,1,Research lab HPV,HPV unknown
3337,1,1,Research lab p16,p16 unknown
3337,1,1,Treatment Modality,Sx
3337,1,1,Tumor Site,oral cavity
3337,1,1,Metastasis,M0
3337,1,1,Status,Alive w/o disease
3337,1,1,Occurrence #,1st primary
3337,1,1,Second Failure Type,no known failure
3337,1,1,Nodal Stage,N0
3337,1,1,Overall Stage,I
3337,1,1,Tumor Stage,T1
3337,1,1,First Failure Type,no known failure
3337,1,1,Clinical lab p16,p16 unknown
3338,1,1,Second Failure Type,no known failure
3338,1,1,Occurrence #,1st primary
3338,1,1,Status,Alive w/ disease
3338,1,1,Tumor Stage,T2
3338,1,1,Overall Stage,II
3338,1,1,First Failure Type,no known failure
3338,1,1,Research lab p16,p16 unknown
3338,1,1,Tumor Site,oral cavity
3338,1,1,Clinical lab p16,p16 unknown
3338,1,1,Nodal Stage,N0
3338,1,1,Research lab HPV,HPV unknown
3338,1,1,Metastasis,M0
3338,1,1,Treatment Modality,Sx
3339,1,1,Tumor Stage,T1
3339,1,1,Metastasis,M0
3339,1,1,Overall Stage,I
3339,1,1,Tumor Site,oral cavity
3339,1,1,Second Failure Type,no known failure
3339,1,1,First Failure Type,no known failure
3339,1,1,Clinical lab p16,p16 unknown
3339,1,1,Research lab p16,p16 unknown
3339,1,1,Research lab HPV,HPV unknown
3339,1,1,Treatment Modality,Sx
3339,1,1,Occurrence #,1st primary
3339,1,1,Nodal Stage,N0
3339,1,1,Status,Alive w/o disease
3340,1,1,Second Failure Type,no known failure
3340,1,1,Tumor Stage,T1
3340,1,1,Status,Alive w/o disease
3340,1,1,Tumor Site,oral cavity
3340,1,1,First Failure Type,no known failure
3340,1,1,Nodal Stage,N0
3340,1,1,Clinical lab p16,p16 unknown
3340,1,1,Treatment Modality,Sx
3340,1,1,Overall Stage,I
3340,1,1,Research lab HPV,HPV unknown
3340,1,1,Research lab p16,p16 unknown
3340,1,1,Occurrence #,1st primary
3340,1,1,Metastasis,M0
3341,1,1,Treatment Modality,Sx
3341,1,1,Occurrence #,1st primary
3341,1,1,Nodal Stage,N2
3341,1,1,Research lab HPV,HPV unknown
3341,1,1,Clinical lab p16,p16 unknown
3341,1,1,First Failure Type,no known failure
3341,1,1,Tumor Site,oral cavity
3341,1,1,Overall Stage,IVa
3341,1,1,Metastasis,M0
3341,1,1,Research lab p16,p16 unknown
3341,1,1,Second Failure Type,no known failure
3341,1,1,Tumor Stage,T1
3341,1,1,Status,Alive w/ disease
3342,1,1,Clinical lab p16,p16 unknown
3342,1,1,Nodal Stage,Unknown
3342,1,1,Metastasis,Unknown
3342,1,1,Status,Alive w/o disease
3342,1,1,Tumor Stage,Unknown
3342,1,1,First Failure Type,no known failure
3342,1,1,Research lab p16,p16 unknown
3342,1,1,Research lab HPV,HPV unknown
3342,1,1,Second Failure Type,no known failure
3342,1,1,Tumor Site,oral cavity
3342,1,1,Overall Stage,Unknown
3342,1,1,Occurrence #,1st primary
3342,1,1,Treatment Modality,Sx
3343,1,1,Metastasis,M0
3343,1,1,Status,Alive w/ disease
3343,1,1,Tumor Stage,T2
3343,1,1,First Failure Type,no known failure
3343,1,1,Occurrence #,1st primary
3343,1,1,Research lab p16,p16 unknown
3343,1,1,Overall Stage,IVa
3343,1,1,Second Failure Type,no known failure
3343,1,1,Treatment Modality,CTX-RT
3343,1,1,Initial Chemotherapy Agent,cetux
3343,1,1,Nodal Stage,N2
3343,1,1,Radiation Dosage,70.2
3343,1,1,Clinical lab p16,p16 unknown
3343,1,1,Research lab HPV,HPV unknown
3343,1,1,Tumor Site,oropharynx
3344,1,1,Treatment Modality,Sx
3344,1,1,Occurrence #,1st primary
3344,1,1,First Failure Type,no known failure
3344,1,1,Second Failure Type,no known failure
3344,1,1,Research lab HPV,HPV unknown
3344,1,1,Status,Alive w/o disease
3344,1,1,Tumor Site,oral cavity
3344,1,1,Overall Stage,I
3344,1,1,Research lab p16,p16 unknown
3344,1,1,Nodal Stage,N0
3344,1,1,Clinical lab p16,p16 unknown
3344,1,1,Metastasis,M0
3344,1,1,Tumor Stage,T1
3345,1,1,Tumor Stage,T1
3345,1,1,Tumor Site,oral cavity
3345,1,1,Status,Alive w/o disease
3345,1,1,Research lab HPV,HPV unknown
3345,1,1,Overall Stage,I
3345,1,1,Occurrence #,1st primary
3345,1,1,First Failure Type,no known failure
3345,1,1,Nodal Stage,N0
3345,1,1,Second Failure Type,no known failure
3345,1,1,Treatment Modality,Sx
3345,1,1,Metastasis,M0
3345,1,1,Clinical lab p16,p16 unknown
3345,1,1,Research lab p16,p16 unknown
3346,1,1,Metastasis,M0
3346,1,1,Research lab HPV,HPV unknown
3346,1,1,Occurrence #,1st primary
3346,1,1,Overall Stage,IVa
3346,1,1,Tumor Site,oral cavity
3346,1,1,Radiation Dosage,60
3346,1,1,Tumor Stage,T4a
3346,1,1,Nodal Stage,N0
3346,1,1,Clinical lab p16,p16 unknown
3346,1,1,Status,Alive w/o disease
3346,1,1,Research lab p16,p16 unknown
3346,1,1,Second Failure Type,no known failure
3346,1,1,Treatment Modality,Sx & RT
3346,1,1,First Failure Type,no known failure
3347,1,1,Second Failure Type,no known failure
3347,1,1,Overall Stage,II
3347,1,1,Status,Alive w/o disease
3347,1,1,Metastasis,M0
3347,1,1,First Failure Type,no known failure
3347,1,1,Tumor Site,oral cavity
3347,1,1,Tumor Stage,T2
3347,1,1,Nodal Stage,N0
3347,1,1,Treatment Modality,Sx
3347,1,1,Clinical lab p16,p16 unknown
3347,1,1,Research lab HPV,HPV unknown
3347,1,1,Research lab p16,p16 unknown
3347,1,1,Occurrence #,1st primary
3348,1,1,Research lab p16,p16 unknown
3348,1,1,Occurrence #,1st primary
3348,1,1,Research lab HPV,HPV unknown
3348,1,1,Overall Stage,I
3348,1,1,Second Failure Type,no known failure
3348,1,1,Nodal Stage,N0
3348,1,1,Treatment Modality,Sx
3348,1,1,Tumor Site,oral cavity
3348,1,1,Clinical lab p16,p16 unknown
3348,1,1,Tumor Stage,T1
3348,1,1,Status,Alive w/o disease
3348,1,1,First Failure Type,no known failure
3348,1,1,Metastasis,M0
3349,1,1,Research lab HPV,HPV unknown
3349,1,1,Research lab p16,p16 unknown
3349,1,1,Status,Alive w/o disease
3349,1,1,Tumor Stage,T2
3349,1,1,First Failure Type,no known failure
3349,1,1,Second Failure Type,no known failure
3349,1,1,Tumor Site,oral cavity
3349,1,1,Clinical lab p16,p16 unknown
3349,1,1,Occurrence #,1st primary
3349,1,1,Overall Stage,II
3349,1,1,Treatment Modality,Sx
3349,1,1,Metastasis,M0
3349,1,1,Nodal Stage,N0
3350,1,1,Research lab p16,p16 unknown
3350,1,1,Overall Stage,IVa
3350,1,1,Metastasis,M0
3350,1,1,Occurrence #,1st primary
3350,1,1,Radiation Dosage,66
3350,1,1,Clinical lab p16,p16 unknown
3350,1,1,Treatment Modality,Sx & RT
3350,1,1,First Failure Type,no known failure
3350,1,1,Tumor Stage,T4a
3350,1,1,Research lab HPV,HPV unknown
3350,1,1,Nodal Stage,N0
3350,1,1,Status,Alive w/o disease
3350,1,1,Second Failure Type,no known failure
3350,1,1,Tumor Site,oral cavity
3351,1,1,Occurrence #,1st primary
3351,1,1,Treatment Modality,Sx
3351,1,1,Tumor Stage,T3
3351,1,1,Nodal Stage,N0
3351,1,1,Metastasis,M0
3351,1,1,Clinical lab p16,p16 unknown
3351,1,1,Second Failure Type,no known failure
3351,1,1,Research lab HPV,HPV unknown
3351,1,1,Tumor Site,oral cavity
3351,1,1,First Failure Type,no known failure
3351,1,1,Research lab p16,p16 unknown
3351,1,1,Status,Alive w/o disease
3351,1,1,Overall Stage,III
3352,1,1,Treatment Modality,Sx
3352,1,1,Tumor Site,oral cavity
3352,1,1,Overall Stage,I
3352,1,1,Clinical lab p16,p16 unknown
3352,1,1,Occurrence #,1st primary
3352,1,1,First Failure Type,no known failure
3352,1,1,Research lab HPV,HPV unknown
3352,1,1,Status,Alive w/o disease
3352,1,1,Second Failure Type,no known failure
3352,1,1,Metastasis,M0
3352,1,1,Nodal Stage,N0
3352,1,1,Research lab p16,p16 unknown
3352,1,1,Tumor Stage,T1
3353,1,1,Nodal Stage,N2
3353,1,1,Occurrence #,1st primary
3353,1,1,Radiation Dosage,59.4
3353,1,1,Second Failure Type,no known failure
3353,1,1,Clinical lab p16,p16 unknown
3353,1,1,Research lab HPV,HPV unknown
3353,1,1,Research lab p16,p16 unknown
3353,1,1,Treatment Modality,Sx & RT
3353,1,1,Overall Stage,IVa
3353,1,1,Tumor Site,oral cavity
3353,1,1,Tumor Stage,T4a
3353,1,1,Status,Alive w/o disease
3353,1,1,First Failure Type,no known failure
3353,1,1,Metastasis,M0
3354,1,1,Status,Alive w/o disease
3354,1,1,Overall Stage,I
3354,1,1,Second Failure Type,no known failure
3354,1,1,Research lab HPV,HPV unknown
3354,1,1,First Failure Type,no known failure
3354,1,1,Metastasis,M0
3354,1,1,Tumor Stage,T1
3354,1,1,Research lab p16,p16 unknown
3354,1,1,Treatment Modality,Sx
3354,1,1,Nodal Stage,N0
3354,1,1,Clinical lab p16,p16 unknown
3354,1,1,Tumor Site,oral cavity
3354,1,1,Occurrence #,1st primary
3355,1,1,Occurrence #,1st primary
3355,1,1,Research lab HPV,HPV unknown
3355,1,1,Second Failure Type,no known failure
3355,1,1,Clinical lab p16,p16 unknown
3355,1,1,Status,Alive w/o disease
3355,1,1,Metastasis,M0
3355,1,1,First Failure Type,no known failure
3355,1,1,Overall Stage,I
3355,1,1,Treatment Modality,Sx
3355,1,1,Tumor Site,oral cavity
3355,1,1,Tumor Stage,T1
3355,1,1,Nodal Stage,N0
3355,1,1,Research lab p16,p16 unknown
3356,1,1,Overall Stage,II
3356,1,1,Clinical lab p16,p16 unknown
3356,1,1,Status,Alive w/o disease
3356,1,1,Treatment Modality,Sx
3356,1,1,Second Failure Type,no known failure
3356,1,1,Research lab HPV,HPV unknown
3356,1,1,First Failure Type,no known failure
3356,1,1,Metastasis,M0
3356,1,1,Research lab p16,p16 unknown
3356,1,1,Nodal Stage,N0
3356,1,1,Tumor Site,oral cavity
3356,1,1,Occurrence #,1st primary
3356,1,1,Tumor Stage,T2
3357,1,1,Nodal Stage,N0
3357,1,1,Treatment Modality,Sx
3357,1,1,Overall Stage,I
3357,1,1,Research lab HPV,HPV unknown
3357,1,1,Status,Alive w/ disease
3357,1,1,Metastasis,M0
3357,1,1,First Failure Type,no known failure
3357,1,1,Tumor Site,oral cavity
3357,1,1,Research lab p16,p16 unknown
3357,1,1,Tumor Stage,T1
3357,1,1,Occurrence #,1st primary
3357,1,1,Clinical lab p16,p16 unknown
3357,1,1,Second Failure Type,no known failure
3357,1,1,First Failure Treatment Modality,Sx
3358,1,1,Metastasis,M0
3358,1,1,Nodal Stage,N0
3358,1,1,Tumor Stage,T1
3358,1,1,Second Failure Type,no known failure
3358,1,1,Research lab HPV,HPV unknown
3358,1,1,Status,Alive w/o disease
3358,1,1,Occurrence #,1st primary
3358,1,1,Clinical lab p16,p16 unknown
3358,1,1,Research lab p16,p16 unknown
3358,1,1,Tumor Site,oral cavity
3358,1,1,Overall Stage,I
3358,1,1,First Failure Type,no known failure
3358,1,1,Treatment Modality,Sx
3359,1,1,Status,Alive w/o disease
3359,1,1,First Failure Type,no known failure
3359,1,1,Second Failure Type,no known failure
3359,1,1,Occurrence #,1st primary
3359,1,1,Tumor Stage,T2
3359,1,1,Research lab p16,p16 unknown
3359,1,1,Treatment Modality,Sx & CTX-RT
3359,1,1,Nodal Stage,N2
3359,1,1,Initial Chemotherapy Agent,Carbo/ PTX
3359,1,1,Research lab HPV,HPV unknown
3359,1,1,Overall Stage,IVa
3359,1,1,Metastasis,M0
3359,1,1,Radiation Dosage,66.6
3359,1,1,Clinical lab p16,p16 unknown
3359,1,1,Tumor Site,oral cavity
3360,1,1,Overall Stage,IVa
3360,1,1,Status,Alive w/o disease
3360,1,1,Tumor Site,oral cavity
3360,1,1,Research lab p16,p16 unknown
3360,1,1,Initial Chemotherapy Agent,cis
3360,1,1,Occurrence #,1st primary
3360,1,1,Nodal Stage,N1
3360,1,1,First Failure Type,no known failure
3360,1,1,Research lab HPV,HPV unknown
3360,1,1,Tumor Stage,T4a
3360,1,1,Second Failure Type,no known failure
3360,1,1,Treatment Modality,Sx & CTX-RT
3360,1,1,Metastasis,M0
3360,1,1,Clinical lab p16,p16 unknown
3360,1,1,Radiation Dosage,unknown
3361,1,1,Occurrence #,1st primary
3361,1,1,Second Failure Type,no known failure
3361,1,1,Nodal Stage,N0
3361,1,1,First Failure Type,no known failure
3361,1,1,Research lab HPV,HPV unknown
3361,1,1,Research lab p16,p16 unknown
3361,1,1,Tumor Site,oral cavity
3361,1,1,Metastasis,M0
3361,1,1,Treatment Modality,Sx
3361,1,1,Tumor Stage,T2
3361,1,1,Overall Stage,II
3361,1,1,Status,Alive w/o disease
3361,1,1,Clinical lab p16,p16 unknown
3362,1,1,Overall Stage,I
3362,1,1,Second Failure Type,no known failure
3362,1,1,Status,Alive w/o disease
3362,1,1,Nodal Stage,N0
3362,1,1,Treatment Modality,Sx
3362,1,1,Clinical lab p16,p16 unknown
3362,1,1,Research lab HPV,HPV unknown
3362,1,1,Tumor Stage,T1
3362,1,1,Metastasis,M0
3362,1,1,Tumor Site,oral cavity
3362,1,1,First Failure Type,no known failure
3362,1,1,Research lab p16,p16 unknown
3362,1,1,Occurrence #,1st primary
3363,1,1,Clinical lab p16,p16 unknown
3363,1,1,First Failure Treatment Modality,Sx
3363,1,1,Tumor Site,oropharynx
3363,1,1,Research lab HPV,HPV unknown
3363,1,1,Nodal Stage,N2
3363,1,1,Tumor Stage,T1
3363,1,1,Second Failure Type,no known failure
3363,1,1,Metastasis,M0
3363,1,1,Overall Stage,IVa
3363,1,1,Occurrence #,recurrence
3363,1,1,Status,Alive w/o disease
3363,1,1,Research lab p16,p16 unknown
3363,1,1,First Failure Type,no known failure
3363,1,1,Treatment Modality,Sx & CTX-RT
3364,1,1,Clinical lab p16,p16 unknown
3364,1,1,Nodal Stage,N0
3364,1,1,Research lab p16,p16 unknown
3364,1,1,Second Failure Type,no known failure
3364,1,1,Tumor Stage,T1
3364,1,1,Status,Alive w/o disease
3364,1,1,Research lab HPV,HPV unknown
3364,1,1,Occurrence #,1st primary
3364,1,1,Metastasis,M0
3364,1,1,Overall Stage,I
3364,1,1,Tumor Site,oral cavity
3364,1,1,Treatment Modality,Sx
3364,1,1,First Failure Type,no known failure
3365,1,1,Tumor Site,oral cavity
3365,1,1,Occurrence #,1st primary
3365,1,1,Research lab p16,p16 unknown
3365,1,1,Research lab HPV,HPV unknown
3365,1,1,Nodal Stage,N0
3365,1,1,Treatment Modality,Sx
3365,1,1,First Failure Site,oral cavity
3365,1,1,Status,Alive w/o disease
3365,1,1,Second Failure Type,no known failure
3365,1,1,First Failure Treatment Modality,Sx
3365,1,1,Overall Stage,II
3365,1,1,Metastasis,M0
3365,1,1,Tumor Stage,T2
3365,1,1,Clinical lab p16,p16 unknown
3365,1,1,First Failure Type,no known failure
3366,1,1,Clinical lab p16,p16 unknown
3366,1,1,Overall Stage,III
3366,1,1,Research lab HPV,HPV unknown
3366,1,1,Nodal Stage,N1
3366,1,1,Status,Alive w/o disease
3366,1,1,Tumor Stage,T2
3366,1,1,Treatment Modality,Sx
3366,1,1,Research lab p16,p16 unknown
3366,1,1,Occurrence #,1st primary
3366,1,1,Tumor Site,oral cavity
3366,1,1,Metastasis,M0
3366,1,1,Second Failure Type,no known failure
3366,1,1,First Failure Type,no known failure
3367,1,1,Status,Alive w/o disease
3367,1,1,Tumor Site,oral cavity
3367,1,1,Metastasis,M0
3367,1,1,Occurrence #,1st primary
3367,1,1,Tumor Stage,T1
3367,1,1,First Failure Type,no known failure
3367,1,1,Research lab HPV,HPV unknown
3367,1,1,Research lab p16,p16 unknown
3367,1,1,Treatment Modality,Sx
3367,1,1,Second Failure Type,no known failure
3367,1,1,Overall Stage,I
3367,1,1,Nodal Stage,N0
3367,1,1,Clinical lab p16,p16 unknown
3368,1,1,Treatment Modality,Sx
3368,1,1,Metastasis,M0
3368,1,1,Clinical lab p16,p16 unknown
3368,1,1,Overall Stage,IVa
3368,1,1,Research lab HPV,HPV unknown
3368,1,1,Status,Alive w/o disease
3368,1,1,Second Failure Type,no known failure
3368,1,1,Research lab p16,p16 unknown
3368,1,1,Nodal Stage,N0
3368,1,1,Tumor Site,oral cavity
3368,1,1,Occurrence #,1st primary
3368,1,1,First Failure Type,no known failure
3368,1,1,Tumor Stage,T4a
3369,1,1,Treatment Modality,Sx
3369,1,1,Nodal Stage,N0
3369,1,1,Research lab p16,p16 unknown
3369,1,1,Tumor Site,oral cavity
3369,1,1,Metastasis,M0
3369,1,1,Research lab HPV,HPV unknown
3369,1,1,Overall Stage,I
3369,1,1,First Failure Type,no known failure
3369,1,1,Status,Alive w/o disease
3369,1,1,Second Failure Type,no known failure
3369,1,1,Occurrence #,1st primary
3369,1,1,Tumor Stage,T1
3369,1,1,Clinical lab p16,p16 unknown
3370,1,1,First Failure Site,oral cavity
3370,1,1,Research lab HPV,HPV unknown
3370,1,1,Status,Dead w/ disease
3370,1,1,Second Failure Type,no known failure
3370,1,1,First Failure Treatment Modality,Sx
3370,1,1,Metastasis,M0
3370,1,1,Occurrence #,other primary
3370,1,1,Treatment Modality,Sx
3370,1,1,Radiation Dosage,64
3370,1,1,Tumor Site,oral cavity
3370,1,1,Tumor Stage,T1
3370,1,1,Clinical lab p16,p16 unknown
3370,1,1,First Failure Type,no known failure
3370,1,1,Overall Stage,III
3370,1,1,Research lab p16,p16 unknown
3370,1,1,Nodal Stage,N1
3371,1,1,Tumor Stage,T1
3371,1,1,Second Failure Type,no known failure
3371,1,1,Nodal Stage,N0
3371,1,1,Treatment Modality,Sx
3371,1,1,Occurrence #,1st primary
3371,1,1,Tumor Site,oral cavity
3371,1,1,Metastasis,M0
3371,1,1,Research lab p16,p16 unknown
3371,1,1,First Failure Type,no known failure
3371,1,1,Clinical lab p16,p16 unknown
3371,1,1,Overall Stage,I
3371,1,1,Research lab HPV,HPV unknown
3371,1,1,Status,Dead w/o disease
3372,1,1,Metastasis,M0
3372,1,1,Tumor Site,oral cavity
3372,1,1,First Failure Type,no known failure
3372,1,1,Research lab p16,p16 unknown
3372,1,1,Occurrence #,other primary
3372,1,1,Nodal Stage,N2
3372,1,1,Clinical lab p16,p16 unknown
3372,1,1,Research lab HPV,HPV unknown
3372,1,1,Tumor Stage,T2
3372,1,1,Overall Stage,IVa
3372,1,1,Status,Dead w/ disease
3372,1,1,Second Failure Type,no known failure
3372,1,1,Treatment Modality,Sx
3373,1,1,Status,Dead w/o disease
3373,1,1,Tumor Site,oral cavity
3373,1,1,Clinical lab p16,p16 unknown
3373,1,1,Research lab p16,p16 unknown
3373,1,1,Research lab HPV,HPV unknown
3373,1,1,First Failure Type,no known failure
3373,1,1,Occurrence #,other primary
3373,1,1,Treatment Modality,Sx
3373,1,1,Overall Stage,I
3373,1,1,Tumor Stage,T1
3373,1,1,Metastasis,M0
3373,1,1,Second Failure Type,no known failure
3373,1,1,Nodal Stage,N0
3374,1,1,Research lab p16,p16 unknown
3374,1,1,Occurrence #,other primary
3374,1,1,Metastasis,M0
3374,1,1,Treatment Modality,Sx
3374,1,1,Status,Dead w/ disease
3374,1,1,Research lab HPV,HPV unknown
3374,1,1,Nodal Stage,N0
3374,1,1,Tumor Site,oral cavity
3374,1,1,Clinical lab p16,p16 unknown
3374,1,1,First Failure Type,no known failure
3374,1,1,Overall Stage,IVa
3374,1,1,Tumor Stage,T4a
3374,1,1,Second Failure Type,no known failure
3375,1,1,Metastasis,M0
3375,1,1,Second Failure Type,no known failure
3375,1,1,Status,Dead w/ disease
3375,1,1,Occurrence #,1st primary
3375,1,1,Treatment Modality,Unknown
3375,1,1,Overall Stage,IVa
3375,1,1,Clinical lab p16,p16 unknown
3375,1,1,Tumor Stage,T4a
3375,1,1,First Failure Type,no known failure
3375,1,1,Research lab HPV,HPV unknown
3375,1,1,Nodal Stage,N2
3375,1,1,Tumor Site,oral cavity
3375,1,1,Research lab p16,p16 unknown
3376,1,1,Research lab HPV,HPV unknown
3376,1,1,Radiation Dosage,44
3376,1,1,Clinical lab p16,p16 unknown
3376,1,1,Status,Dead w/ disease
3376,1,1,Treatment Modality,Sx & CTX-RT
3376,1,1,Overall Stage,IVa
3376,1,1,Tumor Stage,T4a
3376,1,1,Initial Chemotherapy Agent,Carbo
3376,1,1,Occurrence #,1st primary
3376,1,1,Nodal Stage,N1
3376,1,1,Metastasis,M0
3376,1,1,First Failure Type,no known failure
3376,1,1,Second Failure Type,no known failure
3376,1,1,Tumor Site,oral cavity
3376,1,1,Research lab p16,p16 unknown
3377,1,1,First Failure Type,locoregional
3377,1,1,Occurrence #,1st primary
3377,1,1,Research lab HPV,HPV unknown
3377,1,1,Treatment Modality,Sx
3377,1,1,Overall Stage,III
3377,1,1,First Failure Radiation Dosage,28
3377,1,1,Time to First Failure,0.8
3377,1,1,Tumor Stage,T3
3377,1,1,Metastasis,M0
3377,1,1,Nodal Stage,N0
3377,1,1,Status,Dead w/o disease
3377,1,1,Second Failure Type,no known failure
3377,1,1,Tumor Site,oral cavity
3377,1,1,Clinical lab p16,p16 unknown
3377,1,1,Research lab p16,p16 unknown
3377,1,1,First Failure Site,oral cavity
3377,1,1,First Failure Initial Chemotherapy Agent,carbo
3378,1,1,Tumor Site,oral cavity
3378,1,1,Nodal Stage,N0
3378,1,1,First Failure Type,no known failure
3378,1,1,Second Failure Type,no known failure
3378,1,1,Status,Dead w/o disease
3378,1,1,Research lab HPV,HPV unknown
3378,1,1,Research lab p16,p16 unknown
3378,1,1,Treatment Modality,Sx
3378,1,1,Overall Stage,I
3378,1,1,Occurrence #,other primary
3378,1,1,Clinical lab p16,p16 unknown
3378,1,1,Tumor Stage,T1
3378,1,1,Metastasis,M0
3379,1,1,Occurrence #,1st primary
3379,1,1,Tumor Stage,T4a
3379,1,1,Research lab p16,p16 unknown
3379,1,1,Tumor Site,oral cavity
3379,1,1,Status,Dead w/o disease
3379,1,1,First Failure Type,no known failure
3379,1,1,Clinical lab p16,p16 unknown
3379,1,1,Nodal Stage,N1
3379,1,1,Overall Stage,IVa
3379,1,1,Second Failure Type,no known failure
3379,1,1,Treatment Modality,Sx
3379,1,1,Metastasis,M0
3379,1,1,Research lab HPV,HPV unknown
3380,1,1,Overall Stage,III
3380,1,1,First Failure Site,oral cavity
3380,1,1,Clinical lab p16,p16 unknown
3380,1,1,Treatment Modality,Sx
3380,1,1,Research lab p16,p16 unknown
3380,1,1,Metastasis,M0
3380,1,1,Occurrence #,1st primary
3380,1,1,Status,Dead w/ disease
3380,1,1,Research lab HPV,HPV unknown
3380,1,1,First Failure Treatment Modality,Sx
3380,1,1,Second Failure Type,no known failure
3380,1,1,First Failure Type,locoregional
3380,1,1,Nodal Stage,N1
3380,1,1,Tumor Site,oral cavity
3380,1,1,Time to First Failure,0.3
3380,1,1,Tumor Stage,T2
3381,1,1,Research lab p16,p16 unknown
3381,1,1,Overall Stage,IVa
3381,1,1,Occurrence #,recurrence
3381,1,1,Second Failure Type,no known failure
3381,1,1,First Failure Type,no known failure
3381,1,1,Treatment Modality,Sx
3381,1,1,Status,Dead w/ disease
3381,1,1,Tumor Stage,T4a
3381,1,1,Nodal Stage,N0
3381,1,1,Clinical lab p16,p16 unknown
3381,1,1,Tumor Site,oral cavity
3381,1,1,Metastasis,M0
3381,1,1,Research lab HPV,HPV unknown
3382,1,1,First Failure Type,no known failure
3382,1,1,Nodal Stage,N3
3382,1,1,Overall Stage,IVb
3382,1,1,Occurrence #,1st primary
3382,1,1,Research lab HPV,HPV unknown
3382,1,1,Tumor Site,oropharynx
3382,1,1,Status,Dead w/ disease
3382,1,1,Treatment Modality,Sx
3382,1,1,Clinical lab p16,p16 unknown
3382,1,1,Metastasis,M0
3382,1,1,Second Failure Type,no known failure
3382,1,1,Research lab p16,p16 unknown
3382,1,1,Tumor Stage,T4a
3383,1,1,Second Failure Type,no known failure
3383,1,1,Status,Dead w/o disease
3383,1,1,Tumor Stage,T1
3383,1,1,Research lab p16,p16 unknown
3383,1,1,Metastasis,M0
3383,1,1,Clinical lab p16,p16 unknown
3383,1,1,Nodal Stage,N0
3383,1,1,Treatment Modality,Sx
3383,1,1,Occurrence #,1st primary
3383,1,1,First Failure Type,no known failure
3383,1,1,Overall Stage,I
3383,1,1,Tumor Site,oral cavity
3383,1,1,Research lab HPV,HPV unknown
3384,1,1,First Failure Type,distant
3384,1,1,Time to First Failure,-0.7
3384,1,1,Tumor Site,oral cavity
3384,1,1,Status,Dead w/ disease
3384,1,1,Initial Chemotherapy Agent,Cis/5FU
3384,1,1,Nodal Stage,N2
3384,1,1,Second Line Chemotherapy Agent,Cis/Doce
3384,1,1,Overall Stage,IVa
3384,1,1,Treatment Modality,CTX
3384,1,1,Occurrence #,1st primary
3384,1,1,Metastasis,M0
3384,1,1,Research lab HPV,HPV unknown
3384,1,1,Research lab p16,p16 unknown
3384,1,1,Tumor Stage,T2
3384,1,1,Second Failure Type,no known failure
3384,1,1,Clinical lab p16,p16 unknown
3385,1,1,Clinical lab p16,p16 unknown
3385,1,1,Nodal Stage,N3
3385,1,1,Research lab HPV,HPV unknown
3385,1,1,Status,Dead w/ disease
3385,1,1,Overall Stage,IVb
3385,1,1,Treatment Modality,CTX-RT
3385,1,1,Occurrence #,1st primary
3385,1,1,Metastasis,M0
3385,1,1,Radiation Dosage,70.2
3385,1,1,Tumor Stage,T4a
3385,1,1,Second Failure Type,no known failure
3385,1,1,Research lab p16,p16 unknown
3385,1,1,Tumor Site,oropharynx
3385,1,1,Initial Chemotherapy Agent,cis
3385,1,1,First Failure Type,no known failure
3386,1,1,Occurrence #,1st primary
3386,1,1,Tumor Stage,T1
3386,1,1,Second Failure Type,no known failure
3386,1,1,Research lab HPV,HPV unknown
3386,1,1,Nodal Stage,N0
3386,1,1,First Failure Type,no known failure
3386,1,1,Status,Dead w/o disease
3386,1,1,Metastasis,M0
3386,1,1,Research lab p16,p16 unknown
3386,1,1,Tumor Site,oral cavity
3386,1,1,Treatment Modality,Sx
3386,1,1,Overall Stage,I
3386,1,1,Clinical lab p16,p16 unknown
3387,1,1,Research lab HPV,HPV unknown
3387,1,1,Metastasis,M0
3387,1,1,Treatment Modality,CTX-RT
3387,1,1,First Failure Treatment Modality,CTX-RT
3387,1,1,Occurrence #,1st primary
3387,1,1,Tumor Stage,T2
3387,1,1,Overall Stage,II
3387,1,1,First Failure Type,no known failure
3387,1,1,Second Failure Type,no known failure
3387,1,1,Nodal Stage,N0
3387,1,1,Clinical lab p16,p16 unknown
3387,1,1,First Failure Initial Chemotherapy Agent,carbo/PTX
3387,1,1,Radiation Dosage,38
3387,1,1,Initial Chemotherapy Agent,Carbo/PTX
3387,1,1,First Failure Radiation Dosage,38
3387,1,1,Research lab p16,p16 unknown
3387,1,1,Tumor Site,oral cavity
3387,1,1,Status,Dead w/ disease
3388,1,1,Tumor Stage,T2
3388,1,1,Research lab HPV,HPV unknown
3388,1,1,Metastasis,M0
3388,1,1,Research lab p16,p16 unknown
3388,1,1,Status,Dead w/ disease
3388,1,1,Nodal Stage,N1
3388,1,1,Radiation Dosage,63
3388,1,1,Clinical lab p16,p16 unknown
3388,1,1,Tumor Site,oral cavity
3388,1,1,Treatment Modality,Sx & RT
3388,1,1,First Failure Type,no known failure
3388,1,1,Second Failure Type,no known failure
3388,1,1,Overall Stage,III
3388,1,1,Occurrence #,recurrence
3389,1,1,Nodal Stage,N1
3389,1,1,Status,Dead w/ disease
3389,1,1,Metastasis,M0
3389,1,1,Overall Stage,III
3389,1,1,Treatment Modality,Sx
3389,1,1,Tumor Site,oral cavity
3389,1,1,Tumor Stage,T3
3389,1,1,Occurrence #,1st primary
3389,1,1,Second Failure Type,no known failure
3389,1,1,Research lab HPV,HPV unknown
3389,1,1,Clinical lab p16,p16 unknown
3389,1,1,First Failure Type,locoregional
3389,1,1,Research lab p16,p16 unknown
3389,1,1,Time to First Failure,0.7
3390,1,1,First Failure Treatment Modality,CTX
3390,1,1,Tumor Stage,T1
3390,1,1,Occurrence #,1st primary
3390,1,1,Overall Stage,IVa
3390,1,1,Second Failure Type,no known failure
3390,1,1,Research lab p16,p16 unknown
3390,1,1,First Failure Second Line Chemotherapy Agent,Nivo
3390,1,1,Radiation Dosage,66
3390,1,1,Treatment Modality,Sx & CTX-RT
3390,1,1,Status,Dead w/ disease
3390,1,1,First Failure Initial Chemotherapy Agent,carbo
3390,1,1,Metastasis,M0
3390,1,1,Clinical lab p16,p16 unknown
3390,1,1,Tumor Site,oral cavity
3390,1,1,First Failure Type,no known failure
3390,1,1,Initial Chemotherapy Agent,cis
3390,1,1,Research lab HPV,HPV unknown
3390,1,1,Nodal Stage,N2
3391,1,1,Status,Dead w/ disease
3391,1,1,Tumor Stage,T4a
3391,1,1,First Failure Type,no known failure
3391,1,1,Second Failure Type,no known failure
3391,1,1,Occurrence #,1st primary
3391,1,1,Nodal Stage,N0
3391,1,1,Overall Stage,IVa
3391,1,1,Treatment Modality,Sx
3391,1,1,Tumor Site,oral cavity
3391,1,1,Research lab HPV,HPV unknown
3391,1,1,Clinical lab p16,p16 unknown
3391,1,1,Metastasis,M0
3391,1,1,Research lab p16,p16 unknown
3392,1,1,Research lab HPV,HPV unknown
3392,1,1,Metastasis,M0
3392,1,1,Second Failure Type,no known failure
3392,1,1,Occurrence #,1st primary
3392,1,1,First Failure Type,no known failure
3392,1,1,Clinical lab p16,p16 unknown
3392,1,1,Status,Dead w/o disease
3392,1,1,Nodal Stage,N0
3392,1,1,Tumor Site,oral cavity
3392,1,1,Treatment Modality,Sx
3392,1,1,Overall Stage,I
3392,1,1,Research lab p16,p16 unknown
3392,1,1,Tumor Stage,T1
3393,1,1,First Failure Type,no known failure
3393,1,1,Tumor Stage,T4a
3393,1,1,Metastasis,M0
3393,1,1,Research lab p16,p16 unknown
3393,1,1,Radiation Dosage,33.8
3393,1,1,Treatment Modality,CTX-RT
3393,1,1,Research lab HPV,HPV unknown
3393,1,1,Status,Dead w/ disease
3393,1,1,Overall Stage,IVb
3393,1,1,Nodal Stage,N3
3393,1,1,Occurrence #,1st primary
3393,1,1,Initial Chemotherapy Agent,Carbo
3393,1,1,Tumor Site,oral cavity
3393,1,1,Second Failure Type,no known failure
3393,1,1,Clinical lab p16,p16 unknown
3394,1,1,Treatment Modality,Sx & RT
3394,1,1,Second Failure Type,no known failure
3394,1,1,Time to First Failure,0.4
3394,1,1,Clinical lab p16,p16 unknown
3394,1,1,Nodal Stage,N0
3394,1,1,Tumor Stage,T4a
3394,1,1,Occurrence #,other primary
3394,1,1,First Failure Type,locoregional
3394,1,1,Tumor Site,oral cavity
3394,1,1,Status,Dead w/ disease
3394,1,1,Overall Stage,IVa
3394,1,1,Research lab HPV,HPV unknown
3394,1,1,Radiation Dosage,Unknown
3394,1,1,Research lab p16,p16 unknown
3394,1,1,Metastasis,M0
3395,1,1,Tumor Stage,T2
3395,1,1,Metastasis,M0
3395,1,1,Status,Dead w/o disease
3395,1,1,First Failure Type,no known failure
3395,1,1,Research lab HPV,HPV unknown
3395,1,1,Overall Stage,III
3395,1,1,Treatment Modality,Sx
3395,1,1,Second Failure Type,no known failure
3395,1,1,Research lab p16,p16 unknown
3395,1,1,Nodal Stage,N1
3395,1,1,Tumor Site,oral cavity
3395,1,1,Clinical lab p16,p16 unknown
3395,1,1,Occurrence #,other primary
3396,1,1,Occurrence #,1st primary
3396,1,1,Second Failure Type,no known failure
3396,1,1,Nodal Stage,N0
3396,1,1,Treatment Modality,Sx
3396,1,1,Overall Stage,I
3396,1,1,Clinical lab p16,p16 unknown
3396,1,1,Tumor Site,oral cavity
3396,1,1,Research lab p16,p16 unknown
3396,1,1,Research lab HPV,HPV unknown
3396,1,1,Time to First Failure,0.3
3396,1,1,Status,Dead w/ disease
3396,1,1,Metastasis,M0
3396,1,1,Tumor Stage,T1
3396,1,1,First Failure Type,locoregional
3397,1,1,Tumor Stage,T4a
3397,1,1,Occurrence #,recurrence
3397,1,1,Clinical lab p16,p16 unknown
3397,1,1,Tumor Site,oral cavity
3397,1,1,Status,Dead w/ disease
3397,1,1,First Failure Type,no known failure
3397,1,1,Metastasis,M0
3397,1,1,Research lab HPV,HPV unknown
3397,1,1,Initial Chemotherapy Agent,5FU/Doce/cis
3397,1,1,Second Failure Type,no known failure
3397,1,1,Treatment Modality,Sx & CTX
3397,1,1,Nodal Stage,N2
3397,1,1,Overall Stage,IVa
3397,1,1,Research lab p16,p16 unknown
3398,1,1,Nodal Stage,Unknown
3398,1,1,Second Failure Type,no known failure
3398,1,1,Clinical lab p16,p16 unknown
3398,1,1,Treatment Modality,Unknown
3398,1,1,Research lab HPV,HPV unknown
3398,1,1,First Failure Type,no known failure
3398,1,1,Overall Stage,Unknown
3398,1,1,Status,Dead w/o disease
3398,1,1,Metastasis,Unknown
3398,1,1,Tumor Site,oral cavity
3398,1,1,Research lab p16,p16 unknown
3398,1,1,Occurrence #,1st primary
3398,1,1,Tumor Stage,Unknown
3399,1,1,Nodal Stage,N0
3399,1,1,Tumor Stage,T2
3399,1,1,First Failure Type,no known failure
3399,1,1,Treatment Modality,Sx
3399,1,1,Clinical lab p16,p16 unknown
3399,1,1,Status,Dead w/o disease
3399,1,1,Research lab p16,p16 unknown
3399,1,1,Occurrence #,1st primary
3399,1,1,Metastasis,M0
3399,1,1,Research lab HPV,HPV unknown
3399,1,1,Second Failure Type,no known failure
3399,1,1,Overall Stage,II
3399,1,1,Tumor Site,oral cavity
3400,1,1,Treatment Modality,Sx
3400,1,1,Occurrence #,1st primary
3400,1,1,Overall Stage,IVa
3400,1,1,Nodal Stage,N0
3400,1,1,Research lab HPV,HPV unknown
3400,1,1,Status,Dead w/ disease
3400,1,1,First Failure Type,no known failure
3400,1,1,Metastasis,M0
3400,1,1,Second Failure Type,no known failure
3400,1,1,Research lab p16,p16 unknown
3400,1,1,Tumor Site,oral cavity
3400,1,1,Clinical lab p16,p16 unknown
3400,1,1,Tumor Stage,T4a
3401,1,1,First Failure Second Line Chemotherapy Agent,Cis/cap
3401,1,1,First Failure Type,no known failure
3401,1,1,Status,Dead w/o disease
3401,1,1,First Failure Initial Chemotherapy Agent,Carbo/PTX
3401,1,1,First Failure Treatment Modality,Sx & CTX-RT
3401,1,1,Tumor Stage,T1
3401,1,1,Metastasis,M0
3401,1,1,Tumor Site,oral cavity
3401,1,1,Research lab p16,p16 unknown
3401,1,1,Nodal Stage,N0
3401,1,1,Clinical lab p16,p16 unknown
3401,1,1,Second Failure Type,no known failure
3401,1,1,Overall Stage,I
3401,1,1,Research lab HPV,HPV unknown
3401,1,1,Treatment Modality,Sx
3401,1,1,First Failure Radiation Dosage,50
3401,1,1,Occurrence #,1st primary
3402,1,1,Clinical lab p16,p16 unknown
3402,1,1,Research lab HPV,HPV unknown
3402,1,1,Research lab p16,p16 unknown
3402,1,1,Nodal Stage,N0
3402,1,1,Treatment Modality,Sx
3402,1,1,Tumor Stage,T2
3402,1,1,Second Failure Type,no known failure
3402,1,1,Tumor Site,oral cavity
3402,1,1,Metastasis,M0
3402,1,1,Status,Dead w/o disease
3402,1,1,Overall Stage,II
3402,1,1,First Failure Type,no known failure
3402,1,1,Occurrence #,1st primary
3403,1,1,Status,Dead w/ disease
3403,1,1,Overall Stage,IVa
3403,1,1,Clinical lab p16,p16 unknown
3403,1,1,First Failure Type,no known failure
3403,1,1,Tumor Stage,T1
3403,1,1,Second Failure Type,no known failure
3403,1,1,Nodal Stage,N2
3403,1,1,Research lab p16,p16 unknown
3403,1,1,Metastasis,M0
3403,1,1,Occurrence #,1st primary
3403,1,1,Treatment Modality,Unknown
3403,1,1,Research lab HPV,HPV unknown
3403,1,1,Tumor Site,oropharynx
3404,1,1,Overall Stage,III
3404,1,1,Nodal Stage,N1
3404,1,1,Tumor Site,oral cavity
3404,1,1,First Failure Site,oropharynx
3404,1,1,First Failure Treatment Modality,Sx
3404,1,1,Status,Dead w/ disease
3404,1,1,Occurrence #,1st primary
3404,1,1,Metastasis,M0
3404,1,1,Research lab HPV,HPV unknown
3404,1,1,First Failure Type,no known failure
3404,1,1,Second Failure Type,no known failure
3404,1,1,Research lab p16,p16 unknown
3404,1,1,Tumor Stage,T2
3404,1,1,Clinical lab p16,p16 unknown
3404,1,1,Treatment Modality,Sx & RT
3405,1,1,Status,Dead w/ disease
3405,1,1,Tumor Site,oral cavity
3405,1,1,Occurrence #,1st primary
3405,1,1,Treatment Modality,Sx
3405,1,1,Tumor Stage,T2
3405,1,1,First Failure Type,no known failure
3405,1,1,Second Failure Type,no known failure
3405,1,1,Clinical lab p16,p16 unknown
3405,1,1,Research lab HPV,HPV unknown
3405,1,1,Research lab p16,p16 unknown
3405,1,1,Metastasis,M0
3405,1,1,Nodal Stage,N2
3405,1,1,Overall Stage,IVa
3406,1,1,Tumor Stage,T4a
3406,1,1,Second Failure Type,no known failure
3406,1,1,Status,Dead w/o disease
3406,1,1,Treatment Modality,Sx
3406,1,1,Occurrence #,1st primary
3406,1,1,Metastasis,M0
3406,1,1,Research lab p16,p16 unknown
3406,1,1,Research lab HPV,HPV unknown
3406,1,1,Nodal Stage,N0
3406,1,1,Tumor Site,oral cavity
3406,1,1,First Failure Type,no known failure
3406,1,1,Overall Stage,IVa
3406,1,1,Clinical lab p16,p16 unknown
3407,1,1,Overall Stage,I
3407,1,1,Occurrence #,recurrence
3407,1,1,Metastasis,M0
3407,1,1,Research lab p16,p16 unknown
3407,1,1,Treatment Modality,Sx
3407,1,1,Second Failure Type,no known failure
3407,1,1,Nodal Stage,N0
3407,1,1,Status,Dead w/ disease
3407,1,1,Tumor Site,oropharynx
3407,1,1,Research lab HPV,HPV unknown
3407,1,1,Tumor Stage,T1
3407,1,1,Clinical lab p16,p16 unknown
3407,1,1,First Failure Type,no known failure
3408,1,1,Status,Alive w/ disease
3408,1,1,Metastasis,M0
3408,1,1,Research lab HPV,HPV unknown
3408,1,1,Research lab p16,p16 unknown
3408,1,1,Tumor Stage,T2
3408,1,1,Overall Stage,II
3408,1,1,First Failure Type,no known failure
3408,1,1,Clinical lab p16,p16 unknown
3408,1,1,Occurrence #,1st primary
3408,1,1,Treatment Modality,Sx
3408,1,1,Tumor Site,oral cavity
3408,1,1,Nodal Stage,N0
3408,1,1,Second Failure Type,no known failure
3409,1,1,Clinical lab p16,p16 unknown
3409,1,1,Nodal Stage,N0
3409,1,1,Research lab HPV,HPV unknown
3409,1,1,Tumor Site,oral cavity
3409,1,1,Second Failure Type,no known failure
3409,1,1,Metastasis,M0
3409,1,1,First Failure Type,no known failure
3409,1,1,Treatment Modality,Sx
3409,1,1,Occurrence #,1st primary
3409,1,1,Research lab p16,p16 unknown
3409,1,1,Tumor Stage,T4a
3409,1,1,Overall Stage,IVa
3409,1,1,Status,Dead w/o disease
3410,1,1,Overall Stage,I
3410,1,1,Metastasis,M0
3410,1,1,First Failure Type,no known failure
3410,1,1,Second Failure Type,no known failure
3410,1,1,Occurrence #,1st primary
3410,1,1,Clinical lab p16,p16 unknown
3410,1,1,Treatment Modality,Sx
3410,1,1,Status,Dead w/ disease
3410,1,1,Tumor Site,oropharynx
3410,1,1,Nodal Stage,N0
3410,1,1,Research lab p16,p16 unknown
3410,1,1,Tumor Stage,T1
3410,1,1,Research lab HPV,HPV unknown
3411,1,1,Status,Dead w/o disease
3411,1,1,Research lab HPV,HPV unknown
3411,1,1,Metastasis,M0
3411,1,1,Research lab p16,p16 unknown
3411,1,1,Occurrence #,1st primary
3411,1,1,Tumor Stage,T1
3411,1,1,Treatment Modality,Sx
3411,1,1,Second Failure Type,no known failure
3411,1,1,Overall Stage,I
3411,1,1,Nodal Stage,N0
3411,1,1,Clinical lab p16,p16 unknown
3411,1,1,First Failure Type,no known failure
3411,1,1,Tumor Site,oral cavity
3412,1,1,Tumor Stage,T1
3412,1,1,Overall Stage,I
3412,1,1,Research lab HPV,HPV unknown
3412,1,1,Research lab p16,p16 unknown
3412,1,1,Nodal Stage,N0
3412,1,1,First Failure Site,oral cavity
3412,1,1,Treatment Modality,Sx
3412,1,1,First Failure Initial Chemotherapy Agent,cis
3412,1,1,First Failure Treatment Modality,Sx & CTX-RT
3412,1,1,Clinical lab p16,p16 unknown
3412,1,1,First Failure Type,no known failure
3412,1,1,Tumor Site,oral cavity
3412,1,1,Metastasis,M0
3412,1,1,Second Failure Type,no known failure
3412,1,1,Occurrence #,1st primary
3412,1,1,Status,Dead w/o disease
3413,1,1,Treatment Modality,Sx & CTX-RT
3413,1,1,Tumor Stage,T3
3413,1,1,Overall Stage,IVc
3413,1,1,Clinical lab p16,p16 unknown
3413,1,1,Second Failure Type,no known failure
3413,1,1,Radiation Dosage,aborted during 2nd week
3413,1,1,Research lab p16,p16 unknown
3413,1,1,Tumor Site,oral cavity
3413,1,1,Nodal Stage,N2
3413,1,1,Research lab HPV,HPV unknown
3413,1,1,Status,Dead w/ disease
3413,1,1,Initial Chemotherapy Agent,cis
3413,1,1,Occurrence #,1st primary
3413,1,1,Metastasis,M1
3413,1,1,First Failure Type,no known failure
3414,1,1,Initial Chemotherapy Agent,Cis
3414,1,1,Metastasis,M0
3414,1,1,Occurrence #,1st primary
3414,1,1,Status,Dead w/ disease
3414,1,1,Clinical lab p16,p16 unknown
3414,1,1,Treatment Modality,CTX-RT
3414,1,1,Research lab p16,p16 unknown
3414,1,1,Overall Stage,IVa
3414,1,1,Tumor Stage,T4a
3414,1,1,Nodal Stage,N1
3414,1,1,Research lab HPV,HPV unknown
3414,1,1,Tumor Site,oral cavity
3414,1,1,Radiation Dosage,70.2
3414,1,1,First Failure Type,no known failure
3414,1,1,Second Failure Type,no known failure
3415,1,1,Clinical lab p16,p16 unknown
3415,1,1,Radiation Dosage,70.2
3415,1,1,Overall Stage,IVa
3415,1,1,Metastasis,M0
3415,1,1,Research lab p16,p16 unknown
3415,1,1,Treatment Modality,CTX-RT
3415,1,1,Time to First Failure,0.2
3415,1,1,Initial Chemotherapy Agent,carbo
3415,1,1,Tumor Site,oropharynx
3415,1,1,Nodal Stage,N2
3415,1,1,Tumor Stage,T3
3415,1,1,Status,Dead w/ disease
3415,1,1,First Failure Type,locoregional
3415,1,1,Occurrence #,1st primary
3415,1,1,Second Failure Type,no known failure
3415,1,1,Research lab HPV,HPV unknown
3416,1,1,Second Failure Type,no known failure
3416,1,1,Overall Stage,Unknown
3416,1,1,Tumor Site,oropharynx
3416,1,1,Nodal Stage,Unknown
3416,1,1,Metastasis,Unknown
3416,1,1,Tumor Stage,Unknown
3416,1,1,Occurrence #,other primary
3416,1,1,Clinical lab p16,p16 unknown
3416,1,1,First Failure Type,no known failure
3416,1,1,Treatment Modality,Sx
3416,1,1,Research lab p16,p16 unknown
3416,1,1,Status,Dead w/ disease
3416,1,1,Research lab HPV,HPV unknown
3417,1,1,Radiation Dosage,74.4
3417,1,1,Metastasis,M0
3417,1,1,Tumor Site,larynx
3417,1,1,First Failure Treatment Modality,Sx & RT
3417,1,1,First Failure Site,larynx
3417,1,1,Occurrence #,1st primary
3417,1,1,First Failure Radiation Dosage,60
3417,1,1,Tumor Stage,T2
3417,1,1,Clinical lab p16,p16 unknown
3417,1,1,First Failure Type,no known failure
3417,1,1,Treatment Modality,RT
3417,1,1,Research lab p16,p16 unknown
3417,1,1,Status,Dead w/ disease
3417,1,1,Overall Stage,II
3417,1,1,Second Failure Type,no known failure
3417,1,1,Nodal Stage,N0
3417,1,1,Research lab HPV,HPV unknown
3418,1,1,Tumor Site,oral cavity
3418,1,1,Clinical lab p16,p16 unknown
3418,1,1,First Failure Type,no known failure
3418,1,1,Metastasis,M0
3418,1,1,Research lab HPV,HPV unknown
3418,1,1,Occurrence #,1st primary
3418,1,1,Second Failure Type,no known failure
3418,1,1,Status,Dead w/o disease
3418,1,1,Overall Stage,III
3418,1,1,Research lab p16,p16 unknown
3418,1,1,Treatment Modality,Sx
3418,1,1,Tumor Stage,T1
3418,1,1,Nodal Stage,N1
3419,1,1,Tumor Site,oral cavity
3419,1,1,Treatment Modality,Sx & RT
3419,1,1,Research lab HPV,HPV unknown
3419,1,1,Second Failure Type,no known failure
3419,1,1,Research lab p16,p16 unknown
3419,1,1,Overall Stage,IVa
3419,1,1,Nodal Stage,N0
3419,1,1,Clinical lab p16,p16 unknown
3419,1,1,Tumor Stage,T4a
3419,1,1,Radiation Dosage,66.6
3419,1,1,Occurrence #,1st primary
3419,1,1,Status,Dead w/o disease
3419,1,1,Metastasis,M0
3419,1,1,First Failure Type,no known failure
3420,1,1,Nodal Stage,N0
3420,1,1,Research lab p16,p16 unknown
3420,1,1,Second Failure Type,no known failure
3420,1,1,Tumor Stage,T4a
3420,1,1,Treatment Modality,Sx
3420,1,1,First Failure Type,no known failure
3420,1,1,Research lab HPV,HPV unknown
3420,1,1,Overall Stage,IVa
3420,1,1,Occurrence #,1st primary
3420,1,1,Status,Dead w/ disease
3420,1,1,Metastasis,M0
3420,1,1,Tumor Site,oral cavity
3420,1,1,Clinical lab p16,p16 unknown
3421,1,1,Tumor Stage,T2
3421,1,1,Metastasis,M0
3421,1,1,Research lab HPV,HPV unknown
3421,1,1,Status,Dead w/o disease
3421,1,1,Occurrence #,1st primary
3421,1,1,Research lab p16,p16 unknown
3421,1,1,Second Failure Type,no known failure
3421,1,1,Clinical lab p16,p16 unknown
3421,1,1,Overall Stage,IVa
3421,1,1,Tumor Site,oral cavity
3421,1,1,Nodal Stage,N2
3421,1,1,First Failure Type,no known failure
3421,1,1,Treatment Modality,Sx
3422,1,1,Second Failure Type,no known failure
3422,1,1,Metastasis,M0
3422,1,1,Tumor Stage,T4a
3422,1,1,Occurrence #,1st primary
3422,1,1,Status,Dead w/ disease
3422,1,1,Research lab p16,p16 unknown
3422,1,1,Overall Stage,IVa
3422,1,1,Nodal Stage,N0
3422,1,1,Clinical lab p16,p16 unknown
3422,1,1,Treatment Modality,Sx
3422,1,1,Tumor Site,oral cavity
3422,1,1,Research lab HPV,HPV unknown
3422,1,1,First Failure Type,no known failure
3423,1,1,Overall Stage,I
3423,1,1,Second Failure Type,no known failure
3423,1,1,Research lab p16,p16 unknown
3423,1,1,First Failure Type,no known failure
3423,1,1,Nodal Stage,N0
3423,1,1,Tumor Stage,T1
3423,1,1,Clinical lab p16,p16 unknown
3423,1,1,Treatment Modality,Sx
3423,1,1,Status,Dead w/o disease
3423,1,1,Tumor Site,oral cavity
3423,1,1,Research lab HPV,HPV unknown
3423,1,1,Metastasis,M0
3423,1,1,Occurrence #,1st primary
3424,1,1,Clinical lab p16,p16 unknown
3424,1,1,Time to First Failure,0.8
3424,1,1,Metastasis,M0
3424,1,1,Tumor Stage,T2
3424,1,1,Nodal Stage,N2
3424,1,1,Treatment Modality,Sx
3424,1,1,First Failure Site,oropharynx
3424,1,1,First Failure Initial Chemotherapy Agent,Carbo
3424,1,1,Tumor Site,oropharynx
3424,1,1,Research lab p16,p16 unknown
3424,1,1,Second Failure Type,no known failure
3424,1,1,First Failure Type,locoregional
3424,1,1,Status,Dead w/o disease
3424,1,1,Age at Death,51.6
3424,1,1,Overall Stage,IVa
3424,1,1,Time to Death,1.5
3424,1,1,First Failure Treatment Modality,Sx & CTX-RT
3424,1,1,Research lab HPV,HPV unknown
3424,1,1,Occurrence #,other primary
3424,1,1,First Failure Radiation Dosage,60
3424,1,1,Date of Death,2013-08-21 00:00:00
3425,1,1,Status,Dead w/ disease
3425,1,1,Tumor Stage,T2
3425,1,1,Nodal Stage,N0
3425,1,1,Second Failure Type,no known failure
3425,1,1,Metastasis,M0
3425,1,1,Overall Stage,II
3425,1,1,Research lab p16,p16 unknown
3425,1,1,Tumor Site,oral cavity
3425,1,1,Clinical lab p16,p16 unknown
3425,1,1,Research lab HPV,HPV unknown
3425,1,1,Treatment Modality,Sx
3425,1,1,First Failure Type,no known failure
3425,1,1,Occurrence #,recurrence
3426,1,1,Tumor Stage,T2
3426,1,1,Research lab HPV,HPV unknown
3426,1,1,Clinical lab p16,p16 unknown
3426,1,1,First Failure Type,no known failure
3426,1,1,Research lab p16,p16 unknown
3426,1,1,Overall Stage,IVa
3426,1,1,Nodal Stage,N2
3426,1,1,Metastasis,M0
3426,1,1,Second Failure Type,no known failure
3426,1,1,First Failure Treatment Modality,Sx
3426,1,1,Treatment Modality,Sx
3426,1,1,Occurrence #,1st primary
3426,1,1,Status,Dead w/ disease
3426,1,1,First Failure Site,oral cavity
3426,1,1,Tumor Site,oral cavity
3427,1,1,Overall Stage,IVa
3427,1,1,Research lab p16,p16 unknown
3427,1,1,Nodal Stage,N2
3427,1,1,Tumor Site,oral cavity
3427,1,1,Research lab HPV,HPV unknown
3427,1,1,Clinical lab p16,p16 unknown
3427,1,1,First Failure Type,no known failure
3427,1,1,Status,Dead w/o disease
3427,1,1,Metastasis,M0
3427,1,1,Occurrence #,1st primary
3427,1,1,Treatment Modality,Sx
3427,1,1,Tumor Stage,T2
3427,1,1,Second Failure Type,no known failure
3428,1,1,Metastasis,M0
3428,1,1,Overall Stage,IVa
3428,1,1,First Failure Type,no known failure
3428,1,1,Occurrence #,1st primary
3428,1,1,Research lab p16,p16 unknown
3428,1,1,Research lab HPV,HPV unknown
3428,1,1,Initial Chemotherapy Agent,cis
3428,1,1,Treatment Modality,Sx & CTX-RT
3428,1,1,Radiation Dosage,63
3428,1,1,Second Failure Type,no known failure
3428,1,1,Clinical lab p16,p16 unknown
3428,1,1,Nodal Stage,N2
3428,1,1,Status,Dead w/o disease
3428,1,1,Tumor Site,oral cavity
3428,1,1,Tumor Stage,T4a
3429,1,1,Tumor Site,oral cavity
3429,1,1,Nodal Stage,N0
3429,1,1,Research lab HPV,HPV unknown
3429,1,1,First Failure Treatment Modality,Sx
3429,1,1,Occurrence #,1st primary
3429,1,1,Clinical lab p16,p16 unknown
3429,1,1,First Failure Site,oral cavity
3429,1,1,Overall Stage,I
3429,1,1,Metastasis,M0
3429,1,1,Second Failure Type,no known failure
3429,1,1,Time to First Failure,0.1
3429,1,1,Status,Dead w/ disease
3429,1,1,Treatment Modality,Sx
3429,1,1,Research lab p16,p16 unknown
3429,1,1,First Failure Type,locoregional
3429,1,1,Tumor Stage,T1
3430,1,1,Second Failure Type,no known failure
3430,1,1,Clinical lab p16,p16 unknown
3430,1,1,Tumor Site,oral cavity
3430,1,1,Research lab p16,p16 unknown
3430,1,1,Overall Stage,IVa
3430,1,1,Research lab HPV,HPV unknown
3430,1,1,Treatment Modality,Sx
3430,1,1,Metastasis,M0
3430,1,1,Tumor Stage,T4a
3430,1,1,First Failure Type,no known failure
3430,1,1,Status,Dead w/o disease
3430,1,1,Occurrence #,1st primary
3430,1,1,Nodal Stage,N0
3431,1,1,Research lab p16,p16 unknown
3431,1,1,Treatment Modality,Sx & CTX-RT
3431,1,1,Initial Chemotherapy Agent,Cis
3431,1,1,Clinical lab p16,p16 unknown
3431,1,1,Research lab HPV,HPV unknown
3431,1,1,Tumor Stage,T3
3431,1,1,Radiation Dosage,63
3431,1,1,Occurrence #,1st primary
3431,1,1,Overall Stage,IVa
3431,1,1,Tumor Site,oral cavity
3431,1,1,Status,Dead w/o disease
3431,1,1,Metastasis,M0
3431,1,1,Nodal Stage,N2
3431,1,1,Second Failure Type,no known failure
3431,1,1,First Failure Type,no known failure
3432,1,1,Research lab HPV,HPV unknown
3432,1,1,Overall Stage,IVa
3432,1,1,Second Failure Type,no known failure
3432,1,1,Tumor Site,oral cavity
3432,1,1,Radiation Dosage,Unknown
3432,1,1,Clinical lab p16,p16 unknown
3432,1,1,Treatment Modality,Sx & CTX-RT
3432,1,1,Tumor Stage,T4a
3432,1,1,First Failure Type,distant
3432,1,1,Metastasis,Unknown
3432,1,1,Occurrence #,1st primary
3432,1,1,Nodal Stage,N2
3432,1,1,Initial Chemotherapy Agent,cis
3432,1,1,Status,Dead w/o disease
3432,1,1,Time to First Failure,0.2
3432,1,1,Research lab p16,p16 unknown
3433,1,1,Tumor Site,oral cavity
3433,1,1,Metastasis,M0
3433,1,1,Occurrence #,1st primary
3433,1,1,Nodal Stage,N0
3433,1,1,Research lab HPV,HPV unknown
3433,1,1,First Failure Type,no known failure
3433,1,1,Overall Stage,I
3433,1,1,Treatment Modality,Sx
3433,1,1,Second Failure Type,no known failure
3433,1,1,Tumor Stage,T1
3433,1,1,Status,Dead w/o disease
3433,1,1,Research lab p16,p16 unknown
3433,1,1,Clinical lab p16,p16 unknown
3434,1,1,First Failure Type,no known failure
3434,1,1,Overall Stage,II
3434,1,1,Occurrence #,1st primary
3434,1,1,First Failure Treatment Modality,Sx
3434,1,1,Nodal Stage,N0
3434,1,1,Second Failure Type,no known failure
3434,1,1,Treatment Modality,Sx & RT
3434,1,1,Tumor Site,oral cavity
3434,1,1,First Failure Site,oral cavity
3434,1,1,Clinical lab p16,p16 unknown
3434,1,1,Tumor Stage,T2
3434,1,1,Research lab p16,p16 unknown
3434,1,1,Status,Dead w/ disease
3434,1,1,Research lab HPV,HPV unknown
3434,1,1,Metastasis,M0
3435,1,1,Tumor Site,oral cavity
3435,1,1,Treatment Modality,Sx
3435,1,1,First Failure Type,no known failure
3435,1,1,Second Failure Type,no known failure
3435,1,1,Clinical lab p16,p16 unknown
3435,1,1,Overall Stage,I
3435,1,1,Metastasis,M0
3435,1,1,Research lab HPV,HPV unknown
3435,1,1,Status,Dead w/o disease
3435,1,1,Research lab p16,p16 unknown
3435,1,1,Nodal Stage,N0
3435,1,1,Tumor Stage,T1
3435,1,1,Occurrence #,1st primary
3436,1,1,Tumor Stage,T4a
3436,1,1,Clinical lab p16,p16 unknown
3436,1,1,Occurrence #,other primary
3436,1,1,Research lab p16,p16 unknown
3436,1,1,Status,Dead w/ disease
3436,1,1,Overall Stage,IVa
3436,1,1,Tumor Site,oral cavity
3436,1,1,Nodal Stage,N2
3436,1,1,Metastasis,M0
3436,1,1,Second Failure Type,no known failure
3436,1,1,Research lab HPV,HPV unknown
3436,1,1,First Failure Type,no known failure
3436,1,1,Treatment Modality,Sx
3437,1,1,Second Failure Type,no known failure
3437,1,1,Nodal Stage,N0
3437,1,1,Occurrence #,other primary
3437,1,1,Metastasis,M0
3437,1,1,Tumor Stage,T4a
3437,1,1,Overall Stage,IVa
3437,1,1,Tumor Site,oral cavity
3437,1,1,First Failure Type,no known failure
3437,1,1,Research lab p16,p16 unknown
3437,1,1,Clinical lab p16,p16 unknown
3437,1,1,Status,Dead w/o disease
3437,1,1,Treatment Modality,Sx
3437,1,1,Research lab HPV,HPV unknown
3438,1,1,Research lab HPV,HPV unknown
3438,1,1,First Failure Type,no known failure
3438,1,1,Treatment Modality,Sx
3438,1,1,Nodal Stage,N0
3438,1,1,Second Failure Type,no known failure
3438,1,1,Occurrence #,1st primary
3438,1,1,Tumor Site,oral cavity
3438,1,1,Metastasis,M0
3438,1,1,Clinical lab p16,p16 unknown
3438,1,1,Research lab p16,p16 unknown
3438,1,1,Overall Stage,II
3438,1,1,Status,Dead w/o disease
3438,1,1,Tumor Stage,T2
3439,1,1,Research lab HPV,HPV unknown
3439,1,1,Clinical lab p16,p16 unknown
3439,1,1,Tumor Stage,T4a
3439,1,1,Overall Stage,IVa
3439,1,1,Research lab p16,p16 unknown
3439,1,1,Nodal Stage,N0
3439,1,1,Occurrence #,other primary
3439,1,1,Treatment Modality,Sx
3439,1,1,Tumor Site,oropharynx
3439,1,1,Metastasis,M0
3439,1,1,First Failure Type,no known failure
3439,1,1,Second Failure Type,no known failure
3439,1,1,Status,Dead w/ disease
3440,1,1,Overall Stage,III
3440,1,1,Occurrence #,1st primary
3440,1,1,Research lab p16,p16 unknown
3440,1,1,Research lab HPV,HPV unknown
3440,1,1,Metastasis,M0
3440,1,1,Tumor Site,oral cavity
3440,1,1,Treatment Modality,Sx
3440,1,1,Clinical lab p16,p16 unknown
3440,1,1,Status,Dead w/ disease
3440,1,1,Second Failure Type,no known failure
3440,1,1,Nodal Stage,N2
3440,1,1,First Failure Type,no known failure
3440,1,1,Tumor Stage,T2
3441,1,1,First Failure Site,oral cavity
3441,1,1,Second Failure Type,no known failure
3441,1,1,Research lab HPV,HPV unknown
3441,1,1,Metastasis,M0
3441,1,1,Tumor Stage,T2
3441,1,1,First Failure Treatment Modality,Sx
3441,1,1,Research lab p16,p16 unknown
3441,1,1,Nodal Stage,N0
3441,1,1,Clinical lab p16,p16 unknown
3441,1,1,Tumor Site,oral cavity
3441,1,1,Occurrence #,1st primary
3441,1,1,First Failure Type,no known failure
3441,1,1,Overall Stage,II
3441,1,1,Treatment Modality,Sx
3441,1,1,Status,Dead w/o disease
3442,1,1,Treatment Modality,Sx
3442,1,1,Status,Dead w/o disease
3442,1,1,Metastasis,Unknown
3442,1,1,Research lab HPV,HPV unknown
3442,1,1,First Failure Type,no known failure
3442,1,1,Overall Stage,Unknown
3442,1,1,Occurrence #,1st primary
3442,1,1,Clinical lab p16,p16 unknown
3442,1,1,Tumor Site,oropharynx
3442,1,1,Research lab p16,p16 unknown
3442,1,1,Tumor Stage,Unknown
3442,1,1,Second Failure Type,no known failure
3442,1,1,Nodal Stage,Unknown
3443,1,1,Research lab HPV,HPV unknown
3443,1,1,Overall Stage,IVa
3443,1,1,Clinical lab p16,p16 unknown
3443,1,1,Status,Dead w/o disease
3443,1,1,Research lab p16,p16 unknown
3443,1,1,Tumor Site,oral cavity
3443,1,1,Treatment Modality,Sx
3443,1,1,Second Failure Type,no known failure
3443,1,1,Occurrence #,1st primary
3443,1,1,Metastasis,M0
3443,1,1,First Failure Type,no known failure
3443,1,1,Tumor Stage,T4a
3443,1,1,Nodal Stage,N0
3444,1,1,Clinical lab p16,p16 unknown
3444,1,1,Status,Dead w/ disease
3444,1,1,First Failure Type,no known failure
3444,1,1,Nodal Stage,N2
3444,1,1,Second Failure Type,no known failure
3444,1,1,Occurrence #,1st primary
3444,1,1,Initial Chemotherapy Agent,cis
3444,1,1,Tumor Stage,T4a
3444,1,1,Overall Stage,IVa
3444,1,1,Treatment Modality,CTX-RT
3444,1,1,Tumor Site,oropharynx
3444,1,1,Metastasis,M0
3444,1,1,Research lab p16,p16 unknown
3444,1,1,Research lab HPV,HPV unknown
3444,1,1,Radiation Dosage,70.2
3445,1,1,Research lab p16,p16 unknown
3445,1,1,Second Failure Type,no known failure
3445,1,1,Occurrence #,1st primary
3445,1,1,Status,Dead w/o disease
3445,1,1,First Failure Type,no known failure
3445,1,1,Clinical lab p16,p16 unknown
3445,1,1,Overall Stage,IVa
3445,1,1,Treatment Modality,Sx
3445,1,1,Metastasis,M0
3445,1,1,Research lab HPV,HPV unknown
3445,1,1,Tumor Site,oral cavity
3445,1,1,Tumor Stage,T4a
3445,1,1,Nodal Stage,N0
3446,1,1,Tumor Stage,T2
3446,1,1,Second Failure Type,no known failure
3446,1,1,Occurrence #,1st primary
3446,1,1,Nodal Stage,N0
3446,1,1,Overall Stage,II
3446,1,1,Status,Dead w/o disease
3446,1,1,Metastasis,M0
3446,1,1,Tumor Site,oral cavity
3446,1,1,Clinical lab p16,p16 unknown
3446,1,1,Research lab HPV,HPV unknown
3446,1,1,First Failure Type,no known failure
3446,1,1,Treatment Modality,Sx
3446,1,1,Research lab p16,p16 unknown
3447,1,1,Research lab HPV,HPV unknown
3447,1,1,Status,Dead w/ disease
3447,1,1,Nodal Stage,N1
3447,1,1,Metastasis,M0
3447,1,1,Treatment Modality,Sx
3447,1,1,Tumor Site,oral cavity
3447,1,1,First Failure Type,no known failure
3447,1,1,Tumor Stage,T2
3447,1,1,Research lab p16,p16 unknown
3447,1,1,Second Failure Type,no known failure
3447,1,1,Occurrence #,1st primary
3447,1,1,Overall Stage,III
3447,1,1,Clinical lab p16,p16 unknown
3448,1,1,First Failure Type,no known failure
3448,1,1,Status,Dead w/o disease
3448,1,1,Second Failure Type,no known failure
3448,1,1,Tumor Stage,T4a
3448,1,1,Nodal Stage,N0
3448,1,1,Research lab p16,p16 unknown
3448,1,1,Overall Stage,IVa
3448,1,1,Tumor Site,oral cavity
3448,1,1,Research lab HPV,HPV unknown
3448,1,1,Clinical lab p16,p16 unknown
3448,1,1,Occurrence #,recurrence
3448,1,1,Metastasis,M0
3448,1,1,Treatment Modality,Sx
3449,1,1,Tumor Site,oral cavity
3449,1,1,Overall Stage,IVb
3449,1,1,Research lab p16,p16 unknown
3449,1,1,Status,Dead w/ disease
3449,1,1,Tumor Stage,T4a
3449,1,1,Occurrence #,recurrence
3449,1,1,First Failure Type,no known failure
3449,1,1,Treatment Modality,Sx
3449,1,1,Clinical lab p16,p16 unknown
3449,1,1,Second Failure Type,no known failure
3449,1,1,Nodal Stage,N2
3449,1,1,Research lab HPV,HPV unknown
3449,1,1,Metastasis,M0
3450,1,1,Status,Dead w/o disease
3450,1,1,Tumor Site,oral cavity
3450,1,1,Second Failure Type,no known failure
3450,1,1,Occurrence #,1st primary
3450,1,1,Research lab HPV,HPV unknown
3450,1,1,Tumor Stage,T1
3450,1,1,Clinical lab p16,p16 unknown
3450,1,1,Research lab p16,p16 unknown
3450,1,1,Treatment Modality,Sx
3450,1,1,First Failure Type,no known failure
3450,1,1,Metastasis,M0
3450,1,1,Overall Stage,III
3450,1,1,Nodal Stage,N2
3451,1,1,First Failure Type,no known failure
3451,1,1,Status,Dead w/o disease
3451,1,1,Tumor Stage,T4a
3451,1,1,Nodal Stage,N2
3451,1,1,Second Failure Type,no known failure
3451,1,1,Metastasis,M0
3451,1,1,Overall Stage,IVa
3451,1,1,Occurrence #,1st primary
3451,1,1,Tumor Site,oral cavity
3451,1,1,Clinical lab p16,p16 unknown
3451,1,1,Research lab HPV,HPV unknown
3451,1,1,Treatment Modality,Sx
3451,1,1,Research lab p16,p16 unknown
3452,1,1,First Failure Type,no known failure
3452,1,1,Status,Dead w/ disease
3452,1,1,Treatment Modality,Sx
3452,1,1,Research lab HPV,HPV unknown
3452,1,1,Clinical lab p16,p16 unknown
3452,1,1,Research lab p16,p16 unknown
3452,1,1,Overall Stage,IVa
3452,1,1,Metastasis,M0
3452,1,1,Nodal Stage,N2
3452,1,1,Tumor Stage,T4a
3452,1,1,Second Failure Type,no known failure
3452,1,1,Tumor Site,oral cavity
3452,1,1,Occurrence #,1st primary
3453,1,1,First Failure Type,no known failure
3453,1,1,Occurrence #,1st primary
3453,1,1,Tumor Site,oral cavity
3453,1,1,Tumor Stage,T4a
3453,1,1,Nodal Stage,N0
3453,1,1,Metastasis,M0
3453,1,1,Overall Stage,IVa
3453,1,1,Research lab p16,p16 unknown
3453,1,1,Clinical lab p16,p16 unknown
3453,1,1,Research lab HPV,HPV unknown
3453,1,1,Treatment Modality,Sx
3453,1,1,Second Failure Type,no known failure
3453,1,1,Status,Dead w/o disease
